Details of the Probe

General Information of Probe

Probe ID
LDPC0068
Probe Name
DBIA
Probe Type
ABPP Probe
Structure
2D MOL
Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 424.283
Lipid-water partition coefficient (xlogp) 0.6742
Rotatable Bond Count (rotbonds) 10
Hydrogen Bond Donor Count (hbonddonor) 4
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C14H25IN4O3
Canonical SMILES
CC1NC(=O)NC1CCCCCC(=O)NCCNC(=O)CI
InChI
InChI=1S/C14H25IN4O3/c1-10-11(19-14(22)18-10)5-3-2-4-6-12(20)16-7-8-17-13(21)9-15/h10-11H,2-9H2,1H3,(H,16,20)(H,17,21)(H2,18,19,22)
InChIKey
ASKKBTGJVCEXOA-UHFFFAOYSA-N

The Probe Interaction Atlas

Target(s) List of this Probe

4048 Enzyme Labeled by This Probe
Target Name Target ID Binding Site(Ratio) Interaction ID
(3R)-3-hydroxyacyl-CoA dehydrogenase (HSD17B8) LDTP09770 C147(1.13)  LDD0080 
(E2-independent) E3 ubiquitin-conjugating enzyme FATS (C10orf90) LDTP10568 C130(3.95)  LDD3430 
(E3-independent) E2 ubiquitin-conjugating enzyme (UBE2O) LDTP11601 C375(1.22); C370(1.20); C910(1.17); C913(1.17)  LDD0078 
(Lyso)-N-acylphosphatidylethanolamine lipase (ABHD4) LDTP09326 C38(0.94)  LDD3353 
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (CYP24A1) LDTP05541 C512(1.38)  LDD0533 
1,4-alpha-glucan-branching enzyme (GBE1) LDTP05419 C81(0.85); C88(0.85)  LDD0078 
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (AGPAT1) LDTP11012 C229(1.13)  LDD0531 
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (AGPAT2) LDTP00543 C248(1.20)  LDD3367 
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (AGPAT4) LDTP12550 C175(1.30)  LDD0531 
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (AGPAT5) LDTP12639 C217(1.12); C252(0.96)  LDD0531 
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (AGPAT3) LDTP12551 C274(1.34)  LDD3312 
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (ABHD5) LDTP09542 C140(0.95)  LDD0531 
1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACCS) LDTP15815 C468(1.39)  LDD3334 
1-phosphatidylinositol 3-phosphate 5-kinase (PIKFYVE) LDTP13873 C161(1.25)  LDD0080 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (PLCB1) LDTP12397 C1049(1.19)  LDD3323 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (PLCB2) LDTP05256 C429(3.54)  LDD3310 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (PLCB3) LDTP05327 C358(1.00)  LDD0531 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (PLCB4) LDTP06329 C380(2.55)  LDD3311 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (PLCD1) LDTP04410 C96(1.99)  LDD3312 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (PLCD3) LDTP08828 C699(0.98)  LDD0531 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (PLCD4) LDTP11105 C490(1.19)  LDD2252 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (PLCE1) LDTP13011 C441(5.19)  LDD3373 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 (PLCH1) LDTP06856 C1074(3.83); C1079(3.83)  LDD0080 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (PLCG1) LDTP02984 C247(1.47); C881(1.77)  LDD3311 
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (PLCG2) LDTP02867 C791(1.12)  LDD0080 
11-beta-hydroxysteroid dehydrogenase 1 (HSD11B1) LDTP03456 C241(1.96)  LDD3389 
11-beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) LDTP05161 C264(1.37)  LDD0533 
116 kDa U5 small nuclear ribonucleoprotein component (EFTUD2) LDTP06286 C144(1.08); C166(0.89)  LDD0078 
12S rRNA N4-methylcytidine (m4C) methyltransferase (METTL15) LDTP00108 C172(0.91)  LDD1187 
14 kDa phosphohistidine phosphatase (PHPT1) LDTP12543 C69(1.53)  LDD0078 
15-hydroxyprostaglandin dehydrogenase [NAD(+)] (HPGD) LDTP02788 C61(3.31)  LDD3314 
17-beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) LDTP02708 C55(1.65); C157(3.68)  LDD2282 
17-beta-hydroxysteroid dehydrogenase type 2 (HSD17B2) LDTP03835 C99(1.29); C188(1.48)  LDD3368 
18S rRNA aminocarboxypropyltransferase (TSR3) LDTP16211 C284(1.47); C283(0.88)  LDD0078 
2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) LDTP02356 C111(0.90)  LDD0078 
2',5'-phosphodiesterase 12 (PDE12) LDTP07447 C108(1.10); C119(1.10); C268(0.89); C277(0.89)  LDD0078 
2'-5'-oligoadenylate synthase 1 (OAS1) LDTP01808 C54(1.47); C38(0.96)  LDD3310 
2'-5'-oligoadenylate synthase 2 (OAS2) LDTP03500 C108(37.16)  LDD0209 
2'-5'-oligoadenylate synthase 3 (OAS3) LDTP14266 C648(1.30); C444(0.86); C449(0.86)  LDD0078 
2'-5'-oligoadenylate synthase-like protein (OASL) LDTP06433 C181(0.92); C188(0.92)  LDD0078 
2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial (DECR1) LDTP06612 C86(7.65)  LDD0209 
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (DPH1) LDTP11537 C428(1.13); C431(1.13)  LDD0078 
2-5A-dependent ribonuclease (RNASEL) LDTP05464 C301(1.06)  LDD0078 
2-acylglycerol O-acyltransferase 2 (MOGAT2) LDTP06799 C313(3.90)  LDD2269 
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (GCAT) LDTP01268 C404(34.90)  LDD0204 
2-aminoethanethiol dioxygenase (ADO) LDTP10828 C18(0.97); C239(0.87)  LDD0078 
2-aminomuconic semialdehyde dehydrogenase (ALDH8A1) LDTP11805 C247(1.56)  LDD2252 
2-Hydroxyacid oxidase 1 (HAO1) LDTP13389 C7(2.47)  LDD3442 
2-hydroxyacyl-CoA lyase 1 (HACL1) LDTP13375 C261(1.22)  LDD3310 
2-hydroxyacyl-CoA lyase 2 (ILVBL) LDTP00032 C354(0.99); C608(0.86)  LDD0078 
2-iminobutanoate/2-iminopropanoate deaminase (RIDA) LDTP04529 C71(3.83)  LDD3312 
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (COQ5) LDTP06988 C170(95.80)  LDD0209 
2-oxoadipate dehydrogenase complex component E1 (DHTKD1) LDTP10404 C383(0.89)  LDD0078 
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (OGFOD2) LDTP15090 C51(5.86)  LDD0209 
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (OGFOD3) LDTP15132 C103(1.57)  LDD3333 
2-oxoglutarate and iron-dependent oxygenase JMJD4 (JMJD4) LDTP12112 C249(0.88)  LDD0813 
2-oxoglutarate dehydrogenase complex component E1 (OGDH) LDTP05341 C395(1.52)  LDD0080 
2-oxoglutarate dehydrogenase-like, mitochondrial (OGDHL) LDTP13536 C553(15.31)  LDD0209 
2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (BCKDHA) LDTP02627 C197(2.92)  LDD0080 
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (BCKDHB) LDTP03144 C235(0.93); C177(0.87)  LDD0078 
2-phosphoxylose phosphatase 1 (PXYLP1) LDTP09486 C116(1.03)  LDD1508 
26S proteasome non-ATPase regulatory subunit 1 (PSMD1) LDTP10869 C898(0.94)  LDD0078 
26S proteasome non-ATPase regulatory subunit 12 (PSMD12) LDTP00224 C255(0.90)  LDD0078 
26S proteasome non-ATPase regulatory subunit 13 (PSMD13) LDTP13667 C357(0.99)  LDD0078 
26S proteasome non-ATPase regulatory subunit 14 (PSMD14) LDTP00294 C238(1.76)  LDD0080 
26S proteasome non-ATPase regulatory subunit 2 (PSMD2) LDTP05782 C251(0.89); C448(0.87)  LDD0078 
26S proteasome non-ATPase regulatory subunit 3 (PSMD3) LDTP00714 C483(1.71)  LDD0080 
26S proteasome non-ATPase regulatory subunit 4 (PSMD4) LDTP04655 C37(1.19); C87(1.42)  LDD0531 
26S proteasome non-ATPase regulatory subunit 5 (PSMD5) LDTP06532 C290(0.78); C412(0.79); C64(0.92)  LDD0531 
26S proteasome non-ATPase regulatory subunit 7 (PSMD7) LDTP04441 C116(1.06)  LDD0078 
26S proteasome non-ATPase regulatory subunit 8 (PSMD8) LDTP04196 C173(1.02)  LDD0078 
26S proteasome non-ATPase regulatory subunit 9 (PSMD9) LDTP00225 C59(1.09)  LDD0078 
26S proteasome regulatory subunit 10B (PSMC6) LDTP04987 C170(0.90); C193(0.88); C228(0.86)  LDD0078 
26S proteasome regulatory subunit 4 (PSMC1) LDTP04962 C399(1.15)  LDD0078 
26S proteasome regulatory subunit 6A (PSMC3) LDTP02933 C387(0.89); C396(0.89)  LDD0078 
26S proteasome regulatory subunit 6B (PSMC4) LDTP04061 C210(0.95); C379(0.90)  LDD0078 
26S proteasome regulatory subunit 7 (PSMC2) LDTP03797 C180(0.89)  LDD0078 
26S proteasome regulatory subunit 8 (PSMC5) LDTP04963 C209(1.01)  LDD0078 
28S rRNA (cytosine-C(5))-methyltransferase (NSUN5) LDTP10649 C41(5.35)  LDD3312 
3 beta-hydroxysteroid dehydrogenase type 7 (HSD3B7) LDTP11816 C161(2.77)  LDD3347 
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 (HSD3B1) LDTP02707 C183(1.95)  LDD2282 
3'(2'),5'-bisphosphate nucleotidase 1 (BPNT1) LDTP01697 C243(1.33); C59(1.76); C206(1.93); C45(1.99)  LDD3312 
3',5'-cyclic-AMP phosphodiesterase 4B (PDE4B) LDTP05519 C671(1.15)  LDD0532 
3',5'-cyclic-AMP phosphodiesterase 4D (PDE4D) LDTP05566 C53(3.20)  LDD3318 
3'-5' exoribonuclease 1 (ERI1) LDTP08482 C294(31.69); C314(46.29); C243(6.55); C314(14.85)  LDD0209 
3'-5' exoribonuclease HELZ2 (HELZ2) LDTP11467 C829(1.23); C831(1.23); C821(1.14); C103(1.13)  LDD0078 
3'-5' RNA helicase YTHDC2 (YTHDC2) LDTP11996 C25(1.13)  LDD0078 
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) LDTP02000 C620(1.45); C903(3.26)  LDD3360 
3-hydroxyacyl-CoA dehydrogenase type-2 (HSD17B10) LDTP10954 C214(0.90)  LDD0078 
3-hydroxyanthranilate 3,4-dioxygenase (HAAO) LDTP04118 C23(1.27)  LDD3333 
3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) LDTP03611 C75(1.12)  LDD3310 
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (HIBCH) LDTP07483 C95(0.99); C45(0.96)  LDD0531 
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (HSD17B7) LDTP04768 C32(0.83); C35(0.83)  LDD0531 
3-ketoacyl-CoA thiolase, mitochondrial (ACAA2) LDTP03998 C103(0.87); C107(0.87); C92(0.87)  LDD0078 
3-ketoacyl-CoA thiolase, peroxisomal (ACAA1) LDTP02329 C123(1.07); C218(0.96); C381(0.90)  LDD0078 
3-ketodihydrosphingosine reductase (KDSR) LDTP05476 C121(20.00)  LDD0080 
3-mercaptopyruvate sulfurtransferase (MPST) LDTP03319 C65(1.66)  LDD0533 
3-oxoacyl-[acyl-carrier-protein] reductase (CBR4) LDTP08877 C55(1.44)  LDD3312 
3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (OXSM) LDTP12734 C86(6.61)  LDD0209 
3-phosphoinositide-dependent protein kinase 1 (PDPK1) LDTP00670 C21(1.08); C23(1.08)  LDD0078 
4'-phosphopantetheine phosphatase (PANK4) LDTP12673 C537(0.97)  LDD0078 
4-aminobutyrate aminotransferase, mitochondrial (ABAT) LDTP05163 C224(1.31)  LDD3313 
4-hydroxy-2-oxoglutarate aldolase, mitochondrial (HOGA1) LDTP08356 C302(1.68)  LDD3399 
4-hydroxybenzoate polyprenyltransferase, mitochondrial (COQ2) LDTP10377 C127(0.91)  LDD0531 
4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) LDTP10424 C9(1.99)  LDD3364 
4-trimethylaminobutyraldehyde dehydrogenase (ALDH9A1) LDTP04232 C288(1.17); C289(1.17)  LDD0078 
5' exonuclease Apollo (DCLRE1B) LDTP12044 C416(1.02); C238(1.14)  LDD1507 
5'(3')-deoxyribonucleotidase, cytosolic type (NT5C) LDTP09379 C165(1.27); C166(1.27)  LDD0080 
5'-3' DNA helicase ZGRF1 (ZGRF1) LDTP08392 C1250(0.98)  LDD0547 
5'-3' exonuclease PLD3 (PLD3) LDTP08476 C366(2.03)  LDD0080 
5'-3' exonuclease PLD4 (PLD4) LDTP10149 C313(0.89)  LDD3339 
5'-3' exoribonuclease 1 (XRN1) LDTP08701 C398(1.15)  LDD0078 
5'-3' exoribonuclease 2 (XRN2) LDTP11701 C557(0.89)  LDD0078 
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1) LDTP05761 C185(7.46)  LDD0209 
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2) LDTP04620 C200(7.97)  LDD3310 
5'-AMP-activated protein kinase subunit beta-1 (PRKAB1) LDTP14027 C223(1.70)  LDD3337 
5'-AMP-activated protein kinase subunit beta-2 (PRKAB2) LDTP00853 C178(1.03)  LDD0078 
5'-AMP-activated protein kinase subunit gamma-1 (PRKAG1) LDTP04619 C6(4.01)  LDD3310 
5'-AMP-activated protein kinase subunit gamma-2 (PRKAG2) LDTP13229 C29(2.54)  LDD3310 
5'-deoxynucleotidase HDDC2 (HDDC2) LDTP15251 C82(1.63)  LDD3332 
5'-nucleotidase (NT5E) LDTP03120 C353(0.96)  LDD0531 
5'-nucleotidase domain-containing protein 1 (NT5DC1) LDTP17247 C119(1.64)  LDD0078 
5'-nucleotidase domain-containing protein 2 (NT5DC2) LDTP18414 C504(6.51); C507(6.51)  LDD0080 
5'-nucleotidase domain-containing protein 3 (NT5DC3) LDTP15290 C276(1.30)  LDD0080 
5,6-dihydroxyindole-2-carboxylic acid oxidase (TYRP1) LDTP02910 C521(2.12)  LDD3332 
5-aminolevulinate synthase, non-specific, mitochondrial (ALAS1) LDTP02647 C124(2.74); C249(14.23)  LDD0080 
5-demethoxyubiquinone hydroxylase, mitochondrial (COQ7) LDTP10984 C207(1.00); C137(0.97)  LDD1492 
5-formyltetrahydrofolate cyclo-ligase (MTHFS) LDTP04332 C160(0.84)  LDD0531 
5-hydroxymethyl-dUMP N-hydrolase (DNPH1) LDTP00813 C26(2.15)  LDD3310 
5-methylcytosine rRNA methyltransferase NSUN4 (NSUN4) LDTP10167 C196(1.78); C197(1.78)  LDD0080 
5-oxoprolinase (OPLAH) LDTP00456 C910(141.50)  LDD0209 
5-phosphohydroxy-L-lysine phospho-lyase (PHYKPL) LDTP08474 C443(0.85)  LDD3336 
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (PFKFB2) LDTP01055 C430(1.06)  LDD0078 
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) LDTP06654 C102(2.88)  LDD0080 
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) LDTP06655 C29(1.94)  LDD0080 
6-phosphogluconate dehydrogenase, decarboxylating (PGD) LDTP04499 C402(1.24)  LDD0078 
6-phosphogluconolactonase (PGLS) LDTP14535 C32(1.42); C33(1.14); C237(0.88)  LDD0078 
6-pyruvoyl tetrahydrobiopterin synthase (PTS) LDTP05401 C10(0.96); C43(1.02)  LDD0531 
60 kDa heat shock protein, mitochondrial (HSPD1) LDTP02522 C442(1.01)  LDD0078 
7-dehydrocholesterol reductase (DHCR7) LDTP13131 C380(8.90); C368(18.76)  LDD0209 
7-methylguanosine phosphate-specific 5'-nucleotidase (NT5C3B) LDTP10032 C210(1.43)  LDD0080 
72 kDa type IV collagenase (MMP2) LDTP02267 C60(1.58)  LDD3332 
7SK snRNA methylphosphate capping enzyme (MEPCE) LDTP07948 C419(1.10); C522(1.05); C324(0.98); C54(0.97)  LDD0078 
A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1) LDTP13287 C333(4.07)  LDD0080 
A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) LDTP04814 C673(0.82)  LDD0532 
A disintegrin and metalloproteinase with thrombospondin motifs 14 (ADAMTS14) LDTP09717 C955(1.34)  LDD3439 
A disintegrin and metalloproteinase with thrombospondin motifs 15 (ADAMTS15) LDTP09477 C480(1.04)  LDD1507 
A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAMTS16) LDTP09476 C1138(1.42); C1142(1.42); C927(1.30); C939(1.30)  LDD0078 
A disintegrin and metalloproteinase with thrombospondin motifs 17 (ADAMTS17) LDTP09475 C609(1.79)  LDD3427 
A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) LDTP09479 C958(2.97)  LDD3380 
A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAMTS2) LDTP01605 C517(1.28); C526(1.28); C655(1.11); C659(1.11)  LDD0078 
A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAMTS3) LDTP00529 C1047(0.92)  LDD0531 
A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) LDTP13649 C209(1.54); C594(1.77)  LDD3401 
A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAMTS6) LDTP13474 C565(3.16)  LDD3312 
A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAMTS9) LDTP13069 C368(2.10)  LDD2469 
AarF domain-containing protein kinase 1 (ADCK1) LDTP08208 C481(1.66)  LDD0531 
Abasic site processing protein HMCES (HMCES) LDTP10322 C97(1.39)  LDD0080 
ABC-type organic anion transporter ABCA8 (ABCA8) LDTP01459 C563(2.35); C1312(1.41)  LDD3312 
Acetoacetyl-CoA synthetase (AACS) LDTP15291 C487(1.17); C493(1.17)  LDD0078 
Acetyl-CoA acetyltransferase, cytosolic (ACAT2) LDTP11321 C65(2.00); C148(2.40); C158(2.40); C88(2.15)  LDD0080 
Acetyl-CoA acetyltransferase, mitochondrial (ACAT1) LDTP03291 C413(1.06); C119(1.00)  LDD0078 
Acetyl-CoA carboxylase 1 (ACACA) LDTP05742 C1297(66.51); C743(18.14)  LDD0209 
Acetyl-CoA carboxylase 2 (ACACB) LDTP00342 C1412(1.72)  LDD0080 
Acetyl-coenzyme A synthetase 2-like, mitochondrial (ACSS1) LDTP12622 C30(2.17); C422(2.09)  LDD3312 
Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2) LDTP12463 C104(3.49)  LDD3314 
Acid sphingomyelinase-like phosphodiesterase 3b (SMPDL3B) LDTP09764 C177(1.74)  LDD0532 
Acireductone dioxygenase (ADI1) LDTP11268 C70(1.04)  LDD0078 
Aconitate hydratase, mitochondrial (ACO2) LDTP10982 C448(5.21); C451(2.33); C385(2.03)  LDD0080 
Actin maturation protease (ACTMAP) LDTP06950 C338(1.02); C349(1.02)  LDD0078 
Actin, alpha skeletal muscle (ACTA1) LDTP05073 C219(0.97)  LDD1492 
Actin, aortic smooth muscle (ACTA2) LDTP04999 C219(2.42)  LDD3314 
Actin, cytoplasmic 1 (ACTB) LDTP04876 C257(1.15); C272(1.15)  LDD0078 
Actin, cytoplasmic 2 (ACTG1) LDTP05059 C917(1.10)  LDD3311 
Actin-histidine N-methyltransferase (SETD3) LDTP08206 C295(0.77); C297(0.77); C36(1.16)  LDD0531 
Activated CDC42 kinase 1 (TNK2) LDTP05537 C882(4.33); C458(2.21)  LDD3311 
Activating signal cointegrator 1 complex subunit 3 (ASCC3) LDTP08826 C310(1.16); C2101(1.13); C1315(0.97); C225(0.97)  LDD0078 
Activin receptor type-1 (ACVR1) LDTP05435 C477(1.22)  LDD0531 
Activin receptor type-1B (ACVR1B) LDTP03822 C448(0.99); C476(0.78); C417(1.00); C172(0.96)  LDD1492 
Activin receptor type-1C (ACVR1C) LDTP09169 C517(2.94)  LDD3339 
Activin receptor type-2A (ACVR2A) LDTP03379 C474(2.60)  LDD3356 
Activin receptor type-2B (ACVR2B) LDTP05970 C49(0.99); C473(1.01); C288(0.95)  LDD1492 
Acyl-CoA (8-3)-desaturase (FADS1) LDTP00968 C407(3.33)  LDD3310 
Acyl-CoA dehydrogenase family member 10 (ACAD10) LDTP07435 C427(1.97); C109(1.27)  LDD3312 
Acyl-CoA dehydrogenase family member 11 (ACAD11) LDTP07873 C953(3.61)  LDD3310 
Acyl-CoA synthetase short-chain family member 3, mitochondrial (ACSS3) LDTP11992 C498(1.45)  LDD3312 
Acyl-coenzyme A diphosphatase FITM2 (FITM2) LDTP08943 C7(6.58)  LDD0209 
Acyl-coenzyme A diphosphatase NUDT19 (NUDT19) LDTP00150 C219(0.92); C220(0.92)  LDD0532 
Acyl-coenzyme A synthetase ACSM2B, mitochondrial (ACSM2B) LDTP07310 C188(2.83)  LDD3424 
Acyl-coenzyme A synthetase ACSM3, mitochondrial (ACSM3) LDTP06894 C349(2.10)  LDD3314 
Acyl-coenzyme A thioesterase 11 (ACOT11) LDTP09707 C368(81.67)  LDD0209 
Acyl-coenzyme A thioesterase 13 (ACOT13) LDTP12375 C74(1.14); C40(1.05)  LDD3312 
Acyl-coenzyme A thioesterase 2, mitochondrial (ACOT2) LDTP04291 C401(0.91)  LDD0078 
Acyl-coenzyme A thioesterase 8 (ACOT8) LDTP00415 C275(9.05)  LDD0209 
Acyl-coenzyme A thioesterase 9, mitochondrial (ACOT9) LDTP16274 C308(1.66)  LDD3310 
Acyl-coenzyme A thioesterase MBLAC2 (MBLAC2) LDTP07323 C176(0.97)  LDD1508 
Acyl-coenzyme A thioesterase THEM4 (THEM4) LDTP07094 C46(1.10)  LDD0531 
Acyl-protein thioesterase 1 (LYPLA1) LDTP01273 C169(0.42); C173(0.42)  LDD0563 
Acyl-protein thioesterase 2 (LYPLA2) LDTP01573 C171(1.08); C56(0.66)  LDD0531 
Acylamino-acid-releasing enzyme (APEH) LDTP02693 C30(0.95); C312(1.04)  LDD0531 
Acylglycerol kinase, mitochondrial (AGK) LDTP06905 C34(0.99)  LDD0078 
Acyloxyacyl hydrolase (AOAH) LDTP03410 C249(2.33)  LDD3370 
Acylphosphatase-2 (ACYP2) LDTP14633 C22(0.97)  LDD0078 
Acylpyruvase FAHD1, mitochondrial (FAHD1) LDTP07540 C22(1.90); C129(1.48)  LDD3310 
ADAMTS-like protein 2 (ADAMTSL2) LDTP08196 C74(2.24)  LDD3390 
ADAMTS-like protein 4 (ADAMTSL4) LDTP07725 C474(0.68); C484(0.54)  LDD1093 
Adenine DNA glycosylase (MUTYH) LDTP13341 C514(143.62)  LDD0209 
Adenine nucleotide translocase lysine N-methyltransferase (ANTKMT) LDTP11073 C128(1.64)  LDD0080 
Adenine phosphoribosyltransferase (APRT) LDTP02220 C83(1.00)  LDD0593 
Adenosine 5'-monophosphoramidase HINT1 (HINT1) LDTP04306 C84(0.97); C38(0.92)  LDD0078 
Adenosine 5'-monophosphoramidase HINT2 (HINT2) LDTP11356 C75(1.60)  LDD3312 
Adenosine 5'-monophosphoramidase HINT3 (HINT3) LDTP12415 C66(1.81); C73(1.81); C16(2.37); C32(2.37)  LDD0080 
Adenosine deaminase (ADA) LDTP01803 C75(1.19)  LDD0078 
Adenosine deaminase 2 (ADA2) LDTP12911 C408(2.15)  LDD3338 
Adenosine deaminase-like protein (ADAL) LDTP07363 C66(1.12)  LDD1507 
Adenosine kinase (ADK) LDTP04689 C353(1.28)  LDD0078 
Adenosylhomocysteinase (AHCY) LDTP03242 C421(1.10); C195(1.06)  LDD0078 
Adenosylhomocysteinase 3 (AHCYL2) LDTP10394 C373(1.03); C374(1.03)  LDD0078 
Adenylate cyclase type 2 (ADCY2) LDTP05562 C366(2.16)  LDD2359 
Adenylate cyclase type 3 (ADCY3) LDTP00932 C479(1.48)  LDD0532 
Adenylate cyclase type 4 (ADCY4) LDTP09210 C912(2.17)  LDD3410 
Adenylate cyclase type 5 (ADCY5) LDTP01639 C64(0.25)  LDD3436 
Adenylate cyclase type 6 (ADCY6) LDTP00738 C63(1.23)  LDD0078 
Adenylate cyclase type 7 (ADCY7) LDTP04478 C1068(0.88)  LDD0078 
Adenylate cyclase type 8 (ADCY8) LDTP03880 C517(1.97)  LDD3332 
Adenylate cyclase type 9 (ADCY9) LDTP00989 C581(4.47); C583(4.47)  LDD0080 
Adenylate kinase 2, mitochondrial (AK2) LDTP04636 C40(0.85); C42(0.85)  LDD0078 
Adenylate kinase 4, mitochondrial (AK4) LDTP03381 C22(20.28)  LDD3310 
Adenylate kinase isoenzyme 1 (AK1) LDTP01788 C187(2.51)  LDD3316 
Adenylate kinase isoenzyme 5 (AK5) LDTP14267 C627(1.39)  LDD3311 
Adenylate kinase isoenzyme 6 (AK6) LDTP13984 C81(0.95)  LDD0078 
Adenylosuccinate lyase (ADSL) LDTP03551 C98(2.83); C27(1.78)  LDD0080 
Adenylosuccinate synthetase isozyme 1 (ADSS1) LDTP08753 C63(2.48)  LDD3319 
Adenylosuccinate synthetase isozyme 2 (ADSS2) LDTP03541 C182(1.07); C338(0.65); C58(0.74)  LDD0531 
Adenylyltransferase and sulfurtransferase MOCS3 (MOCS3) LDTP01586 C193(1.04)  LDD0531 
Adipocyte enhancer-binding protein 1 (AEBP1) LDTP08471 C385(1.32)  LDD3332 
Adipocyte plasma membrane-associated protein (APMAP) LDTP12293 C140(1.63); C149(1.33)  LDD0531 
ADP-dependent glucokinase (ADPGK) LDTP11127 C40(1.08); C415(1.26)  LDD0531 
ADP-ribose glycohydrolase MACROD1 (MACROD1) LDTP11059 C186(3.57); C199(1.09)  LDD0080 
ADP-ribose glycohydrolase MACROD2 (MACROD2) LDTP00041 C132(3.57)  LDD3493 
ADP-ribose glycohydrolase OARD1 (OARD1) LDTP14086 C33(1.37); C38(1.37); C122(0.98)  LDD0078 
ADP-ribose pyrophosphatase, mitochondrial (NUDT9) LDTP11318 C207(1.36)  LDD0080 
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38) LDTP03458 C275(1.72)  LDD3397 
ADP-ribosylation factor 1 (ARF1) LDTP05192 C159(0.74)  LDD0532 
ADP-ribosylation factor 3 (ARF3) LDTP04907 C159(1.33)  LDD3332 
ADP-ribosylation factor 4 (ARF4) LDTP02942 C62(1.10)  LDD0078 
ADP-ribosylation factor 5 (ARF5) LDTP05193 C62(1.03)  LDD0078 
ADP-ribosylation factor 6 (ARF6) LDTP04986 C90(1.32)  LDD0080 
ADP-ribosylation factor-like protein 1 (ARL1) LDTP03900 C80(8.81); C95(8.81)  LDD0080 
ADP-ribosylation factor-like protein 13B (ARL13B) LDTP06791 C158(0.94); C165(0.94)  LDD0580 
ADP-ribosylation factor-like protein 15 (ARL15) LDTP18489 C53(1.74)  LDD3312 
ADP-ribosylation factor-like protein 16 (ARL16) LDTP05606 C86(1.34); C98(1.34)  LDD0531 
ADP-ribosylation factor-like protein 2 (ARL2) LDTP03805 C102(1.75)  LDD3310 
ADP-ribosylation factor-like protein 3 (ARL3) LDTP03806 C118(0.99)  LDD0078 
ADP-ribosylation factor-like protein 4C (ARL4C) LDTP04748 C64(1.10)  LDD1571 
ADP-ribosylation factor-like protein 5A (ARL5A) LDTP16329 C95(1.98)  LDD3311 
ADP-ribosylation factor-like protein 5B (ARL5B) LDTP15758 C132(1.08)  LDD0531 
ADP-ribosylation factor-like protein 6 (ARL6) LDTP11708 C160(1.90); C148(1.97)  LDD3331 
ADP-ribosylation factor-like protein 8A (ARL8A) LDTP10131 C158(1.01); C159(1.01); C164(0.90)  LDD0078 
ADP-ribosylation factor-like protein 8B (ARL8B) LDTP12682 C159(3.75); C158(3.50); C164(2.35)  LDD0080 
ADP-ribosylation factor-related protein 1 (ARFRP1) LDTP05982 C125(1.47)  LDD0080 
ADP-ribosylhydrolase ARH1 (ADPRH) LDTP04648 C129(1.52)  LDD3333 
ADP-ribosylhydrolase ARH3 (ADPRS) LDTP12756 C132(0.97)  LDD3314 
ADP-sugar pyrophosphatase (NUDT5) LDTP13462 C76(1.07)  LDD0080 
Adrenodoxin, mitochondrial (FDX1) LDTP02473 C155(1.05)  LDD1492 
AFG1-like ATPase (AFG1L) LDTP09600 C100(28.51)  LDD0209 
AFG3-like protein 2 (AFG3L2) LDTP14075 C313(1.01)  LDD0078 
Aflatoxin B1 aldehyde reductase member 2 (AKR7A2) LDTP00776 C214(1.28)  LDD0531 
Aflatoxin B1 aldehyde reductase member 3 (AKR7A3) LDTP01508 C214(0.93)  LDD3310 
Aflatoxin B1 aldehyde reductase member 4 (AKR7L) LDTP15563 C128(1.88)  LDD3333 
Alanine aminotransferase 1 (GPT) LDTP03270 C254(0.87)  LDD3346 
Alanine aminotransferase 2 (GPT2) LDTP09416 C142(1.02); C158(1.02)  LDD0078 
Alanine--glyoxylate aminotransferase (AGXT) LDTP03115 C366(0.96)  LDD3351 
Alanine--glyoxylate aminotransferase 2, mitochondrial (AGXT2) LDTP11497 C241(1.80)  LDD3369 
Alanine--tRNA ligase, cytoplasmic (AARS1) LDTP04262 C773(1.02); C901(0.98); C903(0.98); C671(0.89)  LDD0078 
Alanine--tRNA ligase, mitochondrial (AARS2) LDTP07015 C596(0.90); C609(0.90)  LDD0078 
Alanyl-tRNA editing protein Aarsd1 (AARSD1) LDTP11198 C266(1.00)  LDD0531 
Alcohol dehydrogenase 1C (ADH1C) LDTP01765 C47(1.68)  LDD3327 
Alcohol dehydrogenase 6 (ADH6) LDTP03434 C241(1.75); C47(1.41)  LDD3346 
Alcohol dehydrogenase class-3 (ADH5) LDTP02587 C170(1.13); C174(1.13); C100(0.95); C97(0.95)  LDD0078 
Aldehyde dehydrogenase 1A1 (ALDH1A1) LDTP01767 C370(1.71)  LDD3312 
Aldehyde dehydrogenase family 16 member A1 (ALDH16A1) LDTP15371 C249(0.92); C467(0.90)  LDD0078 
Aldehyde dehydrogenase family 3 member A2 (ALDH3A2) LDTP04437 C50(1.17)  LDD3310 
Aldehyde dehydrogenase family 3 member B1 (ALDH3B1) LDTP04036 C217(1.04); C223(1.04); C244(0.95); C252(0.95)  LDD0078 
Aldehyde dehydrogenase X, mitochondrial (ALDH1B1) LDTP03560 C169(0.89)  LDD0078 
Aldehyde dehydrogenase, dimeric NADP-preferring (ALDH3A1) LDTP03561 C344(1.06)  LDD3321 
Aldehyde dehydrogenase, mitochondrial (ALDH2) LDTP02074 C472(1.22); C179(1.30); C386(1.88)  LDD3311 
Aldehyde oxidase (AOX1) LDTP05483 C943(2.07)  LDD3340 
Aldo-keto reductase family 1 member A1 (AKR1A1) LDTP02729 C46(1.30)  LDD3318 
Aldo-keto reductase family 1 member B1 (AKR1B1) LDTP02765 C299(1.06); C81(0.89); C304(0.88)  LDD0078 
Aldo-keto reductase family 1 member B10 (AKR1B10) LDTP00912 C45(1.45)  LDD3354 
Aldo-keto reductase family 1 member B15 (AKR1B15) LDTP00174 C215(1.67)  LDD3319 
Aldo-keto reductase family 1 member C1 (AKR1C1) LDTP05436 C188(0.90); C193(0.90)  LDD0078 
Aldo-keto reductase family 1 member C2 (AKR1C2) LDTP04543 C242(0.85)  LDD3312 
Aldo-keto reductase family 1 member C3 (AKR1C3) LDTP03976 C26(1.06)  LDD3314 
Aldo-keto reductase family 1 member C4 (AKR1C4) LDTP02902 C242(0.90)  LDD3364 
ALK tyrosine kinase receptor (ALK) LDTP13611 C1182(2.25); C1354(2.34)  LDD3311 
Alkaline ceramidase 2 (ACER2) LDTP07048 C265(0.91)  LDD1511 
Alkaline phosphatase, placental type (ALPP) LDTP02100 C123(2.08)  LDD3490 
Alkaline phosphatase, tissue-nonspecific isozyme (ALPL) LDTP02099 C64(1.60)  LDD3414 
Alkylated DNA repair protein alkB homolog 8 (ALKBH8) LDTP10142 C299(3.45)  LDD3407 
Alkyldihydroxyacetonephosphate synthase, peroxisomal (AGPS) LDTP00186 C226(1.18)  LDD0078 
All trans-polyprenyl-diphosphate synthase PDSS1 (PDSS1) LDTP07104 C148(1.23); C275(1.12)  LDD0531 
All trans-polyprenyl-diphosphate synthase PDSS2 (PDSS2) LDTP08401 C132(1.38); C144(1.38)  LDD0078 
All-trans-retinol 13,14-reductase (RETSAT) LDTP15097 C105(1.06); C106(1.06); C534(0.92)  LDD0078 
All-trans-retinol dehydrogenase [NAD(+)] ADH1B (ADH1B) LDTP01764 C241(1.11)  LDD3323 
All-trans-retinol dehydrogenase [NAD(+)] ADH4 (ADH4) LDTP02272 C265(2.62); C99(1.85)  LDD3424 
All-trans-retinol dehydrogenase [NAD(+)] ADH7 (ADH7) LDTP03895 C118(1.55)  LDD3352 
Alpha-(1,3)-fucosyltransferase 11 (FUT11) LDTP06822 C103(1.59)  LDD3332 
Alpha-(1,3)-fucosyltransferase 4 (FUT4) LDTP03154 C508(1.67)  LDD3333 
Alpha-(1,6)-fucosyltransferase (FUT8) LDTP11448 C266(1.21)  LDD3312 
Alpha-1,2-mannosyltransferase ALG9 (ALG9) LDTP12002 C64(1.75)  LDD3345 
Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (MGAT1) LDTP03362 C303(3.62)  LDD3427 
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (MGAT4B) LDTP13749 C356(2.28)  LDD2347 
Alpha-1,3/1,6-mannosyltransferase ALG2 (ALG2) LDTP11946 C70(7.23)  LDD0209 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (MGAT2) LDTP05622 C378(0.89)  LDD0078 
Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (MGAT5) LDTP05593 C681(3.01)  LDD3325 
Alpha-adducin (ADD1) LDTP03770 C236(2.08); C556(1.33)  LDD3310 
Alpha-aminoadipic semialdehyde dehydrogenase (ALDH7A1) LDTP04253 C522(1.22)  LDD0078 
Alpha-aminoadipic semialdehyde synthase, mitochondrial (AASS) LDTP13186 C534(0.96)  LDD0078 
Alpha-enolase (ENO1) LDTP02159 C357(1.03)  LDD0078 
Alpha-galactosidase A (GLA) LDTP02141 C52(11.48); C63(11.48); C56(4.95); C90(6.45)  LDD0080 
Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (ALKBH3) LDTP10725 C91(1.78)  LDD0531 
Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (ALKBH4) LDTP12794 C26(2.08)  LDD0080 
Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (ALKBH6) LDTP06768 C212(0.71)  LDD1507 
Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (ALKBH7) LDTP11181 C128(1.25)  LDD1094 
Alpha-ketoglutarate-dependent dioxygenase FTO (FTO) LDTP11595 C171(0.99)  LDD0078 
Alpha-mannosidase 2 (MAN2A1) LDTP06613 C430(0.87)  LDD0531 
Alpha-mannosidase 2C1 (MAN2C1) LDTP12607 C322(1.32); C40(0.93)  LDD3310 
Alpha-mannosidase 2x (MAN2A2) LDTP04271 C1083(1.81)  LDD3325 
Alpha-methylacyl-CoA racemase (AMACR) LDTP13292 C117(1.15)  LDD3313 
Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase (ST6GALNAC4) LDTP11921 C76(0.37); C99(0.37)  LDD1093 
Alpha-N-acetylgalactosaminidase (NAGA) LDTP02883 C343(1.33)  LDD3314 
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (ST6GALNAC3) LDTP09135 C196(1.57)  LDD3419 
Alpha-N-acetylglucosaminidase (NAGLU) LDTP04634 C97(0.93); C99(0.93)  LDD0078 
Alpha-protein kinase 1 (ALPK1) LDTP10742 C326(3.16)  LDD3397 
Alpha-protein kinase 2 (ALPK2) LDTP08191 C1610(2.87)  LDD3378 
Alpha-protein kinase 3 (ALPK3) LDTP10535 C1620(1.04)  LDD0078 
Alpha-tubulin N-acetyltransferase 1 (ATAT1) LDTP07060 C298(1.02)  LDD1492 
Alpha/beta hydrolase domain-containing protein 17A (ABHD17A) LDTP10362 C101(0.95)  LDD1492 
Alpha/beta hydrolase domain-containing protein 17B (ABHD17B) LDTP07208 C39(0.97)  LDD3317 
Alpha/beta hydrolase domain-containing protein 17C (ABHD17C) LDTP07558 C122(2.30)  LDD3346 
Alpha/beta-tubulin-N-acetyltransferase 9 (NAT9) LDTP18306 C56(0.96)  LDD2419 
Amidophosphoribosyltransferase (PPAT) LDTP05480 C100(1.01); C105(1.01); C426(0.97)  LDD0078 
Amine oxidase [flavin-containing] A (MAOA) LDTP03109 C374(1.15)  LDD0547 
Amine oxidase [flavin-containing] B (MAOB) LDTP03384 C365(1.16)  LDD0531 
Aminoacylase-1 (ACY1) LDTP05395 C116(0.89)  LDD0531 
Aminomethyltransferase, mitochondrial (AMT) LDTP04208 C351(1.94); C325(1.84)  LDD3424 
Aminopeptidase B (RNPEP) LDTP15993 C254(1.03)  LDD0078 
Aminopeptidase N (ANPEP) LDTP02766 C223(2.48)  LDD3310 
Aminopeptidase Q (LVRN) LDTP07616 C250(1.06)  LDD2284 
Aminopeptidase RNPEPL1 (RNPEPL1) LDTP12140 C501(23.93)  LDD0209 
AMP deaminase 1 (AMPD1) LDTP03206 C766(1.08)  LDD3411 
AMP deaminase 2 (AMPD2) LDTP05289 C230(1.01)  LDD0078 
AMP deaminase 3 (AMPD3) LDTP05288 C756(1.10)  LDD3313 
AMSH-like protease (STAMBPL1) LDTP10307 C98(6.78)  LDD0209 
Anaphase-promoting complex subunit 1 (ANAPC1) LDTP11756 C988(1.16)  LDD0078 
Anaphase-promoting complex subunit 10 (ANAPC10) LDTP13603 C36(1.25)  LDD0080 
Anaphase-promoting complex subunit 11 (ANAPC11) LDTP12828 C73(0.86); C76(0.86)  LDD0078 
Anaphase-promoting complex subunit 7 (ANAPC7) LDTP13409 C131(1.11); C329(0.99)  LDD0078 
Androgen-induced gene 1 protein (AIG1) LDTP12697 C6(1.09)  LDD0531 
Angiotensin-converting enzyme (ACE) LDTP02632 C503(2.68)  LDD3343 
Angiotensin-converting enzyme 2 (ACE2) LDTP11455 C344(4.60); C361(3.59); C530(2.85)  LDD3380 
Ankyrin repeat and IBR domain-containing protein 1 (ANKIB1) LDTP13047 C359(0.88)  LDD0078 
Ankyrin repeat and LEM domain-containing protein 1 (ANKLE1) LDTP09026 C517(2.51)  LDD3334 
Anterior gradient protein 2 homolog (AGR2) LDTP01737 C81(3.98)  LDD2379 
Anterior gradient protein 3 (AGR3) LDTP09406 C71(2.68)  LDD2268 
Antigen peptide transporter 1 (TAP1) LDTP05408 C795(0.88)  LDD0078 
Antigen peptide transporter 2 (TAP2) LDTP05409 C213(0.87); C353(1.31); C362(1.59)  LDD0531 
Antiviral innate immune response receptor RIG-I (RIGI) LDTP01675 C680(1.01)  LDD0078 
AP2-associated protein kinase 1 (AAK1) LDTP06699 C87(0.92)  LDD0531 
Apolipoprotein(a) (LPA) LDTP02278 C4522(1.27)  LDD0531 
Apoptosis-enhancing nuclease (AEN) LDTP09536 C93(2.83)  LDD3311 
Apoptosis-inducing factor 1, mitochondrial (AIFM1) LDTP01687 C441(1.41)  LDD0080 
Apoptosis-resistant E3 ubiquitin protein ligase 1 (AREL1) LDTP00514 C817(0.79)  LDD1507 
Aprataxin (APTX) LDTP08015 C5(1.95)  LDD3323 
Aprataxin and PNK-like factor (APLF) LDTP08522 C111(1.27)  LDD1095 
Arachidonate 12-lipoxygenase, 12R-type (ALOX12B) LDTP01181 C229(2.28)  LDD3424 
Archaemetzincin-1 (AMZ1) LDTP17118 C131(1.68)  LDD2247 
Archaemetzincin-2 (AMZ2) LDTP17590 C115(9.42)  LDD0204 
Arginase-2, mitochondrial (ARG2) LDTP05140 C63(1.42)  LDD3395 
Arginine--tRNA ligase, cytoplasmic (RARS1) LDTP04601 C32(0.97); C34(0.97)  LDD0078 
Arginine-hydroxylase NDUFAF5, mitochondrial (NDUFAF5) LDTP07188 C98(0.89)  LDD0078 
Argininosuccinate lyase (ASL) LDTP02039 C307(2.12)  LDD3352 
Argininosuccinate synthase (ASS1) LDTP01807 C132(1.10)  LDD0078 
Arginyl-tRNA--protein transferase 1 (ATE1) LDTP14534 C71(1.14); C72(1.14)  LDD0078 
Aromatic-L-amino-acid decarboxylase (DDC) LDTP03068 C311(1.97)  LDD3340 
Arrestin domain-containing protein 1 (ARRDC1) LDTP08899 C49(1.33)  LDD0531 
Arsenite methyltransferase (AS3MT) LDTP12188 C360(11.65); C369(11.65); C368(3.41); C32(2.27)  LDD0080 
Arylacetamide deacetylase (AADAC) LDTP03195 C340(1.65)  LDD3368 
Arylamine N-acetyltransferase 1 (NAT1) LDTP02951 C44(29.11)  LDD0209 
Arylsulfatase A (ARSA) LDTP02776 C493(1.17); C489(1.02)  LDD1507 
Arylsulfatase B (ARSB) LDTP02807 C117(0.99); C121(0.99)  LDD0078 
Arylsulfatase G (ARSG) LDTP10259 C310(1.00)  LDD1512 
Arylsulfatase L (ARSL) LDTP04453 C492(3.04)  LDD3380 
Asparagine synthetase [glutamine-hydrolyzing] (ASNS) LDTP02264 C43(1.18); C44(1.18)  LDD0078 
Asparagine--tRNA ligase, cytoplasmic (NARS1) LDTP00866 C438(1.29); C537(1.32)  LDD0531 
Asparaginyl-tRNA synthetase (NARS2) LDTP10413 C291(6.26); C298(6.26)  LDD0080 
Aspartate aminotransferase, cytoplasmic (GOT1) LDTP02888 C46(1.08)  LDD0080 
Aspartate aminotransferase, mitochondrial (GOT2) LDTP01783 C272(0.98); C274(0.98); C295(0.91)  LDD0078 
Aspartate beta-hydroxylase domain-containing protein 1 (ASPHD1) LDTP19423 C122(3.48)  LDD3330 
Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2) LDTP17326 C116(0.92); C303(0.52); C313(0.52)  LDD0531 
Aspartate--tRNA ligase, cytoplasmic (DARS1) LDTP02752 C203(1.10); C259(0.96); C349(0.96); C130(0.86)  LDD0078 
Aspartate--tRNA ligase, mitochondrial (DARS2) LDTP07581 C449(2.61); C590(1.83); C202(1.62); C152(1.37)  LDD0080 
Aspartoacylase (ASPA) LDTP04067 C276(0.72)  LDD3332 
Aspartyl aminopeptidase (DNPEP) LDTP13527 C327(1.35); C413(1.06)  LDD0531 
Aspartyl/asparaginyl beta-hydroxylase (ASPH) LDTP05652 C641(0.85)  LDD0078 
Ataxin-3 (ATXN3) LDTP04604 C114(2.59)  LDD0080 
Ataxin-3-like protein (ATXN3L) LDTP15989 C99(3.19)  LDD3335 
Atlastin-2 (ATL2) LDTP09251 C287(0.94); C293(0.94); C441(1.08)  LDD0531 
Atlastin-3 (ATL3) LDTP07362 C429(1.16)  LDD0080 
ATP synthase membrane subunit K, mitochondrial (ATP5MK) LDTP10432 C30(0.87)  LDD1492 
ATP synthase subunit C lysine N-methyltransferase (ATPSCKMT) LDTP07535 C67(1.03)  LDD1507 
ATP synthase subunit epsilon, mitochondrial (ATP5F1E) LDTP04740 C19(1.34)  LDD0080 
ATP synthase subunit epsilon-like protein, mitochondrial (ATP5F1EP2) LDTP17268 C19(1.01)  LDD0078 
ATP synthase subunit s, mitochondrial (DMAC2L) LDTP10976 C134(0.94); C141(0.94)  LDD0532 
ATP-binding cassette sub-family A member 13 (ABCA13) LDTP08242 C4999(3.34)  LDD3315 
ATP-binding cassette sub-family A member 2 (ABCA2) LDTP11523 C1070(1.73)  LDD3383 
ATP-binding cassette sub-family A member 6 (ABCA6) LDTP08751 C561(1.99)  LDD3443 
ATP-binding cassette sub-family B member 6 (ABCB6) LDTP12303 C646(1.07)  LDD0532 
ATP-binding cassette sub-family C member 10 (ABCC10) LDTP07109 C248(1.55)  LDD0531 
ATP-binding cassette sub-family C member 2 (ABCC2) LDTP09916 C1346(0.81); C631(1.24)  LDD0531 
ATP-binding cassette sub-family C member 3 (ABCC3) LDTP00638 C716(1.90); C1486(2.82)  LDD3310 
ATP-binding cassette sub-family C member 4 (ABCC4) LDTP00639 C577(0.41); C579(0.41)  LDD1093 
ATP-binding cassette sub-family C member 5 (ABCC5) LDTP00640 C1339(2.35)  LDD3310 
ATP-binding cassette sub-family D member 1 (ABCD1) LDTP03676 C511(1.78); C599(1.62)  LDD0080 
ATP-binding cassette sub-family D member 2 (ABCD2) LDTP13121 C515(2.44)  LDD3312 
ATP-binding cassette sub-family D member 3 (ABCD3) LDTP03424 C477(13.37); C472(9.77)  LDD0080 
ATP-binding cassette sub-family E member 1 (ABCE1) LDTP04909 C227(4.36); C231(4.36); C201(1.67); C88(1.24)  LDD0080 
ATP-binding cassette sub-family G member 1 (ABCG1) LDTP04069 C409(3.47)  LDD3313 
ATP-citrate synthase (ACLY) LDTP04561 C20(1.53); C845(1.05); C229(1.01)  LDD0078 
ATP-dependent (S)-NAD(P)H-hydrate dehydratase (NAXD) LDTP08526 C95(1.55)  LDD3311 
ATP-dependent 6-phosphofructokinase, liver type (PFKL) LDTP02925 C708(21.84); C351(4.84); C630(16.51)  LDD0209 
ATP-dependent 6-phosphofructokinase, muscle type (PFKM) LDTP02261 C185(1.84); C780(2.10)  LDD3310 
ATP-dependent 6-phosphofructokinase, platelet type (PFKP) LDTP05314 C112(1.27); C360(0.99); C641(0.96)  LDD0078 
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial (CLPX) LDTP01382 C108(1.20); C112(1.20)  LDD0080 
ATP-dependent Clp protease proteolytic subunit, mitochondrial (CLPP) LDTP06618 C86(0.94)  LDD1509 
ATP-dependent DNA helicase DDX11 (DDX11) LDTP10301 C755(0.95); C759(0.95)  LDD0078 
ATP-dependent DNA helicase Q1 (RECQL) LDTP04083 C478(1.24); C606(1.17); C49(1.03); C321(1.03)  LDD0078 
ATP-dependent DNA helicase Q4 (RECQL4) LDTP01408 C853(5.11); C857(5.11); C855(5.11); C77(3.11)  LDD0080 
ATP-dependent DNA helicase Q5 (RECQL5) LDTP01409 C261(1.23); C266(1.14); C272(1.12); C281(1.12)  LDD0078 
ATP-dependent DNA/RNA helicase DHX36 (DHX36) LDTP11841 C135(0.88)  LDD0078 
ATP-dependent RNA helicase A (DHX9) LDTP05550 C1029(0.98); C777(0.95); C469(0.90)  LDD0078 
ATP-dependent RNA helicase DDX1 (DDX1) LDTP09766 C631(1.11)  LDD0078 
ATP-dependent RNA helicase DDX18 (DDX18) LDTP12688 C472(3.46); C481(3.46); C435(5.30)  LDD0080 
ATP-dependent RNA helicase DDX19A (DDX19A) LDTP12646 C392(1.19)  LDD0078 
ATP-dependent RNA helicase DDX19B (DDX19B) LDTP13618 C314(3.48); C393(3.04)  LDD3312 
ATP-dependent RNA helicase DDX24 (DDX24) LDTP15942 C599(1.07); C832(1.05); C620(1.03)  LDD0078 
ATP-dependent RNA helicase DDX39A (DDX39A) LDTP00192 C164(1.02)  LDD0078 
ATP-dependent RNA helicase DDX3X (DDX3X) LDTP00314 C223(1.01)  LDD0078 
ATP-dependent RNA helicase DDX3Y (DDX3Y) LDTP00664 C296(8.41)  LDD0209 
ATP-dependent RNA helicase DDX42 (DDX42) LDTP08369 C281(1.02); C333(0.91); C339(0.90); C346(0.87)  LDD0531 
ATP-dependent RNA helicase DDX50 (DDX50) LDTP11051 C242(1.01)  LDD0078 
ATP-dependent RNA helicase DDX51 (DDX51) LDTP15453 C402(1.23); C187(0.90); C419(0.89); C420(0.89)  LDD0078 
ATP-dependent RNA helicase DDX54 (DDX54) LDTP09428 C149(17.77)  LDD0205 
ATP-dependent RNA helicase DDX55 (DDX55) LDTP09258 C437(0.95)  LDD0078 
ATP-dependent RNA helicase DHX15 (DHX15) LDTP00684 C226(0.88); C774(0.86)  LDD0078 
ATP-dependent RNA helicase DHX29 (DHX29) LDTP08064 C1025(1.00); C784(0.89)  LDD0078 
ATP-dependent RNA helicase DHX30 (DHX30) LDTP07946 C461(37.13); C346(5.83); C1183(42.84)  LDD0209 
ATP-dependent RNA helicase DHX33 (DHX33) LDTP11991 C437(11.01)  LDD0204 
ATP-dependent RNA helicase DHX58 (DHX58) LDTP10154 C221(1.91)  LDD3325 
ATP-dependent RNA helicase DHX8 (DHX8) LDTP06147 C636(0.94); C637(0.94)  LDD0078 
ATP-dependent RNA helicase SUPV3L1, mitochondrial (SUPV3L1) LDTP08641 C418(2.81)  LDD0080 
ATP-dependent RNA helicase TDRD9 (TDRD9) LDTP09125 C1328(0.50)  LDD2236 
ATP-dependent translocase ABCB1 (ABCB1) LDTP02254 C431(2.05)  LDD3318 
ATP-dependent zinc metalloprotease YME1L1 (YME1L1) LDTP10848 C433(0.71)  LDD0580 
ATPase family AAA domain-containing protein 2 (ATAD2) LDTP07607 C635(1.26); C1388(1.15); C643(1.07); C649(1.07)  LDD0078 
ATPase family AAA domain-containing protein 2B (ATAD2B) LDTP13550 C437(0.95); C475(0.92); C1267(0.92); C1285(0.92)  LDD0078 
ATPase family AAA domain-containing protein 3B (ATAD3B) LDTP07154 C606(1.82); C611(1.82); C616(1.15); C624(1.15)  LDD0078 
ATPase family AAA domain-containing protein 5 (ATAD5) LDTP10734 C827(0.99); C831(0.99)  LDD0078 
ATPase family gene 2 protein homolog A (AFG2A) LDTP09044 C318(1.22); C291(1.13); C672(1.00); C568(0.97)  LDD0078 
ATPase family gene 2 protein homolog B (AFG2B) LDTP11298 C580(0.99); C57(0.91); C59(0.91)  LDD0078 
ATPase GET3 (GET3) LDTP00836 C53(0.64); C55(0.87)  LDD0531 
ATPase MORC2 (MORC2) LDTP14308 C525(0.85); C536(0.85)  LDD0078 
ATPase PAAT (PAAT) LDTP12057 C353(5.01)  LDD0209 
ATPase WRNIP1 (WRNIP1) LDTP10801 C272(0.81)  LDD0531 
Atrial natriuretic peptide receptor 1 (NPR1) LDTP02822 C981(1.55); C943(3.69); C666(2.55)  LDD3365 
Atrial natriuretic peptide receptor 2 (NPR2) LDTP03059 C966(1.53)  LDD2252 
Atypical kinase COQ8A, mitochondrial (COQ8A) LDTP09285 C406(4.42); C641(1.63)  LDD0080 
Atypical kinase COQ8B, mitochondrial (COQ8B) LDTP10201 C293(9.03)  LDD0080 
Aurora kinase A (AURKA) LDTP00491 C290(1.00); C8(0.99); C49(0.95)  LDD0078 
Aurora kinase B (AURKB) LDTP10346 C170(1.70)  LDD0080 
Aurora kinase C (AURKC) LDTP13756 C235(2.40)  LDD3326 
Auxilin (DNAJC6) LDTP01110 C185(1.85)  LDD3310 
Azurocidin (AZU1) LDTP03036 C52(1.47)  LDD3338 
B box and SPRY domain-containing protein (BSPRY) LDTP15050 C262(1.19); C316(1.19)  LDD0531 
Baculoviral IAP repeat-containing protein 2 (BIRC2) LDTP05893 C308(1.24)  LDD0080 
Baculoviral IAP repeat-containing protein 3 (BIRC3) LDTP05892 C28(1.00)  LDD0078 
Baculoviral IAP repeat-containing protein 6 (BIRC6) LDTP12459 C777(1.15); C2892(1.05); C2123(1.01); C1417(1.01)  LDD0078 
Baculoviral IAP repeat-containing protein 7 (BIRC7) LDTP10165 C45(1.83)  LDD3427 
BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 (BNIP2) LDTP05716 C357(1.73)  LDD3332 
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (GCNT1) LDTP05367 C217(1.53)  LDD3310 
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (GCNT3) LDTP01585 C382(5.33)  LDD3360 
Beta-1,3-galactosyltransferase 1 (B3GALT1) LDTP14187 C167(1.22)  LDD1507 
Beta-1,3-galactosyltransferase 2 (B3GALT2) LDTP00881 C405(3.30)  LDD3410 
Beta-1,3-galactosyltransferase 5 (B3GALT5) LDTP13845 C276(3.11)  LDD3380 
Beta-1,3-galactosyltransferase 6 (B3GALT6) LDTP10530 C271(6.63)  LDD3310 
Beta-1,3-glucosyltransferase (B3GLCT) LDTP07757 C365(0.93)  LDD1507 
Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (LFNG) LDTP09170 C50(1.55)  LDD3314 
Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG) LDTP16327 C238(1.29)  LDD2367 
Beta-1,4-galactosyltransferase 1 (B4GALT1) LDTP02777 C172(2.22)  LDD3320 
Beta-1,4-galactosyltransferase 3 (B4GALT3) LDTP00994 C119(1.06)  LDD0547 
Beta-1,4-galactosyltransferase 4 (B4GALT4) LDTP00995 C208(4.00)  LDD3342 
Beta-1,4-galactosyltransferase 5 (B4GALT5) LDTP00726 C248(1.27)  LDD0531 
Beta-1,4-galactosyltransferase 7 (B4GALT7) LDTP13166 C214(2.38)  LDD3310 
Beta-1,4-glucuronyltransferase 1 (B4GAT1) LDTP00783 C182(3.08)  LDD3360 
Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (MGAT3) LDTP05592 C117(1.43)  LDD2260 
Beta-adducin (ADD2) LDTP03771 C177(1.00); C277(0.94); C201(0.95); C210(0.95)  LDD1492 
Beta-adrenergic receptor kinase 1 (GRK2) LDTP03308 C340(0.97)  LDD0078 
Beta-alanine-activating enzyme (AASDH) LDTP06858 C13(0.63)  LDD0531 
Beta-citrylglutamate synthase B (RIMKLB) LDTP13551 C230(1.08); C239(1.10)  LDD0812 
Beta-enolase (ENO3) LDTP02700 C357(0.75)  LDD3310 
Beta-galactosidase (GLB1) LDTP02837 C426(1.11); C393(1.75)  LDD3312 
Beta-galactosidase-1-like protein (GLB1L) LDTP17424 C62(3.24)  LDD3430 
Beta-galactosidase-1-like protein 2 (GLB1L2) LDTP17633 C562(1.17)  LDD3364 
Beta-galactosidase-1-like protein 3 (GLB1L3) LDTP17783 C462(2.31)  LDD3328 
Beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1) LDTP02812 C184(1.82)  LDD3424 
Beta-glucuronidase (GUSB) LDTP02260 C644(1.05)  LDD1492 
Beta-hexosaminidase subunit alpha (HEXA) LDTP02169 C522(1.46)  LDD3381 
Beta-hexosaminidase subunit beta (HEXB) LDTP02216 C309(1.37)  LDD0080 
Beta-mannosidase (MANBA) LDTP00282 C176(0.88)  LDD0531 
Betaine--homocysteine S-methyltransferase 1 (BHMT) LDTP09978 C131(1.88)  LDD3378 
Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (WRN) LDTP06076 C1374(1.32); C1382(1.32)  LDD0078 
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) LDTP00717 C360(0.86)  LDD0078 
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2) LDTP01564 C53(1.94); C117(1.42)  LDD3310 
Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (JMJD6) LDTP07492 C207(3.42)  LDD3310 
Bifunctional coenzyme A synthase (COASY) LDTP05736 C244(3.50)  LDD3312 
Bifunctional epoxide hydrolase 2 (EPHX2) LDTP03692 C88(1.78); C423(1.80)  LDD3335 
Bifunctional glutamate/proline--tRNA ligase (EPRS1) LDTP02222 C1148(0.98); C1377(0.98); C1076(0.97); C105(0.92)  LDD0078 
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (NDST1) LDTP04540 C818(0.91)  LDD1095 
Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (NDST2) LDTP04541 C306(0.66)  LDD1573 
Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2, mitochondrial (MTHFD2L) LDTP12076 C180(1.04)  LDD1508 
Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial (MTHFD2) LDTP02706 C145(2.14)  LDD0080 
Bifunctional peptidase and arginyl-hydroxylase JMJD5 (KDM8) LDTP08819 C202(2.65)  LDD3334 
Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) LDTP03159 C81(2.04); C100(2.04)  LDD0080 
Bifunctional polynucleotide phosphatase/kinase (PNKP) LDTP10840 C353(1.27); C516(0.99)  LDD0078 
Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) LDTP13781 C17(157.93); C357(454.81); C388(5.56)  LDD0209 
Bile salt export pump (ABCB11) LDTP01565 C1270(2.95)  LDD3318 
Biliverdin reductase A (BLVRA) LDTP04552 C204(1.11)  LDD0080 
Biotin--protein ligase (HLCS) LDTP04381 C289(1.01)  LDD0078 
Biotinidase (BTD) LDTP04030 C371(1.70)  LDD0080 
Bis(5'-adenosyl)-triphosphatase (FHIT) LDTP04308 C39(1.48)  LDD3370 
Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (NUDT2) LDTP04376 C123(0.70)  LDD0531 
Bis(monoacylglycero)phosphate synthase CLN5 (CLN5) LDTP01241 C231(1.08)  LDD0080 
Bisphosphoglycerate mutase (BPGM) LDTP02219 C23(0.93)  LDD0078 
Bleomycin hydrolase (BLMH) LDTP05992 C73(1.20)  LDD0078 
BMP-2-inducible protein kinase (BMP2K) LDTP12597 C32(1.10)  LDD0078 
Bone morphogenetic protein 1 (BMP1) LDTP02657 C617(0.91)  LDD0078 
Bone morphogenetic protein receptor type-1A (BMPR1A) LDTP03821 C475(4.29)  LDD3386 
Bone morphogenetic protein receptor type-1B (BMPR1B) LDTP00227 C473(0.99)  LDD1492 
Bone morphogenetic protein receptor type-2 (BMPR2) LDTP05994 C496(1.99)  LDD3330 
Brain-specific serine protease 4 (PRSS22) LDTP11631 C139(1.46)  LDD3314 
Branched-chain alpha-ketoacid dehydrogenase kinase (BCKDK) LDTP00462 C111(1.35)  LDD0080 
Branched-chain-amino-acid aminotransferase, cytosolic (BCAT1) LDTP04622 C233(1.55)  LDD3310 
Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT2) LDTP00624 C342(1.01)  LDD0078 
BRCA1-associated protein (BRAP) LDTP08084 C391(1.13); C396(1.13); C264(0.98); C267(0.98)  LDD0078 
BRCA1-associated RING domain protein 1 (BARD1) LDTP10961 C733(1.01); C743(1.01)  LDD0078 
Breakpoint cluster region protein (BCR) LDTP02560 C753(0.87)  LDD0078 
Breast cancer type 1 susceptibility protein (BRCA1) LDTP03851 C636(3.67); C644(3.67); C801(4.42); C805(4.42)  LDD0080 
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2) LDTP13672 C119(2.24)  LDD2370 
BTB/POZ domain-containing protein 1 (BTBD1) LDTP11699 C252(11.21)  LDD0209 
BTB/POZ domain-containing protein 2 (BTBD2) LDTP11357 C294(7.17)  LDD0209 
BTB/POZ domain-containing protein 3 (BTBD3) LDTP13857 C381(1.60)  LDD3343 
C-1-tetrahydrofolate synthase, cytoplasmic (MTHFD1) LDTP02580 C147(1.12); C152(1.10); C143(1.08); C195(1.03)  LDD0078 
C-terminal-binding protein 1 (CTBP1) LDTP05842 C312(1.42)  LDD3314 
C-terminal-binding protein 2 (CTBP2) LDTP04745 C44(1.13)  LDD0080 
C1GALT1-specific chaperone 1 (C1GALT1C1) LDTP10278 C226(4.26)  LDD3323 
CAAX prenyl protease 2 (RCE1) LDTP13808 C328(0.91)  LDD0531 
Calcium-activated chloride channel regulator 1 (CLCA1) LDTP00131 C187(3.69); C727(2.91); C386(4.52)  LDD3380 
Calcium-activated chloride channel regulator 2 (CLCA2) LDTP13758 C393(2.36)  LDD2269 
Calcium-activated chloride channel regulator 4 (CLCA4) LDTP06258 C124(3.18)  LDD3412 
Calcium-independent phospholipase A2-gamma (PNPLA8) LDTP12318 C714(1.71)  LDD3312 
Calcium-transporting ATPase type 2C member 1 (ATP2C1) LDTP05228 C49(70.64)  LDD0209 
Calcium-transporting ATPase type 2C member 2 (ATP2C2) LDTP01157 C557(2.91)  LDD3314 
Calcium/calmodulin-dependent protein kinase kinase 1 (CAMKK1) LDTP08906 C243(0.85)  LDD1508 
Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) LDTP10779 C121(1.10); C123(1.10)  LDD0078 
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1) LDTP06023 C354(1.80); C355(1.80)  LDD0080 
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D) LDTP08437 C347(0.97); C354(0.97)  LDD0078 
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B) LDTP05919 C35(3.54)  LDD3330 
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D) LDTP05921 C273(2.18); C398(1.28)  LDD3310 
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G) LDTP05920 C273(4.05)  LDD3310 
Calcium/calmodulin-dependent protein kinase type IV (CAMK4) LDTP06558 C9(42.57)  LDD0209 
Calcyclin-binding protein (CACYBP) LDTP12163 C154(1.31)  LDD0080 
Calmodulin-lysine N-methyltransferase (CAMKMT) LDTP08109 C25(1.35)  LDD0078 
Calpain-1 catalytic subunit (CAPN1) LDTP02204 C384(0.90)  LDD0078 
Calpain-10 (CAPN10) LDTP12223 C355(0.90)  LDD2470 
Calpain-11 (CAPN11) LDTP13617 C615(0.95)  LDD1507 
Calpain-13 (CAPN13) LDTP17353 C297(4.33)  LDD2268 
Calpain-15 (CAPN15) LDTP01315 C346(0.89)  LDD0078 
Calpain-2 catalytic subunit (CAPN2) LDTP02911 C640(1.05); C301(1.00); C374(0.86)  LDD0078 
Calpain-5 (CAPN5) LDTP00650 C246(1.02)  LDD3312 
Calpain-6 (CAPN6) LDTP14284 C506(3.82); C374(1.98)  LDD3311 
Calpain-7 (CAPN7) LDTP14297 C242(0.87)  LDD0078 
Calpain-8 (CAPN8) LDTP14362 C82(1.56)  LDD3360 
Calpain-9 (CAPN9) LDTP00447 C334(1.79)  LDD3360 
CaM kinase-like vesicle-associated protein (CAMKV) LDTP09087 C301(2.38)  LDD3331 
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (PDE10A) LDTP13790 C436(2.51)  LDD3342 
cAMP-dependent protein kinase catalytic subunit beta (PRKACB) LDTP03188 C247(3.63)  LDD3312 
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG) LDTP03181 C200(0.41)  LDD2236 
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX) LDTP04475 C205(0.95)  LDD0531 
Cancer-related nucleoside-triphosphatase (NTPCR) LDTP11152 C110(4.10); C101(2.28); C184(1.55)  LDD0080 
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (CMTR1) LDTP08773 C403(1.36); C593(1.44)  LDD0531 
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (CMTR2) LDTP08668 C111(0.92); C116(0.92); C363(1.00); C364(1.00)  LDD0531 
Carbamoyl-phosphate synthase [ammonia], mitochondrial (CPS1) LDTP03591 C606(1.82); C767(1.73); C231(1.82)  LDD3343 
Carbohydrate deacetylase (YDJC) LDTP16689 C182(1.39); C212(1.90)  LDD0080 
Carbohydrate sulfotransferase 11 (CHST11) LDTP12353 C128(5.42)  LDD0209 
Carbohydrate sulfotransferase 12 (CHST12) LDTP12494 C175(2.36)  LDD3338 
Carbohydrate sulfotransferase 14 (CHST14) LDTP09096 C117(1.43); C159(0.95)  LDD0531 
Carbohydrate sulfotransferase 15 (CHST15) LDTP07988 C264(1.27)  LDD0547 
Carbohydrate sulfotransferase 4 (CHST4) LDTP09094 C156(1.40)  LDD2379 
Carbohydrate sulfotransferase 7 (CHST7) LDTP12570 C202(0.92); C207(0.92)  LDD0078 
Carbohydrate sulfotransferase 9 (CHST9) LDTP07941 C186(8.48)  LDD3380 
Carbonic anhydrase 12 (CA12) LDTP00805 C230(1.93)  LDD3310 
Carbonic anhydrase 5B, mitochondrial (CA5B) LDTP16260 C149(1.01)  LDD1492 
Carbonic anhydrase 9 (CA9) LDTP06630 C156(1.55)  LDD3310 
Carbonic anhydrase-related protein (CA8) LDTP03710 C266(0.95); C200(1.84)  LDD3331 
Carbonyl reductase [NADPH] 1 (CBR1) LDTP02831 C227(1.63); C226(1.09)  LDD0078 
Carbonyl reductase [NADPH] 3 (CBR3) LDTP01321 C143(0.99)  LDD0078 
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (CTDSP1) LDTP11653 C45(0.98)  LDD1509 
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (CTDSP2) LDTP00379 C94(1.34)  LDD3313 
Carboxylesterase 3 (CES3) LDTP07683 C406(0.82)  LDD1507 
Carboxymethylenebutenolidase homolog (CMBL) LDTP10215 C132(11.98)  LDD0080 
Carboxypeptidase A4 (CPA4) LDTP13329 C250(1.98)  LDD3455 
Carboxypeptidase B2 (CPB2) LDTP10434 C250(2.53)  LDD2351 
Carboxypeptidase D (CPD) LDTP01372 C720(0.87); C195(0.87)  LDD0078 
Carboxypeptidase E (CPE) LDTP02865 C300(0.94)  LDD1508 
Carboxypeptidase M (CPM) LDTP02723 C341(1.30)  LDD3312 
Cardiolipin synthase (CMP-forming) (CRLS1) LDTP13379 C230(2.39)  LDD0080 
Carnitine O-acetyltransferase (CRAT) LDTP04022 C169(1.85); C180(1.85)  LDD0533 
Carnitine O-palmitoyltransferase 1, liver isoform (CPT1A) LDTP04358 C96(1.14); C608(0.98); C613(0.98)  LDD0078 
Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1B) LDTP09776 C586(1.71)  LDD3310 
Carnitine O-palmitoyltransferase 2, mitochondrial (CPT2) LDTP03257 C84(4.64)  LDD0209 
Carnosine N-methyltransferase (CARNMT1) LDTP08867 C18(0.69); C180(1.31)  LDD0531 
Cartilage-associated protein (CRTAP) LDTP01300 C84(1.67)  LDD0080 
Casein kinase I isoform alpha (CSNK1A1) LDTP04209 C153(2.41)  LDD3319 
Casein kinase I isoform alpha-like (CSNK1A1L) LDTP08959 C291(2.02); C277(1.77)  LDD3310 
Casein kinase I isoform delta (CSNK1D) LDTP04210 C255(0.81)  LDD0531 
Casein kinase I isoform epsilon (CSNK1E) LDTP04275 C241(1.23); C255(1.09)  LDD0531 
Casein kinase I isoform gamma-1 (CSNK1G1) LDTP12262 C110(1.15)  LDD0533 
Casein kinase I isoform gamma-2 (CSNK1G2) LDTP05111 C111(0.86)  LDD0078 
Casein kinase I isoform gamma-3 (CSNK1G3) LDTP14273 C51(6.72)  LDD0209 
Casein kinase II subunit alpha (CSNK2A1) LDTP05077 C147(1.06)  LDD1492 
Casein kinase II subunit alpha 3 (CSNK2A3) LDTP09176 C147(0.44)  LDD0533 
Casein kinase II subunit alpha' (CSNK2A2) LDTP03011 C336(0.95)  LDD0078 
Casein kinase II subunit beta (CSNK2B) LDTP05067 C109(1.25)  LDD0080 
Caspase-1 (CASP1) LDTP03490 C244(2.22); C43(1.77); C285(1.55)  LDD3310 
Caspase-10 (CASP10) LDTP09904 C97(4.88)  LDD0209 
Caspase-14 (CASP14) LDTP03616 C132(1.17)  LDD3337 
Caspase-2 (CASP2) LDTP03985 C320(1.10); C30(1.05); C343(0.99)  LDD0078 
Caspase-3 (CASP3) LDTP03984 C163(1.20); C170(1.05); C184(1.05)  LDD0078 
Caspase-4 (CASP4) LDTP04274 C53(1.75)  LDD3310 
Caspase-5 (CASP5) LDTP04484 C328(2.46)  LDD3310 
Caspase-6 (CASP6) LDTP04687 C163(0.80)  LDD0531 
Caspase-7 (CASP7) LDTP04685 C323(2.27)  LDD3310 
Caspase-8 (CASP8) LDTP06211 C419(1.43)  LDD3310 
Caspase-9 (CASP9) LDTP04686 C403(1.12); C287(0.97)  LDD0078 
Catalase (CAT) LDTP02001 C377(0.98)  LDD0078 
Catechol O-methyltransferase (COMT) LDTP03145 C223(1.06); C238(1.00); C241(1.00)  LDD0078 
Catechol O-methyltransferase domain-containing protein 1 (COMTD1) LDTP17587 C231(1.32)  LDD0080 
Cathepsin B (CTSB) LDTP02223 C105(1.12); C108(1.12); C93(0.92); C211(0.91)  LDD0078 
Cathepsin D (CTSD) LDTP02198 C286(1.53)  LDD3311 
Cathepsin F (CTSF) LDTP13172 C333(2.13)  LDD3383 
Cathepsin G (CTSG) LDTP02271 C49(2.50); C207(1.42)  LDD3334 
Cathepsin L2 (CTSV) LDTP01084 C94(1.02)  LDD0602 
Cathepsin S (CTSS) LDTP03329 C213(1.65)  LDD3312 
Cathepsin Z (CTSZ) LDTP13147 C173(0.96); C170(0.87)  LDD0078 
CCA tRNA nucleotidyltransferase 1, mitochondrial (TRNT1) LDTP10716 C373(2.11)  LDD0080 
CCR4-NOT transcription complex subunit 4 (CNOT4) LDTP01640 C175(3.11)  LDD3311 
CCR4-NOT transcription complex subunit 6 (CNOT6) LDTP13565 C210(0.95)  LDD0532 
CCR4-NOT transcription complex subunit 6-like (CNOT6L) LDTP10548 C449(1.24)  LDD0531 
CCR4-NOT transcription complex subunit 7 (CNOT7) LDTP13362 C18(1.17)  LDD0080 
CCR4-NOT transcription complex subunit 8 (CNOT8) LDTP13213 C67(0.85)  LDD0533 
CDGSH iron-sulfur domain-containing protein 1 (CISD1) LDTP12873 C83(0.94)  LDD0531 
CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (PGS1) LDTP06749 C444(0.90)  LDD0532 
Cell cycle checkpoint control protein RAD9A (RAD9A) LDTP10929 C114(5.21)  LDD0204 
Cell cycle checkpoint control protein RAD9B (RAD9B) LDTP15171 C96(1.36)  LDD3331 
Cell cycle checkpoint protein RAD1 (RAD1) LDTP01024 C148(0.93)  LDD0078 
Cell division control protein 42 homolog (CDC42) LDTP04886 C157(2.05); C18(1.09)  LDD0080 
Cell division cycle 7-related protein kinase (CDC7) LDTP00249 C345(14.03); C353(14.03)  LDD0080 
Cell division cycle and apoptosis regulator protein 1 (CCAR1) LDTP08583 C373(8.09); C376(8.09)  LDD0080 
Cell division cycle protein 16 homolog (CDC16) LDTP05732 C544(0.98)  LDD0078 
Cell division cycle protein 23 homolog (CDC23) LDTP13408 C536(1.17); C537(1.17); C334(0.90); C335(0.90)  LDD0078 
Cell division cycle protein 27 homolog (CDC27) LDTP03525 C629(5.35)  LDD3311 
Cell migration-inducing and hyaluronan-binding protein (CEMIP) LDTP09577 C462(2.75)  LDD3342 
Centromere-associated protein E (CENPE) LDTP05343 C1484(1.09); C1485(1.09); C1644(1.06)  LDD0078 
Ceramide glucosyltransferase (UGCG) LDTP06617 C143(0.62)  LDD0531 
Ceramide kinase (CERK) LDTP09391 C517(1.17)  LDD0532 
Ceramide synthase 1 (CERS1) LDTP03394 C37(6.09); C40(6.09)  LDD0080 
Ceramide synthase 4 (CERS4) LDTP12118 C107(1.83)  LDD3468 
Ceramide synthase 5 (CERS5) LDTP08891 C369(1.13)  LDD0078 
Ceramide synthase 6 (CERS6) LDTP07766 C84(7.26)  LDD3386 
Ceruloplasmin (CP) LDTP01777 C240(1.44)  LDD3312 
cGMP-dependent 3',5'-cyclic phosphodiesterase (PDE2A) LDTP00264 C504(2.91)  LDD3342 
cGMP-dependent protein kinase 1 (PRKG1) LDTP06016 C173(2.80)  LDD3380 
cGMP-dependent protein kinase 2 (PRKG2) LDTP05797 C240(1.04)  LDD1509 
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (PDE3A) LDTP06118 C74(5.08)  LDD3314 
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B (PDE3B) LDTP05845 C576(4.56); C579(4.56)  LDD0080 
cGMP-specific 3',5'-cyclic phosphodiesterase (PDE5A) LDTP01393 C79(1.12); C81(1.12)  LDD0078 
Chitinase domain-containing protein 1 (CHID1) LDTP11336 C306(3.62)  LDD3314 
Chitinase-3-like protein 1 (CHI3L1) LDTP03799 C300(1.05)  LDD3325 
Chitinase-3-like protein 2 (CHI3L2) LDTP06471 C372(4.46)  LDD3397 
Chitobiosyldiphosphodolichol beta-mannosyltransferase (ALG1) LDTP11178 C396(1.44)  LDD0080 
Cholesterol transporter ABCA5 (ABCA5) LDTP09677 C736(2.12)  LDD3332 
Choline dehydrogenase, mitochondrial (CHDH) LDTP15505 C99(0.94)  LDD0531 
Choline kinase alpha (CHKA) LDTP03787 C95(28.94)  LDD0209 
Choline-phosphate cytidylyltransferase A (PCYT1A) LDTP04261 C139(1.25); C73(1.23)  LDD0531 
Choline/ethanolamine kinase (CHKB) LDTP13811 C28(1.67)  LDD3360 
Choline/ethanolaminephosphotransferase 1 (CEPT1) LDTP14264 C11(1.44); C30(1.44)  LDD0078 
Cholinephosphotransferase 1 (CHPT1) LDTP09570 C386(2.37)  LDD0080 
Cholinesterase (BCHE) LDTP02140 C428(2.48)  LDD3332 
Chondroitin sulfate glucuronyltransferase (CHPF2) LDTP13042 C246(1.09); C393(0.85)  LDD0531 
Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (CSGALNACT2) LDTP08933 C490(1.65)  LDD1576 
Chondroitin sulfate synthase 1 (CHSY1) LDTP08351 C48(1.59)  LDD0080 
Chondroitin sulfate synthase 2 (CHPF) LDTP08686 C243(1.09); C266(0.94); C405(1.08); C736(0.99)  LDD0531 
Chondroitin sulfate synthase 3 (CHSY3) LDTP07889 C45(0.97)  LDD0547 
Chromatin-remodeling ATPase INO80 (INO80) LDTP13544 C887(6.23)  LDD0209 
Chromodomain Y-like protein (CDYL) LDTP13789 C515(1.35)  LDD0080 
Chromodomain-helicase-DNA-binding protein 1 (CHD1) LDTP00394 C758(0.92); C759(0.92); C762(0.92); C411(0.88)  LDD0078 
Chromodomain-helicase-DNA-binding protein 1-like (CHD1L) LDTP08334 C63(0.90); C67(0.90)  LDD0078 
Chromodomain-helicase-DNA-binding protein 2 (CHD2) LDTP00395 C365(1.08); C415(1.00)  LDD0531 
Chromodomain-helicase-DNA-binding protein 3 (CHD3) LDTP05676 C1523(1.64)  LDD3323 
Chromodomain-helicase-DNA-binding protein 4 (CHD4) LDTP06219 C396(0.91)  LDD3311 
Chromodomain-helicase-DNA-binding protein 5 (CHD5) LDTP09436 C1476(1.06)  LDD0531 
Chromodomain-helicase-DNA-binding protein 6 (CHD6) LDTP09415 C1307(0.96)  LDD0078 
Chromodomain-helicase-DNA-binding protein 7 (CHD7) LDTP13037 C1251(0.93); C1252(0.93)  LDD0078 
Chromodomain-helicase-DNA-binding protein 8 (CHD8) LDTP12252 C1116(1.41)  LDD0080 
Chromodomain-helicase-DNA-binding protein 9 (CHD9) LDTP06770 C801(0.93); C1375(0.93); C1705(0.92)  LDD0078 
Chromosome-associated kinesin KIF4A (KIF4A) LDTP01539 C16(1.00); C1224(1.00); C1106(0.98); C1111(0.98)  LDD0078 
Chromosome-associated kinesin KIF4B (KIF4B) LDTP06733 C190(3.96)  LDD3320 
Chronophin (PDXP) LDTP10344 C163(1.19)  LDD3310 
Cilia- and flagella-associated protein 36 (CFAP36) LDTP10331 C83(1.14)  LDD3345 
Circadian locomoter output cycles protein kaput (CLOCK) LDTP00660 C250(1.56)  LDD0532 
Citramalyl-CoA lyase, mitochondrial (CLYBL) LDTP08734 C183(2.59)  LDD3386 
Citrate synthase, mitochondrial (CS) LDTP01205 C101(4.94); C211(12.39)  LDD0209 
Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial (CSKMT) LDTP00143 C84(0.79); C90(0.79)  LDD0531 
Citron Rho-interacting kinase (CIT) LDTP00375 C1730(6.69)  LDD3310 
Cleavage and polyadenylation specificity factor subunit 2 (CPSF2) LDTP13053 C577(0.94); C578(0.94); C621(0.88)  LDD0078 
Cleavage and polyadenylation specificity factor subunit 3 (CPSF3) LDTP13449 C498(3.63); C527(1.13); C278(1.16)  LDD0080 
Cleavage and polyadenylation specificity factor subunit 5 (NUDT21) LDTP00873 C144(0.61)  LDD0532 
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (ST3GAL2) LDTP06646 C152(0.92)  LDD3323 
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 (ST3GAL4) LDTP05638 C46(1.34)  LDD2253 
Coagulation factor IX (F9) LDTP01794 C178(1.93)  LDD0812 
Coagulation factor V (F5) LDTP02610 C526(4.70)  LDD3377 
Coagulation factor X (F10) LDTP01795 C443(1.60)  LDD0531 
Coagulation factor XII (F12) LDTP01798 C570(3.41)  LDD3473 
Coagulation factor XIII A chain (F13A1) LDTP01780 C410(0.86)  LDD0531 
Collagen triple helix repeat-containing protein 1 (CTHRC1) LDTP10173 C55(1.91)  LDD3313 
Complement C1r subcomponent (C1R) LDTP01791 C338(2.91)  LDD3314 
Complement C1r subcomponent-like protein (C1RL) LDTP12928 C402(2.24)  LDD3466 
Complement C2 (C2) LDTP02151 C600(1.72)  LDD3329 
Complement factor B (CFB) LDTP01801 C145(2.67)  LDD3323 
Complement factor I (CFI) LDTP02090 C67(1.18)  LDD0532 
Complex I assembly factor ACAD9, mitochondrial (ACAD9) LDTP12048 C507(1.04)  LDD0078 
COP9 signalosome complex subunit 3 (COPS3) LDTP13675 C104(0.67); C170(1.19); C25(0.97); C298(0.91)  LDD0531 
COP9 signalosome complex subunit 4 (COPS4) LDTP11187 C378(3.38)  LDD0080 
COP9 signalosome complex subunit 5 (COPS5) LDTP09925 C218(0.90)  LDD0078 
COP9 signalosome complex subunit 6 (COPS6) LDTP07966 C299(1.08)  LDD0531 
Copper chaperone for superoxide dismutase (CCS) LDTP00384 C244(5.34); C246(5.34)  LDD0080 
Copper-transporting ATPase 1 (ATP7A) LDTP05422 C241(2.85)  LDD3410 
Copper-transporting ATPase 2 (ATP7B) LDTP03779 C154(4.03); C157(4.03)  LDD0080 
Corrinoid adenosyltransferase MMAB (MMAB) LDTP10286 C119(1.10); C132(1.10)  LDD0078 
Creatine kinase B-type (CKB) LDTP02616 C283(0.96)  LDD0078 
Creatine kinase M-type (CKM) LDTP02158 C283(17.69)  LDD3401 
Creatine kinase S-type, mitochondrial (CKMT2) LDTP02904 C210(1.32)  LDD3310 
Creatine kinase U-type, mitochondrial (CKMT1A; CKMT1B) LDTP02622 C89(1.14)  LDD3310 
CREB-binding protein (CREBBP) LDTP09875 C404(1.31); C409(1.31); C1775(1.14); C1785(1.14)  LDD0078 
Crossover junction endonuclease EME1 (EME1) LDTP10100 C369(1.62); C133(1.94)  LDD0080 
Crossover junction endonuclease MUS81 (MUS81) LDTP10644 C74(0.92)  LDD0078 
Cryptochrome-1 (CRY1) LDTP06541 C24(0.84); C315(1.17)  LDD1492 
Cryptochrome-2 (CRY2) LDTP06832 C382(0.85)  LDD0531 
CTD nuclear envelope phosphatase 1 (CTDNEP1) LDTP01616 C6(0.96)  LDD0580 
CTD small phosphatase-like protein (CTDSPL) LDTP00565 C197(1.35)  LDD3312 
CTD small phosphatase-like protein 2 (CTDSPL2) LDTP14814 C379(1.02); C381(0.96)  LDD0531 
CTP synthase 1 (CTPS1) LDTP02922 C362(1.26); C218(1.04); C299(1.04); C234(1.04)  LDD0078 
CTP synthase 2 (CTPS2) LDTP12505 C313(0.87)  LDD0078 
Cullin-1 (CUL1) LDTP05946 C496(1.12)  LDD0080 
Cullin-2 (CUL2) LDTP05947 C721(4.96)  LDD0205 
Cullin-3 (CUL3) LDTP05948 C298(0.97)  LDD0078 
Cullin-4A (CUL4A) LDTP05949 C241(1.05)  LDD0078 
Cullin-4B (CUL4B) LDTP05950 C787(0.89)  LDD0078 
Cullin-5 (CUL5) LDTP09965 C112(1.75)  LDD0080 
Cullin-associated NEDD8-dissociated protein 1 (CAND1) LDTP08296 C942(1.32); C802(0.87)  LDD0078 
Cullin-associated NEDD8-dissociated protein 2 (CAND2) LDTP01145 C807(3.80); C815(3.80); C945(1.30)  LDD0080 
Cyanocobalamin reductase / alkylcobalamin dealkylase (MMACHC) LDTP14073 C149(1.12)  LDD0531 
Cyclic GMP-AMP phosphodiesterase SMPDL3A (SMPDL3A) LDTP09763 C62(1.95)  LDD3428 
Cyclic GMP-AMP synthase (CGAS) LDTP08974 C446(0.92)  LDD3313 
Cyclin-dependent kinase 1 (CDK1) LDTP02149 C119(1.67)  LDD3331 
Cyclin-dependent kinase 10 (CDK10) LDTP06327 C71(0.92)  LDD3316 
Cyclin-dependent kinase 11A (CDK11A) LDTP13752 C428(1.13); C420(0.92); C57(0.91)  LDD0078 
Cyclin-dependent kinase 11B (CDK11B) LDTP03098 C440(1.05); C432(0.96)  LDD0078 
Cyclin-dependent kinase 12 (CDK12) LDTP12852 C862(1.02); C952(0.94); C956(0.94)  LDD0078 
Cyclin-dependent kinase 13 (CDK13) LDTP06019 C987(0.92); C995(0.92); C930(0.88); C934(0.88)  LDD0078 
Cyclin-dependent kinase 14 (CDK14) LDTP01463 C402(2.29)  LDD3440 
Cyclin-dependent kinase 17 (CDK17) LDTP05247 C351(6.69)  LDD3310 
Cyclin-dependent kinase 18 (CDK18) LDTP05507 C411(1.69)  LDD3344 
Cyclin-dependent kinase 19 (CDK19) LDTP11340 C64(0.76)  LDD0533 
Cyclin-dependent kinase 2 (CDK2) LDTP03299 C118(0.40); C177(1.26)  LDD0531 
Cyclin-dependent kinase 4 (CDK4) LDTP02589 C78(0.95); C135(0.91)  LDD0078 
Cyclin-dependent kinase 5 (CDK5) LDTP05245 C157(2.61); C117(1.51); C94(1.22)  LDD0080 
Cyclin-dependent kinase 6 (CDK6) LDTP05244 C83(1.13)  LDD0078 
Cyclin-dependent kinase 7 (CDK7) LDTP04379 C305(0.94); C312(0.94)  LDD0078 
Cyclin-dependent kinase 8 (CDK8) LDTP04245 C291(250.29)  LDD0209 
Cyclin-dependent kinase 9 (CDK9) LDTP04384 C10(4.25)  LDD0209 
Cyclin-dependent kinase inhibitor 3 (CDKN3) LDTP06603 C39(5.66); C51(5.66)  LDD0080 
Cyclin-dependent kinase-like 2 (CDKL2) LDTP09866 C816(3.33)  LDD3310 
Cyclin-G-associated kinase (GAK) LDTP00497 C87(1.10); C190(1.10); C504(1.01); C508(1.01)  LDD0078 
Cystathionine beta-synthase (CBS) LDTP03753 C52(0.97); C109(0.86); C370(1.00); C165(0.94)  LDD1492 
Cystathionine gamma-lyase (CTH) LDTP03656 C252(2.85); C255(2.85)  LDD0080 
Cysteine desulfurase (NFS1) LDTP14223 C158(0.95); C163(0.95)  LDD0078 
Cysteine protease ATG4A (ATG4A) LDTP09740 C124(1.17); C125(1.17)  LDD0078 
Cysteine protease ATG4C (ATG4C) LDTP10228 C107(1.11); C111(1.11)  LDD0078 
Cysteine protease ATG4D (ATG4D) LDTP08200 C263(0.72)  LDD1508 
Cysteine sulfinic acid decarboxylase (CSAD) LDTP14190 C503(1.12)  LDD3382 
Cysteine--tRNA ligase, cytoplasmic (CARS1) LDTP04263 C589(1.99); C608(2.64); C27(1.89)  LDD3311 
Cytidine deaminase (CDA) LDTP03642 C14(0.99); C8(0.99); C102(0.98); C99(0.98)  LDD0078 
Cytochrome b-245 heavy chain (CYBB) LDTP02056 C537(2.34); C428(9.47)  LDD3333 
Cytochrome b-c1 complex subunit 1, mitochondrial (UQCRC1) LDTP03610 C453(0.87)  LDD0078 
Cytochrome b-c1 complex subunit 2, mitochondrial (UQCRC2) LDTP03189 C125(0.94)  LDD0078 
Cytochrome b-c1 complex subunit 6, mitochondrial (UQCRH) LDTP02229 C81(0.73)  LDD0531 
Cytochrome b-c1 complex subunit 6-like, mitochondrial (UQCRHL) LDTP16398 C37(1.19)  LDD3313 
Cytochrome b5 reductase 4 (CYB5R4) LDTP07942 C213(0.97)  LDD1508 
Cytochrome b5 type B (CYB5B) LDTP00697 C115(1.24)  LDD0531 
Cytochrome c oxidase assembly factor 7 (COA7) LDTP10137 C62(9.82); C71(9.82); C37(3.83); C172(3.65)  LDD0080 
Cytochrome c oxidase subunit 1 (MT-CO1) LDTP01772 C498(1.31)  LDD3332 
Cytochrome c oxidase subunit 2 (MT-CO2) LDTP01773 C196(0.85); C200(0.85)  LDD1094 
Cytochrome c oxidase subunit 6B1 (COX6B1) LDTP02748 C54(0.93)  LDD0078 
Cytochrome c oxidase subunit NDUFA4 (NDUFA4) LDTP00293 C44(1.62)  LDD0080 
Cytochrome c1, heme protein, mitochondrial (CYC1) LDTP02283 C139(1.19); C271(0.98)  LDD0531 
Cytochrome P450 1A1 (CYP1A1) LDTP02054 C289(1.15)  LDD3493 
Cytochrome P450 1B1 (CYP1B1) LDTP06608 C92(1.65)  LDD3310 
Cytochrome P450 20A1 (CYP20A1) LDTP17410 C326(0.80); C331(0.80)  LDD0533 
Cytochrome P450 26B1 (CYP26B1) LDTP12480 C257(3.34)  LDD3455 
Cytochrome P450 2C18 (CYP2C18) LDTP03667 C372(3.18)  LDD3490 
Cytochrome P450 2C19 (CYP2C19) LDTP03668 C338(1.08)  LDD2388 
Cytochrome P450 2J2 (CYP2J2) LDTP04431 C193(1.60)  LDD2270 
Cytochrome P450 2S1 (CYP2S1) LDTP10821 C440(1.79)  LDD3314 
Cytochrome P450 2U1 (CYP2U1) LDTP08061 C490(0.94)  LDD1508 
Cytochrome P450 2W1 (CYP2W1) LDTP09318 C153(1.87)  LDD3452 
Cytochrome P450 4F11 (CYP4F11) LDTP12185 C206(0.72); C214(0.72)  LDD0531 
Cytochrome P450 4F12 (CYP4F12) LDTP12267 C50(2.53); C468(1.25)  LDD3321 
Cytochrome P450 4V2 (CYP4V2) LDTP07866 C282(0.96); C406(1.48)  LDD3320 
Cytochrome P450 4X1 (CYP4X1) LDTP15397 C203(0.78)  LDD1492 
Cytochrome P450 7B1 (CYP7B1) LDTP01336 C203(2.67)  LDD3311 
Cytoglobin (CYGB) LDTP09656 C38(1.86)  LDD3332 
Cytokine-like nuclear factor N-PAC (GLYR1) LDTP06828 C413(0.91); C416(0.91)  LDD0078 
Cytoplasmic aconitate hydratase (ACO1) LDTP03110 C369(0.65); C370(0.74)  LDD0531 
Cytoplasmic tRNA 2-thiolation protein 1 (CTU1) LDTP15267 C237(1.14); C299(0.99); C302(0.99)  LDD0078 
Cytoplasmic tyrosine-protein kinase BMX (BMX) LDTP04472 C366(1.54)  LDD3395 
Cytosol aminopeptidase (LAP3) LDTP03455 C445(1.09); C129(1.04); C462(0.97); C376(0.95)  LDD0078 
Cytosolic 10-formyltetrahydrofolate dehydrogenase (ALDH1L1) LDTP01341 C248(1.92); C96(1.33)  LDD3319 
Cytosolic 5'-nucleotidase 3A (NT5C3A) LDTP11723 C73(1.09)  LDD0078 
Cytosolic acyl coenzyme A thioester hydrolase (ACOT7) LDTP00194 C288(1.03)  LDD0078 
Cytosolic carboxypeptidase 1 (AGTPBP1) LDTP13727 C1143(3.29)  LDD3333 
Cytosolic endo-beta-N-acetylglucosaminidase (ENGASE) LDTP15517 C113(1.46)  LDD0080 
Cytosolic iron-sulfur assembly component 3 (CIAO3) LDTP11990 C71(2.60); C77(2.60); C74(2.60)  LDD0080 
Cytosolic non-specific dipeptidase (CNDP2) LDTP10514 C192(1.62)  LDD0613 
Cytosolic phospholipase A2 (PLA2G4A) LDTP04124 C726(2.24)  LDD0080 
Cytosolic phospholipase A2 epsilon (PLA2G4E) LDTP06784 C338(0.87)  LDD3360 
Cytosolic phospholipase A2 gamma (PLA2G4C) LDTP13687 C361(1.76)  LDD2361 
Cytosolic phospholipase A2 zeta (PLA2G4F) LDTP07326 C834(2.38)  LDD3486 
Cytosolic purine 5'-nucleotidase (NT5C2) LDTP04327 C181(0.89)  LDD0078 
D-2-hydroxyglutarate dehydrogenase, mitochondrial (D2HGDH) LDTP08855 C286(1.26); C299(1.26)  LDD1095 
D-3-phosphoglycerate dehydrogenase (PHGDH) LDTP00701 C19(1.05)  LDD0078 
D-aminoacyl-tRNA deacylase 1 (DTD1) LDTP09489 C28(0.81)  LDD1507 
D-aspartate oxidase (DDO) LDTP10875 C356(2.51)  LDD3439 
D-beta-hydroxybutyrate dehydrogenase, mitochondrial (BDH1) LDTP14805 C209(1.35); C221(0.86); C86(0.49)  LDD0531 
D-dopachrome decarboxylase-like protein (DDTL) LDTP18807 C24(1.01)  LDD0531 
D-glucuronyl C5-epimerase (GLCE) LDTP01464 C256(3.02)  LDD3427 
D-glutamate cyclase, mitochondrial (DGLUCY) LDTP15241 C270(2.81)  LDD3311 
D-ribitol-5-phosphate cytidylyltransferase (CRPPA) LDTP00059 C56(3.87)  LDD3334 
Damage-control phosphatase ARMT1 (ARMT1) LDTP12085 C343(0.74)  LDD3332 
DBH-like monooxygenase protein 1 (MOXD1) LDTP07662 C480(0.99)  LDD3332 
DCN1-like protein 1 (DCUN1D1) LDTP10349 C115(1.09)  LDD0078 
DCN1-like protein 2 (DCUN1D2) LDTP07576 C115(34.67)  LDD0209 
DCN1-like protein 3 (DCUN1D3) LDTP08538 C140(59.60)  LDD0209 
DCN1-like protein 4 (DCUN1D4) LDTP09799 C51(8.27); C56(8.27); C253(1.30)  LDD0080 
DCN1-like protein 5 (DCUN1D5) LDTP11199 C115(6.00); C51(2.58); C117(1.12)  LDD0080 
dCTP pyrophosphatase 1 (DCTPP1) LDTP12013 C162(1.45)  LDD0080 
DDB1- and CUL4-associated factor 1 (DCAF1) LDTP14038 C1070(1.19)  LDD0078 
DDB1- and CUL4-associated factor 11 (DCAF11) LDTP09490 C77(2.44)  LDD3332 
DDB1- and CUL4-associated factor 5 (DCAF5) LDTP10472 C884(0.97); C890(0.97); C812(0.91); C883(0.87)  LDD0078 
DDB1- and CUL4-associated factor 6 (DCAF6) LDTP06941 C590(1.71)  LDD3316 
DDB1- and CUL4-associated factor 8 (DCAF8) LDTP07169 C272(1.51); C273(1.51)  LDD0080 
DDB1- and CUL4-associated factor 8-like protein 1 (DCAF8L1) LDTP18792 C209(2.46)  LDD3312 
DDB1- and CUL4-associated factor 8-like protein 2 (DCAF8L2) LDTP19059 C209(0.87)  LDD0533 
Deaminated glutathione amidase (NIT1) LDTP15311 C165(34.34)  LDD0209 
Death-associated protein kinase 1 (DAPK1) LDTP04556 C975(1.45)  LDD3310 
Death-associated protein kinase 3 (DAPK3) LDTP00730 C451(1.98)  LDD0080 
Decapping and exoribonuclease protein (DXO) LDTP01405 C108(0.92)  LDD3351 
Dehydrodolichyl diphosphate synthase complex subunit DHDDS (DHDDS) LDTP08177 C117(2.28)  LDD3333 
Dehydrodolichyl diphosphate synthase complex subunit NUS1 (NUS1) LDTP10245 C287(0.99)  LDD0078 
Dehydrogenase/reductase SDR family member 1 (DHRS1) LDTP10550 C256(1.01)  LDD0078 
Dehydrogenase/reductase SDR family member 11 (DHRS11) LDTP07678 C195(1.76)  LDD3335 
Dehydrogenase/reductase SDR family member 13 (DHRS13) LDTP15154 C28(1.15)  LDD0625 
Dehydrogenase/reductase SDR family member 2, mitochondrial (DHRS2) LDTP05809 C92(1.19); C212(1.51)  LDD3310 
Dehydrogenase/reductase SDR family member 4 (DHRS4) LDTP11216 C209(0.97); C88(0.98)  LDD1492 
Dehydrogenase/reductase SDR family member 4-like 2 (DHRS4L2) LDTP15133 C88(1.99)  LDD3319 
Dehydrogenase/reductase SDR family member 6 (BDH2) LDTP11251 C44(1.06)  LDD3313 
Dehydrogenase/reductase SDR family member 7 (DHRS7) LDTP13959 C147(1.21); C94(0.97)  LDD0531 
Dehydrogenase/reductase SDR family member 7B (DHRS7B) LDTP07402 C220(0.92)  LDD1492 
Dehydrogenase/reductase SDR family member 9 (DHRS9) LDTP11038 C60(2.66)  LDD3312 
Deleted in malignant brain tumors 1 protein (DMBT1) LDTP13236 C406(4.70)  LDD3354 
Delta(14)-sterol reductase LBR (LBR) LDTP06200 C591(10.69)  LDD0209 
Delta(14)-sterol reductase TM7SF2 (TM7SF2) LDTP01389 C184(1.55); C406(0.62)  LDD0531 
Delta(24)-sterol reductase (DHCR24) LDTP06375 C252(1.13)  LDD0078 
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (ECH1) LDTP05724 C187(0.96)  LDD0580 
Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (ALDH4A1) LDTP03507 C421(4.60); C432(4.60)  LDD0080 
Delta-1-pyrroline-5-carboxylate synthase (ALDH18A1) LDTP04646 C88(1.18); C606(0.90); C612(0.90); C546(0.88)  LDD0078 
Delta-aminolevulinic acid dehydratase (ALAD) LDTP02684 C75(1.15)  LDD3316 
Deoxycytidine kinase (DCK) LDTP03400 C9(2.18); C45(1.10); C59(1.07)  LDD0080 
Deoxycytidylate deaminase (DCTD) LDTP03643 C71(1.21); C94(0.88)  LDD3310 
Deoxyguanosine kinase, mitochondrial (DGUOK) LDTP06651 C87(0.97)  LDD0078 
Deoxyhypusine hydroxylase (DOHH) LDTP11225 C232(1.37)  LDD0080 
Deoxyhypusine synthase (DHPS) LDTP04248 C177(0.88)  LDD0078 
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (SAMHD1) LDTP14016 C341(0.92)  LDD0078 
Deoxyribonuclease gamma (DNASE1L3) LDTP05941 C68(1.61)  LDD3370 
Deoxyribonuclease TATDN1 (TATDN1) LDTP17371 C113(0.87); C168(1.39); C150(1.12)  LDD0531 
Deoxyribonuclease-1-like 1 (DNASE1L1) LDTP04231 C224(1.31)  LDD3365 
Deoxyribonuclease-1-like 2 (DNASE1L2) LDTP09910 C42(1.40)  LDD3345 
Deoxyribonuclease-2-alpha (DNASE2) LDTP00185 C327(0.93); C308(0.91)  LDD1492 
Deoxyribose-phosphate aldolase (DERA) LDTP13941 C182(0.92); C118(0.87)  LDD0078 
Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (DUT) LDTP03669 C222(0.94)  LDD0078 
Dephospho-CoA kinase domain-containing protein (DCAKD) LDTP18087 C135(0.97)  LDD0078 
Dermatan-sulfate epimerase (DSE) LDTP13504 C494(1.28); C506(1.28)  LDD0080 
Desumoylating isopeptidase 1 (DESI1) LDTP07407 C108(1.16)  LDD3331 
DET1 homolog (DET1) LDTP07969 C493(1.56)  LDD3314 
Deubiquitinase DESI2 (DESI2) LDTP11174 C144(0.96); C108(0.99); C137(0.98); C144(0.98)  LDD1492 
Deubiquitinase MYSM1 (MYSM1) LDTP07230 C440(0.96); C445(0.96)  LDD0078 
Deubiquitinase OTUD6B (OTUD6B) LDTP08942 C292(0.98)  LDD0078 
Deubiquitinating protein VCPIP1 (VCPIP1) LDTP10466 C207(0.99); C219(0.99); C344(1.00); C397(1.11)  LDD0531 
Developmentally-regulated GTP-binding protein 1 (DRG1) LDTP13836 C195(0.92)  LDD0078 
Developmentally-regulated GTP-binding protein 2 (DRG2) LDTP04656 C241(1.91)  LDD0080 
DGAT1/2-independent enzyme synthesizing storage lipids (TMEM68) LDTP19892 C183(1.57)  LDD3311 
Di-N-acetylchitobiase (CTBS) LDTP14801 C281(2.77)  LDD3310 
Diacylglycerol kinase alpha (DGKA) LDTP03251 C707(120.63); C277(7.27); C645(5.75)  LDD0209 
Diacylglycerol kinase beta (DGKB) LDTP14294 C140(5.80)  LDD3344 
Diacylglycerol kinase delta (DGKD) LDTP06619 C121(1.25)  LDD0532 
Diacylglycerol kinase epsilon (DGKE) LDTP04506 C415(1.10); C420(1.10)  LDD0078 
Diacylglycerol kinase eta (DGKH) LDTP08368 C1038(29.74)  LDD0209 
Diacylglycerol kinase gamma (DGKG) LDTP04267 C357(3.32); C413(2.72)  LDD2412 
Diacylglycerol kinase theta (DGKQ) LDTP04539 C607(2.08); C108(2.97); C123(1.58)  LDD3314 
Diacylglycerol kinase zeta (DGKZ) LDTP05931 C59(1.10); C63(1.10)  LDD0078 
Diacylglycerol lipase-beta (DAGLB) LDTP09095 C658(1.08); C661(1.08)  LDD0078 
Diacylglycerol O-acyltransferase 1 (DGAT1) LDTP01346 C218(1.09)  LDD0531 
Diamine acetyltransferase 1 (SAT1) LDTP03121 C14(1.84)  LDD3407 
Diamine oxidase [copper-containing] (AOC1) LDTP03013 C181(1.95)  LDD3440 
Dihydrofolate reductase (DHFR) LDTP01769 C7(1.42)  LDD2836 
Dihydrolipoyl dehydrogenase, mitochondrial (DLD) LDTP02362 C80(1.03); C85(1.03)  LDD0078 
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (DLAT) LDTP02497 C586(2.31)  LDD0080 
Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (DLST) LDTP03829 C66(1.70)  LDD3310 
Dihydropteridine reductase (QDPR) LDTP02342 C104(0.28)  LDD0563 
Dihydropyrimidinase-related protein 1 (CRMP1) LDTP06078 C362(2.31)  LDD3331 
Dihydropyrimidinase-related protein 3 (DPYSL3) LDTP06079 C362(2.10); C562(2.25)  LDD3311 
Dihydropyrimidinase-related protein 4 (DPYSL4) LDTP00366 C174(2.01); C176(2.01)  LDD0080 
Dihydropyrimidinase-related protein 5 (DPYSL5) LDTP11035 C241(0.89)  LDD3327 
Dihydropyrimidine dehydrogenase [NADP(+)] (DPYD) LDTP05679 C322(0.85); C324(0.85)  LDD0078 
Dihydroxyacetone phosphate acyltransferase (GNPAT) LDTP00577 C668(1.10); C650(1.05); C54(1.01)  LDD0078 
Dimethyladenosine transferase 1, mitochondrial (TFB1M) LDTP09613 C304(9.61)  LDD0209 
Dimethyladenosine transferase 2, mitochondrial (TFB2M) LDTP11960 C149(0.71)  LDD0531 
Dimethylaniline monooxygenase [N-oxide-forming] 4 (FMO4) LDTP03599 C63(2.04)  LDD3325 
Dipeptidase 1 (DPEP1) LDTP02850 C87(1.96)  LDD3402 
Dipeptidyl peptidase 1 (CTSC) LDTP04572 C258(1.11); C255(1.05); C136(1.03); C321(1.00)  LDD0078 
Dipeptidyl peptidase 2 (DPP7) LDTP13294 C332(1.01); C338(1.01)  LDD0531 
Dipeptidyl peptidase 3 (DPP3) LDTP12803 C509(102.29)  LDD0209 
Dipeptidyl peptidase 4 (DPP4) LDTP03391 C394(0.98)  LDD3316 
Dipeptidyl peptidase 8 (DPP8) LDTP07728 C596(1.59)  LDD3331 
Dipeptidyl peptidase 9 (DPP9) LDTP08198 C213(1.36)  LDD3318 
Diphosphoinositol polyphosphate phosphohydrolase 1 (NUDT3) LDTP01734 C68(0.71)  LDD3310 
Diphosphoinositol polyphosphate phosphohydrolase 2 (NUDT4) LDTP12910 C147(52.49)  LDD0209 
Diphosphoinositol polyphosphate phosphohydrolase 3-beta (NUDT11) LDTP10335 C80(1.91)  LDD3333 
Diphosphoinositol polyphosphate phosphohydrolase NUDT4B (NUDT4B) LDTP14314 C96(2.70)  LDD3331 
Diphosphomevalonate decarboxylase (MVD) LDTP04567 C108(0.88)  LDD0078 
Diphthine methyl ester synthase (DPH5) LDTP11835 C231(1.26)  LDD3325 
Diphthine methyltransferase (DPH7) LDTP15886 C377(0.97); C380(0.97)  LDD0078 
Diphthine--ammonia ligase (DPH6) LDTP15219 C130(1.48)  LDD3419 
DIS3-like exonuclease 1 (DIS3L) LDTP09525 C482(1.07); C312(0.95); C316(0.95)  LDD0078 
DIS3-like exonuclease 2 (DIS3L2) LDTP08640 C216(1.02)  LDD0078 
Disco-interacting protein 2 homolog A (DIP2A) LDTP06185 C252(0.75)  LDD0531 
Discoidin domain-containing receptor 2 (DDR2) LDTP06644 C831(5.56); C716(3.71); C288(3.24)  LDD3310 
Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) LDTP00403 C173(0.84); C435(1.07)  LDD0531 
Disintegrin and metalloproteinase domain-containing protein 12 (ADAM12) LDTP00704 C367(0.94); C369(0.94)  LDD0078 
Disintegrin and metalloproteinase domain-containing protein 15 (ADAM15) LDTP05874 C733(1.33); C134(1.12); C136(1.12)  LDD0078 
Disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) LDTP05137 C469(0.99)  LDD0078 
Disintegrin and metalloproteinase domain-containing protein 19 (ADAM19) LDTP11678 C748(1.15)  LDD0078 
Disintegrin and metalloproteinase domain-containing protein 22 (ADAM22) LDTP12962 C711(1.05)  LDD1492 
Disintegrin and metalloproteinase domain-containing protein 23 (ADAM23) LDTP01115 C475(1.95)  LDD3419 
Disintegrin and metalloproteinase domain-containing protein 28 (ADAM28) LDTP13476 C585(1.51)  LDD3368 
Disintegrin and metalloproteinase domain-containing protein 8 (ADAM8) LDTP05091 C566(1.02); C571(1.02)  LDD0078 
Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9) LDTP05873 C370(1.48)  LDD0078 
Distal membrane-arm assembly complex protein 2 (DMAC2) LDTP12708 C200(3.25)  LDD3310 
DNA (cytosine-5)-methyltransferase 1 (DNMT1) LDTP03350 C1071(52.30)  LDD0209 
DNA (cytosine-5)-methyltransferase 3A (DNMT3A) LDTP14265 C136(3.19); C137(3.19); C557(2.96); C562(2.96)  LDD0080 
DNA (cytosine-5)-methyltransferase 3B (DNMT3B) LDTP13098 C524(1.17); C527(1.17)  LDD0078 
DNA annealing helicase and endonuclease ZRANB3 (ZRANB3) LDTP06970 C915(1.06); C920(1.06)  LDD0078 
DNA cross-link repair 1A protein (DCLRE1A) LDTP07601 C72(1.04); C84(1.04)  LDD0078 
DNA dC->dU-editing enzyme APOBEC-3B (APOBEC3B) LDTP13251 C247(4.20)  LDD0080 
DNA dC->dU-editing enzyme APOBEC-3C (APOBEC3C) LDTP12539 C130(1.08)  LDD0078 
DNA dC->dU-editing enzyme APOBEC-3D (APOBEC3D) LDTP10086 C261(1.38)  LDD0531 
DNA dC->dU-editing enzyme APOBEC-3F (APOBEC3F) LDTP08470 C261(1.26)  LDD3315 
DNA dC->dU-editing enzyme APOBEC-3G (APOBEC3G) LDTP12209 C243(1.40); C36(2.33)  LDD3367 
DNA endonuclease RBBP8 (RBBP8) LDTP10952 C368(55.17)  LDD0209 
DNA excision repair protein ERCC-1 (ERCC1) LDTP02237 C274(1.68)  LDD3339 
DNA excision repair protein ERCC-5 (ERCC5) LDTP03451 C1021(4.98); C12(9.12)  LDD0209 
DNA excision repair protein ERCC-6 (ERCC6) LDTP05407 C1464(1.10)  LDD0078 
DNA excision repair protein ERCC-6-like (ERCC6L) LDTP06713 C998(1.95)  LDD0080 
DNA excision repair protein ERCC-6-like 2 (ERCC6L2) LDTP07150 C46(1.89)  LDD3397 
DNA fragmentation factor subunit beta (DFFB) LDTP01394 C194(0.98); C306(0.98)  LDD0078 
DNA helicase B (HELB) LDTP09239 C60(20.76)  LDD0209 
DNA helicase MCM8 (MCM8) LDTP13380 C588(5.49)  LDD3373 
DNA helicase MCM9 (MCM9) LDTP12785 C185(0.90)  LDD0547 
DNA ligase 1 (LIG1) LDTP02971 C895(0.97); C508(0.89)  LDD0078 
DNA ligase 3 (LIG3) LDTP04334 C929(1.06)  LDD0078 
DNA ligase 4 (LIG4) LDTP04335 C807(1.26)  LDD0078 
DNA nucleotidylexotransferase (DNTT) LDTP02003 C302(2.00); C403(3.02); C216(1.24); C437(1.40)  LDD3339 
DNA oxidative demethylase ALKBH2 (ALKBH2) LDTP07457 C165(1.55); C192(1.30)  LDD0080 
DNA polymerase alpha catalytic subunit (POLA1) LDTP02376 C1310(4.58); C1315(4.58); C514(2.34); C1393(1.49)  LDD0080 
DNA polymerase alpha subunit B (POLA2) LDTP06069 C198(1.01)  LDD0078 
DNA polymerase beta (POLB) LDTP02163 C267(0.52)  LDD0533 
DNA polymerase delta catalytic subunit (POLD1) LDTP03437 C1011(4.64); C1015(4.64); C1012(4.64); C1061(2.21)  LDD0080 
DNA polymerase delta subunit 2 (POLD2) LDTP04223 C91(9.03); C92(9.03); C83(1.24)  LDD0080 
DNA polymerase delta subunit 4 (POLD4) LDTP12273 C61(1.70)  LDD3312 
DNA polymerase epsilon catalytic subunit A (POLE) LDTP05532 C445(1.07); C1076(0.91); C1443(0.86); C1445(0.86)  LDD0078 
DNA polymerase epsilon subunit 2 (POLE2) LDTP04737 C403(0.95); C408(1.52)  LDD0531 
DNA polymerase eta (POLH) LDTP13806 C72(1.00)  LDD1492 
DNA polymerase iota (POLI) LDTP13652 C336(0.99)  LDD0531 
DNA polymerase kappa (POLK) LDTP13158 C681(2.27)  LDD0080 
DNA polymerase lambda (POLL) LDTP13242 C241(1.24)  LDD0563 
DNA polymerase subunit gamma-1 (POLG) LDTP04596 C647(24.48)  LDD0209 
DNA polymerase subunit gamma-2 (POLG2) LDTP13297 C377(1.24)  LDD0532 
DNA polymerase theta (POLQ) LDTP01212 C2411(2.04)  LDD0080 
DNA polymerase zeta catalytic subunit (REV3L) LDTP01025 C3099(0.88); C3104(0.88)  LDD0078 
DNA primase large subunit (PRIM2) LDTP04273 C111(4.94)  LDD0209 
DNA primase small subunit (PRIM1) LDTP04272 C121(0.90); C128(0.90)  LDD0078 
DNA repair and recombination protein RAD54-like (RAD54L) LDTP09846 C578(11.37)  LDD0080 
DNA repair and recombination protein RAD54B (RAD54B) LDTP14201 C607(1.08); C611(1.08); C592(0.86); C596(0.86)  LDD0078 
DNA repair endonuclease XPF (ERCC4) LDTP09918 C560(0.82)  LDD0531 
DNA repair nuclease/redox regulator APEX1 (APEX1) LDTP03398 C65(0.89)  LDD0532 
DNA repair protein RAD50 (RAD50) LDTP09912 C48(14.18); C1296(4.60); C102(12.38); C53(7.12)  LDD0209 
DNA replication ATP-dependent helicase/nuclease DNA2 (DNA2) LDTP04420 C402(3.82); C848(2.00); C621(1.77)  LDD0080 
DNA replication licensing factor MCM2 (MCM2) LDTP04286 C315(0.89); C332(2.00); C340(2.00); C522(1.16)  LDD0531 
DNA replication licensing factor MCM3 (MCM3) LDTP03316 C148(3.15); C360(1.48)  LDD0080 
DNA replication licensing factor MCM4 (MCM4) LDTP03680 C605(0.85)  LDD0078 
DNA replication licensing factor MCM5 (MCM5) LDTP03681 C197(0.92); C207(0.89); C221(0.87)  LDD0078 
DNA replication licensing factor MCM6 (MCM6) LDTP06150 C301(1.21); C302(1.21); C721(1.03); C180(0.98)  LDD0078 
DNA replication licensing factor MCM7 (MCM7) LDTP03682 C482(0.84)  LDD0078 
DNA topoisomerase 1 (TOP1) LDTP02567 C630(0.93)  LDD0078 
DNA topoisomerase 2-alpha (TOP2A) LDTP02568 C170(4.82)  LDD0209 
DNA topoisomerase 2-beta (TOP2B) LDTP05379 C191(0.87)  LDD0078 
DNA topoisomerase 3-alpha (TOP3A) LDTP05885 C705(0.86); C708(0.86)  LDD0078 
DNA topoisomerase 3-beta-1 (TOP3B) LDTP01732 C161(2.38); C166(2.38); C190(1.05); C771(1.24)  LDD0080 
DNA topoisomerase I, mitochondrial (TOP1MT) LDTP10018 C268(95.73)  LDD0209 
DNA transposase THAP9 (THAP9) LDTP15999 C186(1.11)  LDD1507 
DNA-(apurinic or apyrimidinic site) endonuclease 2 (APEX2) LDTP13182 C27(0.93)  LDD0078 
DNA-3-methyladenine glycosylase (MPG) LDTP03481 C61(0.95)  LDD0533 
DNA-binding protein SMUBP-2 (IGHMBP2) LDTP03862 C612(4.62)  LDD0204 
DNA-dependent metalloprotease SPRTN (SPRTN) LDTP11680 C169(1.06); C173(1.06)  LDD0078 
DNA-dependent protein kinase catalytic subunit (PRKDC) LDTP05136 C1499(1.13); C1507(1.13); C1312(1.11); C3837(1.05)  LDD0078 
DNA-directed DNA/RNA polymerase mu (POLM) LDTP12323 C409(3.15)  LDD3373 
DNA-directed primase/polymerase protein (PRIMPOL) LDTP10562 C446(2.79); C451(2.79)  LDD0080 
DNA-directed RNA polymerase I subunit RPA1 (POLR1A) LDTP01636 C968(0.97); C733(0.95)  LDD0078 
DNA-directed RNA polymerase I subunit RPA12 (POLR1H) LDTP13001 C41(1.03)  LDD3312 
DNA-directed RNA polymerase I subunit RPA2 (POLR1B) LDTP12113 C855(1.13); C1061(1.58); C307(1.07)  LDD0080 
DNA-directed RNA polymerase I subunit RPA34 (POLR1G) LDTP00642 C491(1.10); C16(1.61)  LDD3311 
DNA-directed RNA polymerase I subunit RPA43 (POLR1F) LDTP14904 C193(1.26)  LDD0080 
DNA-directed RNA polymerase I subunit RPA49 (POLR1E) LDTP11642 C200(1.10)  LDD0078 
DNA-directed RNA polymerase II subunit GRINL1A (POLR2M) LDTP02406 C82(8.49)  LDD0209 
DNA-directed RNA polymerase II subunit RPB1 (POLR2A) LDTP03298 C1402(1.34); C1407(1.34); C184(1.15); C451(1.01)  LDD0078 
DNA-directed RNA polymerase II subunit RPB11-a (POLR2J) LDTP04508 C31(1.21)  LDD0080 
DNA-directed RNA polymerase II subunit RPB11-b1 (POLR2J2) LDTP18358 C31(1.84)  LDD3345 
DNA-directed RNA polymerase II subunit RPB11-b2 (POLR2J3) LDTP18370 C107(282.95)  LDD0209 
DNA-directed RNA polymerase II subunit RPB2 (POLR2B) LDTP03564 C1093(1.14); C572(1.10); C221(0.99); C1119(0.93)  LDD0078 
DNA-directed RNA polymerase II subunit RPB3 (POLR2C) LDTP02992 C107(1.49)  LDD0080 
DNA-directed RNA polymerase II subunit RPB4 (POLR2D) LDTP00659 C104(0.71); C99(0.71)  LDD0532 
DNA-directed RNA polymerase II subunit RPB7 (POLR2G) LDTP04991 C127(0.63); C38(0.96)  LDD0531 
DNA-directed RNA polymerase II subunit RPB9 (POLR2I) LDTP03826 C42(0.92); C52(0.92)  LDD0078 
DNA-directed RNA polymerase III subunit RPC1 (POLR3A) LDTP00442 C19(1.04); C491(0.95); C493(0.95)  LDD0078 
DNA-directed RNA polymerase III subunit RPC10 (POLR3K) LDTP13930 C102(0.90); C97(0.90)  LDD0078 
DNA-directed RNA polymerase III subunit RPC2 (POLR3B) LDTP12702 C480(0.94); C490(0.94)  LDD0078 
DNA-directed RNA polymerase III subunit RPC3 (POLR3C) LDTP11237 C79(0.91)  LDD0078 
DNA-directed RNA polymerase III subunit RPC4 (POLR3D) LDTP02113 C316(1.11)  LDD0532 
DNA-directed RNA polymerase III subunit RPC5 (POLR3E) LDTP12693 C103(1.04)  LDD0078 
DNA-directed RNA polymerase III subunit RPC6 (POLR3F) LDTP11762 C221(2.75)  LDD3312 
DNA-directed RNA polymerase III subunit RPC8 (POLR3H) LDTP14087 C74(0.67)  LDD1511 
DNA-directed RNA polymerase, mitochondrial (POLRMT) LDTP00267 C174(1.03); C178(1.03); C398(1.01); C119(0.95)  LDD0078 
DNA-directed RNA polymerases I and III subunit RPAC1 (POLR1C) LDTP00557 C256(0.87)  LDD0531 
DNA-directed RNA polymerases I and III subunit RPAC2 (POLR1D) LDTP02448 C39(0.97)  LDD1492 
DNA-directed RNA polymerases I, II, and III subunit RPABC1 (POLR2E) LDTP02993 C21(1.08)  LDD0532 
DNA-directed RNA polymerases I, II, and III subunit RPABC2 (POLR2F) LDTP04908 C76(1.01)  LDD3312 
DNA-directed RNA polymerases I, II, and III subunit RPABC3 (POLR2H) LDTP04507 C30(2.16)  LDD3310 
DnaJ homolog subfamily C member 10 (DNAJC10) LDTP08590 C728(2.35); C735(2.35)  LDD0080 
Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (ALG10) LDTP06949 C181(0.63)  LDD1095 
Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (ALG3) LDTP09841 C21(1.04)  LDD0078 
Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (ALG12) LDTP11259 C328(1.26)  LDD0547 
Dolichol kinase (DOLK) LDTP13709 C99(1.06)  LDD1507 
Dolichol-phosphate mannosyltransferase subunit 1 (DPM1) LDTP01047 C202(1.16)  LDD1507 
Dolichol-phosphate mannosyltransferase subunit 3 (DPM3) LDTP13087 C97(2.48)  LDD3312 
Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (ALG6) LDTP14213 C280(0.75)  LDD0531 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (STT3A) LDTP04120 C637(1.07)  LDD0078 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (STT3B) LDTP09388 C715(1.01); C40(0.97)  LDD0078 
Dolichyl-phosphate beta-glucosyltransferase (ALG5) LDTP14214 C194(0.93)  LDD0078 
Dolichyldiphosphatase 1 (DOLPP1) LDTP15328 C86(0.97)  LDD0531 
Dopamine beta-hydroxylase (DBH) LDTP02331 C596(2.41)  LDD3433 
Double-strand break repair protein MRE11 (MRE11) LDTP04337 C336(1.67)  LDD0080 
Double-stranded RNA-specific adenosine deaminase (ADAR) LDTP04690 C622(104.40); C630(361.85); C649(4.31); C499(18.32)  LDD0209 
Double-stranded RNA-specific editase 1 (ADARB1) LDTP05149 C991(2.53)  LDD3310 
dTDP-D-glucose 4,6-dehydratase (TGDS) LDTP14538 C175(1.04)  LDD0531 
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (PDE11A) LDTP12266 C91(2.70)  LDD2348 
Dual oxidase 1 (DUOX1) LDTP12501 C656(1.76)  LDD3375 
Dual oxidase 2 (DUOX2) LDTP12500 C804(1.84); C1520(2.17)  LDD3410 
Dual serine/threonine and tyrosine protein kinase (DSTYK) LDTP07752 C669(0.93); C678(0.93)  LDD0078 
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (PDE1B) LDTP05271 C476(1.66)  LDD3413 
Dual specificity mitogen-activated protein kinase kinase 1 (MAP2K1) LDTP05369 C277(0.99)  LDD0078 
Dual specificity mitogen-activated protein kinase kinase 2 (MAP2K2) LDTP03808 C384(1.03)  LDD0078 
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3) LDTP04103 C310(3.87)  LDD3311 
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4) LDTP04077 C266(15.37); C246(4.34)  LDD0209 
Dual specificity mitogen-activated protein kinase kinase 5 (MAP2K5) LDTP05774 C109(14.31)  LDD0209 
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6) LDTP04509 C38(5.97); C212(7.03)  LDD3331 
Dual specificity mitogen-activated protein kinase kinase 7 (MAP2K7) LDTP00414 C280(7.00); C260(4.63)  LDD0209 
Dual specificity protein kinase CLK1 (CLK1) LDTP04297 C9(138.29)  LDD0209 
Dual specificity protein kinase CLK2 (CLK2) LDTP04298 C180(27.90)  LDD0209 
Dual specificity protein kinase CLK3 (CLK3) LDTP04299 C258(0.87); C294(0.50); C321(1.05)  LDD0531 
Dual specificity protein kinase CLK4 (CLK4) LDTP12151 C81(3.10)  LDD0080 
Dual specificity protein kinase TTK (TTK) LDTP03679 C322(1.06); C269(1.04); C229(0.98)  LDD0078 
Dual specificity protein phosphatase 1 (DUSP1) LDTP03446 C132(0.88); C136(0.88)  LDD0593 
Dual specificity protein phosphatase 10 (DUSP10) LDTP14299 C218(2.76)  LDD3331 
Dual specificity protein phosphatase 12 (DUSP12) LDTP13663 C307(0.94); C309(0.94)  LDD0078 
Dual specificity protein phosphatase 14 (DUSP14) LDTP01504 C133(1.01)  LDD0078 
Dual specificity protein phosphatase 15 (DUSP15) LDTP11776 C69(2.36)  LDD3411 
Dual specificity protein phosphatase 16 (DUSP16) LDTP11446 C170(1.66)  LDD3444 
Dual specificity protein phosphatase 19 (DUSP19) LDTP09539 C150(0.83)  LDD1492 
Dual specificity protein phosphatase 22 (DUSP22) LDTP12540 C52(2.63)  LDD3339 
Dual specificity protein phosphatase 23 (DUSP23) LDTP11289 C67(0.82)  LDD0547 
Dual specificity protein phosphatase 3 (DUSP3) LDTP04415 C171(0.93)  LDD0532 
Dual specificity protein phosphatase 4 (DUSP4) LDTP05754 C45(1.06); C158(0.97); C244(1.08); C280(0.93)  LDD0531 
Dual specificity protein phosphatase 5 (DUSP5) LDTP06609 C115(1.12); C139(1.02); C140(1.02); C161(0.87)  LDD0531 
Dual specificity protein phosphatase 6 (DUSP6) LDTP06641 C353(1.50)  LDD0532 
Dual specificity protein phosphatase 7 (DUSP7) LDTP06642 C166(0.87)  LDD0547 
Dual specificity protein phosphatase 9 (DUSP9) LDTP11016 C134(2.44); C138(2.44)  LDD0080 
Dual specificity protein phosphatase CDC14A (CDC14A) LDTP13659 C12(0.91)  LDD1492 
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) LDTP05953 C312(1.21)  LDD0531 
Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DYRK1B) LDTP14022 C312(3.64)  LDD3334 
Dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3) LDTP00867 C43(1.12); C46(1.12); C51(1.12)  LDD0078 
Dual specificity tyrosine-phosphorylation-regulated kinase 4 (DYRK4) LDTP12464 C504(4.08)  LDD3365 
Dynamin-1 (DNM1) LDTP05447 C427(1.53)  LDD3311 
Dynamin-1-like protein (DNM1L) LDTP00273 C644(1.22); C361(1.03); C505(0.98)  LDD0078 
Dynamin-2 (DNM2) LDTP04374 C86(2.50)  LDD3310 
Dynamin-3 (DNM3) LDTP13744 C86(2.42); C453(2.89)  LDD3342 
Dynamin-like 120 kDa protein, mitochondrial (OPA1) LDTP00950 C841(1.51)  LDD3310 
Dystrobrevin beta (DTNB) LDTP01094 C197(1.03); C243(1.50); C246(1.50)  LDD0531 
E1A-binding protein p400 (EP400) LDTP10532 C1775(0.98); C2007(0.97)  LDD0078 
E3 ISG15--protein ligase HERC5 (HERC5) LDTP13349 C608(31.49); C302(10.46)  LDD0209 
E3 SUMO-protein ligase CBX4 (CBX4) LDTP00233 C413(1.49); C424(1.49)  LDD0078 
E3 SUMO-protein ligase EGR2 (EGR2) LDTP02543 C251(8.85)  LDD2471 
E3 SUMO-protein ligase KIAA1586 (KIAA1586) LDTP16044 C718(0.96)  LDD0531 
E3 SUMO-protein ligase NSE2 (NSMCE2) LDTP10583 C210(0.96); C215(0.96)  LDD0078 
E3 SUMO-protein ligase PIAS1 (PIAS1) LDTP01356 C49(1.48); C209(1.44); C220(1.44)  LDD0080 
E3 SUMO-protein ligase PIAS2 (PIAS2) LDTP01357 C220(0.94); C231(0.94)  LDD0078 
E3 SUMO-protein ligase PIAS3 (PIAS3) LDTP14303 C366(1.04); C369(1.04)  LDD0531 
E3 SUMO-protein ligase PIAS4 (PIAS4) LDTP08808 C196(1.82); C202(1.82); C50(1.47)  LDD0080 
E3 SUMO-protein ligase RanBP2 (RANBP2) LDTP04310 C2407(1.17); C2710(1.06); C1435(1.05); C1438(1.05)  LDD0078 
E3 SUMO-protein ligase ZBED1 (ZBED1) LDTP01746 C610(6.68)  LDD0204 
E3 SUMO-protein ligase ZNF451 (ZNF451) LDTP14050 C150(3.59); C1025(1.37); C940(1.06)  LDD0080 
E3 ubiquitin ligase RNF121 (RNF121) LDTP16021 C272(0.95); C264(0.93); C259(0.96); C272(1.00)  LDD1492 
E3 ubiquitin ligase RNF157 (RNF157) LDTP10705 C312(11.38); C315(11.38)  LDD0080 
E3 ubiquitin-protein ligase AMFR (AMFR) LDTP13491 C375(1.52); C378(1.52)  LDD0080 
E3 ubiquitin-protein ligase ARIH1 (ARIH1) LDTP14079 C269(0.95); C357(0.89); C362(0.89)  LDD0078 
E3 ubiquitin-protein ligase ARIH2 (ARIH2) LDTP01575 C156(1.10); C161(1.10)  LDD0078 
E3 ubiquitin-protein ligase Arkadia (RNF111) LDTP07790 C108(1.81)  LDD3369 
E3 ubiquitin-protein ligase BRE1A (RNF20) LDTP07218 C925(0.89)  LDD0078 
E3 ubiquitin-protein ligase BRE1B (RNF40) LDTP01141 C963(1.08); C968(1.08); C971(1.08); C890(0.93)  LDD0078 
E3 ubiquitin-protein ligase CBL (CBL) LDTP03186 C567(1.07); C572(1.07)  LDD0078 
E3 ubiquitin-protein ligase CBL-B (CBLB) LDTP05781 C736(0.97); C741(0.97); C607(0.97)  LDD0078 
E3 ubiquitin-protein ligase CBL-C (CBLC) LDTP13582 C354(1.87)  LDD3320 
E3 ubiquitin-protein ligase CHFR (CHFR) LDTP10270 C601(0.88); C603(0.88); C604(0.88)  LDD0078 
E3 ubiquitin-protein ligase CHIP (STUB1) LDTP13655 C199(1.08); C48(1.02)  LDD0078 
E3 ubiquitin-protein ligase COP1 (COP1) LDTP09272 C151(1.36); C156(1.36)  LDD0532 
E3 ubiquitin-protein ligase DTX1 (DTX1) LDTP08377 C378(2.17)  LDD3403 
E3 ubiquitin-protein ligase DTX3L (DTX3L) LDTP09424 C582(1.09); C585(1.09); C561(1.05); C564(1.05)  LDD0078 
E3 ubiquitin-protein ligase DZIP3 (DZIP3) LDTP08379 C279(0.69)  LDD0531 
E3 ubiquitin-protein ligase E3D (UBE3D) LDTP08124 C189(1.12); C190(1.12); C197(1.12)  LDD0078 
E3 ubiquitin-protein ligase FANCL (FANCL) LDTP12705 C12(1.11)  LDD1507 
E3 ubiquitin-protein ligase HACE1 (HACE1) LDTP08672 C481(1.03)  LDD0531 
E3 ubiquitin-protein ligase Hakai (CBLL1) LDTP07910 C73(1.07); C166(0.89); C172(0.89); C130(0.86)  LDD0078 
E3 ubiquitin-protein ligase HECTD1 (HECTD1) LDTP13574 C2545(1.05); C487(1.03); C2579(1.03); C254(1.02)  LDD0078 
E3 ubiquitin-protein ligase HECTD3 (HECTD3) LDTP07112 C556(8.54); C530(4.17)  LDD0209 
E3 ubiquitin-protein ligase HECW1 (HECW1) LDTP07925 C1574(1.47)  LDD0531 
E3 ubiquitin-protein ligase HECW2 (HECW2) LDTP13072 C942(1.95)  LDD3311 
E3 ubiquitin-protein ligase HERC2 (HERC2) LDTP01657 C2760(1.34); C2025(1.17); C349(1.12); C2726(0.95)  LDD0078 
E3 ubiquitin-protein ligase HUWE1 (HUWE1) LDTP08135 C2721(1.13); C1832(1.05); C3361(1.03); C1891(0.96)  LDD0078 
E3 ubiquitin-protein ligase Itchy homolog (ITCH) LDTP10441 C57(0.94)  LDD0078 
E3 ubiquitin-protein ligase Jade-2 (JADE2) LDTP12411 C516(1.06)  LDD0531 
E3 ubiquitin-protein ligase KCMF1 (KCMF1) LDTP12961 C33(1.13); C12(0.98); C9(0.98)  LDD0078 
E3 ubiquitin-protein ligase listerin (LTN1) LDTP01430 C595(90.49); C981(4.91); C1146(33.70); C498(72.81)  LDD0209 
E3 ubiquitin-protein ligase LNX (LNX1) LDTP09335 C87(1.77)  LDD3339 
E3 ubiquitin-protein ligase LRSAM1 (LRSAM1) LDTP07672 C397(15.86)  LDD0204 
E3 ubiquitin-protein ligase makorin-1 (MKRN1) LDTP13266 C214(1.02); C222(1.02); C98(0.92)  LDD0078 
E3 ubiquitin-protein ligase makorin-2 (MKRN2) LDTP11676 C45(1.21); C171(0.99); C179(0.99)  LDD0078 
E3 ubiquitin-protein ligase MARCHF3 (MARCHF3) LDTP08221 C16(1.29); C6(1.29)  LDD0078 
E3 ubiquitin-protein ligase MARCHF4 (MARCHF4) LDTP13043 C187(1.27); C192(1.27); C166(1.59); C179(1.59)  LDD1093 
E3 ubiquitin-protein ligase MARCHF5 (MARCHF5) LDTP12757 C65(0.96); C68(0.96)  LDD0078 
E3 ubiquitin-protein ligase MARCHF6 (MARCHF6) LDTP00956 C39(1.03); C52(1.01); C55(1.01)  LDD0078 
E3 ubiquitin-protein ligase MARCHF7 (MARCHF7) LDTP12084 C555(0.83); C570(0.83); C572(1.14); C583(1.14)  LDD0531 
E3 ubiquitin-protein ligase MARCHF8 (MARCHF8) LDTP07089 C241(0.98)  LDD1507 
E3 ubiquitin-protein ligase MARCHF9 (MARCHF9) LDTP08403 C313(0.94)  LDD1508 
E3 ubiquitin-protein ligase Mdm2 (MDM2) LDTP05267 C374(8.80)  LDD0204 
E3 ubiquitin-protein ligase MGRN1 (MGRN1) LDTP00939 C528(1.00)  LDD1492 
E3 ubiquitin-protein ligase MIB1 (MIB1) LDTP08416 C88(1.10); C913(1.01); C914(1.01); C834(1.00)  LDD0078 
E3 ubiquitin-protein ligase MIB2 (MIB2) LDTP10099 C380(1.90)  LDD3315 
E3 ubiquitin-protein ligase Midline-1 (MID1) LDTP00611 C119(1.04); C122(1.04); C578(0.92)  LDD0078 
E3 ubiquitin-protein ligase MSL2 (MSL2) LDTP12245 C490(1.11); C493(1.11); C495(1.11)  LDD0078 
E3 ubiquitin-protein ligase MYCBP2 (MYCBP2) LDTP01265 C3152(5.18); C2531(2.51); C2532(2.51); C2662(2.63)  LDD0080 
E3 ubiquitin-protein ligase NEDD4 (NEDD4) LDTP04114 C663(1.21)  LDD3312 
E3 ubiquitin-protein ligase NEDD4-like (NEDD4L) LDTP10699 C874(1.07)  LDD0078 
E3 ubiquitin-protein ligase NEURL1 (NEURL1) LDTP01386 C143(1.33)  LDD2440 
E3 ubiquitin-protein ligase NEURL1B (NEURL1B) LDTP00136 C300(1.51)  LDD3323 
E3 ubiquitin-protein ligase NRDP1 (RNF41) LDTP11935 C63(1.68)  LDD3312 
E3 ubiquitin-protein ligase parkin (PRKN) LDTP00930 C95(1.85)  LDD3335 
E3 ubiquitin-protein ligase PDZRN3 (PDZRN3) LDTP13708 C142(1.58); C146(1.58)  LDD0080 
E3 ubiquitin-protein ligase pellino homolog 1 (PELI1) LDTP10300 C282(0.86)  LDD1508 
E3 ubiquitin-protein ligase pellino homolog 2 (PELI2) LDTP12136 C284(32.45)  LDD0209 
E3 ubiquitin-protein ligase PPP1R11 (PPP1R11) LDTP01086 C85(4.42); C90(4.42)  LDD0080 
E3 ubiquitin-protein ligase Praja-1 (PJA1) LDTP09241 C635(33.44)  LDD0209 
E3 ubiquitin-protein ligase Praja-2 (PJA2) LDTP00694 C415(2.12)  LDD0080 
E3 ubiquitin-protein ligase RAD18 (RAD18) LDTP12573 C204(1.02); C207(1.02); C60(0.92); C63(0.91)  LDD0531 
E3 ubiquitin-protein ligase RBBP6 (RBBP6) LDTP08116 C161(1.24)  LDD0532 
E3 ubiquitin-protein ligase RBX1 (RBX1) LDTP05019 C94(1.87)  LDD0080 
E3 ubiquitin-protein ligase RFWD3 (RFWD3) LDTP07560 C682(0.95); C696(0.95)  LDD0078 
E3 ubiquitin-protein ligase rififylin (RFFL) LDTP09752 C85(0.96); C88(0.96)  LDD0078 
E3 ubiquitin-protein ligase RING1 (RING1) LDTP05496 C69(1.47); C72(1.16)  LDD0078 
E3 ubiquitin-protein ligase RING2 (RNF2) LDTP10877 C72(1.16)  LDD0078 
E3 ubiquitin-protein ligase RNF10 (RNF10) LDTP08907 C483(19.88)  LDD0209 
E3 ubiquitin-protein ligase RNF113A (RNF113A) LDTP00676 C282(1.02); C285(1.02); C296(0.96); C299(0.96)  LDD0078 
E3 ubiquitin-protein ligase RNF114 (RNF114) LDTP14083 C8(1.03)  LDD0078 
E3 ubiquitin-protein ligase RNF115 (RNF115) LDTP14067 C38(1.06)  LDD2381 
E3 ubiquitin-protein ligase RNF123 (RNF123) LDTP07277 C1277(1.13)  LDD3312 
E3 ubiquitin-protein ligase RNF126 (RNF126) LDTP11269 C229(1.24); C232(1.24)  LDD0080 
E3 ubiquitin-protein ligase RNF128 (RNF128) LDTP09491 C295(1.57)  LDD3376 
E3 ubiquitin-protein ligase RNF13 (RNF13) LDTP00804 C266(2.58)  LDD3346 
E3 ubiquitin-protein ligase RNF130 (RNF130) LDTP08373 C320(1.05)  LDD1507 
E3 ubiquitin-protein ligase RNF135 (RNF135) LDTP08449 C44(1.43)  LDD3312 
E3 ubiquitin-protein ligase RNF138 (RNF138) LDTP09605 C159(5.53); C162(5.53); C34(1.21); C39(1.21)  LDD0080 
E3 ubiquitin-protein ligase RNF139 (RNF139) LDTP09556 C582(1.45); C585(1.45)  LDD0637 
E3 ubiquitin-protein ligase RNF14 (RNF14) LDTP13154 C262(1.08)  LDD0080 
E3 ubiquitin-protein ligase RNF144A (RNF144A) LDTP04386 C20(1.80)  LDD3340 
E3 ubiquitin-protein ligase RNF144B (RNF144B) LDTP08056 C77(2.25)  LDD3379 
E3 ubiquitin-protein ligase RNF146 (RNF146) LDTP12616 C57(1.35); C60(1.35)  LDD0080 
E3 ubiquitin-protein ligase RNF149 (RNF149) LDTP09079 C295(0.91)  LDD0531 
E3 ubiquitin-protein ligase RNF166 (RNF166) LDTP10060 C127(0.96)  LDD1513 
E3 ubiquitin-protein ligase RNF167 (RNF167) LDTP12005 C256(1.11)  LDD3333 
E3 ubiquitin-protein ligase RNF168 (RNF168) LDTP08675 C355(2.90); C378(2.90)  LDD0080 
E3 ubiquitin-protein ligase RNF169 (RNF169) LDTP09101 C293(0.90)  LDD0078 
E3 ubiquitin-protein ligase RNF182 (RNF182) LDTP08929 C100(1.13)  LDD1508 
E3 ubiquitin-protein ligase RNF185 (RNF185) LDTP10348 C76(1.63); C79(1.63)  LDD0080 
E3 ubiquitin-protein ligase RNF187 (RNF187) LDTP07157 C105(0.95); C108(0.95)  LDD0078 
E3 ubiquitin-protein ligase RNF19A (RNF19A) LDTP12659 C264(2.14)  LDD3389 
E3 ubiquitin-protein ligase RNF19B (RNF19B) LDTP07780 C290(5.00)  LDD0209 
E3 ubiquitin-protein ligase RNF213 (RNF213) LDTP07283 CAmbiguous(26.23); C3084(14.51); C2536(5.58); C3330(4.31)  LDD0209 
E3 ubiquitin-protein ligase RNF216 (RNF216) LDTP12715 C75(3.99)  LDD3314 
E3 ubiquitin-protein ligase RNF217 (RNF217) LDTP09369 C474(1.04)  LDD1573 
E3 ubiquitin-protein ligase RNF220 (RNF220) LDTP07216 C336(1.09); C359(1.09)  LDD0078 
E3 ubiquitin-protein ligase RNF25 (RNF25) LDTP10125 C198(1.53); C201(1.53)  LDD0080 
E3 ubiquitin-protein ligase RNF26 (RNF26) LDTP11444 C395(1.93)  LDD3352 
E3 ubiquitin-protein ligase RNF31 (RNF31) LDTP10269 C699(1.18); C702(1.18)  LDD0078 
E3 ubiquitin-protein ligase RNF34 (RNF34) LDTP10008 C65(49.02)  LDD0209 
E3 ubiquitin-protein ligase RNF4 (RNF4) LDTP05088 C173(1.22); C176(1.22); C132(1.02); C135(1.02)  LDD0078 
E3 ubiquitin-protein ligase RNF5 (RNF5) LDTP11011 C27(1.50); C30(1.50); C64(1.38); C67(1.38)  LDD0080 
E3 ubiquitin-protein ligase RNF6 (RNF6) LDTP13805 C632(0.87); C635(0.87)  LDD0078 
E3 ubiquitin-protein ligase RNF8 (RNF8) LDTP01390 C181(1.53)  LDD0080 
E3 ubiquitin-protein ligase RNFT1 (RNFT1) LDTP07033 C368(1.08); C378(1.08)  LDD0532 
E3 ubiquitin-protein ligase SH3RF1 (SH3RF1) LDTP08121 C816(1.21); C831(1.21); C28(0.90); C33(0.90)  LDD0078 
E3 ubiquitin-protein ligase SH3RF3 (SH3RF3) LDTP09499 C194(3.68)  LDD3407 
E3 ubiquitin-protein ligase SHPRH (SHPRH) LDTP06253 C520(2.11); C489(1.82); C688(1.59); C1432(1.54)  LDD0080 
E3 ubiquitin-protein ligase SIAH1 (SIAH1) LDTP08463 C71(0.94)  LDD1492 
E3 ubiquitin-protein ligase SIAH2 (SIAH2) LDTP00718 C138(1.08)  LDD0531 
E3 ubiquitin-protein ligase SMURF1 (SMURF1) LDTP12236 C725(0.87)  LDD0078 
E3 ubiquitin-protein ligase SMURF2 (SMURF2) LDTP12138 C356(1.06); C362(1.06)  LDD0078 
E3 ubiquitin-protein ligase synoviolin (SYVN1) LDTP08203 C326(2.42); C329(2.42)  LDD0078 
E3 ubiquitin-protein ligase TM129 (TMEM129) LDTP00011 C346(0.96); C349(0.96)  LDD0532 
E3 ubiquitin-protein ligase Topors (TOPORS) LDTP12560 C103(1.08); C106(1.08)  LDD0078 
E3 ubiquitin-protein ligase TRAF7 (TRAF7) LDTP07615 C233(1.18); C239(1.18); C130(1.05); C131(1.05)  LDD0078 
E3 ubiquitin-protein ligase TRAIP (TRAIP) LDTP11323 C408(1.99)  LDD3472 
E3 ubiquitin-protein ligase TRIM11 (TRIM11) LDTP10294 C43(0.91); C53(0.91); C56(0.91); C111(0.88)  LDD0078 
E3 ubiquitin-protein ligase TRIM13 (TRIM13) LDTP01065 C132(1.27)  LDD3312 
E3 ubiquitin-protein ligase TRIM21 (TRIM21) LDTP03001 C103(1.00)  LDD0531 
E3 ubiquitin-protein ligase TRIM22 (TRIM22) LDTP08661 C441(2.09)  LDD3339 
E3 ubiquitin-protein ligase TRIM23 (TRIM23) LDTP03807 C351(1.15)  LDD0531 
E3 ubiquitin-protein ligase TRIM32 (TRIM32) LDTP05735 C464(0.97); C509(0.88); C511(0.88)  LDD0078 
E3 ubiquitin-protein ligase TRIM33 (TRIM33) LDTP13702 C582(1.07); C786(1.00); C288(0.97); C291(0.97)  LDD0078 
E3 ubiquitin-protein ligase TRIM34 (TRIM34) LDTP11465 C38(2.00)  LDD3352 
E3 ubiquitin-protein ligase TRIM36 (TRIM36) LDTP12403 C115(1.33); C118(1.33); C290(0.86); C499(0.79)  LDD0531 
E3 ubiquitin-protein ligase TRIM37 (TRIM37) LDTP01476 C748(1.30)  LDD0078 
E3 ubiquitin-protein ligase TRIM38 (TRIM38) LDTP00330 C58(1.10); C59(0.94); C62(0.94)  LDD0078 
E3 ubiquitin-protein ligase TRIM4 (TRIM4) LDTP11584 C49(0.92); C52(0.92)  LDD0078 
E3 ubiquitin-protein ligase TRIM41 (TRIM41) LDTP09597 C180(1.40)  LDD0078 
E3 ubiquitin-protein ligase TRIM45 (TRIM45) LDTP12069 C29(1.88); C32(1.88)  LDD0080 
E3 ubiquitin-protein ligase TRIM47 (TRIM47) LDTP10546 C454(1.08); C347(1.07); C199(0.92); C201(0.92)  LDD0078 
E3 ubiquitin-protein ligase TRIM48 (TRIM48) LDTP08574 C152(3.43)  LDD3434 
E3 ubiquitin-protein ligase TRIM56 (TRIM56) LDTP11142 C181(0.99); C184(0.99); C123(0.98); C131(0.98)  LDD0078 
E3 ubiquitin-protein ligase TRIM58 (TRIM58) LDTP09238 C240(3.95)  LDD3345 
E3 ubiquitin-protein ligase TRIM62 (TRIM62) LDTP11282 C103(3.58)  LDD3410 
E3 ubiquitin-protein ligase TRIM63 (TRIM63) LDTP10019 C109(2.38)  LDD3413 
E3 ubiquitin-protein ligase TRIM65 (TRIM65) LDTP07596 C112(1.13); C114(1.13); C117(1.13); C421(1.05)  LDD0078 
E3 ubiquitin-protein ligase TRIM68 (TRIM68) LDTP07355 C73(2.37)  LDD3339 
E3 ubiquitin-protein ligase TRIM7 (TRIM7) LDTP11581 C141(1.19); C378(1.09); C56(0.71); C78(1.03)  LDD0531 
E3 ubiquitin-protein ligase TRIM71 (TRIM71) LDTP06717 C661(1.53)  LDD3383 
E3 ubiquitin-protein ligase TRIM8 (TRIM8) LDTP11562 C110(0.85); C114(0.85); C115(0.85)  LDD0078 
E3 ubiquitin-protein ligase TRIM9 (TRIM9) LDTP11580 C125(1.55); C131(1.55); C128(1.55); C249(1.28)  LDD0080 
E3 ubiquitin-protein ligase TRIP12 (TRIP12) LDTP06173 CAmbiguous(14.33)  LDD0209 
E3 ubiquitin-protein ligase TTC3 (TTC3) LDTP04588 C422(0.97); C424(0.97)  LDD0078 
E3 ubiquitin-protein ligase UBR1 (UBR1) LDTP08564 C1603(1.00)  LDD0078 
E3 ubiquitin-protein ligase UBR2 (UBR2) LDTP08565 C1717(0.97)  LDD0078 
E3 ubiquitin-protein ligase UBR3 (UBR3) LDTP07830 C288(4.81)  LDD0209 
E3 ubiquitin-protein ligase UBR4 (UBR4) LDTP07118 C1033(32.95); C4663(10.44); C2554(4.97); C2222(160.05)  LDD0209 
E3 ubiquitin-protein ligase UBR5 (UBR5) LDTP01495 C883(0.84); C888(0.84)  LDD0078 
E3 ubiquitin-protein ligase UHRF1 (UHRF1) LDTP10845 CAmbiguous(5.17); C403(25.03)  LDD0209 
E3 ubiquitin-protein ligase UHRF2 (UHRF2) LDTP10698 C389(1.08); C392(1.08); C671(1.07); C347(1.03)  LDD0078 
E3 ubiquitin-protein ligase XIAP (XIAP) LDTP05220 C12(1.29); C213(0.99)  LDD0078 
E3 ubiquitin-protein ligase ZFP91 (ZFP91) LDTP10481 C520(1.26); C182(1.09); C313(1.03); C318(1.03)  LDD0078 
E3 ubiquitin-protein ligase ZNF598 (ZNF598) LDTP08231 C49(1.21); C662(1.05); C676(1.05); C29(1.02)  LDD0078 
E3 ubiquitin-protein ligase ZNRF1 (ZNRF1) LDTP09114 C272(1.18)  LDD3345 
E3 ubiquitin-protein ligase ZNRF2 (ZNRF2) LDTP09249 C236(1.01)  LDD3365 
E3 ubiquitin-protein ligase ZNRF3 (ZNRF3) LDTP13573 C433(1.71)  LDD3402 
E3 ubiquitin-protein ligase ZSWIM2 (ZSWIM2) LDTP17804 C362(0.92)  LDD3348 
E3 ubiquitin-protein transferase MAEA (MAEA) LDTP07970 C136(1.68); C314(1.99); C317(1.99); C195(1.24)  LDD0080 
E3 ubiquitin-protein transferase RMND5A (RMND5A) LDTP12051 C109(1.09); C374(0.89); C377(0.89); C328(0.89)  LDD0078 
E3 ubiquitin-protein transferase RMND5B (RMND5B) LDTP10337 C310(0.93)  LDD0532 
E3 ubiquitin/ISG15 ligase TRIM25 (TRIM25) LDTP06098 C475(1.17); C36(1.10); C28(0.96); C33(0.96)  LDD0078 
E3 UFM1-protein ligase 1 (UFL1) LDTP01444 C372(1.06)  LDD0080 
Ecto-ADP-ribosyltransferase 4 (ART4) LDTP09972 C308(2.10)  LDD3334 
Ecto-ADP-ribosyltransferase 5 (ART5) LDTP15767 C150(0.94)  LDD0547 
Ecto-NOX disulfide-thiol exchanger 1 (ENOX1) LDTP09375 C230(2.23)  LDD0080 
Ecto-NOX disulfide-thiol exchanger 2 (ENOX2) LDTP06516 C569(4.79); C575(4.79)  LDD0080 
Ectonucleoside triphosphate diphosphohydrolase 2 (ENTPD2) LDTP14135 C242(2.78)  LDD3389 
Ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3) LDTP01188 C116(1.99)  LDD3393 
Ectonucleoside triphosphate diphosphohydrolase 6 (ENTPD6) LDTP01187 C325(2.63)  LDD3312 
Ectonucleoside triphosphate diphosphohydrolase 7 (ENTPD7) LDTP12456 C296(1.08)  LDD1514 
Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1) LDTP03170 C6(1.55)  LDD0080 
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2) LDTP05986 C466(1.52)  LDD3314 
Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3) LDTP00389 C478(1.44)  LDD2410 
eEF1A lysine and N-terminal methyltransferase (METTL13) LDTP08947 C226(1.01)  LDD0078 
EEF1A lysine methyltransferase 1 (EEF1AKMT1) LDTP15632 C212(1.18)  LDD0080 
EEF1A lysine methyltransferase 2 (EEF1AKMT2) LDTP06998 C192(0.95)  LDD0078 
EGF domain-specific O-linked N-acetylglucosamine transferase (EOGT) LDTP07040 C61(1.98)  LDD3310 
EGF-like repeat and discoidin I-like domain-containing protein 3 (EDIL3) LDTP00888 C301(1.33)  LDD3312 
Egl nine homolog 1 (EGLN1) LDTP11649 C42(1.06); C43(0.96); C201(0.95); C21(0.93)  LDD0078 
EH domain-containing protein 3 (EHD3) LDTP12922 C138(1.18)  LDD3331 
EH domain-containing protein 4 (EHD4) LDTP11788 C141(0.91)  LDD0078 
eIF-2-alpha kinase GCN2 (EIF2AK4) LDTP13062 C1255(5.14)  LDD0078 
Electron transfer flavoprotein beta subunit lysine methyltransferase (ETFBKMT) LDTP08611 C126(1.00)  LDD1512 
Electron transfer flavoprotein subunit alpha, mitochondrial (ETFA) LDTP02694 C109(0.97)  LDD0078 
Electron transfer flavoprotein subunit beta (ETFB) LDTP03849 C42(8.66)  LDD0204 
Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETFDH) LDTP06511 C586(0.85); C589(0.85)  LDD0078 
Elongation factor 1-alpha 1 (EEF1A1) LDTP05071 C411(0.96)  LDD0078 
Elongation factor 1-alpha 2 (EEF1A2) LDTP05460 C111(0.54); C31(0.92); C326(0.94); C411(1.24)  LDD0531 
Elongation factor 2 (EEF2) LDTP02672 C136(1.33); C812(1.22); C651(1.04); C41(1.02)  LDD0078 
Elongation factor G, mitochondrial (GFM1) LDTP10774 C742(1.32)  LDD3310 
Elongation factor Tu, mitochondrial (TUFM) LDTP04251 C222(1.05); C147(0.97); C127(0.94); C290(0.89)  LDD0078 
Elongation factor-like GTPase 1 (EFL1) LDTP08023 C953(1.03); C474(1.00); C921(0.96); C934(0.96)  LDD0078 
Elongator complex protein 3 (ELP3) LDTP12110 C215(4.48); C227(4.48)  LDD0080 
Endonuclease 8-like 1 (NEIL1) LDTP10306 C26(1.88)  LDD3339 
Endonuclease 8-like 2 (NEIL2) LDTP10026 C291(48.10)  LDD0209 
Endonuclease 8-like 3 (NEIL3) LDTP09314 C579(80.02)  LDD0209 
Endonuclease domain-containing 1 protein (ENDOD1) LDTP01462 C375(1.03)  LDD0531 
Endonuclease G, mitochondrial (ENDOG) LDTP06095 C196(1.19)  LDD0531 
Endonuclease III-like protein 1 (NTHL1) LDTP05143 C297(3.07); C306(3.07); C300(3.07)  LDD0080 
Endonuclease V (ENDOV) LDTP08980 C76(1.71)  LDD3311 
Endoplasmic reticulum aminopeptidase 1 (ERAP1) LDTP12868 C498(2.57); C193(1.71)  LDD3310 
Endoplasmic reticulum aminopeptidase 2 (ERAP2) LDTP07503 C503(0.96); C514(0.96)  LDD0078 
Endoplasmic reticulum chaperone BiP (HSPA5) LDTP02534 C41(0.98)  LDD0533 
Endoplasmic reticulum metallopeptidase 1 (ERMP1) LDTP08017 C43(1.04)  LDD0078 
Endoplasmic reticulum protein SC65 (P3H4) LDTP09874 C101(1.03)  LDD0078 
Endoplasmic reticulum transmembrane helix translocase (ATP13A1) LDTP12279 C969(1.08); C971(1.08); C530(0.93); C531(0.93)  LDD0078 
Endoribonuclease Dicer (DICER1) LDTP13733 C1621(1.15); C686(1.07); C1197(1.00)  LDD0078 
Endoribonuclease LACTB2 (LACTB2) LDTP06910 C100(0.89)  LDD0078 
Endoribonuclease YbeY (YBEY) LDTP14732 C41(0.81)  LDD0532 
Endoribonuclease ZC3H12A (ZC3H12A) LDTP06957 C306(1.29)  LDD3403 
Endothelial lipase (LIPG) LDTP14177 C316(2.48)  LDD3493 
Endothelin-converting enzyme 1 (ECE1) LDTP04008 C388(1.17)  LDD0532 
Endothelin-converting enzyme-like 1 (ECEL1) LDTP01648 C441(5.76)  LDD3356 
Enolase-phosphatase E1 (ENOPH1) LDTP13314 C56(1.61)  LDD3327 
Enoyl-CoA delta isomerase 1, mitochondrial (ECI1) LDTP03965 C114(0.89)  LDD0078 
Enoyl-CoA delta isomerase 2 (ECI2) LDTP01245 C380(1.02)  LDD0078 
Enoyl-CoA hydratase domain-containing protein 2, mitochondrial (ECHDC2) LDTP17605 C180(5.01)  LDD3369 
Enoyl-CoA hydratase domain-containing protein 3, mitochondrial (ECHDC3) LDTP15708 C52(1.03)  LDD3350 
Enoyl-CoA hydratase, mitochondrial (ECHS1) LDTP03518 C111(1.00)  LDD0078 
Enoyl-[acyl-carrier-protein] reductase, mitochondrial (MECR) LDTP11271 C263(1.02)  LDD0078 
Eosinophil cationic protein (RNASE3) LDTP02628 C138(0.27)  LDD2236 
Eosinophil peroxidase (EPX) LDTP02582 C455(2.27)  LDD2499 
Ephrin type-A receptor 1 (EPHA1) LDTP03124 C650(0.99)  LDD0531 
Ephrin type-A receptor 2 (EPHA2) LDTP03474 C105(1.53); C115(1.53); C753(1.01); C842(0.80)  LDD0531 
Ephrin type-A receptor 3 (EPHA3) LDTP03475 C636(2.77)  LDD3423 
Ephrin type-A receptor 4 (EPHA4) LDTP04633 C812(2.38)  LDD3310 
Ephrin type-A receptor 5 (EPHA5) LDTP04630 C319(2.72)  LDD3373 
Ephrin type-A receptor 6 (EPHA6) LDTP13207 C690(1.99)  LDD3401 
Ephrin type-A receptor 7 (EPHA7) LDTP06370 C296(1.79)  LDD3406 
Ephrin type-B receptor 1 (EPHB1) LDTP04632 C849(0.75); C860(0.75)  LDD1094 
Ephrin type-B receptor 2 (EPHB2) LDTP03477 C286(1.04); C289(1.04)  LDD0078 
Ephrin type-B receptor 3 (EPHB3) LDTP04629 C632(1.37)  LDD3353 
Ephrin type-B receptor 4 (EPHB4) LDTP04631 C320(1.91)  LDD3318 
Ephrin type-B receptor 6 (EPHB6) LDTP00567 C424(2.15)  LDD3331 
Epidermal growth factor receptor (EGFR) LDTP01785 C775(1.11); C1058(1.04); C1049(0.86)  LDD0078 
Epidermal retinol dehydrogenase 2 (SDR16C5) LDTP08846 C81(1.65); C222(1.04)  LDD3312 
Epididymis-specific alpha-mannosidase (MAN2B2) LDTP13853 C288(1.01)  LDD0078 
Epimerase family protein SDR39U1 (SDR39U1) LDTP16070 C52(0.94)  LDD1492 
Epithelial discoidin domain-containing receptor 1 (DDR1) LDTP05554 C778(1.59)  LDD3310 
Epoxide hydrolase 1 (EPHX1) LDTP02175 C80(1.02)  LDD3312 
Epoxide hydrolase 4 (EPHX4) LDTP17617 C287(0.95)  LDD0531 
ER degradation-enhancing alpha-mannosidase-like protein 1 (EDEM1) LDTP09817 C629(1.59)  LDD3338 
ER degradation-enhancing alpha-mannosidase-like protein 2 (EDEM2) LDTP11275 C558(2.60)  LDD3325 
ER degradation-enhancing alpha-mannosidase-like protein 3 (EDEM3) LDTP11558 C441(18.63)  LDD0209 
ERI1 exoribonuclease 2 (ERI2) LDTP14391 C118(0.91)  LDD0532 
ERI1 exoribonuclease 3 (ERI3) LDTP14454 C110(1.03); C116(1.03); C285(1.03)  LDD0078 
ERO1-like protein alpha (ERO1A) LDTP10386 C94(1.01); C166(1.00); C391(0.89); C394(0.89)  LDD0078 
ERO1-like protein beta (ERO1B) LDTP08393 C100(0.97); C95(0.97)  LDD0532 
Ester hydrolase C11orf54 (C11orf54) LDTP11738 C226(1.02)  LDD0080 
Esterase OVCA2 (OVCA2) LDTP18110 C64(0.90)  LDD0078 
Estradiol 17-beta-dehydrogenase 11 (HSD17B11) LDTP09063 C215(0.73); C217(0.71); C94(1.23)  LDD0531 
Ethanolamine kinase 1 (ETNK1) LDTP12197 C307(0.91); C313(0.91)  LDD0078 
Ethanolamine kinase 2 (ETNK2) LDTP12675 C39(1.34)  LDD3318 
Ethanolamine-phosphate cytidylyltransferase (PCYT2) LDTP10865 C296(1.65)  LDD3310 
Ethylmalonyl-CoA decarboxylase (ECHDC1) LDTP16095 C133(0.63)  LDD0531 
Eukaryotic elongation factor 2 kinase (EEF2K) LDTP00268 C213(0.79)  LDD1507 
Eukaryotic initiation factor 4A-I (EIF4A1) LDTP04878 C134(0.95); C131(0.91)  LDD0078 
Eukaryotic initiation factor 4A-II (EIF4A2) LDTP06089 C266(2.09)  LDD3323 
Eukaryotic initiation factor 4A-III (EIF4A3) LDTP03861 C137(0.90); C140(0.90)  LDD0078 
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) LDTP02770 C465(1.62)  LDD3312 
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (GSPT2) LDTP08642 C591(2.03)  LDD3310 
Eukaryotic translation initiation factor 2 subunit 3 (EIF2S3) LDTP03915 C269(1.14); C105(1.07); C348(1.02); C101(1.00)  LDD0078 
Eukaryotic translation initiation factor 2 subunit 3B (EIF2S3B) LDTP14895 C348(2.82); C236(1.30)  LDD3310 
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1) LDTP11083 C140(1.44)  LDD0080 
Eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3) LDTP12907 C813(0.84)  LDD0547 
Eukaryotic translation initiation factor 3 subunit F (EIF3F) LDTP00246 C256(2.41)  LDD0080 
Eukaryotic translation initiation factor 5B (EIF5B) LDTP01063 C853(0.98)  LDD0078 
Exonuclease 1 (EXO1) LDTP13751 C608(1.58)  LDD0078 
Exonuclease 3'-5' domain-containing protein 2 (EXD2) LDTP12676 C202(1.09); C358(1.07); C369(1.07); C371(1.07)  LDD0078 
Exonuclease mut-7 homolog (EXD3) LDTP15469 C476(1.55)  LDD2268 
Exonuclease V (EXO5) LDTP12016 C215(1.97)  LDD3440 
Exopolyphosphatase PRUNE1 (PRUNE1) LDTP08204 C437(1.00); C180(0.88); C274(1.06)  LDD1507 
Exosome complex component 10 (EXOSC10) LDTP05312 C73(1.10)  LDD0078 
Exosome complex component CSL4 (EXOSC1) LDTP13968 C8(1.74); C40(1.20)  LDD0080 
Exosome complex component MTR3 (EXOSC6) LDTP07054 C117(3.12)  LDD0080 
Exosome complex component RRP41 (EXOSC4) LDTP12346 C97(1.98)  LDD0080 
Exosome complex component RRP42 (EXOSC7) LDTP06283 C238(2.20); C34(1.21)  LDD0080 
Exosome complex component RRP43 (EXOSC8) LDTP10110 C89(1.45)  LDD0080 
Exosome complex component RRP45 (EXOSC9) LDTP05482 C9(4.01)  LDD0209 
Exosome complex component RRP46 (EXOSC5) LDTP12433 C26(0.99)  LDD0078 
Exosome complex exonuclease RRP44 (DIS3) LDTP13887 C533(1.14); C799(1.01); C474(0.99); C483(0.99)  LDD0078 
Exosome RNA helicase MTR4 (MTREX) LDTP03975 C297(1.29); C938(1.48); C650(1.46)  LDD0080 
Exostosin-1 (EXT1) LDTP06531 C312(0.96)  LDD1492 
Exostosin-2 (EXT2) LDTP09971 C184(3.22)  LDD3380 
Exostosin-like 1 (EXTL1) LDTP09937 C169(3.02)  LDD3484 
Exostosin-like 2 (EXTL2) LDTP13144 C243(0.74)  LDD1507 
Exostosin-like 3 (EXTL3) LDTP00899 C83(1.22)  LDD0080 
Extracellular sulfatase Sulf-1 (SULF1) LDTP08560 C112(1.15); C174(1.02)  LDD1492 
Extracellular sulfatase Sulf-2 (SULF2) LDTP08559 C464(1.20)  LDD3493 
Extracellular tyrosine-protein kinase PKDCC (PKDCC) LDTP06876 C132(1.41)  LDD1507 
Eyes absent homolog 1 (EYA1) LDTP10881 C495(0.96)  LDD1507 
Eyes absent homolog 3 (EYA3) LDTP10882 C476(1.09)  LDD0593 
Eyes absent homolog 4 (EYA4) LDTP01650 C16(1.79)  LDD3332 
F-box DNA helicase 1 (FBH1) LDTP09233 C302(4.72)  LDD0209 
F-box only protein 10 (FBXO10) LDTP13434 C778(1.79)  LDD3339 
F-box only protein 11 (FBXO11) LDTP08361 C581(1.13)  LDD3321 
F-box only protein 17 (FBXO17) LDTP10258 C193(3.64); C195(3.64); C148(1.95); C156(1.95)  LDD0080 
F-box only protein 2 (FBXO2) LDTP13419 C128(1.31); C137(1.14); C176(1.36)  LDD0531 
F-box only protein 27 (FBXO27) LDTP15569 C89(1.48)  LDD0532 
F-box only protein 31 (FBXO31) LDTP07278 C131(0.62)  LDD0531 
F-box only protein 44 (FBXO44) LDTP11932 C170(1.18)  LDD3464 
F-box only protein 6 (FBXO6) LDTP12498 C37(0.80); C41(1.05)  LDD0531 
F-box/LRR-repeat protein 12 (FBXL12) LDTP16132 C134(7.18)  LDD0209 
F-box/LRR-repeat protein 17 (FBXL17) LDTP13208 C300(0.92); C207(0.70); C210(0.70); C308(1.00)  LDD0531 
F-box/LRR-repeat protein 18 (FBXL18) LDTP15784 C406(9.10)  LDD0209 
F-box/LRR-repeat protein 19 (FBXL19) LDTP07562 C50(2.28); C56(2.28); C53(2.28); C142(1.14)  LDD0080 
F-box/LRR-repeat protein 2 (FBXL2) LDTP13444 C89(3.13)  LDD3367 
F-box/LRR-repeat protein 3 (FBXL3) LDTP13483 C128(1.17); C137(1.17)  LDD0532 
F-box/LRR-repeat protein 6 (FBXL6) LDTP17711 C327(50.75)  LDD0209 
F-box/LRR-repeat protein 8 (FBXL8) LDTP18136 C304(1.48)  LDD3411 
F-box/SPRY domain-containing protein 1 (FBXO45) LDTP02395 C69(2.07); C98(2.16)  LDD3323 
FACT complex subunit SPT16 (SUPT16H) LDTP14109 C889(3.65)  LDD0080 
FAD synthase (FLAD1) LDTP09200 C409(1.29); C499(1.15); C236(1.12)  LDD0078 
FAD-dependent oxidoreductase domain-containing protein 1 (FOXRED1) LDTP10188 C239(1.19)  LDD0532 
FAD-dependent oxidoreductase domain-containing protein 2 (FOXRED2) LDTP08540 C588(1.04); C338(0.85)  LDD1492 
FAD-linked sulfhydryl oxidase ALR (GFER) LDTP04713 C165(0.96); C171(0.96)  LDD0078 
Fanconi anemia group J protein (BRIP1) LDTP11353 C942(1.00); C948(1.00); C1053(0.98); C1067(0.98)  LDD0078 
Fanconi anemia group M protein (FANCM) LDTP08643 C921(1.01); C927(1.01)  LDD0078 
Fanconi-associated nuclease 1 (FAN1) LDTP13890 C299(0.90); C301(0.90)  LDD0078 
Farnesyl pyrophosphate synthase (FDPS) LDTP02721 C183(1.03); C333(0.85); C340(0.85)  LDD0078 
Fas-activated serine/threonine kinase (FASTK) LDTP06101 C459(0.77)  LDD0531 
FAST kinase domain-containing protein 1, mitochondrial (FASTKD1) LDTP06919 C670(1.12); C673(1.12)  LDD0078 
FAST kinase domain-containing protein 2, mitochondrial (FASTKD2) LDTP12862 C377(0.84)  LDD0078 
FAST kinase domain-containing protein 3, mitochondrial (FASTKD3) LDTP06264 C525(2.00); C526(2.00)  LDD0080 
FAST kinase domain-containing protein 4 (TBRG4) LDTP10049 C246(0.57)  LDD0531 
FAST kinase domain-containing protein 5, mitochondrial (FASTKD5) LDTP07979 C670(1.24); C685(1.11); C689(1.11)  LDD0078 
Fatty acid 2-hydroxylase (FA2H) LDTP07963 C25(2.51)  LDD3472 
Fatty acid CoA ligase Acsl3 (ACSL3) LDTP01634 C652(1.34); C503(0.93); C504(0.93); C561(0.91)  LDD0078 
Fatty acid desaturase 3 (FADS3) LDTP14143 C24(0.97)  LDD0531 
Fatty acid synthase (FASN) LDTP04243 C2202(1.23); C1992(1.07); C1186(1.05); C1558(1.03)  LDD0078 
Fatty acyl-CoA reductase 1 (FAR1) LDTP09628 C438(3.66)  LDD3333 
Fatty acyl-CoA reductase 2 (FAR2) LDTP10491 C72(1.12)  LDD3323 
Fatty-acid amide hydrolase 1 (FAAH) LDTP00302 C269(0.84)  LDD0531 
Ferredoxin-2, mitochondrial (FDX2) LDTP07534 C154(1.34)  LDD3339 
Ferredoxin-fold anticodon-binding domain-containing protein 1 (FDXACB1) LDTP18299 C91(2.08)  LDD0080 
Ferric-chelate reductase 1 (FRRS1) LDTP17469 C211(3.01)  LDD3373 
Ferritin heavy chain (FTH1) LDTP01974 C103(0.87); C91(0.87)  LDD0531 
Ferrochelatase, mitochondrial (FECH) LDTP03198 C202(2.05); C366(1.86); C300(2.14)  LDD3311 
Ferroptosis suppressor protein 1 (AIFM2) LDTP11124 C242(2.64)  LDD3314 
FGGY carbohydrate kinase domain-containing protein (FGGY) LDTP10155 C280(1.43)  LDD3314 
Fibroblast growth factor receptor 1 (FGFR1) LDTP02566 C615(2.15)  LDD3376 
Fibroblast growth factor receptor 2 (FGFR2) LDTP03133 C90(2.60); C767(3.71); C607(6.09)  LDD3489 
Fibroblast growth factor receptor 3 (FGFR3) LDTP03180 C547(3.46)  LDD3377 
Fibroblast growth factor receptor 4 (FGFR4) LDTP03172 C477(0.99)  LDD0531 
Fibronectin type III and SPRY domain-containing protein 1 (FSD1) LDTP11211 C463(1.90); C87(2.55)  LDD3340 
Fibronectin type III domain-containing protein 3B (FNDC3B) LDTP06883 C558(1.45); C366(1.12); C377(1.12); C565(1.10)  LDD0078 
Fibronectin type-III domain-containing protein 3A (FNDC3A) LDTP13868 C465(1.20); C696(1.14)  LDD0078 
Fidgetin (FIGN) LDTP14969 C672(0.93)  LDD1571 
Fidgetin-like protein 1 (FIGNL1) LDTP07593 C247(5.41); C252(5.41); C26(2.01)  LDD0080 
Fizzy-related protein homolog (FZR1) LDTP13602 C395(0.93); C403(0.93)  LDD1093 
FK506-binding protein 15 (FKBP15) LDTP07096 C809(0.88)  LDD0078 
Flap endonuclease 1 (FEN1) LDTP03872 C141(1.68); C182(1.54)  LDD0080 
Flap endonuclease GEN homolog 1 (GEN1) LDTP06666 C707(1.18); C715(1.18)  LDD0078 
Flavin reductase (NADPH) (BLVRB) LDTP03511 C109(1.35)  LDD3310 
Flavin-containing monooxygenase 1 (FMO1) LDTP05311 C63(3.04)  LDD2330 
Flavin-containing monooxygenase 3 (FMO3) LDTP03600 C397(1.26)  LDD3410 
Flavin-containing monooxygenase 5 (FMO5) LDTP04242 C248(1.93)  LDD3312 
Focal adhesion kinase 1 (PTK2) LDTP05453 C348(2.07); C647(1.98); C459(2.37)  LDD3310 
Folylpolyglutamate synthase, mitochondrial (FPGS) LDTP05468 C171(1.14)  LDD0078 
Formimidoyltransferase-cyclodeaminase (FTCD) LDTP01723 C313(2.56); C535(2.58); C57(2.13)  LDD3424 
Formylglycine-generating enzyme (SUMF1) LDTP09058 C336(1.28)  LDD3310 
Fructosamine-3-kinase (FN3K) LDTP11904 C24(1.18)  LDD0531 
Fructose-1,6-bisphosphatase 1 (FBP1) LDTP02347 C39(2.88)  LDD3338 
Fructose-2,6-bisphosphatase TIGAR (TIGAR) LDTP12405 C114(0.93)  LDD0078 
Fructose-bisphosphate aldolase A (ALDOA) LDTP02008 C393(2.31)  LDD3311 
Fructose-bisphosphate aldolase B (ALDOB) LDTP02070 C256(1.98)  LDD3311 
Fructose-bisphosphate aldolase C (ALDOC) LDTP02386 C256(2.27)  LDD3310 
FSD1-like protein (FSD1L) LDTP18326 C250(0.96)  LDD0531 
Fucose-1-phosphate guanylyltransferase (FPGT) LDTP00427 C519(0.99)  LDD0080 
Fumarate hydratase, mitochondrial (FH) LDTP02235 C333(4.86)  LDD0209 
Fumarylacetoacetase (FAH) LDTP02868 C408(34.16)  LDD0209 
Fumarylacetoacetate hydrolase domain-containing protein 2A (FAHD2A) LDTP18161 C110(1.05); C119(1.05)  LDD0078 
Fumarylacetoacetate hydrolase domain-containing protein 2B (FAHD2B) LDTP19501 C110(2.05); C119(2.05)  LDD0080 
Furin (FURIN) LDTP02384 C450(2.38)  LDD3325 
G protein-coupled receptor kinase 3 (GRK3) LDTP03774 C103(10.44)  LDD0209 
G protein-coupled receptor kinase 5 (GRK5) LDTP03696 C201(0.58); C203(0.58)  LDD0533 
G protein-coupled receptor kinase 6 (GRK6) LDTP04029 C138(23.31); C57(6.96); C71(7.63)  LDD0209 
G/T mismatch-specific thymine DNA glycosylase (TDG) LDTP05927 C233(1.28); C351(1.10); C356(1.10)  LDD0078 
G2/M phase-specific E3 ubiquitin-protein ligase (G2E3) LDTP07971 C666(0.91); C669(0.91)  LDD1094 
Galactocerebrosidase (GALC) LDTP04635 C287(0.81)  LDD1093 
Galactokinase (GALK1) LDTP04424 C203(5.55); C243(5.51); C170(290.63); C182(290.63)  LDD0209 
Galactose mutarotase (GALM) LDTP10157 C247(1.03)  LDD0625 
Galactose-1-phosphate uridylyltransferase (GALT) LDTP02226 C75(0.97)  LDD3333 
Galactosylceramide sulfotransferase (GAL3ST1) LDTP11034 C390(3.87)  LDD3389 
Gamma-adducin (ADD3) LDTP13204 C73(1.07)  LDD0080 
Gamma-enolase (ENO2) LDTP02328 C337(16.16)  LDD0209 
Gamma-glutamyl hydrolase (GGH) LDTP09886 C314(0.91)  LDD1507 
Gamma-glutamylaminecyclotransferase (GGACT) LDTP11295 C84(1.02)  LDD0080 
Gamma-glutamylcyclotransferase (GGCT) LDTP01164 C50(1.13)  LDD3312 
Gamma-interferon-inducible lysosomal thiol reductase (IFI30) LDTP02651 C117(0.85); C124(0.85)  LDD0078 
GATOR2 complex protein WDR24 (WDR24) LDTP10792 C607(1.75)  LDD0080 
GDH/6PGL endoplasmic bifunctional protein (H6PD) LDTP01618 C95(1.76); C404(1.58)  LDD3310 
GDP-D-glucose phosphorylase 1 (GDPGP1) LDTP15184 C64(1.53)  LDD3319 
GDP-fucose protein O-fucosyltransferase 1 (POFUT1) LDTP11905 C267(1.44); C126(1.38)  LDD3310 
GDP-fucose protein O-fucosyltransferase 2 (POFUT2) LDTP13862 C419(1.71)  LDD3314 
GDP-L-fucose synthase (GFUS) LDTP05954 C112(1.38); C116(1.38)  LDD0078 
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (ALG11) LDTP06721 C345(0.97); C84(1.02)  LDD0531 
GDP-mannose 4,6 dehydratase (GMDS) LDTP00999 C336(0.90)  LDD0078 
General transcription and DNA repair factor IIH helicase subunit XPB (ERCC3) LDTP03000 C342(20.00)  LDD0080 
General transcription and DNA repair factor IIH helicase subunit XPD (ERCC2) LDTP02938 C489(1.15); C491(1.15); C259(1.00); C588(0.98)  LDD0078 
General transcription factor 3C polypeptide 4 (GTF3C4) LDTP13471 C257(1.11); C116(0.95); C129(0.87)  LDD0078 
Geranylgeranyl pyrophosphate synthase (GGPS1) LDTP01665 C138(0.99)  LDD0080 
Geranylgeranyl transferase type-1 subunit beta (PGGT1B) LDTP04568 C32(1.82); C147(2.69)  LDD3311 
Geranylgeranyl transferase type-2 subunit alpha (RABGGTA) LDTP09845 C354(5.71)  LDD0209 
Geranylgeranyl transferase type-2 subunit beta (RABGGTB) LDTP04569 C40(1.10)  LDD0078 
Germ cell-less protein-like 1 (GMCL1) LDTP10420 C440(0.74)  LDD0814 
Germinal-center associated nuclear protein (MCM3AP) LDTP00952 C1268(1.35); C1269(1.35); C931(1.32); C1309(1.06)  LDD0078 
Glomulin (GLMN) LDTP09956 C174(6.61); C177(6.61); C176(6.61); C537(1.47)  LDD0080 
Glucosamine 6-phosphate N-acetyltransferase (GNPNAT1) LDTP10264 C179(1.01); C128(0.94); C157(0.93)  LDD0078 
Glucosamine-6-phosphate isomerase 1 (GNPDA1) LDTP04113 C48(1.66)  LDD0080 
Glucosamine-6-phosphate isomerase 2 (GNPDA2) LDTP09449 C48(1.37)  LDD3312 
Glucose 1,6-bisphosphate synthase (PGM2L1) LDTP07561 C348(1.34); C81(1.24)  LDD0080 
Glucose-6-phosphatase 3 (G6PC3) LDTP11243 C269(1.01)  LDD0078 
Glucose-6-phosphate 1-dehydrogenase (G6PD) LDTP02569 C13(16.44)  LDD0209 
Glucose-6-phosphate isomerase (GPI) LDTP02162 C415(1.07)  LDD3310 
Glucose-fructose oxidoreductase domain-containing protein 1 (GFOD1) LDTP12774 C68(0.97); C146(1.00)  LDD1514 
Glucose-fructose oxidoreductase domain-containing protein 2 (GFOD2) LDTP17098 C377(0.96)  LDD1492 
Glucosidase 2 subunit beta (PRKCSH) LDTP02718 C471(1.76)  LDD0080 
Glucoside xylosyltransferase 1 (GXYLT1) LDTP14932 C123(1.07)  LDD0078 
Glucosylceramide transporter ABCA12 (ABCA12) LDTP08229 C2390(1.31)  LDD3325 
Glutamate dehydrogenase 1, mitochondrial (GLUD1) LDTP01768 C327(1.20)  LDD0531 
Glutamate dehydrogenase 2, mitochondrial (GLUD2) LDTP04256 C5(1.89)  LDD3311 
Glutamate--cysteine ligase catalytic subunit (GCLC) LDTP04185 C613(1.09); C615(1.09); C553(1.03); C501(1.00)  LDD0078 
Glutamate--cysteine ligase regulatory subunit (GCLM) LDTP04186 C35(0.99); C46(0.99)  LDD0078 
Glutaminase kidney isoform, mitochondrial (GLS) LDTP01465 C525(1.11)  LDD0078 
Glutaminase liver isoform, mitochondrial (GLS2) LDTP13324 C542(107.61)  LDD0209 
Glutamine amidotransferase-like class 1 domain-containing protein 1 (GATD1) LDTP17777 C154(1.47)  LDD0080 
Glutamine synthetase (GLUL) LDTP02764 C346(1.20)  LDD3311 
Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (GFPT1) LDTP05481 C55(0.96); C478(0.94)  LDD0078 
Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (GFPT2) LDTP01423 C621(1.43); C226(1.13); C603(1.07); C553(1.07)  LDD0078 
Glutamine--tRNA ligase (QARS1) LDTP04135 C358(1.33); C657(1.17); C665(1.17); C536(0.97)  LDD0078 
Glutamine-dependent NAD(+) synthetase (NADSYN1) LDTP07399 C428(1.04); C531(0.92)  LDD0078 
Glutamyl aminopeptidase (ENPEP) LDTP05512 C502(3.10); C233(2.78)  LDD3423 
Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (QRSL1) LDTP11728 C278(132.30)  LDD0209 
Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (GATB) LDTP01334 C170(1.08)  LDD0078 
Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (GATC) LDTP00848 C99(2.04)  LDD3323 
Glutaredoxin-1 (GLRX) LDTP03786 C79(1.15); C83(1.15); C23(1.07); C26(1.07)  LDD0078 
Glutaredoxin-3 (GLRX3) LDTP01374 C146(1.06); C229(0.96)  LDD0078 
Glutaredoxin-related protein 5, mitochondrial (GLRX5) LDTP08181 C67(0.96)  LDD0078 
Glutaryl-CoA dehydrogenase, mitochondrial (GCDH) LDTP09939 C176(0.94)  LDD0078 
Glutathione hydrolase 5 proenzyme (GGT5) LDTP03801 C530(1.28)  LDD2484 
Glutathione hydrolase 7 (GGT7) LDTP13367 C100(1.26); C102(1.26)  LDD0078 
Glutathione peroxidase 1 (GPX1) LDTP02184 C156(0.99); C78(0.87)  LDD0531 
Glutathione peroxidase 2 (GPX2) LDTP02947 C55(1.22)  LDD3344 
Glutathione peroxidase 7 (GPX7) LDTP10817 C86(0.47)  LDD3332 
Glutathione reductase, mitochondrial (GSR) LDTP01771 C102(0.99); C107(0.91)  LDD0078 
Glutathione S-transferase 3, mitochondrial (MGST3) LDTP00464 C56(5.52)  LDD0080 
Glutathione S-transferase kappa 1 (GSTK1) LDTP13900 C232(4.49)  LDD3310 
Glutathione S-transferase LANCL1 (LANCL1) LDTP00874 C363(41.25)  LDD0209 
Glutathione S-transferase Mu 2 (GSTM2) LDTP03420 C174(1.44); C87(1.20)  LDD3338 
Glutathione S-transferase Mu 3 (GSTM3) LDTP03103 C208(0.92); C39(0.92)  LDD0078 
Glutathione S-transferase Mu 4 (GSTM4) LDTP05387 C115(4.23)  LDD0209 
Glutathione S-transferase Mu 5 (GSTM5) LDTP04095 C115(2.02)  LDD3314 
Glutathione S-transferase omega-1 (GSTO1) LDTP05128 C32(95.41)  LDD0209 
Glutathione S-transferase omega-2 (GSTO2) LDTP11942 C32(0.43); C121(1.29)  LDD0531 
Glutathione S-transferase P (GSTP1) LDTP02333 C48(1.11)  LDD0078 
Glutathione S-transferase theta-1 (GSTT1) LDTP03556 C14(1.38)  LDD3314 
Glutathione S-transferase theta-2 (GSTT2) LDTP14613 C105(1.07)  LDD0531 
Glutathione S-transferase theta-2B (GSTT2B) LDTP02410 C105(1.42)  LDD3332 
Glutathione synthetase (GSS) LDTP04200 C294(1.49); C409(1.23)  LDD3312 
Glutathione-specific gamma-glutamylcyclotransferase 2 (CHAC2) LDTP15626 C59(1.71)  LDD0080 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) LDTP02038 C152(1.26); C156(1.26); C247(1.17)  LDD0078 
Glyceraldehyde-3-phosphate dehydrogenase, testis-specific (GAPDHS) LDTP00369 C319(1.16)  LDD3413 
Glycerate kinase (GLYCTK) LDTP08513 C67(1.87)  LDD3424 
Glycerol kinase (GK) LDTP03628 C387(0.88)  LDD0078 
Glycerol kinase 3 (GK3) LDTP14842 C387(2.06)  LDD3314 
Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAM) LDTP12253 C813(0.94)  LDD0078 
Glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2) LDTP07468 C235(1.29)  LDD2477 
Glycerol-3-phosphate acyltransferase 4 (GPAT4) LDTP08232 C285(1.77)  LDD0080 
Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1L) LDTP08814 C164(7.34); C104(7.43)  LDD0209 
Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD2) LDTP04032 C45(0.96); C385(0.88)  LDD0078 
Glycerol-3-phosphate phosphatase (PGP) LDTP00089 C297(5.85)  LDD0209 
Glycerophosphocholine phosphodiesterase GPCPD1 (GPCPD1) LDTP16057 C640(0.91); C642(0.91)  LDD0078 
Glycerophosphodiester phosphodiesterase 1 (GDE1) LDTP12886 C127(0.91)  LDD1492 
Glycine amidinotransferase, mitochondrial (GATM) LDTP04359 C50(1.22)  LDD3312 
Glycine dehydrogenase (decarboxylating), mitochondrial (GLDC) LDTP03221 C444(1.07); C250(1.36); C1000(1.47); C1002(1.47)  LDD0080 
Glycine N-acyltransferase-like protein 1 (GLYATL1) LDTP15673 C92(2.31)  LDD3395 
Glycine N-methyltransferase (GNMT) LDTP06202 C58(1.32)  LDD3493 
Glycine--tRNA ligase (GARS1) LDTP03946 C466(1.27); C471(1.27); C442(0.91); C444(0.91)  LDD0078 
Glycogen phosphorylase, brain form (PYGB) LDTP02552 C437(0.95)  LDD0078 
Glycogen phosphorylase, liver form (PYGL) LDTP02161 C143(1.16); C496(1.45)  LDD3310 
Glycogen phosphorylase, muscle form (PYGM) LDTP02553 C373(1.55)  LDD3310 
Glycogen synthase kinase-3 alpha (GSK3A) LDTP04318 C262(1.22); C281(0.97)  LDD0078 
Glycogen synthase kinase-3 beta (GSK3B) LDTP04319 C170(2.10); C330(2.13)  LDD3310 
Glycogen [starch] synthase, muscle (GYS1) LDTP02696 C699(1.11); C214(1.01)  LDD0078 
Glycogenin-1 (GYG1) LDTP04119 C89(0.76)  LDD1109 
Glycogenin-2 (GYG2) LDTP00651 C131(0.92)  LDD1507 
Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (C1GALT1) LDTP12553 C232(0.83)  LDD1514 
Glycosaminoglycan xylosylkinase (FAM20B) LDTP01111 C211(0.78)  LDD1571 
Glycosyltransferase 8 domain-containing protein 1 (GLT8D1) LDTP17305 C200(0.91)  LDD0812 
Glycylpeptide N-tetradecanoyltransferase 1 (NMT1) LDTP03537 C483(2.22)  LDD3333 
Glycylpeptide N-tetradecanoyltransferase 2 (NMT2) LDTP01001 C104(2.87); C485(3.04)  LDD0080 
Glyoxalase domain-containing protein 4 (GLOD4) LDTP16040 C197(1.13)  LDD3311 
Glyoxylate reductase/hydroxypyruvate reductase (GRHPR) LDTP13145 C123(0.84)  LDD3337 
GMP reductase 1 (GMPR) LDTP03830 C186(1.50); C222(1.23); C224(1.23)  LDD0531 
GMP reductase 2 (GMPR2) LDTP13080 C334(1.88)  LDD3312 
GMP synthase [glutamine-hydrolyzing] (GMPS) LDTP04333 C489(1.02); C554(0.95); C456(0.93); C530(0.89)  LDD0078 
Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase (BPNT2) LDTP12763 C302(0.95)  LDD1508 
GPI ethanolamine phosphate transferase 2 (PIGG) LDTP06977 C607(0.91)  LDD0813 
GPI ethanolamine phosphate transferase 3 (PIGO) LDTP09505 C439(2.33)  LDD3383 
GPI inositol-deacylase (PGAP1) LDTP07913 C455(2.52)  LDD3393 
GPI mannosyltransferase 3 (PIGB) LDTP09774 C248(6.66)  LDD3332 
GPI-anchor transamidase (PIGK) LDTP09835 C206(1.01)  LDD0080 
GPN-loop GTPase 1 (GPN1) LDTP12260 C21(1.02)  LDD0602 
GPN-loop GTPase 2 (GPN2) LDTP18426 C262(0.76)  LDD0531 
GPN-loop GTPase 3 (GPN3) LDTP16204 C258(2.72)  LDD3393 
Granzyme B (GZMB) LDTP02476 C209(2.75)  LDD2412 
GTP cyclohydrolase 1 (GCH1) LDTP03558 C18(1.09); C141(0.99)  LDD1507 
GTP-binding nuclear protein Ran (RAN) LDTP05007 C112(4.27); C120(4.27)  LDD0080 
GTP-binding protein 1 (GTPBP1) LDTP14415 C669(0.97)  LDD0078 
GTP-binding protein 10 (GTPBP10) LDTP00062 C88(0.97)  LDD1492 
GTP-binding protein 2 (GTPBP2) LDTP11348 C36(1.06); C450(0.98)  LDD0078 
GTP-binding protein 4 (GTPBP4) LDTP11529 C174(1.52); C261(1.03)  LDD0080 
GTP-binding protein 8 (GTPBP8) LDTP17699 C114(0.96)  LDD0531 
GTP-binding protein Di-Ras1 (DIRAS1) LDTP01490 C55(2.29)  LDD0531 
GTP-binding protein Di-Ras2 (DIRAS2) LDTP15740 C123(1.41)  LDD3365 
GTP-binding protein Di-Ras3 (DIRAS3) LDTP14541 C135(1.87)  LDD3417 
GTP-binding protein RAD (RRAD) LDTP04658 C227(0.90)  LDD0078 
GTP-binding protein Rit1 (RIT1) LDTP09946 C175(3.91)  LDD3367 
GTP-binding protein SAR1a (SAR1A) LDTP12470 C102(0.52)  LDD0531 
GTP-binding protein SAR1b (SAR1B) LDTP14231 C102(0.91)  LDD0532 
GTP:AMP phosphotransferase AK3, mitochondrial (AK3) LDTP13352 C81(1.92)  LDD3312 
GTPase Era, mitochondrial (ERAL1) LDTP01275 C150(0.99)  LDD0078 
GTPase HRas (HRAS) LDTP01826 C181(0.97); C184(0.97)  LDD0078 
GTPase IMAP family member 1 (GIMAP1) LDTP09659 C181(6.49); C186(5.87)  LDD0209 
GTPase IMAP family member 2 (GIMAP2) LDTP13219 C227(8.51)  LDD0204 
GTPase IMAP family member 4 (GIMAP4) LDTP12648 C220(3.08)  LDD2313 
GTPase IMAP family member 5 (GIMAP5) LDTP10291 C238(209.70)  LDD0209 
GTPase IMAP family member 6 (GIMAP6) LDTP15121 C197(11.77)  LDD0209 
GTPase IMAP family member 8 (GIMAP8) LDTP15496 C166(2.36)  LDD2412 
GTPase KRas (KRAS) LDTP01827 C12(6.66)  LDD0078 
GTPase NRas (NRAS) LDTP01825 C80(1.69)  LDD3338 
Guanidino acid hydrolase, mitochondrial (AGMAT) LDTP15873 C250(1.60)  LDD3333 
Guanidinoacetate N-methyltransferase (GAMT) LDTP06110 C91(2.95)  LDD0080 
Guanine deaminase (GDA) LDTP13909 C218(2.91); C63(2.75)  LDD2236 
Guanine nucleotide-binding protein-like 1 (GNL1) LDTP14676 C607(0.97)  LDD0078 
Guanine nucleotide-binding protein-like 3 (GNL3) LDTP11297 C280(1.00); C158(0.91); C251(0.90); C131(0.87)  LDD0078 
Guanine nucleotide-binding protein-like 3-like protein (GNL3L) LDTP12687 C490(1.14); C213(1.11); C89(1.05); C244(0.98)  LDD0078 
Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (HDDC3) LDTP08873 C133(0.95)  LDD3335 
Guanylate cyclase soluble subunit alpha-1 (GUCY1A1) LDTP05336 C610(1.83)  LDD3340 
Guanylate cyclase soluble subunit alpha-2 (GUCY1A2) LDTP03670 C296(0.84)  LDD1508 
Guanylate cyclase soluble subunit beta-1 (GUCY1B1) LDTP05338 C214(2.25)  LDD3364 
Guanylate kinase (GUK1) LDTP06625 C98(2.52)  LDD3312 
Guanylate-binding protein 1 (GBP1) LDTP03646 C235(3.05)  LDD3311 
Guanylate-binding protein 2 (GBP2) LDTP03647 C82(2.03)  LDD3310 
Guanylate-binding protein 4 (GBP4) LDTP10692 C284(2.25)  LDD3323 
Guanylate-binding protein 6 (GBP6) LDTP07789 C248(1.21)  LDD3339 
Guanylate-binding protein 7 (GBP7) LDTP08986 C421(4.67)  LDD3323 
Guanylyl cyclase C (GUCY2C) LDTP03307 C727(3.60); C997(2.80)  LDD3452 
H/ACA ribonucleoprotein complex subunit DKC1 (DKC1) LDTP01061 C310(0.99)  LDD0078 
Haloacid dehalogenase-like hydrolase domain-containing 5 (HDHD5) LDTP18330 C109(4.71)  LDD0209 
Haloacid dehalogenase-like hydrolase domain-containing protein 2 (HDHD2) LDTP18367 C244(0.83)  LDD3377 
Haloacid dehalogenase-like hydrolase domain-containing protein 3 (HDHD3) LDTP15879 C109(0.96)  LDD0078 
Haptoglobin-related protein (HPR) LDTP01793 C266(1.79)  LDD3360 
HBS1-like protein (HBS1L) LDTP14019 C566(0.85); C569(0.85)  LDD0078 
Heat shock cognate 71 kDa protein (HSPA8) LDTP02541 C17(1.03)  LDD0078 
Heat shock protein HSP 90-alpha (HSP90AA1) LDTP02225 C720(1.58)  LDD3311 
Helicase ARIP4 (RAD54L2) LDTP14036 C1230(1.12); C1242(1.12); C841(1.08); C848(1.08)  LDD0078 
Helicase MOV-10 (MOV10) LDTP12233 C172(1.21); C553(0.89); C564(0.89)  LDD0078 
Helicase POLQ-like (HELQ) LDTP09434 C629(0.98)  LDD1507 
Helicase SRCAP (SRCAP) LDTP07815 C3036(1.06)  LDD0078 
Helicase-like transcription factor (HLTF) LDTP06139 C461(1.17); C360(0.90); C942(0.89)  LDD0078 
Heme A synthase COX15 (COX15) LDTP07931 C76(0.80)  LDD0531 
Heme oxygenase 2 (HMOX2) LDTP03540 C282(2.03)  LDD0078 
Hemopexin (HPX) LDTP01972 C188(0.89)  LDD1492 
Heparan sulfate 2-O-sulfotransferase 1 (HS2ST1) LDTP07990 C201(1.26); C209(1.26)  LDD0637 
Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST2) LDTP10591 C381(0.96); C373(0.86); C256(0.96)  LDD1492 
Hepatic triacylglycerol lipase (LIPC) LDTP02542 C321(1.48)  LDD3489 
Hepatocyte growth factor (HGF) LDTP02716 C177(0.92)  LDD0533 
Hepatocyte growth factor receptor (MET) LDTP02286 C520(3.65); C1326(1.19); C584(3.38)  LDD3310 
Hepatocyte growth factor-like protein (MST1) LDTP03375 C507(0.89)  LDD0814 
Hexokinase HKDC1 (HKDC1) LDTP06728 C438(2.41)  LDD3312 
Hexokinase-1 (HK1) LDTP02991 C838(2.45); C890(2.28); C827(3.03)  LDD3311 
Hexokinase-2 (HK2) LDTP04531 C909(1.22); C628(1.10)  LDD0078 
Hexokinase-3 (HK3) LDTP04532 C915(1.94)  LDD3334 
Hexosaminidase D (HEXD) LDTP09602 C147(71.46)  LDD0209 
High affinity 3',5'-cyclic-AMP phosphodiesterase 7A (PDE7A) LDTP06009 C402(1.06)  LDD1492 
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (PDE8A) LDTP01018 C279(1.26); C119(1.01)  LDD0080 
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (PDE8B) LDTP01548 C334(1.47)  LDD3493 
High affinity nerve growth factor receptor (NTRK1) LDTP02046 C501(1.58); C656(2.37)  LDD2412 
Histamine N-methyltransferase (HNMT) LDTP04341 C82(1.03)  LDD3312 
Histidine protein methyltransferase 1 homolog (METTL18) LDTP01632 C48(1.71)  LDD3342 
Histidine--tRNA ligase, cytoplasmic (HARS1) LDTP02602 C507(1.15); C235(0.90)  LDD0078 
Histidine--tRNA ligase, mitochondrial (HARS2) LDTP04264 C84(1.86)  LDD3310 
Histo-blood group ABO system transferase (ABO) LDTP02849 C80(1.23)  LDD3331 
Histone acetyltransferase KAT2A (KAT2A) LDTP09890 C815(0.96)  LDD0078 
Histone acetyltransferase KAT2B (KAT2B) LDTP09891 C564(3.07)  LDD3310 
Histone acetyltransferase KAT5 (KAT5) LDTP09957 C350(2.78)  LDD3466 
Histone acetyltransferase KAT6A (KAT6A) LDTP09876 C209(1.47); C212(1.47)  LDD0080 
Histone acetyltransferase KAT6B (KAT6B) LDTP09734 C266(0.98); C269(0.98); C709(0.92); C716(0.92)  LDD0078 
Histone acetyltransferase KAT7 (KAT7) LDTP01543 C368(0.87); C371(0.87)  LDD0078 
Histone acetyltransferase KAT8 (KAT8) LDTP12039 C210(1.21); C213(1.21); C230(1.12); C260(0.56)  LDD0531 
Histone acetyltransferase p300 (EP300) LDTP05596 C364(1.10); C369(1.10); C1258(1.08); C1272(1.08)  LDD0078 
Histone acetyltransferase type B catalytic subunit (HAT1) LDTP00479 C101(1.02)  LDD0078 
Histone deacetylase 1 (HDAC1) LDTP05918 C273(1.00); C408(0.93)  LDD0078 
Histone deacetylase 2 (HDAC2) LDTP09865 C274(1.28)  LDD0080 
Histone deacetylase 3 (HDAC3) LDTP00622 C94(6.23)  LDD0204 
Histone deacetylase 4 (HDAC4) LDTP04742 C952(20.59)  LDD0209 
Histone deacetylase 5 (HDAC5) LDTP13764 C807(1.05)  LDD1514 
Histone deacetylase 6 (HDAC6) LDTP13136 C572(1.81); C578(1.81)  LDD0080 
Histone deacetylase 7 (HDAC7) LDTP09575 C943(1.45)  LDD3316 
Histone deacetylase 8 (HDAC8) LDTP11433 C244(6.10)  LDD0204 
Histone deacetylase complex subunit SAP130 (SAP130) LDTP11703 C951(1.07)  LDD1507 
Histone demethylase UTY (UTY) LDTP00380 C293(3.91)  LDD3310 
Histone lysine demethylase PHF8 (PHF8) LDTP13703 C271(2.98)  LDD3310 
Histone PARylation factor 1 (HPF1) LDTP12743 C152(1.10); C17(1.19); C29(1.65)  LDD0531 
Histone-arginine methyltransferase CARM1 (CARM1) LDTP08352 C420(1.15)  LDD0531 
Histone-lysine N-methyltransferase 2A (KMT2A) LDTP05396 C2786(1.23)  LDD3310 
Histone-lysine N-methyltransferase 2B (KMT2B) LDTP13615 C1344(1.23); C1297(1.00); C1300(1.00); C1432(0.95)  LDD0078 
Histone-lysine N-methyltransferase 2C (KMT2C) LDTP09186 C473(1.39)  LDD3310 
Histone-lysine N-methyltransferase 2D (KMT2D) LDTP00408 C369(1.36); C5107(2.46)  LDD3310 
Histone-lysine N-methyltransferase ASH1L (ASH1L) LDTP12475 C2225(0.90); C2229(0.90)  LDD0078 
Histone-lysine N-methyltransferase EHMT1 (EHMT1) LDTP12089 C276(1.18); C1025(0.84); C1034(0.84)  LDD0078 
Histone-lysine N-methyltransferase EHMT2 (EHMT2) LDTP10517 C446(2.02); C459(2.02); C1168(1.79); C1170(1.79)  LDD0080 
Histone-lysine N-methyltransferase EZH1 (EZH1) LDTP09879 C17(2.90)  LDD3312 
Histone-lysine N-methyltransferase EZH2 (EZH2) LDTP06502 C663(6.73)  LDD0204 
Histone-lysine N-methyltransferase KMT5B (KMT5B) LDTP06837 C156(0.74)  LDD0531 
Histone-lysine N-methyltransferase KMT5C (KMT5C) LDTP08391 C298(1.09); C301(1.09)  LDD0078 
Histone-lysine N-methyltransferase MECOM (MECOM) LDTP05392 C1119(1.03)  LDD1492 
Histone-lysine N-methyltransferase NSD2 (NSD2) LDTP01759 C1193(1.13); C1198(1.13); C44(1.01); C730(0.98)  LDD0078 
Histone-lysine N-methyltransferase NSD3 (NSD3) LDTP11518 C1273(2.80); C798(3.51); C802(3.51); C799(3.51)  LDD0080 
Histone-lysine N-methyltransferase PRDM16 (PRDM16) LDTP12152 C176(1.93); C178(1.93); C410(1.68)  LDD0080 
Histone-lysine N-methyltransferase SETD1A (SETD1A) LDTP00518 C1695(0.85); C1697(0.85); C1702(0.85)  LDD0078 
Histone-lysine N-methyltransferase SETD1B (SETD1B) LDTP13714 C1698(5.06)  LDD3319 
Histone-lysine N-methyltransferase SETD2 (SETD2) LDTP11504 C1125(1.10); C667(1.09); C687(1.09); C574(1.08)  LDD0078 
Histone-lysine N-methyltransferase SETD5 (SETD5) LDTP11593 C717(20.00); C721(20.00)  LDD0080 
Histone-lysine N-methyltransferase SETD7 (SETD7) LDTP09543 C200(0.94)  LDD0531 
Histone-lysine N-methyltransferase SETDB1 (SETDB1) LDTP06295 C92(1.04)  LDD0078 
Histone-lysine N-methyltransferase SETDB2 (SETDB2) LDTP10842 C707(1.16); C709(1.16)  LDD0531 
Histone-lysine N-methyltransferase SETMAR (SETMAR) LDTP06906 C281(1.18); C293(1.18); C311(1.09); C321(1.09)  LDD0078 
Histone-lysine N-methyltransferase SMYD1 (SMYD1) LDTP09035 C417(1.55)  LDD3401 
Histone-lysine N-methyltransferase SMYD3 (SMYD3) LDTP12020 C261(1.14); C258(1.14); C41(0.97)  LDD0078 
Histone-lysine N-methyltransferase SUV39H1 (SUV39H1) LDTP00772 C228(2.43); C232(2.43)  LDD0080 
Histone-lysine N-methyltransferase SUV39H2 (SUV39H2) LDTP11953 C400(1.51); C405(1.51)  LDD0080 
Histone-lysine N-methyltransferase, H3 lysine-36 specific (NSD1) LDTP10531 C2124(1.07); C2133(1.07); C1583(1.01); C1586(1.01)  LDD0078 
Histone-lysine N-methyltransferase, H3 lysine-79 specific (DOT1L) LDTP09500 C696(25.71)  LDD0209 
Histone-lysine N-trimethyltransferase SMYD5 (SMYD5) LDTP07388 C73(1.02)  LDD0078 
Holocytochrome c-type synthase (HCCS) LDTP04581 C35(1.29); C178(1.04); C46(1.03); C66(0.89)  LDD0078 
Homeodomain-interacting protein kinase 1 (HIPK1) LDTP08426 C1024(1.22); C1025(1.22)  LDD0078 
Homeodomain-interacting protein kinase 2 (HIPK2) LDTP11849 C960(2.84)  LDD3373 
Homogentisate 1,2-dioxygenase (HGD) LDTP09983 C418(1.86)  LDD3346 
Hormone-sensitive lipase (LIPE) LDTP05454 C1072(1.32)  LDD0531 
HSPB1-associated protein 1 (HSPBAP1) LDTP10280 C293(2.95)  LDD3393 
Hyaluronan synthase 2 (HAS2) LDTP09885 C336(2.24)  LDD3455 
Hyaluronan synthase 3 (HAS3) LDTP00219 C312(0.86)  LDD0531 
Hyaluronan-binding protein 2 (HABP2) LDTP06135 C424(2.27)  LDD3316 
Hyaluronidase-2 (HYAL2) LDTP05684 C429(1.52); C438(1.52); C227(1.05); C427(1.52)  LDD0531 
Hyaluronidase-3 (HYAL3) LDTP00878 C77(1.64)  LDD3334 
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HADH) LDTP06645 C211(0.44)  LDD2236 
Hydroxyacylglutathione hydrolase, mitochondrial (HAGH) LDTP06626 C219(1.86)  LDD3316 
Hydroxyacylglutathione hydrolase-like protein (HAGHL) LDTP17393 C188(1.07)  LDD3312 
Hydroxylysine kinase (HYKK) LDTP00050 C221(0.99)  LDD1507 
Hydroxymethylglutaryl-CoA lyase, mitochondrial (HMGCL) LDTP03794 C323(1.10)  LDD0078 
Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMGCS1) LDTP05301 C86(1.15); C224(1.02); C406(0.86)  LDD0078 
Hydroxymethylglutaryl-CoA synthase, mitochondrial (HMGCS2) LDTP04645 C261(2.13)  LDD3373 
Hydroxysteroid dehydrogenase-like protein 2 (HSDL2) LDTP07762 C166(1.26); C218(1.02); C11(0.84)  LDD0078 
Hypoxanthine-guanine phosphoribosyltransferase (HPRT1) LDTP01782 C106(1.06)  LDD0078 
Immunity-related GTPase family Q protein (IRGQ) LDTP19838 C373(2.04)  LDD0080 
Inactive C-alpha-formylglycine-generating enzyme 2 (SUMF2) LDTP09056 C68(2.55)  LDD3316 
Inactive glycosyltransferase 25 family member 3 (CERCAM) LDTP07114 C182(1.36)  LDD3332 
Inactive histone-lysine N-methyltransferase 2E (KMT2E) LDTP08693 C839(3.02)  LDD0080 
Inactive hydroxysteroid dehydrogenase-like protein 1 (HSDL1) LDTP06787 C265(20.00); C328(1.58)  LDD0080 
Inactive phospholipase C-like protein 1 (PLCL1) LDTP06317 C33(1.94)  LDD3397 
Inactive phospholipase C-like protein 2 (PLCL2) LDTP13711 C90(6.33); C59(12.36); C1028(64.75)  LDD0209 
Inactive rhomboid protein 2 (RHBDF2) LDTP07597 C499(0.95); C508(0.95)  LDD0078 
Inactive serine/threonine-protein kinase 19 (STK19) LDTP04320 C230(3.46)  LDD3369 
Inactive tyrosine-protein kinase PEAK1 (PEAK1) LDTP12017 C712(2.86)  LDD0080 
Inactive tyrosine-protein kinase PRAG1 (PRAG1) LDTP08419 C903(1.27); C910(1.27); C284(1.20); C288(1.20)  LDD0078 
Inactive ubiquitin carboxyl-terminal hydrolase 53 (USP53) LDTP07879 C224(2.07); C228(2.07)  LDD0080 
Inactive ubiquitin carboxyl-terminal hydrolase 54 (USP54) LDTP07881 C1004(1.01); C1009(1.01); C145(0.95); C150(0.95)  LDD0078 
Inactive ubiquitin thioesterase OTULINL (OTULINL) LDTP12645 C177(1.09)  LDD0078 
Inactive Ufm1-specific protease 1 (UFSP1) LDTP07482 C35(1.25)  LDD3311 
Indoleamine 2,3-dioxygenase 1 (IDO1) LDTP02753 C308(1.28)  LDD3318 
Inhibitor of nuclear factor kappa-B kinase subunit alpha (CHUK) LDTP00538 C406(1.08); C379(1.00); C300(0.92)  LDD0078 
Inhibitor of nuclear factor kappa-B kinase subunit beta (IKBKB) LDTP00475 C464(1.27); C114(0.90)  LDD0078 
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) LDTP06065 C33(2.31)  LDD3313 
Inorganic pyrophosphatase (PPA1) LDTP14854 C274(1.01); C254(0.98); C270(0.95); C242(0.85)  LDD0078 
Inorganic pyrophosphatase 2, mitochondrial (PPA2) LDTP11842 C161(13.91); C171(13.91)  LDD0209 
Inosine triphosphate pyrophosphatase (ITPA) LDTP11432 C33(1.00); C146(0.87); C154(0.87)  LDD0078 
Inosine-5'-monophosphate dehydrogenase 1 (IMPDH1) LDTP03084 C331(61.80)  LDD0209 
Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) LDTP02611 C331(1.09); C339(1.09); C140(1.02); C173(0.99)  LDD0078 
Inositol 1,4,5-trisphosphate receptor-interacting protein (ITPRIP) LDTP08532 C228(1.55); C268(1.21); C255(1.20); C257(1.20)  LDD0078 
Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1 (ITPRIPL1) LDTP15076 C418(0.93)  LDD1509 
Inositol 1,4,5-trisphosphate receptor-interacting protein-like 2 (ITPRIPL2) LDTP19281 C300(0.97); C301(0.97); C371(0.78)  LDD0531 
Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 (PPIP5K1) LDTP07572 C544(1.08); C559(1.08)  LDD0078 
Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (PPIP5K2) LDTP00744 C532(1.06); C547(1.06); C488(1.03)  LDD0078 
Inositol hexakisphosphate kinase 1 (IP6K1) LDTP09792 C261(1.37); C275(1.37); C248(0.96)  LDD0078 
Inositol hexakisphosphate kinase 2 (IP6K2) LDTP13283 C217(9.90)  LDD0209 
Inositol monophosphatase 1 (IMPA1) LDTP03470 C243(1.70); C83(0.49)  LDD3310 
Inositol monophosphatase 2 (IMPA2) LDTP00413 C90(2.36); C107(2.36)  LDD0080 
Inositol polyphosphate 1-phosphatase (INPP1) LDTP14697 C97(1.67)  LDD3312 
Inositol polyphosphate 4-phosphatase type II (INPP4B) LDTP00609 C210(1.05); C206(1.05); C212(1.05)  LDD0531 
Inositol polyphosphate 5-phosphatase K (INPP5K) LDTP11182 C173(1.04)  LDD0078 
Inositol polyphosphate 5-phosphatase OCRL (OCRL) LDTP05326 C811(18.12)  LDD0209 
Inositol polyphosphate multikinase (IPMK) LDTP09223 C220(1.09)  LDD0080 
Inositol polyphosphate-4-phosphatase type I A (INPP4A) LDTP10676 C559(1.00); C565(1.00); C569(1.00)  LDD0078 
Inositol polyphosphate-5-phosphatase A (INPP5A) LDTP06164 C159(0.96)  LDD0531 
Inositol-3-phosphate synthase 1 (ISYNA1) LDTP12364 C485(1.29); C541(0.79)  LDD0531 
Inositol-pentakisphosphate 2-kinase (IPPK) LDTP12070 C293(10.18)  LDD0209 
Inositol-tetrakisphosphate 1-kinase (ITPK1) LDTP05929 C391(1.19); C403(1.19); C355(1.07); C361(1.07)  LDD0078 
Inositol-trisphosphate 3-kinase A (ITPKA) LDTP03250 C342(1.10)  LDD0531 
Inositol-trisphosphate 3-kinase B (ITPKB) LDTP03409 C693(10.60)  LDD0204 
Inositol-trisphosphate 3-kinase C (ITPKC) LDTP10231 C321(1.01); C325(1.01)  LDD0078 
Insulin receptor (INSR) LDTP02137 C1272(0.78)  LDD0532 
Insulin receptor-related protein (INSRR) LDTP02732 C210(1.34)  LDD3380 
Insulin-degrading enzyme (IDE) LDTP02743 C414(1.03)  LDD0531 
Insulin-like growth factor 1 receptor (IGF1R) LDTP02243 C692(1.05); C699(0.92); C700(0.92); C702(0.92)  LDD0078 
Integrator complex subunit 11 (INTS11) LDTP07158 C94(1.55)  LDD3329 
Integrator complex subunit 6 (INTS6) LDTP13505 C347(7.42); C211(4.66)  LDD0209 
Integrator complex subunit 6-like (INTS6L) LDTP19352 C745(2.45)  LDD0080 
Integrator complex subunit 9 (INTS9) LDTP12663 C578(4.66)  LDD0209 
Integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP) LDTP11700 C190(0.98)  LDD0078 
Integrin-linked protein kinase (ILK) LDTP05859 C428(0.90); C239(0.89)  LDD0078 
Interferon regulatory factor 2-binding protein 1 (IRF2BP1) LDTP08436 C280(1.06); C12(0.99); C15(0.99); C36(0.99)  LDD0078 
Interferon-induced GTP-binding protein Mx1 (MX1) LDTP03057 C533(1.19); C42(0.87)  LDD0078 
Interferon-induced helicase C domain-containing protein 1 (IFIH1) LDTP11507 C981(56.26)  LDD0209 
Interferon-induced, double-stranded RNA-activated protein kinase (EIF2AK2) LDTP03003 C361(2.40); C369(2.40)  LDD0080 
Interferon-stimulated 20 kDa exonuclease-like 2 (ISG20L2) LDTP18423 C168(0.83)  LDD0531 
Interleukin-1 receptor accessory protein (IL1RAP) LDTP12365 C47(2.14); C332(1.62)  LDD3312 
Interleukin-1 receptor-associated kinase 1 (IRAK1) LDTP04435 C302(1.48); C307(1.48)  LDD0078 
Interleukin-1 receptor-associated kinase 3 (IRAK3) LDTP14197 C581(1.17); C572(1.04); C532(0.87); C539(0.87)  LDD0078 
Interleukin-1 receptor-associated kinase 4 (IRAK4) LDTP12744 C13(0.98)  LDD0078 
Interleukin-1 receptor-associated kinase-like 2 (IRAK2) LDTP00706 C244(1.01)  LDD0078 
Interleukin-18 receptor 1 (IL18R1) LDTP05887 C385(2.18)  LDD3372 
Intermediate filament family orphan 2 (IFFO2) LDTP19414 C305(4.72)  LDD2236 
Interstitial collagenase (MMP1) LDTP01992 C92(1.86)  LDD3381 
Intraflagellar transport protein 22 homolog (IFT22) LDTP16015 C57(0.90); C64(0.90); C73(0.89)  LDD0078 
Iron-responsive element-binding protein 2 (IREB2) LDTP04168 C178(2.75)  LDD0080 
Isoamyl acetate-hydrolyzing esterase 1 homolog (IAH1) LDTP17082 C137(0.84); C150(0.84)  LDD0078 
Isoaspartyl peptidase/L-asparaginase (ASRGL1) LDTP07944 C176(0.92)  LDD0531 
Isobutyryl-CoA dehydrogenase, mitochondrial (ACAD8) LDTP13488 C150(40.11)  LDD0209 
Isochorismatase domain-containing protein 1 (ISOC1) LDTP19851 C215(1.16)  LDD3340 
Isochorismatase domain-containing protein 2 (ISOC2) LDTP18123 C84(1.59)  LDD0080 
Isocitrate dehydrogenase [NADP] cytoplasmic (IDH1) LDTP01333 C269(20.00)  LDD0080 
Isocitrate dehydrogenase [NADP], mitochondrial (IDH2) LDTP04211 C418(0.89); C308(0.86)  LDD0078 
Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (IDH3A) LDTP04345 C331(1.00)  LDD0078 
Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (IDH3B) LDTP00885 C185(1.49)  LDD0080 
Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (IDH3G) LDTP04423 C236(2.20); C235(2.47); C148(1.51)  LDD0080 
Isoleucine--tRNA ligase, cytoplasmic (IARS1) LDTP03947 C87(0.97)  LDD0078 
Isoleucine--tRNA ligase, mitochondrial (IARS2) LDTP12588 C91(1.04); C521(0.92)  LDD0078 
Isopentenyl-diphosphate Delta-isomerase 1 (IDI1) LDTP06006 C172(0.99)  LDD1492 
Isopentenyl-diphosphate delta-isomerase 2 (IDI2) LDTP11405 C96(1.69)  LDD3383 
Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) LDTP03359 C251(2.69); C258(2.69)  LDD0080 
Josephin-1 (JOSD1) LDTP06290 C142(1.16)  LDD0625 
Josephin-2 (JOSD2) LDTP09291 C24(0.98); C47(0.98)  LDD1142 
Kalirin (KALRN) LDTP00914 C2905(2.90)  LDD3344 
Kallikrein-10 (KLK10) LDTP00713 C190(1.77)  LDD3373 
Kallikrein-11 (KLK11) LDTP13176 C83(0.80)  LDD3364 
Kallikrein-2 (KLK2) LDTP03034 C50(3.48)  LDD3486 
Kallikrein-6 (KLK6) LDTP09911 C218(1.51)  LDD3360 
Kallikrein-7 (KLK7) LDTP04322 C36(2.01)  LDD3440 
Katanin p60 ATPase-containing subunit A-like 1 (KATNAL1) LDTP11313 C424(0.98)  LDD0531 
Katanin p60 ATPase-containing subunit A-like 2 (KATNAL2) LDTP08670 C311(0.65)  LDD0531 
Katanin p60 ATPase-containing subunit A1 (KATNA1) LDTP01226 C491(1.24)  LDD0080 
Ketohexokinase (KHK) LDTP04340 C282(2.87)  LDD2268 
Ketosamine-3-kinase (FN3KRP) LDTP16025 C24(0.95)  LDD0078 
Kinase suppressor of Ras 1 (KSR1) LDTP08515 C164(1.84); C148(5.38); C155(5.38)  LDD0080 
Kinesin heavy chain isoform 5A (KIF5A) LDTP05665 C296(4.23)  LDD0080 
Kinesin heavy chain isoform 5C (KIF5C) LDTP00936 C393(2.89)  LDD3340 
Kinesin-like protein KIF11 (KIF11) LDTP04519 C723(1.08); C773(0.95)  LDD0078 
Kinesin-like protein KIF12 (KIF12) LDTP15723 C632(3.13)  LDD3389 
Kinesin-like protein KIF13A (KIF13A) LDTP11765 C929(1.12)  LDD0078 
Kinesin-like protein KIF13B (KIF13B) LDTP12435 C127(5.52)  LDD0209 
Kinesin-like protein KIF14 (KIF14) LDTP06303 C1202(1.12); C1524(1.10); C1534(1.10); C508(1.05)  LDD0078 
Kinesin-like protein KIF15 (KIF15) LDTP12572 C50(33.16); C576(9.43)  LDD0209 
Kinesin-like protein KIF17 (KIF17) LDTP13040 C24(4.64); C32(4.64); C872(2.74); C885(1.44)  LDD0080 
Kinesin-like protein KIF18A (KIF18A) LDTP09286 C460(0.94)  LDD0078 
Kinesin-like protein KIF18B (KIF18B) LDTP08390 C320(42.24)  LDD0209 
Kinesin-like protein KIF1A (KIF1A) LDTP05639 C618(2.04); C1754(3.84)  LDD3331 
Kinesin-like protein KIF1B (KIF1B) LDTP00954 C1771(3.06); C1447(1.51)  LDD3310 
Kinesin-like protein KIF1C (KIF1C) LDTP00895 C685(1.03)  LDD0078 
Kinesin-like protein KIF20A (KIF20A) LDTP01535 C762(1.33); C763(1.33); C860(0.87); C866(0.87)  LDD0078 
Kinesin-like protein KIF20B (KIF20B) LDTP10726 C480(3.87); C1210(1.24)  LDD3342 
Kinesin-like protein KIF21A (KIF21A) LDTP08077 C235(1.80)  LDD3310 
Kinesin-like protein KIF21B (KIF21B) LDTP01103 C203(2.57)  LDD3370 
Kinesin-like protein KIF22 (KIF22) LDTP06214 C65(1.69); C575(1.31); C72(1.48)  LDD0080 
Kinesin-like protein KIF23 (KIF23) LDTP05344 C759(1.24); C447(1.11); C717(1.09); C725(1.09)  LDD0078 
Kinesin-like protein KIF24 (KIF24) LDTP07141 C910(0.95)  LDD1513 
Kinesin-like protein KIF26A (KIF26A) LDTP13553 C1802(2.43)  LDD3340 
Kinesin-like protein KIF26B (KIF26B) LDTP14880 C1679(4.08); C1463(2.51); C2013(3.72); C819(2.39)  LDD3340 
Kinesin-like protein KIF27 (KIF27) LDTP08286 C1103(2.75)  LDD3423 
Kinesin-like protein KIF2A (KIF2A) LDTP00188 C225(24.35); C227(24.35)  LDD0204 
Kinesin-like protein KIF2B (KIF2B) LDTP08872 C309(4.22)  LDD3310 
Kinesin-like protein KIF2C (KIF2C) LDTP10935 C287(1.05); C560(0.96); C572(0.96)  LDD0078 
Kinesin-like protein KIF3A (KIF3A) LDTP14033 C621(3.45); C12(1.33)  LDD0080 
Kinesin-like protein KIF3C (KIF3C) LDTP00432 C654(4.96)  LDD0209 
Kinesin-like protein KIF7 (KIF7) LDTP06695 C1065(2.70)  LDD0080 
Kinesin-like protein KIFC1 (KIFC1) LDTP11309 C509(1.23); C485(1.07); C144(1.03); C95(0.99)  LDD0078 
Kinesin-like protein KIFC3 (KIFC3) LDTP11283 C682(3.62)  LDD3346 
Kynureninase (KYNU) LDTP06615 C45(1.04); C327(1.00)  LDD0078 
Kynurenine 3-monooxygenase (KMO) LDTP00578 C341(4.88); C235(1.71); C25(2.70)  LDD3423 
Kynurenine formamidase (AFMID) LDTP15054 C28(13.92)  LDD0209 
Kynurenine--oxoglutarate transaminase 1 (KYAT1) LDTP06624 C280(1.00)  LDD1513 
Kynurenine--oxoglutarate transaminase 3 (KYAT3) LDTP07763 C236(10.08)  LDD0204 
L-2-hydroxyglutarate dehydrogenase, mitochondrial (L2HGDH) LDTP12105 C113(1.07); C124(1.07); C252(1.02); C258(1.02)  LDD0078 
L-amino-acid oxidase (IL4I1) LDTP10777 C274(1.79)  LDD3383 
L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (AASDHPPT) LDTP12524 C23(1.83)  LDD0080 
L-dopachrome tautomerase (DCT) LDTP03879 C118(2.66); C61(2.95); C52(1.92)  LDD3332 
L-fucose kinase (FCSK) LDTP08731 C516(1.05); C819(1.24); C568(1.60)  LDD3312 
L-lactate dehydrogenase A chain (LDHA) LDTP01766 C322(0.50); C64(0.99)  LDD3310 
L-lactate dehydrogenase A-like 6A (LDHAL6A) LDTP15177 C192(1.02)  LDD3310 
L-lactate dehydrogenase B chain (LDHB) LDTP02179 C164(5.01)  LDD0209 
L-lactate dehydrogenase C chain (LDHC) LDTP02224 C293(0.98)  LDD1507 
L-seryl-tRNA(Sec) kinase (PSTK) LDTP17621 C21(2.41); C24(2.41)  LDD0080 
L-xylulose reductase (DCXR) LDTP08082 C138(1.15); C244(1.14)  LDD0078 
Lactadherin (MFGE8) LDTP05561 C66(2.53)  LDD3310 
Lactosylceramide 4-alpha-galactosyltransferase (A4GALT) LDTP12342 C342(1.17)  LDD3360 
Lactosylceramide alpha-2,3-sialyltransferase (ST3GAL5) LDTP13670 C8(3.74)  LDD3332 
Lactotransferrin (LTF) LDTP01971 C424(0.74)  LDD0613 
Lactoylglutathione lyase (GLO1) LDTP05434 C61(1.08)  LDD0078 
Lambda-crystallin homolog (CRYL1) LDTP13905 C125(1.15)  LDD0531 
Lanosterol 14-alpha demethylase (CYP51A1) LDTP06648 C345(1.22); C449(0.64)  LDD0531 
Lanosterol synthase (LSS) LDTP04183 C616(10.46)  LDD0204 
Large ribosomal subunit protein mL39 (MRPL39) LDTP12835 C133(0.90); C335(1.16)  LDD0531 
Large ribosomal subunit protein mL44 (MRPL44) LDTP12098 C96(0.97)  LDD0078 
Large ribosomal subunit protein mL62 (MRPL58) LDTP06080 C82(1.16)  LDD0078 
Large subunit GTPase 1 homolog (LSG1) LDTP11687 C112(0.93)  LDD0078 
Lariat debranching enzyme (DBR1) LDTP13429 C139(0.95); C8(1.03); C9(0.99)  LDD0531 
Lathosterol oxidase (SC5D) LDTP01329 C285(2.59)  LDD3314 
Legumain (LGMN) LDTP10888 C219(0.89)  LDD0078 
Leishmanolysin-like peptidase (LMLN) LDTP10518 C441(1.06)  LDD1507 
Leucine carboxyl methyltransferase 1 (LCMT1) LDTP13337 C250(1.05); C258(1.05); C13(0.92); C14(0.92)  LDD0078 
Leucine--tRNA ligase, cytoplasmic (LARS1) LDTP13056 C554(1.17); C546(0.97); C573(0.97)  LDD0078 
Leucine--tRNA ligase, mitochondrial (LARS2) LDTP06287 C167(1.26); C225(1.01); C578(0.97)  LDD0078 
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1) LDTP06755 C425(2.38)  LDD3339 
Leucine-rich repeat-containing protein 47 (LRRC47) LDTP15404 C249(1.38); C367(1.12)  LDD0080 
Leucyl-cystinyl aminopeptidase (LNPEP) LDTP13358 C103(1.11)  LDD0078 
Leukotriene A-4 hydrolase (LTA4H) LDTP02385 C147(0.82)  LDD3311 
LIM domain kinase 1 (LIMK1) LDTP04573 C349(21.61); C297(14.56)  LDD0209 
LIM domain kinase 2 (LIMK2) LDTP04574 C317(1.38); C329(1.38)  LDD0078 
LINE-1 retrotransposable element ORF1 protein (L1RE1) LDTP13646 C76(0.91)  LDD0078 
LINE-1 type transposase domain-containing protein 1 (L1TD1) LDTP15009 C744(5.31)  LDD3380 
Lipid droplet-associated hydrolase (LDAH) LDTP16007 C280(1.24)  LDD3310 
Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (DBT) LDTP02550 C333(2.70); C279(3.61); C365(3.59)  LDD3312 
Lipoprotein lipase (LPL) LDTP02168 C243(0.44); C310(0.39)  LDD2236 
Lipoyl amidotransferase LIPT1, mitochondrial (LIPT1) LDTP13791 C352(2.72)  LDD3330 
Lipoyl synthase, mitochondrial (LIAS) LDTP00863 C106(2.10)  LDD3314 
Little elongation complex subunit 1 (ICE1) LDTP13856 C1817(1.43); C1063(1.02); C1076(1.02); C1485(0.93)  LDD0078 
LON peptidase N-terminal domain and RING finger protein 2 (LONRF2) LDTP06675 C476(3.14); C486(3.14); C483(3.14); C190(2.46)  LDD0080 
Lon protease homolog 2, peroxisomal (LONP2) LDTP08323 C372(0.49)  LDD0533 
Lon protease homolog, mitochondrial (LONP1) LDTP03817 C682(0.90)  LDD0078 
Long-chain fatty acid transport protein 1 (SLC27A1) LDTP07559 C406(1.08); C439(0.93); C442(0.93)  LDD0531 
Long-chain fatty acid transport protein 2 (SLC27A2) LDTP00496 C301(1.03); C414(1.04)  LDD0531 
Long-chain fatty acid transport protein 3 (SLC27A3) LDTP07028 C112(0.95); C411(0.79)  LDD0532 
Long-chain fatty acid transport protein 4 (SLC27A4) LDTP07511 C389(6.97); C403(6.97); C391(6.97); C560(4.07)  LDD0080 
Long-chain fatty acid transport protein 6 (SLC27A6) LDTP13895 C147(1.27); C300(1.41)  LDD0531 
Long-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADL) LDTP03432 C342(1.45)  LDD0080 
Long-chain-fatty-acid--CoA ligase 1 (ACSL1) LDTP03662 C108(0.81)  LDD0531 
Long-chain-fatty-acid--CoA ligase 4 (ACSL4) LDTP00982 C494(1.40); C495(1.40)  LDD0078 
Long-chain-fatty-acid--CoA ligase 5 (ACSL5) LDTP13533 C177(2.54); C93(2.75); C666(1.87); C378(2.64)  LDD3311 
Long-chain-fatty-acid--CoA ligase 6 (ACSL6) LDTP13486 C167(1.38); C650(1.40); C452(2.12)  LDD3430 
Low molecular weight phosphotyrosine protein phosphatase (ACP1) LDTP03289 C18(1.84)  LDD0080 
Lymphoid-specific helicase (HELLS) LDTP12552 C205(1.00)  LDD0078 
Lymphokine-activated killer T-cell-originated protein kinase (PBK) LDTP10500 C22(1.60); C112(1.66)  LDD0080 
Lys-63-specific deubiquitinase BRCC36 (BRCC3) LDTP04104 C172(1.03)  LDD0532 
Lysine--tRNA ligase (KARS1) LDTP06294 C462(1.67)  LDD3311 
Lysine-specific demethylase 2A (KDM2A) LDTP13885 C577(1.15); C585(1.15); C620(1.02); C623(1.02)  LDD0078 
Lysine-specific demethylase 2B (KDM2B) LDTP09254 C716(1.39); C719(1.50)  LDD0080 
Lysine-specific demethylase 3A (KDM3A) LDTP14040 C496(1.24); C497(1.24); C279(1.08); C287(1.08)  LDD0078 
Lysine-specific demethylase 3B (KDM3B) LDTP07982 C1124(1.18); C1126(1.18); C295(1.00); C569(0.98)  LDD0078 
Lysine-specific demethylase 4A (KDM4A) LDTP01148 C560(1.08)  LDD0078 
Lysine-specific demethylase 4B (KDM4B) LDTP01470 C235(2.40); C309(1.15)  LDD0080 
Lysine-specific demethylase 4C (KDM4C) LDTP11880 C236(1.02)  LDD0533 
Lysine-specific demethylase 4D (KDM4D) LDTP07356 C10(1.99); C16(1.99)  LDD0080 
Lysine-specific demethylase 5A (KDM5A) LDTP03484 C1610(1.03); C1615(1.03); C1619(1.03); C683(0.84)  LDD0078 
Lysine-specific demethylase 5B (KDM5B) LDTP13233 C650(2.13)  LDD3310 
Lysine-specific demethylase 5C (KDM5C) LDTP03939 C371(2.17); C376(1.89); C327(1.32)  LDD0080 
Lysine-specific demethylase 5D (KDM5D) LDTP11440 C265(1.54)  LDD2348 
Lysine-specific demethylase 6A (KDM6A) LDTP00678 C1023(1.66); C384(2.00); C797(2.13)  LDD0080 
Lysine-specific demethylase 6B (KDM6B) LDTP00520 C1547(2.96)  LDD3331 
Lysine-specific demethylase 7A (KDM7A) LDTP07778 C542(0.85)  LDD1512 
Lysine-specific demethylase 9 (RSBN1) LDTP17276 C207(1.02)  LDD0078 
Lysine-specific demethylase hairless (HR) LDTP00811 C690(1.00); C692(1.00)  LDD0533 
Lysine-specific demethylase PHF2 (PHF2) LDTP01142 C23(0.98); C26(0.98)  LDD0078 
Lysine-specific demethylase RSBN1L (RSBN1L) LDTP17384 C818(1.11)  LDD0078 
Lysine-specific histone demethylase 1A (KDM1A) LDTP00957 C195(1.03); C573(0.86)  LDD0078 
Lysine-specific histone demethylase 2 (KDM1B) LDTP09043 C234(2.73); C278(1.76); C227(1.29)  LDD0080 
Lysocardiolipin acyltransferase 1 (LCLAT1) LDTP07679 C304(1.03)  LDD0531 
Lysophosphatidic acid phosphatase type 6 (ACP6) LDTP12363 C267(1.04)  LDD3313 
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) LDTP09188 C330(1.13)  LDD0080 
Lysophosphatidylcholine acyltransferase 2 (LPCAT2) LDTP07967 C223(0.96)  LDD0531 
Lysophosphatidylserine lipase ABHD12 (ABHD12) LDTP08799 C93(6.46)  LDD3312 
Lysophospholipase D GDPD1 (GDPD1) LDTP09000 C124(2.07); C126(2.07); C107(1.21)  LDD0080 
Lysophospholipase D GDPD3 (GDPD3) LDTP07965 C91(0.86)  LDD0532 
Lysophospholipase-like protein 1 (LYPLAL1) LDTP07247 C12(0.94)  LDD0078 
Lysophospholipid acyltransferase 1 (MBOAT1) LDTP07792 C266(1.08)  LDD1513 
Lysophospholipid acyltransferase 2 (MBOAT2) LDTP07867 C505(1.83)  LDD0080 
Lysophospholipid acyltransferase 5 (LPCAT3) LDTP07504 C316(2.07)  LDD0080 
Lysophospholipid acyltransferase 7 (MBOAT7) LDTP10612 C310(0.97); C304(0.86)  LDD0078 
Lysophospholipid acyltransferase LPCAT4 (LPCAT4) LDTP07290 C206(1.02); C89(0.98)  LDD0531 
Lysosomal acid glucosylceramidase (GBA1) LDTP02005 C165(1.03)  LDD0078 
Lysosomal acid lipase/cholesteryl ester hydrolase (LIPA) LDTP03858 C209(0.87)  LDD3332 
Lysosomal acid phosphatase (ACP2) LDTP02539 C159(3.66)  LDD3310 
Lysosomal cobalamin transporter ABCD4 (ABCD4) LDTP00404 C361(0.95)  LDD1492 
Lysosomal Pro-X carboxypeptidase (PRCP) LDTP04004 C331(1.48)  LDD3368 
Lysosomal protective protein (CTSA) LDTP02505 C281(1.11)  LDD0531 
Lysosomal thioesterase PPT2 (PPT2) LDTP13620 C296(1.14)  LDD1509 
Lysozyme C (LYZ) LDTP04933 C146(2.41); C83(3.14)  LDD3336 
Lysyl oxidase homolog 2 (LOXL2) LDTP14063 C424(2.91); C414(1.72); C625(1.65); C158(4.17)  LDD3323 
Lysyl oxidase homolog 3 (LOXL3) LDTP04810 C727(1.53)  LDD3332 
Lysyl oxidase homolog 4 (LOXL4) LDTP10455 C336(2.26)  LDD3345 
M-phase inducer phosphatase 1 (CDC25A) LDTP03531 C159(1.06); C256(1.06)  LDD1513 
M-phase inducer phosphatase 3 (CDC25C) LDTP03533 C121(1.11); C128(1.11)  LDD0078 
m7GpppN-mRNA hydrolase (DCP2) LDTP08433 C140(2.12)  LDD0080 
m7GpppX diphosphatase (DCPS) LDTP10163 C37(1.25)  LDD0080 
Macrophage migration inhibitory factor (MIF) LDTP02713 C81(1.13)  LDD0080 
Macrophage-stimulating protein receptor (MST1R) LDTP05441 C385(0.98); C386(0.98); C533(1.13); C558(0.87)  LDD0531 
Malate dehydrogenase, cytoplasmic (MDH1) LDTP03907 C65(1.38); C48(1.23)  LDD3311 
Malate dehydrogenase, mitochondrial (MDH2) LDTP03908 C93(1.82); C285(1.56)  LDD0080 
Male-specific lethal 1 homolog (MSL1) LDTP07329 C369(0.94); C377(0.94)  LDD0078 
Maleylacetoacetate isomerase (GSTZ1) LDTP00844 C205(1.08)  LDD0080 
Malonate--CoA ligase ACSF3, mitochondrial (ACSF3) LDTP06848 C399(0.73); C86(1.39); C88(1.39)  LDD0531 
Malonyl-CoA decarboxylase, mitochondrial (MLYCD) LDTP01686 C360(1.16)  LDD0080 
Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCAT) LDTP08512 C62(1.69)  LDD0080 
Maltase-glucoamylase (MGAM) LDTP00770 C1071(1.31)  LDD3311 
Mannan-binding lectin serine protease 1 (MASP1) LDTP04214 C260(0.99)  LDD1507 
Mannose-1-phosphate guanyltransferase alpha (GMPPA) LDTP10418 C442(2.41)  LDD3312 
Mannose-1-phosphate guanyltransferase beta (GMPPB) LDTP14141 C306(9.76)  LDD0205 
Mannose-6-phosphate isomerase (MPI) LDTP03697 C283(0.79); C289(0.79)  LDD0593 
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (MAN1A1) LDTP03677 C579(1.26)  LDD0531 
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (MAN1A2) LDTP00975 C494(0.82)  LDD1492 
Mannosyl-oligosaccharide glucosidase (MOGS) LDTP05971 C602(1.31)  LDD0532 
MAP kinase-activated protein kinase 2 (MAPKAPK2) LDTP04229 C98(1.13)  LDD0531 
MAP kinase-activated protein kinase 3 (MAPKAPK3) LDTP06589 C203(1.06); C379(0.98)  LDD0078 
MAP kinase-interacting serine/threonine-protein kinase 1 (MKNK1) LDTP11228 C101(1.58)  LDD3384 
MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2) LDTP12182 C299(1.57); C303(1.57)  LDD0078 
MAP/microtubule affinity-regulating kinase 3 (MARK3) LDTP03388 C46(1.82)  LDD3346 
MAP/microtubule affinity-regulating kinase 4 (MARK4) LDTP10526 C459(17.84)  LDD0209 
MAPK/MAK/MRK overlapping kinase (MOK) LDTP13742 C32(0.64)  LDD1109 
Maspardin (SPG21) LDTP12893 C260(1.11)  LDD0531 
Mast/stem cell growth factor receptor Kit (KIT) LDTP02516 C906(4.24)  LDD3314 
Maternal embryonic leucine zipper kinase (MELK) LDTP06180 C413(0.97)  LDD0078 
Matrilysin (MMP7) LDTP02336 C87(4.25)  LDD3375 
Matrix metalloproteinase-14 (MMP14) LDTP04352 C574(5.17)  LDD3310 
Matrix metalloproteinase-15 (MMP15) LDTP04417 C661(5.17)  LDD3444 
Matrix metalloproteinase-16 (MMP16) LDTP04418 C599(2.77)  LDD2469 
Mediator of RNA polymerase II transcription subunit 20 (MED20) LDTP12079 C120(1.11)  LDD0078 
Mediator of RNA polymerase II transcription subunit 21 (MED21) LDTP05899 C103(0.84)  LDD1509 
Medium-chain acyl-CoA ligase ACSF2, mitochondrial (ACSF2) LDTP10177 C64(6.03)  LDD0080 
Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADM) LDTP02565 C156(0.99); C156(1.23); C159(1.23)  LDD1492 
Megakaryocyte-associated tyrosine-protein kinase (MATK) LDTP03988 C82(1.36)  LDD2361 
Membrane-associated phosphatidylinositol transfer protein 3 (PITPNM3) LDTP11516 C724(1.33)  LDD3353 
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (PKMYT1) LDTP10930 C169(0.98); C170(0.93)  LDD0531 
Membrane-bound transcription factor site-2 protease (MBTPS2) LDTP00771 C358(3.58)  LDD3328 
Mesoderm-specific transcript homolog protein (MEST) LDTP06961 C174(1.40)  LDD3409 
Metallo-beta-lactamase domain-containing protein 1 (MBLAC1) LDTP00066 C7(0.72)  LDD3445 
Metalloendopeptidase OMA1, mitochondrial (OMA1) LDTP10249 C268(1.04); C273(1.04)  LDD0532 
Metalloreductase STEAP2 (STEAP2) LDTP09218 C168(1.09)  LDD0078 
Metalloreductase STEAP3 (STEAP3) LDTP07292 C150(1.44)  LDD3310 
Metalloreductase STEAP4 (STEAP4) LDTP07307 C156(0.77); C5(2.84)  LDD3313 
Methanethiol oxidase (SELENBP1) LDTP05793 C5(2.76); C8(2.20)  LDD0080 
Methenyltetrahydrofolate synthase domain-containing protein (MTHFSD) LDTP17073 C113(0.99); C215(1.06)  LDD0531 
Methionine adenosyltransferase 2 subunit beta (MAT2B) LDTP12915 C58(0.91)  LDD0078 
Methionine aminopeptidase 1 (METAP1) LDTP04565 C22(1.18); C25(1.18); C36(1.08); C40(1.08)  LDD0078 
Methionine aminopeptidase 1D, mitochondrial (METAP1D) LDTP07650 C152(2.58)  LDD0812 
Methionine aminopeptidase 2 (METAP2) LDTP04375 C436(4.84); C448(4.84); C121(1.68)  LDD0080 
Methionine synthase (MTR) LDTP10951 C798(0.91)  LDD0078 
Methionine synthase reductase (MTRR) LDTP13124 C132(1.03)  LDD0078 
Methionine--tRNA ligase, cytoplasmic (MARS1) LDTP04730 C38(1.09); C405(1.51); C408(1.51); C333(1.59)  LDD0080 
Methionine--tRNA ligase, mitochondrial (MARS2) LDTP10365 C170(0.98); C175(0.98)  LDD0078 
Methionine-R-sulfoxide reductase B2, mitochondrial (MSRB2) LDTP13980 C149(1.16)  LDD3312 
Methionyl-tRNA formyltransferase, mitochondrial (MTFMT) LDTP10222 C365(1.43)  LDD0080 
Methyl-CpG-binding domain protein 4 (MBD4) LDTP01540 C88(1.25); C289(1.15); C296(1.15); C254(1.08)  LDD0078 
Methylated-DNA--protein-cysteine methyltransferase (MGMT) LDTP02852 C150(1.05); C145(0.87)  LDD0078 
Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCC2) LDTP12227 C392(0.97); C267(0.94)  LDD0078 
Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCC1) LDTP10776 C129(1.10); C142(1.10); C332(1.05)  LDD0078 
Methylcytosine dioxygenase TET1 (TET1) LDTP09224 C1870(1.78)  LDD0080 
Methylcytosine dioxygenase TET2 (TET2) LDTP07452 C1811(1.30)  LDD3323 
Methylenetetrahydrofolate reductase (NADPH) (MTHFR) LDTP04009 C32(13.03)  LDD0209 
Methylglutaconyl-CoA hydratase, mitochondrial (AUH) LDTP05988 C138(0.97)  LDD3313 
Methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase [acylating], mitochondrial (ALDH6A1) LDTP05346 C368(6.47)  LDD0209 
Methylmalonic aciduria type A protein, mitochondrial (MMAA) LDTP08498 C184(2.74)  LDD3312 
Methylmalonyl-CoA epimerase, mitochondrial (MCEE) LDTP10677 C166(0.91)  LDD1509 
Methylmalonyl-CoA mutase, mitochondrial (MMUT) LDTP03150 C433(1.25)  LDD3337 
Methylsterol monooxygenase 1 (MSMO1) LDTP06477 C142(1.43); C145(1.43)  LDD1109 
Methylthioribose-1-phosphate isomerase (MRI1) LDTP11260 C168(0.97); C285(0.87)  LDD0078 
Methylthioribulose-1-phosphate dehydratase (APIP) LDTP10368 C11(1.15); C12(1.15)  LDD0078 
Methyltransferase-like protein 17, mitochondrial (METTL17) LDTP12027 C216(43.36)  LDD0209 
Methyltransferase-like protein 25B (METTL25B) LDTP18157 C260(1.11)  LDD1507 
Mevalonate kinase (MVK) LDTP05405 C173(1.39)  LDD0080 
Microsomal glutathione S-transferase 1 (MGST1) LDTP02506 C50(0.97)  LDD0078 
Microtubule-associated serine/threonine-protein kinase 1 (MAST1) LDTP13869 C291(1.13)  LDD1507 
Microtubule-associated serine/threonine-protein kinase 2 (MAST2) LDTP07501 C930(10.95)  LDD0209 
Microtubule-associated serine/threonine-protein kinase 3 (MAST3) LDTP00947 C541(32.76)  LDD0209 
Microtubule-associated serine/threonine-protein kinase 4 (MAST4) LDTP00511 C1286(16.13)  LDD0209 
Minor histocompatibility antigen H13 (HM13) LDTP09396 C326(2.27)  LDD3310 
Mismatch repair endonuclease PMS2 (PMS2) LDTP04610 C297(5.03)  LDD0209 
Misshapen-like kinase 1 (MINK1) LDTP08863 C129(1.04)  LDD0533 
Mitochondrial 10-formyltetrahydrofolate dehydrogenase (ALDH1L2) LDTP06796 C728(8.89); C558(1.90); C445(2.27); C783(1.24)  LDD0080 
Mitochondrial amidoxime reducing component 2 (MTARC2) LDTP10050 C272(0.75); C299(0.87)  LDD0531 
Mitochondrial amidoxime-reducing component 1 (MTARC1) LDTP07214 C290(2.07); C287(2.08)  LDD3321 
Mitochondrial cardiolipin hydrolase (PLD6) LDTP08790 C69(1.29); C71(1.29)  LDD0531 
Mitochondrial coenzyme A diphosphatase NUDT8 (NUDT8) LDTP09598 C224(3.23)  LDD0080 
Mitochondrial disaggregase (CLPB) LDTP11683 C647(0.64)  LDD0531 
Mitochondrial enolase superfamily member 1 (ENOSF1) LDTP07968 C194(0.93); C307(0.91)  LDD0078 
Mitochondrial genome maintenance exonuclease 1 (MGME1) LDTP11090 C79(1.80)  LDD0080 
Mitochondrial import inner membrane translocase subunit TIM50 (TIMM50) LDTP06810 C249(7.78)  LDD0209 
Mitochondrial inner membrane protease ATP23 homolog (ATP23) LDTP14252 C161(0.82)  LDD1508 
Mitochondrial inner membrane protease subunit 1 (IMMP1L) LDTP18196 C128(1.10)  LDD1509 
Mitochondrial intermediate peptidase (MIPEP) LDTP10981 C142(0.98)  LDD0078 
Mitochondrial mRNA pseudouridine synthase RPUSD3 (RPUSD3) LDTP07499 C172(3.68); C147(20.00)  LDD0080 
Mitochondrial peptide methionine sulfoxide reductase (MSRA) LDTP13371 C229(4.21); C220(2.60)  LDD0533 
Mitochondrial Rho GTPase 1 (RHOT1) LDTP08597 C507(2.68)  LDD3310 
Mitochondrial Rho GTPase 2 (RHOT2) LDTP08596 C543(1.14)  LDD0531 
Mitochondrial ribonuclease P catalytic subunit (PRORP) LDTP00536 C507(1.02); C568(0.95); C570(0.95)  LDD0078 
Mitochondrial ribosome-associated GTPase 1 (MTG1) LDTP11177 C23(3.41)  LDD0080 
Mitochondrial ribosome-associated GTPase 2 (MTG2) LDTP11928 C206(0.99)  LDD0078 
Mitochondrial tRNA methylthiotransferase CDK5RAP1 (CDK5RAP1) LDTP10829 C183(1.22)  LDD0078 
Mitochondrial tRNA-specific 2-thiouridylase 1 (TRMU) LDTP01284 C54(0.88)  LDD0078 
Mitochondrial ubiquitin ligase activator of NFKB 1 (MUL1) LDTP10038 C302(1.17); C305(1.17); C113(1.00)  LDD0078 
Mitochondrial-processing peptidase subunit alpha (PMPCA) LDTP05632 C466(0.96)  LDD0078 
Mitochondrial-processing peptidase subunit beta (PMPCB) LDTP01220 C265(1.23); C62(0.97); C485(0.93)  LDD0078 
Mitofusin-1 (MFN1) LDTP08530 C411(0.97); C418(0.97)  LDD0078 
Mitofusin-2 (MFN2) LDTP01503 C521(1.02); C530(1.02)  LDD0078 
Mitogen-activated protein kinase 1 (MAPK1) LDTP03445 C166(0.98)  LDD0078 
Mitogen-activated protein kinase 10 (MAPK10) LDTP04584 C283(5.26)  LDD0209 
Mitogen-activated protein kinase 11 (MAPK11) LDTP06463 C119(34.60)  LDD0209 
Mitogen-activated protein kinase 12 (MAPK12) LDTP04583 C165(1.10)  LDD1492 
Mitogen-activated protein kinase 13 (MAPK13) LDTP00594 C165(1.27)  LDD3312 
Mitogen-activated protein kinase 14 (MAPK14) LDTP06547 C39(1.54)  LDD0531 
Mitogen-activated protein kinase 3 (MAPK3) LDTP03387 C82(1.45); C178(1.74)  LDD0080 
Mitogen-activated protein kinase 7 (MAPK7) LDTP05775 C69(2.14)  LDD3404 
Mitogen-activated protein kinase 8 (MAPK8) LDTP04075 C175(1.47)  LDD3325 
Mitogen-activated protein kinase 9 (MAPK9) LDTP04076 C222(0.99)  LDD0078 
Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) LDTP05796 C1012(1.50); C1091(3.45); C1097(3.45)  LDD0080 
Mitogen-activated protein kinase kinase kinase 11 (MAP3K11) LDTP06564 C327(0.97)  LDD1514 
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15) LDTP07783 C1143(0.73)  LDD1507 
Mitogen-activated protein kinase kinase kinase 2 (MAP3K2) LDTP13912 C373(0.77)  LDD0532 
Mitogen-activated protein kinase kinase kinase 20 (MAP3K20) LDTP12837 C571(1.46); C22(1.18); C285(0.99); C231(0.90)  LDD0078 
Mitogen-activated protein kinase kinase kinase 21 (MAP3K21) LDTP07181 C281(3.56)  LDD3411 
Mitogen-activated protein kinase kinase kinase 3 (MAP3K3) LDTP10975 C461(3.09)  LDD3332 
Mitogen-activated protein kinase kinase kinase 4 (MAP3K4) LDTP14291 C326(1.16); C596(0.91)  LDD0078 
Mitogen-activated protein kinase kinase kinase 5 (MAP3K5) LDTP10940 C225(1.36); C226(1.36)  LDD0563 
Mitogen-activated protein kinase kinase kinase 6 (MAP3K6) LDTP01578 C232(1.10)  LDD0078 
Mitogen-activated protein kinase kinase kinase 7 (MAP3K7) LDTP00747 C174(0.99); C180(0.99)  LDD0078 
Mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1) LDTP09931 CAmbiguous(92.44); C484(7.50)  LDD0209 
Mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2) LDTP05669 C117(1.02); C481(0.95)  LDD0531 
Mitogen-activated protein kinase kinase kinase kinase 3 (MAP4K3) LDTP08499 C720(0.99)  LDD0078 
Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) LDTP01685 C269(3.01)  LDD3310 
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5) LDTP14065 C437(0.98); C418(0.91)  LDD0078 
Mitotic checkpoint serine/threonine-protein kinase BUB1 (BUB1) LDTP00837 C633(1.15); C641(1.15); C689(1.10); C698(1.10)  LDD0078 
Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (BUB1B) LDTP01004 C723(20.03); C700(17.31)  LDD0209 
Molybdenum cofactor sulfurase (MOCOS) LDTP10268 C811(1.34); C815(1.34); C686(0.96); C422(0.86)  LDD0078 
Molybdopterin synthase catalytic subunit (MOCS2) LDTP01747 C182(1.09)  LDD0078 
Monoacylglycerol lipase ABHD6 (ABHD6) LDTP11261 C134(0.98); C296(1.26); C304(1.26)  LDD0532 
Monofunctional C1-tetrahydrofolate synthase, mitochondrial (MTHFD1L) LDTP07651 C302(1.12); C906(0.94); C198(0.89)  LDD0078 
Monoglyceride lipase (MGLL) LDTP10942 C201(1.01)  LDD0078 
MORN repeat-containing protein 1 (MORN1) LDTP19388 C172(0.94)  LDD1514 
MPN domain-containing protein (MPND) LDTP08889 C241(3.89); C63(1.70)  LDD0080 
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase (PCIF1) LDTP11944 C361(1.32)  LDD0080 
mRNA cap guanine-N7 methyltransferase (RNMT) LDTP00686 C225(1.79)  LDD3312 
mRNA-capping enzyme (RNGTT) LDTP01095 C419(0.99)  LDD0078 
mRNA-decapping enzyme 1A (DCP1A) LDTP12371 C39(1.02); C149(1.01)  LDD1492 
mRNA-decapping enzyme 1B (DCP1B) LDTP08694 C291(7.81); C240(10.84)  LDD0209 
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) LDTP13195 C71(0.89); C77(0.89)  LDD0078 
Multidrug resistance-associated protein 1 (ABCC1) LDTP03671 C991(1.63)  LDD3311 
Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 (PLOD3) LDTP01005 C691(0.91); C282(0.87)  LDD0078 
Multifunctional protein CAD (CAD) LDTP03401 C1889(1.08); C1374(1.03); C1455(1.00); C280(0.93)  LDD0078 
Multiple inositol polyphosphate phosphatase 1 (MINPP1) LDTP13678 C475(1.42); C232(1.10)  LDD0078 
Myelin regulatory factor (MYRF) LDTP13859 C167(2.48)  LDD3444 
Myeloperoxidase (MPO) LDTP02094 C762(1.63); C736(2.70); C341(1.66)  LDD3333 
MYG1 exonuclease (MYG1) LDTP12154 C56(0.54); C62(0.54)  LDD0533 
Myocardial zonula adherens protein (MYZAP) LDTP02405 C447(1.17)  LDD3318 
Myosin light chain kinase 3 (MYLK3) LDTP06746 C312(2.07)  LDD3343 
Myosin light chain kinase, smooth muscle (MYLK) LDTP06459 C1305(1.16); C1307(1.16); C828(0.99); C832(0.99)  LDD0078 
Myosin-10 (MYH10) LDTP03765 C759(3.24); C398(4.17)  LDD3311 
Myosin-11 (MYH11) LDTP03785 C881(4.49)  LDD3312 
Myosin-14 (MYH14) LDTP08050 C332(2.21)  LDD3311 
Myosin-15 (MYH15) LDTP13882 C1261(0.84)  LDD0531 
Myosin-3 (MYH3) LDTP02537 C401(6.38); C1089(2.62); C796(6.58); C38(4.42)  LDD3401 
Myosin-4 (MYH4) LDTP14202 C817(4.15)  LDD3401 
Myosin-7B (MYH7B) LDTP00122 C1345(2.01)  LDD3402 
Myosin-9 (MYH9) LDTP03764 C1437(1.01); C1379(0.95); C988(0.89)  LDD0078 
Myosin-IIIb (MYO3B) LDTP09714 C1212(3.00)  LDD3387 
Myotubularin (MTM1) LDTP05897 C482(1.11); C53(0.96)  LDD0531 
Myotubularin-related protein 1 (MTMR1) LDTP05943 C170(1.37)  LDD0080 
Myotubularin-related protein 10 (MTMR10) LDTP18483 C707(30.92)  LDD0209 
Myotubularin-related protein 11 (MTMR11) LDTP14339 C40(1.14)  LDD3493 
Myotubularin-related protein 12 (MTMR12) LDTP11617 C152(1.09)  LDD0078 
Myotubularin-related protein 13 (SBF2) LDTP08330 C1184(1.25); C1540(0.69)  LDD0531 
Myotubularin-related protein 14 (MTMR14) LDTP09092 C70(1.07); C82(1.07)  LDD0078 
Myotubularin-related protein 2 (MTMR2) LDTP05944 C95(1.18)  LDD0080 
Myotubularin-related protein 3 (MTMR3) LDTP05945 C915(0.92); C922(0.92)  LDD0078 
Myotubularin-related protein 4 (MTMR4) LDTP12819 C932(0.95); C933(0.95)  LDD0078 
Myotubularin-related protein 5 (SBF1) LDTP01541 C1551(96.27); C987(66.37)  LDD0209 
Myotubularin-related protein 6 (MTMR6) LDTP13777 C383(1.01)  LDD0531 
Myotubularin-related protein 8 (MTMR8) LDTP10257 C216(1.01)  LDD1512 
Myotubularin-related protein 9 (MTMR9) LDTP10738 C380(0.68); C386(0.68)  LDD0531 
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (AGA) LDTP03093 C179(4.57)  LDD3428 
N(6)-adenine-specific methyltransferase METTL4 (METTL4) LDTP08833 C33(0.98); C34(0.98)  LDD0078 
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH1) LDTP01407 C75(0.85)  LDD3314 
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (B4GALNT4) LDTP15212 C932(2.14)  LDD2252 
N-acetyl-D-glucosamine kinase (NAGK) LDTP13372 C314(2.12)  LDD3310 
N-acetylaspartylglutamate synthase A (RIMKLA) LDTP08607 C108(25.79)  LDD0209 
N-acetylgalactosamine kinase (GALK2) LDTP05287 C175(1.94)  LDD3314 
N-acetylgalactosaminyltransferase 7 (GALNT7) LDTP08164 C545(1.90); C435(2.80); C562(2.27); C600(1.95)  LDD3310 
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (NAGPA) LDTP13420 C408(1.06); C412(1.06)  LDD0531 
N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (GNPTAB) LDTP06802 C1094(1.75)  LDD2253 
N-acetylglucosamine-6-phosphate deacetylase (AMDHD2) LDTP13939 C261(1.45)  LDD3311 
N-acetylglucosamine-6-sulfatase (GNS) LDTP02799 C140(1.01)  LDD1507 
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) LDTP13840 C268(1.32); C335(1.11)  LDD0532 
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (GCNT2) LDTP08730 C191(1.07)  LDD0078 
N-acetylmuramoyl-L-alanine amidase (PGLYRP2) LDTP10672 C506(3.85); C196(1.81)  LDD2268 
N-acetylneuraminate 9-O-acetyltransferase (CASD1) LDTP10665 C344(2.32)  LDD2268 
N-acetyltransferase ESCO1 (ESCO1) LDTP06971 C362(2.66)  LDD0080 
N-acetyltransferase ESCO2 (ESCO2) LDTP06930 C182(0.89); C35(1.11); C518(1.11)  LDD0531 
N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming) (ACY3) LDTP10385 C61(1.50)  LDD3370 
N-acylglucosamine 2-epimerase (RENBP) LDTP04432 C249(2.65)  LDD3310 
N-acylneuraminate cytidylyltransferase (CMAS) LDTP09228 C432(1.09); C364(1.00); C394(0.91)  LDD0078 
N-acylneuraminate-9-phosphatase (NANP) LDTP09343 C60(3.63); C67(3.63)  LDD0080 
N-alpha-acetyltransferase 10 (NAA10) LDTP03938 C194(1.13); C17(1.01); C21(1.01)  LDD0078 
N-alpha-acetyltransferase 15, NatA auxiliary subunit (NAA15) LDTP11388 C214(1.12); C238(1.12); C721(1.01); C322(0.91)  LDD0078 
N-alpha-acetyltransferase 16, NatA auxiliary subunit (NAA16) LDTP07455 C322(0.97)  LDD0078 
N-alpha-acetyltransferase 20 (NAA20) LDTP04929 C9(0.97)  LDD0531 
N-alpha-acetyltransferase 25, NatB auxiliary subunit (NAA25) LDTP06262 C339(1.35)  LDD0078 
N-alpha-acetyltransferase 30 (NAA30) LDTP06212 C195(1.08); C27(0.92); C38(0.92)  LDD0078 
N-alpha-acetyltransferase 35, NatC auxiliary subunit (NAA35) LDTP07259 C409(1.10)  LDD0078 
N-alpha-acetyltransferase 40 (NAA40) LDTP08265 C204(3.23); C205(3.23); C26(1.33)  LDD0080 
N-alpha-acetyltransferase 50 (NAA50) LDTP11671 C60(5.02); C61(5.02)  LDD0080 
N-alpha-acetyltransferase 60 (NAA60) LDTP12036 C19(2.11)  LDD3312 
N-alpha-acetyltransferase 80 (NAA80) LDTP09963 C75(1.00); C250(0.95); C18(1.01)  LDD1492 
N-lysine methyltransferase KMT5A (KMT5A) LDTP12427 C311(1.41)  LDD0080 
N-lysine methyltransferase SETD6 (SETD6) LDTP09349 C375(1.57)  LDD3333 
N-lysine methyltransferase SMYD2 (SMYD2) LDTP12509 C74(1.03)  LDD0531 
N-sulphoglucosamine sulphohydrolase (SGSH) LDTP04452 C183(0.88); C194(0.88)  LDD0078 
N-terminal kinase-like protein (SCYL1) LDTP10503 C241(1.04); C88(0.89); C309(0.86)  LDD0078 
N-terminal Xaa-Pro-Lys N-methyltransferase 1 (NTMT1) LDTP11273 C195(1.11); C64(0.88); C68(0.88)  LDD0078 
N6-adenosine-methyltransferase catalytic subunit (METTL3) LDTP08214 C314(1.13); C320(1.13); C326(1.13)  LDD0078 
NACHT, LRR and PYD domains-containing protein 1 (NLRP1) LDTP11576 C1310(11.30); C264(89.22); C11(12.52)  LDD0209 
NACHT, LRR and PYD domains-containing protein 3 (NLRP3) LDTP10652 C730(1.52)  LDD3311 
NAD kinase (NADK) LDTP01628 C79(1.01)  LDD0078 
NAD kinase 2, mitochondrial (NADK2) LDTP06839 C311(1.49)  LDD0080 
NAD(+) hydrolase SARM1 (SARM1) LDTP07640 C482(1.12)  LDD0080 
NAD(P) transhydrogenase, mitochondrial (NNT) LDTP05862 C308(16.54)  LDD0209 
NAD(P)H-hydrate epimerase (NAXE) LDTP09110 C283(2.54)  LDD0080 
NAD-capped RNA hydrolase NUDT12 (NUDT12) LDTP11081 C117(1.35)  LDD0080 
NAD-dependent malic enzyme, mitochondrial (ME2) LDTP03220 C198(0.49); C202(0.49); C441(1.50)  LDD0531 
NAD-dependent protein deacetylase sirtuin-1 (SIRT1) LDTP10253 C67(1.10)  LDD0078 
NAD-dependent protein deacetylase sirtuin-2 (SIRT2) LDTP08598 C164(1.19)  LDD0531 
NAD-dependent protein deacetylase sirtuin-3, mitochondrial (SIRT3) LDTP12603 C280(0.58); C283(0.58)  LDD0531 
NAD-dependent protein deacetylase sirtuin-7 (SIRT7) LDTP12497 C266(0.99)  LDD0531 
NAD-dependent protein deacylase sirtuin-5, mitochondrial (SIRT5) LDTP12771 C293(0.89); C303(0.89)  LDD0078 
NAD-dependent protein deacylase sirtuin-6 (SIRT6) LDTP08951 C18(1.06)  LDD0531 
NADH dehydrogenase 1 alpha subcomplex subunit 10, mitochondrial (NDUFA10) LDTP01561 C253(1.60)  LDD0080 
NADH dehydrogenase 1 alpha subcomplex subunit 11 (NDUFA11) LDTP08385 C18(2.50)  LDD3333 
NADH dehydrogenase 1 alpha subcomplex subunit 2 (NDUFA2) LDTP00833 C58(0.83)  LDD0531 
NADH dehydrogenase 1 alpha subcomplex subunit 5 (NDUFA5) LDTP06614 C17(1.08)  LDD0080 
NADH dehydrogenase 1 alpha subcomplex subunit 7 (NDUFA7) LDTP01518 C55(0.94)  LDD0078 
NADH dehydrogenase 1 alpha subcomplex subunit 8 (NDUFA8) LDTP04494 C66(6.24); C78(11.33); C88(11.33)  LDD0080 
NADH dehydrogenase 1 alpha subcomplex subunit 9, mitochondrial (NDUFA9) LDTP06631 C86(0.93)  LDD1507 
NADH dehydrogenase 1 beta subcomplex subunit 1 (NDUFB1) LDTP01219 C25(1.53)  LDD1492 
NADH dehydrogenase 1 beta subcomplex subunit 10 (NDUFB10) LDTP01743 C119(3.09)  LDD3310 
NADH dehydrogenase 1 beta subcomplex subunit 11, mitochondrial (NDUFB11) LDTP12752 C141(0.91)  LDD1492 
NADH dehydrogenase 1 beta subcomplex subunit 4 (NDUFB4) LDTP01514 C93(0.94)  LDD1507 
NADH dehydrogenase 1 beta subcomplex subunit 7 (NDUFB7) LDTP02907 C80(0.98)  LDD0532 
NADH dehydrogenase 1 beta subcomplex subunit 9 (NDUFB9) LDTP14276 C42(2.32); C31(1.37)  LDD0080 
NADH dehydrogenase 1 subunit C2 (NDUFC2) LDTP01560 C39(1.33)  LDD1511 
NADH dehydrogenase flavoprotein 1, mitochondrial (NDUFV1) LDTP04317 C142(11.27)  LDD0209 
NADH dehydrogenase flavoprotein 2, mitochondrial (NDUFV2) LDTP02995 C225(1.01)  LDD0531 
NADH dehydrogenase iron-sulfur protein 2, mitochondrial (NDUFS2) LDTP01168 C109(14.98)  LDD0204 
NADH dehydrogenase iron-sulfur protein 3, mitochondrial (NDUFS3) LDTP01238 C80(1.06)  LDD1492 
NADH dehydrogenase iron-sulfur protein 5 (NDUFS5) LDTP00905 C43(1.82)  LDD3310 
NADH dehydrogenase iron-sulfur protein 6, mitochondrial (NDUFS6) LDTP14493 C112(1.06); C115(1.06)  LDD0078 
NADH dehydrogenase iron-sulfur protein 7, mitochondrial (NDUFS7) LDTP01165 C183(1.25)  LDD3342 
NADH dehydrogenase iron-sulfur protein 8, mitochondrial (NDUFS8) LDTP00218 C117(0.38); C121(0.38)  LDD0563 
NADH-cytochrome b5 reductase 1 (CYB5R1) LDTP13303 C208(1.93)  LDD3312 
NADH-cytochrome b5 reductase 3 (CYB5R3) LDTP01770 C237(1.32)  LDD3310 
NADH-cytochrome b5 reductase-like (CYB5RL) LDTP15083 C68(1.40)  LDD1571 
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (NDUFS1) LDTP03433 C554(32.90)  LDD0209 
NADH-ubiquinone oxidoreductase chain 3 (MT-ND3) LDTP01984 C39(1.85)  LDD0078 
NADH-ubiquinone oxidoreductase chain 5 (MT-ND5) LDTP01986 C518(1.75)  LDD1095 
NADP-dependent malic enzyme (ME1) LDTP04164 C556(1.06)  LDD0078 
NADP-dependent malic enzyme, mitochondrial (ME3) LDTP06632 C145(0.90); C199(1.57)  LDD3310 
NADPH oxidase 1 (NOX1) LDTP14156 C423(1.06)  LDD3452 
NADPH--cytochrome P450 reductase (POR) LDTP02848 C566(1.31)  LDD0080 
NADPH-dependent diflavin oxidoreductase 1 (NDOR1) LDTP13259 C486(4.79)  LDD0209 
NADPH:adrenodoxin oxidoreductase, mitochondrial (FDXR) LDTP03179 C395(22.17); C105(4.56)  LDD0209 
Napsin-A (NAPSA) LDTP01749 C215(1.74); C274(1.44)  LDD3311 
Nardilysin (NRDC) LDTP00886 C758(4.10); C966(1.77)  LDD3310 
NEDD4-binding protein 1 (N4BP1) LDTP01126 C56(1.02)  LDD0531 
NEDD4-binding protein 2 (N4BP2) LDTP08258 C597(1.00); C601(1.00)  LDD0078 
NEDD4-like E3 ubiquitin-protein ligase WWP1 (WWP1) LDTP11719 C335(1.42)  LDD0080 
NEDD4-like E3 ubiquitin-protein ligase WWP2 (WWP2) LDTP00248 C186(0.79)  LDD0531 
NEDD8-activating enzyme E1 catalytic subunit (UBA3) LDTP09338 C28(0.98)  LDD0078 
NEDD8-activating enzyme E1 regulatory subunit (NAE1) LDTP05925 C384(0.95)  LDD0531 
NEDD8-conjugating enzyme Ubc12 (UBE2M) LDTP04898 C95(2.89); C111(2.89); C65(0.97)  LDD0080 
NEDD8-conjugating enzyme UBE2F (UBE2F) LDTP10014 C92(1.55)  LDD3325 
Neprilysin (MME) LDTP02274 C80(2.63)  LDD3332 
Neuralized-like protein 4 (NEURL4) LDTP15752 C57(1.04)  LDD0078 
Neuroendocrine convertase 1 (PCSK1) LDTP03467 C494(4.32); C212(4.83); C347(4.49)  LDD3342 
Neuroendocrine convertase 2 (PCSK2) LDTP02856 C225(4.68)  LDD3342 
Neuroglobin (NGB) LDTP12359 C46(1.95)  LDD3344 
Neurolysin, mitochondrial (NLN) LDTP11494 C199(1.02); C451(0.87); C458(0.87); C153(0.87)  LDD0078 
Neuron navigator 2 (NAV2) LDTP08503 C1965(0.93)  LDD0078 
Neuronal-specific septin-3 (SEPTIN3) LDTP13250 C138(5.87)  LDD3340 
Neurotrypsin (PRSS12) LDTP04759 C259(2.80)  LDD3345 
Neutral alpha-glucosidase AB (GANAB) LDTP06192 C524(0.97)  LDD3310 
Neutral alpha-glucosidase C (GANC) LDTP15615 C114(1.07)  LDD3312 
Neutral cholesterol ester hydrolase 1 (NCEH1) LDTP07591 C353(1.97)  LDD3316 
Neutrophil elastase (ELANE) LDTP02265 C151(3.54); C187(1.92)  LDD3333 
NF-kappa-B inhibitor-interacting Ras-like protein 1 (NKIRAS1) LDTP12849 C10(1.00)  LDD0547 
NF-kappa-B inhibitor-interacting Ras-like protein 2 (NKIRAS2) LDTP12848 C122(1.77); C10(1.47)  LDD0080 
Nicotinamide N-methyltransferase (NNMT) LDTP03891 C50(1.48); C115(0.82)  LDD3314 
Nicotinamide phosphoribosyltransferase (NAMPT) LDTP04051 C401(1.25); C39(1.06); C287(0.99)  LDD0078 
Nicotinamide riboside kinase 1 (NMRK1) LDTP12739 C125(1.83); C72(1.68)  LDD0080 
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMNAT1) LDTP12128 C155(1.38)  LDD3310 
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 (NMNAT3) LDTP10841 C75(2.26); C97(1.32)  LDD3314 
Nicotinate phosphoribosyltransferase (NAPRT) LDTP07750 C463(1.44)  LDD3310 
Nicotinate-nucleotide pyrophosphorylase [carboxylating] (QPRT) LDTP06346 C27(1.47)  LDD3312 
NIF3-like protein 1 (NIF3L1) LDTP11648 C148(0.85); C21(1.07)  LDD0532 
Nik-related protein kinase (NRK) LDTP08021 C864(2.98)  LDD3358 
Nitric oxide synthase 1 (NOS1) LDTP03492 C913(1.16)  LDD3344 
Nitric oxide synthase 3 (NOS3) LDTP03491 C99(2.25)  LDD3311 
Nitric oxide synthase, inducible (NOS2) LDTP03716 C526(0.96)  LDD1507 
Nitric oxide synthase-interacting protein (NOSIP) LDTP13940 C236(0.94); C250(0.94)  LDD0078 
Nitric oxide-associated protein 1 (NOA1) LDTP09083 C505(0.98)  LDD0078 
NK-tumor recognition protein (NKTR) LDTP03536 C393(2.14); C964(1.72)  LDD0080 
NmrA-like family domain-containing protein 1 (NMRAL1) LDTP12190 C217(1.20)  LDD0078 
Nocturnin (NOCT) LDTP13423 C165(1.09); C273(1.19); C302(1.08)  LDD0531 
Non-homologous end joining factor IFFO1 (IFFO1) LDTP05600 C341(0.85)  LDD1507 
Non-lysosomal glucosylceramidase (GBA2) LDTP12239 C511(1.36); C45(1.36)  LDD0080 
Non-receptor tyrosine-protein kinase TNK1 (TNK1) LDTP05884 C109(1.07); C117(1.12); C126(0.98); C348(0.73)  LDD0531 
Non-receptor tyrosine-protein kinase TYK2 (TYK2) LDTP03497 C838(1.02); C848(1.02); C736(0.98); C1140(0.92)  LDD0078 
Non-structural maintenance of chromosomes element 1 homolog (NSMCE1) LDTP09593 C215(1.75)  LDD3332 
Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial (EARS2) LDTP06997 C140(5.76); C142(5.76); C386(1.59)  LDD0080 
NUAK family SNF1-like kinase 1 (NUAK1) LDTP00938 C519(1.28)  LDD3338 
NUAK family SNF1-like kinase 2 (NUAK2) LDTP11688 C351(3.48)  LDD2236 
Nuclear pore complex protein Nup98-Nup96 (NUP98) LDTP04547 C1068(1.19); C1711(1.06); C1727(1.00); C1312(1.00)  LDD0078 
Nuclear prelamin A recognition factor (NARF) LDTP13302 C228(4.26)  LDD0209 
Nuclear receptor coactivator 1 (NCOA1) LDTP06474 C215(1.19)  LDD0080 
Nuclear receptor coactivator 3 (NCOA3) LDTP14288 C575(1.30); C585(1.30); C22(1.12); C31(1.12)  LDD0078 
Nuclear receptor-binding protein (NRBP1) LDTP13313 C449(17.34)  LDD0204 
Nuclear receptor-binding protein 2 (NRBP2) LDTP16091 C116(1.42)  LDD0080 
Nuclear receptor-interacting protein 3 (NRIP3) LDTP18455 C206(2.61)  LDD2276 
Nuclear valosin-containing protein-like (NVL) LDTP00623 C431(1.87); C309(1.86); C192(1.71); C785(1.26)  LDD0080 
Nuclease EXOG, mitochondrial (EXOG) LDTP13846 C76(2.40)  LDD3383 
Nucleic acid dioxygenase ALKBH1 (ALKBH1) LDTP05967 C129(1.12); C322(0.64); C330(0.64)  LDD0532 
Nucleolar GTP-binding protein 2 (GNL2) LDTP05987 C257(2.52)  LDD0080 
Nucleolar RNA helicase 2 (DDX21) LDTP12469 C445(0.88)  LDD0078 
Nucleoredoxin (NXN) LDTP07367 C302(1.03)  LDD0532 
Nucleoredoxin-like protein 1 (NXNL1) LDTP15703 C148(1.68)  LDD2529 
Nucleoside diphosphate kinase 3 (NME3) LDTP05795 C126(2.38)  LDD3313 
Nucleoside diphosphate kinase 6 (NME6) LDTP01211 C163(0.94); C167(0.94)  LDD0078 
Nucleoside diphosphate kinase A (NME1) LDTP02796 C170(0.67)  LDD3331 
Nucleoside diphosphate kinase B (NME2) LDTP03169 C94(2.13)  LDD3312 
Nucleoside diphosphate kinase homolog 7 (NME7) LDTP14108 C228(1.20)  LDD0080 
Nucleoside diphosphate phosphatase ENTPD5 (ENTPD5) LDTP01189 C303(1.40)  LDD2379 
Nucleoside diphosphate-linked moiety X motif 6 (NUDT6) LDTP04559 C44(11.42)  LDD3319 
Nucleotide triphosphate diphosphatase NUDT15 (NUDT15) LDTP12657 C23(0.99)  LDD0078 
Nucleotidyltransferase MB21D2 (MB21D2) LDTP08636 C16(1.42)  LDD0080 
O-phosphoseryl-tRNA(Sec) selenium transferase (SEPSECS) LDTP12284 C22(2.38)  LDD3332 
Obg-like ATPase 1 (OLA1) LDTP12610 C55(2.05); C187(1.06)  LDD0080 
Octanoyl-[acyl-carrier-protein]:protein N-octanoyltransferase LIPT2, mitochondrial (LIPT2) LDTP00110 C99(1.04)  LDD1492 
Oligoribonuclease, mitochondrial (REXO2) LDTP13972 C97(1.03)  LDD0078 
Omega-amidase NIT2 (NIT2) LDTP12428 C153(1.14)  LDD0078 
ORC ubiquitin ligase 1 (OBI1) LDTP07266 C52(1.25); C55(1.25); C65(0.98)  LDD0078 
Ornithine aminotransferase, mitochondrial (OAT) LDTP02021 C93(1.39)  LDD0080 
Ornithine decarboxylase (ODC1) LDTP02594 C360(0.91); C114(0.86)  LDD0078 
OTU domain-containing protein 1 (OTUD1) LDTP15036 C320(1.68)  LDD0812 
OTU domain-containing protein 3 (OTUD3) LDTP07103 C49(2.22); C294(1.25)  LDD0080 
OTU domain-containing protein 4 (OTUD4) LDTP05313 C685(2.84); C488(2.27); C902(1.63); C45(1.37)  LDD0080 
OTU domain-containing protein 5 (OTUD5) LDTP10336 C519(1.06)  LDD0078 
OTU domain-containing protein 7A (OTUD7A) LDTP09473 C210(0.97)  LDD1507 
OTU domain-containing protein 7B (OTUD7B) LDTP07390 C708(1.02)  LDD1492 
Outer mitochondrial transmembrane helix translocase (ATAD1) LDTP09070 C359(1.20); C137(1.03)  LDD0078 
Oxidized purine nucleoside triphosphate hydrolase (NUDT1) LDTP03816 C104(0.72)  LDD1575 
Oxidoreductase HTATIP2 (HTATIP2) LDTP11247 C206(1.85)  LDD3310 
Oxidoreductase NAD-binding domain-containing protein 1 (OXNAD1) LDTP18168 C69(1.08)  LDD0080 
Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial (CPOX) LDTP03813 C198(1.32)  LDD0078 
p53-induced death domain-containing protein 1 (PIDD1) LDTP12164 C691(1.89)  LDD3407 
Pachytene checkpoint protein 2 homolog (TRIP13) LDTP06432 C14(77.68)  LDD0209 
Paladin (PALD1) LDTP16235 C65(1.74)  LDD0080 
Palmitoleoyl-protein carboxylesterase NOTUM (NOTUM) LDTP07548 C80(3.10)  LDD3402 
Palmitoyl thioesterase CPT1C (CPT1C) LDTP09385 C373(2.16)  LDD3340 
Palmitoyl-protein thioesterase 1 (PPT1) LDTP04388 C152(1.08); C160(1.08)  LDD0078 
Palmitoyl-protein thioesterase ABHD10, mitochondrial (ABHD10) LDTP12628 C229(0.61); C239(0.61); C100(0.67)  LDD0531 
Palmitoyltransferase ZDHHC12 (ZDHHC12) LDTP10360 C157(1.91)  LDD3310 
Palmitoyltransferase ZDHHC13 (ZDHHC13) LDTP08455 C431(1.08)  LDD0531 
Palmitoyltransferase ZDHHC14 (ZDHHC14) LDTP08709 C195(0.93)  LDD1492 
Palmitoyltransferase ZDHHC16 (ZDHHC16) LDTP10041 C157(1.05)  LDD1508 
Palmitoyltransferase ZDHHC17 (ZDHHC17) LDTP08456 C453(1.02); C456(1.02)  LDD0531 
Palmitoyltransferase ZDHHC18 (ZDHHC18) LDTP12625 C375(1.02); C4(0.72)  LDD0531 
Palmitoyltransferase ZDHHC20 (ZDHHC20) LDTP07268 C263(0.82)  LDD0531 
Palmitoyltransferase ZDHHC21 (ZDHHC21) LDTP08511 C92(1.13)  LDD3312 
Palmitoyltransferase ZDHHC23 (ZDHHC23) LDTP08662 C212(2.57)  LDD3319 
Palmitoyltransferase ZDHHC3 (ZDHHC3) LDTP12827 C143(1.03); C133(1.02)  LDD1492 
Palmitoyltransferase ZDHHC4 (ZDHHC4) LDTP12362 C151(1.07); C154(1.07); C337(1.06)  LDD0531 
Palmitoyltransferase ZDHHC5 (ZDHHC5) LDTP11596 C245(4.12)  LDD3310 
Palmitoyltransferase ZDHHC6 (ZDHHC6) LDTP11994 C396(1.00); C398(1.00)  LDD0078 
Palmitoyltransferase ZDHHC7 (ZDHHC7) LDTP12778 C149(0.94); C136(0.95)  LDD1492 
Palmitoyltransferase ZDHHC8 (ZDHHC8) LDTP13535 C370(1.13)  LDD1512 
Palmitoyltransferase ZDHHC9 (ZDHHC9) LDTP13960 C169(0.97)  LDD1507 
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (PAN2) LDTP06874 C669(1.17)  LDD0531 
PAN2-PAN3 deadenylation complex subunit PAN3 (PAN3) LDTP06935 C506(2.13)  LDD0080 
Pantetheinase (VNN1) LDTP01623 C411(1.35)  LDD2479 
Pantothenate kinase 1 (PANK1) LDTP09470 C315(1.08)  LDD1509 
Pantothenate kinase 2, mitochondrial (PANK2) LDTP11513 C276(1.21); C360(1.02)  LDD0531 
Pantothenate kinase 3 (PANK3) LDTP12086 C141(0.92)  LDD3359 
Pappalysin-1 (PAPPA) LDTP05790 C47(2.10)  LDD3343 
Pappalysin-2 (PAPPA2) LDTP11399 C656(1.24); C586(1.46)  LDD3380 
Paraplegin (SPG7) LDTP13753 C353(0.91)  LDD0078 
Parkinson disease protein 7 (PARK7) LDTP10878 C46(0.95)  LDD0078 
PAS domain-containing serine/threonine-protein kinase (PASK) LDTP10759 C128(99.23); C991(4.54); C108(107.84)  LDD0209 
Patatin-like phospholipase domain-containing protein 2 (PNPLA2) LDTP10077 C439(6.43)  LDD0209 
Patatin-like phospholipase domain-containing protein 4 (PNPLA4) LDTP03945 C237(1.43)  LDD3389 
Patatin-like phospholipase domain-containing protein 6 (PNPLA6) LDTP08617 C418(2.69); C1208(3.56)  LDD3310 
Patatin-like phospholipase domain-containing protein 7 (PNPLA7) LDTP07849 C574(1.33); C1215(1.40)  LDD2284 
Peptide deformylase, mitochondrial (PDF) LDTP12179 C108(1.08); C222(0.74)  LDD0531 
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (NGLY1) LDTP10429 C283(0.91); C286(0.91)  LDD0078 
Peptidyl-glycine alpha-amidating monooxygenase (PAM) LDTP02976 C181(0.97)  LDD1492 
Peptidyl-prolyl cis-trans isomerase A (PPIA) LDTP05028 C161(1.07); C115(1.02); C62(0.94)  LDD0078 
Peptidyl-prolyl cis-trans isomerase A-like 4A (PPIAL4A) LDTP18582 C52(1.24)  LDD3311 
Peptidyl-prolyl cis-trans isomerase B (PPIB) LDTP03216 C202(1.42)  LDD0080 
Peptidyl-prolyl cis-trans isomerase D (PPID) LDTP05573 C176(1.09); C181(1.09)  LDD0531 
Peptidyl-prolyl cis-trans isomerase E (PPIE) LDTP13671 C198(2.06)  LDD3427 
Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIF) LDTP03534 C104(1.56)  LDD3318 
Peptidyl-prolyl cis-trans isomerase FKBP10 (FKBP10) LDTP10101 C447(1.63)  LDD0080 
Peptidyl-prolyl cis-trans isomerase FKBP11 (FKBP11) LDTP16141 C104(1.71)  LDD3371 
Peptidyl-prolyl cis-trans isomerase FKBP1A (FKBP1A) LDTP05029 C23(1.13)  LDD3397 
Peptidyl-prolyl cis-trans isomerase FKBP2 (FKBP2) LDTP03374 C97(1.03)  LDD3377 
Peptidyl-prolyl cis-trans isomerase FKBP3 (FKBP3) LDTP05255 C133(0.76)  LDD0531 
Peptidyl-prolyl cis-trans isomerase FKBP4 (FKBP4) LDTP05372 C328(1.84); C342(1.66)  LDD0080 
Peptidyl-prolyl cis-trans isomerase FKBP5 (FKBP5) LDTP05877 C103(1.10); C107(1.10); C215(0.77); C339(1.37)  LDD0531 
Peptidyl-prolyl cis-trans isomerase FKBP7 (FKBP7) LDTP14218 C46(1.01)  LDD1492 
Peptidyl-prolyl cis-trans isomerase FKBP8 (FKBP8) LDTP06104 C227(16.62)  LDD0209 
Peptidyl-prolyl cis-trans isomerase FKBP9 (FKBP9) LDTP01562 C47(2.39); C267(3.10)  LDD3310 
Peptidyl-prolyl cis-trans isomerase G (PPIG) LDTP05866 C310(0.96)  LDD0078 
Peptidyl-prolyl cis-trans isomerase H (PPIH) LDTP00769 C131(0.97)  LDD0078 
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) LDTP05912 C113(0.96)  LDD0078 
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (PIN4) LDTP13793 C70(1.81)  LDD3377 
Peptidyl-prolyl cis-trans isomerase-like 1 (PPIL1) LDTP13976 C133(1.12)  LDD0531 
Peptidyl-prolyl cis-trans isomerase-like 3 (PPIL3) LDTP11823 C18(0.80)  LDD3310 
Peptidyl-prolyl cis-trans isomerase-like 4 (PPIL4) LDTP15620 C426(1.04)  LDD0078 
Peptidyl-tRNA hydrolase (PTRH1) LDTP17604 C20(0.99)  LDD0531 
Peptidyl-tRNA hydrolase 2, mitochondrial (PTRH2) LDTP13989 C111(1.04)  LDD0080 
Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (PPWD1) LDTP10135 C185(1.52)  LDD0080 
Peripheral plasma membrane protein CASK (CASK) LDTP00482 C578(1.18); C698(0.99)  LDD0078 
Peroxidasin homolog (PXDN) LDTP09829 C243(2.01)  LDD3314 
Peroxiredoxin-1 (PRDX1) LDTP05503 C71(1.19); C83(1.19)  LDD0078 
Peroxiredoxin-2 (PRDX2) LDTP03626 C172(0.70)  LDD0532 
Peroxiredoxin-4 (PRDX4) LDTP05773 C51(1.17)  LDD0078 
Peroxiredoxin-5, mitochondrial (PRDX5) LDTP03512 C100(0.91)  LDD0078 
Peroxiredoxin-6 (PRDX6) LDTP03510 C91(0.97); C47(0.88)  LDD0078 
Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] (DECR2) LDTP12627 C22(6.60)  LDD0080 
Peroxisomal acyl-coenzyme A oxidase 1 (ACOX1) LDTP06307 C199(1.40)  LDD0080 
Peroxisomal acyl-coenzyme A oxidase 2 (ACOX2) LDTP10859 C412(1.48)  LDD3380 
Peroxisomal acyl-coenzyme A oxidase 3 (ACOX3) LDTP00589 C214(0.92); C220(0.92)  LDD0078 
Peroxisomal ATPase PEX1 (PEX1) LDTP00910 C1002(0.86)  LDD0078 
Peroxisomal ATPase PEX6 (PEX6) LDTP05940 C496(1.10); C500(1.10)  LDD0078 
Peroxisomal bifunctional enzyme (EHHADH) LDTP05560 C227(0.35); C233(0.35); C476(1.02); C559(0.35)  LDD0531 
Peroxisomal carnitine O-octanoyltransferase (CROT) LDTP13453 C238(0.72)  LDD3311 
Peroxisomal coenzyme A diphosphatase NUDT7 (NUDT7) LDTP02387 C72(7.58)  LDD3335 
Peroxisomal leader peptide-processing protease (TYSND1) LDTP06720 C106(1.22); C110(1.22)  LDD0078 
Peroxisomal multifunctional enzyme type 2 (HSD17B4) LDTP04440 C214(4.29)  LDD3311 
Peroxisomal sarcosine oxidase (PIPOX) LDTP12992 C119(2.02)  LDD3344 
Peroxisomal succinyl-coenzyme A thioesterase (ACOT4) LDTP09004 C407(0.95); C14(0.91)  LDD0078 
Peroxisomal trans-2-enoyl-CoA reductase (PECR) LDTP11437 C191(1.06)  LDD0078 
Peroxisome biogenesis factor 10 (PEX10) LDTP01030 C173(0.81)  LDD1507 
Peroxisome biogenesis factor 2 (PEX2) LDTP03430 C178(0.86)  LDD0532 
Peroxynitrite isomerase THAP4 (THAP4) LDTP09729 C360(1.15); C361(1.15)  LDD0078 
Persulfide dioxygenase ETHE1, mitochondrial (ETHE1) LDTP01633 C170(11.39)  LDD0209 
PH domain leucine-rich repeat-containing protein phosphatase 1 (PHLPP1) LDTP00959 C1516(1.02); C1522(1.02)  LDD0078 
PH domain leucine-rich repeat-containing protein phosphatase 2 (PHLPP2) LDTP07853 C1234(4.25)  LDD0080 
PHD finger protein 10 (PHF10) LDTP09568 C477(0.90)  LDD0078 
Phenazine biosynthesis-like domain-containing protein (PBLD) LDTP03508 C24(1.07)  LDD3346 
Phenylalanine--tRNA ligase alpha subunit (FARSA) LDTP13831 C493(1.47)  LDD0080 
Phenylalanine--tRNA ligase beta subunit (FARSB) LDTP12586 C195(1.05); C151(0.92)  LDD0078 
Phenylalanine--tRNA ligase, mitochondrial (FARS2) LDTP01571 C344(1.09); C334(1.37)  LDD0080 
Phenylalanine-4-hydroxylase (PAH) LDTP01775 C445(1.66)  LDD3424 
Phenylethanolamine N-methyltransferase (PNMT) LDTP02538 C139(1.34)  LDD3354 
Phosphatase and actin regulator 3 (PHACTR3) LDTP10520 C85(1.00)  LDD2361 
Phosphatase and actin regulator 4 (PHACTR4) LDTP08684 C578(2.73)  LDD3331 
Phosphatidate cytidylyltransferase 1 (CDS1) LDTP09923 C10(0.93)  LDD0533 
Phosphatidate cytidylyltransferase 2 (CDS2) LDTP01649 C286(1.30); C304(1.30)  LDD1094 
Phosphatidate cytidylyltransferase, mitochondrial (TAMM41) LDTP10144 C103(1.84)  LDD3319 
Phosphatidate phosphatase LPIN1 (LPIN1) LDTP06189 C928(1.79)  LDD3310 
Phosphatidate phosphatase LPIN2 (LPIN2) LDTP09784 C874(1.22); C881(1.22)  LDD0078 
Phosphatidate phosphatase LPIN3 (LPIN3) LDTP11088 C712(4.01)  LDD3493 
Phosphatidylcholine translocator ABCB4 (ABCB4) LDTP03111 C1074(0.93)  LDD3314 
Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (PTPMT1) LDTP09578 C81(1.77)  LDD3310 
Phosphatidylinositide phosphatase SAC2 (INPP5F) LDTP13867 C458(1.12); C461(1.12)  LDD0078 
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN) LDTP04867 C296(1.09); C304(1.09)  LDD0078 
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (TPTE2) LDTP07749 C285(1.62)  LDD2243 
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (INPP5D) LDTP09895 C506(1.36)  LDD3314 
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (INPPL1) LDTP00617 C926(1.04); C1121(0.96)  LDD0078 
Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma (PIK3C2G) LDTP01302 C1164(1.83)  LDD3373 
Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) LDTP09155 C336(1.17)  LDD0613 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PIK3CA) LDTP03978 C255(0.41); C257(0.41); C301(0.98); C692(1.18)  LDD0531 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PIK3CB) LDTP03979 C286(0.94); C287(0.94)  LDD0078 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD) LDTP00252 C991(6.96)  LDD0209 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PIK3CG) LDTP04212 C817(1.67); C435(2.03); C219(1.43); C121(4.45)  LDD3338 
Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (INPP5J) LDTP06454 C528(0.91)  LDD1492 
Phosphatidylinositol 4-kinase alpha (PI4KA) LDTP03981 C58(10.58)  LDD0209 
Phosphatidylinositol 4-kinase beta (PI4KB) LDTP13112 C435(1.95)  LDD0080 
Phosphatidylinositol 4-kinase type 2-alpha (PI4K2A) LDTP11209 C320(1.25)  LDD0078 
Phosphatidylinositol 4-kinase type 2-beta (PI4K2B) LDTP09384 C446(1.39)  LDD3310 
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PIK3C2A) LDTP00275 C514(1.10); C669(0.99)  LDD0078 
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PIK3C2B) LDTP00337 C1054(45.87)  LDD0209 
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1A) LDTP10972 C231(2.61)  LDD3310 
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma (PIP5K1C) LDTP00953 C306(3.15)  LDD3312 
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (PIP4K2A) LDTP04177 C343(1.42)  LDD0080 
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (PIP4K2B) LDTP05104 C99(0.80)  LDD0625 
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (PIP4K2C) LDTP09355 C104(0.78); C176(0.54)  LDD0531 
Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (PIGA) LDTP03844 C28(3.40)  LDD0080 
Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH) LDTP06120 C11(0.83); C166(0.97); C30(0.87); C33(0.87)  LDD0531 
Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (PIGQ) LDTP11104 C67(1.18); C69(1.18)  LDD0078 
Phosphatidylinositol polyphosphate 5-phosphatase type IV (INPP5E) LDTP12534 C569(0.65); C576(0.65)  LDD0532 
Phosphatidylinositol-3-phosphatase SAC1 (SACM1L) LDTP12608 C389(3.56); C392(3.56)  LDD0080 
Phosphatidylinositol-glycan biosynthesis class W protein (PIGW) LDTP08142 C409(6.41)  LDD3332 
Phosphatidylserine decarboxylase proenzyme, mitochondrial (PISD) LDTP13220 C224(1.04); C236(1.04)  LDD0078 
Phosphatidylserine lipase ABHD16A (ABHD16A) LDTP01704 C248(0.78); C416(0.75)  LDD0531 
Phosphatidylserine synthase 1 (PTDSS1) LDTP04203 C347(0.88)  LDD0078 
Phosphoacetylglucosamine mutase (PGM3) LDTP01584 C228(1.32)  LDD3310 
Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PCK2) LDTP06638 C92(1.43); C306(0.98)  LDD0078 
Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PCK1) LDTP03760 C288(1.34)  LDD3407 
Phosphoethanolamine/phosphocholine phosphatase (PHOSPHO1) LDTP09392 C234(1.00)  LDD3382 
Phosphoglucomutase-1 (PGM1) LDTP03818 C119(1.19); C178(0.96)  LDD3310 
Phosphoglucomutase-like protein 5 (PGM5) LDTP06324 C124(1.89)  LDD3337 
Phosphoglycerate kinase 1 (PGK1) LDTP01787 C108(0.96); C379(0.87); C380(0.87)  LDD0078 
Phosphoglycerate mutase 1 (PGAM1) LDTP02963 C153(6.43); C55(1.84)  LDD0080 
Phosphoglycerate mutase 2 (PGAM2) LDTP02774 C55(1.04); C153(1.20)  LDD3377 
Phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4) LDTP10899 C955(1.17); C565(0.99)  LDD0078 
Phosphoinositide-3-kinase-interacting protein 1 (PIK3IP1) LDTP10303 C71(2.92)  LDD3312 
Phospholipase A and acyltransferase 3 (PLAAT3) LDTP04591 C89(1.33)  LDD3310 
Phospholipase A-2-activating protein (PLAA) LDTP13814 C193(1.58)  LDD0078 
Phospholipase A1 member A (PLA1A) LDTP06908 C420(1.20)  LDD3395 
Phospholipase A2 group XV (PLA2G15) LDTP09088 C355(3.37)  LDD3310 
Phospholipase A2, membrane associated (PLA2G2A) LDTP02730 C117(4.13)  LDD2275 
Phospholipase ABHD3 (ABHD3) LDTP09561 C73(0.45); C86(0.45)  LDD1093 
Phospholipase D1 (PLD1) LDTP05848 C650(2.18)  LDD3310 
Phospholipase D2 (PLD2) LDTP00483 C84(1.46)  LDD0532 
Phospholipase DDHD1 (DDHD1) LDTP09161 C273(0.75)  LDD0532 
Phospholipase DDHD2 (DDHD2) LDTP01435 C470(1.04)  LDD0531 
Phospholipid hydroperoxide glutathione peroxidase GPX4 (GPX4) LDTP03831 C134(1.06)  LDD0080 
Phospholipid phosphatase 1 (PLPP1) LDTP00348 C40(1.90)  LDD3412 
Phospholipid phosphatase 2 (PLPP2) LDTP00840 C276(2.50)  LDD3311 
Phospholipid phosphatase 3 (PLPP3) LDTP00349 C68(4.87)  LDD3310 
Phospholipid phosphatase 5 (PLPP5) LDTP09154 C261(0.95)  LDD1509 
Phospholipid phosphatase-related protein type 2 (PLPPR2) LDTP10352 C191(2.14)  LDD3369 
Phospholipid phosphatase-related protein type 4 (PLPPR4) LDTP08014 C512(2.44)  LDD3340 
Phospholipid scramblase 1 (PLSCR1) LDTP00558 C254(1.11)  LDD0080 
Phospholipid-transporting ATPase ABCA1 (ABCA1) LDTP01617 C309(5.43)  LDD3310 
Phospholipid-transporting ATPase ABCA3 (ABCA3) LDTP10974 C1494(1.89)  LDD3312 
Phospholipid-transporting ATPase ABCA7 (ABCA7) LDTP08725 C2005(1.89)  LDD3365 
Phospholipid-transporting ATPase IA (ATP8A1) LDTP13899 C416(1.75)  LDD3372 
Phospholipid-transporting ATPase IC (ATP8B1) LDTP00789 C62(1.00)  LDD3315 
Phospholipid-transporting ATPase ID (ATP8B2) LDTP05230 C66(1.52)  LDD3383 
Phospholipid-transporting ATPase IF (ATP11B) LDTP13861 C422(1.80)  LDD3310 
Phospholipid-transporting ATPase IG (ATP11C) LDTP09040 C427(1.15); C428(1.15)  LDD0080 
Phospholipid-transporting ATPase IH (ATP11A) LDTP05229 C128(1.20)  LDD3311 
Phospholipid-transporting ATPase VA (ATP10A) LDTP00949 C246(1.63)  LDD3382 
Phospholipid-transporting ATPase VB (ATP10B) LDTP01431 C149(2.39)  LDD3413 
Phospholipid-transporting ATPase VD (ATP10D) LDTP13016 C742(2.07)  LDD3386 
Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) LDTP11677 C53(2.21)  LDD3382 
Phosphomannomutase 1 (PMM1) LDTP09909 C201(11.98)  LDD0209 
Phosphomannomutase 2 (PMM2) LDTP00606 C136(1.32)  LDD0532 
Phosphomevalonate kinase (PMVK) LDTP06326 C92(1.04)  LDD0078 
Phosphopantothenoylcysteine decarboxylase (PPCDC) LDTP10169 C7(1.09)  LDD0531 
Phosphopentomutase (PGM2) LDTP10326 C573(0.99)  LDD0078 
Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPSAP1) LDTP06146 C19(4.10)  LDD0209 
Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPSAP2) LDTP00927 C135(1.05)  LDD0078 
Phosphoribosylformylglycinamidine synthase (PFAS) LDTP00527 C1287(1.72); C270(0.97); C584(0.95); C587(0.95)  LDD0078 
Phosphoribosyltransferase domain-containing protein 1 (PRTFDC1) LDTP12508 C213(0.60); C82(0.73)  LDD3310 
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHKG2) LDTP02802 C294(2.35); C353(1.33)  LDD0080 
Phosphorylase b kinase regulatory subunit alpha, liver isoform (PHKA2) LDTP04079 C681(1.45)  LDD0080 
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform (PHKA1) LDTP04080 C656(1.63); C551(1.07)  LDD0080 
Phosphorylase b kinase regulatory subunit beta (PHKB) LDTP09984 C76(1.95)  LDD0080 
Phosphoserine aminotransferase (PSAT1) LDTP14198 C291(1.57); C98(1.26)  LDD0080 
Phosphoserine phosphatase (PSPH) LDTP05093 C38(0.75)  LDD3333 
Phosphotriesterase-related protein (PTER) LDTP18130 C36(1.00); C38(1.00); C43(1.00)  LDD0078 
Phytanoyl-CoA dioxygenase domain-containing protein 1 (PHYHD1) LDTP07065 C49(1.43)  LDD3339 
Phytanoyl-CoA dioxygenase, peroxisomal (PHYH) LDTP00454 C34(2.51)  LDD3310 
PiggyBac transposable element-derived protein 5 (PGBD5) LDTP08848 C405(1.93)  LDD3389 
Pirin (PIR) LDTP00325 C106(0.89)  LDD3332 
PITH domain-containing protein 1 (PITHD1) LDTP15939 C42(2.01)  LDD3310 
Piwi-like protein 2 (PIWIL2) LDTP09372 C723(1.99)  LDD3423 
Plasma alpha-L-fucosidase (FUCA2) LDTP11215 C277(1.02); C269(0.92)  LDD0078 
Plasma kallikrein (KLKB1) LDTP01991 C781(1.75)  LDD3335 
Plasma membrane calcium-transporting ATPase 1 (ATP2B1) LDTP03024 C463(3.74); C473(3.74)  LDD0080 
Plasma membrane calcium-transporting ATPase 3 (ATP2B3) LDTP06616 C29(1.39); C640(3.51)  LDD3340 
Plasma membrane calcium-transporting ATPase 4 (ATP2B4) LDTP03249 C632(1.12)  LDD0078 
Plasminogen (PLG) LDTP01797 C426(0.95); C316(0.85)  LDD0078 
Platelet-activating factor acetylhydrolase 2, cytoplasmic (PAFAH2) LDTP10874 C147(1.79); C40(1.25); C59(0.89); C72(0.93)  LDD0531 
Platelet-activating factor acetylhydrolase IB subunit alpha1 (PAFAH1B3) LDTP06315 C205(4.05)  LDD0209 
Platelet-activating factor acetylhydrolase IB subunit alpha2 (PAFAH1B2) LDTP05078 C35(2.99)  LDD3314 
Platelet-derived growth factor receptor alpha (PDGFRA) LDTP02836 C664(1.42)  LDD3342 
Platelet-derived growth factor receptor beta (PDGFRB) LDTP02361 C835(1.60)  LDD3351 
Poly [ADP-ribose] polymerase 1 (PARP1) LDTP02375 C311(1.09)  LDD0078 
Poly [ADP-ribose] polymerase 2 (PARP2) LDTP13240 C288(0.57); C474(1.18)  LDD0531 
Poly [ADP-ribose] polymerase tankyrase-1 (TNKS) LDTP01551 C670(0.58); C677(0.58)  LDD0531 
Poly [ADP-ribose] polymerase tankyrase-2 (TNKS2) LDTP11828 C13(0.94); C6(0.94)  LDD0078 
Poly(A) polymerase alpha (PAPOLA) LDTP04394 C36(0.97)  LDD0078 
Poly(A) polymerase gamma (PAPOLG) LDTP11338 C530(1.69)  LDD0080 
Poly(A) RNA polymerase GLD2 (TENT2) LDTP07594 C132(121.06)  LDD0209 
Poly(A) RNA polymerase, mitochondrial (MTPAP) LDTP12696 C82(5.03)  LDD0209 
Poly(A)-specific ribonuclease PARN (PARN) LDTP01607 C317(1.36); C169(2.03)  LDD0080 
Poly(ADP-ribose) glycohydrolase (PARG) LDTP08319 C397(0.87)  LDD0078 
Polyamine deacetylase HDAC10 (HDAC10) LDTP10029 C23(4.39)  LDD0209 
Polyamine-transporting ATPase 13A2 (ATP13A2) LDTP12386 C194(1.51)  LDD3310 
Polyamine-transporting ATPase 13A3 (ATP13A3) LDTP12026 C529(32.76)  LDD0209 
Polycomb complex protein BMI-1 (BMI1) LDTP03714 C53(2.94); C56(2.94)  LDD0080 
Polycomb group RING finger protein 1 (PCGF1) LDTP11165 C172(0.95)  LDD1492 
Polycomb group RING finger protein 2 (PCGF2) LDTP03715 C233(4.40)  LDD0209 
Polycomb group RING finger protein 3 (PCGF3) LDTP06760 C118(1.15)  LDD3316 
Polycomb group RING finger protein 5 (PCGF5) LDTP08163 C145(1.39)  LDD0080 
Polycomb group RING finger protein 6 (PCGF6) LDTP11453 C150(0.76); C155(0.76); C302(0.79); C308(0.79)  LDD0531 
Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 (PLPP6) LDTP08621 C55(0.91)  LDD0078 
Polynucleotide 5'-hydroxyl-kinase NOL9 (NOL9) LDTP07077 C648(1.40)  LDD0078 
Polypeptide N-acetylgalactosaminyltransferase 1 (GALNT1) LDTP05624 C442(2.61)  LDD3380 
Polypeptide N-acetylgalactosaminyltransferase 10 (GALNT10) LDTP08178 C356(2.32)  LDD3314 
Polypeptide N-acetylgalactosaminyltransferase 11 (GALNT11) LDTP09111 C578(4.52)  LDD3369 
Polypeptide N-acetylgalactosaminyltransferase 12 (GALNT12) LDTP08601 C566(1.60)  LDD3317 
Polypeptide N-acetylgalactosaminyltransferase 13 (GALNT13) LDTP08447 C407(1.11)  LDD1507 
Polypeptide N-acetylgalactosaminyltransferase 14 (GALNT14) LDTP10310 C207(2.41)  LDD3378 
Polypeptide N-acetylgalactosaminyltransferase 16 (GALNT16) LDTP08851 C331(0.92); C340(0.92)  LDD0078 
Polypeptide N-acetylgalactosaminyltransferase 18 (GALNT18) LDTP07549 C333(1.22)  LDD0531 
Polypeptide N-acetylgalactosaminyltransferase 2 (GALNT2) LDTP05623 C345(0.94); C354(0.94)  LDD0078 
Polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3) LDTP06119 C149(0.98)  LDD0531 
Polypeptide N-acetylgalactosaminyltransferase 4 (GALNT4) LDTP08859 C518(3.85)  LDD3380 
Polypeptide N-acetylgalactosaminyltransferase 5 (GALNT5) LDTP08159 C873(3.62)  LDD3310 
Polypeptide N-acetylgalactosaminyltransferase 6 (GALNT6) LDTP09098 C149(1.53)  LDD2274 
Polypeptide N-acetylgalactosaminyltransferase 9 (GALNT9) LDTP12264 C525(1.72)  LDD3468 
Polyphosphoinositide phosphatase (FIG4) LDTP09797 C839(1.10); C489(1.08); C486(0.99)  LDD0078 
Polyprenol reductase (SRD5A3) LDTP12064 C57(1.15); C66(1.15); C238(1.07)  LDD0078 
Polyribonucleotide 5'-hydroxyl-kinase Clp1 (CLP1) LDTP09955 C338(1.44)  LDD0080 
Polyribonucleotide nucleotidyltransferase 1, mitochondrial (PNPT1) LDTP09390 C668(1.21)  LDD0080 
Polyunsaturated fatty acid 5-lipoxygenase (ALOX5) LDTP02380 C265(1.40)  LDD3312 
Polyunsaturated fatty acid lipoxygenase ALOX15 (ALOX15) LDTP02821 C209(1.77)  LDD3368 
Polyunsaturated fatty acid lipoxygenase ALOX15B (ALOX15B) LDTP00602 C395(1.56)  LDD2267 
Porphobilinogen deaminase (HMBS) LDTP02273 C211(1.42)  LDD3335 
Post-GPI attachment to proteins factor 6 (PGAP6) LDTP12259 C379(1.09)  LDD3314 
PR domain zinc finger protein 1 (PRDM1) LDTP01277 C700(1.88)  LDD3377 
PR domain zinc finger protein 10 (PRDM10) LDTP12438 C732(1.99)  LDD3335 
PR domain zinc finger protein 15 (PRDM15) LDTP04778 C819(1.20)  LDD3339 
PR domain zinc finger protein 2 (PRDM2) LDTP05730 C1204(4.00)  LDD0080 
PR domain zinc finger protein 4 (PRDM4) LDTP13469 C547(1.92); C549(1.92)  LDD0080 
PR domain zinc finger protein 5 (PRDM5) LDTP12447 C221(1.28)  LDD3433 
PR domain zinc finger protein 8 (PRDM8) LDTP12440 C526(1.52)  LDD3442 
PR domain-containing protein 11 (PRDM11) LDTP12437 C74(1.06)  LDD0078 
Pre-mRNA-processing factor 19 (PRPF19) LDTP13623 C351(0.99); C355(0.99); C114(0.85)  LDD0078 
Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (DHX16) LDTP00915 C450(1.07); C486(1.21); C714(0.77); C932(1.32)  LDD0531 
Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (DHX38) LDTP09824 C20(1.08); C27(1.08)  LDD0078 
pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (FTSJ3) LDTP08629 C577(1.13)  LDD0078 
Pre-rRNA-processing protein TSR1 homolog (TSR1) LDTP14888 C126(1.02)  LDD0078 
Prenylcysteine oxidase 1 (PCYOX1) LDTP13282 C242(0.92)  LDD0547 
Prenylcysteine oxidase-like (PCYOX1L) LDTP15480 C250(4.22)  LDD3319 
Presenilin-2 (PSEN2) LDTP04315 C31(1.97)  LDD3331 
Presenilin-associated rhomboid-like protein, mitochondrial (PARL) LDTP11852 C288(0.97)  LDD1492 
Presequence protease, mitochondrial (PITRM1) LDTP07003 C627(1.48)  LDD3310 
Pro-cathepsin H (CTSH) LDTP02366 C272(1.48)  LDD3330 
Probable 18S rRNA (guanine-N(7))-methyltransferase (BUD23) LDTP00845 C203(44.63)  LDD0209 
Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (NOP2) LDTP04084 C520(3.34); C496(5.64)  LDD3311 
Probable aminopeptidase NPEPL1 (NPEPL1) LDTP09126 C357(0.76)  LDD3310 
Probable arginine--tRNA ligase, mitochondrial (RARS2) LDTP07092 C576(1.53)  LDD0080 
Probable ATP-dependent RNA helicase DDX10 (DDX10) LDTP05785 C323(1.04); C471(0.84)  LDD0078 
Probable ATP-dependent RNA helicase DDX17 (DDX17) LDTP09899 C277(3.18); C166(1.70); C584(1.93)  LDD0080 
Probable ATP-dependent RNA helicase DDX20 (DDX20) LDTP13285 C524(1.03); C758(0.91)  LDD0078 
Probable ATP-dependent RNA helicase DDX23 (DDX23) LDTP11248 C692(1.07)  LDD0078 
Probable ATP-dependent RNA helicase DDX27 (DDX27) LDTP10358 C259(2.15); C321(1.96); C261(1.37)  LDD0080 
Probable ATP-dependent RNA helicase DDX28 (DDX28) LDTP12633 C170(1.10)  LDD0531 
Probable ATP-dependent RNA helicase DDX31 (DDX31) LDTP12055 C660(1.07)  LDD0078 
Probable ATP-dependent RNA helicase DDX41 (DDX41) LDTP13401 C582(1.26); C585(1.26)  LDD0080 
Probable ATP-dependent RNA helicase DDX43 (DDX43) LDTP16135 C71(1.76); C143(1.77)  LDD3392 
Probable ATP-dependent RNA helicase DDX46 (DDX46) LDTP07932 C501(1.77)  LDD0080 
Probable ATP-dependent RNA helicase DDX47 (DDX47) LDTP11730 C36(0.77); C39(0.77)  LDD0532 
Probable ATP-dependent RNA helicase DDX49 (DDX49) LDTP16335 C265(2.09); C45(1.35)  LDD0080 
Probable ATP-dependent RNA helicase DDX5 (DDX5) LDTP02924 C191(1.86); C234(1.34)  LDD0080 
Probable ATP-dependent RNA helicase DDX52 (DDX52) LDTP13904 C536(2.13); C342(1.31); C364(1.11)  LDD0080 
Probable ATP-dependent RNA helicase DDX53 (DDX53) LDTP08202 C163(1.23)  LDD2260 
Probable ATP-dependent RNA helicase DDX56 (DDX56) LDTP12814 C185(1.18)  LDD0078 
Probable ATP-dependent RNA helicase DDX59 (DDX59) LDTP07098 C414(0.91)  LDD0078 
Probable ATP-dependent RNA helicase DDX6 (DDX6) LDTP03348 C102(1.14); C324(0.97)  LDD0078 
Probable ATP-dependent RNA helicase DDX60 (DDX60) LDTP08619 C351(1.95); C843(1.49); C1591(1.27)  LDD3311 
Probable ATP-dependent RNA helicase DDX60-like (DDX60L) LDTP14968 C502(0.85)  LDD0078 
Probable ATP-dependent RNA helicase DHX34 (DHX34) LDTP06052 C628(1.31)  LDD0078 
Probable ATP-dependent RNA helicase DHX35 (DHX35) LDTP11967 C609(0.93)  LDD0531 
Probable ATP-dependent RNA helicase DHX37 (DHX37) LDTP08625 C456(1.42); C1083(1.30); C680(1.36); C638(1.29)  LDD0080 
Probable ATP-dependent RNA helicase DHX40 (DHX40) LDTP15348 C641(1.04)  LDD0078 
Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein (ASMTL) LDTP01647 C274(1.19); C333(1.15)  LDD0078 
Probable C-mannosyltransferase DPY19L4 (DPY19L4) LDTP17534 C672(0.93)  LDD1573 
Probable cation-transporting ATPase 13A4 (ATP13A4) LDTP06869 C480(2.05)  LDD2267 
Probable crossover junction endonuclease EME2 (EME2) LDTP00068 C13(3.24)  LDD2390 
Probable cysteine--tRNA ligase, mitochondrial (CARS2) LDTP16026 C387(1.11)  LDD0531 
Probable D-lactate dehydrogenase, mitochondrial (LDHD) LDTP08341 C85(1.28)  LDD3325 
Probable dimethyladenosine transferase (DIMT1) LDTP13673 C84(5.64)  LDD0209 
Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (ALG8) LDTP11290 C277(7.30); C218(5.97)  LDD3365 
Probable E3 ubiquitin-protein ligase DTX2 (DTX2) LDTP08260 C537(1.12)  LDD0547 
Probable E3 ubiquitin-protein ligase DTX3 (DTX3) LDTP09003 C275(2.66)  LDD3340 
Probable E3 ubiquitin-protein ligase HECTD4 (HECTD4) LDTP14048 C1084(2.25)  LDD0080 
Probable E3 ubiquitin-protein ligase HERC1 (HERC1) LDTP06461 C4837(1.14); C2525(0.99)  LDD0078 
Probable E3 ubiquitin-protein ligase HERC3 (HERC3) LDTP14851 C337(3.15)  LDD3339 
Probable E3 ubiquitin-protein ligase HERC4 (HERC4) LDTP06976 C175(0.95)  LDD0078 
Probable E3 ubiquitin-protein ligase HERC6 (HERC6) LDTP08516 C47(2.13)  LDD3310 
Probable E3 ubiquitin-protein ligase IRF2BPL (IRF2BPL) LDTP11759 C14(1.42); C17(1.42); C63(1.00); C742(0.99)  LDD0078 
Probable E3 ubiquitin-protein ligase makorin-3 (MKRN3) LDTP05738 C109(1.76)  LDD3338 
Probable E3 ubiquitin-protein ligase MID2 (MID2) LDTP13400 C718(1.06); C720(1.06)  LDD0078 
Probable E3 ubiquitin-protein ligase TRIML1 (TRIML1) LDTP15472 C405(0.96)  LDD2171 
Probable global transcription activator SNF2L1 (SMARCA1) LDTP03442 C459(0.87); C460(0.87)  LDD0078 
Probable global transcription activator SNF2L2 (SMARCA2) LDTP04421 C91(1.04); C399(1.01)  LDD0078 
Probable gluconokinase (IDNK) LDTP17235 C83(1.12)  LDD3339 
Probable glutathione peroxidase 8 (GPX8) LDTP09495 C79(0.89)  LDD0532 
Probable helicase senataxin (SETX) LDTP08024 C555(12.92); C1262(5.53); C1959(32.95)  LDD0209 
Probable helicase with zinc finger domain (HELZ) LDTP03993 C100(11.00); C101(11.00); C1770(3.78); C1784(3.78)  LDD0080 
Probable hydrolase PNKD (PNKD) LDTP08858 C209(0.92)  LDD3310 
Probable inactive tRNA-specific adenosine deaminase-like protein 3 (ADAT3) LDTP15720 C13(2.12)  LDD3339 
Probable JmjC domain-containing histone demethylation protein 2C (JMJD1C) LDTP06437 C1814(0.88)  LDD0563 
Probable maltase-glucoamylase 2 (MGAM2) LDTP14883 C1390(2.32)  LDD3380 
Probable methyltransferase TARBP1 (TARBP1) LDTP05850 C483(1.05); C1556(1.02); C202(0.93)  LDD0078 
Probable methyltransferase-like protein 25 (METTL25) LDTP19717 C96(16.94); C504(6.45)  LDD0209 
Probable N-acetyltransferase 14 (NAT14) LDTP18083 C108(2.87)  LDD3316 
Probable oxidoreductase PXDNL (PXDNL) LDTP00031 C594(2.33)  LDD3318 
Probable palmitoyltransferase ZDHHC24 (ZDHHC24) LDTP07699 C242(1.04); C113(0.92)  LDD1511 
Probable phospholipid-transporting ATPase IIA (ATP9A) LDTP01124 C781(0.80); C798(0.80)  LDD0531 
Probable phospholipid-transporting ATPase IIB (ATP9B) LDTP00889 C122(11.63)  LDD0209 
Probable polypeptide N-acetylgalactosaminyltransferase 8 (GALNT8) LDTP12801 C395(2.00)  LDD3380 
Probable proline--tRNA ligase, mitochondrial (PARS2) LDTP15217 C329(0.82)  LDD0531 
Probable ribonuclease ZC3H12B (ZC3H12B) LDTP14972 C334(1.82)  LDD3372 
Probable ribonuclease ZC3H12C (ZC3H12C) LDTP15932 C333(1.01)  LDD0532 
Probable ribonuclease ZC3H12D (ZC3H12D) LDTP00042 C312(1.35)  LDD3325 
Probable serine carboxypeptidase CPVL (CPVL) LDTP15988 C320(4.70)  LDD3312 
Probable tRNA (uracil-O(2)-)-methyltransferase (TRMT44) LDTP15359 C482(0.95); C490(0.95)  LDD0078 
Probable tRNA(His) guanylyltransferase (THG1L) LDTP12742 C47(0.93); C51(0.93)  LDD0078 
Probable ubiquitin carboxyl-terminal hydrolase FAF-X (USP9X) LDTP09961 C673(1.08); C1237(1.04); C842(0.99); C540(0.89)  LDD0078 
Probable ubiquitin carboxyl-terminal hydrolase FAF-Y (USP9Y) LDTP00300 C1062(5.21); C148(2.88); C674(2.45); C1773(1.03)  LDD3311 
Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (MINDY4) LDTP14929 C456(0.75); C465(0.75)  LDD0531 
Procathepsin L (CTSL) LDTP02217 C138(0.97)  LDD0078 
Procollagen C-endopeptidase enhancer 1 (PCOLCE) LDTP06318 C159(1.94)  LDD3311 
Procollagen C-endopeptidase enhancer 2 (PCOLCE2) LDTP13503 C154(1.02)  LDD1492 
Procollagen galactosyltransferase 1 (COLGALT1) LDTP09055 C412(1.12); C203(0.85)  LDD0078 
Procollagen galactosyltransferase 2 (COLGALT2) LDTP08657 C204(2.40)  LDD3310 
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1) LDTP05373 C267(2.61); C270(2.61); C680(1.45)  LDD0080 
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (PLOD2) LDTP00285 C494(2.38)  LDD3311 
Proliferation-associated protein 2G4 (PA2G4) LDTP13750 C179(1.37); C296(1.19)  LDD0080 
Proline dehydrogenase 1, mitochondrial (PRODH) LDTP00721 C208(1.63); C256(1.44); C477(0.75)  LDD3312 
Prolyl 3-hydroxylase 1 (P3H1) LDTP06750 C645(3.00)  LDD3310 
Prolyl 3-hydroxylase 2 (P3H2) LDTP08504 C584(0.99); C593(0.99)  LDD0078 
Prolyl 3-hydroxylase 3 (P3H3) LDTP08505 C128(1.01)  LDD0078 
Prolyl 3-hydroxylase OGFOD1 (OGFOD1) LDTP08883 C154(2.12)  LDD3323 
Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) LDTP02679 C528(1.52)  LDD0080 
Prolyl 4-hydroxylase subunit alpha-2 (P4HA2) LDTP00645 C294(1.06); C510(0.88)  LDD0078 
Prolyl endopeptidase (PREP) LDTP04163 C601(1.10); C255(1.04); C25(0.96); C57(0.93)  LDD0078 
Prolyl endopeptidase FAP (FAP) LDTP05680 C305(2.47)  LDD3374 
Prolyl endopeptidase-like (PREPL) LDTP06849 C127(0.88); C404(0.85); C409(0.85); C160(0.85)  LDD0078 
Prolyl hydroxylase EGLN3 (EGLN3) LDTP12007 C302(2.98)  LDD3325 
Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCA) LDTP02095 C85(0.74)  LDD3310 
Propionyl-CoA carboxylase beta chain, mitochondrial (PCCB) LDTP02096 C311(1.84)  LDD3310 
Proprotein convertase subtilisin/kexin type 5 (PCSK5) LDTP09888 C494(3.12)  LDD3385 
Proprotein convertase subtilisin/kexin type 6 (PCSK6) LDTP03468 C528(2.34)  LDD3380 
Proprotein convertase subtilisin/kexin type 7 (PCSK7) LDTP06551 C699(1.13)  LDD0531 
Proprotein convertase subtilisin/kexin type 9 (PCSK9) LDTP09062 C588(1.45)  LDD0531 
Prostacyclin synthase (PTGIS) LDTP06590 C441(2.10)  LDD3331 
Prostaglandin E synthase (PTGES) LDTP00407 C59(0.95)  LDD0531 
Prostaglandin E synthase 2 (PTGES2) LDTP12040 C110(1.45)  LDD0078 
Prostaglandin E synthase 3 (PTGES3) LDTP06338 C40(1.04); C58(0.91)  LDD0078 
Prostaglandin G/H synthase 1 (PTGS1) LDTP03210 C599(2.17)  LDD3335 
Prostaglandin G/H synthase 2 (PTGS2) LDTP03736 C145(1.89); C561(1.81)  LDD3316 
Prostaglandin reductase 1 (PTGR1) LDTP06227 C239(1.10)  LDD0078 
Prostaglandin reductase 2 (PTGR2) LDTP08979 C187(1.16)  LDD3311 
Prostaglandin reductase 3 (PTGR3) LDTP15422 C198(0.85); C204(0.85)  LDD0078 
Prostaglandin-H2 D-isomerase (PTGDS) LDTP03934 C65(7.37)  LDD3335 
Prostamide/prostaglandin F synthase (PRXL2B) LDTP09344 C44(53.87)  LDD0209 
Proteasome subunit alpha type-1 (PSMA1) LDTP03330 C85(33.39); C85(84.06)  LDD0209 
Proteasome subunit alpha type-2 (PSMA2) LDTP03331 C213(1.60)  LDD3317 
Proteasome subunit alpha type-4 (PSMA4) LDTP03333 C107(0.64); C115(0.64); C163(0.94)  LDD0531 
Proteasome subunit alpha type-5 (PSMA5) LDTP03413 C165(1.39)  LDD0080 
Proteasome subunit alpha type-6 (PSMA6) LDTP04884 C154(2.01); C161(1.15)  LDD0080 
Proteasome subunit alpha type-7 (PSMA7) LDTP00449 C63(1.38); C70(1.38)  LDD0080 
Proteasome subunit beta type-1 (PSMB1) LDTP03060 C82(1.04); C89(1.04)  LDD0078 
Proteasome subunit beta type-10 (PSMB10) LDTP03893 C17(3.17)  LDD3333 
Proteasome subunit beta type-2 (PSMB2) LDTP04285 C91(1.02)  LDD0078 
Proteasome subunit beta type-3 (PSMB3) LDTP04284 C19(4.08)  LDD0204 
Proteasome subunit beta type-5 (PSMB5) LDTP03419 C161(1.24)  LDD0531 
Proteasome subunit beta type-6 (PSMB6) LDTP03418 C186(1.53)  LDD3312 
Proteasome subunit beta type-7 (PSMB7) LDTP10862 C219(1.64)  LDD3332 
Proteasome subunit beta type-8 (PSMB8) LDTP03411 C120(1.27); C160(1.03)  LDD0078 
Protein ABHD13 (ABHD13) LDTP17516 C242(1.25)  LDD0532 
Protein ABHD14A (ABHD14A) LDTP18311 C251(0.87)  LDD1508 
Protein ABHD15 (ABHD15) LDTP17437 C392(1.10)  LDD0532 
Protein ABHD18 (ABHD18) LDTP17019 C150(0.73)  LDD0533 
Protein adenylyltransferase FICD (FICD) LDTP11278 C75(1.19)  LDD1507 
Protein adenylyltransferase SelO, mitochondrial (SELENOO) LDTP11294 C81(13.21); C382(40.83)  LDD0209 
Protein arginine methyltransferase NDUFAF7, mitochondrial (NDUFAF7) LDTP07961 C315(120.46)  LDD0209 
Protein arginine N-methyltransferase 1 (PRMT1) LDTP10997 C109(2.41); C216(1.03); C350(1.01)  LDD0080 
Protein arginine N-methyltransferase 2 (PRMT2) LDTP04705 C252(1.03); C299(1.15)  LDD1507 
Protein arginine N-methyltransferase 3 (PRMT3) LDTP01028 C67(1.33); C417(1.79)  LDD3310 
Protein arginine N-methyltransferase 5 (PRMT5) LDTP00418 C42(1.09)  LDD0080 
Protein arginine N-methyltransferase 6 (PRMT6) LDTP10538 C229(2.24)  LDD3331 
Protein arginine N-methyltransferase 7 (PRMT7) LDTP12684 C534(1.04); C537(1.04)  LDD0078 
Protein arginine N-methyltransferase 9 (PRMT9) LDTP07525 C683(1.74)  LDD0080 
Protein argonaute-2 (AGO2) LDTP13492 C188(1.02)  LDD0078 
Protein argonaute-3 (AGO3) LDTP12096 C273(1.47); C491(1.01); C493(0.93)  LDD0531 
Protein ARK2N (ARK2N) LDTP10109 C57(1.31)  LDD0532 
Protein artemis (DCLRE1C) LDTP10812 C272(11.52)  LDD0209 
Protein C-mannosyl-transferase DPY19L1 (DPY19L1) LDTP17080 C619(1.73)  LDD0080 
Protein C-mannosyl-transferase DPY19L3 (DPY19L3) LDTP17476 C91(1.18)  LDD0078 
Protein DDI1 homolog 1 (DDI1) LDTP09546 C7(2.20)  LDD3365 
Protein DDI1 homolog 2 (DDI2) LDTP07186 C361(2.44)  LDD3312 
Protein disulfide isomerase CRELD1 (CRELD1) LDTP10384 C292(1.62)  LDD3413 
Protein disulfide isomerase CRELD2 (CRELD2) LDTP07709 C255(1.07)  LDD3312 
Protein disulfide-isomerase (P4HB) LDTP02188 C397(1.44)  LDD0078 
Protein disulfide-isomerase A2 (PDIA2) LDTP05743 C74(2.16); C421(1.97)  LDD3377 
Protein disulfide-isomerase A3 (PDIA3) LDTP03521 C92(1.14); C57(1.04); C60(0.94); C85(0.93)  LDD0078 
Protein disulfide-isomerase A4 (PDIA4) LDTP02677 C558(1.09); C91(1.08); C94(1.06)  LDD0078 
Protein disulfide-isomerase A5 (PDIA5) LDTP06145 C426(7.02)  LDD0080 
Protein disulfide-isomerase A6 (PDIA6) LDTP06314 C190(9.42); C190(4.45)  LDD0209 
Protein farnesyltransferase subunit beta (FNTB) LDTP04247 C299(1.09)  LDD0532 
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (FNTA) LDTP04246 C341(1.61)  LDD3330 
Protein FRA10AC1 (FRA10AC1) LDTP07896 C144(1.32); C175(1.48)  LDD0080 
Protein GUCD1 (GUCD1) LDTP10636 C185(1.60)  LDD3339 
Protein KHNYN (KHNYN) LDTP14438 C157(2.70); C221(2.82); C245(1.93)  LDD0080 
Protein kinase C alpha type (PRKCA) LDTP02891 C143(1.33); C151(1.33); C71(1.27); C50(1.23)  LDD0078 
Protein kinase C beta type (PRKCB) LDTP02123 C572(6.40)  LDD0209 
Protein kinase C delta type (PRKCD) LDTP05461 C208(1.66)  LDD3311 
Protein kinase C epsilon type (PRKCE) LDTP05339 C554(1.93)  LDD0080 
Protein kinase C eta type (PRKCH) LDTP03290 C399(1.08)  LDD1492 
Protein kinase C gamma type (PRKCG) LDTP02086 C586(0.79)  LDD3334 
Protein kinase C iota type (PRKCI) LDTP03960 C154(0.92); C157(0.92)  LDD0078 
Protein kinase C theta type (PRKCQ) LDTP05433 C661(5.22)  LDD0209 
Protein kinase C zeta type (PRKCZ) LDTP05456 C172(1.06); C180(1.06)  LDD0532 
Protein mab-21-like 2 (MAB21L2) LDTP14100 C215(2.19)  LDD3340 
Protein mono-ADP-ribosyltransferase PARP10 (PARP10) LDTP06900 C50(117.72); C768(7.01)  LDD0209 
Protein mono-ADP-ribosyltransferase PARP12 (PARP12) LDTP11715 C284(1.32)  LDD0531 
Protein mono-ADP-ribosyltransferase PARP14 (PARP14) LDTP06813 C208(12.81); C1265(5.74); C1274(27.10); C893(9.55)  LDD0209 
Protein mono-ADP-ribosyltransferase PARP16 (PARP16) LDTP08910 C24(2.14)  LDD3367 
Protein mono-ADP-ribosyltransferase PARP4 (PARP4) LDTP13460 C1002(0.66); C1019(0.98); C1488(0.87); C1687(1.26)  LDD0531 
Protein mono-ADP-ribosyltransferase PARP8 (PARP8) LDTP08825 C367(2.17)  LDD3370 
Protein mono-ADP-ribosyltransferase PARP9 (PARP9) LDTP08610 C388(8.23)  LDD0204 
Protein N-lysine methyltransferase METTL21D (VCPKMT) LDTP12049 C40(1.22)  LDD3331 
Protein N-terminal asparagine amidohydrolase (NTAN1) LDTP10075 C118(1.45)  LDD3335 
Protein N-terminal glutamine amidohydrolase (NTAQ1) LDTP10380 C28(0.79)  LDD0593 
Protein NDRG1 (NDRG1) LDTP09810 C289(1.46)  LDD0080 
Protein NDRG2 (NDRG2) LDTP13638 C321(2.33)  LDD0080 
Protein NDRG3 (NDRG3) LDTP18530 C254(2.12); C273(2.12)  LDD0080 
Protein NYNRIN (NYNRIN) LDTP16182 C73(2.04)  LDD3310 
Protein O-GlcNAcase (OGA) LDTP00988 C596(1.02); C896(0.97); C663(0.96)  LDD0078 
Protein O-glucosyltransferase 1 (POGLUT1) LDTP09059 C102(1.19)  LDD0812 
Protein O-glucosyltransferase 2 (POGLUT2) LDTP07666 C491(1.09); C493(1.09)  LDD0533 
Protein O-glucosyltransferase 3 (POGLUT3) LDTP08070 C495(0.98); C497(0.98)  LDD0078 
Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGNT1) LDTP09755 C175(1.44)  LDD2284 
Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGNT2) LDTP09031 C490(1.87)  LDD2253 
Protein O-mannose kinase (POMK) LDTP11957 C55(1.79)  LDD3323 
Protein O-mannosyl-transferase 2 (POMT2) LDTP13501 C21(10.11)  LDD3311 
Protein O-mannosyl-transferase TMTC2 (TMTC2) LDTP08824 C713(1.15)  LDD3312 
Protein O-mannosyl-transferase TMTC3 (TMTC3) LDTP07868 C779(2.47)  LDD3310 
Protein phosphatase 1 regulatory subunit 1A (PPP1R1A) LDTP05910 C139(1.51)  LDD3434 
Protein phosphatase 1 regulatory subunit 1B (PPP1R1B) LDTP13185 C155(1.09)  LDD3360 
Protein phosphatase 1A (PPM1A) LDTP03788 C363(1.75)  LDD3370 
Protein phosphatase 1B (PPM1B) LDTP01292 C163(1.05); C172(1.05)  LDD0078 
Protein phosphatase 1D (PPM1D) LDTP00603 C104(0.91)  LDD0547 
Protein phosphatase 1E (PPM1E) LDTP09727 C91(2.44); C157(2.32)  LDD3342 
Protein phosphatase 1F (PPM1F) LDTP04266 C315(0.87)  LDD0078 
Protein phosphatase 1G (PPM1G) LDTP00616 C241(1.04); C13(0.93)  LDD0078 
Protein phosphatase 1H (PPM1H) LDTP13571 C239(1.62)  LDD3314 
Protein phosphatase 1L (PPM1L) LDTP07057 C91(1.25)  LDD3314 
Protein phosphatase 3 catalytic subunit alpha (PPP3CA) LDTP05549 C88(1.95)  LDD3312 
Protein phosphatase inhibitor 2 (PPP1R2) LDTP03942 C86(1.18)  LDD1492 
Protein phosphatase methylesterase 1 (PPME1) LDTP14092 C381(2.52); C312(2.53); C238(1.56)  LDD0080 
Protein phosphatase PTC7 homolog (PPTC7) LDTP09282 C57(3.36); C41(1.76)  LDD0080 
Protein phosphatase Slingshot homolog 1 (SSH1) LDTP09739 C649(0.91); C652(0.91)  LDD0078 
Protein phosphatase Slingshot homolog 2 (SSH2) LDTP07919 C1272(1.06); C1281(1.06)  LDD0078 
Protein phosphatase Slingshot homolog 3 (SSH3) LDTP09484 C434(1.72)  LDD0532 
Protein PML (PML) LDTP03496 C338(1.28); C227(1.06); C479(1.04); C484(1.04)  LDD0078 
Protein PPP4R3C (PPP4R3C) LDTP17454 C331(5.27); C781(2.89)  LDD3331 
Protein prenyltransferase alpha subunit repeat-containing protein 1 (PTAR1) LDTP19609 C381(0.97)  LDD0078 
Protein prune homolog 2 (PRUNE2) LDTP09590 C1757(0.96); C1469(1.14)  LDD3332 
Protein regulator of cytokinesis 1 (PRC1) LDTP00828 C236(91.99)  LDD0209 
Protein SCO1 homolog, mitochondrial (SCO1) LDTP01335 C173(0.92)  LDD1575 
Protein SCO2 homolog, mitochondrial (SCO2) LDTP00877 C137(0.83); C133(1.10)  LDD1507 
Protein SLFN14 (SLFN14) LDTP02399 C36(1.99)  LDD2302 
Protein tyrosine phosphatase domain-containing protein 1 (PTPDC1) LDTP14334 C288(1.75)  LDD3419 
Protein tyrosine phosphatase type IVA 1 (PTP4A1) LDTP09980 C49(1.59)  LDD3312 
Protein tyrosine phosphatase type IVA 2 (PTP4A2) LDTP05712 C46(1.19)  LDD0532 
Protein tyrosine phosphatase type IVA 3 (PTP4A3) LDTP01193 C49(0.88)  LDD1507 
Protein yippee-like 2 (YPEL2) LDTP18237 C97(1.16)  LDD3433 
Protein yippee-like 5 (YPEL5) LDTP04996 C20(0.74)  LDD0812 
Protein-arginine deiminase type-1 (PADI1) LDTP13534 C339(0.62); C233(0.97)  LDD3364 
Protein-arginine deiminase type-2 (PADI2) LDTP13879 C647(1.09)  LDD3314 
Protein-arginine deiminase type-3 (PADI3) LDTP13588 C564(1.53); C547(2.86)  LDD3312 
Protein-arginine deiminase type-4 (PADI4) LDTP13601 C645(1.59)  LDD3370 
Protein-associating with the carboxyl-terminal domain of ezrin (SCYL3) LDTP08696 C560(1.76); C573(1.76)  LDD0080 
Protein-cysteine N-palmitoyltransferase HHAT (HHAT) LDTP07220 C410(0.94)  LDD1511 
Protein-glucosylgalactosylhydroxylysine glucosidase (PGGHG) LDTP06745 C615(1.44)  LDD3339 
Protein-glutamine gamma-glutamyltransferase 2 (TGM2) LDTP03146 C370(1.12); C371(1.12); C230(0.93)  LDD0078 
Protein-glutamine gamma-glutamyltransferase 5 (TGM5) LDTP00798 C291(2.07)  LDD3311 
Protein-glutamine gamma-glutamyltransferase E (TGM3) LDTP05548 C367(1.52); C273(1.48)  LDD2252 
Protein-L-histidine N-pros-methyltransferase (METTL9) LDTP15962 C215(1.11)  LDD0531 
Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 (PCMTD1) LDTP10586 C43(2.48)  LDD3316 
Protein-L-isoaspartate O-methyltransferase domain-containing protein 2 (PCMTD2) LDTP12662 C165(4.52)  LDD3360 
Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PCMT1) LDTP03152 C102(0.88)  LDD3312 
Protein-lysine 6-oxidase (LOX) LDTP03427 C238(1.02); C244(1.02)  LDD0078 
Protein-lysine N-methyltransferase EEF2KMT (EEF2KMT) LDTP10327 C290(0.81); C72(1.11)  LDD0531 
Protein-serine O-palmitoleoyltransferase porcupine (PORCN) LDTP11791 C375(2.16)  LDD3331 
Protein-tyrosine kinase 2-beta (PTK2B) LDTP06100 C89(2.35)  LDD3310 
Protein-tyrosine kinase 6 (PTK6) LDTP05996 C433(2.24)  LDD3389 
Prothrombin (F2) LDTP01790 C391(1.04); C550(1.75); C564(1.38); C594(0.94)  LDD0531 
Proto-oncogene tyrosine-protein kinase receptor Ret (RET) LDTP02233 C987(1.88)  LDD3340 
Proto-oncogene tyrosine-protein kinase ROS (ROS1) LDTP02318 C1122(2.41)  LDD2894 
Proto-oncogene tyrosine-protein kinase Src (SRC) LDTP02638 C247(1.60)  LDD3310 
Protoporphyrinogen oxidase (PPOX) LDTP04353 C183(3.88)  LDD0080 
Pseudouridine-5'-phosphatase (PUDP) LDTP05568 C171(1.13)  LDD1508 
Pseudouridylate synthase 1 homolog (PUS1) LDTP14193 C260(1.10)  LDD0080 
Pseudouridylate synthase 7 homolog (PUS7) LDTP10709 C38(0.91)  LDD0078 
Pseudouridylate synthase PUS7L (PUS7L) LDTP11717 C640(1.05); C267(0.93)  LDD0078 
Pseudouridylate synthase RPUSD2 (RPUSD2) LDTP15370 C499(1.29); C502(1.29)  LDD0080 
Pseudouridylate synthase RPUSD4, mitochondrial (RPUSD4) LDTP10176 C149(1.50)  LDD0531 
Pseudouridylate synthase TRUB1 (TRUB1) LDTP09649 C331(0.97)  LDD0078 
Pseudouridylate synthase TRUB2, mitochondrial (TRUB2) LDTP01710 C252(1.24)  LDD0532 
Pterin-4-alpha-carbinolamine dehydratase 2 (PCBD2) LDTP11722 C109(0.90)  LDD3313 
Purine nucleoside phosphorylase (PNP) LDTP01781 C31(1.05)  LDD0078 
Purine nucleoside phosphorylase LACC1 (LACC1) LDTP08478 C284(1.35)  LDD3410 
Puromycin-sensitive aminopeptidase (NPEPPS) LDTP04712 C190(1.01); C537(0.98)  LDD0078 
Puromycin-sensitive aminopeptidase-like protein (NPEPPSL1) LDTP16607 C339(1.98)  LDD3312 
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P) LDTP15068 C181(1.85)  LDD3440 
Putative ATP-dependent RNA helicase DDX11-like protein 8 (DDX11L8) LDTP14392 C838(6.67); C287(11.97)  LDD0209 
Putative ATP-dependent RNA helicase DDX12 (DDX12P) LDTP15665 C369(2.12)  LDD3327 
Putative ATP-dependent RNA helicase DHX57 (DHX57) LDTP07502 C453(1.06); C65(0.98); C1367(0.89); C1369(0.89)  LDD0078 
Putative ATP-dependent RNA helicase TDRD12 (TDRD12) LDTP14954 C1097(6.69); C208(1.70)  LDD3343 
Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (ALG13) LDTP12313 C424(2.82); C499(2.21); C502(2.21)  LDD0080 
Putative cytosolic acyl coenzyme A thioester hydrolase-like (ACOT7L) LDTP15198 C90(3.54)  LDD3311 
Putative dehydrogenase/reductase SDR family member 4-like 1 (DHRS4L1) LDTP16893 C212(0.98)  LDD0531 
Putative deoxyribonuclease TATDN2 (TATDN2) LDTP18118 C546(1.95)  LDD3337 
Putative deoxyribonuclease TATDN3 (TATDN3) LDTP17058 C214(0.96)  LDD1511 
Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (ALG10B) LDTP06992 C196(1.03)  LDD1492 
Putative E3 ubiquitin-protein ligase makorin-4 (MKRN4P) LDTP14831 C294(1.38)  LDD3339 
Putative E3 ubiquitin-protein ligase UBR7 (UBR7) LDTP15447 C424(1.10); C260(1.03); C374(0.99); C314(0.90)  LDD0078 
Putative E3 ubiquitin-protein ligase UNKL (UNKL) LDTP12104 C595(0.84)  LDD0533 
Putative elongation factor 1-alpha-like 3 (EEF1A1P5) LDTP15029 C411(1.27)  LDD0078 
Putative glycerol kinase 5 (GK5) LDTP17488 C505(11.64)  LDD0209 
Putative GTP-binding protein 6 (GTPBP6) LDTP16798 C394(0.89); C305(1.01); C99(0.88)  LDD0531 
Putative HERC2-like protein 3 (HERC2P3) LDTP19925 C91(1.37)  LDD2634 
Putative histone PARylation factor 1-like LDTP18891 C30(1.23); C153(0.98)  LDD0080 
Putative histone-lysine N-methyltransferase PRDM6 (PRDM6) LDTP12446 C426(1.05)  LDD1492 
Putative hydrolase DDAH2 (DDAH2) LDTP01700 C11(1.38)  LDD3311 
Putative hydroxypyruvate isomerase (HYI) LDTP14998 C248(1.04)  LDD1095 
Putative inactive carbonic anhydrase 5B-like protein (CA5BP1) LDTP19826 C149(1.63)  LDD3331 
Putative inactive carboxylesterase 4 (CES1P1) LDTP16229 C117(1.43)  LDD3337 
Putative inactive phosphatidylinositol 4-kinase alpha-like protein P1 (PI4KAP1) LDTP20334 C140(2.10)  LDD3312 
Putative methyltransferase C9orf114 (SPOUT1) LDTP07101 C239(0.99); C10(0.94)  LDD0078 
Putative methyltransferase-like protein 15P1 (METTL15P1) LDTP19060 C172(1.47)  LDD3392 
Putative N-acetylated-alpha-linked acidic dipeptidase (FOLH1B) LDTP16033 C597(1.84)  LDD3486 
Putative NOL1/NOP2/Sun domain family member 5B (NSUN5P1) LDTP17102 C77(2.19); C92(3.05)  LDD3311 
Putative nucleoside diphosphate kinase (NME2P1) LDTP16807 C260(1.20)  LDD3316 
Putative nucleotidyltransferase MAB21L1 (MAB21L1) LDTP05849 C316(1.36)  LDD1507 
Putative peptidyl-tRNA hydrolase PTRHD1 (PTRHD1) LDTP19478 C52(1.55)  LDD0080 
Putative phosphatidylinositol 4-kinase alpha-like protein P2 (PI4KAP2) LDTP16582 C833(4.48)  LDD3319 
Putative phospholipase B-like 2 (PLBD2) LDTP09256 C244(1.13); C342(1.12)  LDD0531 
Putative PIP5K1A and PSMD4-like protein (PIPSL) LDTP16560 C393(1.14)  LDD0593 
Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 (DHX32) LDTP07974 C730(1.11); C733(1.11)  LDD0078 
Putative protein N-methyltransferase FAM86B1 (FAM86B1) LDTP19723 C72(2.17)  LDD3321 
Putative protein N-methyltransferase FAM86B2 (FAM86B2) LDTP16860 C72(1.92)  LDD0080 
Putative protein-lysine deacylase ABHD14B (ABHD14B) LDTP10428 C190(1.22)  LDD3332 
Putative pyridoxal-dependent decarboxylase domain-containing protein 2 (PDXDC2P) LDTP17376 C99(3.34)  LDD3310 
Putative Ras-related protein Rab-1C (RAB1C) LDTP15670 C200(0.83)  LDD0532 
Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 (RPAP2) LDTP08615 C100(0.88); C105(0.88); C136(0.86); C140(0.86)  LDD0078 
Putative serine/threonine-protein kinase SIK1B (SIK1B) LDTP00003 C533(0.49)  LDD2236 
Putative transferase CAF17, mitochondrial (IBA57) LDTP07110 C259(1.81); C170(4.08)  LDD0080 
Putative tripartite motif-containing protein 49B (TRIM49B) LDTP16599 C152(2.66)  LDD3434 
PWWP domain-containing protein 2A (PWWP2A) LDTP10611 C654(1.98)  LDD3339 
PWWP domain-containing protein 2B (PWWP2B) LDTP07471 C410(1.40); C394(1.77)  LDD3310 
PX domain-containing protein kinase-like protein (PXK) LDTP08140 C196(0.86)  LDD0078 
Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (PYROXD1) LDTP09555 C122(1.77)  LDD0080 
Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (PYROXD2) LDTP15408 C321(1.57)  LDD3314 
Pyridoxal kinase (PDXK) LDTP00343 C39(1.55)  LDD3312 
Pyridoxal-dependent decarboxylase domain-containing protein 1 (PDXDC1) LDTP15119 C425(93.84); C361(78.74)  LDD0209 
Pyridoxine-5'-phosphate oxidase (PNPO) LDTP12691 C156(1.58)  LDD0080 
Pyrin (MEFV) LDTP00681 C144(0.97)  LDD3334 
Pyroglutamyl-peptidase 1 (PGPEP1) LDTP12784 C99(12.16)  LDD0209 
Pyrroline-5-carboxylate reductase 1, mitochondrial (PYCR1) LDTP03644 C120(3.29)  LDD0080 
Pyrroline-5-carboxylate reductase 2 (PYCR2) LDTP10159 C232(1.10); C225(1.09)  LDD0078 
Pyrroline-5-carboxylate reductase 3 (PYCR3) LDTP06911 C49(0.99); C56(0.95)  LDD0078 
Pyruvate carboxylase, mitochondrial (PC) LDTP02576 C850(1.06); C622(1.03)  LDD0078 
Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (PDHA1) LDTP02279 C261(4.31)  LDD0209 
Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHB) LDTP02549 C161(1.06); C169(1.06)  LDD0078 
Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPR) LDTP17785 C85(1.28)  LDD0532 
Pyruvate dehydrogenase protein X component, mitochondrial (PDHX) LDTP00253 C307(1.38)  LDD3339 
Pyruvate kinase PKLR (PKLR) LDTP03552 C509(1.24)  LDD3443 
Pyruvate kinase PKM (PKM) LDTP02733 C423(1.16); C424(1.01); C326(0.96); C152(0.85)  LDD0078 
Queuine tRNA-ribosyltransferase accessory subunit 2 (QTRT2) LDTP12080 C324(1.84); C68(1.33)  LDD3311 
Queuine tRNA-ribosyltransferase catalytic subunit 1 (QTRT1) LDTP11400 C317(0.28); C319(0.28); C322(0.28)  LDD0533 
Queuosine 5'-phosphate N-glycosylase/hydrolase (QNG1) LDTP17236 C170(1.62); C227(0.96)  LDD3312 
Quinone oxidoreductase (CRYZ) LDTP05551 C145(0.94)  LDD0531 
Quinone oxidoreductase PIG3 (TP53I3) LDTP06889 C216(0.67)  LDD3310 
Quinone oxidoreductase-like protein 1 (CRYZL1) LDTP16850 C177(0.96)  LDD0078 
Rab-like protein 2B (RABL2B) LDTP13676 C26(2.87)  LDD3312 
Rab-like protein 3 (RABL3) LDTP06986 C180(2.41)  LDD3312 
Rab-like protein 6 (RABL6) LDTP06807 C492(0.77)  LDD3310 
RAC-alpha serine/threonine-protein kinase (AKT1) LDTP03607 C60(1.13)  LDD0531 
RAC-beta serine/threonine-protein kinase (AKT2) LDTP03608 C297(1.01); C311(0.93)  LDD0078 
RAC-gamma serine/threonine-protein kinase (AKT3) LDTP13799 C459(1.06)  LDD1175 
Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (RSAD1) LDTP16027 C53(9.92); C56(9.92)  LDD0080 
RAF proto-oncogene serine/threonine-protein kinase (RAF1) LDTP02002 C588(10.36)  LDD0209 
RalA-binding protein 1 (RALBP1) LDTP06355 C227(29.19)  LDD0209 
RanBP-type and C3HC4-type zinc finger-containing protein 1 (RBCK1) LDTP11468 C300(1.05); C305(1.05); C323(0.97); C332(0.97)  LDD0078 
Ras and EF-hand domain-containing protein (RASEF) LDTP08685 C426(1.16); C435(1.16)  LDD0078 
Ras GTPase-activating protein-binding protein 1 (G3BP1) LDTP05812 C73(2.04)  LDD0080 
Ras-related C3 botulinum toxin substrate 1 (RAC1) LDTP05037 C6(1.61); C124(1.13)  LDD3310 
Ras-related C3 botulinum toxin substrate 2 (RAC2) LDTP02768 C178(1.40)  LDD0078 
Ras-related C3 botulinum toxin substrate 3 (RAC3) LDTP04877 C157(0.93); C178(0.96)  LDD1492 
Ras-related GTP-binding protein A (RRAGA) LDTP07957 C157(0.91); C159(0.91)  LDD0531 
Ras-related GTP-binding protein B (RRAGB) LDTP07263 C280(1.11)  LDD0080 
Ras-related GTP-binding protein C (RRAGC) LDTP12166 C377(1.95)  LDD3311 
Ras-related GTP-binding protein D (RRAGD) LDTP12422 C359(1.05)  LDD0078 
Ras-related protein R-Ras (RRAS) LDTP02490 C70(10.61)  LDD0209 
Ras-related protein R-Ras2 (RRAS2) LDTP04955 C61(1.86)  LDD3310 
Ras-related protein Rab-10 (RAB10) LDTP04895 C124(0.94)  LDD0531 
Ras-related protein Rab-12 (RAB12) LDTP07423 C68(1.05); C71(1.05)  LDD0078 
Ras-related protein Rab-13 (RAB13) LDTP04401 C123(4.09)  LDD3311 
Ras-related protein Rab-14 (RAB14) LDTP04901 C40(1.09)  LDD0078 
Ras-related protein Rab-17 (RAB17) LDTP11731 C53(1.59)  LDD3339 
Ras-related protein Rab-18 (RAB18) LDTP12312 C139(1.56)  LDD3310 
Ras-related protein Rab-19 (RAB19) LDTP14338 C32(4.29)  LDD3314 
Ras-related protein Rab-1A (RAB1A) LDTP05006 C205(1.20)  LDD0531 
Ras-related protein Rab-20 (RAB20) LDTP12760 C106(0.97)  LDD0532 
Ras-related protein Rab-21 (RAB21) LDTP13512 C29(1.07)  LDD0078 
Ras-related protein Rab-22A (RAB22A) LDTP13513 C120(14.13)  LDD0204 
Ras-related protein Rab-23 (RAB23) LDTP13531 C130(2.37)  LDD3312 
Ras-related protein Rab-24 (RAB24) LDTP10020 C113(2.08); C118(2.08)  LDD0080 
Ras-related protein Rab-26 (RAB26) LDTP13586 C78(1.67)  LDD2265 
Ras-related protein Rab-27B (RAB27B) LDTP00210 C123(1.62)  LDD3314 
Ras-related protein Rab-28 (RAB28) LDTP04402 C31(1.71)  LDD0080 
Ras-related protein Rab-2A (RAB2A) LDTP04892 C21(0.83); C212(0.91)  LDD0531 
Ras-related protein Rab-2B (RAB2B) LDTP09569 C154(0.96)  LDD0078 
Ras-related protein Rab-30 (RAB30) LDTP06467 C168(1.07)  LDD0078 
Ras-related protein Rab-31 (RAB31) LDTP05957 C49(0.75)  LDD0532 
Ras-related protein Rab-32 (RAB32) LDTP05958 C162(0.86)  LDD0078 
Ras-related protein Rab-33A (RAB33A) LDTP06031 C57(2.91); C135(1.55)  LDD3332 
Ras-related protein Rab-33B (RAB33B) LDTP11686 C48(3.64)  LDD3331 
Ras-related protein Rab-34 (RAB34) LDTP11535 C38(1.80)  LDD0080 
Ras-related protein Rab-35 (RAB35) LDTP06349 C110(1.22); C114(1.23)  LDD0531 
Ras-related protein Rab-36 (RAB36) LDTP14544 C187(0.48)  LDD0531 
Ras-related protein Rab-37 (RAB37) LDTP10098 C22(3.66)  LDD3333 
Ras-related protein Rab-38 (RAB38) LDTP04795 C147(2.13)  LDD3375 
Ras-related protein Rab-39A (RAB39A) LDTP06239 C41(2.74)  LDD0080 
Ras-related protein Rab-39B (RAB39B) LDTP10206 C125(5.06)  LDD3342 
Ras-related protein Rab-3A (RAB3A) LDTP03047 C184(0.99)  LDD1492 
Ras-related protein Rab-3B (RAB3B) LDTP03048 C137(1.62)  LDD0080 
Ras-related protein Rab-3C (RAB3C) LDTP10244 C192(3.85)  LDD3335 
Ras-related protein Rab-3D (RAB3D) LDTP01659 C184(3.26)  LDD3312 
Ras-related protein Rab-40C (RAB40C) LDTP10794 C273(1.43)  LDD2265 
Ras-related protein Rab-42 (RAB42) LDTP17710 C25(0.93)  LDD3487 
Ras-related protein Rab-43 (RAB43) LDTP08413 C33(249.26)  LDD0209 
Ras-related protein Rab-44 (RAB44) LDTP17559 C950(2.16)  LDD3333 
Ras-related protein Rab-4A (RAB4A) LDTP03049 C28(1.64)  LDD3312 
Ras-related protein Rab-4B (RAB4B) LDTP04891 C58(1.65)  LDD3314 
Ras-related protein Rab-5A (RAB5A) LDTP03050 C63(3.10)  LDD3319 
Ras-related protein Rab-5B (RAB5B) LDTP04893 C63(1.38)  LDD3332 
Ras-related protein Rab-5C (RAB5C) LDTP04398 C97(1.44)  LDD3312 
Ras-related protein Rab-7a (RAB7A) LDTP04399 C143(1.46)  LDD0080 
Ras-related protein Rab-7L1 (RAB29) LDTP00492 C127(1.01)  LDD0078 
Ras-related protein Rab-8A (RAB8A) LDTP04888 C123(1.22)  LDD3312 
Ras-related protein Rab-8B (RAB8B) LDTP09934 C23(1.55)  LDD3332 
Ras-related protein Rab-9A (RAB9A) LDTP04400 C142(0.88)  LDD0531 
Ras-related protein Rab-9B (RAB9B) LDTP12324 C142(1.03); C182(1.04)  LDD1492 
Ras-related protein Rap-1A (RAP1A) LDTP05009 C139(1.00); C118(0.90)  LDD0078 
Ras-related protein Rap-1b (RAP1B) LDTP04910 C51(2.98)  LDD3312 
Ras-related protein Rap-1b-like protein (RAP1BL) LDTP16637 C141(1.38)  LDD0080 
Ras-related protein Rap-2a (RAP2A) LDTP02474 C140(2.28)  LDD3410 
Ras-related protein Rap-2b (RAP2B) LDTP04911 C140(1.08)  LDD0593 
Ras-related protein Rap-2c (RAP2C) LDTP13995 C140(0.65)  LDD0533 
Receptor tyrosine-protein kinase erbB-2 (ERBB2) LDTP02044 C947(0.92)  LDD0531 
Receptor tyrosine-protein kinase erbB-3 (ERBB3) LDTP03138 C331(2.49)  LDD3311 
Receptor tyrosine-protein kinase erbB-4 (ERBB4) LDTP06353 C956(2.82)  LDD3310 
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) LDTP05917 C325(1.05); C233(1.02); C240(1.02); C34(0.90)  LDD0078 
Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) LDTP00751 C380(5.52)  LDD0080 
Receptor-interacting serine/threonine-protein kinase 4 (RIPK4) LDTP04782 C88(0.96)  LDD0078 
Receptor-type tyrosine-protein kinase FLT3 (FLT3) LDTP03820 C843(1.62)  LDD3310 
Receptor-type tyrosine-protein phosphatase alpha (PTPRA) LDTP02950 C359(1.57)  LDD0080 
Receptor-type tyrosine-protein phosphatase beta (PTPRB) LDTP03231 C2067(1.55)  LDD3418 
Receptor-type tyrosine-protein phosphatase C (PTPRC) LDTP02284 C367(36.74)  LDD0209 
Receptor-type tyrosine-protein phosphatase delta (PTPRD) LDTP03232 C1465(1.17)  LDD0080 
Receptor-type tyrosine-protein phosphatase epsilon (PTPRE) LDTP03233 C278(1.00); C287(1.00)  LDD0078 
Receptor-type tyrosine-protein phosphatase eta (PTPRJ) LDTP05693 C1039(0.88)  LDD0078 
Receptor-type tyrosine-protein phosphatase F (PTPRF) LDTP02499 C1460(1.01)  LDD0080 
Receptor-type tyrosine-protein phosphatase gamma (PTPRG) LDTP03234 C427(3.13)  LDD3310 
Receptor-type tyrosine-protein phosphatase kappa (PTPRK) LDTP06344 C270(2.36)  LDD3310 
Receptor-type tyrosine-protein phosphatase mu (PTPRM) LDTP03454 C907(2.84)  LDD3319 
Receptor-type tyrosine-protein phosphatase R (PTPRR) LDTP06342 C605(2.99)  LDD3338 
Receptor-type tyrosine-protein phosphatase S (PTPRS) LDTP05831 C1501(1.34)  LDD0080 
Receptor-type tyrosine-protein phosphatase T (PTPRT) LDTP00359 C1402(2.53)  LDD3369 
Receptor-type tyrosine-protein phosphatase U (PTPRU) LDTP09847 C1136(2.66)  LDD3312 
Receptor-type tyrosine-protein phosphatase zeta (PTPRZ1) LDTP03235 C2188(2.90)  LDD3312 
RecQ-like DNA helicase BLM (BLM) LDTP04600 C361(2.12); C1364(1.85)  LDD0080 
Reelin (RELN) LDTP05134 C1338(1.31)  LDD3386 
Regucalcin (RGN) LDTP06401 C248(0.96)  LDD0812 
Regulator of nonsense transcripts 1 (UPF1) LDTP09921 C209(1.17); C186(1.03); C188(1.03); C683(0.97)  LDD0078 
Regulator of telomere elongation helicase 1 (RTEL1) LDTP12878 C31(22.60)  LDD0204 
Renalase (RNLS) LDTP07257 C220(0.87)  LDD0078 
Renin (REN) LDTP01802 C124(2.78)  LDD2378 
Replication factor C subunit 2 (RFC2) LDTP03726 C171(0.95); C255(0.86)  LDD0078 
Replication factor C subunit 3 (RFC3) LDTP03911 C32(0.99); C164(0.87); C165(0.87)  LDD0078 
Replication factor C subunit 4 (RFC4) LDTP03725 C177(0.87); C180(0.87)  LDD0078 
Replication factor C subunit 5 (RFC5) LDTP03910 C152(0.85)  LDD0078 
Reticulon-4-interacting protein 1, mitochondrial (RTN4IP1) LDTP09666 C349(1.34)  LDD3312 
Retinal dehydrogenase 2 (ALDH1A2) LDTP01419 C387(8.30)  LDD0209 
Retinaldehyde dehydrogenase 3 (ALDH1A3) LDTP04134 C52(0.94)  LDD0078 
Retinoid-inducible serine carboxypeptidase (SCPEP1) LDTP16032 C295(4.19); C62(4.19)  LDD0812 
Retinol dehydrogenase 10 (RDH10) LDTP08722 C242(1.13); C170(1.12)  LDD0078 
Retinol dehydrogenase 11 (RDH11) LDTP09364 C133(1.10)  LDD0078 
Retinol dehydrogenase 13 (RDH13) LDTP09061 C201(1.15)  LDD0078 
Retinol dehydrogenase 14 (RDH14) LDTP12180 C97(1.19); C74(1.92)  LDD3310 
Retinol dehydrogenase 5 (RDH5) LDTP09868 C267(0.92)  LDD3389 
Rho family-interacting cell polarization regulator 1 (RIPOR1) LDTP07819 C925(34.00)  LDD0209 
Rho family-interacting cell polarization regulator 2 (RIPOR2) LDTP14055 C596(9.10)  LDD0209 
Rho-associated protein kinase 1 (ROCK1) LDTP05881 C1206(0.94)  LDD0078 
Rho-associated protein kinase 2 (ROCK2) LDTP01127 C804(1.06); C607(0.96)  LDD0078 
Rho-related BTB domain-containing protein 3 (RHOBTB3) LDTP01471 C143(1.03); C145(1.03); C148(0.85)  LDD0078 
Rho-related GTP-binding protein RhoB (RHOB) LDTP05000 C20(1.21)  LDD0531 
Rho-related GTP-binding protein RhoC (RHOC) LDTP02248 C16(1.68); C20(1.56); C107(1.08)  LDD0080 
Rho-related GTP-binding protein RhoD (RHOD) LDTP00215 C119(1.63)  LDD3312 
Rho-related GTP-binding protein RhoE (RND3) LDTP04928 C197(1.09); C34(1.31); C135(1.73)  LDD3310 
Rho-related GTP-binding protein RhoF (RHOF) LDTP12178 C121(0.93)  LDD0078 
Rho-related GTP-binding protein RhoG (RHOG) LDTP05195 C18(1.18); C102(0.40); C105(0.40); C157(1.17)  LDD0531 
Rho-related GTP-binding protein RhoH (RHOH) LDTP06441 C130(77.28)  LDD0209 
Rho-related GTP-binding protein RhoQ (RHOQ) LDTP02885 C163(1.02)  LDD3310 
Rho-related GTP-binding protein RhoU (RHOU) LDTP07935 C52(0.90)  LDD1492 
Rho-related GTP-binding protein RhoV (RHOV) LDTP15768 C52(2.11)  LDD2243 
Rhomboid domain-containing protein 3 (RHBDD3) LDTP18573 C208(3.38)  LDD3484 
Rhomboid-related protein 4 (RHBDD1) LDTP09492 C158(0.93)  LDD1125 
Ribitol 5-phosphate transferase FKRP (FKRP) LDTP12109 C289(2.36)  LDD3310 
Ribitol-5-phosphate xylosyltransferase 1 (RXYLT1) LDTP13842 C298(4.28)  LDD3311 
Riboflavin kinase (RFK) LDTP09998 C8(1.03)  LDD1492 
Ribokinase (RBKS) LDTP11903 C59(1.75)  LDD3378 
Ribonuclease 3 (DROSHA) LDTP12532 C1244(51.67)  LDD0209 
Ribonuclease H1 (RNASEH1) LDTP01088 C191(8.61)  LDD0209 
Ribonuclease H2 subunit A (RNASEH2A) LDTP01311 C24(0.56)  LDD0531 
Ribonuclease H2 subunit B (RNASEH2B) LDTP07175 C125(1.69)  LDD0861 
Ribonuclease H2 subunit C (RNASEH2C) LDTP09446 C34(1.28)  LDD3310 
Ribonuclease P protein subunit p14 (RPP14) LDTP01491 C31(1.31)  LDD0078 
Ribonuclease P protein subunit p20 (POP7) LDTP01317 C66(1.31)  LDD0078 
Ribonuclease P protein subunit p21 (RPP21) LDTP11970 C65(39.63); C75(39.63)  LDD0209 
Ribonuclease P protein subunit p25 (RPP25) LDTP11242 C16(1.16)  LDD0078 
Ribonuclease P protein subunit p25-like protein (RPP25L) LDTP15427 C131(0.98); C150(0.98)  LDD0078 
Ribonuclease P protein subunit p29 (POP4) LDTP01655 C147(0.95)  LDD0078 
Ribonuclease P protein subunit p30 (RPP30) LDTP05100 C180(32.62); C225(11.63)  LDD0209 
Ribonuclease P protein subunit p38 (RPP38) LDTP05099 C80(0.98)  LDD0078 
Ribonuclease P protein subunit p40 (RPP40) LDTP01318 C219(0.90); C235(0.90)  LDD0531 
Ribonuclease P/MRP protein subunit POP5 (POP5) LDTP10002 C11(2.12)  LDD3352 
Ribonuclease T2 (RNASET2) LDTP00316 C48(1.04)  LDD1492 
Ribonucleases P/MRP protein subunit POP1 (POP1) LDTP10903 C777(1.12)  LDD0078 
Ribonucleoside-diphosphate reductase large subunit (RRM1) LDTP03259 C352(1.29); C254(1.09); C425(1.05); C429(1.05)  LDD0078 
Ribonucleoside-diphosphate reductase subunit M2 (RRM2) LDTP03592 C274(33.86)  LDD0209 
Ribonucleoside-diphosphate reductase subunit M2 B (RRM2B) LDTP07989 C67(1.77)  LDD3312 
Ribose-5-phosphate isomerase (RPIA) LDTP04236 C62(1.03); C69(1.03)  LDD0078 
Ribose-phosphate pyrophosphokinase 1 (PRPS1) LDTP04882 C41(1.37); C265(0.94)  LDD0078 
Ribose-phosphate pyrophosphokinase 2 (PRPS2) LDTP02592 C233(1.50)  LDD3342 
Ribose-phosphate pyrophosphokinase 3 (PRPS1L1) LDTP03097 C91(0.92)  LDD3310 
Ribosomal biogenesis protein LAS1L (LAS1L) LDTP14074 C699(1.12); C706(1.12); C306(1.09); C316(1.09)  LDD0078 
Ribosomal oxygenase 1 (RIOX1) LDTP12003 C584(2.42)  LDD3323 
Ribosomal oxygenase 2 (RIOX2) LDTP08451 C19(0.97)  LDD0078 
Ribosomal protein S6 kinase alpha-1 (RPS6KA1) LDTP06384 C432(9.11)  LDD0209 
Ribosomal protein S6 kinase alpha-2 (RPS6KA2) LDTP06363 C578(3.66)  LDD2469 
Ribosomal protein S6 kinase alpha-3 (RPS6KA3) LDTP04471 C229(5.81); C560(9.58)  LDD0209 
Ribosomal protein S6 kinase alpha-4 (RPS6KA4) LDTP01288 C425(1.04)  LDD0078 
Ribosomal protein S6 kinase alpha-5 (RPS6KA5) LDTP01263 C304(8.84); C475(26.85)  LDD0209 
Ribosomal protein S6 kinase alpha-6 (RPS6KA6) LDTP13421 C536(1.94)  LDD3340 
Ribosomal protein S6 kinase beta-1 (RPS6KB1) LDTP03229 C240(0.90); C90(0.96)  LDD0531 
Ribosomal protein S6 kinase beta-2 (RPS6KB2) LDTP13150 C66(1.54)  LDD0080 
Ribosomal protein S6 kinase delta-1 (RPS6KC1) LDTP10796 C905(1.12); C383(0.94); C389(0.94)  LDD0078 
Ribosomal RNA small subunit methyltransferase NEP1 (EMG1) LDTP09951 C134(0.99); C66(0.97)  LDD0078 
Ribosomal RNA-processing protein 8 (RRP8) LDTP00693 C451(1.25); C317(0.84); C320(0.84)  LDD0078 
Ribosome biogenesis protein BMS1 homolog (BMS1) LDTP06188 C725(1.21); C556(1.05)  LDD0078 
Ribosome-releasing factor 2, mitochondrial (GFM2) LDTP10030 C248(1.20)  LDD0078 
Ribosyldihydronicotinamide dehydrogenase [quinone] (NQO2) LDTP02824 C223(1.01)  LDD0532 
Ribulose-phosphate 3-epimerase (RPE) LDTP10094 C23(0.92)  LDD3379 
RING finger and CHY zinc finger domain-containing protein 1 (RCHY1) LDTP10686 C183(0.93); C186(0.93); C119(0.91)  LDD0078 
RING finger protein 112 (RNF112) LDTP13590 C12(1.48)  LDD3339 
RING finger protein 122 (RNF122) LDTP12111 C111(1.13); C130(0.79); C133(0.79)  LDD1492 
RING finger protein 175 (RNF175) LDTP17706 C273(0.93); C276(0.93)  LDD0078 
RING finger protein 223 (RNF223) LDTP18963 C116(1.48)  LDD3313 
RING finger protein 37 (UBOX5) LDTP01469 C483(1.20); C486(1.20); C99(1.05)  LDD0078 
RING-box protein 2 (RNF7) LDTP13111 C61(1.06); C102(0.98); C99(0.98)  LDD0078 
RING-type E3 ubiquitin-protein ligase PPIL2 (PPIL2) LDTP05838 C304(3.28)  LDD3310 
RIPOR family member 3 (RIPOR3) LDTP18208 C648(2.01); C706(1.86)  LDD2252 
RNA 3'-terminal phosphate cyclase (RTCA) LDTP00274 C166(1.12)  LDD3312 
RNA 3'-terminal phosphate cyclase-like protein (RCL1) LDTP13898 C171(1.15)  LDD0531 
RNA 5'-monophosphate methyltransferase (BCDIN3D) LDTP08105 C97(1.03)  LDD1492 
RNA cytidine acetyltransferase (NAT10) LDTP11690 C658(1.03); C194(0.93)  LDD0078 
RNA cytosine C(5)-methyltransferase NSUN2 (NSUN2) LDTP05588 C321(1.39); C502(1.03); C599(1.01); C758(0.99)  LDD0078 
RNA demethylase ALKBH5 (ALKBH5) LDTP07547 C378(1.01)  LDD0078 
RNA exonuclease 1 homolog (REXO1) LDTP08772 C276(0.95); C282(0.95); C13(0.87); C24(0.87)  LDD0078 
RNA exonuclease 4 (REXO4) LDTP11639 C248(1.30)  LDD3330 
RNA helicase aquarius (AQR) LDTP00946 C28(1.24)  LDD0080 
RNA ligase 1 (RLIG1) LDTP19750 C294(0.99); C13(0.92)  LDD0078 
RNA N6-adenosine-methyltransferase METTL16 (METTL16) LDTP08317 C276(1.00)  LDD0078 
RNA polymerase II subunit A C-terminal domain phosphatase (CTDP1) LDTP14106 C850(1.09)  LDD0078 
RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (SSU72) LDTP12315 C192(1.55); C12(1.23)  LDD3310 
RNA polymerase-associated protein LEO1 (LEO1) LDTP09604 C530(9.70); C530(5.72)  LDD0209 
RNA pseudouridylate synthase domain-containing protein 1 (RPUSD1) LDTP18539 C131(1.13); C138(1.13); C57(0.98); C63(1.17)  LDD0531 
RNA-binding E3 ubiquitin-protein ligase MEX3C (MEX3C) LDTP07199 C319(1.53)  LDD1511 
RNA-binding protein NOB1 (NOB1) LDTP13589 C147(1.11)  LDD0078 
RNA-binding protein PNO1 (PNO1) LDTP12542 C64(0.99)  LDD0078 
RNA-splicing ligase RtcB homolog (RTCB) LDTP13992 C485(0.98)  LDD0080 
RNA/RNP complex-1-interacting phosphatase (DUSP11) LDTP01173 C325(1.13)  LDD0078 
Roquin-1 (RC3H1) LDTP07176 C815(1.90)  LDD0080 
Roquin-2 (RC3H2) LDTP12170 C771(1.27)  LDD0078 
rRNA 2'-O-methyltransferase fibrillarin (FBL) LDTP03155 C268(1.05); C99(0.85)  LDD0078 
rRNA methyltransferase 1, mitochondrial (MRM1) LDTP07416 C182(61.53)  LDD0209 
rRNA methyltransferase 2, mitochondrial (MRM2) LDTP13330 C79(1.06)  LDD0080 
rRNA methyltransferase 3, mitochondrial (MRM3) LDTP12215 C309(1.18); C290(0.90)  LDD0078 
rRNA N6-adenosine-methyltransferase METTL5 (METTL5) LDTP12525 C38(0.99)  LDD1492 
rRNA N6-adenosine-methyltransferase ZCCHC4 (ZCCHC4) LDTP11961 C64(0.89); C67(0.89); C19(0.89)  LDD0078 
rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1 (FBLL1) LDTP14364 C280(1.85)  LDD3340 
RuvB-like 1 (RUVBL1) LDTP13816 C49(1.22)  LDD0080 
RuvB-like 2 (RUVBL2) LDTP13787 C413(1.04)  LDD0080 
RWD domain-containing protein 2A (RWDD2A) LDTP20023 C196(0.91)  LDD1508 
RWD domain-containing protein 2B (RWDD2B) LDTP16976 C228(0.80); C236(0.80)  LDD0532 
RWD domain-containing protein 3 (RWDD3) LDTP14013 C80(1.83)  LDD3409 
S-acyl fatty acid synthase thioesterase, medium chain (OLAH) LDTP12654 C243(0.90)  LDD3480 
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 (TYW1) LDTP16105 C407(1.07); C416(1.07)  LDD0078 
S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1B (TYW1B) LDTP15096 C215(1.34)  LDD3314 
S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) LDTP00890 C292(0.96)  LDD0078 
S-adenosylmethionine decarboxylase proenzyme (AMD1) LDTP02918 C156(0.96)  LDD0531 
S-adenosylmethionine sensor upstream of mTORC1 (BMT2) LDTP06678 C174(2.19)  LDD3329 
S-adenosylmethionine synthase isoform type-1 (MAT1A) LDTP05237 C376(1.92)  LDD3321 
S-adenosylmethionine synthase isoform type-2 (MAT2A) LDTP03577 C104(1.09); C56(1.02); C34(1.00)  LDD0078 
S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (RSAD2) LDTP09698 C288(1.19)  LDD3412 
S-formylglutathione hydrolase (ESD) LDTP02521 C181(1.02); C56(0.91)  LDD0078 
S-methyl-5'-thioadenosine phosphorylase (MTAP) LDTP05758 C131(1.33)  LDD3310 
S-methylmethionine--homocysteine S-methyltransferase BHMT2 (BHMT2) LDTP11832 C208(0.99); C177(0.94); C192(0.94)  LDD0078 
S-phase kinase-associated protein 1 (SKP1) LDTP05052 C160(1.02); C120(0.99)  LDD0078 
S-phase kinase-associated protein 2 (SKP2) LDTP05820 C240(0.73); C255(0.73)  LDD0531 
Saccharopine dehydrogenase-like oxidoreductase (SCCPDH) LDTP15484 C238(0.98)  LDD0078 
Sarcalumenin (SRL) LDTP15280 C670(0.73)  LDD3351 
Sarcoma antigen 1 (SAGE1) LDTP18490 C82(0.84)  LDD3386 
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (ATP2A1) LDTP00503 C471(1.11); C614(2.50); C364(1.22)  LDD3401 
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2) LDTP02860 C364(0.99)  LDD0078 
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (ATP2A3) LDTP09976 C636(4.54); C364(1.70)  LDD3310 
Sarcosine dehydrogenase, mitochondrial (SARDH) LDTP13506 C744(7.86)  LDD0209 
Scavenger receptor class A member 5 (SCARA5) LDTP07770 C418(3.08)  LDD2256 
Scavenger receptor cysteine-rich type 1 protein M160 (CD163L1) LDTP12462 C524(2.28)  LDD2253 
Schlafen family member 11 (SLFN11) LDTP08156 C260(18.11); C150(7.39); C340(5.78); C126(579.08)  LDD0209 
Schlafen family member 12-like (SLFN12L) LDTP17329 C622(2.32)  LDD3310 
Schlafen family member 13 (SLFN13) LDTP07319 C631(2.19)  LDD3310 
Schlafen family member 5 (SLFN5) LDTP17014 C114(1.66); C601(1.21); C610(1.21)  LDD0078 
SCY1-like protein 2 (SCYL2) LDTP07529 C511(81.92)  LDD0209 
SEC23-interacting protein (SEC23IP) LDTP14311 C457(82.98)  LDD0209 
Secernin-1 (SCRN1) LDTP05640 C310(0.83); C344(1.09)  LDD3312 
Secernin-2 (SCRN2) LDTP15725 C277(2.07)  LDD3411 
Secernin-3 (SCRN3) LDTP17022 C143(0.95)  LDD0078 
Secretion-regulating guanine nucleotide exchange factor (SERGEF) LDTP13232 C189(2.08); C157(1.49)  LDD0080 
Sedoheptulokinase (SHPK) LDTP13289 C38(0.76)  LDD0531 
Selenide, water dikinase 1 (SEPHS1) LDTP04328 C71(0.90)  LDD0078 
Selenide, water dikinase 2 (SEPHS2) LDTP10917 C122(1.10)  LDD1508 
Selenocysteine lyase (SCLY) LDTP10406 C22(2.85)  LDD0080 
Selenocysteine-specific elongation factor (EEFSEC) LDTP14723 C442(1.66); C130(0.88); C138(0.88)  LDD0078 
Sentrin-specific protease 1 (SENP1) LDTP12983 C60(1.26)  LDD0078 
Sentrin-specific protease 2 (SENP2) LDTP12218 C283(2.65)  LDD3312 
Sentrin-specific protease 3 (SENP3) LDTP11929 C183(1.07); C184(1.07)  LDD0078 
Sentrin-specific protease 5 (SENP5) LDTP10391 C713(1.01); C721(1.01); C196(0.99); C199(0.99)  LDD0078 
Sentrin-specific protease 6 (SENP6) LDTP11638 C379(1.93)  LDD0080 
Sentrin-specific protease 7 (SENP7) LDTP11078 C221(1.05)  LDD0533 
Sentrin-specific protease 8 (SENP8) LDTP10547 C64(1.08)  LDD1492 
Separin (ESPL1) LDTP06175 C127(0.86); C131(0.86)  LDD0078 
Sepiapterin reductase (SPR) LDTP03730 C159(0.90)  LDD0078 
Septin-1 (SEPTIN1) LDTP09736 C260(11.60)  LDD0209 
Septin-10 (SEPTIN10) LDTP12987 C77(2.07)  LDD3332 
Septin-11 (SEPTIN11) LDTP12667 C293(1.98)  LDD3310 
Septin-2 (SEPTIN2) LDTP06279 C146(1.35)  LDD3310 
Septin-4 (SEPTIN4) LDTP00711 C426(1.65)  LDD3332 
Septin-5 (SEPTIN5) LDTP10957 C193(591.35)  LDD0209 
Septin-6 (SEPTIN6) LDTP06049 C432(1.06); C432(1.05)  LDD0078 
Septin-7 (SEPTIN7) LDTP06513 C204(1.15); C280(1.12)  LDD0531 
Septin-8 (SEPTIN8) LDTP09812 C49(3.29)  LDD3312 
Septin-9 (SEPTIN9) LDTP13272 C248(1.43); C375(1.13); C531(1.13); C531(1.00)  LDD0078 
Serine beta-lactamase-like protein LACTB, mitochondrial (LACTB) LDTP05183 C476(1.06)  LDD0078 
Serine dehydratase-like (SDSL) LDTP10341 C241(0.97); C245(0.97)  LDD0078 
Serine hydrolase RBBP9 (RBBP9) LDTP01338 C39(0.59)  LDD0563 
Serine hydrolase-like protein 2 (SERHL2) LDTP15996 C49(3.88)  LDD3493 
Serine hydroxymethyltransferase, cytosolic (SHMT1) LDTP03688 C204(1.16); C380(1.04); C384(1.04)  LDD0078 
Serine hydroxymethyltransferase, mitochondrial (SHMT2) LDTP03689 C80(1.56); C412(1.25)  LDD0080 
Serine palmitoyltransferase 1 (SPTLC1) LDTP00597 C192(1.12); C438(1.00); C133(0.99)  LDD0078 
Serine palmitoyltransferase 2 (SPTLC2) LDTP00598 C188(1.17)  LDD0078 
Serine palmitoyltransferase 3 (SPTLC3) LDTP12647 C91(2.10)  LDD3332 
Serine protease 23 (PRSS23) LDTP14527 C176(2.17); C370(3.18)  LDD3310 
Serine protease 33 (PRSS33) LDTP15516 C28(2.98)  LDD3378 
Serine protease 56 (PRSS56) LDTP02414 C388(1.63); C256(1.56)  LDD3343 
Serine protease 57 (PRSS57) LDTP07685 C59(2.80)  LDD3333 
Serine protease FAM111A (FAM111A) LDTP10710 C36(44.59); C290(5.16)  LDD0209 
Serine protease FAM111B (FAM111B) LDTP07637 C351(1.02); C212(0.90)  LDD0078 
Serine protease HTRA1 (HTRA1) LDTP09855 C155(1.13)  LDD0078 
Serine protease HTRA2, mitochondrial (HTRA2) LDTP00773 C71(0.94)  LDD1492 
Serine protease HTRA3 (HTRA3) LDTP05182 C126(2.60)  LDD2412 
Serine racemase (SRR) LDTP11646 C217(0.84)  LDD0078 
Serine--tRNA ligase, cytoplasmic (SARS1) LDTP04265 C438(5.88); C300(1.95); C398(1.18)  LDD0080 
Serine--tRNA ligase, mitochondrial (SARS2) LDTP12319 C328(12.04)  LDD0209 
Serine-protein kinase ATM (ATM) LDTP05822 C384(1.04); C2021(0.98)  LDD0078 
Serine/threonine-protein kinase 10 (STK10) LDTP01420 C487(1.10); C491(1.10)  LDD0078 
Serine/threonine-protein kinase 16 (STK16) LDTP01298 C84(6.93)  LDD0204 
Serine/threonine-protein kinase 17A (STK17A) LDTP13196 C62(1.20)  LDD0078 
Serine/threonine-protein kinase 17B (STK17B) LDTP01412 C330(1.40); C334(1.40); C190(1.14)  LDD0078 
Serine/threonine-protein kinase 24 (STK24) LDTP14240 C394(1.84)  LDD0080 
Serine/threonine-protein kinase 25 (STK25) LDTP00299 C357(1.31)  LDD0531 
Serine/threonine-protein kinase 26 (STK26) LDTP13031 C410(1.38)  LDD0080 
Serine/threonine-protein kinase 3 (STK3) LDTP05779 C77(0.91)  LDD0531 
Serine/threonine-protein kinase 32B (STK32B) LDTP16139 C38(1.68)  LDD3342 
Serine/threonine-protein kinase 32C (STK32C) LDTP08262 C129(1.41)  LDD3340 
Serine/threonine-protein kinase 33 (STK33) LDTP11493 C467(1.41); C13(2.15); C16(2.15)  LDD0080 
Serine/threonine-protein kinase 35 (STK35) LDTP09451 C267(0.83); C532(1.12)  LDD0533 
Serine/threonine-protein kinase 36 (STK36) LDTP12527 C442(0.93); C447(0.93)  LDD0078 
Serine/threonine-protein kinase 38 (STK38) LDTP06339 C234(11.00)  LDD0080 
Serine/threonine-protein kinase 38-like (STK38L) LDTP13866 C235(16.63)  LDD0209 
Serine/threonine-protein kinase 4 (STK4) LDTP05733 C80(1.49)  LDD3331 
Serine/threonine-protein kinase A-Raf (ARAF) LDTP02493 C538(1.26)  LDD0078 
Serine/threonine-protein kinase ATR (ATR) LDTP05914 C1042(0.99); C1044(0.99); C1721(0.93); C790(0.91)  LDD0078 
Serine/threonine-protein kinase B-raf (BRAF) LDTP02760 C261(3.97); C264(3.97)  LDD0080 
Serine/threonine-protein kinase BRSK1 (BRSK1) LDTP09427 C311(1.38)  LDD2469 
Serine/threonine-protein kinase BRSK2 (BRSK2) LDTP08550 C311(1.01); C39(1.17); C42(1.17)  LDD1492 
Serine/threonine-protein kinase Chk1 (CHEK1) LDTP00422 C408(1.08)  LDD0078 
Serine/threonine-protein kinase Chk2 (CHEK2) LDTP01754 C362(4.99); C231(22.30); C539(10.14); C121(26.41)  LDD0209 
Serine/threonine-protein kinase D1 (PRKD1) LDTP06328 C726(2.49); C92(3.67)  LDD0080 
Serine/threonine-protein kinase D2 (PRKD2) LDTP11548 C180(2.89); C188(2.89); C84(6.50); C217(1.12)  LDD0080 
Serine/threonine-protein kinase D3 (PRKD3) LDTP01422 C100(1.03)  LDD0078 
Serine/threonine-protein kinase DCLK1 (DCLK1) LDTP00530 C131(1.23)  LDD3332 
Serine/threonine-protein kinase DCLK2 (DCLK2) LDTP08887 C720(2.74)  LDD3417 
Serine/threonine-protein kinase DCLK3 (DCLK3) LDTP11590 C69(0.98)  LDD2302 
Serine/threonine-protein kinase greatwall (MASTL) LDTP10367 C534(1.02); C540(1.02)  LDD0078 
Serine/threonine-protein kinase haspin (HASPIN) LDTP09535 C300(1.07)  LDD0078 
Serine/threonine-protein kinase LATS1 (LATS1) LDTP01691 C850(1.19)  LDD0078 
Serine/threonine-protein kinase LATS2 (LATS2) LDTP12523 C905(1.96)  LDD3368 
Serine/threonine-protein kinase LMTK2 (LMTK2) LDTP08557 C1379(1.07); C1384(1.07)  LDD0078 
Serine/threonine-protein kinase MARK1 (MARK1) LDTP12968 C217(1.70)  LDD0080 
Serine/threonine-protein kinase MARK2 (MARK2) LDTP07930 C553(13.77)  LDD0204 
Serine/threonine-protein kinase MRCK alpha (CDC42BPA) LDTP07212 C912(2.20)  LDD3316 
Serine/threonine-protein kinase MRCK beta (CDC42BPB) LDTP14155 C1039(0.94); C1042(0.94); C1517(0.92); C1122(0.86)  LDD0078 
Serine/threonine-protein kinase MRCK gamma (CDC42BPG) LDTP07375 C217(1.04); C513(1.05)  LDD0531 
Serine/threonine-protein kinase mTOR (MTOR) LDTP03980 C1214(1.16); C674(1.00); C1303(0.92)  LDD0078 
Serine/threonine-protein kinase N1 (PKN1) LDTP06535 C782(2.08)  LDD3332 
Serine/threonine-protein kinase N2 (PKN2) LDTP06536 C338(0.96)  LDD0078 
Serine/threonine-protein kinase N3 (PKN3) LDTP07546 C131(1.00); C840(1.27)  LDD0531 
Serine/threonine-protein kinase Nek1 (NEK1) LDTP10708 C1223(154.18)  LDD0209 
Serine/threonine-protein kinase Nek10 (NEK10) LDTP07863 C639(2.68)  LDD3439 
Serine/threonine-protein kinase Nek2 (NEK2) LDTP04489 C335(1.19)  LDD3333 
Serine/threonine-protein kinase Nek3 (NEK3) LDTP04490 C504(1.29)  LDD0533 
Serine/threonine-protein kinase Nek4 (NEK4) LDTP04491 C664(1.62)  LDD0080 
Serine/threonine-protein kinase Nek6 (NEK6) LDTP12225 C258(113.05); C64(17.02)  LDD0209 
Serine/threonine-protein kinase Nek7 (NEK7) LDTP09464 C247(1.16); C298(1.13); C53(1.05)  LDD0078 
Serine/threonine-protein kinase Nek9 (NEK9) LDTP09412 C11(1.06); C25(1.06); C260(1.05); C878(0.97)  LDD0078 
Serine/threonine-protein kinase NLK (NLK) LDTP13108 C281(0.88)  LDD1093 
Serine/threonine-protein kinase OSR1 (OXSR1) LDTP01664 C271(1.26)  LDD0080 
Serine/threonine-protein kinase PAK 1 (PAK1) LDTP05769 C373(1.43)  LDD3312 
Serine/threonine-protein kinase PAK 2 (PAK2) LDTP05776 C390(0.84)  LDD0078 
Serine/threonine-protein kinase PAK 4 (PAK4) LDTP01751 C462(0.75); C58(0.82)  LDD0531 
Serine/threonine-protein kinase PAK 5 (PAK5) LDTP13029 C590(1.26)  LDD0531 
Serine/threonine-protein kinase PAK 6 (PAK6) LDTP12436 C192(1.85); C198(1.85)  LDD0532 
Serine/threonine-protein kinase pim-1 (PIM1) LDTP02564 C17(2.15)  LDD2324 
Serine/threonine-protein kinase PLK1 (PLK1) LDTP04555 C573(1.20); C212(1.07)  LDD0078 
Serine/threonine-protein kinase PLK2 (PLK2) LDTP12861 C18(2.44)  LDD2268 
Serine/threonine-protein kinase PLK3 (PLK3) LDTP11914 C77(2.81)  LDD2630 
Serine/threonine-protein kinase PRP4 homolog (PRPF4B) LDTP05911 C962(0.92)  LDD0078 
Serine/threonine-protein kinase receptor R3 (ACVRL1) LDTP03833 C389(1.17)  LDD3380 
Serine/threonine-protein kinase RIO1 (RIOK1) LDTP11129 C495(2.00); C506(2.00)  LDD0080 
Serine/threonine-protein kinase RIO2 (RIOK2) LDTP11299 C358(1.02); C365(1.02); C367(1.02)  LDD0078 
Serine/threonine-protein kinase RIO3 (RIOK3) LDTP00412 C171(1.10); C346(1.06)  LDD0078 
Serine/threonine-protein kinase Sgk1 (SGK1) LDTP00189 C77(4.93)  LDD3419 
Serine/threonine-protein kinase Sgk3 (SGK3) LDTP10136 C308(20.00)  LDD0080 
Serine/threonine-protein kinase SIK2 (SIK2) LDTP11716 C697(1.13); C701(1.13); C133(0.90)  LDD0078 
Serine/threonine-protein kinase SIK3 (SIK3) LDTP13881 C165(1.05); C63(0.79)  LDD0531 
Serine/threonine-protein kinase SMG1 (SMG1) LDTP10717 C3186(1.54)  LDD0080 
Serine/threonine-protein kinase STK11 (STK11) LDTP06486 C418(1.91)  LDD3323 
Serine/threonine-protein kinase TAO1 (TAOK1) LDTP07975 C730(1.10)  LDD0078 
Serine/threonine-protein kinase TAO2 (TAOK2) LDTP13523 C261(1.22); C623(0.76); C643(1.09)  LDD0531 
Serine/threonine-protein kinase TAO3 (TAOK3) LDTP11829 C257(1.70); C795(1.42); C730(1.54)  LDD3312 
Serine/threonine-protein kinase TBK1 (TBK1) LDTP13270 C267(19.75)  LDD0209 
Serine/threonine-protein kinase tousled-like 1 (TLK1) LDTP13455 C81(2.72)  LDD3364 
Serine/threonine-protein kinase tousled-like 2 (TLK2) LDTP08226 C172(1.24); C195(1.24); C40(0.88)  LDD0078 
Serine/threonine-protein kinase ULK1 (ULK1) LDTP01202 C552(4.21)  LDD0080 
Serine/threonine-protein kinase ULK3 (ULK3) LDTP07577 C186(0.93)  LDD0531 
Serine/threonine-protein kinase ULK4 (ULK4) LDTP10160 C141(4.14)  LDD2268 
Serine/threonine-protein kinase VRK1 (VRK1) LDTP11030 C50(2.22); C205(1.71)  LDD0080 
Serine/threonine-protein kinase VRK2 (VRK2) LDTP08378 C373(1.96); C194(1.66)  LDD0080 
Serine/threonine-protein kinase VRK3 (VRK3) LDTP08485 C418(0.88)  LDD0532 
Serine/threonine-protein kinase WNK1 (WNK1) LDTP11909 C888(1.36)  LDD3310 
Serine/threonine-protein kinase WNK2 (WNK2) LDTP14009 C433(13.16); C435(13.16); C1153(1.04)  LDD0080 
Serine/threonine-protein kinase WNK3 (WNK3) LDTP11471 C52(4.09)  LDD3332 
Serine/threonine-protein kinase WNK4 (WNK4) LDTP10447 C77(4.10)  LDD3413 
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2) LDTP07923 C816(2.72)  LDD3319 
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PPP2R2A) LDTP05046 C408(1.87)  LDD3312 
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform (PPP2R2B) LDTP05232 C364(1.84)  LDD3311 
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PPP2R2D) LDTP15060 C340(4.26)  LDD0209 
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PPP2R5A) LDTP06336 C72(0.84); C78(0.48); C79(0.48)  LDD0531 
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform (PPP2R5B) LDTP06337 C84(0.96)  LDD1507 
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PPP2R5D) LDTP06199 C484(1.56)  LDD0080 
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform (PPP2R5E) LDTP06546 C106(0.96); C121(0.93)  LDD0531 
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PPP2R5C) LDTP05841 C410(3.36)  LDD3310 
Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PPP2R1A) LDTP03522 C377(1.05); C294(1.00); C148(0.88); C317(0.85)  LDD0078 
Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PPP2R1B) LDTP03523 C160(6.58); C389(31.55)  LDD0209 
Serine/threonine-protein phosphatase 2A activator (PTPA) LDTP06343 C202(1.30)  LDD0080 
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PPP2CA) LDTP05064 C251(1.14); C266(0.91)  LDD0078 
Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PPP2CB) LDTP04998 C196(9.02)  LDD0209 
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PPP2R3A) LDTP05479 C571(3.30)  LDD3325 
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PPP2R3B) LDTP14142 C35(6.68)  LDD0204 
Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (PPP2R3C) LDTP10021 C17(3.53)  LDD0080 
Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (PPP3CB) LDTP02839 C86(2.72)  LDD3310 
Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (PPP3CC) LDTP04184 C224(1.69)  LDD3403 
Serine/threonine-protein phosphatase 4 catalytic subunit (PPP4C) LDTP04870 C193(5.42)  LDD0209 
Serine/threonine-protein phosphatase 4 regulatory subunit 3A (PPP4R3A) LDTP07417 C554(1.14)  LDD0531 
Serine/threonine-protein phosphatase 4 regulatory subunit 3B (PPP4R3B) LDTP07034 C90(1.99)  LDD0080 
Serine/threonine-protein phosphatase 5 (PPP5C) LDTP04554 C11(1.02); C77(0.94)  LDD0078 
Serine/threonine-protein phosphatase 6 catalytic subunit (PPP6C) LDTP00333 C192(7.27)  LDD0209 
Serine/threonine-protein phosphatase CPPED1 (CPPED1) LDTP11107 C54(16.87)  LDD0209 
Serine/threonine-protein phosphatase PGAM5, mitochondrial (PGAM5) LDTP10399 C168(1.10)  LDD0078 
Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PPP1CA) LDTP04959 C202(4.72); C172(5.46)  LDD0209 
Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PPP1CB) LDTP04960 C244(4.43)  LDD0204 
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PPP1CC) LDTP03819 C73(1.48)  LDD3310 
Serine/threonine-protein phosphatase with EF-hands 1 (PPEF1) LDTP00452 C458(1.53)  LDD3433 
Serine/threonine/tyrosine-interacting protein (STYX) LDTP09576 C62(0.96)  LDD0531 
Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1) LDTP14262 C284(0.82)  LDD0531 
Serine/threonine/tyrosine-interacting-like protein 2 (STYXL2) LDTP15049 C534(3.24)  LDD3440 
Serum paraoxonase/arylesterase 1 (PON1) LDTP03382 C496(2.52)  LDD3314 
Serum paraoxonase/arylesterase 2 (PON2) LDTP06333 C42(3.56); C283(3.18)  LDD3312 
Serum paraoxonase/lactonase 3 (PON3) LDTP06334 C220(2.11)  LDD3319 
Sestrin-1 (SESN1) LDTP14283 C470(2.41); C345(2.48); C414(1.75)  LDD3377 
Sestrin-2 (SESN2) LDTP04806 C430(2.06)  LDD3323 
Sestrin-3 (SESN3) LDTP04807 C442(0.99)  LDD3433 
SET and MYND domain-containing protein 4 (SMYD4) LDTP08664 C597(1.42); C602(1.42); C599(1.42)  LDD0080 
SET domain-containing protein 9 (SETD9) LDTP17799 C242(1.35)  LDD3410 
Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2L) LDTP13126 C581(1.31); C207(1.02); C362(0.96)  LDD0078 
Short transient receptor potential channel 4-associated protein (TRPC4AP) LDTP09501 C630(5.68)  LDD0209 
Short-chain dehydrogenase/reductase 3 (DHRS3) LDTP01349 C294(1.13)  LDD0078 
Short-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADS) LDTP02833 C246(1.30); C151(1.09)  LDD3310 
Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (ACADSB) LDTP04072 C175(1.15)  LDD0080 
Sialate O-acetylesterase (SIAE) LDTP12135 C487(1.73)  LDD0532 
Sialic acid synthase (NANS) LDTP12473 C287(0.98)  LDD0078 
Sialidase-1 (NEU1) LDTP10884 C289(1.80)  LDD3311 
Sialidase-3 (NEU3) LDTP13747 C136(1.94)  LDD0080 
Sialidase-4 (NEU4) LDTP09663 C224(2.95)  LDD2359 
Signal peptidase complex subunit 2 (SPCS2) LDTP06270 C17(5.30); C26(1.35)  LDD0080 
Signal peptide peptidase-like 2A (SPPL2A) LDTP09395 C503(1.40)  LDD3332 
Signal peptide peptidase-like 2B (SPPL2B) LDTP09394 C165(1.12)  LDD3337 
Signal peptide peptidase-like 3 (SPPL3) LDTP09393 C298(0.87)  LDD0078 
Signal recognition particle subunit SRP54 (SRP54) LDTP04890 C136(1.26)  LDD0080 
Single-strand selective monofunctional uracil DNA glycosylase (SMUG1) LDTP06916 C73(1.92)  LDD3310 
Single-stranded DNA cytosine deaminase (AICDA) LDTP11666 C30(3.48); C116(3.66)  LDD3372 
Small ribosomal subunit protein uS3 (RPS3) LDTP03223 C97(0.94); C134(0.86)  LDD0078 
Small RNA 2'-O-methyltransferase (HENMT1) LDTP07153 C56(142.26); C356(15.39)  LDD0209 
Sodium/potassium-transporting ATPase subunit alpha-1 (ATP1A1) LDTP02067 C464(1.13); C211(1.05)  LDD0080 
Sodium/potassium-transporting ATPase subunit alpha-2 (ATP1A2) LDTP04392 C436(3.78)  LDD3310 
Sodium/potassium-transporting ATPase subunit alpha-3 (ATP1A3) LDTP02671 C521(3.60); C62(1.05)  LDD3311 
Sodium/potassium-transporting ATPase subunit beta-2 (ATP1B2) LDTP02726 C129(2.06); C10(4.22)  LDD2469 
Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D (SSC5D) LDTP00037 C29(5.64)  LDD3410 
Sorbitol dehydrogenase (SORD) LDTP05258 C45(1.01); C350(1.00); C120(0.98); C130(0.98)  LDD0078 
Spastin (SPAST) LDTP13137 C220(1.08)  LDD0078 
Speckle targeted PIP5K1A-regulated poly(A) polymerase (TUT1) LDTP11980 C669(2.87); C670(2.87)  LDD0080 
Speckle-type POZ protein (SPOP) LDTP00869 C361(4.64)  LDD0209 
Spermidine synthase (SRM) LDTP03008 C25(0.95)  LDD0078 
Spermine oxidase (SMOX) LDTP12719 C409(1.40)  LDD3421 
Spermine synthase (SMS) LDTP04530 C337(1.08); C237(1.07)  LDD0531 
Sphingomyelin phosphodiesterase (SMPD1) LDTP02896 C584(1.24); C588(1.24)  LDD0532 
Sphingomyelin phosphodiesterase 2 (SMPD2) LDTP01081 C304(26.05)  LDD0209 
Sphingomyelin phosphodiesterase 4 (SMPD4) LDTP12776 C812(3.30)  LDD3311 
Sphingosine kinase 1 (SPHK1) LDTP12817 C366(2.48); C402(3.68)  LDD3332 
Sphingosine kinase 2 (SPHK2) LDTP12490 C262(1.83)  LDD3314 
Sphingosine-1-phosphate lyase 1 (SGPL1) LDTP01613 C34(3.42)  LDD3313 
Sphingosine-1-phosphate phosphatase 1 (SGPP1) LDTP11361 C392(1.05); C399(0.99)  LDD0531 
Spliceosome RNA helicase DDX39B (DDX39B) LDTP05991 C315(1.53); C180(2.01)  LDD3311 
Spliceosome-associated protein CWC27 homolog (CWC27) LDTP07688 C164(3.37)  LDD3312 
SPRY domain-containing SOCS box protein 3 (SPSB3) LDTP15129 C321(0.74)  LDD0531 
Squalene monooxygenase (SQLE) LDTP06142 C491(0.91)  LDD0531 
Squalene synthase (FDFT1) LDTP03842 C374(0.97)  LDD0078 
SRSF protein kinase 1 (SRPK1) LDTP10809 C359(3.35)  LDD3312 
SRSF protein kinase 2 (SRPK2) LDTP05107 C691(5.02); C673(3.21)  LDD3311 
SRSF protein kinase 3 (SRPK3) LDTP13692 C320(0.93)  LDD3401 
STAM-binding protein (STAMBP) LDTP01641 C282(0.55); C286(0.55)  LDD0533 
Staphylococcal nuclease domain-containing protein 1 (SND1) LDTP07929 C31(1.25)  LDD0078 
STE20-like serine/threonine-protein kinase (SLK) LDTP11819 C1153(1.02); C358(1.00); C1212(0.95)  LDD0078 
STE20-related kinase adapter protein alpha (STRADA) LDTP07992 C298(1.30)  LDD3376 
STE20-related kinase adapter protein beta (STRADB) LDTP11624 C406(1.04)  LDD1507 
STE20/SPS1-related proline-alanine-rich protein kinase (STK39) LDTP13203 C237(0.98); C99(0.93); C525(0.87)  LDD0078 
Stearoyl-CoA desaturase 5 (SCD5) LDTP08171 C14(1.09)  LDD0532 
Sterol 26-hydroxylase, mitochondrial (CYP27A1) LDTP05348 C427(2.04)  LDD3410 
Sterol carrier protein 2 (SCP2) LDTP03163 C71(1.06)  LDD0080 
Sterol O-acyltransferase 1 (SOAT1) LDTP03769 C92(1.14)  LDD0078 
Sterol O-acyltransferase 2 (SOAT2) LDTP01347 C94(0.90)  LDD3311 
Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (NSDHL) LDTP06455 C86(1.06); C104(0.98)  LDD0078 
Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMCHD1) LDTP00101 C897(1.10); C1656(1.06); C1235(1.03); C1710(1.03)  LDD0078 
Structure-specific endonuclease subunit SLX1 (SLX1A; SLX1B) LDTP11061 C237(0.91)  LDD1492 
Succinate dehydrogenase flavoprotein subunit, mitochondrial (SDHA) LDTP03572 C438(1.04); C443(1.04); C89(0.98); C536(0.91)  LDD0078 
Succinate dehydrogenase iron-sulfur subunit, mitochondrial (SDHB) LDTP03139 C249(2.48)  LDD0080 
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (SUCLA2) LDTP13077 C152(3.99); C158(3.99)  LDD0080 
Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (SUCLG1) LDTP04566 C172(0.87); C181(0.87)  LDD0078 
Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (SUCLG2) LDTP10415 C255(1.27); C162(0.86)  LDD3312 
Succinate-semialdehyde dehydrogenase, mitochondrial (ALDH5A1) LDTP04438 C110(0.95); C285(1.50); C515(0.89); C544(0.86)  LDD3312 
Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (OXCT1) LDTP04715 C504(6.05)  LDD0209 
Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial (OXCT2) LDTP15912 C453(0.76)  LDD1492 
Sucrase-isomaltase, intestinal (SI) LDTP02725 C545(1.59)  LDD3395 
Sulfhydryl oxidase 1 (QSOX1) LDTP00260 C509(1.21); C512(1.21)  LDD0078 
Sulfhydryl oxidase 2 (QSOX2) LDTP07813 C476(0.93); C536(0.85); C539(0.85)  LDD0078 
Sulfide:quinone oxidoreductase, mitochondrial (SQOR) LDTP14278 C379(0.82)  LDD0533 
Sulfiredoxin-1 (SRXN1) LDTP11469 C99(1.29)  LDD0078 
Sulfite oxidase, mitochondrial (SUOX) LDTP04451 C508(2.91)  LDD3369 
Sulfotransferase 1A2 (SULT1A2) LDTP04350 C293(1.77)  LDD3310 
Sulfotransferase 1A4 (SULT1A4) LDTP02431 C287(1.03)  LDD1492 
Sulfotransferase 1B1 (SULT1B1) LDTP00842 C22(2.45)  LDD3373 
Sulfotransferase 1C2 (SULT1C2) LDTP00255 C135(1.48)  LDD3368 
Sulfotransferase 1C4 (SULT1C4) LDTP01343 C32(2.27)  LDD3442 
Sulfotransferase 1E1 (SULT1E1) LDTP04324 C83(1.78)  LDD3337 
Sulfotransferase 2A1 (SULT2A1) LDTP05493 C199(1.90)  LDD3424 
Sulfotransferase 2B1 (SULT2B1) LDTP00213 C225(2.07)  LDD3319 
Sulfotransferase 4A1 (SULT4A1) LDTP11099 C218(1.32)  LDD3340 
SUMO-activating enzyme subunit 1 (SAE1) LDTP13107 C134(1.02)  LDD0080 
SUMO-activating enzyme subunit 2 (UBA2) LDTP13156 C158(0.99); C161(0.99); C30(0.92); C432(0.90)  LDD0078 
SUMO-conjugating enzyme UBC9 (UBE2I) LDTP05062 C43(0.97)  LDD0593 
SUMO-specific isopeptidase USPL1 (USPL1) LDTP07267 C218(1.01); C226(1.01)  LDD0078 
Superkiller complex protein 2 (SKIC2) LDTP06399 C247(0.92)  LDD0078 
Superoxide dismutase [Cu-Zn] (SOD1) LDTP01776 C147(1.12)  LDD0613 
Superoxide dismutase [Mn], mitochondrial (SOD2) LDTP02019 C7(2.03)  LDD3318 
Suppressor of tumorigenicity 14 protein (ST14) LDTP14182 C340(1.38)  LDD0532 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (SMARCAD1) LDTP11931 C951(10.12); C772(12.54)  LDD0209 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5) LDTP00931 C165(0.92)  LDD0078 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (SMARCAL1) LDTP12889 C108(1.62)  LDD3310 
Synaptic vesicle membrane protein VAT-1 homolog (VAT1) LDTP10887 C86(2.09); C50(1.37)  LDD0078 
Synaptic vesicle membrane protein VAT-1 homolog-like (VAT1L) LDTP18442 C78(1.22)  LDD3334 
Synaptobrevin homolog YKT6 (YKT6) LDTP00654 C66(1.32)  LDD0532 
Synaptojanin-1 (SYNJ1) LDTP00764 C1531(1.73)  LDD0080 
Synaptojanin-2 (SYNJ2) LDTP00522 C178(1.04); C63(0.96)  LDD0078 
T-cell differentiation antigen CD6 (CD6) LDTP03524 C155(5.52)  LDD0204 
Tafazzin (TAFAZZIN) LDTP06586 C79(2.55)  LDD3452 
TATA box-binding protein-associated factor RNA polymerase I subunit C (TAF1C) LDTP06418 C621(1.01); C636(1.01)  LDD0078 
TATA box-binding protein-associated factor RNA polymerase I subunit D (TAF1D) LDTP11956 C36(0.94)  LDD1492 
TATA-binding protein-associated factor 172 (BTAF1) LDTP00502 C1303(0.88); C1310(0.88); C936(0.86); C939(0.86)  LDD0078 
Tau-tubulin kinase 2 (TTBK2) LDTP07427 C90(1.91)  LDD3433 
TBC domain-containing protein kinase-like protein (TBCK) LDTP09488 C296(3.24); C309(3.24)  LDD0080 
Telomerase RNA component interacting RNase (TRIR) LDTP11055 C165(1.06)  LDD0078 
Telomerase-binding protein EST1A (SMG6) LDTP08246 C958(0.96); C963(0.96); C278(0.85)  LDD0078 
Tensin-1 (TNS1) LDTP12189 C302(3.50)  LDD3455 
Tensin-2 (TNS2) LDTP07286 C819(1.38)  LDD3312 
Tensin-3 (TNS3) LDTP07317 C928(1.10); C842(1.04); C1241(1.02); C615(0.95)  LDD0078 
Tensin-4 (TNS4) LDTP08723 C427(1.19); C409(1.14); C40(1.03); C59(1.03)  LDD0078 
Terminal nucleotidyltransferase 4A (TENT4A) LDTP07271 C77(0.80)  LDD0531 
Terminal nucleotidyltransferase 4B (TENT4B) LDTP09124 C442(1.44); C466(1.44)  LDD0078 
Terminal nucleotidyltransferase 5A (TENT5A) LDTP10422 C214(3.10)  LDD3332 
Terminal nucleotidyltransferase 5C (TENT5C) LDTP07242 C88(1.16)  LDD3336 
Terminal uridylyltransferase 4 (TUT4) LDTP07171 C204(1.18); C766(0.90); C771(0.90)  LDD0078 
Terminal uridylyltransferase 7 (TUT7) LDTP07256 C343(1.24); C690(1.08)  LDD0078 
Testisin (PRSS21) LDTP14271 C33(1.10); C234(0.90); C244(0.90)  LDD0078 
TGF-beta receptor type-1 (TGFBR1) LDTP03823 C465(5.73)  LDD3336 
TGF-beta receptor type-2 (TGFBR2) LDTP03838 C558(2.53)  LDD3316 
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (TAB1) LDTP06460 C235(1.10); C62(0.89)  LDD0531 
Thialysine N-epsilon-acetyltransferase (SAT2) LDTP10290 C14(13.79)  LDD0209 
Thiamine-triphosphatase (THTPA) LDTP11217 C228(1.30)  LDD3338 
Thimet oligopeptidase (THOP1) LDTP04542 C350(1.17); C682(1.08); C18(0.98); C7(0.98)  LDD0078 
Thiol S-methyltransferase TMT1A (TMT1A) LDTP12056 C79(1.48)  LDD0080 
Thiol S-methyltransferase TMT1B (TMT1B) LDTP15155 C202(1.06); C203(1.06)  LDD0078 
Thiopurine S-methyltransferase (TPMT) LDTP04428 C165(1.05)  LDD0078 
Thioredoxin (TXN) LDTP02502 C73(1.01); C62(0.94); C69(0.94); C32(0.85)  LDD0078 
Thioredoxin domain-containing protein 11 (TXNDC11) LDTP07604 C770(1.00)  LDD0531 
Thioredoxin domain-containing protein 12 (TXNDC12) LDTP01707 C66(1.06); C69(1.06)  LDD0078 
Thioredoxin domain-containing protein 16 (TXNDC16) LDTP13058 C51(1.33)  LDD0080 
Thioredoxin domain-containing protein 5 (TXNDC5) LDTP09067 C121(1.28); C128(1.28)  LDD0080 
Thioredoxin reductase 1, cytoplasmic (TXNRD1) LDTP06658 C339(1.36); C209(1.28); C214(1.21); C647(1.06)  LDD0078 
Thioredoxin reductase 2, mitochondrial (TXNRD2) LDTP12297 C522(1.68)  LDD0080 
Thioredoxin reductase 3 (TXNRD3) LDTP08299 C333(1.08)  LDD3316 
Thioredoxin, mitochondrial (TXN2) LDTP10973 C90(0.97)  LDD0078 
Thioredoxin-dependent peroxide reductase, mitochondrial (PRDX3) LDTP03515 C229(1.10)  LDD0531 
Thioredoxin-like protein 1 (TXNL1) LDTP00758 C135(1.20); C137(1.20)  LDD0078 
Thioredoxin-like protein 4A (TXNL4A) LDTP05187 C38(1.23)  LDD0531 
Thioredoxin-related transmembrane protein 1 (TMX1) LDTP11874 C106(0.74)  LDD0531 
Thiosulfate sulfurtransferase (TST) LDTP06620 C248(1.44)  LDD3310 
Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 (TSTD2) LDTP07149 C251(1.17)  LDD0080 
Thiosulfate:glutathione sulfurtransferase (TSTD1) LDTP09222 C86(1.78)  LDD3377 
Three-prime repair exonuclease 1 (TREX1) LDTP12595 C97(1.15)  LDD0531 
Threonine aspartase 1 (TASP1) LDTP11988 C351(1.32)  LDD0078 
Threonine synthase-like 1 (THNSL1) LDTP19669 C277(1.04)  LDD0078 
Threonine--tRNA ligase 1, cytoplasmic (TARS1) LDTP03365 C254(3.74); C261(3.74); C656(1.06)  LDD0080 
Threonine--tRNA ligase 2, cytoplasmic (TARS3) LDTP00047 C43(1.19); C49(1.19)  LDD0078 
Threonine--tRNA ligase, mitochondrial (TARS2) LDTP11319 C233(9.93); C240(2.32); C603(1.21)  LDD0080 
Threonylcarbamoyl-AMP synthase (YRDC) LDTP08217 C121(0.91); C256(0.80); C95(0.29); C99(0.29)  LDD0531 
Threonylcarbamoyladenosine tRNA methylthiotransferase (CDKAL1) LDTP07227 C338(0.91)  LDD0078 
Thrombospondin type-1 domain-containing protein 4 (THSD4) LDTP07773 C991(5.97)  LDD3410 
Thromboxane-A synthase (TBXAS1) LDTP03285 C355(1.36)  LDD3314 
THUMP domain-containing protein 2 (THUMPD2) LDTP18307 C20(10.18)  LDD0209 
Thymidine kinase 2, mitochondrial (TK2) LDTP00190 C92(1.63)  LDD3313 
Thymidine kinase, cytosolic (TK1) LDTP02022 C153(2.40); C156(2.40); C66(2.61); C230(1.91)  LDD0080 
Thymidine phosphorylase (TYMP) LDTP03023 C361(5.08)  LDD3311 
Thymidylate kinase (DTYMK) LDTP03258 C117(1.08)  LDD0078 
Thymidylate synthase (TYMS) LDTP02055 CAmbiguous(36.79); C180(5.74)  LDD0209 
Thyroid peroxidase (TPO) LDTP02183 C898(1.38)  LDD3311 
Thyrotropin-releasing hormone-degrading ectoenzyme (TRHDE) LDTP13487 C278(3.69)  LDD3365 
Tissue alpha-L-fucosidase (FUCA1) LDTP02006 C296(1.59)  LDD3310 
Tissue-type plasminogen activator (PLAT) LDTP01800 C419(1.59)  LDD3311 
Titin (TTN) LDTP09749 C2466(12.51)  LDD0209 
TLC domain-containing protein 1 (TLCD1) LDTP10182 C231(0.92)  LDD0531 
TLC domain-containing protein 3A (TLCD3A) LDTP18054 C62(1.03)  LDD0531 
TNF receptor-associated factor 2 (TRAF2) LDTP05698 C287(2.36); C112(1.87); C170(2.28); C171(2.28)  LDD0080 
TNF receptor-associated factor 3 (TRAF3) LDTP05753 C88(1.10); C91(1.10)  LDD0080 
TNF receptor-associated factor 4 (TRAF4) LDTP11258 C83(1.52); C90(1.52)  LDD0080 
TNF receptor-associated factor 6 (TRAF6) LDTP14064 C134(0.85); C139(0.85)  LDD0078 
Torsin-1A (TOR1A) LDTP00399 C44(1.24)  LDD0078 
Torsin-1B (TOR1B) LDTP00400 C56(4.38)  LDD2236 
TRAF2 and NCK-interacting protein kinase (TNIK) LDTP13446 C269(0.95)  LDD0547 
Trafficking protein particle complex subunit 12 (TRAPPC12) LDTP09623 C160(0.95); C663(0.89)  LDD0531 
Trans-3-hydroxy-L-proline dehydratase (L3HYPDH) LDTP10267 C205(1.17); C137(1.02); C139(1.02); C39(0.99)  LDD0078 
Transaldolase (TALDO1) LDTP03847 C250(1.11)  LDD0531 
Transcription activator BRG1 (SMARCA4) LDTP04422 C936(2.45); C1359(1.68); C423(3.95)  LDD0080 
Transcription factor E4F1 (E4F1) LDTP07300 C361(2.41)  LDD3340 
Transcription initiation factor IIB (GTF2B) LDTP05240 C34(1.07); C37(1.07); C219(1.05); C223(1.05)  LDD0078 
Transcription initiation factor TFIID subunit 1 (TAF1) LDTP03122 C40(0.90)  LDD3316 
Transcription intermediary factor 1-alpha (TRIM24) LDTP00559 C73(1.02); C78(1.02); C235(0.86); C238(0.86)  LDD0078 
Transcription intermediary factor 1-beta (TRIM28) LDTP05808 C224(0.88); C229(0.88); C209(0.87); C221(0.85)  LDD0078 
Transcription termination factor 2 (TTF2) LDTP13682 C512(1.07); C522(1.07); C224(1.04); C785(0.87)  LDD0078 
Transcriptional adapter 3 (TADA3) LDTP01247 C7(0.98)  LDD0078 
Transcriptional regulator ATRX (ATRX) LDTP04090 C231(1.30); C232(1.30); C1122(1.28); C605(1.13)  LDD0078 
Transcriptional repressor NF-X1 (NFX1) LDTP05718 C947(1.00); C951(1.00); C92(0.99); C890(0.99)  LDD0078 
Transformation/transcription domain-associated protein (TRRAP) LDTP14034 C3075(1.16); C567(1.12); C555(1.04); C3535(1.01)  LDD0078 
Transforming protein RhoA (RHOA) LDTP04927 C16(0.95); C107(0.86)  LDD0078 
Transient receptor potential cation channel subfamily M member 7 (TRPM7) LDTP10746 C29(1.06); C33(1.06); C36(1.06)  LDD0078 
Transitional endoplasmic reticulum ATPase (VCP) LDTP04665 C522(0.99)  LDD0078 
Transketolase (TKT) LDTP03487 C225(4.73); C386(10.99)  LDD0209 
Transketolase-like protein 1 (TKTL1) LDTP04481 C295(4.76); C472(1.39)  LDD3338 
Translation factor GUF1, mitochondrial (GUF1) LDTP15416 C129(0.74); C492(0.80)  LDD0531 
Translation initiation factor IF-2, mitochondrial (MTIF2) LDTP04093 C646(1.07)  LDD0547 
Translin (TSN) LDTP06427 C225(1.24)  LDD0080 
Transmembrane gamma-carboxyglutamic acid protein 1 (PRRG1) LDTP14431 C166(1.10)  LDD0531 
Transmembrane protease serine 11E (TMPRSS11E) LDTP13522 C358(1.49)  LDD3438 
Transmembrane protease serine 13 (TMPRSS13) LDTP11451 C211(1.09)  LDD2249 
Transmembrane protease serine 2 (TMPRSS2) LDTP00628 C31(1.81)  LDD3310 
Transmembrane protein 102 (TMEM102) LDTP09005 C416(0.88)  LDD0532 
Transmembrane protein 62 (TMEM62) LDTP19223 C325(0.98)  LDD3312 
Transmembrane reductase CYB561D2 (CYB561D2) LDTP00373 C135(0.90)  LDD1492 
Transthyretin (TTR) LDTP01962 C30(0.73)  LDD3314 
Tribbles homolog 1 (TRIB1) LDTP10788 C53(1.02); C67(1.02); C110(0.95); C245(1.04)  LDD0531 
Tribbles homolog 3 (TRIB3) LDTP10787 C222(29.30)  LDD0209 
Trifunctional enzyme subunit alpha, mitochondrial (HADHA) LDTP03912 C322(0.95)  LDD0078 
Trifunctional enzyme subunit beta, mitochondrial (HADHB) LDTP04671 C435(1.15)  LDD0531 
Trifunctional purine biosynthetic protein adenosine-3 (GART) LDTP03156 C41(1.09); C168(1.07); C646(0.93); C237(0.93)  LDD0078 
Trimethylguanosine synthase (TGS1) LDTP10780 C602(13.90); C28(8.23); C357(14.52)  LDD0209 
Trimethyllysine dioxygenase, mitochondrial (TMLHE) LDTP12679 C393(31.27)  LDD0209 
Triokinase/FMN cyclase (TKFC) LDTP06779 C155(0.88)  LDD0078 
Triosephosphate isomerase (TPI1) LDTP04851 C104(1.00); C124(1.00)  LDD0078 
Tripartite motif-containing protein 14 (TRIM14) LDTP06050 C20(0.98)  LDD0078 
Tripartite motif-containing protein 16 (TRIM16) LDTP01570 C459(0.73)  LDD0532 
Tripartite motif-containing protein 2 (TRIM2) LDTP11585 C168(1.50); C536(1.02)  LDD3314 
Tripartite motif-containing protein 26 (TRIM26) LDTP05686 C31(1.05); C36(1.05); C121(0.89); C124(0.89)  LDD0078 
Tripartite motif-containing protein 29 (TRIM29) LDTP06044 C225(1.31)  LDD3364 
Tripartite motif-containing protein 3 (TRIM3) LDTP01201 C22(0.95); C25(0.95)  LDD0078 
Tripartite motif-containing protein 43B (TRIM43B) LDTP16592 C237(0.52)  LDD1492 
Tripartite motif-containing protein 44 (TRIM44) LDTP10235 C179(0.92); C190(0.92)  LDD0078 
Tripartite motif-containing protein 46 (TRIM46) LDTP08072 C319(2.49)  LDD3340 
Tripartite motif-containing protein 49C (TRIM49C) LDTP16899 C104(1.47)  LDD2261 
Tripartite motif-containing protein 5 (TRIM5) LDTP11583 C482(1.76); C489(1.76)  LDD0080 
Tripartite motif-containing protein 55 (TRIM55) LDTP11499 C50(1.77)  LDD3378 
Tripartite motif-containing protein 59 (TRIM59) LDTP08551 C109(0.80); C25(1.06); C30(1.06); C314(1.15)  LDD0531 
Tripartite motif-containing protein 6 (TRIM6) LDTP11582 C335(1.16)  LDD1509 
Tripartite motif-containing protein 60 (TRIM60) LDTP17122 C59(1.42)  LDD3334 
Tripartite motif-containing protein 67 (TRIM67) LDTP15191 C714(1.63)  LDD3340 
Tripeptidyl-peptidase 1 (TPP1) LDTP00428 C365(1.75)  LDD0080 
Tripeptidyl-peptidase 2 (TPP2) LDTP03469 C28(1.23); C967(1.16); C150(1.01)  LDD0080 
Triple functional domain protein (TRIO) LDTP01368 C1713(1.26); C1717(1.26); C3028(1.03); C1041(1.03)  LDD0078 
TRMT1-like protein (TRMT1L) LDTP15236 C656(1.13); C488(1.09); C491(1.09); C121(0.88)  LDD0078 
tRNA (adenine(37)-N6)-methyltransferase (TRMO) LDTP15888 C16(0.93); C18(0.93)  LDD0532 
tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (TRMT61A) LDTP10320 C204(0.90)  LDD0078 
tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial (TRMT61B) LDTP11300 C396(1.52)  LDD0080 
tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (FTSJ1) LDTP13200 C295(1.00)  LDD0078 
tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial (NSUN3) LDTP11971 C49(0.84); C214(0.74); C298(0.72); C311(0.72)  LDD0531 
tRNA (cytosine(38)-C(5))-methyltransferase (TRDMT1) LDTP00410 C287(0.96)  LDD0078 
tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (NSUN6) LDTP09487 C415(3.43); C120(1.78); C326(1.83); C337(1.83)  LDD0080 
tRNA (guanine(10)-N2)-methyltransferase homolog (TRMT11) LDTP15250 C161(1.27)  LDD3323 
tRNA (guanine(26)-N(2))-dimethyltransferase (TRMT1) LDTP12782 C621(1.13); C348(0.96); C351(0.96)  LDD0078 
tRNA (guanine(37)-N1)-methyltransferase (TRMT5) LDTP06751 C321(0.98); C340(0.69)  LDD0532 
tRNA (guanine(6)-N2)-methyltransferase THUMP3 (THUMPD3) LDTP11266 C426(0.93)  LDD0078 
tRNA (guanine-N(7)-)-methyltransferase (METTL1) LDTP13140 C136(4.33)  LDD0209 
tRNA (uracil-5-)-methyltransferase homolog A (TRMT2A) LDTP08687 C551(1.08); C243(2.33); C260(2.33); C538(2.64)  LDD0080 
tRNA (uracil-5-)-methyltransferase homolog B (TRMT2B) LDTP10350 C451(1.27); C217(1.23)  LDD3312 
tRNA 2'-phosphotransferase 1 (TRPT1) LDTP15282 C98(1.23)  LDD3313 
tRNA dimethylallyltransferase (TRIT1) LDTP11865 C298(0.78)  LDD0531 
tRNA endonuclease ANKZF1 (ANKZF1) LDTP12072 C48(9.03)  LDD0209 
tRNA methyltransferase 10 homolog A (TRMT10A) LDTP09360 C37(1.09)  LDD0080 
tRNA methyltransferase 10 homolog C (TRMT10C) LDTP07937 C78(1.16)  LDD0078 
tRNA modification GTPase GTPBP3, mitochondrial (GTPBP3) LDTP10048 C210(3.93)  LDD3314 
tRNA N(3)-methylcytidine methyltransferase METTL2A (METTL2A) LDTP10438 C241(1.00)  LDD0080 
tRNA N(3)-methylcytidine methyltransferase METTL2B (METTL2B) LDTP07515 C124(3.10); C126(3.10)  LDD0080 
tRNA N(3)-methylcytidine methyltransferase METTL6 (METTL6) LDTP09377 C256(0.95)  LDD1492 
tRNA N(3)-methylcytidine methyltransferase METTL8, mitochondrial (METTL8) LDTP12045 C96(2.07)  LDD3364 
tRNA N6-adenosine threonylcarbamoyltransferase (OSGEP) LDTP12354 C252(0.85); C265(0.85)  LDD0078 
tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (OSGEPL1) LDTP11913 C390(2.58)  LDD0080 
tRNA pseudouridine synthase Pus10 (PUS10) LDTP06783 C29(2.94)  LDD3310 
tRNA pseudouridine synthase-like 1 (PUSL1) LDTP15392 C292(0.87)  LDD0531 
tRNA pseudouridine(38/39) synthase (PUS3) LDTP11528 C420(124.93)  LDD0209 
tRNA wybutosine-synthesizing protein 2 homolog (TRMT12) LDTP06907 C287(1.20)  LDD0531 
tRNA wybutosine-synthesizing protein 3 homolog (TYW3) LDTP15082 C70(1.22); C71(1.22)  LDD0078 
tRNA wybutosine-synthesizing protein 4 (LCMT2) LDTP00942 C408(3.11); C396(1.23)  LDD0080 
tRNA wybutosine-synthesizing protein 5 (TYW5) LDTP00053 C94(1.27)  LDD3325 
tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (DUS1L) LDTP15109 C395(1.03); C398(1.03); C406(1.01); C411(1.01)  LDD0078 
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like (DUS2) LDTP12767 C475(1.00)  LDD0078 
tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (DUS4L) LDTP14539 C11(0.98); C5(0.98)  LDD0078 
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (DUS3L) LDTP10334 C282(1.02); C408(0.90)  LDD0078 
tRNA-queuosine alpha-mannosyltransferase (GTDC1) LDTP17130 C222(0.98); C226(0.98)  LDD0078 
tRNA-specific adenosine deaminase 1 (ADAT1) LDTP11227 C334(0.86)  LDD0532 
tRNA-specific adenosine deaminase 2 (ADAT2) LDTP08134 C134(1.00); C15(0.88); C154(1.00)  LDD0531 
tRNA-splicing endonuclease subunit Sen2 (TSEN2) LDTP09091 C221(1.19); C222(1.19); C223(1.19)  LDD0078 
tRNA-splicing endonuclease subunit Sen34 (TSEN34) LDTP11171 C291(2.33)  LDD3334 
tRNA-splicing endonuclease subunit Sen54 (TSEN54) LDTP08125 C338(0.98); C277(0.88)  LDD0078 
tRNA-uridine aminocarboxypropyltransferase 1 (DTWD1) LDTP15425 C126(94.64)  LDD0209 
tRNA-uridine aminocarboxypropyltransferase 2 (DTWD2) LDTP15477 C143(2.10)  LDD0080 
tRNA:m(4)X modification enzyme TRM13 homolog (TRMT13) LDTP16101 C373(1.58)  LDD0080 
Trypsin-3 (PRSS3) LDTP03703 C217(0.94); C228(0.94)  LDD0531 
Tryptase beta-2 (TPSB2) LDTP03038 C188(1.87)  LDD3335 
Tryptophan 2,3-dioxygenase (TDO2) LDTP04219 C330(3.59)  LDD2391 
Tryptophan--tRNA ligase, cytoplasmic (WARS1) LDTP03222 C274(1.13)  LDD0080 
Tryptophan--tRNA ligase, mitochondrial (WARS2) LDTP13238 C102(2.94)  LDD3319 
Tubulin alpha-1A chain (TUBA1A) LDTP07907 C295(0.98)  LDD0078 
Tubulin alpha-1B chain (TUBA1B) LDTP05074 C315(3.01); C316(3.01); C376(2.26); C347(1.58)  LDD0080 
Tubulin alpha-1C chain (TUBA1C) LDTP11074 C376(2.01)  LDD0080 
Tubulin alpha-4A chain (TUBA4A) LDTP05075 C347(1.10); C54(0.98); C376(0.98); C295(0.97)  LDD0078 
Tubulin alpha-8 chain (TUBA8) LDTP12810 C347(23.03); C347(47.92)  LDD0209 
Tubulin monoglutamylase TTLL4 (TTLL4) LDTP06179 C829(1.18)  LDD0531 
Tubulin monoglycylase TTLL3 (TTLL3) LDTP14071 C692(0.88)  LDD1492 
Tubulin polymerization-promoting protein (TPPP) LDTP01425 C83(0.80)  LDD3331 
Tubulin--tyrosine ligase (TTL) LDTP15524 C238(1.13); C244(1.13)  LDD0078 
Tubulin--tyrosine ligase-like protein 12 (TTLL12) LDTP06067 C528(1.04); C98(1.03)  LDD0078 
Tubulointerstitial nephritis antigen-like (TINAGL1) LDTP11627 C446(1.92)  LDD3314 
Tudor-interacting repair regulator protein (NUDT16L1) LDTP11111 C171(1.09); C88(0.92)  LDD0078 
Tuftelin (TUFT1) LDTP16053 C8(1.17)  LDD0078 
Tumor necrosis factor alpha-induced protein 3 (TNFAIP3) LDTP03118 C536(1.12); C539(1.12); C387(1.04); C392(1.04)  LDD0078 
Tumor susceptibility gene 101 protein (TSG101) LDTP10987 C73(0.60)  LDD0812 
Twinkle mtDNA helicase (TWNK) LDTP10778 C226(0.93); C330(1.19)  LDD0531 
Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (PIP4P1) LDTP08183 C94(1.37)  LDD3312 
Type 2 lactosamine alpha-2,3-sialyltransferase (ST3GAL6) LDTP13821 C118(2.74)  LDD3428 
Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (PIP4P2) LDTP08868 C61(1.35)  LDD3312 
Type II inositol 1,4,5-trisphosphate 5-phosphatase (INPP5B) LDTP03625 C678(0.81); C701(0.81); C715(0.81)  LDD0531 
Tyrosinase (TYR) LDTP02742 C55(2.13); C46(3.12)  LDD3332 
Tyrosine 3-monooxygenase (TH) LDTP02176 C433(2.14)  LDD3340 
Tyrosine--tRNA ligase, cytoplasmic (YARS1) LDTP04617 C519(6.16); C501(12.47)  LDD0209 
Tyrosine--tRNA ligase, mitochondrial (YARS2) LDTP13937 C413(0.61)  LDD0531 
Tyrosine-protein kinase ABL1 (ABL1) LDTP01784 C1100(70.17)  LDD0209 
Tyrosine-protein kinase ABL2 (ABL2) LDTP03991 C717(0.68)  LDD0532 
Tyrosine-protein kinase BAZ1B (BAZ1B) LDTP13344 C1202(1.28); C1205(1.28); C1420(1.07); C497(1.05)  LDD0078 
Tyrosine-protein kinase Blk (BLK) LDTP04414 C319(17.88)  LDD0204 
Tyrosine-protein kinase BTK (BTK) LDTP05478 C536(3.85); C371(2.36); C97(3.73); C498(3.69)  LDD3333 
Tyrosine-protein kinase CSK (CSK) LDTP03944 C31(1.14)  LDD0078 
Tyrosine-protein kinase Fer (FER) LDTP02859 C796(6.89)  LDD0209 
Tyrosine-protein kinase Fes/Fps (FES) LDTP02196 C221(3.50)  LDD3333 
Tyrosine-protein kinase Fgr (FGR) LDTP02372 C127(1.93)  LDD3377 
Tyrosine-protein kinase FRK (FRK) LDTP03992 C59(5.13)  LDD3314 
Tyrosine-protein kinase Fyn (FYN) LDTP02139 C246(0.95); C487(1.00)  LDD1492 
Tyrosine-protein kinase HCK (HCK) LDTP02293 C482(1.91)  LDD3333 
Tyrosine-protein kinase JAK1 (JAK1) LDTP03230 C1116(1.25); C1120(1.25); C731(1.08); C657(0.90)  LDD0078 
Tyrosine-protein kinase JAK2 (JAK2) LDTP01026 C125(5.79)  LDD0080 
Tyrosine-protein kinase JAK3 (JAK3) LDTP04505 C934(7.28); C1048(17.38); C227(442.70)  LDD0209 
Tyrosine-protein kinase Lck (LCK) LDTP02138 C378(5.19); C465(9.86); C465(24.45)  LDD0209 
Tyrosine-protein kinase Lyn (LYN) LDTP02232 C419(1.00); C203(1.70)  LDD0080 
Tyrosine-protein kinase Mer (MERTK) LDTP05674 C640(0.95)  LDD1507 
Tyrosine-protein kinase receptor TYRO3 (TYRO3) LDTP05488 C781(1.05); C847(1.29)  LDD0532 
Tyrosine-protein kinase receptor UFO (AXL) LDTP03542 C869(1.26); C852(0.86); C854(0.86)  LDD0078 
Tyrosine-protein kinase RYK (RYK) LDTP03693 C598(1.63)  LDD3351 
Tyrosine-protein kinase SYK (SYK) LDTP04048 C593(18.53); C593(19.87); C597(19.87)  LDD0209 
Tyrosine-protein kinase Tec (TEC) LDTP03989 C449(0.99)  LDD0078 
Tyrosine-protein kinase transmembrane receptor ROR2 (ROR2) LDTP05329 C538(1.13)  LDD0625 
Tyrosine-protein kinase Yes (YES1) LDTP02231 C287(3.70)  LDD0080 
Tyrosine-protein kinase ZAP-70 (ZAP70) LDTP04047 CAmbiguous(4.71); C346(8.77); C84(4.06); C249(9.48)  LDD0209 
Tyrosine-protein phosphatase non-receptor type 1 (PTPN1) LDTP02935 C32(1.78); C121(1.09)  LDD0078 
Tyrosine-protein phosphatase non-receptor type 11 (PTPN11) LDTP05475 C567(1.06); C573(1.06); C259(0.97)  LDD0078 
Tyrosine-protein phosphatase non-receptor type 12 (PTPN12) LDTP05449 C495(1.06); C498(1.06); C724(1.03); C736(1.03)  LDD0078 
Tyrosine-protein phosphatase non-receptor type 13 (PTPN13) LDTP05695 C798(2.47)  LDD3314 
Tyrosine-protein phosphatase non-receptor type 14 (PTPN14) LDTP06443 C133(1.20)  LDD0532 
Tyrosine-protein phosphatase non-receptor type 18 (PTPN18) LDTP11015 C46(2.33)  LDD3408 
Tyrosine-protein phosphatase non-receptor type 2 (PTPN2) LDTP02917 C123(1.03); C330(1.12); C94(0.74); C95(0.74)  LDD0531 
Tyrosine-protein phosphatase non-receptor type 23 (PTPN23) LDTP11887 C144(0.96); C149(0.96)  LDD0078 
Tyrosine-protein phosphatase non-receptor type 3 (PTPN3) LDTP03347 C341(3.58); C498(1.77)  LDD0080 
Tyrosine-protein phosphatase non-receptor type 6 (PTPN6) LDTP03478 C482(1.82); C173(1.13)  LDD3310 
Tyrosine-protein phosphatase non-receptor type 7 (PTPN7) LDTP03718 C62(459.81); C228(4.94)  LDD0209 
Tyrosine-protein phosphatase non-receptor type 9 (PTPN9) LDTP04046 C412(1.59)  LDD0078 
Tyrosyl-DNA phosphodiesterase 1 (TDP1) LDTP12649 C48(1.04)  LDD0078 
Tyrosyl-DNA phosphodiesterase 2 (TDP2) LDTP01629 C273(0.85)  LDD1507 
U5 small nuclear ribonucleoprotein 200 kDa helicase (SNRNP200) LDTP01283 C1278(1.20); C576(0.98); C428(0.90); C516(0.86)  LDD0078 
U8 snoRNA-decapping enzyme (NUDT16) LDTP10212 C23(0.94)  LDD1507 
UbiA prenyltransferase domain-containing protein 1 (UBIAD1) LDTP14189 C31(7.76)  LDD0209 
Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (COQ6) LDTP13938 C99(1.04)  LDD3352 
Ubiquinone biosynthesis O-methyltransferase, mitochondrial (COQ3) LDTP12908 C358(0.94)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 1 (USP1) LDTP01418 C534(1.95); C544(1.95); C385(2.73); C394(2.73)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase 10 (USP10) LDTP06190 C302(1.08); C504(2.79)  LDD3310 
Ubiquitin carboxyl-terminal hydrolase 11 (USP11) LDTP04456 C428(1.19); C694(0.98); C701(0.98)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 12 (USP12) LDTP01172 C83(3.93)  LDD3314 
Ubiquitin carboxyl-terminal hydrolase 13 (USP13) LDTP09959 C484(1.31); C483(1.81)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase 14 (USP14) LDTP04618 C203(1.01)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase 15 (USP15) LDTP14051 C633(1.31); C634(1.31); C264(0.98)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 16 (USP16) LDTP14159 C191(1.01); C631(0.88); C636(0.88)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 19 (USP19) LDTP01474 C936(1.73)  LDD3310 
Ubiquitin carboxyl-terminal hydrolase 20 (USP20) LDTP13884 C560(1.09)  LDD0602 
Ubiquitin carboxyl-terminal hydrolase 21 (USP21) LDTP13433 C419(0.88)  LDD1492 
Ubiquitin carboxyl-terminal hydrolase 22 (USP22) LDTP13719 C44(0.93); C383(0.92); C386(0.92); C494(0.90)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 24 (USP24) LDTP13720 C1377(0.98); C1393(0.98); C1287(0.93)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 25 (USP25) LDTP13299 C1085(2.30)  LDD3319 
Ubiquitin carboxyl-terminal hydrolase 27 (USP27X) LDTP00118 C284(0.87); C287(0.87)  LDD0531 
Ubiquitin carboxyl-terminal hydrolase 28 (USP28) LDTP10785 C142(1.08); C1058(0.92)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 3 (USP3) LDTP14257 C362(1.46)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase 30 (USP30) LDTP07876 C284(1.20); C287(1.20)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase 31 (USP31) LDTP07877 C911(1.07)  LDD0533 
Ubiquitin carboxyl-terminal hydrolase 32 (USP32) LDTP09193 C1170(1.10)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 33 (USP33) LDTP09517 C321(0.93); C324(0.93)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 34 (USP34) LDTP07875 C3486(1.51); C3504(1.51); C46(1.17); C48(1.17)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 35 (USP35) LDTP16179 C785(1.09)  LDD0812 
Ubiquitin carboxyl-terminal hydrolase 36 (USP36) LDTP13026 C302(0.95)  LDD3311 
Ubiquitin carboxyl-terminal hydrolase 37 (USP37) LDTP08188 C686(3.60)  LDD3342 
Ubiquitin carboxyl-terminal hydrolase 38 (USP38) LDTP09036 C1007(1.46); C1023(1.46)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 39 (USP39) LDTP06903 C453(0.85)  LDD0531 
Ubiquitin carboxyl-terminal hydrolase 4 (USP4) LDTP05749 C649(0.95)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 40 (USP40) LDTP12672 C313(2.85)  LDD3310 
Ubiquitin carboxyl-terminal hydrolase 42 (USP42) LDTP12099 C231(1.07)  LDD0531 
Ubiquitin carboxyl-terminal hydrolase 43 (USP43) LDTP07884 C892(0.84); C900(0.84)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 44 (USP44) LDTP11704 C505(5.97)  LDD0209 
Ubiquitin carboxyl-terminal hydrolase 46 (USP46) LDTP04954 C79(4.95)  LDD3340 
Ubiquitin carboxyl-terminal hydrolase 47 (USP47) LDTP10495 C856(0.98)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 48 (USP48) LDTP08254 C850(1.95); C39(7.82); C652(1.16); C658(1.16)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase 5 (USP5) LDTP04074 C195(1.11)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase 51 (USP51) LDTP07880 C593(0.64)  LDD0531 
Ubiquitin carboxyl-terminal hydrolase 6 (USP6) LDTP03707 C868(2.05)  LDD3310 
Ubiquitin carboxyl-terminal hydrolase 7 (USP7) LDTP09962 C334(1.23); C961(1.49)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase 8 (USP8) LDTP03904 C809(1.10)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase BAP1 (BAP1) LDTP09796 C638(2.79); C649(2.79)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase CYLD (CYLD) LDTP12413 C526(19.80)  LDD0209 
Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) LDTP02383 C220(1.54); C152(1.18)  LDD0080 
Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCHL3) LDTP02783 C95(1.01)  LDD0078 
Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5) LDTP14130 C191(1.94)  LDD3319 
Ubiquitin carboxyl-terminal hydrolase MINDY-1 (MINDY1) LDTP08901 C20(1.12)  LDD3323 
Ubiquitin carboxyl-terminal hydrolase MINDY-2 (MINDY2) LDTP09065 C385(0.98); C79(0.90)  LDD1492 
Ubiquitin carboxyl-terminal hydrolase MINDY-3 (MINDY3) LDTP12061 C27(1.31)  LDD0080 
Ubiquitin conjugation factor E4 A (UBE4A) LDTP06047 C202(24.60)  LDD0209 
Ubiquitin conjugation factor E4 B (UBE4B) LDTP01509 C1164(17.96)  LDD0209 
Ubiquitin domain-containing protein 1 (UBTD1) LDTP12122 C103(1.06)  LDD1512 
Ubiquitin domain-containing protein 2 (UBTD2) LDTP15624 C152(1.50)  LDD3424 
Ubiquitin thioesterase OTU1 (YOD1) LDTP07231 C210(0.80)  LDD0531 
Ubiquitin thioesterase OTUB1 (OTUB1) LDTP10318 C204(2.96); C23(1.61); C212(0.97)  LDD0080 
Ubiquitin thioesterase OTUB2 (OTUB2) LDTP10211 C51(0.84)  LDD0078 
Ubiquitin thioesterase otulin (OTULIN) LDTP10133 C347(1.07); C17(0.97); C92(0.88)  LDD0078 
Ubiquitin thioesterase ZRANB1 (ZRANB1) LDTP13225 C104(2.83); C107(2.83)  LDD0080 
Ubiquitin-associated and SH3 domain-containing protein B (UBASH3B) LDTP09524 C407(1.51)  LDD0531 
Ubiquitin-associated domain-containing protein 2 (UBAC2) LDTP09060 C72(0.71)  LDD0532 
Ubiquitin-conjugating enzyme E2 A (UBE2A) LDTP04260 C88(1.02)  LDD1492 
Ubiquitin-conjugating enzyme E2 B (UBE2B) LDTP05045 C88(1.12)  LDD0080 
Ubiquitin-conjugating enzyme E2 C (UBE2C) LDTP00341 C114(1.18)  LDD0080 
Ubiquitin-conjugating enzyme E2 D1 (UBE2D1) LDTP04442 C111(0.96)  LDD1492 
Ubiquitin-conjugating enzyme E2 D2 (UBE2D2) LDTP05010 C87(1.80)  LDD3310 
Ubiquitin-conjugating enzyme E2 D3 (UBE2D3) LDTP04897 C82(1.04)  LDD3332 
Ubiquitin-conjugating enzyme E2 D4 (UBE2D4) LDTP13927 C111(0.88)  LDD1573 
Ubiquitin-conjugating enzyme E2 E1 (UBE2E1) LDTP04493 C67(0.94)  LDD0531 
Ubiquitin-conjugating enzyme E2 E3 (UBE2E3) LDTP10031 C136(0.82); C145(0.82); C81(0.83)  LDD0531 
Ubiquitin-conjugating enzyme E2 G1 (UBE2G1) LDTP04967 C90(1.07)  LDD3332 
Ubiquitin-conjugating enzyme E2 G2 (UBE2G2) LDTP04874 C75(0.84)  LDD0531 
Ubiquitin-conjugating enzyme E2 J1 (UBE2J1) LDTP13957 C148(0.99)  LDD0080 
Ubiquitin-conjugating enzyme E2 J2 (UBE2J2) LDTP08800 C33(1.15)  LDD3331 
Ubiquitin-conjugating enzyme E2 K (UBE2K) LDTP04899 C170(1.30)  LDD0080 
Ubiquitin-conjugating enzyme E2 L5 (UBE2L5) LDTP16509 C86(1.97)  LDD3314 
Ubiquitin-conjugating enzyme E2 N (UBE2N) LDTP04900 C87(1.48)  LDD0531 
Ubiquitin-conjugating enzyme E2 Q1 (UBE2Q1) LDTP08146 C157(1.24); C65(0.64); C71(0.64)  LDD0531 
Ubiquitin-conjugating enzyme E2 R1 (CDC34) LDTP04254 C191(0.99)  LDD0078 
Ubiquitin-conjugating enzyme E2 R2 (UBE2R2) LDTP07897 C191(1.07)  LDD0078 
Ubiquitin-conjugating enzyme E2 S (UBE2S) LDTP06621 C118(1.34)  LDD0078 
Ubiquitin-conjugating enzyme E2 T (UBE2T) LDTP12348 C86(1.14); C24(2.10)  LDD0080 
Ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1) LDTP05853 C94(2.77); C218(1.55)  LDD3310 
Ubiquitin-conjugating enzyme E2 variant 3 (UEVLD) LDTP08580 C319(1.07)  LDD0531 
Ubiquitin-conjugating enzyme E2 W (UBE2W) LDTP10106 C180(1.19)  LDD2268 
Ubiquitin-conjugating enzyme E2 Z (UBE2Z) LDTP12046 C254(1.06); C261(0.90); C263(0.90)  LDD0078 
Ubiquitin-like domain-containing CTD phosphatase 1 (UBLCP1) LDTP09629 C154(0.93)  LDD0531 
Ubiquitin-like modifier-activating enzyme 1 (UBA1) LDTP03166 C632(1.13)  LDD0078 
Ubiquitin-like modifier-activating enzyme 5 (UBA5) LDTP11675 C303(0.91)  LDD0531 
Ubiquitin-like modifier-activating enzyme 6 (UBA6) LDTP00013 C178(0.98); C546(0.93)  LDD0078 
Ubiquitin-like modifier-activating enzyme 7 (UBA7) LDTP03937 C599(0.95)  LDD0078 
Ubiquitin-like-conjugating enzyme ATG10 (ATG10) LDTP11741 C38(1.50)  LDD0080 
Ubiquitin-like-conjugating enzyme ATG3 (ATG3) LDTP12599 C259(0.60); C264(0.60)  LDD0532 
Ubiquitin-protein ligase E3A (UBE3A) LDTP05446 C843(0.94)  LDD0078 
Ubiquitin-protein ligase E3B (UBE3B) LDTP15246 C399(1.44)  LDD0080 
Ubiquitin-protein ligase E3C (UBE3C) LDTP06372 C140(2.62); C1051(1.13); C1018(1.23)  LDD0080 
Ubiquitin/ISG15-conjugating enzyme E2 L6 (UBE2L6) LDTP00481 C102(0.97); C86(0.92); C98(0.92)  LDD0078 
Ubl carboxyl-terminal hydrolase 18 (USP18) LDTP13625 C126(2.94)  LDD3323 
UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (B3GALNT1) LDTP01304 C300(1.08)  LDD0078 
UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 (B3GALNT2) LDTP09103 C239(1.86)  LDD3383 
UDP-glucose 4-epimerase (GALE) LDTP06111 C330(1.16)  LDD0080 
UDP-glucose 6-dehydrogenase (UGDH) LDTP01033 C276(0.93); C112(0.89)  LDD0078 
UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1) LDTP12851 C1493(1.10)  LDD0080 
UDP-glucose:glycoprotein glucosyltransferase 2 (UGGT2) LDTP12850 C1468(0.96)  LDD1492 
UDP-glucuronic acid decarboxylase 1 (UXS1) LDTP09074 C74(2.58)  LDD3369 
UDP-glucuronosyltransferase 1-6 (UGT1A6) LDTP02985 C176(1.32)  LDD3365 
UDP-glucuronosyltransferase 1A1 (UGT1A1) LDTP03164 C127(1.35)  LDD2379 
UDP-glucuronosyltransferase 1A10 (UGT1A10) LDTP12148 C153(1.51)  LDD3440 
UDP-glucuronosyltransferase 1A4 (UGT1A4) LDTP03165 C178(0.95)  LDD2379 
UDP-glucuronosyltransferase 1A5 (UGT1A5) LDTP03752 C178(1.34)  LDD3489 
UDP-glucuronosyltransferase 3A2 (UGT3A2) LDTP14918 C307(2.21)  LDD3423 
UDP-N-acetylglucosamine transferase subunit ALG14 homolog (ALG14) LDTP10293 C176(0.94)  LDD1507 
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1) LDTP11867 C42(1.12)  LDD0563 
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (OGT) LDTP00601 C962(2.22); C965(2.22)  LDD0080 
UDP-N-acetylhexosamine pyrophosphorylase (UAP1) LDTP06517 C158(3.13)  LDD0080 
UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (UAP1L1) LDTP17105 C332(0.99)  LDD0533 
Ufm1-specific protease 2 (UFSP2) LDTP12641 C302(1.25)  LDD0080 
Ultra-long-chain fatty acid omega-hydroxylase (CYP4F22) LDTP07463 C214(0.73); C222(0.73)  LDD0531 
UMP-CMP kinase (CMPK1) LDTP03519 C20(332.45)  LDD0209 
UMP-CMP kinase 2, mitochondrial (CMPK2) LDTP06964 C40(9.45)  LDD0209 
Uncharacterized aarF domain-containing protein kinase 2 (ADCK2) LDTP15262 C210(1.12)  LDD3319 
Uncharacterized aarF domain-containing protein kinase 5 (ADCK5) LDTP17114 C398(0.28)  LDD1093 
Unconventional myosin-Ia (MYO1A) LDTP13099 C849(2.44)  LDD3364 
Unconventional myosin-Ib (MYO1B) LDTP00870 C103(1.06); C641(1.00); C613(0.99); C129(0.97)  LDD0078 
Unconventional myosin-Id (MYO1D) LDTP01436 C143(1.35)  LDD0080 
Unconventional myosin-Ie (MYO1E) LDTP05708 C447(1.48); C519(1.09)  LDD0531 
Unconventional myosin-If (MYO1F) LDTP00197 C586(3.43); C579(2.64)  LDD3311 
Unconventional myosin-Ig (MYO1G) LDTP00157 C618(357.39); C503(9.21)  LDD0209 
Unconventional myosin-IXa (MYO9A) LDTP00161 C1541(3.33)  LDD3373 
Unconventional myosin-IXb (MYO9B) LDTP05879 C62(0.98)  LDD0078 
Unconventional myosin-Va (MYO5A) LDTP14061 C1711(42.50); C684(7.43)  LDD0209 
Unconventional myosin-Vb (MYO5B) LDTP13577 C349(1.20); C362(1.20); C1554(1.10); C1581(1.32)  LDD0531 
Unconventional myosin-Vc (MYO5C) LDTP12449 C1658(1.00); C374(1.00)  LDD0531 
Unconventional myosin-VI (MYO6) LDTP13609 C1102(1.14)  LDD0080 
Unconventional myosin-VIIb (MYO7B) LDTP07587 C1377(25.97); C1767(8.17); C1437(6.65); C1265(79.57)  LDD0209 
Unconventional myosin-X (MYO10) LDTP12288 C1123(1.24); C230(1.13); C1874(0.93); C935(0.89)  LDD0078 
Unconventional myosin-XIX (MYO19) LDTP10374 C275(1.19); C242(1.04); C186(0.98)  LDD0078 
Unconventional myosin-XVB (MYO15B) LDTP15753 C1280(0.55)  LDD0531 
Unconventional myosin-XVIIIa (MYO18A) LDTP09819 C250(1.71)  LDD0080 
Unconventional myosin-XVIIIb (MYO18B) LDTP08453 C449(1.81); C178(2.69); C839(3.00)  LDD3401 
Unconventional prefoldin RPB5 interactor 1 (URI1) LDTP01410 C44(1.06); C420(0.94)  LDD0078 
Up-regulator of cell proliferation (URGCP) LDTP09404 C49(0.86)  LDD0078 
Uracil phosphoribosyltransferase homolog (UPRT) LDTP10143 C66(1.78)  LDD3325 
Uracil-DNA glycosylase (UNG) LDTP02643 C290(0.05)  LDD2236 
Uridine 5'-monophosphate synthase (UMPS) LDTP02548 C304(1.13)  LDD0080 
Uridine diphosphate glucose pyrophosphatase NUDT14 (NUDT14) LDTP01694 C12(2.11)  LDD3345 
Uridine phosphorylase 1 (UPP1) LDTP06643 C17(1.01); C80(0.97); C89(0.96); C71(0.96)  LDD0078 
Uridine-cytidine kinase 1 (UCK1) LDTP12116 C241(1.18)  LDD3344 
Uridine-cytidine kinase 2 (UCK2) LDTP11571 C241(1.53)  LDD0078 
Uridine-cytidine kinase-like 1 (UCKL1) LDTP12745 C35(1.14)  LDD0078 
Urokinase-type plasminogen activator (PLAU) LDTP01799 C372(1.73); C382(1.73)  LDD0078 
Uroporphyrinogen decarboxylase (UROD) LDTP02135 C59(1.01)  LDD0078 
Uroporphyrinogen-III synthase (UROS) LDTP02518 C264(1.09); C265(1.09); C14(0.93)  LDD0078 
UTP--glucose-1-phosphate uridylyltransferase (UGP2) LDTP06649 C123(1.41)  LDD0080 
Utrophin (UTRN) LDTP04116 C99(1.69); C990(2.04); C2103(1.44)  LDD3310 
V(D)J recombination-activating protein 1 (RAG1) LDTP02813 C114(1.14)  LDD3339 
V-type proton ATPase 116 kDa subunit a 2 (ATP6V0A2) LDTP14030 C680(4.52); C165(2.62)  LDD0080 
V-type proton ATPase 116 kDa subunit a 3 (TCIRG1) LDTP05891 C238(0.94); C241(0.94)  LDD0531 
V-type proton ATPase catalytic subunit A (ATP6V1A) LDTP03859 C138(1.10); C277(1.09)  LDD0078 
V-type proton ATPase subunit d 2 (ATP6V0D2) LDTP08990 C79(1.94); C334(1.87)  LDD3314 
V-type proton ATPase subunit E 2 (ATP6V1E2) LDTP15684 C136(0.88)  LDD1508 
V-type proton ATPase subunit G 2 (ATP6V1G2) LDTP01646 C104(1.03)  LDD1508 
Vacuolar protein sorting-associated protein 4A (VPS4A) LDTP13639 C403(1.58)  LDD0080 
Vacuolar protein sorting-associated protein 4B (VPS4B) LDTP01186 C240(0.86)  LDD0531 
Valacyclovir hydrolase (BPHL) LDTP08322 C225(1.18)  LDD3310 
Valine--tRNA ligase (VARS1) LDTP03366 C41(1.02); C444(0.99); C682(0.88); C381(0.85)  LDD0078 
Valine--tRNA ligase, mitochondrial (VARS2) LDTP07069 C713(4.78); C230(14.93)  LDD0209 
Vascular endothelial growth factor receptor 1 (FLT1) LDTP02932 C898(1.19)  LDD1507 
Vascular endothelial growth factor receptor 2 (KDR) LDTP03796 C53(1.00)  LDD1514 
Vascular endothelial growth factor receptor 3 (FLT4) LDTP03795 C1054(0.95)  LDD0078 
Very long chain fatty acid elongase 1 (ELOVL1) LDTP11311 C93(1.10)  LDD0080 
Very long chain fatty acid elongase 4 (ELOVL4) LDTP11640 C163(1.52)  LDD1508 
Very long chain fatty acid elongase 5 (ELOVL5) LDTP12841 C61(1,120.86)  LDD0209 
Very long chain fatty acid elongase 6 (ELOVL6) LDTP11955 C99(1.32)  LDD0532 
Very long chain fatty acid elongase 7 (ELOVL7) LDTP00036 C117(0.60)  LDD0531 
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADVL) LDTP04289 C179(1.14); C500(1.78)  LDD3310 
Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (HACD3) LDTP12954 C173(32.95)  LDD0209 
Very-long-chain 3-oxoacyl-CoA reductase (HSD17B12) LDTP06901 C166(0.99)  LDD0078 
Very-long-chain enoyl-CoA reductase (TECR) LDTP12867 C18(192.49)  LDD0209 
Vesicle-fusing ATPase (NSF) LDTP04096 C264(0.99)  LDD0078 
Vitamin K epoxide reductase complex subunit 1 (VKORC1) LDTP11070 C51(0.94)  LDD0078 
Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1L1) LDTP08728 C50(3.07)  LDD0080 
Vitamin K-dependent gamma-carboxylase (GGCX) LDTP03854 C343(1.19)  LDD0531 
von Hippel-Lindau disease tumor suppressor (VHL) LDTP03894 C77(1.49)  LDD0080 
WD and tetratricopeptide repeats protein 1 (WDTC1) LDTP08893 C189(1.02); C199(1.02); C236(1.41); C431(1.00)  LDD0531 
WD repeat-containing protein 82 (WDR82) LDTP07715 C195(0.92)  LDD0078 
Wee1-like protein kinase (WEE1) LDTP03529 C19(1.74); C143(1.66)  LDD0080 
WW domain-containing oxidoreductase (WWOX) LDTP12888 C382(5.72)  LDD0204 
X-linked retinitis pigmentosa GTPase regulator (RPGR) LDTP09894 C440(0.91)  LDD1507 
X-ray repair cross-complementing protein 5 (XRCC5) LDTP02642 C339(0.87); C493(0.86); C346(0.85)  LDD0078 
X-ray repair cross-complementing protein 6 (XRCC6) LDTP02640 C398(1.67)  LDD0531 
Xaa-Arg dipeptidase (PM20D2) LDTP08666 C293(1.02)  LDD0080 
Xaa-Pro aminopeptidase 1 (XPNPEP1) LDTP12444 C322(3.68)  LDD3311 
Xaa-Pro aminopeptidase 3 (XPNPEP3) LDTP12420 C334(1.02); C338(1.02)  LDD0593 
Xaa-Pro dipeptidase (PEPD) LDTP02639 C482(0.98)  LDD0078 
Xanthine dehydrogenase/oxidase (XDH) LDTP04145 C889(1.93)  LDD2286 
Xyloside xylosyltransferase 1 (XXYLT1) LDTP09053 C357(0.93)  LDD0078 
Xylosyl- and glucuronyltransferase LARGE2 (LARGE2) LDTP08845 C328(1.01)  LDD0532 
Xylosyltransferase 2 (XYLT2) LDTP11758 C478(1.13)  LDD0531 
Xylulose kinase (XYLB) LDTP01159 C10(1.04); C134(1.68); C146(1.68); C9(1.04)  LDD0532 
Zinc finger MIZ domain-containing protein 1 (ZMIZ1) LDTP13556 C100(1.33)  LDD0078 
Zinc finger MIZ domain-containing protein 2 (ZMIZ2) LDTP09190 C621(0.86); C632(0.86)  LDD0078 
Zinc finger protein RFP (TRIM27) LDTP02722 C43(0.88); C53(0.88); C56(0.88)  LDD0078 
Zinc finger-containing ubiquitin peptidase 1 (ZUP1) LDTP10089 C360(1.09)  LDD0078 
Zinc phosphodiesterase ELAC protein 2 (ELAC2) LDTP11054 C51(1.14); C670(1.00)  LDD0078 
Zinc-regulated GTPase metalloprotein activator 1A (ZNG1A) LDTP11133 C310(1.89)  LDD0080 
Zinc-regulated GTPase metalloprotein activator 1B (ZNG1B) LDTP17613 C310(2.28)  LDD3377 
[F-actin]-monooxygenase MICAL1 (MICAL1) LDTP09468 C837(3,074.67)  LDD0209 
[F-actin]-monooxygenase MICAL2 (MICAL2) LDTP01439 C295(1.17); C1029(0.87); C1032(0.87)  LDD0078 
[F-actin]-monooxygenase MICAL3 (MICAL3) LDTP07994 C1760(14.24)  LDD0209 
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (PDK1) LDTP06320 C240(1.93)  LDD0080 
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (PDK2) LDTP06321 C45(2.27)  LDD0080 
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (PDK3) LDTP06322 C41(1.04)  LDD3313 
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial (PDK4) LDTP06595 C49(0.31)  LDD2236 
[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP1) LDTP12960 C132(1.03); C275(1.09); C149(0.92)  LDD1492 
[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial (PDP2) LDTP16181 C345(0.72)  LDD0532 
------------------------------------------------------------------------------------
⏷ Show the Full List of 4048 Enzyme
959 Transporter and channel Labeled by This Probe
Target Name Target ID Binding Site(Ratio) Interaction ID
14-3-3 protein epsilon (YWHAE) LDTP04969 C97(0.51); C98(0.75)  LDD0531 
14-3-3 protein gamma (YWHAG) LDTP04953 C112(1.08)  LDD0531 
14-3-3 protein theta (YWHAQ) LDTP03385 C134(0.97)  LDD0078 
14-3-3 protein zeta/delta (YWHAZ) LDTP05043 C25(1.58)  LDD0080 
A-kinase anchor protein 5 (AKAP5) LDTP03286 C62(8.25)  LDD0209 
Acetyl-coenzyme A transporter 1 (SLC33A1) LDTP00262 C479(0.60); C487(0.60)  LDD0531 
Activator of 90 kDa heat shock protein ATPase homolog 1 (AHSA1) LDTP01601 C301(0.98)  LDD0078 
Acyl-CoA-binding domain-containing protein 5 (ACBD5) LDTP07152 C83(1.13)  LDD0532 
Adaptin ear-binding coat-associated protein 1 (NECAP1) LDTP15485 C162(0.97)  LDD0531 
Adaptin ear-binding coat-associated protein 2 (NECAP2) LDTP16115 C133(11.62)  LDD0209 
Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (SLC35B2) LDTP09328 C199(0.78)  LDD0531 
Adiponectin receptor protein 1 (ADIPOR1) LDTP10063 C54(1.15); C369(0.98)  LDD1492 
Adiponectin receptor protein 2 (ADIPOR2) LDTP08269 C96(3.96)  LDD3339 
ADP-ribosylation factor-binding protein GGA1 (GGA1) LDTP13415 C465(1.10)  LDD1507 
ADP-ribosylation factor-binding protein GGA3 (GGA3) LDTP12874 C255(1.68)  LDD3332 
ADP/ATP translocase 1 (SLC25A4) LDTP02608 C160(0.97); C257(0.90)  LDD0078 
ADP/ATP translocase 2 (SLC25A5) LDTP02087 C129(0.89)  LDD0078 
ADP/ATP translocase 3 (SLC25A6) LDTP02609 C160(2.64); C257(2.39)  LDD0080 
Agrin (AGRN) LDTP00284 C1830(1.21); C1836(1.21); C389(1.05); C421(1.05)  LDD0078 
Aladin (AAAS) LDTP12510 C368(0.95); C321(0.88)  LDD0078 
All-trans retinoic acid-induced differentiation factor (ATRAID) LDTP07664 C52(2.94)  LDD3346 
Alpha- and gamma-adaptin-binding protein p34 (AAGAB) LDTP07564 C131(0.68)  LDD0531 
Alpha-actinin-2 (ACTN2) LDTP03768 C351(2.23); C173(3.56)  LDD3311 
Amino acid transporter heavy chain SLC3A1 (SLC3A1) LDTP05531 C273(2.97)  LDD3369 
Amino acid transporter heavy chain SLC3A2 (SLC3A2) LDTP02256 C462(2.57)  LDD3312 
Ammonium transporter Rh type A (RHAG) LDTP05335 C396(1.17)  LDD2324 
Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1) LDTP05352 C742(1.84)  LDD3344 
Amyloid-beta A4 precursor protein-binding family A member 2 (APBA2) LDTP10977 C272(1.13)  LDD3323 
Amyloid-beta precursor protein (APP) LDTP02071 C291(0.86); C300(0.86)  LDD0078 
Anion exchange protein 2 (SLC4A2) LDTP02061 C16(1.96)  LDD3375 
Ankyrin repeat domain-containing protein 50 (ANKRD50) LDTP16236 C43(0.99); C44(0.99)  LDD0078 
Ankyrin-1 (ANK1) LDTP02832 C509(3.42); C311(6.72); C564(1.27); C1257(2.86)  LDD3334 
Ankyrin-2 (ANK2) LDTP05293 C1425(1.23); C60(1.17)  LDD0080 
Ankyrin-3 (ANK3) LDTP05705 C1409(0.96)  LDD0531 
Annexin A1 (ANXA1) LDTP02010 C343(1.08); C324(1.00)  LDD0078 
Annexin A11 (ANXA11) LDTP04393 C384(7.38)  LDD0209 
Annexin A2 (ANXA2) LDTP02199 C280(7.93)  LDD3312 
Annexin A5 (ANXA5) LDTP02307 C316(0.51)  LDD0532 
Annexin A6 (ANXA6) LDTP02247 C59(1.01)  LDD0078 
Anoctamin-1 (ANO1) LDTP07279 C166(0.79); C395(0.75); C706(1.15)  LDD0531 
Anoctamin-10 (ANO10) LDTP12704 C265(1.16)  LDD0531 
Anoctamin-6 (ANO6) LDTP06855 C271(1.66)  LDD3311 
Anoctamin-9 (ANO9) LDTP00027 C405(1.36)  LDD3439 
AP-1 complex subunit beta-1 (AP1B1) LDTP05625 C144(1.15); C95(1.26); C241(2.32); C123(1.39)  LDD0080 
AP-1 complex subunit gamma-1 (AP1G1) LDTP00855 C539(80.19)  LDD0209 
AP-1 complex subunit mu-1 (AP1M1) LDTP11407 C76(0.85)  LDD1492 
AP-1 complex subunit sigma-1A (AP1S1) LDTP04949 C47(1.09)  LDD0531 
AP-2 complex subunit alpha-1 (AP2A1) LDTP01673 C171(0.93); C225(0.93); C267(0.77); C331(0.93)  LDD0531 
AP-2 complex subunit alpha-2 (AP2A2) LDTP01477 C491(1.05); C532(1.01)  LDD0531 
AP-2 complex subunit beta (AP2B1) LDTP05038 C391(8.01); C241(3.67); C66(3.04); C55(4.63)  LDD3310 
AP-2 complex subunit mu (AP2M1) LDTP10190 C246(3.76); C251(3.76)  LDD0080 
AP-3 complex subunit delta-1 (AP3D1) LDTP00383 C60(4.35); C574(7.55); C997(1.91); C971(2.09)  LDD3311 
AP-4 complex accessory subunit RUSC2 (RUSC2) LDTP08809 C1041(3.63)  LDD3325 
AP-4 complex accessory subunit Tepsin (TEPSIN) LDTP10609 C295(0.96)  LDD0078 
AP-4 complex subunit beta-1 (AP4B1) LDTP14232 C144(5.19)  LDD0204 
AP-4 complex subunit epsilon-1 (AP4E1) LDTP13696 C975(1.31); C976(1.31)  LDD0078 
AP-4 complex subunit mu-1 (AP4M1) LDTP00208 C431(0.95)  LDD0531 
AP-4 complex subunit sigma-1 (AP4S1) LDTP14101 C47(1.80)  LDD3323 
Apolipoprotein E (APOE) LDTP01936 C130(1.04)  LDD1492 
Apoptosis regulator BAX (BAX) LDTP05528 C62(1.05)  LDD1507 
Apoptotic chromatin condensation inducer in the nucleus (ACIN1) LDTP13490 C1083(0.95); C1223(0.91)  LDD0078 
Apoptotic protease-activating factor 1 (APAF1) LDTP00411 C203(0.94); C158(0.94)  LDD0078 
Aquaporin-3 (AQP3) LDTP09762 C11(0.96)  LDD0531 
ATP synthase F(0) complex subunit B1, mitochondrial (ATP5PB) LDTP03284 C239(15.53)  LDD3319 
ATP synthase F(0) complex subunit C2, mitochondrial (ATP5MC2) LDTP05474 C48(1.05)  LDD1513 
ATP synthase F(0) complex subunit C3, mitochondrial (ATP5MC3) LDTP04169 C9(0.69)  LDD1507 
ATP synthase protein 8 (MT-ATP8) LDTP01988 C59(1.06)  LDD1492 
ATP synthase subunit alpha, mitochondrial (ATP5F1A) LDTP03327 C294(1.50)  LDD0078 
ATP synthase subunit d, mitochondrial (ATP5PD) LDTP14509 C101(1.47)  LDD0080 
ATP synthase subunit gamma, mitochondrial (ATP5F1C) LDTP03810 C103(4.71)  LDD3310 
ATP synthase subunit O, mitochondrial (ATP5PO) LDTP04150 C141(0.86)  LDD0078 
ATP-binding cassette sub-family B member 10, mitochondrial (ABCB10) LDTP12517 C582(1.07)  LDD3312 
ATP-binding cassette sub-family C member 8 (ABCC8) LDTP05594 C922(4.00)  LDD2268 
ATP-binding cassette sub-family C member 9 (ABCC9) LDTP01035 C1411(1.28); C1318(2.07); C515(1.40)  LDD2412 
ATP-binding cassette sub-family F member 1 (ABCF1) LDTP09149 C741(1.01)  LDD0078 
ATP-binding cassette sub-family F member 2 (ABCF2) LDTP18526 C586(2.12); C388(3.46); C186(1.18)  LDD0080 
ATP-binding cassette sub-family F member 3 (ABCF3) LDTP16103 C102(1.03)  LDD0078 
ATP-sensitive inward rectifier potassium channel 11 (KCNJ11) LDTP06169 C344(1.09)  LDD2268 
ATP-sensitive inward rectifier potassium channel 15 (KCNJ15) LDTP10953 C183(2.50)  LDD3376 
ATP-sensitive inward rectifier potassium channel 8 (KCNJ8) LDTP06491 C43(2.44)  LDD3443 
Autophagy-related protein 101 (ATG101) LDTP11150 C116(1.72)  LDD3331 
Autophagy-related protein 13 (ATG13) LDTP01136 C364(1.72)  LDD3310 
Autophagy-related protein 16-1 (ATG16L1) LDTP07304 C533(1.29)  LDD0531 
Autophagy-related protein 2 homolog A (ATG2A) LDTP06727 C201(1.30)  LDD3423 
Autophagy-related protein 2 homolog B (ATG2B) LDTP10147 C1667(1.19)  LDD0078 
Autophagy-related protein 9A (ATG9A) LDTP08030 C433(0.96); C764(1.79); C197(0.92)  LDD0531 
B-cell receptor-associated protein 29 (BCAP29) LDTP16201 C171(0.97)  LDD1492 
B-lymphocyte antigen CD20 (MS4A1) LDTP02591 C167(1.43)  LDD2355 
Bactericidal permeability-increasing protein (BPI) LDTP02890 C206(2.70)  LDD3333 
Bardet-Biedl syndrome 1 protein (BBS1) LDTP09208 C148(2.01)  LDD3423 
Bardet-Biedl syndrome 2 protein (BBS2) LDTP11371 C662(1.04)  LDD1492 
Bardet-Biedl syndrome 4 protein (BBS4) LDTP10766 C370(0.95); C264(0.95)  LDD1508 
Bardet-Biedl syndrome 5 protein (BBS5) LDTP08832 C33(1.01)  LDD1492 
Bardet-Biedl syndrome 7 protein (BBS7) LDTP08576 C243(0.90)  LDD1507 
Battenin (CLN3) LDTP05814 C92(1.11)  LDD1508 
Bcl-2 homologous antagonist/killer (BAK1) LDTP06573 C166(1.34); C14(1.10)  LDD0078 
Bcl-2-like protein 11 (BCL2L11) LDTP00790 C12(1.72)  LDD3312 
Bcl-2-like protein 2 (BCL2L2) LDTP09900 C29(1.43)  LDD3342 
Bcl-2-related ovarian killer protein (BOK) LDTP13629 C195(0.93)  LDD0531 
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) LDTP05717 C129(1.20)  LDD3427 
Beclin 1-associated autophagy-related key regulator (ATG14) LDTP07793 C43(1.16); C46(1.16); C330(0.97); C335(0.97)  LDD0078 
Beclin-1 (BECN1) LDTP06124 C353(1.09)  LDD0078 
Beta-arrestin-1 (ARRB1) LDTP04250 C251(1.86); C269(1.86); C140(0.89)  LDD0531 
Beta-arrestin-2 (ARRB2) LDTP03627 C162(1.40)  LDD3312 
Beta-defensin 1 (DEFB1) LDTP04848 C59(1.79)  LDD2379 
Blood vessel epicardial substance (BVES) LDTP09150 C221(2.13); C745(1.15); C358(1.39)  LDD3310 
Bone marrow stromal antigen 2 (BST2) LDTP05631 C53(5.51); C63(3.45)  LDD3311 
BOS complex subunit NCLN (NCLN) LDTP10036 C84(3.02)  LDD3311 
BOS complex subunit NOMO2 (NOMO2) LDTP06996 C565(1.38)  LDD0080 
BOS complex subunit TMEM147 (TMEM147) LDTP11292 C116(1.17); C23(0.93)  LDD0531 
Bridge-like lipid transfer protein family member 1 (BLTP1) LDTP06693 C1842(2.92)  LDD3410 
Bridge-like lipid transfer protein family member 3A (BLTP3A) LDTP07361 C81(0.97); C83(0.97)  LDD0078 
Bridge-like lipid transfer protein family member 3B (BLTP3B) LDTP00017 C1090(1.12); C1098(1.12)  LDD0078 
Cadherin-1 (CDH1) LDTP02634 C603(0.84)  LDD0078 
Calcium and integrin-binding protein 1 (CIB1) LDTP10988 C75(1.11)  LDD3312 
Calcium homeostasis modulator protein 6 (CALHM6) LDTP17205 C89(1.05)  LDD1507 
Calcium permeable stress-gated cation channel 1 (TMEM63C) LDTP13002 C256(1.30)  LDD3314 
Calcium uniporter regulatory subunit MCUb, mitochondrial (MCUB) LDTP12725 C147(1.26)  LDD3312 
Calcium uptake protein 1, mitochondrial (MICU1) LDTP11041 C275(12.98)  LDD0209 
Calcium uptake protein 2, mitochondrial (MICU2) LDTP08673 C144(0.85)  LDD0078 
Calcium-activated potassium channel subunit alpha-1 (KCNMA1) LDTP05649 C947(3.21)  LDD3337 
Calcium-binding protein 1 (CABP1) LDTP12941 C105(0.74)  LDD2252 
Calnexin (CANX) LDTP03405 C360(2.25); C366(2.25)  LDD0080 
Calreticulin (CALR) LDTP03402 C137(1.16); C105(0.96)  LDD0078 
Calretinin (CALB2) LDTP14656 C101(0.74)  LDD3312 
Catenin delta-1 (CTNND1) LDTP01037 C618(1.08); C581(0.89); C394(0.86)  LDD0078 
Cation-dependent mannose-6-phosphate receptor (M6PR) LDTP03061 C132(1.73)  LDD0080 
Cation-independent mannose-6-phosphate receptor (IGF2R) LDTP02586 C149(1.04); C519(0.99); C1270(0.97); C1333(0.89)  LDD0078 
Cationic amino acid transporter 2 (SLC7A2) LDTP04512 C416(2.82)  LDD3493 
Caveolin-1 (CAV1) LDTP05394 C143(0.91)  LDD0532 
CBP80/20-dependent translation initiation factor (CTIF) LDTP00741 C556(5.18)  LDD0209 
CCN family member 3 (CCN3) LDTP04216 C315(1.59)  LDD3427 
CD151 antigen (CD151) LDTP04187 C184(0.90); C185(0.91); C192(0.88)  LDD0531 
CD2-associated protein (CD2AP) LDTP14131 C540(1.11)  LDD0531 
CD44 antigen (CD44) LDTP02823 C77(1.04)  LDD0078 
CD81 antigen (CD81) LDTP04849 C175(1.70)  LDD0531 
CD9 antigen (CD9) LDTP03142 C181(1.11)  LDD0637 
Cell cycle control protein 50A (TMEM30A) LDTP12665 C17(1.65)  LDD0080 
Cell division cycle protein 20 homolog (CDC20) LDTP05662 C364(1.02)  LDD0078 
Cellular tumor antigen p53 (TP53) LDTP02048 C135(1.34); C124(1.25); C182(1.30); C277(1.70)  LDD0080 
Ceramide transfer protein (CERT1) LDTP14140 C70(2.33); C587(1.96); C65(1.52)  LDD3314 
Chloride channel CLIC-like protein 1 (CLCC1) LDTP10804 C254(1.23)  LDD3315 
Chloride intracellular channel protein 1 (CLIC1) LDTP00244 C89(1.17); C59(1.14)  LDD0078 
Chloride intracellular channel protein 2 (CLIC2) LDTP00588 C114(1.39)  LDD3310 
Chloride intracellular channel protein 3 (CLIC3) LDTP01689 C22(1.12); C25(1.12)  LDD0078 
Chloride intracellular channel protein 4 (CLIC4) LDTP14222 C234(0.95)  LDD0078 
Chloride intracellular channel protein 5 (CLIC5) LDTP12882 C32(1.13)  LDD3314 
Chloride intracellular channel protein 6 (CLIC6) LDTP10642 C487(1.37)  LDD3312 
Choline transporter-like protein 1 (SLC44A1) LDTP09651 C159(2.94)  LDD3427 
Choline transporter-like protein 2 (SLC44A2) LDTP08531 C401(1.81)  LDD3310 
Chromaffin granule amine transporter (SLC18A1) LDTP04603 C324(1.11); C50(1.87)  LDD3311 
Clathrin heavy chain 1 (CLTC) LDTP05252 C870(1.15); C926(1.02); C934(1.02)  LDD0078 
Clathrin heavy chain 2 (CLTCL1) LDTP04578 C892(1.95)  LDD0080 
Clathrin interactor 1 (CLINT1) LDTP06177 C231(0.91)  LDD1492 
Clathrin light chain A (CLTA) LDTP02352 C218(1.00)  LDD0531 
Clathrin light chain B (CLTB) LDTP02353 C199(1.95)  LDD0080 
Claudin domain-containing protein 1 (CLDND1) LDTP16136 C106(0.96)  LDD1507 
Claudin-7 (CLDN7) LDTP01614 C54(0.64); C64(0.64)  LDD0531 
CMP-sialic acid transporter (SLC35A1) LDTP05116 C127(0.69); C131(0.69)  LDD0531 
Coiled-coil domain-containing protein 22 (CCDC22) LDTP01056 C369(1.08)  LDD0531 
Coiled-coil domain-containing protein 93 (CCDC93) LDTP06928 C282(0.98)  LDD0532 
Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP) LDTP05510 C186(2.14)  LDD3314 
Complex I assembly factor TMEM126B, mitochondrial (TMEM126B) LDTP08469 C140(2.44)  LDD3312 
Copine-1 (CPNE1) LDTP10989 C53(1.54)  LDD0080 
Copine-3 (CPNE3) LDTP01133 C54(0.93)  LDD0078 
Copper homeostasis protein cutC homolog (CUTC) LDTP12611 C248(1.06)  LDD0078 
CSC1-like protein 1 (TMEM63A) LDTP01449 C372(0.89); C377(0.89)  LDD0078 
CSC1-like protein 2 (TMEM63B) LDTP15003 C23(1.60)  LDD0625 
Cystatin-B (CSTB) LDTP02009 C3(12.13)  LDD2236 
Cysteine protease ATG4B (ATG4B) LDTP14068 C277(1.34)  LDD3314 
Cysteine-rich motor neuron 1 protein (CRIM1) LDTP12942 C260(1.19); C268(1.19)  LDD0078 
Cystine/glutamate transporter (SLC7A11) LDTP13734 C414(2.23)  LDD3352 
Cytochrome c (CYCS) LDTP05231 C15(1.22)  LDD1507 
Cytochrome c oxidase assembly protein COX18, mitochondrial (COX18) LDTP08981 C165(0.86)  LDD1492 
Cytochrome c oxidase assembly protein COX20, mitochondrial (COX20) LDTP07053 C41(1.97)  LDD3311 
Cytochrome c oxidase subunit 5B, mitochondrial (COX5B) LDTP02504 C116(0.73)  LDD3314 
Cytochrome c oxidase subunit 7C, mitochondrial (COX7C) LDTP02818 C42(1.22)  LDD3490 
Cytoplasmic dynein 2 intermediate chain 1 (DYNC2I1) LDTP09622 C1047(4.17)  LDD0080 
Cytoplasmic phosphatidylinositol transfer protein 1 (PITPNC1) LDTP13450 C182(0.57); C136(0.57); C142(0.57)  LDD0531 
Cytoskeleton-associated protein 4 (CKAP4) LDTP05511 C100(1.65)  LDD0078 
Defensin-6 (DEFA6) LDTP05296 C94(2.57); C123(3.14)  LDD3377 
Desmocollin-2 (DSC2) LDTP05356 C769(0.89); C871(1.12); C872(1.12)  LDD0531 
Desmoplakin (DSP) LDTP02815 C1499(6.38)  LDD0206 
Dihydropyrimidinase-related protein 2 (DPYSL2) LDTP06554 C504(0.96)  LDD0078 
Disintegrin and metalloproteinase domain-containing protein 11 (ADAM11) LDTP01116 C392(1.31)  LDD1507 
Disks large homolog 1 (DLG1) LDTP05706 C378(3.11)  LDD3312 
DmX-like protein 2 (DMXL2) LDTP09439 C1788(209.34); C1565(61.28); C920(16.15); C1779(90.86)  LDD0209 
DNA damage-regulated autophagy modulator protein 2 (DRAM2) LDTP07697 C252(9.47)  LDD0209 
DnaJ homolog subfamily B member 12 (DNAJB12) LDTP12793 C11(1.34)  LDD3439 
DnaJ homolog subfamily B member 14 (DNAJB14) LDTP09352 C178(1.21)  LDD0078 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST) LDTP03870 C145(0.78)  LDD0533 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (RPN1) LDTP02057 C545(1.13); C477(0.99)  LDD0078 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (RPN2) LDTP02058 C100(4.08)  LDD3319 
Dysferlin (DYSF) LDTP01355 C1430(2.29); C660(2.08); C1923(2.61); C2010(3.05)  LDD3312 
Dystrobrevin alpha (DTNA) LDTP14062 C197(1.00); C309(0.83)  LDD0531 
Dystroglycan 1 (DAG1) LDTP06039 C713(0.40)  LDD0533 
Dystrophin (DMD) LDTP02579 C859(1.08)  LDD3316 
EH domain-containing protein 1 (EHD1) LDTP11934 C138(1.11)  LDD0547 
Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial (SLC25A12) LDTP01301 C375(3.00); C563(1.58)  LDD0080 
Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (SLC25A13) LDTP13393 C504(2.62)  LDD3310 
Endophilin-B1 (SH3GLB1) LDTP13953 C304(4.08)  LDD0209 
Endoplasmic reticulum junction formation protein lunapark (LNPK) LDTP11609 C149(1.16)  LDD0531 
Endosomal/lysosomal proton channel TMEM175 (TMEM175) LDTP11149 C32(1.06)  LDD3323 
Equilibrative nucleobase transporter 1 (SLC43A3) LDTP09052 C344(0.88)  LDD3413 
Equilibrative nucleoside transporter 1 (SLC29A1) LDTP10985 C378(0.98)  LDD1507 
Equilibrative nucleoside transporter 2 (SLC29A2) LDTP06144 C378(1.30); C366(0.82)  LDD1507 
ER lumen protein-retaining receptor 1 (KDELR1) LDTP03277 C29(1.26)  LDD0531 
ER membrane protein complex subunit 1 (EMC1) LDTP08960 C587(1.51); C338(3.02)  LDD3310 
ER membrane protein complex subunit 10 (EMC10) LDTP07203 C49(1.09)  LDD1507 
ER membrane protein complex subunit 2 (EMC2) LDTP06271 C192(0.80)  LDD1510 
ER membrane protein complex subunit 4 (EMC4) LDTP06994 C69(0.93)  LDD0078 
ER membrane protein complex subunit 6 (EMC6) LDTP11272 C29(0.88)  LDD0531 
ER membrane protein complex subunit 8 (EMC8) LDTP00760 C12(0.91); C153(0.95); C161(0.95)  LDD0531 
ER membrane protein complex subunit 9 (EMC9) LDTP16277 C177(0.80)  LDD3311 
Erlin-1 (ERLIN1) LDTP01234 C310(1.12)  LDD0078 
Erlin-2 (ERLIN2) LDTP01455 C262(1.11)  LDD0080 
Etoposide-induced protein 2.4 homolog (EI24) LDTP00405 C24(0.98)  LDD0078 
Eukaryotic translation initiation factor 4E transporter (EIF4ENIF1) LDTP12493 C50(1.89)  LDD3310 
Eukaryotic translation initiation factor 5A-1-like (EIF5AL1) LDTP17347 C159(0.86)  LDD3310 
Eukaryotic translation initiation factor 5A-2 (EIF5A2) LDTP11657 C73(0.83); C93(1.40)  LDD3331 
Excitatory amino acid transporter 1 (SLC1A3) LDTP04010 C375(0.91)  LDD3314 
Excitatory amino acid transporter 3 (SLC1A1) LDTP04012 C343(1.28)  LDD3341 
Excitatory amino acid transporter 4 (SLC1A6) LDTP04204 C194(3.03)  LDD3416 
Exocyst complex component 1 (EXOC1) LDTP12661 C566(1.14); C650(1.06); C27(0.90)  LDD0078 
Exocyst complex component 2 (EXOC2) LDTP10513 C541(5.68); C719(1.50); C388(1.79)  LDD0080 
Exocyst complex component 3 (EXOC3) LDTP01016 C161(1.10)  LDD0078 
Exocyst complex component 4 (EXOC4) LDTP10069 C957(1.14)  LDD0078 
Exocyst complex component 5 (EXOC5) LDTP00287 C111(0.90); C254(0.86)  LDD0078 
Exocyst complex component 6 (EXOC6) LDTP09301 C54(5.32)  LDD0209 
Exocyst complex component 7 (EXOC7) LDTP13716 C550(0.85); C667(0.66)  LDD0532 
Exocyst complex component 8 (EXOC8) LDTP08651 C428(0.99); C664(1.40)  LDD0531 
Exportin-1 (XPO1) LDTP00501 C1070(1.24); C498(1.06); C528(0.98)  LDD0078 
Exportin-2 (CSE1L) LDTP04662 C387(0.90); C939(0.87); C842(0.87)  LDD0078 
Exportin-4 (XPO4) LDTP11607 C723(1.54); C796(1.06); C868(1.42)  LDD0080 
Exportin-5 (XPO5) LDTP12142 C1131(1.10); C736(0.94); C941(0.94); C44(0.93)  LDD0078 
Exportin-7 (XPO7) LDTP13335 C123(1.17)  LDD0080 
Exportin-T (XPOT) LDTP00810 C650(1.36); C845(0.86)  LDD0078 
Extended synaptotagmin-1 (ESYT1) LDTP11161 C532(2.36)  LDD3311 
Extended synaptotagmin-2 (ESYT2) LDTP00014 C831(2.42)  LDD3310 
Extended synaptotagmin-3 (ESYT3) LDTP00015 C503(1.53)  LDD3383 
Failed axon connections homolog (FAXC) LDTP17250 C235(2.41)  LDD3410 
Fatty acid-binding protein 5 (FABP5) LDTP05292 C87(0.86)  LDD0078 
Fermitin family homolog 1 (FERMT1) LDTP11089 C423(0.89); C517(0.68)  LDD0531 
Fibroblast growth factor 2 (FGF2) LDTP02325 C229(1.43)  LDD0078 
Filamin-A (FLNA) LDTP03107 C483(1.10); C2476(1.09); C2479(1.09); C2199(1.05)  LDD0078 
Filamin-B (FLNB) LDTP01197 C2556(9.72)  LDD0209 
Filamin-C (FLNC) LDTP06103 C1348(1.14); C618(1.07); C626(1.07); C1066(1.01)  LDD0078 
Flotillin-1 (FLOT1) LDTP01366 C85(2.12); C34(2.57)  LDD3310 
Folate receptor alpha (FOLR1) LDTP02781 C135(1.01)  LDD3313 
FYVE and coiled-coil domain-containing protein 1 (FYCO1) LDTP11094 C1203(2.47); C1207(2.47); C1206(2.47); C1179(1.59)  LDD0080 
G protein-activated inward rectifier potassium channel 4 (KCNJ5) LDTP04189 C60(1.61)  LDD2377 
G-protein coupled receptor-associated protein LMBRD2 (LMBRD2) LDTP15064 C275(2.32)  LDD3311 
G1/S-specific cyclin-D1 (CCND1) LDTP03274 C239(1.03); C243(1.03)  LDD0078 
G2/mitotic-specific cyclin-B1 (CCNB1) LDTP02735 C238(1.01)  LDD0078 
G2/mitotic-specific cyclin-B2 (CCNB2) LDTP01492 C106(3.18); C115(3.18)  LDD0080 
Galectin-3 (LGALS3) LDTP02929 C173(0.47)  LDD0531 
Gap junction alpha-1 protein (GJA1) LDTP02894 C271(1.11)  LDD0078 
Gap junction alpha-8 protein (GJA8) LDTP04165 C405(0.43)  LDD2236 
Gap junction beta-3 protein (GJB3) LDTP01297 C113(0.86)  LDD0531 
Gap junction gamma-1 protein (GJC1) LDTP03803 C214(1.38)  LDD3360 
Gasdermin-A (GSDMA) LDTP10728 C201(2.50)  LDD2319 
Gasdermin-D (GSDMD) LDTP04801 C268(1.10); C56(1.18)  LDD0531 
Gasdermin-E (GSDME) LDTP00970 C45(1.40); C180(0.88)  LDD0078 
Glioma pathogenesis-related protein 1 (GLIPR1) LDTP14694 C195(1.28); C192(1.09)  LDD0078 
Glucose-6-phosphate exchanger SLC37A1 (SLC37A1) LDTP04776 C250(1.53)  LDD3348 
Glucose-6-phosphate exchanger SLC37A4 (SLC37A4) LDTP00882 C242(1.18)  LDD1492 
Glutamate receptor 4 (GRIA4) LDTP04155 C878(2.24)  LDD2469 
Glutamate receptor-interacting protein 1 (GRIP1) LDTP14006 C515(0.98); C1065(1.00)  LDD1508 
Glycosylated lysosomal membrane protein (GLMP) LDTP09643 C216(1.71)  LDD3427 
Golgi resident protein GCP60 (ACBD3) LDTP11877 C169(1.33)  LDD0080 
Golgi SNAP receptor complex member 1 (GOSR1) LDTP01542 C34(1.54)  LDD3330 
Golgi-associated PDZ and coiled-coil motif-containing protein (GOPC) LDTP12281 C408(2.08)  LDD0080 
Golgin subfamily A member 5 (GOLGA5) LDTP09333 C208(1.56)  LDD0080 
Growth hormone-inducible transmembrane protein (GHITM) LDTP11869 C235(2.69)  LDD3338 
Guanine nucleotide exchange factor VAV2 (VAV2) LDTP04520 C201(0.86); C202(0.86)  LDD0078 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 (GNGT2) LDTP00381 C40(1.73)  LDD3335 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (GNB1) LDTP05017 C148(1.02); C149(1.02); C204(0.90)  LDD0078 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (GNB2) LDTP05020 C204(0.93)  LDD0078 
Guanine nucleotide-binding protein subunit alpha-11 (GNA11) LDTP03506 C144(0.59)  LDD0532 
Guided entry of tail-anchored proteins factor 1 (GET1) LDTP00234 C1496(1.44)  LDD3310 
Guided entry of tail-anchored proteins factor CAMLG (CAMLG) LDTP04227 C123(2.24)  LDD3312 
H(+)/Cl(-) exchange transporter 3 (CLCN3) LDTP04459 C733(1.64)  LDD3310 
H(+)/Cl(-) exchange transporter 4 (CLCN4) LDTP04460 C85(1.43)  LDD3332 
H(+)/Cl(-) exchange transporter 5 (CLCN5) LDTP04461 C783(1.71)  LDD3319 
H(+)/Cl(-) exchange transporter 6 (CLCN6) LDTP04462 C759(1.34)  LDD3337 
H(+)/Cl(-) exchange transporter 7 (CLCN7) LDTP04463 C211(1.45)  LDD0080 
Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1) LDTP14123 C130(0.87)  LDD1492 
Heat shock protein HSP 90-beta (HSP90AB1) LDTP02262 C590(1.06); C589(1.05); C564(0.98)  LDD0078 
Heme transporter FLVCR1 (FLVCR1) LDTP14178 C185(0.79)  LDD1492 
HIG1 domain family member 2A, mitochondrial (HIGD2A) LDTP15898 C53(0.94)  LDD1492 
High affinity cationic amino acid transporter 1 (SLC7A1) LDTP03559 C628(1.13)  LDD0080 
High affinity copper uptake protein 1 (SLC31A1) LDTP00636 C189(0.91)  LDD0078 
Histone deacetylase complex subunit SAP18 (SAP18) LDTP00270 C26(309.64)  LDD0209 
Hsp90 co-chaperone Cdc37 (CDC37) LDTP06549 C336(0.98)  LDD0078 
Huntingtin (HTT) LDTP04007 C664(0.92)  LDD0078 
Huntingtin-interacting protein 1 (HIP1) LDTP00241 C613(1.47); C220(0.95)  LDD0078 
Hypoxia up-regulated protein 1 (HYOU1) LDTP14066 C352(24.00)  LDD0209 
Importin subunit alpha-1 (KPNA2) LDTP04501 C223(1.11)  LDD0078 
Importin subunit alpha-3 (KPNA4) LDTP00328 C174(0.93); C191(0.93)  LDD0078 
Importin subunit alpha-4 (KPNA3) LDTP00298 C174(0.93); C191(0.93)  LDD0078 
Importin subunit alpha-5 (KPNA1) LDTP04502 C240(1.97)  LDD0080 
Importin subunit alpha-6 (KPNA5) LDTP00549 C357(1.22)  LDD0532 
Importin subunit alpha-7 (KPNA6) LDTP01031 C139(1.36)  LDD0080 
Importin subunit beta-1 (KPNB1) LDTP06242 C223(0.85); C228(0.85)  LDD0078 
Importin-11 (IPO11) LDTP13322 C252(7.78)  LDD0204 
Importin-13 (IPO13) LDTP01434 C810(7.94); C848(45.47)  LDD0209 
Importin-4 (IPO4) LDTP09515 C797(14.05); C708(17.13); C782(5.61); C459(4.74)  LDD0209 
Importin-5 (IPO5) LDTP00266 C682(4.36); C687(4.36); C560(4.44)  LDD0204 
Importin-7 (IPO7) LDTP01574 C113(0.84); C415(1.03); C477(0.78); C484(0.74)  LDD0531 
Importin-8 (IPO8) LDTP00630 C727(0.86); C736(0.86)  LDD0078 
Importin-9 (IPO9) LDTP10663 C90(1.13); C864(0.87)  LDD0078 
Inositol 1,4,5-triphosphate receptor associated 2 (IRAG2) LDTP05692 C287(1.22)  LDD3312 
Inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) LDTP06165 C1656(1.01); C1663(1.01)  LDD0078 
Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2) LDTP06152 C1879(9.26)  LDD0209 
Inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) LDTP06153 C2668(1.10)  LDD0078 
Insulin-induced gene 2 protein (INSIG2) LDTP14161 C215(3.52)  LDD3325 
Integral membrane protein 2A (ITM2A) LDTP14461 C90(2.36)  LDD3423 
Integral membrane protein 2B (ITM2B) LDTP13833 C89(1.49)  LDD0602 
Integral membrane protein 2C (ITM2C) LDTP12451 C96(1.59)  LDD0532 
Integrin alpha-1 (ITGA1) LDTP04731 C567(2.66); C297(3.82)  LDD3346 
Integrin alpha-11 (ITGA11) LDTP13497 C988(0.34)  LDD2236 
Integrin alpha-5 (ITGA5) LDTP02295 C192(3.55); C731(2.99)  LDD3310 
Integrin alpha-6 (ITGA6) LDTP03211 C86(0.90); C665(0.83); C671(0.83)  LDD0531 
Integrin alpha-7 (ITGA7) LDTP05965 C140(2.16)  LDD3332 
Integrin alpha-L (ITGAL) LDTP03066 C929(3.44); C150(4.39); C111(1.73)  LDD3333 
Integrin alpha-V (ITGAV) LDTP02166 C158(1.27); C138(0.91); C626(0.89); C632(0.89)  LDD0078 
Integrin beta-1 (ITGB1) LDTP02122 C691(1.69); C75(1.44)  LDD3310 
Integrin beta-1-binding protein 1 (ITGB1BP1) LDTP00409 C60(1.03)  LDD0078 
Integrin beta-like protein 1 (ITGBL1) LDTP14553 C50(1.84)  LDD3369 
Interferon-induced GTP-binding protein Mx2 (MX2) LDTP03058 C52(2.90)  LDD3312 
Intermembrane lipid transfer protein VPS13A (VPS13A) LDTP10769 C1608(1.11)  LDD0593 
Intermembrane lipid transfer protein VPS13B (VPS13B) LDTP08151 C2130(35.83)  LDD0209 
Intraflagellar transport protein 122 homolog (IFT122) LDTP12176 C519(9.68)  LDD0204 
Intraflagellar transport protein 27 homolog (IFT27) LDTP11316 C166(1.00)  LDD0078 
Intraflagellar transport protein 56 (IFT56) LDTP00010 C227(2.44)  LDD3311 
Intraflagellar transport protein 74 homolog (IFT74) LDTP10541 C53(3.14)  LDD3493 
Intraflagellar transport protein 81 homolog (IFT81) LDTP09731 C535(1.36)  LDD0080 
Intraflagellar transport protein 88 homolog (IFT88) LDTP05747 C549(32.19)  LDD0204 
Inward rectifier potassium channel 16 (KCNJ16) LDTP12373 C363(1.75)  LDD3478 
Ion channel TACAN (TMEM120A) LDTP11387 C47(0.90)  LDD0531 
Iron-sulfur clusters transporter ABCB7, mitochondrial (ABCB7) LDTP01100 C752(1.02)  LDD1492 
Junctophilin-1 (JPH1) LDTP12292 C101(1.62); C626(3.07)  LDD0080 
Junctophilin-2 (JPH2) LDTP11100 C29(1.56)  LDD3331 
Junctophilin-3 (JPH3) LDTP09703 C30(1.04)  LDD3331 
Kidney mitochondrial carrier protein 1 (SLC25A30) LDTP17213 C239(4.19); C248(4.19)  LDD0080 
Kinase D-interacting substrate of 220 kDa (KIDINS220) LDTP13546 C1656(0.95); C1670(0.95)  LDD0078 
Kinesin-1 heavy chain (KIF5B) LDTP03664 C421(0.99)  LDD0078 
Kinesin-like protein KIF16B (KIF16B) LDTP10534 C126(4.08)  LDD3310 
Kunitz-type protease inhibitor 1 (SPINT1) LDTP00722 C424(1.15)  LDD0078 
Kunitz-type protease inhibitor 2 (SPINT2) LDTP00728 C158(0.87); C166(0.87)  LDD0078 
Large neutral amino acids transporter small subunit 1 (SLC7A5) LDTP05305 C496(1.06)  LDD0531 
Large neutral amino acids transporter small subunit 2 (SLC7A8) LDTP13284 C491(1.11)  LDD1508 
Large neutral amino acids transporter small subunit 3 (SLC43A1) LDTP01204 C384(1.04)  LDD1508 
Large neutral amino acids transporter small subunit 4 (SLC43A2) LDTP08818 C295(1.04)  LDD1507 
Latent-transforming growth factor beta-binding protein 1 (LTBP1) LDTP06205 C361(2.31)  LDD3318 
LETM1 domain-containing protein 1 (LETMD1) LDTP07514 C47(3.51)  LDD3310 
LETM1 domain-containing protein LETM2, mitochondrial (LETM2) LDTP14898 C379(2.76)  LDD3310 
Leucine zipper putative tumor suppressor 1 (LZTS1) LDTP13803 C450(1.01); C251(3.90); C385(2.50)  LDD3332 
Leucine-rich repeat transmembrane protein FLRT3 (FLRT3) LDTP12938 C355(1.98)  LDD3369 
Leucine-rich repeat-containing protein 15 (LRRC15) LDTP09531 C433(1.52)  LDD3332 
Leucine-rich repeat-containing protein 59 (LRRC59) LDTP10081 C48(0.92)  LDD0078 
LHFPL tetraspan subfamily member 6 protein (LHFPL6) LDTP18588 C50(1.06)  LDD1507 
Lipid scramblase CLPTM1L (CLPTM1L) LDTP10499 C496(0.92)  LDD1507 
Low-density lipoprotein receptor (LDLR) LDTP01829 C377(0.86); C379(0.86)  LDD0531 
Low-density lipoprotein receptor-related protein 2 (LRP2) LDTP05218 C4401(2.51)  LDD3365 
Low-density lipoprotein receptor-related protein 4 (LRP4) LDTP01122 C331(0.77)  LDD3318 
Ly6/PLAUR domain-containing protein 6B (LYPD6B) LDTP15570 C155(1.53)  LDD3380 
Lysosomal cholesterol signaling protein (GPR155) LDTP17536 C629(1.70)  LDD3377 
Lysosomal cobalamin transport escort protein LMBD1 (LMBRD1) LDTP12636 C466(1.03); C475(1.03)  LDD0531 
Lysosomal-associated transmembrane protein 4A (LAPTM4A) LDTP06275 C19(0.84)  LDD1512 
Lysosomal-associated transmembrane protein 5 (LAPTM5) LDTP05928 C218(2.00)  LDD2351 
Lysosome membrane protein 2 (SCARB2) LDTP06034 C274(1.04)  LDD0533 
Lysosome-associated membrane glycoprotein 1 (LAMP1) LDTP02562 C338(1.16)  LDD0531 
Lysosome-associated membrane glycoprotein 2 (LAMP2) LDTP02655 C153(6.52)  LDD3311 
Macoilin (MACO1) LDTP08897 C315(1.11); C502(1.11)  LDD0078 
Macrophage-expressed gene 1 protein (MPEG1) LDTP06701 C534(1.10)  LDD3334 
Magnesium transporter MRS2 homolog, mitochondrial (MRS2) LDTP12280 C148(1.21)  LDD3331 
Magnesium transporter NIPA1 (NIPA1) LDTP07993 C126(0.98); C130(0.98)  LDD1094 
Magnesium transporter NIPA2 (NIPA2) LDTP17753 C340(1.00)  LDD1512 
Magnesium transporter NIPA3 (NIPAL1) LDTP17362 C393(1.09)  LDD1513 
Major facilitator superfamily domain-containing protein 12 (MFSD12) LDTP07480 C87(0.84)  LDD1508 
Major facilitator superfamily domain-containing protein 3 (MFSD3) LDTP18153 C296(0.92)  LDD1511 
Major facilitator superfamily domain-containing protein 6 (MFSD6) LDTP07826 C743(1.15)  LDD1507 
Major prion protein (PRNP) LDTP02018 C214(0.96)  LDD1509 
Major vault protein (MVP) LDTP06203 C572(0.93); C59(0.71)  LDD0531 
MARVEL domain-containing protein 2 (MARVELD2) LDTP08875 C395(1.16)  LDD0078 
MARVEL domain-containing protein 3 (MARVELD3) LDTP10067 C195(2.34)  LDD3486 
Meckelin (TMEM67) LDTP06985 C817(1.12)  LDD3315 
Melanoma inhibitory activity protein 2 (MIA2) LDTP10669 C739(1.76)  LDD3312 
Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (MAGI2) LDTP08233 C1378(1.44)  LDD3369 
Membrane-associated phosphatidylinositol transfer protein 1 (PITPNM1) LDTP00311 C259(2.52)  LDD3312 
Membrane-associated phosphatidylinositol transfer protein 2 (PITPNM2) LDTP11517 C752(1.82)  LDD3337 
Membrane-associated progesterone receptor component 1 (PGRMC1) LDTP00235 C129(0.98)  LDD1507 
Membrane-associated progesterone receptor component 2 (PGRMC2) LDTP00562 C183(1.26)  LDD3310 
Membrane-associated transporter protein (SLC45A2) LDTP13632 C171(2.58)  LDD3413 
Metal cation symporter ZIP14 (SLC39A14) LDTP06293 C322(8.04)  LDD0080 
Metal cation symporter ZIP8 (SLC39A8) LDTP11623 C289(0.91); C291(0.91)  LDD0532 
Metal transporter CNNM1 (CNNM1) LDTP16077 C733(1.87)  LDD3483 
Metal transporter CNNM2 (CNNM2) LDTP12060 C293(1.03)  LDD0532 
Metal transporter CNNM3 (CNNM3) LDTP09144 C376(1.59)  LDD3317 
Metal transporter CNNM4 (CNNM4) LDTP07537 C736(1.60)  LDD0080 
Metaxin-1 (MTX1) LDTP05900 C326(2.20)  LDD3310 
Metaxin-2 (MTX2) LDTP01217 C246(0.96)  LDD0531 
Metaxin-3 (MTX3) LDTP14970 C230(1.28)  LDD0531 
Methylosome subunit pICln (CLNS1A) LDTP04597 C73(1.29)  LDD0080 
MICOS complex subunit MIC10 (MICOS10) LDTP07191 C13(1.08)  LDD0531 
MICOS complex subunit MIC26 (APOO) LDTP11250 C71(1.15); C78(1.15)  LDD0532 
MICOS complex subunit MIC60 (IMMT) LDTP06660 C603(0.77)  LDD0531 
Microsomal triglyceride transfer protein large subunit (MTTP) LDTP04677 C301(2.15)  LDD3380 
Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (MACF1) LDTP13698 C5131(1.44); C222(1.35)  LDD0080 
Mitochondrial 2-oxodicarboxylate carrier (SLC25A21) LDTP11095 C46(1.92)  LDD0080 
Mitochondrial 2-oxoglutarate/malate carrier protein (SLC25A11) LDTP05384 C184(1.04)  LDD0531 
Mitochondrial adenyl nucleotide antiporter SLC25A24 (SLC25A24) LDTP07472 C330(0.90)  LDD0078 
Mitochondrial adenyl nucleotide antiporter SLC25A25 (SLC25A25) LDTP07439 C249(3.63)  LDD3311 
Mitochondrial basic amino acids transporter (SLC25A29) LDTP08982 C181(1.02)  LDD0531 
Mitochondrial carnitine/acylcarnitine carrier protein (SLC25A20) LDTP00865 C58(1.01); C283(0.99)  LDD0078 
Mitochondrial carrier homolog 1 (MTCH1) LDTP12909 C385(1.15)  LDD0078 
Mitochondrial carrier homolog 2 (MTCH2) LDTP14235 C49(1.22); C160(1.14); C163(1.14); C296(1.13)  LDD0078 
Mitochondrial carrier protein SCaMC-3L (SLC25A41) LDTP15431 C368(2.41)  LDD3379 
Mitochondrial chaperone BCS1 (BCS1L) LDTP13823 C234(1.04)  LDD0531 
Mitochondrial coenzyme A transporter SLC25A42 (SLC25A42) LDTP08279 C235(1.29)  LDD1507 
Mitochondrial dicarboxylate carrier (SLC25A10) LDTP13174 C249(2.16); C69(1.92)  LDD3310 
Mitochondrial glutamate carrier 1 (SLC25A22) LDTP12078 C271(1.01)  LDD0078 
Mitochondrial glutamate carrier 2 (SLC25A18) LDTP11772 C25(1.71)  LDD3442 
Mitochondrial glycine transporter (SLC25A38) LDTP10233 C140(0.89)  LDD1492 
Mitochondrial import inner membrane translocase subunit Tim10 (TIMM10) LDTP04956 C50(2.68)  LDD3310 
Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A) LDTP10913 C17(0.77)  LDD0531 
Mitochondrial import inner membrane translocase subunit Tim17-B (TIMM17B) LDTP01059 C17(2.67)  LDD3427 
Mitochondrial import inner membrane translocase subunit Tim22 (TIMM22) LDTP14099 C160(0.90)  LDD0580 
Mitochondrial import inner membrane translocase subunit Tim23 (TIMM23) LDTP00477 C170(0.96)  LDD1507 
Mitochondrial import inner membrane translocase subunit TIM44 (TIMM44) LDTP00821 C426(1.42); C343(1.40)  LDD0080 
Mitochondrial import receptor subunit TOM40 homolog (TOMM40) LDTP01748 C74(1.00); C86(0.89); C76(0.87)  LDD0078 
Mitochondrial inner membrane protein OXA1L (OXA1L) LDTP06308 C153(1.95)  LDD0080 
Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (SLC25A51) LDTP15966 C166(1.03); C107(1.04)  LDD1507 
Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A52 (SLC25A52) LDTP14916 C166(0.77)  LDD1492 
Mitochondrial ornithine transporter 1 (SLC25A15) LDTP14200 C50(2.91); C51(2.91)  LDD0080 
Mitochondrial outer membrane protein SLC25A46 (SLC25A46) LDTP10080 C93(7.23)  LDD3312 
Mitochondrial potassium channel ATP-binding subunit (ABCB8) LDTP12644 C478(1.27); C483(1.25); C364(1.30)  LDD0533 
Mitochondrial proton/calcium exchanger protein (LETM1) LDTP01525 C552(1.61)  LDD0080 
Mitochondrial pyruvate carrier 1 (MPC1) LDTP14163 C83(2.32)  LDD3337 
Mitochondrial pyruvate carrier 2 (MPC2) LDTP01631 C54(0.98)  LDD1492 
Mitochondrial S-adenosylmethionine carrier protein (SLC25A26) LDTP07885 C103(0.84)  LDD1492 
Mitochondrial sodium/calcium exchanger protein (SLC8B1) LDTP07432 C123(0.97)  LDD1509 
Mitochondrial thiamine pyrophosphate carrier (SLC25A19) LDTP12210 C222(0.98)  LDD0531 
Mitoferrin-2 (SLC25A28) LDTP15688 C49(2.98)  LDD3310 
Mitoguardin 1 (MIGA1) LDTP09028 C509(1.96); C240(1.49)  LDD0080 
Mitoguardin 2 (MIGA2) LDTP07953 C343(1.02)  LDD1511 
Mixed lineage kinase domain-like protein (MLKL) LDTP09038 C184(1.10)  LDD0078 
Molybdate-anion transporter (MFSD5) LDTP07456 C33(267.50)  LDD0209 
Monocarboxylate transporter 1 (SLC16A1) LDTP04592 C399(0.62); C400(0.62)  LDD0580 
Monocarboxylate transporter 10 (SLC16A10) LDTP09532 C334(1.07)  LDD1507 
Monocarboxylate transporter 13 (SLC16A13) LDTP08011 C340(1.01)  LDD1492 
Monocarboxylate transporter 4 (SLC16A3) LDTP00635 C161(0.70)  LDD0531 
Monocarboxylate transporter 6 (SLC16A5) LDTP14447 C474(1.37)  LDD2390 
Monocyte differentiation antigen CD14 (CD14) LDTP02281 C306(1.78)  LDD3343 
Mpv17-like protein 2 (MPV17L2) LDTP14952 C198(0.98)  LDD0531 
mRNA export factor GLE1 (GLE1) LDTP06902 C287(1.03)  LDD0078 
mRNA export factor RAE1 (RAE1) LDTP05122 C106(2.90)  LDD0080 
Mucin-13 (MUC13) LDTP11882 C360(1.49)  LDD3368 
Mucolipin-1 (MCOLN1) LDTP11650 C53(0.95)  LDD0547 
Mucolipin-2 (MCOLN2) LDTP08705 C53(3.02)  LDD3427 
Mucolipin-3 (MCOLN3) LDTP09430 C528(2.66)  LDD3332 
Multidrug and toxin extrusion protein 1 (SLC47A1) LDTP10309 C466(2.99)  LDD3369 
Multiple C2 and transmembrane domain-containing protein 2 (MCTP2) LDTP07370 C604(2.71)  LDD3310 
Myelin proteolipid protein (PLP1) LDTP04852 C201(1.57)  LDD3376 
Myeloid-associated differentiation marker (MYADM) LDTP10806 C288(0.90)  LDD0532 
Myoferlin (MYOF) LDTP12916 C1131(1.31); C1392(1.21); C1402(1.39); C1425(0.90)  LDD0531 
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF1) LDTP00419 C206(1.30)  LDD0531 
Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF2) LDTP06423 C271(0.88)  LDD0078 
Natural resistance-associated macrophage protein 2 (SLC11A2) LDTP04239 C14(2.78)  LDD3314 
Neurensin-2 (NRSN2) LDTP18360 C115(1.00)  LDD1492 
Neurogenic locus notch homolog protein 1 (NOTCH1) LDTP04098 C1293(1.14); C1295(1.14)  LDD0078 
Neuroligin-2 (NLGN2) LDTP09235 C317(1.31); C328(1.31)  LDD2171 
Neuron-specific calcium-binding protein hippocalcin (HPCA) LDTP05191 C185(1.01)  LDD0078 
Neuropilin-1 (NRP1) LDTP00433 C661(1.08)  LDD0078 
Neuropilin-2 (NRP2) LDTP00973 C149(1.06)  LDD3323 
Neutral amino acid transporter 9 (SLC38A9) LDTP09072 C41(1.84)  LDD3310 
Neutral amino acid transporter A (SLC1A4) LDTP04013 C500(0.77)  LDD0531 
Neutral amino acid transporter B(0) (SLC1A5) LDTP06462 C39(1.19)  LDD0078 
NPC intracellular cholesterol transporter 1 (NPC1) LDTP00541 C1261(1.08)  LDD0078 
NPC intracellular cholesterol transporter 2 (NPC2) LDTP04940 C42(1.21); C47(1.21)  LDD0533 
Nuclear cap-binding protein subunit 1 (NCBP1) LDTP05591 C320(1.74); C44(1.24)  LDD0080 
Nuclear cap-binding protein subunit 2 (NCBP2) LDTP04503 C81(1.31)  LDD0078 
Nuclear envelope integral membrane protein 1 (NEMP1) LDTP00361 C366(1.05); C371(1.05)  LDD0078 
Nuclear envelope pore membrane protein POM 121 (POM121) LDTP10378 C268(1.56); C307(1.53)  LDD0080 
Nuclear envelope pore membrane protein POM 121C (POM121C) LDTP00127 C284(1.17); C245(1.09)  LDD0078 
Nuclear pore complex protein Nup107 (NUP107) LDTP04800 C78(5.32)  LDD0080 
Nuclear pore complex protein Nup133 (NUP133) LDTP09579 C530(1.06)  LDD0078 
Nuclear pore complex protein Nup153 (NUP153) LDTP04309 C68(2.85); C66(3.04); C1129(1.61); C667(1.49)  LDD0080 
Nuclear pore complex protein Nup155 (NUP155) LDTP01295 C667(1.04); C1344(1.01)  LDD0078 
Nuclear pore complex protein Nup160 (NUP160) LDTP05642 C1124(1.40); C1131(1.40); C1166(1.06); C480(1.03)  LDD0078 
Nuclear pore complex protein Nup205 (NUP205) LDTP09825 C921(1.10); C922(1.10); C925(1.10); C698(0.96)  LDD0078 
Nuclear pore complex protein Nup214 (NUP214) LDTP03777 C728(10.40)  LDD0209 
Nuclear pore complex protein Nup50 (NUP50) LDTP13498 C151(1.01)  LDD0078 
Nuclear pore complex protein Nup85 (NUP85) LDTP11310 C51(0.88)  LDD0078 
Nuclear pore complex protein Nup88 (NUP88) LDTP10897 C713(2.56); C447(3.62); C608(1.95); C454(2.28)  LDD0080 
Nuclear pore complex protein Nup93 (NUP93) LDTP08769 C422(1.10); C522(1.03); C392(0.98)  LDD0078 
Nuclear pore glycoprotein p62 (NUP62) LDTP03839 C475(0.95)  LDD0078 
Nuclear pore membrane glycoprotein 210 (NUP210) LDTP09502 C1592(1.91)  LDD0531 
Nuclear protein localization protein 4 homolog (NPLOC4) LDTP09315 C188(1.82); C391(1.73); C355(2.77)  LDD3311 
Nuclear receptor coactivator 7 (NCOA7) LDTP09276 C487(1.78)  LDD0080 
Nuclear RNA export factor 1 (NXF1) LDTP13163 C252(0.93)  LDD0078 
Nucleoporin NDC1 (NDC1) LDTP11213 C468(1.05)  LDD0078 
Nucleoporin NUP188 (NUP188) LDTP07064 C1270(0.91)  LDD0078 
Nucleoporin NUP35 (NUP35) LDTP09204 C255(0.96)  LDD0078 
Nucleoporin Nup37 (NUP37) LDTP09203 C96(1.36)  LDD3310 
Nucleoporin Nup43 (NUP43) LDTP09202 C222(1.04)  LDD0531 
Nucleoporin p54 (NUP54) LDTP08029 C180(1.11)  LDD0078 
Nucleoporin p58/p45 (NUP58) LDTP11293 C252(1.14)  LDD0532 
Nucleoporin SEH1 (SEH1L) LDTP10256 C315(2.59); C77(1.36)  LDD3311 
Nucleoprotein TPR (TPR) LDTP02612 C1127(0.92)  LDD0078 
Occludin (OCLN) LDTP06581 C409(0.99)  LDD1492 
Oligosaccharyltransferase complex subunit OSTC (OSTC) LDTP12526 C14(3.96)  LDD3311 
Optineurin (OPTN) LDTP10189 C334(1.75)  LDD3313 
Organic cation/carnitine transporter 2 (SLC22A5) LDTP01398 C81(2.70)  LDD3310 
Oxysterol-binding protein-related protein 5 (OSBPL5) LDTP11740 C458(1.03); C459(1.03)  LDD0531 
Oxysterol-binding protein-related protein 8 (OSBPL8) LDTP11531 C617(1.17)  LDD0078 
P protein (OCA2) LDTP05423 C457(1.48)  LDD3337 
P2X purinoceptor 4 (P2RX4) LDTP10900 C286(2.24)  LDD3312 
P2X purinoceptor 7 (P2RX7) LDTP10901 C29(2.57); C82(2.83)  LDD3413 
p53 apoptosis effector related to PMP-22 (PERP) LDTP10321 C51(0.69); C65(0.69)  LDD0531 
Pannexin-1 (PANX1) LDTP10754 C84(0.76)  LDD0593 
PAT complex subunit CCDC47 (CCDC47) LDTP10059 C209(0.91)  LDD0078 
PDZ domain-containing protein 8 (PDZD8) LDTP09165 C884(1.52); C891(1.52); C667(2.01); C785(1.45)  LDD0080 
Pecanex-like protein 2 (PCNX2) LDTP00112 C296(2.03)  LDD3311 
Perforin-1 (PRF1) LDTP02717 C102(3.33)  LDD2412 
Pericentriolar material 1 protein (PCM1) LDTP06331 C582(1.17); C568(1.16); C1325(1.15); C1328(1.15)  LDD0078 
Peripheral-type benzodiazepine receptor-associated protein 1 (TSPOAP1) LDTP01507 C508(1.89)  LDD3323 
Peripherin-2 (PRPH2) LDTP03260 C144(2.34); C324(3.57)  LDD3340 
Peroxisomal biogenesis factor 19 (PEX19) LDTP03905 C128(0.92)  LDD0078 
Peroxisomal biogenesis factor 3 (PEX3) LDTP04749 C235(3.03); C251(3.03)  LDD0080 
Peroxisomal membrane protein 11A (PEX11A) LDTP01160 C203(3.24)  LDD3493 
Peroxisomal membrane protein PEX13 (PEX13) LDTP09948 C220(1.01)  LDD1512 
Peroxisomal membrane protein PEX14 (PEX14) LDTP01200 C342(1.16)  LDD1492 
Peroxisomal targeting signal 2 receptor (PEX7) LDTP00327 C207(0.96)  LDD0532 
Peroxisome assembly protein 12 (PEX12) LDTP00324 C304(1.25); C307(1.25)  LDD0078 
Peroxisome assembly protein 26 (PEX26) LDTP08053 C58(3.46)  LDD3314 
Phosphatidylinositol transfer protein alpha isoform (PITPNA) LDTP05236 C187(0.64); C191(0.66)  LDD0531 
Phosphatidylinositol transfer protein beta isoform (PITPNB) LDTP04213 C232(2.49)  LDD3310 
Phosphofurin acidic cluster sorting protein 2 (PACS2) LDTP08295 C846(1.15)  LDD3318 
Phospholipid scramblase 3 (PLSCR3) LDTP12548 C103(0.96)  LDD0531 
Phospholipid scramblase 4 (PLSCR4) LDTP12528 C181(1.55)  LDD3310 
Phospholipid transfer protein C2CD2L (C2CD2L) LDTP00360 C115(2.27)  LDD3314 
Phosphorylated adapter RNA export protein (PHAX) LDTP12043 C51(1.04)  LDD0078 
Piezo-type mechanosensitive ion channel component 1 (PIEZO1) LDTP09771 C95(0.65)  LDD0533 
Piezo-type mechanosensitive ion channel component 2 (PIEZO2) LDTP11954 C668(1.49)  LDD3374 
Pinin (PNN) LDTP11855 C249(20.00)  LDD0080 
Platelet glycoprotein 4 (CD36) LDTP02863 C272(2.88)  LDD2303 
Pleckstrin homology domain-containing family F member 1 (PLEKHF1) LDTP10807 C21(1.21); C183(0.89); C186(0.89); C158(0.88)  LDD0078 
Podocalyxin (PODXL) LDTP00321 C344(1.24); C381(0.97)  LDD0531 
Polycystin-1-like protein 3 (PKD1L3) LDTP08060 C1242(0.80)  LDD1508 
Polycystin-2 (PKD2) LDTP05924 C33(1.13); C47(1.13)  LDD0532 
Potassium channel subfamily K member 1 (KCNK1) LDTP00204 C329(1.02)  LDD0531 
Potassium voltage-gated channel subfamily B member 2 (KCNB2) LDTP09942 C883(0.84)  LDD1492 
Potassium voltage-gated channel subfamily D member 3 (KCND3) LDTP13418 C93(1.19)  LDD3344 
Potassium voltage-gated channel subfamily H member 1 (KCNH1) LDTP01547 C67(1.13)  LDD0078 
Potassium voltage-gated channel subfamily H member 6 (KCNH6) LDTP11795 C831(2.04)  LDD3433 
Potassium voltage-gated channel subfamily KQT member 5 (KCNQ5) LDTP12484 C641(2.52); C934(2.11)  LDD3332 
PRA1 family protein 2 (PRAF2) LDTP01060 C28(62.78)  LDD0209 
Prenylated Rab acceptor protein 1 (RABAC1) LDTP13320 C64(0.97)  LDD0532 
Probable glucose sensor protein SLC5A4 (SLC5A4) LDTP12813 C607(6.22)  LDD3332 
Probable mitochondrial glutathione transporter SLC25A39 (SLC25A39) LDTP15924 C94(0.90)  LDD0531 
Probable mitochondrial glutathione transporter SLC25A40 (SLC25A40) LDTP18053 C55(1.04); C67(1.04); C69(1.04)  LDD0078 
Probable proton-coupled zinc antiporter SLC30A4 (SLC30A4) LDTP00460 C95(0.94); C98(0.83)  LDD0812 
Progesterone receptor (PGR) LDTP02147 C488(1.31)  LDD3379 
Programmed cell death protein 6 (PDCD6) LDTP01180 C155(0.86)  LDD0531 
Prohibitin 1 (PHB1) LDTP03717 C69(1.00)  LDD0531 
Prolactin regulatory element-binding protein (PREB) LDTP12272 C128(1.08)  LDD0078 
Prolow-density lipoprotein receptor-related protein 1 (LRP1) LDTP05538 C2939(0.94); C2944(0.94); C3822(0.94); C3828(0.94)  LDD0078 
Prominin-1 (PROM1) LDTP00777 C624(2.85)  LDD3368 
Prosaposin (PSAP) LDTP02215 C33(5.73); C241(2.90); C42(5.31)  LDD3310 
Protein 4.1 (EPB41) LDTP02547 C39(1.04); C49(1.04)  LDD0078 
Protein ARV1 (ARV1) LDTP11812 C34(1.29); C37(1.29); C30(0.91)  LDD0078 
Protein Aster-A (GRAMD1A) LDTP10181 C576(2.42); C480(2.33)  LDD0080 
Protein Aster-B (GRAMD1B) LDTP06767 C65(1.08)  LDD3323 
Protein Aster-C (GRAMD1C) LDTP15361 C396(1.16)  LDD3224 
Protein CASC3 (CASC3) LDTP00582 C36(1.73)  LDD0532 
Protein cereblon (CRBN) LDTP10826 C219(5.18)  LDD0209 
Protein cornichon homolog 1 (CNIH1) LDTP01592 C115(1.10)  LDD1095 
Protein cornichon homolog 3 (CNIH3) LDTP09341 C45(2.31)  LDD3314 
Protein ELYS (AHCTF1) LDTP09742 C354(56.76)  LDD0209 
Protein ERGIC-53 (LMAN1) LDTP04237 C230(1.23)  LDD0080 
Protein FAM8A1 (FAM8A1) LDTP16190 C38(1.18)  LDD3310 
Protein GPR107 (GPR107) LDTP07236 C109(1.35)  LDD1576 
Protein GPR108 (GPR108) LDTP12383 C104(1.73)  LDD3325 
Protein mago nashi homolog (MAGOH) LDTP04920 C131(9.35)  LDD0204 
Protein Mpv17 (MPV17) LDTP03869 C59(0.82)  LDD0531 
Protein OS-9 (OS9) LDTP05871 C181(3.27)  LDD3311 
Protein PTHB1 (BBS9) LDTP06801 C337(1.53)  LDD3314 
Protein RFT1 homolog (RFT1) LDTP10073 C448(0.96)  LDD0078 
Protein S100-A10 (S100A10) LDTP04885 C62(5.94)  LDD0209 
Protein SEC13 homolog (SEC13) LDTP04707 C31(1.72); C299(1.07); C245(1.09); C187(2.43)  LDD0080 
Protein sel-1 homolog 1 (SEL1L) LDTP13164 C153(3.02); C539(4.73)  LDD3310 
Protein shisa-9 (SHISA9) LDTP14407 C200(1.24)  LDD3383 
Protein SON (SON) LDTP02959 C2380(44.16)  LDD0209 
Protein spinster homolog 1 (SPNS1) LDTP11844 C96(1.61)  LDD3442 
Protein transport protein Sec31A (SEC31A) LDTP01478 C458(1.42); C173(2.93)  LDD3310 
Protein transport protein Sec61 subunit alpha isoform 1 (SEC61A1) LDTP04932 C13(0.98)  LDD0531 
Protein transport protein Sec61 subunit alpha isoform 2 (SEC61A2) LDTP18424 C13(1.00)  LDD1507 
Protein transport protein Sec61 subunit beta (SEC61B) LDTP04866 C39(4.13)  LDD0209 
Protein transport protein Sec61 subunit gamma (SEC61G) LDTP04850 C25(1.28)  LDD1507 
Protein tweety homolog 3 (TTYH3) LDTP11615 C486(1.92)  LDD3312 
Protein unc-93 homolog B1 (UNC93B1) LDTP11760 C583(170.45)  LDD0209 
Protein wntless homolog (WLS) LDTP07156 C71(3.65)  LDD3311 
Proteolipid protein 2 (PLP2) LDTP05443 C12(0.94); C16(0.94)  LDD0078 
Proton myo-inositol cotransporter (SLC2A13) LDTP10733 C314(0.90)  LDD1507 
Proton-activated chloride channel (PACC1) LDTP12042 C223(1.13)  LDD1508 
Proton-associated sugar transporter A (SLC45A1) LDTP13921 C55(1.02); C68(1.02)  LDD0531 
Proton-coupled amino acid transporter 1 (SLC36A1) LDTP08016 C370(0.75)  LDD1507 
Proton-coupled folate transporter (SLC46A1) LDTP10637 C21(1.26)  LDD3313 
Proton-coupled zinc antiporter SLC30A1 (SLC30A1) LDTP14274 C469(1.10); C433(0.96); C437(0.96)  LDD0078 
Proton-coupled zinc antiporter SLC30A5 (SLC30A5) LDTP09294 C645(2.13)  LDD3312 
Proton-coupled zinc antiporter SLC30A9, mitochondrial (SLC30A9) LDTP07610 C141(1.88)  LDD3311 
Proton-transporting V-type ATPase complex assembly regulator TMEM9 (TMEM9) LDTP12981 C33(1.06)  LDD1507 
Protrudin (ZFYVE27) LDTP07116 C374(0.98); C402(1.27); C165(1.11)  LDD1507 
Putative divalent cation/proton antiporter TMEM165 (TMEM165) LDTP12207 C278(0.97); C280(0.97)  LDD0531 
Putative lipid scramblase CLPTM1 (CLPTM1) LDTP01745 C308(0.59)  LDD0531 
Rab5 GDP/GTP exchange factor (RABGEF1) LDTP13369 C359(1.00); C161(0.95); C173(0.86)  LDD0078 
Ran GTPase-activating protein 1 (RANGAP1) LDTP04082 C274(5.59); C169(2.94); C303(2.80); C141(2.41)  LDD0080 
Ran-binding protein 17 (RANBP17) LDTP15975 C765(0.94)  LDD1492 
Ran-binding protein 6 (RANBP6) LDTP16811 C48(3.49); C1065(1.33)  LDD0080 
Rapamycin-insensitive companion of mTOR (RICTOR) LDTP07626 C218(5.80); C68(4.94)  LDD0209 
Receptor activity-modifying protein 1 (RAMP1) LDTP01077 C82(1.35)  LDD3430 
Receptor expression-enhancing protein 1 (REEP1) LDTP12075 C106(0.90)  LDD1492 
Receptor for retinol uptake STRA6 (STRA6) LDTP11359 C233(3.71)  LDD2305 
Reduced folate transporter (SLC19A1) LDTP03952 C220(0.97); C246(0.85)  LDD0078 
Reticulon-1 (RTN1) LDTP06633 C678(4.56)  LDD3344 
Reticulophagy regulator 1 (RETREG1) LDTP11987 C235(1.02)  LDD1573 
Retinol-binding protein 4 (RBP4) LDTP01958 C178(0.85)  LDD0531 
RNA-binding protein 8A (RBM8A) LDTP14157 C149(0.96)  LDD0078 
Ryanodine receptor 1 (RYR1) LDTP03136 C2158(1.16)  LDD3401 
Ryanodine receptor 2 (RYR2) LDTP09852 C1078(1.56)  LDD3423 
SCO-spondin (SSPOP) LDTP00056 C80(1.93)  LDD3311 
SEC14-like protein 1 (SEC14L1) LDTP09768 C644(1.06); C258(0.86)  LDD1492 
SEC14-like protein 4 (SEC14L4) LDTP13191 C271(1.29)  LDD0531 
Secreted frizzled-related protein 1 (SFRP1) LDTP08856 C68(3.34)  LDD3413 
Secretogranin-1 (CHGB) LDTP02069 C36(1.73); C57(3.63)  LDD3340 
Secretory carrier-associated membrane protein 1 (SCAMP1) LDTP00546 C132(0.96)  LDD1492 
Secretory carrier-associated membrane protein 2 (SCAMP2) LDTP00547 C127(1.24)  LDD0563 
Secretory carrier-associated membrane protein 3 (SCAMP3) LDTP00451 C142(1.40); C147(1.40)  LDD1094 
Secretory carrier-associated membrane protein 4 (SCAMP4) LDTP09987 C20(0.98)  LDD0531 
Seipin (BSCL2) LDTP10340 C18(2.18)  LDD3373 
Serine incorporator 3 (SERINC3) LDTP05913 C72(5.80)  LDD3310 
Serine/arginine repetitive matrix protein 1 (SRRM1) LDTP08637 C33(1.42)  LDD0080 
Serine/threonine-protein kinase/endoribonuclease IRE1 (ERN1) LDTP01228 C605(1.01)  LDD0531 
SH3 and multiple ankyrin repeat domains protein 3 (SHANK3) LDTP11447 C70(1.88)  LDD3335 
Short transient receptor potential channel 1 (TRPC1) LDTP04222 C55(4.04)  LDD3392 
Short transient receptor potential channel 6 (TRPC6) LDTP13774 C267(1.00)  LDD3314 
Sialin (SLC17A5) LDTP12492 C362(1.09)  LDD0532 
SID1 transmembrane family member 2 (SIDT2) LDTP09057 C335(1.77)  LDD3311 
Sideroflexin-1 (SFXN1) LDTP12090 C190(14.16)  LDD0209 
Sideroflexin-2 (SFXN2) LDTP10621 C290(1.08)  LDD0533 
Sideroflexin-4 (SFXN4) LDTP07531 C70(1.44)  LDD0531 
Sigma intracellular receptor 2 (TMEM97) LDTP06945 C72(0.99)  LDD1507 
Signal recognition particle 14 kDa protein (SRP14) LDTP03837 C56(0.42)  LDD2236 
Signal recognition particle 19 kDa protein (SRP19) LDTP02330 C17(1.53)  LDD0531 
Signal recognition particle 9 kDa protein (SRP9) LDTP04259 C48(1.00)  LDD0078 
Signal recognition particle subunit SRP68 (SRP68) LDTP13262 C562(1.04); C247(0.98)  LDD0078 
Signal recognition particle subunit SRP72 (SRP72) LDTP01402 C179(3.16); C184(3.16); C323(1.70); C50(1.62)  LDD0080 
Signal-regulatory protein beta-1 (SIRPB1) LDTP00228 C331(2.15)  LDD3427 
Slit homolog 1 protein (SLIT1) LDTP01120 C893(2.04); C914(2.38); C242(1.99)  LDD2469 
Slit homolog 2 protein (SLIT2) LDTP01427 C512(4.84); C519(4.84); C943(3.32); C945(3.32)  LDD0080 
Slit homolog 3 protein (SLIT3) LDTP01121 C738(5.56)  LDD0080 
Small G protein signaling modulator 3 (SGSM3) LDTP10401 C505(2.54); C593(3.59)  LDD3369 
Small ribosomal subunit protein RACK1 (RACK1) LDTP05057 C249(1.16); C153(0.98); C286(0.98); C138(0.94)  LDD0078 
SNARE-associated protein Snapin (SNAPIN) LDTP01558 C66(0.90)  LDD0078 
Snurportin-1 (SNUPN) LDTP01505 C199(1.25)  LDD0080 
Sodium bicarbonate cotransporter 3 (SLC4A7) LDTP14275 C993(2.16)  LDD3330 
Sodium channel modifier 1 (SCNM1) LDTP11325 C127(1.11); C128(1.11)  LDD0078 
Sodium channel protein type 5 subunit alpha (SCN5A) LDTP06136 C373(0.23)  LDD1093 
Sodium- and chloride-dependent betaine transporter (SLC6A12) LDTP04158 C90(1.32)  LDD3314 
Sodium- and chloride-dependent creatine transporter 1 (SLC6A8) LDTP04148 C82(0.72)  LDD0531 
Sodium- and chloride-dependent GABA transporter 3 (SLC6A11) LDTP04159 C612(1.82)  LDD0080 
Sodium- and chloride-dependent glycine transporter 1 (SLC6A9) LDTP04160 C498(1.10)  LDD3383 
Sodium-coupled neutral amino acid symporter 1 (SLC38A1) LDTP11824 C131(2.21)  LDD0080 
Sodium-coupled neutral amino acid symporter 2 (SLC38A2) LDTP10731 C403(0.95)  LDD1492 
Sodium-coupled neutral amino acid transporter 7 (SLC38A7) LDTP12668 C30(2.18)  LDD3312 
Sodium-dependent glucose transporter 1 (MFSD4B) LDTP17246 C281(0.98)  LDD1509 
Sodium-dependent lysophosphatidylcholine symporter 1 (MFSD2A) LDTP09014 C473(1.20)  LDD1509 
Sodium-dependent multivitamin transporter (SLC5A6) LDTP13834 C628(0.87)  LDD0531 
Sodium-dependent neutral amino acid transporter B(0)AT2 (SLC6A15) LDTP11826 C91(4.43)  LDD0080 
Sodium-dependent neutral amino acid transporter SLC6A17 (SLC6A17) LDTP11778 C91(4.90)  LDD3332 
Sodium-dependent noradrenaline transporter (SLC6A2) LDTP03263 C39(2.06)  LDD3323 
Sodium-dependent phosphate transporter 1 (SLC20A1) LDTP09581 C403(0.79)  LDD0531 
Sodium-dependent phosphate transporter 2 (SLC20A2) LDTP05555 C48(3.82)  LDD3313 
Sodium-dependent serotonin transporter (SLC6A4) LDTP03605 C2971(3.49); C636(2.36)  LDD3311 
Sodium/bile acid cotransporter 4 (SLC10A4) LDTP10272 C333(0.97); C344(0.97)  LDD0531 
Sodium/bile acid cotransporter 7 (SLC10A7) LDTP05603 C113(1.03)  LDD1508 
Sodium/hydrogen exchanger 1 (SLC9A1) LDTP03009 C561(4.76)  LDD3311 
Sodium/hydrogen exchanger 6 (SLC9A6) LDTP09807 C571(1.01)  LDD1492 
Sodium/hydrogen exchanger 7 (SLC9A7) LDTP10844 C132(0.87)  LDD3318 
Sodium/myo-inositol cotransporter (SLC5A3) LDTP04585 C575(1.21)  LDD0531 
Sodium/potassium-transporting ATPase subunit beta-1 (ATP1B1) LDTP02068 C213(8.80)  LDD3328 
Sodium/potassium-transporting ATPase subunit beta-3 (ATP1B3) LDTP04624 C191(3.99)  LDD3323 
Sodium/potassium/calcium exchanger 2 (SLC24A2) LDTP13328 C394(0.96)  LDD1507 
Solute carrier family 12 member 2 (SLC12A2) LDTP04653 C630(1.10)  LDD0531 
Solute carrier family 12 member 4 (SLC12A4) LDTP13690 C764(2.90)  LDD3310 
Solute carrier family 12 member 6 (SLC12A6) LDTP13310 C390(3.02)  LDD3312 
Solute carrier family 12 member 7 (SLC12A7) LDTP14212 C762(3.18)  LDD3310 
Solute carrier family 12 member 8 (SLC12A8) LDTP00008 C90(8.01)  LDD3319 
Solute carrier family 12 member 9 (SLC12A9) LDTP11397 C771(2.20)  LDD3310 
Solute carrier family 15 member 1 (SLC15A1) LDTP04081 C189(3.35)  LDD3383 
Solute carrier family 15 member 2 (SLC15A2) LDTP06526 C561(1.56)  LDD2282 
Solute carrier family 15 member 4 (SLC15A4) LDTP08926 C133(1.49)  LDD0531 
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1) LDTP02544 C133(1.76)  LDD3365 
Solute carrier family 2, facilitated glucose transporter member 12 (SLC2A12) LDTP15604 C601(0.98)  LDD3323 
Solute carrier family 2, facilitated glucose transporter member 9 (SLC2A9) LDTP12520 C36(0.91)  LDD3312 
Solute carrier family 22 member 17 (SLC22A17) LDTP09573 C525(1.04)  LDD1507 
Solute carrier family 22 member 18 (SLC22A18) LDTP10126 C369(1.85)  LDD3312 
Solute carrier family 22 member 23 (SLC22A23) LDTP00028 C223(0.96)  LDD1509 
Solute carrier family 22 member 3 (SLC22A3) LDTP01303 C127(0.34); C541(0.29)  LDD2236 
Solute carrier family 22 member 4 (SLC22A4) LDTP11679 C81(3.46)  LDD3310 
Solute carrier family 23 member 2 (SLC23A2) LDTP13224 C406(1.35)  LDD1507 
Solute carrier family 25 member 16 (SLC25A16) LDTP14636 C48(0.70); C49(0.70)  LDD0532 
Solute carrier family 25 member 3 (SLC25A3) LDTP05238 C136(1.93)  LDD0080 
Solute carrier family 25 member 32 (SLC25A32) LDTP11813 C68(0.90)  LDD1492 
Solute carrier family 25 member 33 (SLC25A33) LDTP11162 C20(0.75); C30(0.75)  LDD0531 
Solute carrier family 25 member 36 (SLC25A36) LDTP10183 C15(0.60); C25(0.60)  LDD0531 
Solute carrier family 25 member 44 (SLC25A44) LDTP15733 C219(0.96)  LDD1507 
Solute carrier family 26 member 6 (SLC26A6) LDTP11409 C628(1.34)  LDD0078 
Solute carrier family 35 member B1 (SLC35B1) LDTP05117 C156(4.85)  LDD3440 
Solute carrier family 35 member E1 (SLC35E1) LDTP18177 C34(0.79)  LDD1509 
Solute carrier family 35 member E3 (SLC35E3) LDTP08137 C121(4.12)  LDD3403 
Solute carrier family 35 member E4 (SLC35E4) LDTP07411 C4(1.69)  LDD3386 
Solute carrier family 35 member F5 (SLC35F5) LDTP18086 C492(0.79)  LDD1508 
Solute carrier family 35 member F6 (SLC35F6) LDTP08817 C36(0.43)  LDD0533 
Solute carrier family 38 member 10 (SLC38A10) LDTP16037 C301(0.98)  LDD0531 
Solute carrier family 4 member 11 (SLC4A11) LDTP09066 C50(1.50)  LDD0637 
Solute carrier family 41 member 2 (SLC41A2) LDTP10486 C118(1.03)  LDD0078 
Solute carrier family 41 member 3 (SLC41A3) LDTP10370 C14(1.75)  LDD3427 
Solute carrier family 45 member 4 (SLC45A4) LDTP17162 C437(1.65)  LDD3310 
Solute carrier family 49 member 4 (SLC49A4) LDTP10816 C135(1.55)  LDD3410 
Solute carrier family 52, riboflavin transporter, member 1 (SLC52A1) LDTP12714 C159(0.98)  LDD1492 
Solute carrier family 52, riboflavin transporter, member 2 (SLC52A2) LDTP12119 C439(1.18)  LDD0593 
Solute carrier family 53 member 1 (XPR1) LDTP13117 C188(5.94)  LDD0080 
Solute carrier organic anion transporter family member 2A1 (SLCO2A1) LDTP09945 C594(1.10)  LDD0078 
Solute carrier organic anion transporter family member 4A1 (SLCO4A1) LDTP10119 C60(1.09); C208(1.03); C216(0.98); C574(1.80)  LDD0531 
Sortilin (SORT1) LDTP10885 C702(6.15)  LDD0080 
Sortilin-related receptor (SORL1) LDTP09838 C1549(2.27)  LDD3312 
Sorting and assembly machinery component 50 homolog (SAMM50) LDTP14084 C457(1.17)  LDD0078 
Sorting nexin-1 (SNX1) LDTP05938 C318(2.02)  LDD3312 
Sorting nexin-11 (SNX11) LDTP14170 C181(1.06); C182(1.06)  LDD0531 
Sorting nexin-12 (SNX12) LDTP13634 C141(0.85)  LDD0532 
Sorting nexin-13 (SNX13) LDTP14169 C864(1.00)  LDD1164 
Sorting nexin-14 (SNX14) LDTP14168 C890(5.76)  LDD3319 
Sorting nexin-15 (SNX15) LDTP12537 C192(0.61)  LDD3367 
Sorting nexin-16 (SNX16) LDTP04802 C230(1.46)  LDD3343 
Sorting nexin-17 (SNX17) LDTP06288 C277(0.91)  LDD0531 
Sorting nexin-19 (SNX19) LDTP09788 C476(1.19); C482(1.19)  LDD0078 
Sorting nexin-2 (SNX2) LDTP01043 C332(2.17)  LDD3314 
Sorting nexin-20 (SNX20) LDTP08108 C195(1.54)  LDD3370 
Sorting nexin-21 (SNX21) LDTP15679 C252(1.62); C163(1.84)  LDD3331 
Sorting nexin-22 (SNX22) LDTP15769 C33(2.67)  LDD3339 
Sorting nexin-24 (SNX24) LDTP18568 C114(1.12)  LDD1093 
Sorting nexin-25 (SNX25) LDTP15987 C504(2.50)  LDD0080 
Sorting nexin-27 (SNX27) LDTP10533 C30(1.16)  LDD0531 
Sorting nexin-29 (SNX29) LDTP18067 C121(2.15)  LDD3311 
Sorting nexin-3 (SNX3) LDTP00983 C140(1.03)  LDD0531 
Sorting nexin-30 (SNX30) LDTP07239 C381(1.35)  LDD0080 
Sorting nexin-32 (SNX32) LDTP15314 C49(1.13)  LDD2397 
Sorting nexin-33 (SNX33) LDTP09596 C188(2.77)  LDD3310 
Sorting nexin-4 (SNX4) LDTP01531 C172(1.06)  LDD0531 
Sorting nexin-5 (SNX5) LDTP14174 C347(1.15)  LDD0078 
Sorting nexin-6 (SNX6) LDTP13661 C264(0.95); C149(0.90)  LDD0078 
Sorting nexin-7 (SNX7) LDTP13660 C389(3.35)  LDD3332 
Sorting nexin-8 (SNX8) LDTP14173 C192(1.12); C200(1.12)  LDD0078 
SPARC (SPARC) LDTP02349 C149(2.85); C155(1.65)  LDD3310 
Spectrin beta chain, non-erythrocytic 1 (SPTBN1) LDTP05273 C1900(1.01); C183(0.95)  LDD0078 
Splicing factor, arginine/serine-rich 19 (SCAF1) LDTP12030 C826(1.02); C362(0.96); C675(0.86)  LDD0078 
Stabilin-1 (STAB1) LDTP12797 C1260(1.22)  LDD3338 
StAR-related lipid transfer protein 3 (STARD3) LDTP06221 C291(1.72); C317(2.13)  LDD3312 
StAR-related lipid transfer protein 7, mitochondrial (STARD7) LDTP18459 C362(1.06)  LDD0078 
Starch-binding domain-containing protein 1 (STBD1) LDTP01528 C108(0.82)  LDD0531 
STEAP1 protein (STEAP1) LDTP16198 C336(0.93)  LDD0531 
Stimulator of interferon genes protein (STING1) LDTP08344 C88(1.01); C91(0.99)  LDD0531 
Stomatin (STOM) LDTP03380 C87(3.07)  LDD3315 
Stomatin-like protein 2, mitochondrial (STOML2) LDTP13416 C167(1.20)  LDD0078 
Stromal interaction molecule 1 (STIM1) LDTP05934 C49(6.16)  LDD0209 
Stromal interaction molecule 2 (STIM2) LDTP13018 C313(121.39)  LDD0209 
Succinate dehydrogenase cytochrome b small subunit, mitochondrial (SDHD) LDTP00358 C140(1.11); C150(1.11)  LDD1492 
Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (SDHC) LDTP10931 C107(0.89)  LDD0531 
Sulfate transporter (SLC26A2) LDTP04360 C700(1.27)  LDD0080 
SUN domain-containing protein 1 (SUN1) LDTP01454 C799(2.57)  LDD3310 
SUN domain-containing protein 2 (SUN2) LDTP13256 C601(20.31)  LDD0204 
Surfeit locus protein 4 (SURF4) LDTP00592 C32(1.16)  LDD0531 
Synaptic vesicle glycoprotein 2B (SV2B) LDTP07939 C159(1.58)  LDD3341 
Synaptic vesicular amine transporter (SLC18A2) LDTP05469 C488(2.06)  LDD3340 
Synaptophysin (SYP) LDTP02266 C72(1.59)  LDD3340 
Synaptosomal-associated protein 23 (SNAP23) LDTP00198 C112(1.03)  LDD0078 
Synaptotagmin-like protein 2 (SYTL2) LDTP12243 C802(7.16); C469(1.75)  LDD3314 
Synaptotagmin-like protein 4 (SYTL4) LDTP10158 C477(0.81)  LDD0531 
Syncytin-1 (ERVW-1) LDTP13761 C387(4.00)  LDD3311 
Syntaxin-17 (STX17) LDTP04770 C290(15.50)  LDD0209 
Syntaxin-4 (STX4) LDTP05667 C141(1.34)  LDD3311 
Syntaxin-5 (STX5) LDTP05780 C68(1.03)  LDD0531 
Syntaxin-binding protein 1 (STXBP1) LDTP04936 C110(1.64)  LDD3312 
Syntenin-1 (SDCBP) LDTP00310 C166(0.96)  LDD0531 
T-cell surface glycoprotein CD3 epsilon chain (CD3E) LDTP02221 C49(2.69)  LDD3397 
T-complex protein 1 subunit delta (CCT4) LDTP04391 C295(0.88)  LDD0078 
Talin-1 (TLN1) LDTP14031 C2161(0.98); C1353(0.96); C1939(0.95)  LDD0078 
Talin-2 (TLN2) LDTP14057 C118(1.08); C1954(1.04)  LDD0080 
Target of Myb1 membrane trafficking protein (TOM1) LDTP01051 C77(1.09); C415(1.00)  LDD1492 
TBC1 domain family member 1 (TBC1D1) LDTP08197 C676(1.20)  LDD0078 
TBC1 domain family member 4 (TBC1D4) LDTP00958 C1286(72.90)  LDD0209 
TBC1 domain family member 5 (TBC1D5) LDTP09816 C96(1.87); C728(1.33)  LDD3310 
Tectonic-like complex member MKS1 (MKS1) LDTP12772 C141(1.50)  LDD3402 
Tetraspanin-10 (TSPAN10) LDTP15967 C30(0.83)  LDD1492 
Tetraspanin-14 (TSPAN14) LDTP09240 C200(1.51)  LDD0547 
Tetratricopeptide repeat protein 8 (TTC8) LDTP09305 C322(0.83)  LDD0533 
Thiamine transporter 1 (SLC19A2) LDTP01049 C224(0.78)  LDD1492 
Thiamine transporter 2 (SLC19A3) LDTP11565 C272(5.41)  LDD3380 
Thioredoxin domain-containing protein 17 (TXNDC17) LDTP11103 C43(0.90)  LDD0078 
Thioredoxin-interacting protein (TXNIP) LDTP11873 C247(1.38); C120(0.87)  LDD0078 
Thioredoxin-related transmembrane protein 2 (TMX2) LDTP13943 C186(0.99)  LDD0078 
THO complex subunit 1 (THOC1) LDTP10317 C49(0.98); C156(0.85)  LDD0078 
THO complex subunit 2 (THOC2) LDTP09279 C1044(1.16); C1518(1.00)  LDD0078 
THO complex subunit 5 homolog (THOC5) LDTP05978 C613(0.97); C608(0.94)  LDD0078 
THO complex subunit 6 homolog (THOC6) LDTP08315 C314(0.93)  LDD0078 
THO complex subunit 7 homolog (THOC7) LDTP07397 C38(1.36)  LDD0531 
Tight junction protein ZO-1 (TJP1) LDTP05515 C1718(0.90); C1727(0.81); C1740(0.81)  LDD0531 
Tissue factor (F3) LDTP02686 C81(0.98); C89(0.98)  LDD0078 
Toll-like receptor 1 (TLR1) LDTP06379 C667(1.13)  LDD2324 
Toll-like receptor 2 (TLR2) LDTP01009 C382(1.84)  LDD2324 
Toll-like receptor 3 (TLR3) LDTP00643 C95(3.21)  LDD3314 
Tomoregulin-1 (TMEFF1) LDTP08665 C64(1.03)  LDD1510 
TP53-regulated inhibitor of apoptosis 1 (TRIAP1) LDTP00847 C18(1.65); C47(2.08)  LDD0080 
Transcription and mRNA export factor ENY2 (ENY2) LDTP12334 C40(0.86)  LDD0078 
Transferrin receptor protein 1 (TFRC) LDTP01969 C353(1.54)  LDD3312 
Transferrin receptor protein 2 (TFR2) LDTP13686 C416(1.68)  LDD2302 
Transient receptor potential cation channel subfamily A member 1 (TRPA1) LDTP01305 C104(1.60)  LDD2267 
Transient receptor potential cation channel subfamily M member 2 (TRPM2) LDTP01406 C1364(1.58)  LDD3333 
Transient receptor potential cation channel subfamily M member 4 (TRPM4) LDTP09418 C630(1.28)  LDD0593 
Transient receptor potential cation channel subfamily V member 2 (TRPV2) LDTP14154 C332(1.89)  LDD3325 
Transient receptor potential cation channel subfamily V member 4 (TRPV4) LDTP12168 C853(1.16)  LDD3360 
Translocating chain-associated membrane protein 1-like 1 (TRAM1L1) LDTP08914 C360(1.34)  LDD3365 
Translocation protein SEC62 (SEC62) LDTP15838 C82(1.12)  LDD0080 
Translocation protein SEC63 homolog (SEC63) LDTP13243 C490(1.15); C295(1.04)  LDD0078 
Transmembrane 4 L6 family member 5 (TM4SF5) LDTP00466 C145(5.37)  LDD3380 
Transmembrane 9 superfamily member 1 (TM9SF1) LDTP14444 C445(1.20)  LDD0531 
Transmembrane 9 superfamily member 2 (TM9SF2) LDTP15845 C174(1.19); C182(1.22)  LDD0531 
Transmembrane 9 superfamily member 3 (TM9SF3) LDTP18448 C428(1.05)  LDD0078 
Transmembrane 9 superfamily member 4 (TM9SF4) LDTP09789 C100(1.19); C104(1.19); C64(0.76)  LDD0531 
Transmembrane and coiled-coil domain protein 3 (TMCC3) LDTP16241 C180(1.31)  LDD3312 
Transmembrane and coiled-coil domain-containing protein 3 (TMCO3) LDTP15146 C667(1.82)  LDD2337 
Transmembrane and coiled-coil domains protein 1 (TMCC1) LDTP01446 C555(1.15)  LDD1492 
Transmembrane channel-like protein 8 (TMC8) LDTP08434 C30(1.19)  LDD3370 
Transmembrane emp24 domain-containing protein 1 (TMED1) LDTP05875 C106(1.68)  LDD3312 
Transmembrane emp24 domain-containing protein 2 (TMED2) LDTP06365 C93(1.37)  LDD3338 
Transmembrane emp24 domain-containing protein 3 (TMED3) LDTP14002 C144(1.02)  LDD3310 
Transmembrane emp24 domain-containing protein 7 (TMED7) LDTP13969 C151(3.87)  LDD3314 
Transmembrane emp24 domain-containing protein 9 (TMED9) LDTP11291 C49(1.02)  LDD0531 
Transmembrane protein 101 (TMEM101) LDTP15744 C26(1.23); C31(1.23)  LDD0532 
Transmembrane protein 104 (TMEM104) LDTP17797 C455(0.87)  LDD0531 
Transmembrane protein 106B (TMEM106B) LDTP12635 C253(1.68)  LDD0080 
Transmembrane protein 126A (TMEM126A) LDTP15948 C98(11.43); C101(11.43)  LDD0080 
Transmembrane protein 127 (TMEM127) LDTP01162 C61(0.85)  LDD1492 
Transmembrane protein 132A (TMEM132A) LDTP06680 C752(2.68)  LDD3312 
Transmembrane protein 14A (TMEM14A) LDTP14247 C37(0.94)  LDD1508 
Transmembrane protein 168 (TMEM168) LDTP15957 C604(0.89)  LDD0078 
Transmembrane protein 17 (TMEM17) LDTP15309 C194(3.90)  LDD3332 
Transmembrane protein 181 (TMEM181) LDTP18514 C262(2.45)  LDD3352 
Transmembrane protein 184A (TMEM184A) LDTP17451 C326(0.91)  LDD0532 
Transmembrane protein 184B (TMEM184B) LDTP18580 C71(1.15); C74(1.09)  LDD0547 
Transmembrane protein 192 (TMEM192) LDTP08633 C266(1.64)  LDD0080 
Transmembrane protein 199 (TMEM199) LDTP08881 C124(2.49)  LDD0080 
Transmembrane protein 201 (TMEM201) LDTP07058 C164(1.26); C167(1.26); C626(1.08)  LDD0078 
Transmembrane protein 214 (TMEM214) LDTP07477 C468(0.96); C529(0.91); C464(0.90)  LDD0078 
Transmembrane protein 223 (TMEM223) LDTP14325 C156(1.14)  LDD3312 
Transmembrane protein 234 (TMEM234) LDTP09730 C122(6.33)  LDD3367 
Transmembrane protein 255B (TMEM255B) LDTP18085 C263(1.23); C273(1.23)  LDD0531 
Transmembrane protein 33 (TMEM33) LDTP04787 C224(0.99); C232(1.08)  LDD0531 
Transmembrane protein 39A (TMEM39A) LDTP12660 C29(0.54)  LDD0533 
Transmembrane protein 44 (TMEM44) LDTP14890 C342(3.96)  LDD3389 
Transmembrane protein 50A (TMEM50A) LDTP01680 C10(0.87); C13(0.87)  LDD0078 
Transmembrane protein 50B (TMEM50B) LDTP04747 C89(10.18)  LDD0209 
Transmembrane protein 59 (TMEM59) LDTP11406 C80(1.00)  LDD1492 
Transmembrane protein 59-like (TMEM59L) LDTP18543 C326(1.09)  LDD1507 
Transmembrane protein 65 (TMEM65) LDTP07583 C217(0.88)  LDD1507 
Transmembrane protein 74 (TMEM74) LDTP15796 C46(0.68); C42(1.08)  LDD1507 
Transmembrane protein 79 (TMEM79) LDTP11153 C383(2.89)  LDD3367 
Transmembrane protein 87A (TMEM87A) LDTP15481 C431(1.01); C89(1.09)  LDD0531 
Transmembrane protein 87B (TMEM87B) LDTP15756 C422(0.72)  LDD0602 
Transmembrane protein 94 (TMEM94) LDTP17025 C684(1.52)  LDD3312 
Transport and Golgi organization protein 1 homolog (MIA3) LDTP07002 C124(1.07)  LDD0078 
Transportin-1 (TNPO1) LDTP09949 C467(1.53); C205(0.89)  LDD0078 
Transportin-2 (TNPO2) LDTP00434 C195(1.14); C275(1.26); C287(1.26); C375(1.05)  LDD0531 
Transportin-3 (TNPO3) LDTP14133 C908(5.10); C793(8.47); C912(10.83)  LDD0209 
Tricarboxylate transport protein, mitochondrial (SLC25A1) LDTP04553 C262(2.40)  LDD0080 
Tripartite motif-containing protein 72 (TRIM72) LDTP07779 C242(0.79); C108(0.98); C144(1.15); C456(1.08)  LDD0531 
Tubulin beta-1 chain (TUBB1) LDTP11916 C340(1.29); C354(1.16)  LDD0531 
Tumor necrosis factor alpha-induced protein 2 (TNFAIP2) LDTP14808 C45(1.06); C512(0.98); C603(0.90)  LDD0078 
Tumor necrosis factor receptor superfamily member 16 (NGFR) LDTP02249 C381(2.03)  LDD3401 
Tumor suppressor candidate 3 (TUSC3) LDTP05878 C123(1.26)  LDD0080 
UAP56-interacting factor (FYTTD1) LDTP10732 C242(0.92)  LDD1492 
Ubiquilin-4 (UBQLN4) LDTP12533 C29(0.96)  LDD0078 
Ubiquitin-like modifier-activating enzyme ATG7 (ATG7) LDTP01568 C646(1.00); C649(1.00); C358(0.92); C368(0.92)  LDD0078 
Ubiquitin-like protein ATG12 (ATG12) LDTP01428 C134(1.09)  LDD0080 
UDP-galactose translocator (SLC35A2) LDTP05115 C82(2.04)  LDD3337 
UDP-N-acetylglucosamine transporter (SLC35A3) LDTP13850 C54(0.72)  LDD1507 
Uncharacterized protein C9orf85 (C9orf85) LDTP19891 C45(0.94)  LDD0078 
Uncharacterized protein CXorf38 (CXorf38) LDTP15581 C12(3.99); C77(20.00); C80(20.00)  LDD0080 
Unconventional myosin-Ic (MYO1C) LDTP00196 C575(2.20)  LDD0080 
Urea transporter 1 (SLC14A1) LDTP05832 C81(2.08)  LDD3457 
Uroplakin-1b (UPK1B) LDTP01326 C205(3.71); C218(2.08)  LDD3365 
Uroplakin-2 (UPK2) LDTP00304 C80(1.96)  LDD3452 
V-type proton ATPase 116 kDa subunit a 1 (ATP6V0A1) LDTP09968 C244(4.60)  LDD3310 
V-type proton ATPase subunit B, brain isoform (ATP6V1B2) LDTP03104 C162(0.86)  LDD0078 
V-type proton ATPase subunit B, kidney isoform (ATP6V1B1) LDTP02780 C106(2.38); C45(1.64)  LDD3319 
V-type proton ATPase subunit C 1 (ATP6V1C1) LDTP03105 C15(0.92)  LDD0078 
V-type proton ATPase subunit d 1 (ATP6V0D1) LDTP04924 C335(1.41)  LDD0080 
V-type proton ATPase subunit G 1 (ATP6V1G1) LDTP01185 C104(35.40)  LDD0209 
V-type proton ATPase subunit H (ATP6V1H) LDTP13319 C85(1.09)  LDD0078 
Vacuolar protein sorting-associated protein 26B (VPS26B) LDTP17131 C334(1.41)  LDD0080 
Vacuolar protein sorting-associated protein 29 (VPS29) LDTP13142 C19(1.30)  LDD3312 
Vacuolar protein sorting-associated protein 35 (VPS35) LDTP10741 C653(0.91)  LDD0078 
Vacuolar protein sorting-associated protein 8 homolog (VPS8) LDTP08839 C216(26.90)  LDD0209 
Vacuole membrane protein 1 (VMP1) LDTP10343 C192(0.89)  LDD0531 
Vang-like protein 1 (VANGL1) LDTP09288 C485(1.15)  LDD1508 
Vesicle-associated membrane protein-associated protein A (VAPA) LDTP12966 C128(1.50)  LDD3311 
Vesicle-associated membrane protein-associated protein B/C (VAPB) LDTP01556 C121(0.60)  LDD0533 
Vesicular integral-membrane protein VIP36 (LMAN2) LDTP05690 C107(1.76)  LDD0533 
Vezatin (VEZT) LDTP12191 C76(1.29); C514(1.19); C519(1.19)  LDD0078 
Vitamin D3 receptor (VDR) LDTP02572 C84(1.22)  LDD3373 
Vitronectin (VTN) LDTP01999 C430(2.77)  LDD2330 
Voltage-dependent anion-selective channel protein 1 (VDAC1) LDTP03132 C232(1.41)  LDD0078 
Voltage-dependent anion-selective channel protein 2 (VDAC2) LDTP04071 C227(1.04); C210(1.02); C47(1.01); C76(0.97)  LDD0078 
Voltage-dependent anion-selective channel protein 3 (VDAC3) LDTP13824 C65(2.02)  LDD0080 
Voltage-dependent calcium channel beta subunit-associated regulatory protein (CBARP) LDTP08816 C184(0.97)  LDD1514 
Voltage-dependent calcium channel subunit alpha-2/delta-1 (CACNA2D1) LDTP04612 C1026(0.76)  LDD0812 
Voltage-dependent calcium channel subunit alpha-2/delta-2 (CACNA2D2) LDTP12805 C341(1.79); C1083(2.21)  LDD2412 
Voltage-dependent L-type calcium channel subunit beta-2 (CACNB2) LDTP05552 C621(1.84)  LDD3423 
Voltage-dependent P/Q-type calcium channel subunit alpha-1A (CACNA1A) LDTP00308 C2462(1.86)  LDD3339 
Voltage-gated hydrogen channel 1 (HVCN1) LDTP10204 C249(4.36)  LDD3333 
Voltage-gated potassium channel subunit beta-2 (KCNAB2) LDTP05817 C248(27.72)  LDD0209 
Voltage-gated potassium channel subunit beta-3 (KCNAB3) LDTP14455 C304(31.07)  LDD0209 
Volume-regulated anion channel subunit LRRC8A (LRRC8A) LDTP08556 C163(0.85)  LDD0531 
Volume-regulated anion channel subunit LRRC8B (LRRC8B) LDTP07554 C799(1.30)  LDD3320 
Volume-regulated anion channel subunit LRRC8C (LRRC8C) LDTP09459 C682(3.80)  LDD3335 
Volume-regulated anion channel subunit LRRC8D (LRRC8D) LDTP07943 C820(3.55)  LDD3310 
Volume-regulated anion channel subunit LRRC8E (LRRC8E) LDTP07460 C675(2.23)  LDD3346 
VPS10 domain-containing receptor SorCS1 (SORCS1) LDTP09724 C236(3.56)  LDD3404 
VWFA and cache domain-containing protein 1 (CACHD1) LDTP15033 C641(0.98); C890(0.94); C1063(1.00)  LDD1492 
WASH complex subunit 2A (WASHC2A) LDTP07289 C594(1.13)  LDD0078 
WASH complex subunit 2C (WASHC2C) LDTP14049 C828(1.41)  LDD3323 
WASH complex subunit 3 (WASHC3) LDTP13973 C48(4.50)  LDD0209 
WASH complex subunit 4 (WASHC4) LDTP06702 C604(1.04)  LDD0080 
WD repeat-containing protein 35 (WDR35) LDTP13064 C1044(1.24)  LDD0080 
WD repeat-containing protein 47 (WDR47) LDTP01475 C145(1.60)  LDD3323 
Wolframin (WFS1) LDTP01380 C847(1.45); C850(1.45)  LDD0078 
Y+L amino acid transporter 2 (SLC7A6) LDTP09781 C497(1.13)  LDD1507 
Zinc finger FYVE domain-containing protein 16 (ZFYVE16) LDTP08040 C377(1.18); C385(1.18); C62(1.16); C66(1.16)  LDD0078 
Zinc transporter 6 (SLC30A6) LDTP07490 C184(0.92)  LDD1492 
Zinc transporter 7 (SLC30A7) LDTP09180 C308(0.76)  LDD0531 
Zinc transporter SLC39A7 (SLC39A7) LDTP09769 C375(1.01)  LDD1507 
Zinc transporter ZIP1 (SLC39A1) LDTP12799 C211(1.01)  LDD1492 
Zinc transporter ZIP10 (SLC39A10) LDTP13543 C598(0.57)  LDD0531 
Zinc transporter ZIP13 (SLC39A13) LDTP10375 C46(0.85)  LDD0078 
Zinc transporter ZIP4 (SLC39A4) LDTP07544 C57(0.82); C62(0.82)  LDD0531 
Zinc transporter ZIP6 (SLC39A6) LDTP05869 C303(2.82)  LDD3369 
------------------------------------------------------------------------------------
⏷ Show the Full List of 959 Transporter and channel
862 Transcription factor Labeled by This Probe
Target Name Target ID Binding Site(Ratio) Interaction ID
52 kDa repressor of the inhibitor of the protein kinase (THAP12) LDTP00762 C644(1.75)  LDD0080 
Achaete-scute homolog 2 (ASCL2) LDTP11006 C20(2.82)  LDD3402 
Activity-dependent neuroprotector homeobox protein (ADNP) LDTP11834 C75(0.93); C79(0.93)  LDD0078 
Activity-dependent neuroprotector homeobox protein 2 (ADNP2) LDTP15084 C74(0.92); C75(0.97); C78(0.97)  LDD0531 
AF4/FMR2 family member 1 (AFF1) LDTP04476 C193(2.16)  LDD3337 
AF4/FMR2 family member 3 (AFF3) LDTP04477 C428(1.17)  LDD3427 
AF4/FMR2 family member 4 (AFF4) LDTP13261 C315(1.08)  LDD0078 
Alpha-globin transcription factor CP2 (TFCP2) LDTP05654 C453(2.68)  LDD0080 
ALX homeobox protein 1 (ALX1) LDTP06447 C123(1.44)  LDD0080 
Androgen receptor (AR) LDTP02488 C619(1.63)  LDD0080 
Arginine-glutamic acid dipeptide repeats protein (RERE) LDTP13076 C344(0.99); C353(0.99)  LDD0078 
Aryl hydrocarbon receptor (AHR) LDTP03790 C101(1.26); C639(1.04); C316(0.95)  LDD0078 
Aryl hydrocarbon receptor nuclear translocator (ARNT) LDTP03393 C351(1.03); C358(1.03)  LDD0078 
Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) LDTP12206 C310(2.20)  LDD3332 
AT-rich interactive domain-containing protein 1A (ARID1A) LDTP00350 C336(1.06); C2043(1.01)  LDD0078 
AT-rich interactive domain-containing protein 1B (ARID1B) LDTP09198 C2127(9.81)  LDD3313 
AT-rich interactive domain-containing protein 2 (ARID2) LDTP07313 C711(1.01)  LDD0078 
AT-rich interactive domain-containing protein 3A (ARID3A) LDTP10995 C327(1.96)  LDD0080 
AT-rich interactive domain-containing protein 3B (ARID3B) LDTP08519 C304(2.10)  LDD3380 
AT-rich interactive domain-containing protein 4A (ARID4A) LDTP03483 C559(1.66); C573(1.66)  LDD0080 
AT-rich interactive domain-containing protein 4B (ARID4B) LDTP06862 C828(1.04); C833(1.04)  LDD0078 
AT-rich interactive domain-containing protein 5A (ARID5A) LDTP05415 C248(1.10)  LDD1509 
AT-rich interactive domain-containing protein 5B (ARID5B) LDTP06223 C74(3.15)  LDD3470 
Attractin (ATRN) LDTP01337 C933(5.43)  LDD3310 
B-cell lymphoma 3 protein (BCL3) LDTP03072 C213(1.94); C340(2.24)  LDD3310 
B-cell lymphoma 6 protein (BCL6) LDTP03925 C339(1.32); C348(1.32)  LDD0078 
B-cell lymphoma/leukemia 11A (BCL11A) LDTP11750 C607(3.18)  LDD3339 
B-cell lymphoma/leukemia 11B (BCL11B) LDTP11622 C808(1.76)  LDD3311 
BAH and coiled-coil domain-containing protein 1 (BAHCC1) LDTP18512 C2009(0.82); C2022(0.82)  LDD0533 
Basic helix-loop-helix ARNT-like protein 1 (BMAL1) LDTP00251 C164(1.17)  LDD0531 
Basic helix-loop-helix ARNT-like protein 2 (BMAL2) LDTP09732 C553(7.52)  LDD0204 
BEN domain-containing protein 3 (BEND3) LDTP07125 C95(0.98); C288(0.91); C291(0.91)  LDD0078 
BRCA2-interacting transcriptional repressor EMSY (EMSY) LDTP08086 C971(1.75)  LDD0080 
Bromodomain and PHD finger-containing protein 3 (BRPF3) LDTP13538 C258(0.88); C488(0.83)  LDD0531 
Bromodomain-containing protein 1 (BRD1) LDTP01653 C937(1.58)  LDD3312 
Calmodulin-binding transcription activator 2 (CAMTA2) LDTP01479 C50(2.82)  LDD3407 
cAMP-responsive element modulator (CREM) LDTP05390 C98(2.71)  LDD3331 
Carbohydrate-responsive element-binding protein (MLXIPL) LDTP12311 C143(1.44); C218(0.77)  LDD0532 
CCAAT/enhancer-binding protein beta (CEBPB) LDTP02914 C184(1.16); C248(1.11); C156(0.94)  LDD0078 
CCAAT/enhancer-binding protein zeta (CEBPZ) LDTP14809 C411(1.04); C282(0.93); C560(0.88)  LDD0078 
CDKN2A-interacting protein (CDKN2AIP) LDTP12792 C516(1.19); C178(1.01)  LDD0078 
Cell division cycle 5-like protein (CDC5L) LDTP10868 C96(2.38)  LDD3312 
Cell growth-regulating nucleolar protein (LYAR) LDTP12761 C30(0.92); C33(0.92); C36(0.92)  LDD0078 
Chorion-specific transcription factor GCMb (GCM2) LDTP01270 C454(2.83)  LDD3392 
Chromatin accessibility complex protein 1 (CHRAC1) LDTP12507 C55(1.51)  LDD0078 
Class E basic helix-loop-helix protein 40 (BHLHE40) LDTP00351 C13(2.93)  LDD3419 
Class E basic helix-loop-helix protein 41 (BHLHE41) LDTP11621 C203(3.57)  LDD3365 
Core-binding factor subunit beta (CBFB) LDTP06012 C48(2.00)  LDD3311 
COUP transcription factor 1 (NR2F1) LDTP02501 C207(20.00); C220(20.00); C122(1.23); C128(1.07)  LDD0080 
COUP transcription factor 2 (NR2F2) LDTP03280 C200(1.26); C213(1.26); C343(0.99)  LDD0078 
CREB3 regulatory factor (CREBRF) LDTP08465 C231(2.40)  LDD3369 
CXXC-type zinc finger protein 1 (CXXC1) LDTP12984 C580(14.83); C566(72.79); C592(4.81)  LDD0209 
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) LDTP02968 C153(1.27)  LDD1512 
Cyclic AMP-dependent transcription factor ATF-4 (ATF4) LDTP02969 C310(1.93)  LDD3412 
Cyclic AMP-dependent transcription factor ATF-6 beta (ATF6B) LDTP11010 C340(1.25); C501(0.95)  LDD0078 
Cyclic AMP-dependent transcription factor ATF-7 (ATF7) LDTP02906 C409(1.36)  LDD3314 
Cyclic AMP-responsive element-binding protein 1 (CREB1) LDTP02834 C337(5.18)  LDD0209 
Cyclic AMP-responsive element-binding protein 3-like protein 2 (CREB3L2) LDTP07890 C329(0.95)  LDD1492 
Cyclic AMP-responsive element-binding protein 3-like protein 4 (CREB3L4) LDTP09516 C252(2.88)  LDD3493 
Cyclic AMP-responsive element-binding protein 5 (CREB5) LDTP05381 C69(2.66); C80(2.66)  LDD0080 
Cysteine/serine-rich nuclear protein 2 (CSRNP2) LDTP15961 C518(0.95)  LDD1573 
D site-binding protein (DBP) LDTP05628 C157(1.89)  LDD3367 
Dachshund homolog 1 (DACH1) LDTP13326 C243(3.05)  LDD3370 
Deformed epidermal autoregulatory factor 1 homolog (DEAF1) LDTP01207 C504(1.08); C507(1.08)  LDD0078 
Deoxynucleotidyltransferase terminal-interacting protein 1 (DNTTIP1) LDTP11746 C156(2.25)  LDD0080 
DNA (cytosine-5)-methyltransferase 3-like (DNMT3L) LDTP13404 C779(3.10)  LDD3487 
DNA methyltransferase 1-associated protein 1 (DMAP1) LDTP12355 C381(0.90); C384(0.90)  LDD0531 
DNA polymerase epsilon subunit 4 (POLE4) LDTP12471 C84(0.86); C85(0.86)  LDD0078 
DNA-binding protein Ikaros (IKZF1) LDTP05861 C394(12.72)  LDD0209 
DNA-binding protein inhibitor ID-1 (ID1) LDTP03916 C45(10.79)  LDD0209 
DNA-binding protein inhibitor ID-4 (ID4) LDTP04141 C63(9.74); C71(9.74); C66(9.74)  LDD0080 
DNA-binding protein RFX2 (RFX2) LDTP04174 C434(0.86); C436(0.86)  LDD0078 
DNA-binding protein RFX5 (RFX5) LDTP04176 C160(0.86)  LDD0078 
DNA-binding protein RFX7 (RFX7) LDTP06690 C78(1.04)  LDD0531 
DNA-binding protein RFXANK (RFXANK) LDTP00377 C205(75.08)  LDD0209 
DNA-binding protein SATB1 (SATB1) LDTP05316 C209(125.10)  LDD0209 
DNA-binding protein SATB2 (SATB2) LDTP13728 C159(2.08); C246(1.00); C539(1.49)  LDD0080 
DnaJ homolog subfamily C member 1 (DNAJC1) LDTP10501 C380(1.03)  LDD0078 
DnaJ homolog subfamily C member 2 (DNAJC2) LDTP10891 C394(1.53); C402(1.53); C276(1.25)  LDD0080 
Double homeobox protein 4-like protein 2 (DUX4L2) LDTP19098 C281(2.51)  LDD3339 
Doublesex- and mab-3-related transcription factor 2 (DMRT2) LDTP14151 C105(1.83)  LDD3410 
Doublesex- and mab-3-related transcription factor B1 (DMRTB1) LDTP15782 C118(1.33)  LDD2263 
Dr1-associated corepressor (DRAP1) LDTP06229 C54(3.07)  LDD3311 
eIF5-mimic protein 1 (BZW2) LDTP14241 C270(4.60)  LDD0209 
eIF5-mimic protein 2 (BZW1) LDTP07940 C35(4.05)  LDD0209 
Endoplasmic reticulum membrane sensor NFE2L1 (NFE2L1) LDTP06127 C671(0.83)  LDD0531 
Endothelial PAS domain-containing protein 1 (EPAS1) LDTP10986 C297(2.74)  LDD2259 
Endothelial transcription factor GATA-2 (GATA2) LDTP03255 C413(0.95)  LDD3340 
Enhancer of rudimentary homolog (ERH) LDTP05194 C28(0.97); C33(0.97)  LDD0078 
Erythroid transcription factor (GATA1) LDTP02819 C199(1.49); C27(1.83)  LDD3334 
Estrogen receptor (ESR1) LDTP01981 C72(1.69)  LDD2268 
ETS domain-containing transcription factor ERF (ERF) LDTP04370 C72(0.80)  LDD0532 
ETS translocation variant 3 (ETV3) LDTP03922 C81(0.77)  LDD0531 
ETS translocation variant 5 (ETV5) LDTP03921 C300(1.42); C308(1.42)  LDD1093 
ETS-related transcription factor Elf-2 (ELF2) LDTP06452 C348(2.28); C470(2.16)  LDD0080 
FACT complex subunit SSRP1 (SSRP1) LDTP05577 C200(0.89); C343(0.88); C340(0.87)  LDD0078 
Flt3-interacting zinc finger protein 1 (FIZ1) LDTP15830 C455(4.24)  LDD3342 
Forkhead box protein C1 (FOXC1) LDTP05702 C529(3.48); C550(2.46); C135(1.75)  LDD0080 
Forkhead box protein C2 (FOXC2) LDTP11017 C75(1.76)  LDD3364 
Forkhead box protein D2 (FOXD2) LDTP01000 C184(1.00)  LDD1507 
Forkhead box protein D3 (FOXD3) LDTP13398 C104(1.01)  LDD1492 
Forkhead box protein E1 (FOXE1) LDTP00258 C224(1.37)  LDD3310 
Forkhead box protein F1 (FOXF1) LDTP05700 C339(2.32)  LDD2440 
Forkhead box protein F2 (FOXF2) LDTP05701 C157(4.15)  LDD3455 
Forkhead box protein J2 (FOXJ2) LDTP12964 C145(1.07)  LDD0078 
Forkhead box protein K1 (FOXK1) LDTP05201 C665(1.05)  LDD0078 
Forkhead box protein K2 (FOXK2) LDTP05282 C357(2,661.27)  LDD0209 
Forkhead box protein L2 (FOXL2) LDTP04808 C176(2.59)  LDD3331 
Forkhead box protein M1 (FOXM1) LDTP05543 C210(11.59)  LDD0209 
Forkhead box protein N3 (FOXN3) LDTP00265 C469(0.82)  LDD1508 
Forkhead box protein O1 (FOXO1) LDTP05646 C612(1.05)  LDD1492 
Forkhead box protein O3 (FOXO3) LDTP00791 C31(0.78)  LDD0547 
Forkhead box protein O4 (FOXO4) LDTP05225 C415(1.05)  LDD1507 
Forkhead box protein P1 (FOXP1) LDTP11861 C566(0.91)  LDD1514 
Forkhead box protein P2 (FOXP2) LDTP00634 C406(3.35)  LDD3310 
Forkhead box protein P4 (FOXP4) LDTP08497 C342(6.52)  LDD0209 
Fos-related antigen 1 (FOSL1) LDTP02786 C172(1.10)  LDD0078 
Fos-related antigen 2 (FOSL2) LDTP02787 C191(1.57)  LDD3342 
G protein-coupled receptor associated sorting protein 3 (GPRASP3) LDTP07582 C274(0.91); C281(0.91)  LDD0078 
G-protein coupled receptor-associated sorting protein 2 (GPRASP2) LDTP10195 C460(0.92); C466(0.92)  LDD0078 
GA-binding protein alpha chain (GABPA) LDTP05494 C421(1.05)  LDD0078 
Gamma-interferon-inducible protein 16 (IFI16) LDTP06602 C637(1.19); C679(0.88)  LDD0078 
GATA zinc finger domain-containing protein 1 (GATAD1) LDTP09585 C179(1.00)  LDD0078 
GDNF-inducible zinc finger protein 1 (GZF1) LDTP11745 C118(8.90); C125(8.90)  LDD0080 
General transcription factor II-I (GTF2I) LDTP05101 C215(0.99); C80(0.90)  LDD0078 
General transcription factor II-I repeat domain-containing protein 1 (GTF2IRD1) LDTP13295 C434(3.32)  LDD3310 
Glucocorticoid modulatory element-binding protein 1 (GMEB1) LDTP14220 C174(1.02); C178(1.02)  LDD0078 
Glucocorticoid modulatory element-binding protein 2 (GMEB2) LDTP13445 C171(0.95); C175(0.95)  LDD0531 
Glucocorticoid receptor (NR3C1) LDTP02016 C638(20.00); C643(20.00); C622(5.32); C302(2.63)  LDD0080 
Golgin-45 (BLZF1) LDTP11821 C349(2.83)  LDD3312 
Grainyhead-like protein 1 homolog (GRHL1) LDTP12901 C335(4.49)  LDD3319 
Grainyhead-like protein 2 homolog (GRHL2) LDTP07429 C446(1.00)  LDD0531 
Grainyhead-like protein 3 homolog (GRHL3) LDTP09485 C325(1.80)  LDD3323 
Heat shock factor protein 1 (HSF1) LDTP05253 C373(1.29); C378(1.29)  LDD0078 
Heat shock factor protein 2 (HSF2) LDTP05414 C369(1.11)  LDD1511 
Hepatocyte nuclear factor 1-alpha (HNF1A) LDTP03082 C50(2.51)  LDD3380 
Hepatocyte nuclear factor 3-alpha (FOXA1) LDTP04701 C258(1.43)  LDD0078 
Hepatocyte nuclear factor 3-beta (FOXA2) LDTP13812 C253(5.56); C222(4.70)  LDD3342 
Hepatocyte nuclear factor 3-gamma (FOXA3) LDTP04702 C227(3.29)  LDD3395 
Hepatocyte nuclear factor 4-alpha (HNF4A) LDTP03941 C285(0.78)  LDD3333 
Hepatocyte nuclear factor 4-gamma (HNF4G) LDTP06143 C91(1.47)  LDD3333 
High mobility group protein B1 (HMGB1) LDTP02343 C23(0.97)  LDD0078 
High mobility group protein B2 (HMGB2) LDTP03363 C106(1.11)  LDD0531 
High mobility group protein B3 (HMGB3) LDTP00612 C23(1.27)  LDD0078 
Histone H4 transcription factor (HINFP) LDTP11067 C178(1.02)  LDD1508 
HMG box transcription factor BBX (BBX) LDTP09725 C606(1.04)  LDD0078 
HMG box-containing protein 1 (HBP1) LDTP00963 C501(2.20)  LDD3325 
HMG domain-containing protein 3 (HMGXB3) LDTP19232 C390(1.00); C396(1.00)  LDD0078 
HMG domain-containing protein 4 (HMGXB4) LDTP13248 C12(1.64)  LDD3360 
Homeobox and leucine zipper protein Homez (HOMEZ) LDTP08584 C378(1.37)  LDD0080 
Homeobox protein CDX-2 (CDX2) LDTP10926 C166(2.39)  LDD0080 
Homeobox protein cut-like 1 (CUX1) LDTP03874 C421(2.78)  LDD3314 
Homeobox protein cut-like 2 (CUX2) LDTP00364 C973(3.56)  LDD3410 
Homeobox protein Hox-A1 (HOXA1) LDTP04269 C40(1.13); C47(1.13)  LDD0078 
Homeobox protein Hox-A10 (HOXA10) LDTP03580 C200(2.67)  LDD0080 
Homeobox protein Hox-A11 (HOXA11) LDTP03583 C200(1.87)  LDD0080 
Homeobox protein Hox-A13 (HOXA13) LDTP03584 C194(1.52)  LDD3364 
Homeobox protein Hox-A3 (HOXA3) LDTP00753 C179(0.99); C71(0.89)  LDD0078 
Homeobox protein Hox-A5 (HOXA5) LDTP03070 C233(1.05); C103(0.98)  LDD1492 
Homeobox protein Hox-A6 (HOXA6) LDTP14664 C146(0.87)  LDD1512 
Homeobox protein Hox-A9 (HOXA9) LDTP03582 C54(0.96)  LDD1492 
Homeobox protein Hox-B4 (HOXB4) LDTP02900 C60(0.98)  LDD0531 
Homeobox protein Hox-B5 (HOXB5) LDTP02326 C233(1.75)  LDD3345 
Homeobox protein Hox-B6 (HOXB6) LDTP02901 C184(1.90)  LDD3407 
Homeobox protein Hox-B8 (HOXB8) LDTP02898 C215(2.25)  LDD0080 
Homeobox protein Hox-B9 (HOXB9) LDTP02899 C161(1.53)  LDD3407 
Homeobox protein Hox-C10 (HOXC10) LDTP12824 C111(1.12); C112(1.12)  LDD0078 
Homeobox protein Hox-C11 (HOXC11) LDTP00715 C92(1.23)  LDD1571 
Homeobox protein Hox-C4 (HOXC4) LDTP02324 C194(2.38)  LDD3433 
Homeobox protein Hox-C5 (HOXC5) LDTP05241 C76(1.89)  LDD3402 
Homeobox protein Hox-C6 (HOXC6) LDTP14592 C97(1.33)  LDD3380 
Homeobox protein Hox-C9 (HOXC9) LDTP03586 C130(1.34)  LDD3478 
Homeobox protein Hox-D11 (HOXD11) LDTP14665 C225(0.98)  LDD1492 
Homeobox protein Hox-D13 (HOXD13) LDTP03746 C271(6.57)  LDD0080 
Homeobox protein Meis1 (MEIS1) LDTP00286 C90(7.33)  LDD3418 
Homeobox protein Meis2 (MEIS2) LDTP00425 C168(7.42); C172(7.42)  LDD0080 
Homeobox protein Nkx-2.1 (NKX2-1) LDTP04063 C445(2.03)  LDD3312 
Homeobox protein Nkx-2.5 (NKX2-5) LDTP04549 C114(0.95); C46(1.02)  LDD1492 
Homeobox protein Nkx-6.1 (NKX6-1) LDTP05131 C221(2.70)  LDD3418 
Homeobox protein OTX1 (OTX1) LDTP03632 C340(0.75)  LDD1492 
Homeobox protein PKNOX1 (PKNOX1) LDTP04706 C326(0.95)  LDD0533 
Homeobox protein PKNOX2 (PKNOX2) LDTP10509 C91(5.60)  LDD3439 
Homeobox protein SIX1 (SIX1) LDTP06398 C130(2.71)  LDD0080 
Homeobox protein SIX2 (SIX2) LDTP12345 C130(2.03)  LDD0080 
Homeobox protein SIX4 (SIX4) LDTP13361 C229(0.71)  LDD0531 
Homeobox protein SIX5 (SIX5) LDTP08763 C93(2.10); C95(2.10)  LDD0080 
Homeobox protein SIX6 (SIX6) LDTP01615 C44(37.04)  LDD0209 
Homeobox protein TGIF1 (TGIF1) LDTP06421 C349(0.92)  LDD0078 
Homeobox protein TGIF2 (TGIF2) LDTP11630 C130(0.98)  LDD1507 
Homeobox protein unc-4 homolog (UNCX) LDTP14371 C103(4.25)  LDD3332 
Homeodomain-only protein (HOPX) LDTP11042 C86(1.63)  LDD3316 
Hypermethylated in cancer 2 protein (HIC2) LDTP10453 C444(2.32); C447(2.32); C361(1.55); C395(1.27)  LDD0080 
Hypoxia-inducible factor 1-alpha (HIF1A) LDTP06601 C90(3.59)  LDD3369 
Insulin gene enhancer protein ISL-2 (ISL2) LDTP15689 C52(1.16)  LDD0080 
Insulinoma-associated protein 1 (INSM1) LDTP05276 C510(1.89)  LDD3342 
Insulinoma-associated protein 2 (INSM2) LDTP15836 C77(1.81); C306(3.22)  LDD3433 
Interferon regulatory factor 1 (IRF1) LDTP02529 C53(0.28)  LDD2236 
Interferon regulatory factor 2 (IRF2) LDTP02719 C83(2.38)  LDD3339 
Interferon regulatory factor 2-binding protein 2 (IRF2BP2) LDTP08097 C505(1.14); C506(0.89); C509(0.89)  LDD0078 
Interferon regulatory factor 3 (IRF3) LDTP06168 C222(0.88); C267(0.87); C371(1.10)  LDD0531 
Interferon regulatory factor 4 (IRF4) LDTP06354 C274(1.66); C343(1.31)  LDD3332 
Interferon regulatory factor 5 (IRF5) LDTP05926 C44(1.27)  LDD3318 
Interferon regulatory factor 6 (IRF6) LDTP00467 C249(0.78)  LDD0593 
Interferon regulatory factor 7 (IRF7) LDTP09953 C394(10.13)  LDD0209 
Interferon regulatory factor 8 (IRF8) LDTP05362 C349(2.92)  LDD3333 
Interferon regulatory factor 9 (IRF9) LDTP05266 C241(2.31)  LDD3314 
Iroquois-class homeodomain protein IRX-5 (IRX5) LDTP05124 C229(2.57)  LDD3337 
Krueppel-like factor 10 (KLF10) LDTP05756 C165(1.07); C170(1.07)  LDD0078 
Krueppel-like factor 12 (KLF12) LDTP14078 C290(0.93)  LDD1510 
Krueppel-like factor 16 (KLF16) LDTP15906 C129(1.28); C134(1.28); C233(0.87)  LDD0531 
Krueppel-like factor 5 (KLF5) LDTP06000 C66(2.85)  LDD3452 
Krueppel-like factor 6 (KLF6) LDTP10918 C48(1.04)  LDD0533 
Leucine zipper transcription factor-like protein 1 (LZTFL1) LDTP12394 C35(1.59)  LDD0080 
Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1) LDTP06748 C726(1.11); C742(1.11); C14(1.04); C334(1.04)  LDD0078 
Leucine-rich repeat flightless-interacting protein 2 (LRRFIP2) LDTP14194 C435(0.98)  LDD3323 
Leucine-zipper-like transcriptional regulator 1 (LZTR1) LDTP08917 C342(2.28); C427(1.34)  LDD0080 
Ligand-dependent corepressor (LCOR) LDTP10478 C531(2.41)  LDD3333 
Ligand-dependent nuclear receptor corepressor-like protein (LCORL) LDTP15414 C89(1.39); C92(1.39)  LDD0531 
LIM homeobox transcription factor 1-beta (LMX1B) LDTP01020 C165(1.50)  LDD3401 
LIM/homeobox protein Lhx2 (LHX2) LDTP04364 C53(1.30); C56(1.30)  LDD2171 
LIM/homeobox protein Lhx9 (LHX9) LDTP12398 C120(1.49)  LDD3342 
Lymphoid enhancer-binding factor 1 (LEF1) LDTP13397 C321(6.97)  LDD0209 
MAX gene-associated protein (MGA) LDTP08542 C474(35.86); C1402(12.19); C2241(10.93)  LDD0209 
Max-binding protein MNT (MNT) LDTP10907 C239(5.45)  LDD3332 
Max-interacting protein 1 (MXI1) LDTP04368 C64(1.84)  LDD3418 
Max-like protein X (MLX) LDTP13255 C159(1.20)  LDD1514 
Mesoderm induction early response protein 1 (MIER1) LDTP08741 C316(1.52)  LDD3346 
Mesoderm induction early response protein 2 (MIER2) LDTP08815 C300(1.17)  LDD0078 
Mesoderm induction early response protein 3 (MIER3) LDTP08037 C214(1.22)  LDD3331 
Metal regulatory transcription factor 1 (MTF1) LDTP06224 C632(0.99); C636(0.99); C638(0.99)  LDD0078 
Metal-response element-binding transcription factor 2 (MTF2) LDTP14028 C202(1.05); C204(1.05); C206(1.05)  LDD0078 
Metastasis-associated protein MTA1 (MTA1) LDTP05830 C417(1.06); C420(1.06); C393(0.84); C396(0.84)  LDD0078 
Metastasis-associated protein MTA2 (MTA2) LDTP01414 C261(1.43); C394(1.61); C391(1.44)  LDD0080 
Metastasis-associated protein MTA3 (MTA3) LDTP11193 C403(0.60); C406(0.60)  LDD0531 
Methyl-CpG-binding domain protein 1 (MBD1) LDTP13360 C70(1.30); C57(1.54)  LDD3310 
MHC class II regulatory factor RFX1 (RFX1) LDTP03183 C794(0.85)  LDD0078 
Microphthalmia-associated transcription factor (MITF) LDTP01101 C46(0.98)  LDD3314 
Mineralocorticoid receptor (NR3C2) LDTP02259 C649(2.41)  LDD3319 
Mitotic deacetylase-associated SANT domain protein (MIDEAS) LDTP15130 C442(1.20); C16(0.91)  LDD0078 
MLX-interacting protein (MLXIP) LDTP12129 C681(1.00); C690(1.00); C705(1.00)  LDD0078 
Mothers against decapentaplegic homolog 1 (SMAD1) LDTP06476 C57(0.86); C64(0.88)  LDD0531 
Mothers against decapentaplegic homolog 2 (SMAD2) LDTP06475 C70(0.96)  LDD0078 
Mothers against decapentaplegic homolog 3 (SMAD3) LDTP05190 C374(2.84)  LDD3311 
Mothers against decapentaplegic homolog 4 (SMAD4) LDTP05889 C115(0.87)  LDD0078 
Mothers against decapentaplegic homolog 5 (SMAD5) LDTP10956 C378(0.86)  LDD0531 
Mothers against decapentaplegic homolog 7 (SMAD7) LDTP00537 C319(2.17)  LDD2806 
Mothers against decapentaplegic homolog 9 (SMAD9) LDTP00568 C380(1.78)  LDD3314 
Motor neuron and pancreas homeobox protein 1 (MNX1) LDTP04346 C88(0.96)  LDD1492 
Msx2-interacting protein (SPEN) LDTP10839 C1066(2.91)  LDD0080 
Myb-related protein B (MYBL2) LDTP02485 C69(2.05)  LDD0080 
Myb/SANT-like DNA-binding domain-containing protein 2 (MSANTD2) LDTP19498 C99(10.01)  LDD0209 
Myb/SANT-like DNA-binding domain-containing protein 3 (MSANTD3) LDTP18164 C162(1.03); C172(1.03)  LDD0078 
Myc proto-oncogene protein (MYC) LDTP01824 C315(3.27)  LDD3339 
Myc-associated zinc finger protein (MAZ) LDTP04734 C66(1.01)  LDD3315 
Myelin transcription factor 1 (MYT1) LDTP05298 C944(2.42)  LDD3340 
Myelin transcription factor 1-like protein (MYT1L) LDTP13526 C929(1.30)  LDD3340 
Myeloid cell nuclear differentiation antigen (MNDA) LDTP03930 C371(3.38)  LDD3322 
Myoblast determination protein 1 (MYOD1) LDTP02771 C135(2.61); C225(2.43); C251(2.83)  LDD3401 
Myocardin-related transcription factor A (MRTFA) LDTP10039 C508(0.88); C509(0.88)  LDD0078 
Myocardin-related transcription factor B (MRTFB) LDTP13549 C636(2.08)  LDD0080 
Myocyte-specific enhancer factor 2A (MEF2A) LDTP05331 C96(1.06)  LDD1508 
Myoneurin (MYNN) LDTP12344 C371(0.98)  LDD0078 
N-myc proto-oncogene protein (MYCN) LDTP02024 C186(2.69)  LDD3340 
NAC-alpha domain-containing protein 1 (NACAD) LDTP14440 C1053(1.93)  LDD3331 
Nascent polypeptide-associated complex subunit alpha, muscle-specific form (NACA) LDTP14411 C1717(2.42)  LDD3401 
Netrin-1 (NTN1) LDTP01642 C287(1.75)  LDD3383 
Neuronal PAS domain-containing protein 1 (NPAS1) LDTP15844 C41(2.75)  LDD2253 
Neurotrophin receptor-interacting factor homolog (ZNF274) LDTP10342 C361(1.12)  LDD1509 
NF-kappa-B inhibitor alpha (NFKBIA) LDTP03341 C239(1.68)  LDD0531 
NF-kappa-B inhibitor beta (NFKBIB) LDTP06438 C121(1.22); C135(1.01); C240(1.07)  LDD0531 
NF-kappa-B inhibitor epsilon (NFKBIE) LDTP00221 C457(5.97)  LDD0209 
NF-kappa-B inhibitor-like protein 1 (NFKBIL1) LDTP13096 C82(2.71)  LDD0080 
NF-kappa-B-repressing factor (NKRF) LDTP00576 C37(14.31); C424(15.78)  LDD0204 
NF-X1-type zinc finger protein NFXL1 (NFXL1) LDTP15183 C652(1.36); C660(1.36); C748(1.18); C764(1.12)  LDD0078 
NFX1-type zinc finger-containing protein 1 (ZNFX1) LDTP13041 C112(1.14); C1390(1.05); C1398(1.05)  LDD0078 
Non-POU domain-containing octamer-binding protein (NONO) LDTP06341 C145(1.20)  LDD0078 
Nuclear autoantigen Sp-100 (SP100) LDTP03237 C309(1.62)  LDD3310 
Nuclear body protein SP140 (SP140) LDTP05833 C224(6.04)  LDD3372 
Nuclear body protein SP140-like protein (SP140L) LDTP18419 C191(0.95)  LDD0078 
Nuclear factor 1 A-type (NFIA) LDTP05671 C404(1.04)  LDD1492 
Nuclear factor 1 C-type (NFIC) LDTP02296 C88(1.17)  LDD0080 
Nuclear factor erythroid 2-related factor 2 (NFE2L2) LDTP06518 C595(3.58)  LDD3323 
Nuclear factor erythroid 2-related factor 3 (NFE2L3) LDTP14035 C595(2.93)  LDD0080 
Nuclear factor interleukin-3-regulated protein (NFIL3) LDTP06591 C175(1.02)  LDD1573 
Nuclear factor NF-kappa-B p100 subunit (NFKB2) LDTP05254 C57(1.02); C738(0.86)  LDD0078 
Nuclear factor NF-kappa-B p105 subunit (NFKB1) LDTP03017 C162(2.08)  LDD3310 
Nuclear factor of activated T-cells 5 (NFAT5) LDTP01461 C32(1.42); C288(2.75)  LDD3311 
Nuclear factor of activated T-cells, cytoplasmic 1 (NFATC1) LDTP01645 C383(1.51)  LDD0531 
Nuclear factor of activated T-cells, cytoplasmic 2 (NFATC2) LDTP05883 C515(3.05)  LDD3331 
Nuclear factor of activated T-cells, cytoplasmic 3 (NFATC3) LDTP05710 C242(3.42)  LDD3345 
Nuclear factor of activated T-cells, cytoplasmic 4 (NFATC4) LDTP06231 C751(4.10)  LDD3469 
Nuclear receptor coactivator 2 (NCOA2) LDTP06422 C200(0.91); C380(1.24)  LDD0531 
Nuclear receptor corepressor 1 (NCOR1) LDTP01198 C994(1.21)  LDD0078 
Nuclear receptor corepressor 2 (NCOR2) LDTP14199 C1511(1.03)  LDD0078 
Nuclear receptor ROR-alpha (RORA) LDTP03740 C54(1.60)  LDD2469 
Nuclear receptor ROR-beta (RORB) LDTP09859 C57(2.15)  LDD3397 
Nuclear receptor ROR-gamma (RORC) LDTP04413 C73(1.61)  LDD3451 
Nuclear receptor subfamily 0 group B member 1 (NR0B1) LDTP04480 C104(5.64); C109(5.64); C107(5.64)  LDD0080 
Nuclear receptor subfamily 1 group D member 1 (NR1D1) LDTP03053 C132(1.07)  LDD0547 
Nuclear receptor subfamily 1 group D member 2 (NR1D2) LDTP06249 C374(1.00)  LDD0580 
Nuclear receptor subfamily 2 group C member 1 (NR2C1) LDTP02644 C200(1.05); C113(0.92); C116(0.92); C185(0.91)  LDD0078 
Nuclear receptor subfamily 2 group C member 2 (NR2C2) LDTP04228 C479(21.50)  LDD0204 
Nuclear receptor subfamily 2 group F member 6 (NR2F6) LDTP02500 C203(0.91); C304(1.01)  LDD0531 
Nuclear receptor subfamily 4 group A member 2 (NR4A2) LDTP04037 C340(1.53)  LDD3410 
Nuclear receptor subfamily 4 group A member 3 (NR4A3) LDTP09803 C605(5.56); C339(1.59)  LDD3332 
Nuclear receptor subfamily 4immunitygroup A member 1 (NR4A1) LDTP03192 C316(1.49)  LDD3427 
Nuclear respiratory factor 1 (NRF1) LDTP06597 C134(1.05); C229(0.94)  LDD1492 
Nuclear transcription factor Y subunit beta (NFYB) LDTP03317 C85(1.02); C89(1.02)  LDD1093 
Nuclear transcription factor Y subunit gamma (NFYC) LDTP06013 C345(1.15)  LDD1492 
Nucleolar transcription factor 1 (UBTF) LDTP02897 C68(1.69)  LDD0080 
Nucleus accumbens-associated protein 1 (NACC1) LDTP10756 C178(0.98)  LDD0078 
Nucleus accumbens-associated protein 2 (NACC2) LDTP10124 C393(0.97)  LDD0078 
Oligodendrocyte transcription factor 2 (OLIG2) LDTP05907 C47(0.97)  LDD2471 
Oxysterols receptor LXR-beta (NR1H2) LDTP04659 C87(1.24)  LDD3310 
Paired box protein Pax-1 (PAX1) LDTP02808 C134(0.99)  LDD1492 
Paired box protein Pax-2 (PAX2) LDTP05383 C82(1.22)  LDD3323 
Paired box protein Pax-5 (PAX5) LDTP05361 C52(4.68)  LDD3339 
Paired box protein Pax-6 (PAX6) LDTP03351 C94(0.82); C40(1.23)  LDD3423 
Paired box protein Pax-8 (PAX8) LDTP05499 C45(3.39); C147(2.41)  LDD3365 
Paired box protein Pax-9 (PAX9) LDTP04709 C206(1.52)  LDD3354 
Paired mesoderm homeobox protein 2 (PRRX2) LDTP15846 C89(1.15)  LDD3434 
Paraspeckle component 1 (PSPC1) LDTP09694 C216(1.17)  LDD0531 
Paternally-expressed gene 3 protein (PEG3) LDTP11651 C1334(1.84)  LDD3343 
Peregrin (BRPF1) LDTP04683 C570(2.96); C11(1.62)  LDD3310 
Peroxisome proliferator-activated receptor delta (PPARD) LDTP05398 C249(1.14); C251(1.14)  LDD0532 
Peroxisome proliferator-activated receptor gamma (PPARG) LDTP03840 C313(3.04)  LDD3311 
PHD finger protein 1 (PHF1) LDTP00707 C327(1.13)  LDD0078 
PHD finger protein 14 (PHF14) LDTP01447 C458(1.13); C463(1.13); C743(0.88); C746(0.88)  LDD0078 
PHD finger protein 19 (PHF19) LDTP07133 C102(0.85); C99(0.85)  LDD0078 
PHD finger-like domain-containing protein 5A (PHF5A) LDTP08006 C40(1.06); C49(1.00); C58(0.95); C72(0.95)  LDD0078 
Pituitary homeobox 1 (PITX1) LDTP05097 C156(0.96)  LDD0078 
Pituitary homeobox 2 (PITX2) LDTP10945 C277(29.06)  LDD0209 
Pituitary homeobox 3 (PITX3) LDTP01192 C357(1.37)  LDD3383 
Pogo transposable element with ZNF domain (POGZ) LDTP08036 C987(1.15); C395(0.95); C397(0.95); C398(0.95)  LDD0078 
POU domain, class 2, transcription factor 1 (POU2F1) LDTP02749 C455(6.46)  LDD3339 
POU domain, class 3, transcription factor 2 (POU3F2) LDTP03041 C361(1.53)  LDD3413 
POU domain, class 3, transcription factor 3 (POU3F3) LDTP03040 C361(1.20)  LDD1507 
POZ-, AT hook-, and zinc finger-containing protein 1 (PATZ1) LDTP12171 C9(1.46); C14(1.00); C497(0.92); C500(0.92)  LDD0078 
Pre-B-cell leukemia transcription factor 1 (PBX1) LDTP03896 C220(1.22)  LDD0531 
Pre-B-cell leukemia transcription factor 2 (PBX2) LDTP03897 C80(3.44)  LDD3311 
Pre-B-cell leukemia transcription factor 3 (PBX3) LDTP03898 C73(1.20)  LDD0531 
Prospero homeobox protein 1 (PROX1) LDTP09873 C615(2.04)  LDD3333 
Protein AF-10 (MLLT10) LDTP04680 C137(1.03); C140(1.03)  LDD0078 
Protein AF-17 (MLLT6) LDTP04681 C65(1.74); C68(1.74)  LDD0080 
Protein C-ets-1 (ETS1) LDTP02755 C237(109.57)  LDD0209 
Protein c-Fos (FOS) LDTP01823 C90(3.08)  LDD3342 
Protein capicua homolog (CIC) LDTP10765 C336(21.13); C1506(4.57)  LDD0209 
Protein cramped-like (CRAMP1) LDTP18265 C260(58.54)  LDD0209 
Protein Jade-1 (JADE1) LDTP07412 C226(1.00); C229(1.00); C234(1.00)  LDD0078 
Protein Jade-3 (JADE3) LDTP09818 C223(1.68); C231(1.68); C226(1.68)  LDD0080 
Protein Jumonji (JARID2) LDTP09893 C522(0.74); C206(1.15); C859(1.12); C865(1.12)  LDD0531 
Protein PHTF2 (PHTF2) LDTP17696 C382(1.39)  LDD3325 
Protein polybromo-1 (PBRM1) LDTP08216 C1233(1.11); C1244(1.08); C1257(1.08)  LDD0078 
Protein rogdi homolog (ROGDI) LDTP11632 C66(0.88)  LDD0531 
Protein Wiz (WIZ) LDTP01674 C915(0.72)  LDD3312 
Proto-oncogene c-Rel (REL) LDTP05439 C143(2.03)  LDD3334 
Putative transcription factor Ovo-like 1 (OVOL1) LDTP14434 C11(1.16); C15(1.16)  LDD0531 
Putative zinc finger protein 286B (ZNF286B) LDTP19081 C395(1.00)  LDD1508 
Putative zinc finger protein 702 (ZNF702P) LDTP18421 C8(3.02)  LDD3319 
Putative zinc finger protein 726P1 (ZNF726P1) LDTP19243 C59(1.54)  LDD3408 
Pyrin and HIN domain-containing protein 1 (PYHIN1) LDTP07436 C163(1.87)  LDD3372 
Ras-responsive element-binding protein 1 (RREB1) LDTP09864 C309(0.78)  LDD3312 
RB-associated KRAB zinc finger protein (RBAK) LDTP12858 C487(1.10); C490(1.10); C165(1.02); C168(1.02)  LDD0078 
RE1-silencing transcription factor (REST) LDTP05759 C402(2.51)  LDD3311 
Recombining binding protein suppressor of hairless (RBPJ) LDTP05485 C397(2.37); C313(2.05)  LDD0080 
Regulatory factor X-associated protein (RFXAP) LDTP00240 C185(0.94)  LDD0078 
Replication initiator 1 (REPIN1) LDTP11322 C240(0.60)  LDD0532 
REST corepressor 2 (RCOR2) LDTP17658 C59(1.10)  LDD1511 
REST corepressor 3 (RCOR3) LDTP13059 C291(1.69)  LDD3321 
Retinoic acid receptor alpha (RARA) LDTP02489 C174(0.84)  LDD1511 
Retinoic acid receptor beta (RARB) LDTP02523 C203(1.27)  LDD0532 
Retinoic acid receptor gamma (RARG) LDTP02670 C54(1.38)  LDD3312 
Retinoic acid receptor RXR-alpha (RXRA) LDTP03012 C135(1.14); C138(1.14); C171(1.01)  LDD0078 
Retinoic acid receptor RXR-beta (RXRB) LDTP03450 C208(110.50)  LDD0209 
Retinoic acid receptor RXR-gamma (RXRG) LDTP04180 C139(0.90); C142(0.90)  LDD0078 
Retinoic acid-induced protein 1 (RAI1) LDTP08093 C1423(1.24); C844(1.10); C845(1.10); C1553(1.07)  LDD0078 
Ribosome quality control complex subunit TCF25 (TCF25) LDTP11060 C216(1.06); C83(0.93)  LDD0078 
Runt-related transcription factor 1 (RUNX1) LDTP05283 C99(1.56)  LDD3451 
Runt-related transcription factor 3 (RUNX3) LDTP05976 C36(2.25)  LDD3372 
Sal-like protein 1 (SALL1) LDTP12581 C216(1.21)  LDD3386 
Sal-like protein 3 (SALL3) LDTP15903 C999(2.45)  LDD3331 
Sal-like protein 4 (SALL4) LDTP13392 C577(1.50)  LDD3380 
SAP30-binding protein (SAP30BP) LDTP13305 C127(2.26)  LDD3319 
Serum response factor (SRF) LDTP02590 C218(2.19)  LDD3350 
Signal transducer and activator of transcription 1-alpha/beta (STAT1) LDTP03969 C492(1.10)  LDD0078 
Signal transducer and activator of transcription 2 (STAT2) LDTP04515 C174(1.13); C676(1.09)  LDD0078 
Signal transducer and activator of transcription 3 (STAT3) LDTP03903 C259(0.96); C542(0.91)  LDD0078 
Signal transducer and activator of transcription 4 (STAT4) LDTP06204 C324(3.66)  LDD3310 
Signal transducer and activator of transcription 5A (STAT5A) LDTP03971 C101(1.43)  LDD3316 
Signal transducer and activator of transcription 5B (STAT5B) LDTP04454 C688(1.01)  LDD0078 
Signal transducer and activator of transcription 6 (STAT6) LDTP03970 C272(0.79)  LDD0533 
snRNA-activating protein complex subunit 4 (SNAPC4) LDTP07076 C1420(5.26); C1425(5.26)  LDD0080 
Sp110 nuclear body protein (SP110) LDTP12160 C55(7.27); C283(5.73)  LDD0209 
Splicing factor, proline- and glutamine-rich (SFPQ) LDTP03212 C431(1.16)  LDD0531 
Steroid hormone receptor ERR1 (ESRRA) LDTP02573 C229(0.94); C46(1.04)  LDD1492 
Steroid hormone receptor ERR2 (ESRRB) LDTP01660 C91(1.06)  LDD1573 
Steroidogenic factor 1 (NR5A1) LDTP05813 C404(1.16)  LDD3310 
Sterol regulatory element-binding protein 1 (SREBF1) LDTP03828 C962(15.26)  LDD3311 
Sterol regulatory element-binding protein 2 (SREBF2) LDTP05644 C1122(0.82); C1125(0.82); C924(1.04)  LDD0531 
Suppression of tumorigenicity 18 protein (ST18) LDTP00937 C840(1.71)  LDD3341 
SWI/SNF complex subunit SMARCC1 (SMARCC1) LDTP09932 C845(1.08); C520(0.87)  LDD0078 
SWI/SNF complex subunit SMARCC2 (SMARCC2) LDTP09311 C145(2.68); C635(2.31)  LDD0080 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related (HMG20B) LDTP12989 C75(2.48)  LDD3374 
T-box brain protein 1 (TBR1) LDTP06592 C209(1.51)  LDD3376 
T-box transcription factor TBX15 (TBX15) LDTP10813 C392(0.97); C402(0.97)  LDD0078 
T-box transcription factor TBX18 (TBX18) LDTP01718 C55(0.75)  LDD1492 
T-box transcription factor TBX2 (TBX2) LDTP05786 C311(1.14)  LDD3380 
T-box transcription factor TBX21 (TBX21) LDTP13509 C207(1.55)  LDD2355 
T-box transcription factor TBX3 (TBX3) LDTP00542 C404(1.70)  LDD0080 
T-cell acute lymphocytic leukemia protein 1 (TAL1) LDTP02905 C94(1.08)  LDD2351 
T-cell leukemia homeobox protein 3 (TLX3) LDTP00846 C179(2.20)  LDD3340 
TATA box-binding protein-like 1 (TBPL1) LDTP04989 C68(2.31)  LDD3323 
TATA box-binding protein-like 2 (TBPL2) LDTP15139 C258(0.76)  LDD0532 
TATA-box-binding protein (TBP) LDTP03037 C221(0.70)  LDD0531 
Teashirt homolog 1 (TSHZ1) LDTP07829 C102(0.68)  LDD1492 
Teashirt homolog 3 (TSHZ3) LDTP07282 C498(2.17)  LDD3401 
Telomere zinc finger-associated protein (ZBTB48) LDTP02470 C265(3.40)  LDD3339 
Telomeric repeat-binding factor 2-interacting protein 1 (TERF2IP) LDTP12820 C54(2.32)  LDD3315 
THAP domain-containing protein 10 (THAP10) LDTP16185 C130(1.39)  LDD3323 
THAP domain-containing protein 11 (THAP11) LDTP10262 C48(1.09)  LDD0078 
THAP domain-containing protein 7 (THAP7) LDTP11184 C43(1.31)  LDD0531 
Thyroid hormone receptor alpha (THRA) LDTP02524 C334(2.62)  LDD3364 
Tonsoku-like protein (TONSL) LDTP10379 C124(1.06)  LDD0078 
TOX high mobility group box family member 4 (TOX4) LDTP01437 C592(0.90); C596(0.90)  LDD0078 
Transcription factor 12 (TCF12) LDTP10852 C129(4.40)  LDD0209 
Transcription factor 20 (TCF20) LDTP13247 C1188(1.20); C1641(1.02); C1647(1.02); C1795(0.91)  LDD0078 
Transcription factor 7 (TCF7) LDTP03804 C112(3.42)  LDD3331 
Transcription factor 7-like 1 (TCF7L1) LDTP12268 C88(3.26)  LDD3376 
Transcription factor 7-like 2 (TCF7L2) LDTP12410 C372(0.90); C480(0.86)  LDD0531 
Transcription factor A, mitochondrial (TFAM) LDTP05235 C246(1.17)  LDD0078 
Transcription factor AP-2 gamma (TFAP2C) LDTP09860 C56(1.74)  LDD3346 
Transcription factor AP-2-alpha (TFAP2A) LDTP02121 C14(1.31)  LDD0080 
Transcription factor AP-2-beta (TFAP2B) LDTP09761 C87(2.18)  LDD3493 
Transcription factor AP-2-epsilon (TFAP2E) LDTP15169 C74(3.63)  LDD3311 
Transcription factor AP-4 (TFAP4) LDTP05307 C29(3.39)  LDD3339 
Transcription factor BTF3 (BTF3) LDTP03043 C22(1.12)  LDD0078 
Transcription factor COE2 (EBF2) LDTP12127 C250(2.13)  LDD3339 
Transcription factor COE3 (EBF3) LDTP11940 C260(2.20)  LDD3339 
Transcription factor COE4 (EBF4) LDTP11097 C355(2.96)  LDD3403 
Transcription factor Dp-1 (TFDP1) LDTP06073 C307(2.49); C314(2.49)  LDD0080 
Transcription factor Dp-2 (TFDP2) LDTP06074 C81(2.01)  LDD3403 
Transcription factor E2-alpha (TCF3) LDTP02814 C576(1.07)  LDD1571 
Transcription factor E2F3 (E2F3) LDTP00332 C244(1.37); C256(1.37)  LDD0078 
Transcription factor E2F4 (E2F4) LDTP06519 C88(1.06); C136(0.89); C146(0.89)  LDD0078 
Transcription factor E2F5 (E2F5) LDTP06360 C121(1.91)  LDD0080 
Transcription factor E2F6 (E2F6) LDTP01229 C26(0.92)  LDD1492 
Transcription factor E2F7 (E2F7) LDTP10095 C151(4.46)  LDD3407 
Transcription factor E2F8 (E2F8) LDTP00012 C96(0.81)  LDD1492 
Transcription factor GATA-6 (GATA6) LDTP09926 C504(0.97); C526(0.97); C411(0.93); C414(0.93)  LDD0078 
Transcription factor HES-1 (HES1) LDTP06125 C117(0.86); C128(0.73)  LDD1492 
Transcription factor HES-4 (HES4) LDTP16042 C146(0.95)  LDD1492 
Transcription factor HIVEP2 (HIVEP2) LDTP03601 C2021(1.06); C2026(1.06); C1030(0.96); C1037(0.96)  LDD0078 
Transcription factor IIIA (GTF3A) LDTP15663 C342(1.11); C350(1.11)  LDD0078 
Transcription factor Jun (JUN) LDTP02111 C99(1.05)  LDD1492 
Transcription factor JunD (JUND) LDTP02903 C336(1.84)  LDD3358 
Transcription factor Maf (MAF) LDTP01222 C46(2.90)  LDD3410 
Transcription factor MafA (MAFA) LDTP09268 C305(1.97)  LDD3325 
Transcription factor MafB (MAFB) LDTP14144 C46(2.04)  LDD3410 
Transcription factor MafF (MAFF) LDTP13593 C68(1.39)  LDD0078 
Transcription factor NF-E2 45 kDa subunit (NFE2) LDTP06579 C283(0.42)  LDD2236 
Transcription factor Ovo-like 2 (OVOL2) LDTP11119 C56(2.05)  LDD3364 
Transcription factor p65 (RELA) LDTP05417 C105(1.01)  LDD0078 
Transcription factor RelB (RELB) LDTP05284 C109(0.93)  LDD0078 
Transcription factor RFX3 (RFX3) LDTP04175 C228(1.84)  LDD3318 
Transcription factor RFX4 (RFX4) LDTP06754 C30(1.58)  LDD2469 
Transcription factor SOX-1 (SOX1) LDTP14423 C336(2.75)  LDD3342 
Transcription factor SOX-10 (SOX10) LDTP04752 C190(1.15); C71(3.19)  LDD3332 
Transcription factor SOX-13 (SOX13) LDTP13645 C501(1.71)  LDD3323 
Transcription factor SOX-2 (SOX2) LDTP04178 C265(1.45)  LDD3333 
Transcription factor SOX-3 (SOX3) LDTP03936 C393(2.16)  LDD2469 
Transcription factor SOX-4 (SOX4) LDTP05505 C52(2.06)  LDD3364 
Transcription factor SOX-5 (SOX5) LDTP03781 C492(2.72)  LDD3332 
Transcription factor SOX-6 (SOX6) LDTP03782 C90(1.86)  LDD3332 
Transcription factor SOX-8 (SOX8) LDTP04779 C67(5.87)  LDD3401 
Transcription factor SOX-9 (SOX9) LDTP04179 C72(4.21)  LDD3332 
Transcription factor Sp1 (SP1) LDTP02241 C604(0.97); C606(0.97); C609(0.97); C68(0.96)  LDD0078 
Transcription factor Sp2 (SP2) LDTP05334 C527(0.85); C532(0.85)  LDD0531 
Transcription factor Sp3 (SP3) LDTP05355 C600(0.95); C602(0.95); C605(0.95)  LDD0078 
Transcription factor Sp4 (SP4) LDTP05354 C55(2.97)  LDD3339 
Transcription factor Sp6 (SP6) LDTP06795 C230(0.93); C233(0.93)  LDD0533 
Transcription factor-like 5 protein (TCFL5) LDTP13520 C336(0.92)  LDD1507 
Transcription initiation factor TFIID subunit 1-like (TAF1L) LDTP08724 C738(3.36)  LDD2379 
Transcription regulator protein BACH1 (BACH1) LDTP00461 C140(1.05); C646(1.01); C435(0.93)  LDD0078 
Transcription regulator protein BACH2 (BACH2) LDTP11502 C370(3.71)  LDD3339 
Transcriptional activator GLI3 (GLI3) LDTP02468 C870(0.92)  LDD0078 
Transcriptional activator Myb (MYB) LDTP02483 C78(0.98)  LDD3333 
Transcriptional activator protein Pur-alpha (PURA) LDTP05248 C272(1.40)  LDD0080 
Transcriptional adapter 2-alpha (TADA2A) LDTP01235 C298(0.92)  LDD0078 
Transcriptional adapter 2-beta (TADA2B) LDTP08199 C268(0.96)  LDD0078 
Transcriptional enhancer factor TEF-1 (TEAD1) LDTP03438 C53(0.96)  LDD1093 
Transcriptional enhancer factor TEF-3 (TEAD4) LDTP06415 C367(2.33)  LDD0080 
Transcriptional enhancer factor TEF-5 (TEAD3) LDTP10912 C368(1.20)  LDD0078 
Transcriptional regulator ERG (ERG) LDTP02563 C28(2.11)  LDD3403 
Transcriptional regulator Kaiso (ZBTB33) LDTP08185 C431(2.06)  LDD0080 
Transcriptional regulator protein Pur-beta (PURB) LDTP10743 C273(1.03); C17(0.99); C238(0.94)  LDD0078 
Transcriptional regulator QRICH1 (QRICH1) LDTP06725 C611(2.01)  LDD0080 
Transcriptional repressor CTCF (CTCF) LDTP04281 C268(2.08); C275(2.08); C271(2.08); C353(1.82)  LDD0080 
Transcriptional repressor p66-alpha (GATAD2A) LDTP08409 C427(3.24)  LDD3337 
Transcriptional repressor p66-beta (GATAD2B) LDTP09710 C308(0.97); C441(0.91); C444(0.91)  LDD0078 
Transcriptional repressor protein YY1 (YY1) LDTP03324 C327(0.98); C330(0.98); C385(0.97); C390(0.97)  LDD0078 
Transcriptional-regulating factor 1 (TRERF1) LDTP10689 C1065(1.36)  LDD0532 
Trinucleotide repeat-containing gene 18 protein (TNRC18) LDTP14449 C2595(1.03)  LDD0531 
TSC22 domain family protein 1 (TSC22D1) LDTP06449 C426(0.93)  LDD0078 
TSC22 domain family protein 2 (TSC22D2) LDTP16817 C63(0.98)  LDD0078 
TSC22 domain family protein 3 (TSC22D3) LDTP10904 C178(1.07)  LDD2284 
Tumor protein 63 (TP63) LDTP11863 C347(1.34)  LDD0532 
Tumor protein p73 (TP73) LDTP00613 C82(2.53)  LDD3313 
Twist-related protein 1 (TWIST1) LDTP06442 C175(2.38)  LDD3433 
Uncharacterized protein C8orf76 (C8orf76) LDTP19877 C152(18.97)  LDD0204 
Undifferentiated embryonic cell transcription factor 1 (UTF1) LDTP07100 C114(1.25)  LDD1512 
Upstream stimulatory factor 1 (USF1) LDTP03171 C248(0.98)  LDD0531 
Upstream stimulatory factor 2 (USF2) LDTP06495 C284(21.48)  LDD0209 
Upstream-binding protein 1 (UBP1) LDTP12903 C435(1.60)  LDD0531 
Vacuolar protein sorting-associated protein 72 homolog (VPS72) LDTP06500 C163(3.73)  LDD3319 
Vascular endothelial zinc finger 1 (VEZF1) LDTP06040 C327(1.37); C316(1.12); C319(1.12)  LDD0078 
Ventral anterior homeobox 1 (VAX1) LDTP07062 C74(1.53)  LDD0080 
Ventral anterior homeobox 2 (VAX2) LDTP13364 C124(2.05)  LDD3423 
Wilms tumor protein (WT1) LDTP03006 C210(3.94)  LDD3392 
Y-box-binding protein 2 (YBX2) LDTP13911 C224(2.52)  LDD3331 
Zinc finger and BTB domain-containing protein 1 (ZBTB1) LDTP13880 C448(1.02); C580(0.94); C583(0.94); C532(0.91)  LDD0078 
Zinc finger and BTB domain-containing protein 11 (ZBTB11) LDTP14540 C39(1.24)  LDD0078 
Zinc finger and BTB domain-containing protein 14 (ZBTB14) LDTP00884 C215(1.09)  LDD0531 
Zinc finger and BTB domain-containing protein 16 (ZBTB16) LDTP05457 C671(1.12)  LDD2324 
Zinc finger and BTB domain-containing protein 17 (ZBTB17) LDTP05748 C349(2.27)  LDD3384 
Zinc finger and BTB domain-containing protein 18 (ZBTB18) LDTP10910 C430(3.21)  LDD3344 
Zinc finger and BTB domain-containing protein 2 (ZBTB2) LDTP08920 C296(2.13)  LDD3312 
Zinc finger and BTB domain-containing protein 20 (ZBTB20) LDTP12221 C120(0.80); C189(1.07); C311(1.30)  LDD0531 
Zinc finger and BTB domain-containing protein 21 (ZBTB21) LDTP13555 C129(1.05); C152(1.00); C594(1.12)  LDD0531 
Zinc finger and BTB domain-containing protein 24 (ZBTB24) LDTP00696 C481(1.30)  LDD0080 
Zinc finger and BTB domain-containing protein 25 (ZBTB25) LDTP03269 C187(0.97)  LDD1571 
Zinc finger and BTB domain-containing protein 3 (ZBTB3) LDTP18398 C95(0.93)  LDD1507 
Zinc finger and BTB domain-containing protein 32 (ZBTB32) LDTP13931 C356(1.67)  LDD2355 
Zinc finger and BTB domain-containing protein 34 (ZBTB34) LDTP15489 C436(1.34)  LDD0080 
Zinc finger and BTB domain-containing protein 38 (ZBTB38) LDTP09029 C209(2.02)  LDD3323 
Zinc finger and BTB domain-containing protein 39 (ZBTB39) LDTP00523 C543(1.36)  LDD3339 
Zinc finger and BTB domain-containing protein 4 (ZBTB4) LDTP13006 C256(1.06)  LDD3311 
Zinc finger and BTB domain-containing protein 40 (ZBTB40) LDTP16098 C394(1.07); C395(1.07)  LDD0078 
Zinc finger and BTB domain-containing protein 41 (ZBTB41) LDTP17212 C539(1.54)  LDD3316 
Zinc finger and BTB domain-containing protein 42 (ZBTB42) LDTP00164 C345(3.67)  LDD2268 
Zinc finger and BTB domain-containing protein 43 (ZBTB43) LDTP00734 C119(0.88); C131(0.88)  LDD0531 
Zinc finger and BTB domain-containing protein 44 (ZBTB44) LDTP09102 C151(2.78)  LDD0080 
Zinc finger and BTB domain-containing protein 45 (ZBTB45) LDTP18178 C49(2.47)  LDD2469 
Zinc finger and BTB domain-containing protein 47 (ZBTB47) LDTP13209 C208(1.04)  LDD1512 
Zinc finger and BTB domain-containing protein 5 (ZBTB5) LDTP00525 C312(3.43)  LDD3340 
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) LDTP01572 C123(1.08); C468(1.37); C471(1.37); C472(1.06)  LDD0531 
Zinc finger and BTB domain-containing protein 7B (ZBTB7B) LDTP00556 C89(1.77); C488(0.88)  LDD3312 
Zinc finger and BTB domain-containing protein 8A (ZBTB8A) LDTP10139 C336(0.96)  LDD1492 
Zinc finger and BTB domain-containing protein 9 (ZBTB9) LDTP10152 C452(1.28)  LDD0078 
Zinc finger and SCAN domain-containing protein 12 (ZSCAN12) LDTP00740 C239(1.24)  LDD1492 
Zinc finger and SCAN domain-containing protein 20 (ZSCAN20) LDTP02881 C350(1.67)  LDD3325 
Zinc finger and SCAN domain-containing protein 21 (ZSCAN21) LDTP14103 C241(2.08)  LDD3314 
Zinc finger and SCAN domain-containing protein 25 (ZSCAN25) LDTP15092 C254(0.92); C264(0.92)  LDD0078 
Zinc finger and SCAN domain-containing protein 26 (ZSCAN26) LDTP06604 C196(1.20)  LDD0532 
Zinc finger and SCAN domain-containing protein 29 (ZSCAN29) LDTP15346 C44(1.31)  LDD0080 
Zinc finger and SCAN domain-containing protein 30 (ZSCAN30) LDTP15296 C311(2.23)  LDD3332 
Zinc finger and SCAN domain-containing protein 31 (ZSCAN31) LDTP15776 C59(1.28)  LDD3351 
Zinc finger BED domain-containing protein 3 (ZBED3) LDTP10427 C227(0.94)  LDD1492 
Zinc finger BED domain-containing protein 4 (ZBED4) LDTP01134 C66(0.89); C68(0.89)  LDD0078 
Zinc finger BED domain-containing protein 5 (ZBED5) LDTP17128 C342(1.11)  LDD0531 
Zinc finger BED domain-containing protein 6 (ZBED6) LDTP05205 C764(1.05); C773(1.05)  LDD1094 
Zinc finger C2HC domain-containing protein 1A (ZC2HC1A) LDTP15732 C122(1.57); C125(1.57); C316(1.64)  LDD0080 
Zinc finger CCCH domain-containing protein 15 (ZC3H15) LDTP09564 C105(0.94); C198(0.92)  LDD0078 
Zinc finger CCCH domain-containing protein 4 (ZC3H4) LDTP13718 C433(1.16); C1302(0.95)  LDD0078 
Zinc finger CCCH domain-containing protein 6 (ZC3H6) LDTP16988 C339(0.90); C345(0.90)  LDD0078 
Zinc finger CCCH domain-containing protein 8 (ZC3H8) LDTP08905 C234(1.03); C258(0.88); C264(0.88)  LDD0078 
Zinc finger CCCH-type with G patch domain-containing protein (ZGPAT) LDTP08890 C322(0.95)  LDD0078 
Zinc finger E-box-binding homeobox 1 (ZEB1) LDTP03843 C82(2.11)  LDD0080 
Zinc finger E-box-binding homeobox 2 (ZEB2) LDTP00951 C583(1.52); C586(1.52)  LDD0080 
Zinc finger homeobox protein 2 (ZFHX2) LDTP11592 C1011(1.11); C1014(1.11)  LDD1492 
Zinc finger homeobox protein 3 (ZFHX3) LDTP06503 C1045(1.33)  LDD0532 
Zinc finger homeobox protein 4 (ZFHX4) LDTP08239 C445(1.04)  LDD3310 
Zinc finger MYM-type protein 1 (ZMYM1) LDTP19380 C460(1.10); C461(1.10); C466(1.10); C213(1.04)  LDD0078 
Zinc finger MYM-type protein 2 (ZMYM2) LDTP13169 C1331(1.28); C539(1.18); C584(1.17); C587(1.17)  LDD0078 
Zinc finger MYM-type protein 3 (ZMYM3) LDTP06081 C1059(2.08); C1048(2.92); C451(3.09); C715(1.62)  LDD0080 
Zinc finger MYM-type protein 4 (ZMYM4) LDTP07262 C365(1.38); C369(1.38); C752(1.09); C756(1.09)  LDD0078 
Zinc finger MYM-type protein 5 (ZMYM5) LDTP13374 C137(1.10)  LDD0533 
Zinc finger MYM-type protein 6 (ZMYM6) LDTP01676 C138(2.01); C141(2.01); C454(1.41)  LDD0080 
Zinc finger protein 1 homolog (ZFP1) LDTP07519 C270(0.79); C273(0.79)  LDD0593 
Zinc finger protein 100 (ZNF100) LDTP17650 C17(101.41); C9(74.72)  LDD0209 
Zinc finger protein 101 (ZNF101) LDTP08692 C284(1.75); C287(1.75)  LDD0080 
Zinc finger protein 107 (ZNF107) LDTP18535 C78(91.02)  LDD0209 
Zinc finger protein 112 (ZNF112) LDTP16212 C196(1.07)  LDD3310 
Zinc finger protein 114 (ZNF114) LDTP09078 C51(1.11)  LDD0531 
Zinc finger protein 12 (ZNF12) LDTP02872 C168(3.09); C171(3.09); C140(2.22); C143(2.22)  LDD0080 
Zinc finger protein 121 (ZNF121) LDTP14731 C93(0.91)  LDD1492 
Zinc finger protein 124 (ZNF124) LDTP06508 C220(0.91)  LDD1492 
Zinc finger protein 131 (ZNF131) LDTP04523 C235(1.46)  LDD0080 
Zinc finger protein 136 (ZNF136) LDTP14706 C291(0.91)  LDD0580 
Zinc finger protein 14 (ZNF14) LDTP16956 C262(1.24); C80(0.88)  LDD0531 
Zinc finger protein 14 homolog (ZFP14) LDTP18444 C296(1.68)  LDD2260 
Zinc finger protein 140 (ZNF140) LDTP04522 C340(1.01)  LDD1507 
Zinc finger protein 142 (ZNF142) LDTP14708 C1230(0.83); C1233(0.83); C838(1.20); C841(1.20)  LDD0532 
Zinc finger protein 143 (ZNF143) LDTP04526 C329(50.49)  LDD0209 
Zinc finger protein 148 (ZNF148) LDTP13771 C14(0.94)  LDD0078 
Zinc finger protein 16 (ZNF16) LDTP02873 C575(1.15); C578(1.15)  LDD2171 
Zinc finger protein 160 (ZNF160) LDTP16043 C143(1.22)  LDD0532 
Zinc finger protein 17 (ZNF17) LDTP02874 C483(17.54)  LDD0209 
Zinc finger protein 174 (ZNF174) LDTP06446 C39(4.34); C45(4.34)  LDD0080 
Zinc finger protein 180 (ZNF180) LDTP13405 C619(1.65)  LDD3380 
Zinc finger protein 181 (ZNF181) LDTP17078 C231(0.97)  LDD1492 
Zinc finger protein 184 (ZNF184) LDTP18281 C234(0.99)  LDD0531 
Zinc finger protein 189 (ZNF189) LDTP16827 C610(0.95); C525(0.91)  LDD0531 
Zinc finger protein 195 (ZNF195) LDTP00387 C302(2.03); C305(2.03)  LDD0080 
Zinc finger protein 20 (ZNF20) LDTP02877 C378(1.12)  LDD3312 
Zinc finger protein 200 (ZNF200) LDTP17005 C389(2.58)  LDD3310 
Zinc finger protein 202 (ZNF202) LDTP01500 C573(1.52)  LDD3311 
Zinc finger protein 211 (ZNF211) LDTP05851 C259(0.99); C133(0.90)  LDD1492 
Zinc finger protein 217 (ZNF217) LDTP01191 C641(1.22); C674(1.19)  LDD0078 
Zinc finger protein 22 (ZNF22) LDTP14639 C175(0.99); C147(1.00)  LDD1492 
Zinc finger protein 224 (ZNF224) LDTP12913 C554(0.91)  LDD0531 
Zinc finger protein 226 (ZNF226) LDTP18497 C354(1.79)  LDD3409 
Zinc finger protein 227 (ZNF227) LDTP17594 C360(0.68); C369(0.68)  LDD0531 
Zinc finger protein 23 (ZNF23) LDTP02878 C431(1.91)  LDD3436 
Zinc finger protein 234 (ZNF234) LDTP17040 C327(0.80)  LDD1514 
Zinc finger protein 236 (ZNF236) LDTP16231 C1200(0.97)  LDD2171 
Zinc finger protein 239 (ZNF239) LDTP06570 C167(1.81)  LDD0080 
Zinc finger protein 24 (ZNF24) LDTP02879 C233(2.26); C253(1.76); C256(1.76)  LDD0080 
Zinc finger protein 26 (ZNF26) LDTP14642 C520(1.89)  LDD3393 
Zinc finger protein 260 (ZNF260) LDTP14922 C57(1.85); C60(1.85)  LDD0080 
Zinc finger protein 263 (ZNF263) LDTP00499 C406(1.08); C411(1.08)  LDD0531 
Zinc finger protein 264 (ZNF264) LDTP00733 C485(2.72); C488(2.72)  LDD0080 
Zinc finger protein 267 (ZNF267) LDTP17039 C122(1.33); C128(1.33); C272(1.20); C276(1.20)  LDD0078 
Zinc finger protein 268 (ZNF268) LDTP06157 C140(1.25); C151(1.25)  LDD0532 
Zinc finger protein 273 (ZNF273) LDTP14846 C180(4.36)  LDD0209 
Zinc finger protein 275 (ZNF275) LDTP12584 C267(0.94); C270(0.94)  LDD0531 
Zinc finger protein 276 (ZNF276) LDTP08884 C436(1.06); C441(1.06)  LDD0078 
Zinc finger protein 277 (ZNF277) LDTP16074 C21(1.51); C215(1.83)  LDD0080 
Zinc finger protein 28 (ZNF28) LDTP14644 C217(25.54); C24(76.49)  LDD0209 
Zinc finger protein 280B (ZNF280B) LDTP15326 C425(1.43)  LDD3310 
Zinc finger protein 280C (ZNF280C) LDTP15497 C530(1.22); C734(1.06); C259(0.99); C260(0.99)  LDD0078 
Zinc finger protein 280D (ZNF280D) LDTP07454 C487(0.93); C655(1.61); C786(1.10)  LDD0531 
Zinc finger protein 281 (ZNF281) LDTP13928 C882(1.08)  LDD0078 
Zinc finger protein 282 (ZNF282) LDTP16191 C299(1.03)  LDD1508 
Zinc finger protein 287 (ZNF287) LDTP18436 C718(1.01)  LDD1509 
Zinc finger protein 292 (ZNF292) LDTP00935 C978(1.01); C982(1.01); C13(0.90); C18(0.90)  LDD0078 
Zinc finger protein 296 (ZNF296) LDTP09584 C390(3.26)  LDD3314 
Zinc finger protein 3 (ZNF3) LDTP02880 C267(0.90)  LDD0531 
Zinc finger protein 30 homolog (ZFP30) LDTP18564 C112(0.97); C124(0.97)  LDD0532 
Zinc finger protein 302 (ZNF302) LDTP12460 C200(2.15); C274(2.33)  LDD0080 
Zinc finger protein 304 (ZNF304) LDTP12275 C144(1.05)  LDD0531 
Zinc finger protein 316 (ZNF316) LDTP16616 C95(1.30)  LDD3312 
Zinc finger protein 317 (ZNF317) LDTP10695 C127(1.93)  LDD0080 
Zinc finger protein 319 (ZNF319) LDTP13046 C307(1.39)  LDD3314 
Zinc finger protein 320 (ZNF320) LDTP16564 C496(1.22)  LDD0531 
Zinc finger protein 322 (ZNF322) LDTP07648 C381(1.22)  LDD1511 
Zinc finger protein 324B (ZNF324B) LDTP17315 C198(2.56)  LDD3323 
Zinc finger protein 331 (ZNF331) LDTP18458 C448(0.95)  LDD3312 
Zinc finger protein 335 (ZNF335) LDTP11943 C964(1.07)  LDD0531 
Zinc finger protein 337 (ZNF337) LDTP13998 C82(4.29)  LDD3430 
Zinc finger protein 33B (ZNF33B) LDTP14815 C173(0.86)  LDD1514 
Zinc finger protein 34 (ZNF34) LDTP15368 C292(1.63)  LDD3377 
Zinc finger protein 35 (ZNF35) LDTP02680 C129(0.93); C156(1.01)  LDD1492 
Zinc finger protein 350 (ZNF350) LDTP11664 C332(1.24)  LDD3395 
Zinc finger protein 354A (ZNF354A) LDTP14479 C337(0.94); C344(0.94)  LDD0078 
Zinc finger protein 354B (ZNF354B) LDTP18198 C505(1.52)  LDD3383 
Zinc finger protein 362 (ZNF362) LDTP17221 C232(1.07)  LDD3319 
Zinc finger protein 37 homolog (ZFP37) LDTP16333 C117(1.58)  LDD3383 
Zinc finger protein 384 (ZNF384) LDTP15619 C42(1.65)  LDD0080 
Zinc finger protein 391 (ZNF391) LDTP20024 C343(0.95)  LDD1492 
Zinc finger protein 394 (ZNF394) LDTP14945 C128(1.21); C235(0.90)  LDD1492 
Zinc finger protein 397 (ZNF397) LDTP09192 C57(1.08)  LDD0531 
Zinc finger protein 398 (ZNF398) LDTP09411 C275(1.05)  LDD1492 
Zinc finger protein 40 (HIVEP1) LDTP02806 C1888(1.53)  LDD0080 
Zinc finger protein 407 (ZNF407) LDTP11613 C1753(5.85)  LDD0209 
Zinc finger protein 408 (ZNF408) LDTP12092 C366(0.90)  LDD0078 
Zinc finger protein 41 homolog (ZFP41) LDTP15463 C185(9.66)  LDD0080 
Zinc finger protein 414 (ZNF414) LDTP10423 C311(1.31)  LDD0080 
Zinc finger protein 417 (ZNF417) LDTP09317 C366(0.99)  LDD0531 
Zinc finger protein 420 (ZNF420) LDTP15578 C318(1.07)  LDD1508 
Zinc finger protein 423 (ZNF423) LDTP06694 C1117(1.25)  LDD1507 
Zinc finger protein 425 (ZNF425) LDTP15086 C315(1.05)  LDD1492 
Zinc finger protein 430 (ZNF430) LDTP18415 C17(12.35)  LDD0080 
Zinc finger protein 431 (ZNF431) LDTP18072 C17(0.96)  LDD0532 
Zinc finger protein 432 (ZNF432) LDTP16835 C150(2.46)  LDD3395 
Zinc finger protein 433 (ZNF433) LDTP15441 C601(4.15)  LDD2469 
Zinc finger protein 440 (ZNF440) LDTP08652 C51(1.54)  LDD3364 
Zinc finger protein 444 (ZNF444) LDTP08736 C181(3.11); C184(3.11)  LDD0080 
Zinc finger protein 445 (ZNF445) LDTP04840 C215(0.89)  LDD0078 
Zinc finger protein 446 (ZNF446) LDTP12730 C33(1.47)  LDD0531 
Zinc finger protein 449 (ZNF449) LDTP07555 C94(1.01)  LDD1507 
Zinc finger protein 460 (ZNF460) LDTP06158 C181(1.16)  LDD0078 
Zinc finger protein 462 (ZNF462) LDTP10475 C930(1.65); C574(2.53)  LDD3310 
Zinc finger protein 467 (ZNF467) LDTP17567 C375(1.74)  LDD3343 
Zinc finger protein 468 (ZNF468) LDTP17260 C62(3.27)  LDD3311 
Zinc finger protein 48 (ZNF48) LDTP10605 C288(1.11)  LDD0533 
Zinc finger protein 480 (ZNF480) LDTP15629 C81(1.19)  LDD3310 
Zinc finger protein 483 (ZNF483) LDTP15617 C59(1.20)  LDD0078 
Zinc finger protein 490 (ZNF490) LDTP13563 C133(25.53); C485(13.73); C317(20.86)  LDD0209 
Zinc finger protein 496 (ZNF496) LDTP10426 C525(1.04)  LDD1507 
Zinc finger protein 497 (ZNF497) LDTP07796 C483(1.07)  LDD1510 
Zinc finger protein 501 (ZNF501) LDTP15706 C176(0.87); C116(0.98); C148(0.92)  LDD1492 
Zinc finger protein 502 (ZNF502) LDTP15593 C361(1.56)  LDD3312 
Zinc finger protein 506 (ZNF506) LDTP17196 C242(1.72)  LDD3311 
Zinc finger protein 507 (ZNF507) LDTP18059 C193(3.66); C201(3.66)  LDD0080 
Zinc finger protein 511 (ZNF511) LDTP09037 C233(1.93)  LDD3325 
Zinc finger protein 512 (ZNF512) LDTP18206 C171(1.08); C174(1.08); C408(1.00); C413(1.00)  LDD0078 
Zinc finger protein 512B (ZNF512B) LDTP10507 C752(1.15); C756(1.15); C757(1.15); C596(0.99)  LDD0078 
Zinc finger protein 513 (ZNF513) LDTP08977 C236(0.76); C239(0.76)  LDD0533 
Zinc finger protein 516 (ZNF516) LDTP09822 C875(1.08); C386(0.92); C398(0.92)  LDD0078 
Zinc finger protein 518A (ZNF518A) LDTP17312 C92(4.92); C96(4.92)  LDD0080 
Zinc finger protein 518B (ZNF518B) LDTP18350 C512(0.86)  LDD0531 
Zinc finger protein 521 (ZNF521) LDTP10498 C1093(1.51); C1096(1.51)  LDD0080 
Zinc finger protein 524 (ZNF524) LDTP10161 C161(1.63)  LDD3312 
Zinc finger protein 525 (ZNF525) LDTP17736 C62(1.05)  LDD0531 
Zinc finger protein 529 (ZNF529) LDTP17372 C201(1.04); C204(1.04)  LDD0078 
Zinc finger protein 532 (ZNF532) LDTP18439 C833(1.07)  LDD3323 
Zinc finger protein 536 (ZNF536) LDTP14441 C1041(1.03)  LDD1510 
Zinc finger protein 541 (ZNF541) LDTP15953 C1291(1.64)  LDD3474 
Zinc finger protein 544 (ZNF544) LDTP17365 C300(1.07); C303(1.07)  LDD0078 
Zinc finger protein 550 (ZNF550) LDTP15239 C354(1.70)  LDD3427 
Zinc finger protein 551 (ZNF551) LDTP15238 C281(1.08); C284(1.08)  LDD0531 
Zinc finger protein 552 (ZNF552) LDTP12009 C121(1.05); C243(0.72); C245(0.72)  LDD0532 
Zinc finger protein 555 (ZNF555) LDTP15512 C575(75.95)  LDD0209 
Zinc finger protein 556 (ZNF556) LDTP18430 C436(2.07)  LDD3401 
Zinc finger protein 561 (ZNF561) LDTP17714 C150(1.33); C225(0.78)  LDD0531 
Zinc finger protein 562 (ZNF562) LDTP17445 C232(1.08); C237(1.08); C127(1.05); C139(1.05)  LDD0078 
Zinc finger protein 564 (ZNF564) LDTP09361 C460(22.64)  LDD0209 
Zinc finger protein 565 (ZNF565) LDTP17762 C62(1.44)  LDD2458 
Zinc finger protein 566 (ZNF566) LDTP15681 C239(1.67)  LDD3478 
Zinc finger protein 569 (ZNF569) LDTP17203 C152(0.71)  LDD0813 
Zinc finger protein 57 (ZNF57) LDTP07334 C80(0.77)  LDD0533 
Zinc finger protein 570 (ZNF570) LDTP18224 C84(1.27); C91(1.27)  LDD1094 
Zinc finger protein 574 (ZNF574) LDTP15182 C745(1.25)  LDD3312 
Zinc finger protein 576 (ZNF576) LDTP16000 C29(1.08)  LDD1507 
Zinc finger protein 579 (ZNF579) LDTP15475 C272(0.86); C275(0.86)  LDD0078 
Zinc finger protein 581 (ZNF581) LDTP12980 C86(1.36)  LDD0532 
Zinc finger protein 587 (ZNF587) LDTP10819 C366(0.96); C214(0.91)  LDD0078 
Zinc finger protein 589 (ZNF589) LDTP08241 C220(1.08)  LDD1507 
Zinc finger protein 592 (ZNF592) LDTP15661 C201(1.05); C463(1.04)  LDD0078 
Zinc finger protein 594 (ZNF594) LDTP18174 C85(0.96)  LDD1510 
Zinc finger protein 595 (ZNF595) LDTP17647 C20(1.28); C55(1.07)  LDD3340 
Zinc finger protein 597 (ZNF597) LDTP10565 C273(1.19)  LDD0078 
Zinc finger protein 600 (ZNF600) LDTP17472 C481(39.75)  LDD0209 
Zinc finger protein 605 (ZNF605) LDTP17572 C104(0.24)  LDD2236 
Zinc finger protein 606 (ZNF606) LDTP15643 C261(2.33)  LDD3319 
Zinc finger protein 607 (ZNF607) LDTP15829 C628(1.08)  LDD1514 
Zinc finger protein 611 (ZNF611) LDTP17747 C317(1.05); C320(1.05)  LDD0547 
Zinc finger protein 613 (ZNF613) LDTP15126 C442(1.43)  LDD3383 
Zinc finger protein 614 (ZNF614) LDTP15451 C104(1.30)  LDD3395 
Zinc finger protein 615 (ZNF615) LDTP15457 C718(2.51)  LDD3342 
Zinc finger protein 616 (ZNF616) LDTP17016 C561(1.50)  LDD0080 
Zinc finger protein 618 (ZNF618) LDTP07148 C712(1.21)  LDD0080 
Zinc finger protein 62 homolog (ZFP62) LDTP17780 C815(3.67); C817(3.67); C703(1.34); C706(1.34)  LDD0080 
Zinc finger protein 620 (ZNF620) LDTP07795 C404(2.61)  LDD0080 
Zinc finger protein 623 (ZNF623) LDTP16816 C489(1.76)  LDD0531 
Zinc finger protein 624 (ZNF624) LDTP16180 C372(1.12)  LDD3323 
Zinc finger protein 625 (ZNF625) LDTP10410 C342(2.74)  LDD3334 
Zinc finger protein 627 (ZNF627) LDTP17518 C234(13.03)  LDD0208 
Zinc finger protein 628 (ZNF628) LDTP14962 C150(1.28); C153(1.28)  LDD0613 
Zinc finger protein 629 (ZNF629) LDTP13198 C214(1.36)  LDD0080 
Zinc finger protein 639 (ZNF639) LDTP13339 C235(0.99)  LDD0531 
Zinc finger protein 64 (ZFP64) LDTP12615 C146(1.29); C302(1.21)  LDD0078 
Zinc finger protein 641 (ZNF641) LDTP10615 C331(0.92)  LDD1492 
Zinc finger protein 644 (ZNF644) LDTP11947 C307(0.97); C313(0.97)  LDD0078 
Zinc finger protein 646 (ZNF646) LDTP00508 C1087(1.45)  LDD3316 
Zinc finger protein 649 (ZNF649) LDTP15872 C360(1.87)  LDD3395 
Zinc finger protein 652 (ZNF652) LDTP16262 C247(1.35)  LDD2270 
Zinc finger protein 653 (ZNF653) LDTP10175 C396(1.13)  LDD1509 
Zinc finger protein 654 (ZNF654) LDTP17662 C549(1.10); C554(1.10)  LDD0078 
Zinc finger protein 655 (ZNF655) LDTP08956 C457(2.04)  LDD3312 
Zinc finger protein 658 (ZNF658) LDTP15025 C269(1.30); C279(1.30); C856(0.99); C859(0.99)  LDD0531 
Zinc finger protein 664 (ZNF664) LDTP15412 C131(0.93)  LDD0531 
Zinc finger protein 667 (ZNF667) LDTP17176 C108(1.80)  LDD3395 
Zinc finger protein 668 (ZNF668) LDTP15757 C126(6.36)  LDD0209 
Zinc finger protein 669 (ZNF669) LDTP10138 C345(0.93)  LDD0531 
Zinc finger protein 670 (ZNF670) LDTP11145 C133(1.18); C136(1.18)  LDD0078 
Zinc finger protein 672 (ZNF672) LDTP17125 C24(0.86)  LDD0078 
Zinc finger protein 680 (ZNF680) LDTP17807 C418(0.76)  LDD0613 
Zinc finger protein 687 (ZNF687) LDTP08771 C707(1.06); C710(1.06); C91(0.99)  LDD0078 
Zinc finger protein 688 (ZNF688) LDTP02402 C20(1.06)  LDD1507 
Zinc finger protein 689 (ZNF689) LDTP18138 C484(1.10); C70(0.96)  LDD1492 
Zinc finger protein 691 (ZNF691) LDTP15037 C176(2.03)  LDD3343 
Zinc finger protein 692 (ZNF692) LDTP11218 C99(2.03)  LDD3484 
Zinc finger protein 696 (ZNF696) LDTP12037 C74(2.13)  LDD3331 
Zinc finger protein 699 (ZNF699) LDTP14901 C458(29.10)  LDD0209 
Zinc finger protein 7 (ZNF7) LDTP14647 C452(40.16)  LDD0209 
Zinc finger protein 70 (ZNF70) LDTP18521 C374(1.02)  LDD1492 
Zinc finger protein 701 (ZNF701) LDTP16106 C427(0.83)  LDD0602 
Zinc finger protein 707 (ZNF707) LDTP15702 C97(2.13)  LDD3466 
Zinc finger protein 709 (ZNF709) LDTP17759 C543(3.51)  LDD0080 
Zinc finger protein 711 (ZNF711) LDTP14021 C542(0.99)  LDD1508 
Zinc finger protein 714 (ZNF714) LDTP15792 C40(1.17); C50(1.17)  LDD0531 
Zinc finger protein 721 (ZNF721) LDTP18069 C42(2.27)  LDD3376 
Zinc finger protein 724 (ZNF724) LDTP18884 C602(1.43)  LDD0080 
Zinc finger protein 736 (ZNF736) LDTP18926 C123(1.06)  LDD1508 
Zinc finger protein 737 (ZNF737) LDTP16820 C436(1.05)  LDD3421 
Zinc finger protein 738 (ZNF738) LDTP17800 C86(1.03)  LDD1492 
Zinc finger protein 74 (ZNF74) LDTP06567 C97(1.53); C183(1.46); C42(1.70)  LDD3368 
Zinc finger protein 740 (ZNF740) LDTP15502 C182(1.02)  LDD0531 
Zinc finger protein 746 (ZNF746) LDTP07474 C476(0.67)  LDD3323 
Zinc finger protein 749 (ZNF749) LDTP16796 C154(1.08)  LDD1507 
Zinc finger protein 76 (ZNF76) LDTP03809 C342(1.18)  LDD1492 
Zinc finger protein 761 (ZNF761) LDTP17600 C735(1.53)  LDD0666 
Zinc finger protein 763 (ZNF763) LDTP14818 C211(6.16)  LDD0209 
Zinc finger protein 765 (ZNF765) LDTP07949 C372(0.96)  LDD3368 
Zinc finger protein 766 (ZNF766) LDTP17175 C133(18.45)  LDD0209 
Zinc finger protein 768 (ZNF768) LDTP11952 C381(1.08)  LDD0531 
Zinc finger protein 77 (ZNF77) LDTP14867 C391(0.91); C223(1.41); C279(1.23)  LDD0531 
Zinc finger protein 770 (ZNF770) LDTP17346 C302(1.88); C314(1.88)  LDD0080 
Zinc finger protein 771 (ZNF771) LDTP15216 C189(1.33)  LDD0531 
Zinc finger protein 772 (ZNF772) LDTP17310 C255(0.99); C261(0.99)  LDD0828 
Zinc finger protein 775 (ZNF775) LDTP15700 C530(1.86)  LDD3419 
Zinc finger protein 776 (ZNF776) LDTP17307 C361(1.17)  LDD0531 
Zinc finger protein 777 (ZNF777) LDTP13539 C741(1.10)  LDD3320 
Zinc finger protein 778 (ZNF778) LDTP18213 C281(0.85); C286(0.85)  LDD0078 
Zinc finger protein 780A (ZNF780A) LDTP16818 C458(0.99)  LDD1492 
Zinc finger protein 787 (ZNF787) LDTP17318 C347(1.12); C350(1.12); C96(0.96); C99(0.96)  LDD0078 
Zinc finger protein 79 (ZNF79) LDTP14868 C172(0.86)  LDD1508 
Zinc finger protein 791 (ZNF791) LDTP17104 C227(0.90); C479(1.01)  LDD0531 
Zinc finger protein 792 (ZNF792) LDTP06765 C405(2.57)  LDD3407 
Zinc finger protein 799 (ZNF799) LDTP18159 C348(1.28)  LDD1507 
Zinc finger protein 8 (ZNF8) LDTP14648 C94(0.92)  LDD0078 
Zinc finger protein 800 (ZNF800) LDTP17085 C49(1.15)  LDD0531 
Zinc finger protein 805 (ZNF805) LDTP17163 C521(0.90)  LDD0547 
Zinc finger protein 808 (ZNF808) LDTP15424 C466(1.37); C752(0.96)  LDD0531 
Zinc finger protein 81 (ZNF81) LDTP14700 C528(0.85)  LDD1492 
Zinc finger protein 813 (ZNF813) LDTP17460 C512(2.58)  LDD2746 
Zinc finger protein 814 (ZNF814) LDTP18936 C122(1.28)  LDD0532 
Zinc finger protein 816 (ZNF816) LDTP17023 C40(1.09)  LDD0531 
Zinc finger protein 82 homolog (ZFP82) LDTP17674 C321(13.30)  LDD0209 
Zinc finger protein 823 (ZNF823) LDTP16954 C399(81.02); C343(47.03)  LDD0209 
Zinc finger protein 827 (ZNF827) LDTP06663 C404(1.22); C407(1.22)  LDD0531 
Zinc finger protein 829 (ZNF829) LDTP06759 C68(3.12)  LDD3343 
Zinc finger protein 841 (ZNF841) LDTP17463 C25(3.69)  LDD3419 
Zinc finger protein 845 (ZNF845) LDTP19875 C24(1.08)  LDD0531 
Zinc finger protein 850 (ZNF850) LDTP18873 C77(0.98)  LDD1093 
Zinc finger protein 865 (ZNF865) LDTP19096 C409(0.79); C412(0.79)  LDD0533 
Zinc finger protein 888 (ZNF888) LDTP19097 C595(1.81)  LDD3369 
Zinc finger protein 90 homolog (ZFP90) LDTP09526 C378(1.62)  LDD3407 
Zinc finger protein 92 (ZNF92) LDTP14811 C20(0.78)  LDD1512 
Zinc finger protein AEBP2 (AEBP2) LDTP07785 C330(1.67); C335(1.67)  LDD0080 
Zinc finger protein Aiolos (IKZF3) LDTP13485 C434(2.24)  LDD3339 
Zinc finger protein basonuclin-1 (BNC1) LDTP05323 C963(1.30)  LDD3416 
Zinc finger protein basonuclin-2 (BNC2) LDTP07786 C863(0.89); C868(0.89)  LDD0078 
Zinc finger protein castor homolog 1 (CASZ1) LDTP08267 C670(1.38)  LDD3311 
Zinc finger protein Gfi-1 (GFI1) LDTP10941 C245(2.53)  LDD3338 
Zinc finger protein Gfi-1b (GFI1B) LDTP07217 C54(1.05); C165(1.16)  LDD2324 
Zinc finger protein GLI2 (GLI2) LDTP02467 C477(1.60)  LDD2250 
Zinc finger protein GLI4 (GLI4) LDTP16949 C113(0.74); C136(0.74)  LDD0533 
Zinc finger protein GLIS2 (GLIS2) LDTP11527 C157(0.29)  LDD2236 
Zinc finger protein OZF (ZNF146) LDTP06309 C46(1.02); C49(1.02)  LDD0532 
Zinc finger protein Pegasus (IKZF5) LDTP11962 C140(1.02); C143(1.02)  LDD0547 
Zinc finger protein PLAGL1 (PLAGL1) LDTP13610 C181(1.53)  LDD0080 
Zinc finger protein PLAGL2 (PLAGL2) LDTP13693 C40(0.97); C42(0.97)  LDD0078 
Zinc finger protein Rlf (RLF) LDTP05760 C942(1.07); C948(1.07); C1686(0.88); C1695(0.88)  LDD0078 
Zinc finger protein SNAI2 (SNAI2) LDTP00823 C151(1.86)  LDD3353 
Zinc finger protein with KRAB and SCAN domains 1 (ZKSCAN1) LDTP14640 C63(1.18)  LDD0078 
Zinc finger protein with KRAB and SCAN domains 2 (ZKSCAN2) LDTP15053 C899(3.98)  LDD0080 
Zinc finger protein with KRAB and SCAN domains 3 (ZKSCAN3) LDTP11125 C195(0.90); C196(0.90)  LDD0078 
Zinc finger protein with KRAB and SCAN domains 4 (ZKSCAN4) LDTP10005 C202(0.90); C203(0.90)  LDD0078 
Zinc finger protein with KRAB and SCAN domains 5 (ZKSCAN5) LDTP16266 C757(1.26)  LDD3330 
Zinc finger protein with KRAB and SCAN domains 8 (ZKSCAN8) LDTP06469 C76(5.47)  LDD3376 
Zinc finger protein ZFAT (ZFAT) LDTP13017 C434(1.11); C437(1.11)  LDD0547 
Zinc finger protein ZFPM1 (ZFPM1) LDTP08582 C264(1.39)  LDD3334 
Zinc finger protein ZIC 5 (ZIC5) LDTP15835 C523(2.28); C528(2.28)  LDD0080 
Zinc finger transcription factor Trps1 (TRPS1) LDTP13279 C681(1.45); C600(1.17)  LDD3310 
Zinc finger X-chromosomal protein (ZFX) LDTP02871 C247(2.05)  LDD0080 
Zinc finger Y-chromosomal protein (ZFY) LDTP02242 C52(1.01)  LDD2253 
Zinc fingers and homeoboxes protein 1 (ZHX1) LDTP13500 C11(1.96)  LDD3364 
Zinc fingers and homeoboxes protein 1, isoform 2 (ZHX1-C8orf76) LDTP15715 C70(4.33)  LDD3325 
Zinc fingers and homeoboxes protein 2 (ZHX2) LDTP14307 C11(4.48)  LDD3339 
Zinc fingers and homeoboxes protein 3 (ZHX3) LDTP11926 C335(1.58)  LDD0080 
------------------------------------------------------------------------------------
⏷ Show the Full List of 862 Transcription factor
59 GPCR Labeled by This Probe
Target Name Target ID Binding Site(Ratio) Interaction ID
Adenosine receptor A2b (ADORA2B) LDTP03472 C311(3.50)  LDD3440 
Adhesion G protein-coupled receptor A2 (ADGRA2) LDTP10675 C979(2.21)  LDD3423 
Adhesion G protein-coupled receptor A3 (ADGRA3) LDTP08544 C1089(0.97); C1098(0.97)  LDD0078 
Adhesion G protein-coupled receptor B3 (ADGRB3) LDTP00923 C80(0.99)  LDD3354 
Adhesion G protein-coupled receptor E2 (ADGRE2) LDTP13312 C328(1.22)  LDD3397 
Adhesion G protein-coupled receptor E5 (ADGRE5) LDTP04221 C802(0.89)  LDD0078 
Adhesion G protein-coupled receptor F5 (ADGRF5) LDTP08698 C954(1.13)  LDD3323 
Adhesion G protein-coupled receptor L1 (ADGRL1) LDTP01458 C140(4.39)  LDD2253 
Adhesion G protein-coupled receptor L2 (ADGRL2) LDTP01622 C148(1.94)  LDD3330 
Adhesion G protein-coupled receptor L3 (ADGRL3) LDTP12132 C135(1.46)  LDD3369 
Adhesion G-protein coupled receptor F1 (ADGRF1) LDTP07127 C287(1.30)  LDD0580 
Adhesion G-protein coupled receptor G1 (ADGRG1) LDTP14207 C562(1.01)  LDD0531 
Adhesion G-protein coupled receptor G2 (ADGRG2) LDTP08712 C570(2.13)  LDD3427 
Adhesion G-protein coupled receptor G6 (ADGRG6) LDTP08174 C1209(0.83)  LDD0531 
Alpha-1D adrenergic receptor (ADRA1D) LDTP03309 C533(1.62)  LDD3434 
C-X-C chemokine receptor type 5 (CXCR5) LDTP03641 C294(2.81)  LDD3372 
C5a anaphylatoxin chemotactic receptor 1 (C5AR1) LDTP03126 C188(7.58)  LDD3366 
Cadherin EGF LAG seven-pass G-type receptor 1 (CELSR1) LDTP12844 C1840(3.07)  LDD3373 
Cadherin EGF LAG seven-pass G-type receptor 2 (CELSR2) LDTP12271 C1761(3.08); C2861(2.07); C1307(2.74)  LDD3368 
Cadherin EGF LAG seven-pass G-type receptor 3 (CELSR3) LDTP12845 C1384(1.71)  LDD3468 
Cannabinoid receptor 1 (CNR1) LDTP03116 C449(1.31)  LDD3417 
Endothelin receptor type B (EDNRB) LDTP03282 C345(1.97)  LDD3427 
Endothelin-1 receptor (EDNRA) LDTP03310 C158(1.00)  LDD1507 
Frizzled-1 (FZD1) LDTP13685 C574(5.87)  LDD3418 
Frizzled-10 (FZD10) LDTP13584 C192(1.39)  LDD1508 
Frizzled-2 (FZD2) LDTP06108 C201(3.10)  LDD3310 
Frizzled-3 (FZD3) LDTP12358 C600(1.05)  LDD1508 
Frizzled-4 (FZD4) LDTP13578 C204(1.13)  LDD1514 
Frizzled-5 (FZD5) LDTP05882 C192(2.78)  LDD3380 
Frizzled-6 (FZD6) LDTP00960 C702(0.94)  LDD0078 
Frizzled-7 (FZD7) LDTP01119 C508(3.67)  LDD3310 
G-protein coupled receptor 143 (GPR143) LDTP04469 C33(2.72)  LDD3369 
G-protein coupled receptor 161 (GPR161) LDTP08952 C224(1.19)  LDD1575 
Leucine-rich repeat-containing G-protein coupled receptor 4 (LGR4) LDTP11366 C930(1.78)  LDD3367 
Leucine-rich repeat-containing G-protein coupled receptor 6 (LGR6) LDTP12202 C756(10.03)  LDD0209 
Lutropin-choriogonadotropic hormone receptor (LHCGR) LDTP03199 C4655(4.87)  LDD3410 
Lysophosphatidic acid receptor 2 (LPAR2) LDTP12199 C228(2.35)  LDD3383 
Melatonin-related receptor (GPR50) LDTP05933 C355(1.05)  LDD1492 
Neuromedin-U receptor 2 (NMUR2) LDTP11635 C262(1.32)  LDD3367 
Neuropeptide S receptor (NPSR1) LDTP07740 C95(2.14)  LDD3352 
Neurotensin receptor type 1 (NTSR1) LDTP03569 C171(1.02)  LDD0531 
Olfactory receptor 10Q1 (OR10Q1) LDTP17935 C407(5.04)  LDD3427 
Olfactory receptor 11G2 (OR11G2) LDTP17844 C248(3.02)  LDD3486 
Olfactory receptor 1D5 (OR1D5) LDTP16977 C169(1.74)  LDD3334 
Olfactory receptor 4M1 (OR4M1) LDTP15528 C47(8.62)  LDD3393 
Olfactory receptor 6S1 (OR6S1) LDTP17997 C84(4.52)  LDD3311 
Oxytocin receptor (OXTR) LDTP03550 C383(2.00)  LDD2284 
P2Y purinoceptor 1 (P2RY1) LDTP04137 C318(1.08)  LDD1507 
Probable G-protein coupled receptor 142 (GPR142) LDTP15260 C84(3.38)  LDD3377 
Probable G-protein coupled receptor 149 (GPR149) LDTP15277 C473(1.54)  LDD3395 
Progestin and adipoQ receptor family member 4 (PAQR4) LDTP19703 C205(1.06); C38(0.76)  LDD0531 
Protein smoothened (SMO) LDTP10991 C712(0.89)  LDD0813 
Proteinase-activated receptor 1 (F2R) LDTP03314 C411(1.20)  LDD0531 
Putative P2Y purinoceptor 10 (P2RY10) LDTP14419 C29(1.94)  LDD3311 
Retinoic acid-induced protein 3 (GPRC5A) LDTP09206 C284(0.93)  LDD0531 
Somatostatin receptor type 2 (SSTR2) LDTP03563 C328(0.79)  LDD1492 
Sphingosine 1-phosphate receptor 2 (S1PR2) LDTP01501 C305(1.95)  LDD3448 
Sphingosine 1-phosphate receptor 4 (S1PR4) LDTP01729 C337(3.07)  LDD3333 
Type-1 angiotensin II receptor (AGTR1) LDTP03549 C355(1.52)  LDD2380 
------------------------------------------------------------------------------------
⏷ Show the Full List of 59 GPCR
167 Immunoglobulin Labeled by This Probe
Target Name Target ID Binding Site(Ratio) Interaction ID
ADAMTS-like protein 1 (ADAMTSL1) LDTP08934 C241(1.39)  LDD3316 
Aggrecan core protein (ACAN) LDTP02827 C2331(2.68)  LDD3413 
Allergin-1 (MILR1) LDTP08131 C110(2.98)  LDD3325 
Amphoterin-induced protein 2 (AMIGO2) LDTP08169 C121(2.75)  LDD3319 
B-cell antigen receptor complex-associated protein alpha chain (CD79A) LDTP02593 C106(2.80)  LDD3419 
Basal cell adhesion molecule (BCAM) LDTP04387 C522(3.57); C337(1.85); C172(2.38)  LDD3312 
Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG2) LDTP05216 C344(0.93); C350(0.93); C359(0.93)  LDD0078 
Basigin (BSG) LDTP03772 C62(1.28)  LDD3310 
Beta-2-microglobulin (B2M) LDTP04937 C45(1.07)  LDD1492 
Brevican core protein (BCAN) LDTP10364 C352(3.32)  LDD3428 
Brother of CDO (BOC) LDTP11341 C931(1.31)  LDD2469 
Butyrophilin subfamily 2 member A1 (BTN2A1) LDTP07927 C374(2.34)  LDD3427 
Butyrophilin subfamily 2 member A2 (BTN2A2) LDTP09625 C475(2.62)  LDD3310 
Butyrophilin subfamily 3 member A1 (BTN3A1) LDTP00291 C511(1.01)  LDD3313 
Butyrophilin subfamily 3 member A3 (BTN3A3) LDTP00290 C22(1.85)  LDD3311 
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) LDTP02157 C215(1.31)  LDD3312 
Cartilage intermediate layer protein 1 (CILP) LDTP01179 C1033(1.61)  LDD3377 
Cartilage intermediate layer protein 2 (CILP2) LDTP17616 C430(0.73)  LDD1509 
CD166 antigen (ALCAM) LDTP05973 C270(3.38); C76(1.80)  LDD3311 
CD276 antigen (CD276) LDTP07280 C383(2.00)  LDD3310 
CD48 antigen (CD48) LDTP02338 C148(1.48)  LDD3372 
CD83 antigen (CD83) LDTP05281 C100(1.09)  LDD1513 
Cell adhesion molecule 1 (CADM1) LDTP11441 C313(2.15)  LDD3311 
Cell adhesion molecule 4 (CADM4) LDTP09237 C245(1.33)  LDD3413 
Cell adhesion molecule-related/down-regulated by oncogenes (CDON) LDTP06851 C191(2.77)  LDD3427 
Cell surface A33 antigen (GPA33) LDTP10980 C43(1.76)  LDD3440 
Cell surface glycoprotein MUC18 (MCAM) LDTP04020 C223(1.52)  LDD0078 
CMRF35-like molecule 8 (CD300A) LDTP13239 C36(1.43)  LDD3333 
Contactin-1 (CNTN1) LDTP05672 C65(2.16)  LDD3433 
Contactin-6 (CNTN6) LDTP13748 C920(2.33)  LDD3413 
Coxsackievirus and adenovirus receptor (CXADR) LDTP05085 C41(2.77)  LDD3342 
Embigin (EMB) LDTP15123 C180(0.82)  LDD1492 
Endothelial cell-selective adhesion molecule (ESAM) LDTP10090 C126(1.66); C158(1.34)  LDD2324 
Fc receptor-like A (FCRLA) LDTP07956 C75(1.37)  LDD3403 
Fc receptor-like B (FCRLB) LDTP07358 C168(3.62)  LDD2413 
Fibroblast growth factor receptor-like 1 (FGFRL1) LDTP08852 C406(1.03)  LDD1508 
Hemicentin-1 (HMCN1) LDTP10789 C5283(1.64)  LDD3410 
Hereditary hemochromatosis protein (HFE) LDTP06742 C61(0.93)  LDD3312 
HLA class I histocompatibility antigen, A alpha chain (HLA-A) LDTP02040 C188(17.35)  LDD3327 
HLA class I histocompatibility antigen, alpha chain E (HLA-E) LDTP02688 C185(1.17)  LDD0532 
HLA class I histocompatibility antigen, alpha chain G (HLA-G) LDTP02916 C66(1.61)  LDD3493 
HLA class I histocompatibility antigen, B alpha chain (HLA-B) LDTP01913 C349(2.50)  LDD3314 
HLA class I histocompatibility antigen, C alpha chain (HLA-C) LDTP02491 C345(7.48); C364(7.48); C350(4.10); C188(3.11)  LDD0080 
HLA class II histocompatibility antigen, DP alpha 1 chain (HLA-DPA1) LDTP03026 C138(2.40)  LDD3314 
HLA class II histocompatibility antigen, DQ alpha 1 chain (HLA-DQA1) LDTP01917 C70(3.44)  LDD3372 
HLA class II histocompatibility antigen, DQ alpha 2 chain (HLA-DQA2) LDTP01916 C189(0.93)  LDD3338 
HLA class II histocompatibility antigen, DQ beta 1 chain (HLA-DQB1) LDTP01919 C111(1.26)  LDD1510 
HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) LDTP01915 C132(2.01)  LDD3338 
HLA class II histocompatibility antigen, DR beta 3 chain (HLA-DRB3) LDTP05150 C108(1.71)  LDD3372 
HLA class II histocompatibility antigen, DR beta 4 chain (HLA-DRB4) LDTP02689 C108(1.51); C146(2.40)  LDD3314 
HLA class II histocompatibility antigen, DR beta 5 chain (HLA-DRB5) LDTP06741 C108(1.68)  LDD3313 
Hyaluronan and proteoglycan link protein 1 (HAPLN1) LDTP02530 C325(1.02)  LDD3387 
IgG receptor FcRn large subunit p51 (FCGRT) LDTP04720 C182(2.17)  LDD3368 
Immunoglobulin alpha Fc receptor (FCAR) LDTP03267 C75(2.70)  LDD3336 
Immunoglobulin heavy constant delta (IGHD) LDTP01912 C15(4.56); C161(2.04)  LDD3339 
Immunoglobulin heavy constant gamma 3 (IGHG3) LDTP01907 C14(1.93)  LDD3448 
Immunoglobulin heavy constant mu (IGHM) LDTP01909 C88(2.44); C134(3.09)  LDD3339 
Immunoglobulin heavy variable 1-46 (IGHV1-46) LDTP14565 C115(4.28)  LDD3339 
Immunoglobulin heavy variable 3-30 (IGHV3-30) LDTP01895 C115(1.18)  LDD3370 
Immunoglobulin iota chain (VPREB1) LDTP02597 C115(1.19)  LDD3403 
Immunoglobulin J chain (JCHAIN) LDTP01875 C131(1.90); C91(1.84); C156(1.25)  LDD3377 
Immunoglobulin kappa constant (IGKC) LDTP01901 C27(1.15); C87(0.87)  LDD3377 
Immunoglobulin kappa variable 1-13 (IGKV1-13) LDTP16931 C45(3.43)  LDD3431 
Immunoglobulin kappa variable 3-15 (IGKV3-15) LDTP14558 C46(0.80)  LDD3370 
Immunoglobulin lambda constant 2 (IGLC2) LDTP02439 C87(3.66); C213(2.36)  LDD3372 
Immunoglobulin lambda constant 7 (IGLC7) LDTP14324 C212(1.27)  LDD3339 
Immunoglobulin lambda variable 3-21 (IGLV3-21) LDTP14784 C41(1.66)  LDD3372 
Immunoglobulin mu Fc receptor (FCMR) LDTP01022 C318(1.41)  LDD2171 
Immunoglobulin superfamily DCC subclass member 4 (IGDCC4) LDTP15613 C1233(1.03)  LDD1508 
Immunoglobulin superfamily member 1 (IGSF1) LDTP08927 C1313(0.55)  LDD2276 
Immunoglobulin superfamily member 3 (IGSF3) LDTP01108 C665(2.23)  LDD3413 
Immunoglobulin superfamily member 8 (IGSF8) LDTP10016 C127(2.64)  LDD3332 
Immunoglobulin-like domain-containing receptor 1 (ILDR1) LDTP08180 C443(2.53)  LDD3354 
Inactive tyrosine-protein kinase 7 (PTK7) LDTP05819 C944(1.58)  LDD3310 
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1) LDTP05328 C848(2.17)  LDD3310 
Insulin-like growth factor-binding protein 7 (IGFBP7) LDTP06520 C120(0.99); C131(0.99); C111(0.94); C113(0.94)  LDD0078 
Insulin-like growth factor-binding protein-like 1 (IGFBPL1) LDTP15641 C115(2.54)  LDD3342 
Intercellular adhesion molecule 1 (ICAM1) LDTP02106 C457(1.05); C92(0.95); C96(0.95); C48(0.87)  LDD0078 
Intercellular adhesion molecule 2 (ICAM2) LDTP02667 C134(1.56)  LDD3380 
Intercellular adhesion molecule 3 (ICAM3) LDTP03657 C190(13.83); C139(20.44)  LDD0209 
Intercellular adhesion molecule 5 (ICAM5) LDTP13614 C552(3.07)  LDD3317 
Junctional adhesion molecule A (F11R) LDTP14203 C50(1.96)  LDD3310 
Junctional adhesion molecule-like (JAML) LDTP08417 C327(2.70)  LDD2324 
Kin of IRRE-like protein 1 (KIRREL1) LDTP10445 C387(3.44)  LDD3310 
Leucine-rich repeat and fibronectin type III domain-containing protein 1 (LRFN1) LDTP16171 C583(0.91)  LDD1511 
Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (LRFN3) LDTP11204 C583(1.02)  LDD1507 
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (LINGO1) LDTP10302 C57(2.06)  LDD3427 
Leucine-rich repeat-containing protein 4 (LRRC4) LDTP12200 C329(1.07)  LDD1508 
Leucine-rich repeat-containing protein 4B (LRRC4B) LDTP12601 C683(1.03)  LDD1514 
Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) LDTP10449 C158(1.17)  LDD3312 
Leucine-rich repeats and immunoglobulin-like domains protein 2 (LRIG2) LDTP01452 C902(1.01); C905(1.01)  LDD0078 
Leucine-rich repeats and immunoglobulin-like domains protein 3 (LRIG3) LDTP15162 C53(0.78); C60(0.78)  LDD0533 
Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4) LDTP09252 C330(1.87)  LDD3333 
Lipolysis-stimulated lipoprotein receptor (LSR) LDTP08348 C302(1.07); C303(1.07); C304(1.07)  LDD0078 
Low affinity immunoglobulin gamma Fc region receptor II-b (FCGR2B) LDTP03621 C261(2.91)  LDD3335 
Matrix remodeling-associated protein 8 (MXRA8) LDTP11114 C85(3.16)  LDD3380 
Matrix-remodeling-associated protein 5 (MXRA5) LDTP12489 C2025(2.79)  LDD2345 
MHC class I polypeptide-related sequence A (MICA) LDTP06683 C273(0.69)  LDD0531 
MHC class I polypeptide-related sequence B (MICB) LDTP06682 C187(7.73)  LDD3392 
Microfibril-associated glycoprotein 3 (MFAP3) LDTP04669 C248(2.26); C360(1.57)  LDD0080 
Microfibrillar-associated protein 3-like (MFAP3L) LDTP01128 C402(1.19)  LDD3386 
Myelin protein zero-like protein 1 (MPZL1) LDTP01559 C203(1.33)  LDD0080 
Myomesin-2 (MYOM2) LDTP04613 C1291(1.22); C1366(2.56); C1242(3.51)  LDD3423 
Myopalladin (MYPN) LDTP08193 C942(1.98); C906(2.22)  LDD3330 
Myosin-binding protein C, fast-type (MYBPC2) LDTP14841 C335(2.69)  LDD3377 
Myosin-binding protein H (MYBPH) LDTP14829 C12(1.03)  LDD3401 
Natural cytotoxicity triggering receptor 3 ligand 1 (NCR3LG1) LDTP07321 C380(2.66); C383(3.41); C382(3.41)  LDD0080 
Nectin-2 (NECTIN2) LDTP09844 C446(1.09)  LDD0078 
Nectin-3 (NECTIN3) LDTP12430 C291(0.92)  LDD1507 
Neogenin (NEO1) LDTP09907 C270(1.02)  LDD1576 
Netrin receptor DCC (DCC) LDTP04021 C565(2.58)  LDD3376 
Netrin receptor UNC5B (UNC5B) LDTP08703 C551(1.10)  LDD0531 
Netrin receptor UNC5C (UNC5C) LDTP01520 C853(1.42)  LDD3340 
Neural cell adhesion molecule 1 (NCAM1) LDTP02666 C829(2.16)  LDD3340 
Neural cell adhesion molecule 2 (NCAM2) LDTP00629 C405(2.65)  LDD3345 
Neural cell adhesion molecule L1 (L1CAM) LDTP03624 C312(6.38); C1043(4.87); C158(1.83)  LDD3332 
Neural cell adhesion molecule L1-like protein (CHL1) LDTP00305 C556(2.19)  LDD3484 
Neurocan core protein (NCAN) LDTP00378 C325(2.75)  LDD2469 
Neuronal cell adhesion molecule (NRCAM) LDTP09887 C525(1.98)  LDD3388 
Neuronal growth regulator 1 (NEGR1) LDTP08027 C60(1.64)  LDD2260 
Neuroplastin (NPTN) LDTP14205 C259(1.44)  LDD3335 
Neurotrimin (NTM) LDTP12995 C83(1.13)  LDD2397 
Nexilin (NEXN) LDTP05620 C667(2.85)  LDD3312 
Obscurin-like protein 1 (OBSL1) LDTP01140 C13(1.21); C581(2.80)  LDD0080 
Palladin (PALLD) LDTP09680 C964(0.92)  LDD0078 
Papilin (PAPLN) LDTP01599 C630(1.05); C79(1.73); C681(1.60)  LDD3323 
Platelet endothelial cell adhesion molecule (PECAM1) LDTP02838 C572(2.60)  LDD3334 
Poliovirus receptor (PVR) LDTP02767 C123(1.20)  LDD1507 
Polymeric immunoglobulin receptor (PIGR) LDTP01900 C544(1.38); C257(1.42); C279(0.94); C152(1.72)  LDD3312 
Pregnancy-specific beta-1-glycoprotein 2 (PSG2) LDTP16950 C394(1.67)  LDD3485 
Pregnancy-specific beta-1-glycoprotein 3 (PSG3) LDTP14871 C95(3.10)  LDD2284 
Pregnancy-specific beta-1-glycoprotein 5 (PSG5) LDTP14856 C262(3.07); C301(3.41)  LDD2284 
Pregnancy-specific beta-1-glycoprotein 6 (PSG6) LDTP05263 C217(3.60)  LDD2284 
Pregnancy-specific beta-1-glycoprotein 8 (PSG8) LDTP18558 C262(3.12)  LDD2284 
Pregnancy-specific beta-1-glycoprotein 9 (PSG9) LDTP05261 C417(3.76)  LDD2284 
Pro-neuregulin-1, membrane-bound isoform (NRG1) LDTP05347 C409(3.66)  LDD3376 
Programmed cell death 1 ligand 1 (CD274) LDTP12930 C272(1.18)  LDD3335 
Programmed cell death protein 1 (PDCD1) LDTP06319 C93(1.71)  LDD3397 
Prostaglandin F2 receptor negative regulator (PTGFRN) LDTP13034 C429(2.42)  LDD3314 
Protein sidekick-1 (SDK1) LDTP08098 C744(1.27)  LDD3316 
Protein sidekick-2 (SDK2) LDTP06937 C666(2.51); C1764(1.93)  LDD3376 
Protein turtle homolog A (IGSF9) LDTP13054 C846(2.98)  LDD3365 
Protein turtle homolog B (IGSF9B) LDTP13730 C442(1.20)  LDD1510 
Roundabout homolog 1 (ROBO1) LDTP14280 C89(2.13)  LDD3310 
Roundabout homolog 2 (ROBO2) LDTP12250 C262(1.85); C384(1.44)  LDD2469 
Semaphorin-3A (SEMA3A) LDTP06148 C269(4.12)  LDD3365 
Semaphorin-3B (SEMA3B) LDTP05787 C534(1.05); C541(1.05)  LDD0078 
Semaphorin-3C (SEMA3C) LDTP11029 C564(2.07)  LDD3313 
Semaphorin-3D (SEMA3D) LDTP14525 C183(1.18)  LDD1508 
Semaphorin-3G (SEMA3G) LDTP16086 C529(1.18); C532(1.18)  LDD0078 
Semaphorin-4C (SEMA4C) LDTP11598 C248(0.96)  LDD0078 
Semaphorin-4D (SEMA4D) LDTP09905 C708(0.79)  LDD1492 
Semaphorin-7A (SEMA7A) LDTP01176 C566(0.99)  LDD0078 
Sialic acid-binding Ig-like lectin 5 (SIGLEC5) LDTP00625 C314(1.55)  LDD2501 
SLAM family member 7 (SLAMF7) LDTP12387 C275(1.15)  LDD3377 
T-cell antigen CD7 (CD7) LDTP02358 C219(4.52)  LDD0209 
T-cell surface glycoprotein CD1e, membrane-associated (CD1E) LDTP02803 C28(1.27)  LDD3397 
T-lymphocyte activation antigen CD86 (CD86) LDTP03964 C63(1.40)  LDD3370 
T-lymphocyte surface antigen Ly-9 (LY9) LDTP12177 C627(2.25); C274(1.88)  LDD3377 
Tapasin (TAPBP) LDTP00671 C115(4.31)  LDD0209 
Tapasin-related protein (TAPBPL) LDTP11352 C39(1.52)  LDD3325 
Thy-1 membrane glycoprotein (THY1) LDTP02026 C28(1.36)  LDD3387 
Triggering receptor expressed on myeloid cells 1 (TREM1) LDTP12330 C69(1.21)  LDD3346 
V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR) LDTP12029 C83(1.16)  LDD3334 
Vascular cell adhesion protein 1 (VCAM1) LDTP02989 C483(4.17)  LDD3351 
Versican core protein (VCAN) LDTP02668 C217(1.12)  LDD0531 
Zinc-alpha-2-glycoprotein (AZGP1) LDTP03318 C186(1.41)  LDD3318 
------------------------------------------------------------------------------------
⏷ Show the Full List of 167 Immunoglobulin
74 Cytokine and receptor Labeled by This Probe
Target Name Target ID Binding Site(Ratio) Interaction ID
Atypical chemokine receptor 2 (ACKR2) LDTP00319 C330(2.11)  LDD3377 
Atypical chemokine receptor 3 (ACKR3) LDTP03313 C196(2.24)  LDD2469 
C-C motif chemokine 26 (CCL26) LDTP13810 C57(3.47); C73(4.12)  LDD3380 
C-C motif chemokine 28 (CCL28) LDTP12514 C99(1.99)  LDD3444 
C-C motif chemokine 5 (CCL5) LDTP02660 C73(3.07)  LDD3411 
C-X-C chemokine receptor type 4 (CXCR4) LDTP04896 C274(0.73)  LDD1492 
C-X-C motif chemokine 13 (CXCL13) LDTP00908 C35(3.43); C60(3.91); C76(3.30)  LDD2268 
C-X-C motif chemokine 14 (CXCL14) LDTP01658 C84(3.62); C63(2.76)  LDD2268 
C-X-C motif chemokine 17 (CXCL17) LDTP07700 C103(4.04)  LDD3358 
C-X-C motif chemokine 5 (CXCL5) LDTP04005 C49(0.93); C51(0.93)  LDD0078 
C-X-C motif chemokine 6 (CXCL6) LDTP05155 C75(3.24)  LDD3310 
Cardiotrophin-1 (CTF1) LDTP06577 C105(0.80)  LDD1507 
CD27 antigen (CD27) LDTP03373 C258(2.08); C185(1.71)  LDD3339 
CD70 antigen (CD70) LDTP03659 C17(2.36)  LDD3370 
Chemokine-like protein TAFA-3 (TAFA3) LDTP17549 C96(3.78)  LDD3311 
CKLF-like MARVEL transmembrane domain-containing protein 3 (CMTM3) LDTP10604 C38(162.54)  LDD0209 
CKLF-like MARVEL transmembrane domain-containing protein 4 (CMTM4) LDTP08715 C45(1.02)  LDD1507 
CKLF-like MARVEL transmembrane domain-containing protein 7 (CMTM7) LDTP10323 C12(1.19)  LDD0602 
Cyclic AMP-dependent transcription factor ATF-2 (ATF2) LDTP02782 C57(1.52)  LDD3312 
Cytokine receptor-like factor 1 (CRLF1) LDTP01230 C351(2.70)  LDD3341 
Cytokine receptor-like factor 3 (CRLF3) LDTP08458 C313(0.93)  LDD0532 
Cytokine SCM-1 beta (XCL2) LDTP13103 C69(3.12)  LDD2355 
Cytokine-like protein 1 (CYTL1) LDTP16076 C107(1.12)  LDD0532 
Endoglin (ENG) LDTP02923 C582(0.96)  LDD0078 
Growth-regulated alpha protein (CXCL1) LDTP02340 C85(1.92)  LDD3369 
Interferon alpha/beta receptor 1 (IFNAR1) LDTP02889 C426(0.98)  LDD1492 
Interferon alpha/beta receptor 2 (IFNAR2) LDTP04193 C85(1.03)  LDD1507 
Interferon gamma receptor 1 (IFNGR1) LDTP02775 C322(1.32)  LDD3312 
Interleukin-1 alpha (IL1A) LDTP01871 C253(1.57)  LDD3367 
Interleukin-1 beta (IL1B) LDTP01872 C124(0.69)  LDD3312 
Interleukin-1 receptor type 1 (IL1R1) LDTP02745 C403(1.40)  LDD2412 
Interleukin-13 receptor subunit alpha-1 (IL13RA1) LDTP05144 C320(2.88)  LDD3360 
Interleukin-13 receptor subunit alpha-2 (IL13RA2) LDTP06163 C197(6.02); C65(2.21); C378(2.29)  LDD3327 
Interleukin-15 (IL15) LDTP03909 C9(1.88)  LDD3466 
Interleukin-17D (IL17D) LDTP09293 C31(1.12)  LDD1508 
Interleukin-18 (IL18) LDTP06037 C74(1.00)  LDD0078 
Interleukin-2 (IL2) LDTP04872 C78(2.41)  LDD3332 
Interleukin-2 receptor subunit beta (IL2RB) LDTP02747 C194(0.94)  LDD2412 
Interleukin-27 receptor subunit alpha (IL27RA) LDTP07670 C261(2.70)  LDD3311 
Interleukin-3 receptor subunit alpha (IL3RA) LDTP03376 C151(1.08)  LDD1573 
Interleukin-33 (IL33) LDTP01670 C40(6.02); C259(4.62)  LDD3346 
Interleukin-37 (IL37) LDTP12897 C207(3.37)  LDD3358 
Interleukin-4 receptor subunit alpha (IL4R) LDTP03278 C342(1.89)  LDD3323 
Interleukin-6 receptor subunit beta (IL6ST) LDTP03881 C419(1.87)  LDD3314 
Interleukin-8 (CXCL8) LDTP02477 C61(1.02)  LDD2379 
Leptin receptor (LEPR) LDTP04173 C37(1.05)  LDD1510 
Leukemia inhibitory factor receptor (LIFR) LDTP03996 C90(1.99)  LDD3368 
Protein Red (IK) LDTP05757 C263(1.48)  LDD0532 
Single Ig IL-1-related receptor (SIGIRR) LDTP07398 C403(1.29)  LDD2260 
Stromal cell-derived factor 1 (CXCL12) LDTP04157 C71(1.13)  LDD1508 
Thrombopoietin receptor (MPL) LDTP03889 C583(1.39)  LDD2324 
Transforming growth factor beta receptor type 3 (TGFBR3) LDTP05397 C660(2.94)  LDD3373 
Transforming growth factor beta-1 proprotein (TGFB1) LDTP01832 C285(1.21)  LDD0078 
Transforming growth factor beta-2 proprotein (TGFB2) LDTP04939 C89(1.54)  LDD3311 
Tumor necrosis factor ligand superfamily member 10 (TNFSF10) LDTP04377 C56(4.36)  LDD3416 
Tumor necrosis factor ligand superfamily member 15 (TNFSF15) LDTP01506 C85(0.82)  LDD3342 
Tumor necrosis factor receptor superfamily member 10A (TNFRSF10A) LDTP00220 C221(0.97); C229(0.97)  LDD0580 
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) LDTP00423 C248(1.16)  LDD0531 
Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C) LDTP00441 C53(1.48)  LDD3346 
Tumor necrosis factor receptor superfamily member 10D (TNFRSF10D) LDTP13135 C326(0.86)  LDD0533 
Tumor necrosis factor receptor superfamily member 12A (TNFRSF12A) LDTP12320 C122(1.14); C49(1.40); C64(1.27); C67(1.27)  LDD0533 
Tumor necrosis factor receptor superfamily member 14 (TNFRSF14) LDTP09944 C185(5.85)  LDD3427 
Tumor necrosis factor receptor superfamily member 18 (TNFRSF18) LDTP14162 C218(0.68)  LDD0602 
Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) LDTP12564 C245(3.12)  LDD3430 
Tumor necrosis factor receptor superfamily member 19L (RELT) LDTP10051 C275(1.01)  LDD1492 
Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) LDTP02998 C44(0.90)  LDD3323 
Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) LDTP03046 C428(1.51)  LDD3342 
Tumor necrosis factor receptor superfamily member 21 (TNFRSF21) LDTP01244 C560(0.88)  LDD3312 
Tumor necrosis factor receptor superfamily member 3 (LTBR) LDTP03824 C191(4.10); C210(4.10)  LDD0080 
Tumor necrosis factor receptor superfamily member 5 (CD40) LDTP03340 C161(0.57); C167(0.57)  LDD0533 
Tumor necrosis factor receptor superfamily member 6 (FAS) LDTP03323 C304(0.89)  LDD0078 
Tumor necrosis factor receptor superfamily member 6B (TNFRSF6B) LDTP01593 C49(1.18); C52(1.18); C62(1.18)  LDD0078 
Tumor necrosis factor receptor superfamily member 8 (TNFRSF8) LDTP03459 C69(9.89)  LDD0209 
Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) LDTP05508 C241(0.96); C243(0.96)  LDD0078 
------------------------------------------------------------------------------------
⏷ Show the Full List of 74 Cytokine and receptor
4808 Other Labeled by This Probe
Target Name Target ID Binding Site(Ratio) Interaction ID
14-3-3 protein beta/alpha (YWHAB) LDTP03617 C96(3.06)  LDD3323 
14-3-3 protein eta (YWHAH) LDTP05442 C112(0.97)  LDD0078 
14-3-3 protein sigma (SFN) LDTP03618 C38(0.98)  LDD0078 
17S U2 SnRNP complex component HTATSF1 (HTATSF1) LDTP00849 C471(1.13); C462(1.02); C512(0.99); C480(0.91)  LDD0078 
182 kDa tankyrase-1-binding protein (TNKS1BP1) LDTP11597 C1114(1.25); C749(1.13); C1175(1.11); C794(1.05)  LDD0078 
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (DPH2) LDTP11071 C251(2.56)  LDD0080 
26S proteasome non-ATPase regulatory subunit 10 (PSMD10) LDTP01323 C107(1.20)  LDD0078 
26S proteasome non-ATPase regulatory subunit 11 (PSMD11) LDTP00223 C289(4.09); C202(1.79)  LDD3311 
26S proteasome non-ATPase regulatory subunit 6 (PSMD6) LDTP06273 C266(1.16)  LDD0080 
40-kDa huntingtin-associated protein (F8A1; F8A2; F8A3) LDTP03248 C62(1.99); C69(1.99)  LDD0080 
43 kDa receptor-associated protein of the synapse (RAPSN) LDTP05969 C109(2.60)  LDD3401 
5-azacytidine-induced protein 2 (AZI2) LDTP11997 C257(4.00); C262(4.00)  LDD0080 
55 kDa erythrocyte membrane protein (MPP1) LDTP05233 C242(2.05); C94(1.46)  LDD0080 
60S ribosomal export protein NMD3 (NMD3) LDTP10200 C214(1.58); C250(1.61)  LDD0080 
60S ribosome subunit biogenesis protein NIP7 homolog (NIP7) LDTP13779 C36(1.33)  LDD0078 
A-kinase anchor protein 1, mitochondrial (AKAP1) LDTP09837 C585(1.00); C376(0.91)  LDD0078 
A-kinase anchor protein 10, mitochondrial (AKAP10) LDTP00806 C110(1.02)  LDD0078 
A-kinase anchor protein 11 (AKAP11) LDTP13439 C1290(1.19); C1435(1.14); C1488(1.10); C461(0.92)  LDD0078 
A-kinase anchor protein 12 (AKAP12) LDTP05382 C1314(1.25); C1521(1.23); C1479(1.20); C265(1.04)  LDD0078 
A-kinase anchor protein 13 (AKAP13) LDTP05655 C732(5.50)  LDD0209 
A-kinase anchor protein 17A (AKAP17A) LDTP05330 C563(1.04); C542(0.97); C549(0.97)  LDD0078 
A-kinase anchor protein 6 (AKAP6) LDTP05729 C833(3.06)  LDD3484 
A-kinase anchor protein 8 (AKAP8) LDTP00880 C173(2.22); C351(1.97)  LDD0080 
A-kinase anchor protein 8-like (AKAP8L) LDTP13591 C128(1.01); C211(0.85)  LDD0078 
A-kinase anchor protein 9 (AKAP9) LDTP11033 C3581(6.22); C1405(4.64); C2877(12.51); C3521(5.06)  LDD0209 
A-kinase anchor protein SPHKAP (SPHKAP) LDTP06704 C960(1.59)  LDD2270 
ABI gene family member 3 (ABI3) LDTP13033 C145(2.37)  LDD3339 
Abl interactor 1 (ABI1) LDTP08710 C488(1.66)  LDD0080 
Abl interactor 2 (ABI2) LDTP12822 C33(0.69)  LDD0531 
Abnormal spindle-like microcephaly-associated protein (ASPM) LDTP08716 C2987(1.13); C911(1.07); C914(1.07); C10(1.05)  LDD0078 
Abscission/NoCut checkpoint regulator (ZFYVE19) LDTP10493 C435(1.14); C441(1.14); C83(0.98); C104(0.89)  LDD0078 
Acetylcholinesterase collagenic tail peptide (COLQ) LDTP13775 C405(2.53)  LDD2412 
Acidic fibroblast growth factor intracellular-binding protein (FIBP) LDTP00765 C262(0.84)  LDD0531 
Acidic leucine-rich nuclear phosphoprotein 32 family member A (ANP32A) LDTP03871 C87(1.17)  LDD3312 
Acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) LDTP09843 C123(1.90)  LDD0080 
Acidic leucine-rich nuclear phosphoprotein 32 family member E (ANP32E) LDTP11207 C123(1.14); C87(1.39)  LDD0531 
Acrosomal protein KIAA1210 (KIAA1210) LDTP18550 C1053(1.31)  LDD3430 
Actin filament-associated protein 1 (AFAP1) LDTP08885 C797(3.28)  LDD3310 
Actin filament-associated protein 1-like 1 (AFAP1L1) LDTP09497 C676(1.18)  LDD3312 
Actin filament-associated protein 1-like 2 (AFAP1L2) LDTP08879 C36(3.58)  LDD3312 
Actin nucleation-promoting factor WASL (WASL) LDTP00263 C431(0.99)  LDD0078 
Actin remodeling regulator NHS (NHS) LDTP07641 C1267(0.43)  LDD2236 
Actin-binding LIM protein 1 (ABLIM1) LDTP00390 C250(1.58)  LDD3316 
Actin-binding LIM protein 2 (ABLIM2) LDTP07395 C71(1.22)  LDD3331 
Actin-binding LIM protein 3 (ABLIM3) LDTP01467 C178(1.01); C181(1.01); C70(0.86)  LDD0078 
Actin-binding protein IPP (IPP) LDTP16287 C263(1.08)  LDD0078 
Actin-binding protein WASF1 (WASF1) LDTP09795 C14(0.95)  LDD0531 
Actin-binding protein WASF2 (WASF2) LDTP14298 C27(1.14)  LDD0531 
Actin-binding protein WASF3 (WASF3) LDTP13735 C28(0.79)  LDD3321 
Actin-like protein 6A (ACTL6A) LDTP01756 C32(0.93)  LDD0078 
Actin-like protein 6B (ACTL6B) LDTP01421 C32(1.01)  LDD3314 
Actin-like protein 8 (ACTL8) LDTP18397 C197(1.40); C58(1.49)  LDD3347 
Actin-related protein 10 (ACTR10) LDTP16150 C37(0.86)  LDD0531 
Actin-related protein 2 (ACTR2) LDTP04903 C20(1.70); C11(1.79); C226(2.38)  LDD3311 
Actin-related protein 2/3 complex subunit 1A (ARPC1A) LDTP15664 C279(0.96)  LDD0078 
Actin-related protein 2/3 complex subunit 1B (ARPC1B) LDTP00550 C342(2.29); C346(2.29)  LDD0080 
Actin-related protein 2/3 complex subunit 2 (ARPC2) LDTP00551 C120(1.67)  LDD0531 
Actin-related protein 2/3 complex subunit 3 (ARPC3) LDTP00552 C162(5.58)  LDD0080 
Actin-related protein 2/3 complex subunit 4 (ARPC4) LDTP04844 C40(1.52)  LDD3311 
Actin-related protein 3 (ACTR3) LDTP04902 C408(1.77)  LDD0080 
Actin-related protein 3B (ACTR3B) LDTP16166 C232(1.11); C235(1.11)  LDD0532 
Actin-related protein 5 (ACTR5) LDTP12095 C569(26.64)  LDD0204 
Actin-related protein 6 (ACTR6) LDTP11629 C210(1.90)  LDD0080 
Actin-related protein 8 (ACTR8) LDTP12082 C340(4.18)  LDD0209 
Actin-related protein T1 (ACTRT1) LDTP09433 C182(5.45)  LDD3332 
Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) LDTP11600 C571(2.05)  LDD3418 
Activating signal cointegrator 1 (TRIP4) LDTP06436 C86(1.47)  LDD0078 
Activating signal cointegrator 1 complex subunit 2 (ASCC2) LDTP11766 C165(4.87)  LDD0204 
Activating transcription factor 7-interacting protein 1 (ATF7IP) LDTP07732 C608(5.29); C612(5.29); C955(1.55); C451(1.59)  LDD0080 
Activator of basal transcription 1 (ABT1) LDTP13585 C37(1.17)  LDD1492 
Active breakpoint cluster region-related protein (ABR) LDTP05713 C201(1.00)  LDD0531 
Active regulator of SIRT1 (RPS19BP1) LDTP08345 C104(2.93)  LDD3312 
Acyl carrier protein, mitochondrial (NDUFAB1) LDTP00372 C140(1.31)  LDD0531 
Acyl-CoA-binding domain-containing protein 6 (ACBD6) LDTP15861 C259(0.90); C267(0.90)  LDD0078 
Acyl-CoA-binding domain-containing protein 7 (ACBD7) LDTP17732 C45(1.54)  LDD0080 
Adapter molecule crk (CRK) LDTP04091 C279(1.22)  LDD3424 
Adenomatous polyposis coli protein (APC) LDTP03303 C1263(1.76); C1270(1.76)  LDD0078 
Adenomatous polyposis coli protein 2 (APC2) LDTP01739 C1346(2.03)  LDD2469 
Adenylyl cyclase-associated protein 1 (CAP1) LDTP05294 C93(0.96)  LDD0078 
Adenylyl cyclase-associated protein 2 (CAP2) LDTP03878 C378(3.65)  LDD3485 
Adipose-secreted signaling protein (ADISSP) LDTP18359 C181(2.82)  LDD3331 
ADP-ribosylation factor GTPase-activating protein 1 (ARFGAP1) LDTP08950 C96(0.72)  LDD3314 
ADP-ribosylation factor GTPase-activating protein 2 (ARFGAP2) LDTP08935 C26(2.96); C97(1.20); C29(1.37)  LDD0080 
ADP-ribosylation factor GTPase-activating protein 3 (ARFGAP3) LDTP12306 C312(1.17); C28(1.12); C241(1.03)  LDD0078 
ADP-ribosylation factor-binding protein GGA2 (GGA2) LDTP13414 C343(0.94)  LDD0078 
ADP-ribosylation factor-like protein 2-binding protein (ARL2BP) LDTP13929 C149(0.98)  LDD0078 
ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL6IP1) LDTP06291 C109(1.08)  LDD0531 
ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL6IP4) LDTP07301 C349(1.09); C182(0.98)  LDD0078 
ADP-ribosylation factor-like protein 6-interacting protein 6 (ARL6IP6) LDTP15434 C48(1.08)  LDD1514 
Adrenocortical dysplasia protein homolog (ACD) LDTP10088 C138(46.49)  LDD0209 
Afadin (AFDN) LDTP04679 C324(1.66); C1206(1.54)  LDD3312 
Afadin- and alpha-actinin-binding protein (SSX2IP) LDTP13852 C547(1.17)  LDD0078 
AFG2-interacting ribosome maturation factor (AIRIM) LDTP12749 C17(1.34)  LDD0533 
Aftiphilin (AFTPH) LDTP07654 C511(1.19); C365(0.90); C369(0.90)  LDD0078 
AH receptor-interacting protein (AIP) LDTP00202 C208(1.05); C121(1.05); C122(1.05)  LDD0078 
Akirin-1 (AKIRIN1) LDTP12102 C141(1.52)  LDD0531 
Akirin-2 (AKIRIN2) LDTP06909 C152(0.72)  LDD0533 
Albumin (ALB) LDTP01963 C97(2.08)  LDD3314 
ALK and LTK ligand 1 (ALKAL1) LDTP07716 C90(1.04)  LDD1507 
Allograft inflammatory factor 1-like (AIF1L) LDTP11082 C35(1.18)  LDD0531 
Alpha-1-antitrypsin (SERPINA1) LDTP01811 C256(2.61)  LDD3325 
Alpha-1-antitrypsin-related protein (SERPINA2) LDTP03085 C1343(2.24); C790(3.12)  LDD3310 
Alpha-1-syntrophin (SNTA1) LDTP05863 C226(1.19)  LDD0080 
Alpha-2-antiplasmin (SERPINF2) LDTP02300 C152(0.82)  LDD0533 
Alpha-2-HS-glycoprotein (AHSG) LDTP01961 C132(2.06); C230(2.64)  LDD3312 
Alpha-2-macroglobulin (A2M) LDTP01814 C595(4.36)  LDD3380 
Alpha-2-macroglobulin-like protein 1 (A2ML1) LDTP00129 C694(1.77)  LDD3315 
Alpha-actinin-1 (ACTN1) LDTP02631 C180(2.48); C370(1.60)  LDD3310 
Alpha-actinin-3 (ACTN3) LDTP05542 C869(1.11)  LDD3380 
Alpha-actinin-4 (ACTN4) LDTP00843 C499(1.10); C173(1.09); C351(0.90); C879(0.90)  LDD0078 
Alpha-catulin (CTNNAL1) LDTP13159 C438(1.00)  LDD0078 
Alpha-centractin (ACTR1A) LDTP04904 C34(0.99)  LDD0078 
Alpha-fetoprotein (AFP) LDTP01964 C416(1.53)  LDD0531 
Alpha-internexin (INA) LDTP06527 C54(1.09)  LDD0078 
Alpha-parvin (PARVA) LDTP12671 C352(0.95)  LDD0531 
Alpha-soluble NSF attachment protein (NAPA) LDTP04647 C42(0.94); C84(0.93); C212(0.85); C215(0.85)  LDD0078 
Alpha-taxilin (TXLNA) LDTP03886 C523(0.99)  LDD0078 
Alpha-tocopherol transfer protein-like (TTPAL) LDTP19922 C141(0.86); C145(0.86)  LDD0531 
ALS2 C-terminal-like protein (ALS2CL) LDTP07281 C342(1.13); C363(1.12); C419(0.82); C424(0.82)  LDD0531 
Alsin (ALS2) LDTP10721 C1454(226.94); C916(15.68)  LDD0209 
Alternative prion protein (PRNP) LDTP16766 C214(1.02)  LDD3312 
Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (AIMP1) LDTP05687 C253(1.87); C185(1.87); C308(1.38)  LDD3310 
Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (AIMP2) LDTP05770 C205(1.16); C23(1.01); C143(0.95)  LDD0078 
AMMECR1-like protein (AMMECR1L) LDTP19476 C153(21.96)  LDD0209 
Amphiphysin (AMPH) LDTP04252 C224(1.59)  LDD3341 
Amphiregulin (AREG) LDTP02792 C172(0.85)  LDD0531 
Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1IP) LDTP08103 C381(4.62); C304(1.48)  LDD3333 
Amyloid beta precursor like protein 2 (APLP2) LDTP05491 C319(1.11)  LDD0078 
Amyloid beta precursor protein binding family B member 1 (APBB1) LDTP00216 C397(2.87)  LDD0080 
Amyloid beta precursor protein binding family B member 2 (APBB2) LDTP09908 C561(3.96); C447(3.09)  LDD3311 
Amyloid protein-binding protein 2 (APPBP2) LDTP09827 C393(1.80)  LDD3340 
Amyloid-beta A4 precursor protein-binding family A member 3 (APBA3) LDTP01755 C500(0.59); C507(0.59)  LDD0532 
AN1-type zinc finger protein 1 (ZFAND1) LDTP09382 C184(1.27)  LDD0078 
AN1-type zinc finger protein 2B (ZFAND2B) LDTP09601 C84(0.95)  LDD3325 
AN1-type zinc finger protein 3 (ZFAND3) LDTP18418 C32(0.89); C18(0.86); C20(0.86)  LDD0078 
AN1-type zinc finger protein 5 (ZFAND5) LDTP01396 C30(1.17); C33(1.17); C76(1.12); C170(0.94)  LDD0078 
AN1-type zinc finger protein 6 (ZFAND6) LDTP07386 C163(1.00); C165(0.89); C170(0.89)  LDD0078 
Anamorsin (CIAPIN1) LDTP07385 C237(1.04); C285(1.02); C288(1.02); C249(1.01)  LDD0078 
Anaphase-promoting complex subunit 15 (ANAPC15) LDTP04845 C24(1.27)  LDD1507 
Anaphase-promoting complex subunit 16 (ANAPC16) LDTP10213 C55(4.73)  LDD3331 
Anaphase-promoting complex subunit 2 (ANAPC2) LDTP13412 C179(1.23); C221(0.97); C224(0.97); C557(0.88)  LDD0078 
Anaphase-promoting complex subunit 4 (ANAPC4) LDTP13411 C7(1.08)  LDD0531 
Anaphase-promoting complex subunit 5 (ANAPC5) LDTP13410 C203(0.89)  LDD0078 
Angio-associated migratory cell protein (AAMP) LDTP05966 C208(1.34); C216(1.04); C220(1.04); C265(1.07)  LDD0531 
Angiogenic factor with G patch and FHA domains 1 (AGGF1) LDTP08812 C494(1.04)  LDD1492 
Angiomotin (AMOT) LDTP06868 C455(1.70); C741(1.40); C1047(1.75)  LDD0080 
Angiomotin-like protein 1 (AMOTL1) LDTP08628 C748(31.89)  LDD0209 
Angiomotin-like protein 2 (AMOTL2) LDTP13878 C558(1.57)  LDD3312 
Angiopoietin-related protein 2 (ANGPTL2) LDTP16228 C70(4.83)  LDD3323 
Angiopoietin-related protein 4 (ANGPTL4) LDTP11442 C49(3.90)  LDD3392 
Anillin (ANLN) LDTP12443 C260(1.31); C309(1.10); C234(1.08); C1117(1.08)  LDD0078 
Ankycorbin (RAI14) LDTP12963 C71(1.81)  LDD3310 
Ankyrin repeat and BTB/POZ domain-containing protein 1 (ABTB1) LDTP10009 C62(0.96)  LDD0078 
Ankyrin repeat and BTB/POZ domain-containing protein 2 (ABTB2) LDTP17757 C56(1.83)  LDD0078 
Ankyrin repeat and BTB/POZ domain-containing protein 3 (ABTB3) LDTP14385 C552(2.66); C554(2.88)  LDD0080 
Ankyrin repeat and EF-hand domain-containing protein 1 (ANKEF1) LDTP16097 C157(2.79)  LDD3365 
Ankyrin repeat and fibronectin type-III domain-containing protein 1 (ANKFN1) LDTP19749 C638(1.76)  LDD2252 
Ankyrin repeat and KH domain-containing protein 1 (ANKHD1) LDTP08573 C873(24.56)  LDD0204 
Ankyrin repeat and LEM domain-containing protein 2 (ANKLE2) LDTP08364 C254(1.10); C176(1.05); C350(0.96); C203(0.94)  LDD0078 
Ankyrin repeat and MYND domain-containing protein 2 (ANKMY2) LDTP17620 C341(0.92); C345(0.92); C227(0.91)  LDD0078 
Ankyrin repeat and SAM domain-containing protein 1A (ANKS1A) LDTP09828 C849(1.15); C866(1.15); C114(1.04); C651(1.03)  LDD0078 
Ankyrin repeat and SAM domain-containing protein 3 (ANKS3) LDTP07862 C519(2.24)  LDD3318 
Ankyrin repeat and SAM domain-containing protein 6 (ANKS6) LDTP07325 C268(0.76)  LDD1507 
Ankyrin repeat and SOCS box protein 1 (ASB1) LDTP14096 C93(5.01)  LDD0204 
Ankyrin repeat and SOCS box protein 13 (ASB13) LDTP09712 C231(0.62)  LDD0532 
Ankyrin repeat and SOCS box protein 3 (ASB3) LDTP14095 C274(50.44)  LDD0209 
Ankyrin repeat and SOCS box protein 6 (ASB6) LDTP12741 C308(0.98); C313(0.98)  LDD0078 
Ankyrin repeat and SOCS box protein 8 (ASB8) LDTP18405 C133(1.77)  LDD3487 
Ankyrin repeat and SOCS box protein 9 (ASB9) LDTP10234 C175(1.22)  LDD3310 
Ankyrin repeat and sterile alpha motif domain-containing protein 1B (ANKS1B) LDTP08118 C965(3.20)  LDD3314 
Ankyrin repeat domain-containing protein 10 (ANKRD10) LDTP12787 C73(6.53)  LDD0209 
Ankyrin repeat domain-containing protein 11 (ANKRD11) LDTP07653 C477(1.16); C501(1.16)  LDD0078 
Ankyrin repeat domain-containing protein 12 (ANKRD12) LDTP07652 C1436(1.01); C1452(1.01); C1310(0.89); C1317(0.89)  LDD0078 
Ankyrin repeat domain-containing protein 13A (ANKRD13A) LDTP08682 C141(0.98); C146(0.98)  LDD0531 
Ankyrin repeat domain-containing protein 13B (ANKRD13B) LDTP08405 C473(1.49)  LDD0812 
Ankyrin repeat domain-containing protein 13C (ANKRD13C) LDTP08949 C249(0.84)  LDD1507 
Ankyrin repeat domain-containing protein 13D (ANKRD13D) LDTP07835 C160(10.09)  LDD0209 
Ankyrin repeat domain-containing protein 16 (ANKRD16) LDTP17380 C32(0.98); C43(0.98)  LDD0078 
Ankyrin repeat domain-containing protein 17 (ANKRD17) LDTP01155 C242(1.25); C644(1.12); C58(1.00)  LDD0078 
Ankyrin repeat domain-containing protein 22 (ANKRD22) LDTP19453 C76(1.79)  LDD2280 
Ankyrin repeat domain-containing protein 26 (ANKRD26) LDTP13715 C1106(0.92); C462(1.08)  LDD1492 
Ankyrin repeat domain-containing protein 27 (ANKRD27) LDTP10639 C431(0.99); C435(0.99); C440(0.99)  LDD0078 
Ankyrin repeat domain-containing protein 36C (ANKRD36C) LDTP17181 C433(2.24)  LDD3410 
Ankyrin repeat domain-containing protein 39 (ANKRD39) LDTP19320 C173(1.01)  LDD0531 
Ankyrin repeat domain-containing protein 40 (ANKRD40) LDTP17314 C209(1.32); C358(1.42)  LDD0531 
Ankyrin repeat domain-containing protein 46 (ANKRD46) LDTP08320 C104(0.84)  LDD3312 
Ankyrin repeat domain-containing protein 54 (ANKRD54) LDTP15104 C265(1.16); C230(0.85)  LDD0078 
Ankyrin repeat domain-containing protein 66 (ANKRD66) LDTP18929 C180(0.91)  LDD1492 
Ankyrin repeat domain-containing protein 9 (ANKRD9) LDTP10130 C109(1.08); C110(1.08)  LDD0532 
Ankyrin repeat domain-containing protein SOWAHB (SOWAHB) LDTP16608 C187(2.29)  LDD3367 
Ankyrin repeat domain-containing protein SOWAHC (SOWAHC) LDTP19319 C84(1.47); C221(1.16)  LDD0078 
Annexin A10 (ANXA10) LDTP18536 C184(0.60)  LDD3345 
Annexin A13 (ANXA13) LDTP03383 C155(1.15)  LDD2379 
Annexin A3 (ANXA3) LDTP02620 C202(1.14)  LDD0531 
Annexin A4 (ANXA4) LDTP02354 C198(0.87)  LDD0531 
Annexin A7 (ANXA7) LDTP03030 C363(0.88)  LDD0078 
Annexin A8-like protein 1 (ANXA8L1) LDTP17262 C99(1.47)  LDD3331 
Annexin A9 (ANXA9) LDTP01381 C301(1.57); C151(2.61)  LDD3312 
Anthrax toxin receptor 1 (ANTXR1) LDTP12004 C177(1.93)  LDD3430 
Antileukoproteinase (SLPI) LDTP01994 C43(1.59)  LDD3337 
Antithrombin-III (SERPINC1) LDTP01810 C160(1.73)  LDD0531 
AP-1 complex subunit gamma-like 2 (AP1G2) LDTP01327 C539(1.25); C555(0.84)  LDD0531 
AP-1 complex subunit mu-2 (AP1M2) LDTP14286 C253(2.84)  LDD3310 
AP-1 complex subunit sigma-2 (AP1S2) LDTP04739 C88(4.08)  LDD3310 
AP-1 complex-associated regulatory protein (AP1AR) LDTP07284 C188(2.15)  LDD3337 
AP-3 complex subunit beta-1 (AP3B1) LDTP00212 C893(1.04)  LDD0078 
AP-3 complex subunit beta-2 (AP3B2) LDTP05843 C973(1.90); C994(1.30)  LDD3340 
AP-3 complex subunit mu-1 (AP3M1) LDTP13908 C10(1.79)  LDD0080 
AP-3 complex subunit mu-2 (AP3M2) LDTP04579 C29(0.96)  LDD0531 
AP-3 complex subunit sigma-1 (AP3S1) LDTP09804 C100(0.73); C105(0.73); C47(1.04)  LDD0531 
AP-4 complex accessory subunit RUSC1 (RUSC1) LDTP11296 C532(0.65)  LDD1492 
AP-5 complex subunit beta-1 (AP5B1) LDTP14896 C800(37.72)  LDD0209 
AP-5 complex subunit mu-1 (AP5M1) LDTP11725 C18(0.94)  LDD0531 
AP-5 complex subunit sigma-1 (AP5S1) LDTP12643 C21(50.34)  LDD0209 
AP-5 complex subunit zeta-1 (AP5Z1) LDTP00735 C775(1.15); C546(0.92)  LDD0078 
APC membrane recruitment protein 1 (AMER1) LDTP07009 C67(1.62)  LDD3364 
APC membrane recruitment protein 2 (AMER2) LDTP08966 C26(1.63); C594(1.79)  LDD3423 
Apical junction component 1 homolog (AJM1) LDTP16738 C726(2.27)  LDD2469 
APOBEC1 complementation factor (A1CF) LDTP12408 C64(9.47)  LDD3380 
Apolipoprotein B receptor (APOBR) LDTP05611 C149(1.24); C129(2.16); C853(0.64)  LDD3333 
Apolipoprotein D (APOD) LDTP02073 C185(1.97)  LDD3395 
Apolipoprotein L domain-containing protein 1 (APOLD1) LDTP15774 C258(2.87)  LDD2329 
Apolipoprotein L3 (APOL3) LDTP01536 C399(1.92)  LDD3310 
Apoptosis inhibitor 5 (API5) LDTP11575 C234(1.32); C297(1.03)  LDD0531 
Apoptosis regulatory protein Siva (SIVA1) LDTP00605 C135(2.43); C138(2.43); C127(2.19); C130(2.19)  LDD0080 
Apoptosis-associated speck-like protein containing a CARD (PYCARD) LDTP13597 C173(0.96)  LDD3323 
Apoptosis-stimulating of p53 protein 1 (PPP1R13B) LDTP10516 C1005(1.21)  LDD0812 
Apoptosis-stimulating of p53 protein 2 (TP53BP2) LDTP05952 C960(1.55)  LDD3467 
ARF GTPase-activating protein GIT1 (GIT1) LDTP13926 C222(1.64)  LDD3312 
ARF GTPase-activating protein GIT2 (GIT2) LDTP06063 C11(1.67); C14(1.67)  LDD0080 
Arf-GAP domain and FG repeat-containing protein 1 (AGFG1) LDTP04513 C89(1.45)  LDD3314 
Arf-GAP domain and FG repeat-containing protein 2 (AGFG2) LDTP16839 C47(1.10); C50(1.10); C30(1.01); C39(0.92)  LDD0078 
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (ACAP1) LDTP06285 C320(2.37); C338(2.78)  LDD3334 
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (ACAP2) LDTP06302 C53(4.69)  LDD0204 
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 (ACAP3) LDTP15800 C68(0.85); C77(0.85)  LDD0078 
Arf-GAP with dual PH domain-containing protein 1 (ADAP1) LDTP01293 C29(2.25)  LDD3314 
Arf-GAP with dual PH domain-containing protein 2 (ADAP2) LDTP12357 C282(1.13)  LDD0593 
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP1) LDTP13706 C817(0.48); C826(0.48); C243(1.04); C417(1.01)  LDD0531 
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11 (AGAP11) LDTP18071 C777(4.08)  LDD3310 
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 (AGAP2) LDTP10876 C1139(0.94); C1148(0.94)  LDD0532 
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 (AGAP3) LDTP10656 C71(4.05)  LDD3310 
Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (ARAP1) LDTP10657 C900(1.25); C1310(1.13); C123(0.87); C128(0.87)  LDD0078 
Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (ARAP3) LDTP09657 C1022(0.94)  LDD0078 
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (ASAP1) LDTP13547 C560(3.94)  LDD3310 
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (ASAP2) LDTP00688 C669(14.52)  LDD0204 
Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 (ASAP3) LDTP09467 C556(0.91)  LDD0531 
Arginine/serine-rich coiled-coil protein 2 (RSRC2) LDTP07954 C382(0.92)  LDD1492 
ARL14 effector protein (ARL14EP) LDTP08983 C75(2.20); C76(2.20)  LDD0080 
Armadillo repeat-containing protein 1 (ARMC1) LDTP12692 C69(9.87)  LDD0209 
Armadillo repeat-containing protein 10 (ARMC10) LDTP08793 C59(1.60)  LDD0078 
Armadillo repeat-containing protein 5 (ARMC5) LDTP10156 C894(7.72)  LDD0209 
Armadillo repeat-containing protein 6 (ARMC6) LDTP15101 C435(1.09); C471(0.86)  LDD0078 
Armadillo repeat-containing protein 7 (ARMC7) LDTP11986 C168(0.90)  LDD0531 
Armadillo repeat-containing protein 8 (ARMC8) LDTP08466 C259(0.92); C264(0.92)  LDD0078 
Armadillo repeat-containing X-linked protein 1 (ARMCX1) LDTP16174 C144(2.75)  LDD3310 
Armadillo repeat-containing X-linked protein 3 (ARMCX3) LDTP16196 C52(2.06)  LDD0080 
Armadillo repeat-containing X-linked protein 4 (ARMCX4) LDTP17174 C279(1.93)  LDD3310 
Armadillo repeat-containing X-linked protein 5 (ARMCX5) LDTP19497 C458(1.12)  LDD0531 
Armadillo-like helical domain-containing protein 3 (ARMH3) LDTP15002 C105(0.79); C80(0.97); C85(1.07)  LDD0531 
Arpin (ARPIN) LDTP08127 C183(2.94)  LDD3493 
Aryl-hydrocarbon-interacting protein-like 1 (AIPL1) LDTP12926 C207(1.19)  LDD3344 
Ashwin (C2orf49) LDTP15896 C48(4.73)  LDD3342 
Asialoglycoprotein receptor 1 (ASGR1) LDTP02191 C277(2.14)  LDD3424 
Asparagine synthetase domain-containing protein 1 (ASNSD1) LDTP18479 C378(2.13)  LDD0080 
Astrotactin-2 (ASTN2) LDTP01132 C694(1.51)  LDD2253 
Ataxin-1 (ATXN1) LDTP04605 C673(0.45)  LDD2236 
Ataxin-1-like (ATXN1L) LDTP02400 C305(1.13)  LDD3332 
Ataxin-10 (ATXN10) LDTP13091 C354(1.08); C356(1.08); C283(0.94); C95(0.92)  LDD0078 
Ataxin-2 (ATXN2) LDTP10947 C892(1.26); C332(0.87)  LDD0078 
Ataxin-2-like protein (ATXN2L) LDTP09655 C135(3.21)  LDD3312 
Ataxin-7 (ATXN7) LDTP00595 C839(3.08)  LDD3416 
Ataxin-7-like protein 1 (ATXN7L1) LDTP16237 C193(1.00)  LDD1492 
Ataxin-7-like protein 2 (ATXN7L2) LDTP19398 C687(1.10); C697(1.10); C126(1.09); C136(1.09)  LDD0078 
Ataxin-7-like protein 3 (ATXN7L3) LDTP06261 C226(5.13)  LDD0205 
Ataxin-7-like protein 3B (ATXN7L3B) LDTP15730 C75(1.13)  LDD0078 
ATP synthase mitochondrial F1 complex assembly factor 1 (ATPAF1) LDTP17240 C321(1.71)  LDD0080 
ATP synthase mitochondrial F1 complex assembly factor 2 (ATPAF2) LDTP08903 C141(1.21)  LDD0531 
ATPase SWSAP1 (SWSAP1) LDTP07481 C166(0.88)  LDD0531 
ATR-interacting protein (ATRIP) LDTP09691 C585(1.12); C680(1.04); C682(1.04)  LDD0078 
Atrial natriuretic peptide receptor 3 (NPR3) LDTP02895 C136(2.73); C473(4.71)  LDD3365 
Atrophin-1 (ATN1) LDTP04607 C777(2.51)  LDD3342 
Autism susceptibility gene 2 protein (AUTS2) LDTP09722 C299(0.92)  LDD1492 
Autophagy protein 5 (ATG5) LDTP11780 C19(0.86)  LDD0532 
Axin interactor, dorsalization-associated protein (AIDA) LDTP10128 C69(1.47)  LDD3310 
Axin-1 (AXIN1) LDTP00561 C451(1.02); C456(1.02)  LDD0078 
Axin-2 (AXIN2) LDTP13907 C716(0.96)  LDD0531 
Axonemal dynein light intermediate polypeptide 1 (DNALI1) LDTP00393 C121(2.27)  LDD3439 
B-cell CLL/lymphoma 7 protein family member A (BCL7A) LDTP14936 C71(1.05)  LDD1492 
B-cell CLL/lymphoma 7 protein family member B (BCL7B) LDTP11077 C189(3.51)  LDD3320 
B-cell CLL/lymphoma 7 protein family member C (BCL7C) LDTP15627 C211(1.63)  LDD3337 
B-cell CLL/lymphoma 9 protein (BCL9) LDTP00301 C125(1.64)  LDD3332 
B-cell CLL/lymphoma 9-like protein (BCL9L) LDTP08250 C68(3.35)  LDD3373 
B-cell linker protein (BLNK) LDTP09595 C271(1.08)  LDD3339 
B-cell lymphoma/leukemia 10 (BCL10) LDTP01742 C119(1.20); C122(1.20); C57(1.11)  LDD0078 
B-cell scaffold protein with ankyrin repeats (BANK1) LDTP09120 C18(4.54)  LDD3372 
B9 domain-containing protein 1 (B9D1) LDTP13697 C33(0.91)  LDD1576 
Baculoviral IAP repeat-containing protein 1 (NAIP) LDTP05739 C576(2.13)  LDD2324 
Baculoviral IAP repeat-containing protein 5 (BIRC5) LDTP00627 C84(0.90); C60(1.03); C31(0.89)  LDD1492 
BAG family molecular chaperone regulator 1 (BAG1) LDTP11008 C272(0.85); C213(0.85)  LDD0078 
BAG family molecular chaperone regulator 2 (BAG2) LDTP01683 C162(0.67)  LDD0531 
BAG family molecular chaperone regulator 3 (BAG3) LDTP01684 C151(1.06); C179(0.97)  LDD0078 
BAG family molecular chaperone regulator 4 (BAG4) LDTP01600 C193(1.03)  LDD0532 
BAG family molecular chaperone regulator 5 (BAG5) LDTP13507 C191(8.06)  LDD0205 
Band 4.1-like protein 1 (EPB41L1) LDTP11923 C143(1.35)  LDD0531 
Band 4.1-like protein 2 (EPB41L2) LDTP00778 C232(1.03); C424(0.92)  LDD0078 
Band 4.1-like protein 3 (EPB41L3) LDTP13877 C480(1.80)  LDD3310 
Band 4.1-like protein 4A (EPB41L4A) LDTP18446 C605(1.47)  LDD3323 
Band 4.1-like protein 4B (EPB41L4B) LDTP11860 C437(0.99)  LDD0531 
Band 4.1-like protein 5 (EPB41L5) LDTP12257 C357(1.52)  LDD3311 
Bardet-Biedl syndrome 10 protein (BBS10) LDTP09304 C110(0.98)  LDD1492 
Barrier-to-autointegration factor (BANF1) LDTP01250 C77(0.58); C80(0.68)  LDD0532 
BCAS3 microtubule associated cell migration factor (BCAS3) LDTP12001 C139(1.73)  LDD3323 
Bcl-2-associated transcription factor 1 (BCLAF1) LDTP12826 C688(0.82)  LDD0531 
Bcl-2-binding component 3, isoforms 1/2 (BBC3) LDTP11376 C37(0.87)  LDD1507 
Bcl-2-like protein 12 (BCL2L12) LDTP16031 C137(0.88); C140(0.88)  LDD0078 
Bcl-2-like protein 13 (BCL2L13) LDTP11389 C139(2.50)  LDD3383 
Bcl-2-modifying factor (BMF) LDTP10545 C139(2.62)  LDD3377 
Bcl-2-related protein A1 (BCL2A1) LDTP06550 C55(2.19)  LDD3419 
BCL-6 corepressor (BCOR) LDTP07738 C23(2.92); C1010(2.08); C1016(2.08); C94(2.50)  LDD0080 
BCL-6 corepressor-like protein 1 (BCORL1) LDTP06979 C1694(1.29)  LDD3312 
BCLAF1 and THRAP3 family member 3 (BCLAF3) LDTP16561 C324(2.17)  LDD0080 
BEN domain-containing protein 4 (BEND4) LDTP17494 C184(0.69)  LDD1507 
BEN domain-containing protein 7 (BEND7) LDTP08969 C317(4.17)  LDD3353 
BET1 homolog (BET1) LDTP00555 C28(1.73)  LDD0080 
Beta-1-syntrophin (SNTB1) LDTP05997 C69(1.14)  LDD1508 
Beta-2-glycoprotein 1 (APOH) LDTP01955 C300(5.94)  LDD3310 
Beta-2-syntrophin (SNTB2) LDTP05864 C391(1.21); C362(1.18)  LDD0078 
Beta-actin-like protein 2 (ACTBL2) LDTP14951 C425(1.73)  LDD3311 
Beta-catenin-like protein 1 (CTNNBL1) LDTP09733 C408(0.87)  LDD0531 
Beta-centractin (ACTR1B) LDTP03963 C222(0.85)  LDD0078 
Beta-chimaerin (CHN2) LDTP04528 C91(2.39)  LDD3378 
Beta-crystallin B1 (CRYBB1) LDTP04577 C80(1.49)  LDD3411 
Beta-microseminoprotein (MSMB) LDTP02245 C107(2.71)  LDD3380 
Beta-sarcoglycan (SGCB) LDTP06565 C307(1.38); C314(1.38)  LDD0531 
Beta-soluble NSF attachment protein (NAPB) LDTP11744 C42(0.99)  LDD0532 
Beta-taxilin (TXLNB) LDTP08838 C432(7.30)  LDD3344 
Beta/gamma crystallin domain-containing protein 1 (CRYBG1) LDTP16284 C976(1.28); C481(1.03); C491(1.03); C541(0.87)  LDD0078 
Beta/gamma crystallin domain-containing protein 2 (CRYBG2) LDTP19682 C1567(2.11)  LDD3320 
BH3-interacting domain death agonist (BID) LDTP04722 C15(0.96)  LDD1492 
BICD family-like cargo adapter 2 (BICDL2) LDTP14329 C185(1.99)  LDD3439 
Bifunctional apoptosis regulator (BFAR) LDTP12936 C70(0.88); C73(0.88)  LDD0532 
Bifunctional purine biosynthesis protein ATIC (ATIC) LDTP03612 C287(2.46); C101(1.17)  LDD0080 
Biglycan (BGN) LDTP03134 C321(4.62)  LDD3342 
Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC1S1) LDTP05138 C61(0.74)  LDD1492 
Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC1S2) LDTP07625 C41(2.59)  LDD0080 
Biogenesis of lysosome-related organelles complex 1 subunit 3 (BLOC1S3) LDTP07624 C180(0.99)  LDD0078 
Biogenesis of lysosome-related organelles complex 1 subunit 4 (BLOC1S4) LDTP16100 C210(0.96); C211(0.96)  LDD0078 
Biogenesis of lysosome-related organelles complex 1 subunit 5 (BLOC1S5) LDTP09435 C117(1.17)  LDD0078 
Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC1S6) LDTP13518 C95(19.53)  LDD0209 
Biorientation of chromosomes in cell division protein 1-like 1 (BOD1L1) LDTP09196 C2570(1.13); C1947(1.05)  LDD0078 
BLOC-1-related complex subunit 5 (BORCS5) LDTP10006 C93(0.98)  LDD0532 
BLOC-1-related complex subunit 6 (BORCS6) LDTP10361 C176(1.09)  LDD0078 
BLOC-1-related complex subunit 7 (BORCS7) LDTP18126 C28(1.62)  LDD3310 
BLOC-1-related complex subunit 8 (BORCS8) LDTP15722 C71(1.22)  LDD1508 
BLOC-2 complex member HPS3 (HPS3) LDTP09994 C417(1.25); C425(1.25); C707(1.02); C39(0.96)  LDD0078 
BLOC-2 complex member HPS5 (HPS5) LDTP13737 C579(1.10); C588(1.10)  LDD0078 
BLOC-2 complex member HPS6 (HPS6) LDTP08420 C162(1.13); C164(1.13); C692(0.93); C408(0.87)  LDD0078 
BLOC-3 complex member HPS1 (HPS1) LDTP09922 C180(11.78); C165(14.88)  LDD0209 
BLOC-3 complex member HPS4 (HPS4) LDTP12419 C547(156.21)  LDD0209 
bMERB domain-containing protein 1 (BMERB1) LDTP18204 C84(2.45)  LDD3401 
BMP-binding endothelial regulator protein (BMPER) LDTP08985 C560(0.95)  LDD1509 
BolA-like protein 1 (BOLA1) LDTP13988 C18(0.91); C20(0.91)  LDD0078 
BolA-like protein 2 (BOLA2; BOLA2B) LDTP11870 C59(1.39)  LDD0080 
BolA-like protein 3 (BOLA3) LDTP06921 C59(1.00)  LDD0078 
Bombesin receptor-activated protein C6orf89 (C6orf89) LDTP07681 C110(1.33); C47(1.46)  LDD3310 
Bone marrow proteoglycan (PRG2) LDTP02687 C147(2.55); C220(1.94); C125(3.18)  LDD3333 
Bone morphogenetic protein 6 (BMP6) LDTP03149 C262(0.94)  LDD1508 
Borealin (CDCA8) LDTP06915 C273(5.79)  LDD0209 
Box C/D snoRNA protein 1 (ZNHIT6) LDTP12718 C254(0.99); C220(0.89); C223(0.89)  LDD0078 
Brain-enriched guanylate kinase-associated protein (BEGAIN) LDTP11236 C124(0.90); C133(0.90)  LDD0533 
Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2) LDTP13755 C195(0.94); C230(0.93)  LDD0531 
Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAIAP2L1) LDTP13304 C182(0.98); C194(0.85)  LDD0078 
Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2 (BAIAP2L2) LDTP07720 C252(4.85)  LDD3389 
BRCA1-A complex subunit Abraxas 1 (ABRAXAS1) LDTP07686 C186(1.00)  LDD0531 
BRCA1-A complex subunit RAP80 (UIMC1) LDTP10767 C298(2.43); C601(1.89); C661(1.86); C691(1.44)  LDD0080 
BRCA1-associated ATM activator 1 (BRAT1) LDTP07598 C513(1.17); C246(1.12); C487(1.12); C228(1.08)  LDD0078 
BRCA2 and CDKN1A-interacting protein (BCCIP) LDTP13030 C275(1.05)  LDD0078 
BRD4-interacting chromatin-remodeling complex-associated protein (BICRA) LDTP12918 C1083(0.94)  LDD0078 
BRD4-interacting chromatin-remodeling complex-associated protein-like (BICRAL) LDTP07352 C776(7.49)  LDD0209 
Break repair meiotic recombinase recruitment factor 1 (BRME1) LDTP05613 C79(0.95)  LDD1507 
Breast cancer anti-estrogen resistance protein 1 (BCAR1) LDTP04769 C628(2.55)  LDD3342 
Breast cancer anti-estrogen resistance protein 3 (BCAR3) LDTP01316 C400(0.67); C408(0.67); C561(0.98); C737(0.98)  LDD0531 
Breast cancer metastasis-suppressor 1 (BRMS1) LDTP12274 C126(1.18); C136(1.11)  LDD0531 
Breast cancer metastasis-suppressor 1-like protein (BRMS1L) LDTP07043 C275(1.86)  LDD0080 
Breast cancer type 2 susceptibility protein (BRCA2) LDTP04430 C1948(0.93); C1958(0.93)  LDD0078 
Breast carcinoma-amplified sequence 1 (BCAS1) LDTP14492 C471(1.52)  LDD3389 
Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) LDTP14238 C88(2.35); C1524(3.00); C1526(3.00); C486(1.81)  LDD0080 
Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (ARFGEF2) LDTP14237 C76(4.83); C437(13.75); C995(7.13); C573(73.25)  LDD0209 
Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF3) LDTP15021 C868(30.09)  LDD0209 
Bridge-like lipid transfer protein family member 2 (BLTP2) LDTP06172 C1979(1.11); C471(0.95); C538(0.94); C541(0.94)  LDD0078 
Bridging integrator 2 (BIN2) LDTP13168 C205(3.63)  LDD3370 
BRISC and BRCA1-A complex member 1 (BABAM1) LDTP12737 C222(6.92)  LDD0209 
BRISC and BRCA1-A complex member 2 (BABAM2) LDTP12788 C129(2.99); C34(3.66)  LDD3310 
BRISC complex subunit Abraxas 2 (ABRAXAS2) LDTP06278 C237(3.42)  LDD3314 
BRO1 domain-containing protein BROX (BROX) LDTP07234 C52(1.98)  LDD3312 
Bromo adjacent homology domain-containing 1 protein (BAHD1) LDTP09340 C535(1.99)  LDD3312 
Bromodomain adjacent to zinc finger domain protein 1A (BAZ1A) LDTP12518 C547(1.43); C1166(1.40); C1169(1.40); C27(1.09)  LDD0078 
Bromodomain adjacent to zinc finger domain protein 2A (BAZ2A) LDTP13343 C583(1.08); C1694(0.99); C1697(0.99); C1701(0.96)  LDD0078 
Bromodomain adjacent to zinc finger domain protein 2B (BAZ2B) LDTP13342 C1956(0.95); C1960(0.95)  LDD0078 
Bromodomain and WD repeat-containing protein 1 (BRWD1) LDTP12589 C1070(2.32)  LDD0080 
Bromodomain and WD repeat-containing protein 3 (BRWD3) LDTP07630 C31(2.75)  LDD3319 
Bromodomain testis-specific protein (BRDT) LDTP06939 C587(1.05)  LDD3312 
Bromodomain-containing protein 2 (BRD2) LDTP03322 C741(0.95)  LDD3313 
Bromodomain-containing protein 3 (BRD3) LDTP06304 C429(2.51)  LDD3310 
Bromodomain-containing protein 4 (BRD4) LDTP01074 C356(0.95); C674(0.87)  LDD0531 
Bromodomain-containing protein 7 (BRD7) LDTP12369 C107(7.30)  LDD0209 
Bromodomain-containing protein 8 (BRD8) LDTP11705 C26(2.75)  LDD3310 
Bromodomain-containing protein 9 (BRD9) LDTP12059 C279(1.58); C288(1.58)  LDD1093 
BSD domain-containing protein 1 (BSDC1) LDTP16116 C99(1.02)  LDD1492 
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (TNFAIP1) LDTP05989 C31(1.57)  LDD3320 
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (KCTD10) LDTP11864 C138(1.06)  LDD0531 
BTB/POZ domain-containing protein 10 (BTBD10) LDTP15875 C143(1.53)  LDD0080 
BTB/POZ domain-containing protein 7 (BTBD7) LDTP16168 C141(0.75); C152(0.75)  LDD1164 
BTB/POZ domain-containing protein 8 (BTBD8) LDTP07273 C21(0.92); C4(0.92)  LDD0078 
BTB/POZ domain-containing protein 9 (BTBD9) LDTP10715 C318(1.00)  LDD0531 
BTB/POZ domain-containing protein KCTD12 (KCTD12) LDTP15705 C50(1.27)  LDD0080 
BTB/POZ domain-containing protein KCTD15 (KCTD15) LDTP10814 C225(1.57)  LDD3343 
BTB/POZ domain-containing protein KCTD17 (KCTD17) LDTP08912 C61(1.06)  LDD3339 
BTB/POZ domain-containing protein KCTD18 (KCTD18) LDTP17390 C385(3.27); C390(3.27)  LDD0080 
BTB/POZ domain-containing protein KCTD20 (KCTD20) LDTP17557 C82(2.74); C369(2.98)  LDD0080 
BTB/POZ domain-containing protein KCTD3 (KCTD3) LDTP16289 C599(1.32)  LDD0078 
BTB/POZ domain-containing protein KCTD4 (KCTD4) LDTP19832 C244(2.22)  LDD3442 
BTB/POZ domain-containing protein KCTD5 (KCTD5) LDTP12791 C28(1.41); C25(1.34)  LDD0080 
BTB/POZ domain-containing protein KCTD6 (KCTD6) LDTP09085 C104(0.85)  LDD1492 
BTB/POZ domain-containing protein KCTD7 (KCTD7) LDTP10594 C277(1.67)  LDD3314 
BTB/POZ domain-containing protein KCTD9 (KCTD9) LDTP07945 C248(0.65); C256(0.78); C257(0.68)  LDD0531 
BUB3-interacting and GLEBS motif-containing protein ZNF207 (ZNF207) LDTP00830 C54(1.27)  LDD3310 
Bystin (BYSL) LDTP06003 C295(8.22); C300(8.22)  LDD0080 
C-Jun-amino-terminal kinase-interacting protein 1 (MAPK8IP1) LDTP13762 C237(1.15)  LDD2171 
C-Jun-amino-terminal kinase-interacting protein 3 (MAPK8IP3) LDTP13717 C664(2.13)  LDD3313 
C-Jun-amino-terminal kinase-interacting protein 4 (SPAG9) LDTP00934 C1155(0.99)  LDD0078 
C-Maf-inducing protein (CMIP) LDTP08620 C40(1.06)  LDD0078 
C-myc promoter-binding protein (DENND4A) LDTP08048 C1561(111.22)  LDD0209 
C-type lectin domain family 11 member A (CLEC11A) LDTP13796 C187(2.10)  LDD3333 
C-type lectin domain family 2 member B (CLEC2B) LDTP15659 C87(1.76)  LDD3335 
C-type lectin domain family 3 member A (CLEC3A) LDTP14500 C78(3.42); C68(3.36); C183(3.42)  LDD2268 
C-type lectin domain family 4 member E (CLEC4E) LDTP13594 C11(0.95)  LDD2552 
C-type mannose receptor 2 (MRC2) LDTP13114 C335(10.10)  LDD0209 
C1q-related factor (C1QL1) LDTP14512 C32(4.52)  LDD3487 
C2 domain-containing protein 2 (C2CD2) LDTP18575 C244(0.98); C253(0.98)  LDD0078 
C2 domain-containing protein 3 (C2CD3) LDTP06835 C1614(1.13)  LDD3323 
C2 domain-containing protein 5 (C2CD5) LDTP08414 C998(1.99)  LDD3310 
C4b-binding protein beta chain (C4BPB) LDTP03087 C202(1.64)  LDD3424 
Cadherin-12 (CDH12) LDTP04697 C699(1.74)  LDD3380 
Cadherin-15 (CDH15) LDTP04699 C333(2.37)  LDD3401 
Cadherin-17 (CDH17) LDTP05673 C340(1.76)  LDD3444 
Cadherin-2 (CDH2) LDTP02977 C703(3.88); C701(3.99); C709(3.99)  LDD0080 
Cadherin-3 (CDH3) LDTP03158 C638(0.90); C556(1.08); C640(0.87); C647(0.84)  LDD0531 
Cadherin-6 (CDH6) LDTP04694 C497(2.04)  LDD3368 
Cadherin-like protein 26 (CDH26) LDTP08595 C232(1.70)  LDD3380 
Calbindin (CALB1) LDTP02128 C43(5.04); C257(3.54)  LDD3342 
Calcineurin B homologous protein 3 (TESC) LDTP10140 C213(1.13)  LDD0532 
Calcineurin subunit B type 1 (PPP3R1) LDTP05042 C154(1.35)  LDD0531 
Calcineurin-binding protein cabin-1 (CABIN1) LDTP14260 C905(20.00); C906(20.00); C756(3.43); C759(3.43)  LDD0080 
Calcipressin-1 (RCAN1) LDTP04589 C83(1.12)  LDD0531 
Calcipressin-2 (RCAN2) LDTP14840 C88(1.27)  LDD3404 
Calcipressin-3 (RCAN3) LDTP13440 C239(1.54)  LDD3332 
Calcitonin gene-related peptide 2 (CALCB) LDTP02472 C83(2.12); C88(2.12)  LDD0080 
Calcium homeostasis endoplasmic reticulum protein (CHERP) LDTP08570 C246(2.21); C69(1.52)  LDD0080 
Calcium uniporter protein, mitochondrial (MCU) LDTP09151 C191(1.68)  LDD3312 
Calcium-binding and coiled-coil domain-containing protein 1 (CALCOCO1) LDTP13007 C57(13.40)  LDD0209 
Calcium-binding and coiled-coil domain-containing protein 2 (CALCOCO2) LDTP05764 C467(1.77)  LDD3315 
Calcium-binding protein 39 (CAB39) LDTP13955 C143(0.70)  LDD0531 
Calcium-binding protein 39-like (CAB39L) LDTP18425 C54(2.47)  LDD3323 
Calcium-dependent secretion activator 1 (CADPS) LDTP13576 C421(3.23); C1275(1.09)  LDD3344 
Calcium-dependent secretion activator 2 (CADPS2) LDTP08259 C218(1.97)  LDD0080 
Calcium-regulated heat-stable protein 1 (CARHSP1) LDTP13916 C112(1.25)  LDD3314 
Calcium-responsive transactivator (SS18L1) LDTP01154 C47(0.91)  LDD0547 
Calcyphosin (CAPS) LDTP06008 C66(1.90)  LDD3321 
Calmegin (CLGN) LDTP00493 C151(2.11)  LDD0080 
Calmin (CLMN) LDTP15754 C445(1.04)  LDD0531 
Calmodulin-like protein 3 (CALML3) LDTP14658 C27(1.71)  LDD3375 
Calmodulin-like protein 4 (CALML4) LDTP18160 C82(1.71)  LDD3364 
Calmodulin-regulated spectrin-associated protein 1 (CAMSAP1) LDTP07126 C1164(6.70)  LDD0209 
Calmodulin-regulated spectrin-associated protein 2 (CAMSAP2) LDTP05579 C1160(1.16); C1161(1.16); C1416(1.07)  LDD0078 
Calmodulin-regulated spectrin-associated protein 3 (CAMSAP3) LDTP13005 C1023(13.88); C1167(33.20)  LDD0209 
Calpain small subunit 1 (CAPNS1) LDTP02047 C144(1.71); C190(1.40)  LDD0080 
Calpain small subunit 2 (CAPNS2) LDTP10528 C156(4.41)  LDD3469 
Calpastatin (CAST) LDTP03079 C328(0.95); C408(0.99); C413(0.98); C661(0.96)  LDD1492 
Calponin-1 (CNN1) LDTP14705 C61(1.35)  LDD3443 
Calponin-2 (CNN2) LDTP10864 C215(2.93)  LDD0080 
Calponin-3 (CNN3) LDTP06383 C173(1.08)  LDD0078 
Calsyntenin-1 (CLSTN1) LDTP01480 C242(0.97)  LDD0547 
Calsyntenin-2 (CLSTN2) LDTP11917 C402(1.18)  LDD1514 
Calsyntenin-3 (CLSTN3) LDTP11096 C99(0.98); C114(0.98); C66(0.86); C242(0.97)  LDD1492 
cAMP-dependent protein kinase type I-alpha regulatory subunit (PRKAR1A) LDTP02511 C18(0.99)  LDD0078 
cAMP-dependent protein kinase type I-beta regulatory subunit (PRKAR1B) LDTP03589 C18(1.04)  LDD0078 
cAMP-dependent protein kinase type II-alpha regulatory subunit (PRKAR2A) LDTP02697 C101(1.27)  LDD0531 
cAMP-dependent protein kinase type II-beta regulatory subunit (PRKAR2B) LDTP03590 C211(5.08)  LDD0209 
Cancer/testis antigen family 45 member A10 (CT45A10) LDTP19134 C22(1.05)  LDD3311 
CAP-Gly domain-containing linker protein 1 (CLIP1) LDTP03553 C1022(0.96)  LDD0531 
CAP-Gly domain-containing linker protein 2 (CLIP2) LDTP13187 C390(1.20)  LDD0531 
CAP-Gly domain-containing linker protein 3 (CLIP3) LDTP10238 C216(2.62)  LDD2469 
CAP-Gly domain-containing linker protein 4 (CLIP4) LDTP08827 C481(4.98)  LDD0209 
Capping protein, Arp2/3 and myosin-I linker protein 2 (CARMIL2) LDTP07382 C1323(1.82); C1339(1.30)  LDD0080 
Capping protein-inhibiting regulator of actin dynamics (CRACD) LDTP07839 C1228(45.21)  LDD0209 
Caprin-1 (CAPRIN1) LDTP06121 C226(1.29)  LDD0531 
Caprin-2 (CAPRIN2) LDTP07415 C923(1.74)  LDD3411 
CapZ-interacting protein (RCSD1) LDTP07434 C181(1.38)  LDD3333 
Carabin (TBC1D10C) LDTP08475 C305(1.14)  LDD3338 
Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (NOS1AP) LDTP01107 C31(1.42)  LDD0080 
Cartilage oligomeric matrix protein (COMP) LDTP04288 C351(1.40); C328(1.25)  LDD0531 
Caskin-1 (CASKIN1) LDTP15644 C156(1.12)  LDD0531 
Caskin-2 (CASKIN2) LDTP18102 C185(1.10)  LDD0531 
CASP8-associated protein 2 (CASP8AP2) LDTP13464 C919(0.93); C925(0.93)  LDD0078 
Caspase activity and apoptosis inhibitor 1 (CAAP1) LDTP18416 C150(1.16); C152(1.16); C226(0.75)  LDD0531 
Caspase recruitment domain-containing protein 10 (CARD10) LDTP11339 C1020(0.97)  LDD0531 
Caspase recruitment domain-containing protein 11 (CARD11) LDTP11391 C150(10.70)  LDD0209 
Caspase recruitment domain-containing protein 14 (CARD14) LDTP11390 C355(0.93)  LDD3348 
Caspase recruitment domain-containing protein 19 (CARD19) LDTP10563 C63(1.60)  LDD3310 
Caspase recruitment domain-containing protein 6 (CARD6) LDTP18323 C975(0.92); C987(0.92)  LDD0078 
Caspase recruitment domain-containing protein 9 (CARD9) LDTP11798 C454(1.72)  LDD3333 
Catenin alpha-1 (CTNNA1) LDTP03711 C526(9.55)  LDD0205 
Catenin alpha-2 (CTNNA2) LDTP03349 C356(1.31)  LDD3311 
Catenin beta-1 (CTNNB1) LDTP03712 C350(1.18); C439(1.09); C466(1.06); C520(0.83)  LDD0531 
Catenin delta-2 (CTNND2) LDTP13754 C1092(2.82)  LDD3332 
Caveolae-associated protein 2 (CAVIN2) LDTP01681 C136(2.08)  LDD3314 
Caveolae-associated protein 4 (CAVIN4) LDTP06951 C141(5.01); C288(2.09)  LDD3401 
CB1 cannabinoid receptor-interacting protein 1 (CNRIP1) LDTP10298 C134(1.20)  LDD1507 
CBY1-interacting BAR domain-containing protein 1 (CIBAR1) LDTP00040 C253(1.13); C263(1.13); C31(0.98)  LDD0531 
CCHC-type zinc finger nucleic acid binding protein (CNBP) LDTP04995 C67(0.96); C74(0.96); C77(0.96)  LDD0078 
CCN family member 1 (CCN1) LDTP00323 C229(1.08); C239(1.08); C314(1.08); C317(0.98)  LDD0078 
CCN family member 2 (CCN2) LDTP03473 C273(0.97); C148(0.88); C228(1.03)  LDD3314 
CCN family member 4 (CCN4) LDTP01579 C101(1.87)  LDD3472 
CCN family member 5 (CCN5) LDTP01395 C39(10.20); C237(4.99); C64(3.03)  LDD2236 
CCR4-NOT transcription complex subunit 1 (CNOT1) LDTP00078 C2359(0.94); C2360(0.94); C1541(0.94); C890(0.89)  LDD0078 
CCR4-NOT transcription complex subunit 10 (CNOT10) LDTP12087 C693(4.06)  LDD3311 
CCR4-NOT transcription complex subunit 11 (CNOT11) LDTP16230 C453(0.94)  LDD1093 
CCR4-NOT transcription complex subunit 2 (CNOT2) LDTP12925 C175(1.68); C504(1.15)  LDD0080 
CCR4-NOT transcription complex subunit 3 (CNOT3) LDTP01153 C643(4.68)  LDD3373 
CCR4-NOT transcription complex subunit 9 (CNOT9) LDTP09813 C99(1.07)  LDD0080 
CD109 antigen (CD109) LDTP07760 C239(1.77)  LDD3312 
CD180 antigen (CD180) LDTP10871 C419(2.83)  LDD3333 
CD2 antigen cytoplasmic tail-binding protein 2 (CD2BP2) LDTP01589 C234(1.71)  LDD3323 
CD302 antigen (CD302) LDTP08581 C217(0.88)  LDD1513 
CD320 antigen (CD320) LDTP12352 C74(1.10); C108(0.92); C116(0.92)  LDD0078 
CD59 glycoprotein (CD59) LDTP02704 C89(2.16)  LDD0080 
CD99 antigen-like protein 2 (CD99L2) LDTP09405 C246(1.74)  LDD3373 
CDAN1-interacting nuclease 1 (CDIN1) LDTP13915 C268(1.86); C277(1.86)  LDD0080 
Cdc42 effector protein 2 (CDC42EP2) LDTP00382 C92(1.08)  LDD0580 
Cdc42 effector protein 3 (CDC42EP3) LDTP13454 C145(1.13)  LDD3325 
Cdc42 effector protein 4 (CDC42EP4) LDTP11878 C313(0.99)  LDD0078 
CDC42 small effector protein 1 (CDC42SE1) LDTP12535 C11(1.02)  LDD1507 
Cdc42-interacting protein 4 (TRIP10) LDTP06430 C99(0.99)  LDD0531 
CDGSH iron-sulfur domain-containing protein 2 (CISD2) LDTP08902 C92(1.71)  LDD0080 
CDGSH iron-sulfur domain-containing protein 3, mitochondrial (CISD3) LDTP02398 C98(3.21); C100(3.21)  LDD0080 
CDK-activating kinase assembly factor MAT1 (MNAT1) LDTP04488 C46(1.53); C49(1.53)  LDD0080 
CDK2-associated and cullin domain-containing protein 1 (CACUL1) LDTP08383 C94(1.11); C362(1.04); C170(0.99); C172(0.99)  LDD0078 
CDK5 and ABL1 enzyme substrate 1 (CABLES1) LDTP09444 C102(0.88); C566(0.88)  LDD0813 
CDK5 and ABL1 enzyme substrate 2 (CABLES2) LDTP18308 C129(1.06); C140(1.06)  LDD0078 
CDK5 regulatory subunit-associated protein 2 (CDK5RAP2) LDTP10818 C528(1.10); C1054(0.95); C1065(0.95); C1697(0.94)  LDD0078 
CDK5 regulatory subunit-associated protein 3 (CDK5RAP3) LDTP10454 C136(2.43)  LDD0080 
Cell cycle and apoptosis regulator protein 2 (CCAR2) LDTP08760 C754(3.61)  LDD3310 
Cell cycle checkpoint protein RAD17 (RAD17) LDTP01363 C326(0.97); C329(0.97)  LDD0078 
Cell cycle progression protein 1 (CCPG1) LDTP13545 C672(3.09)  LDD3377 
Cell cycle regulator of non-homologous end joining (CYREN) LDTP11329 C80(1.93)  LDD3369 
Cell death regulator Aven (AVEN) LDTP16066 C169(1.09); C251(0.96)  LDD0078 
Cell death-inducing p53-target protein 1 (CDIP1) LDTP11853 C197(1.05)  LDD1509 
Cell division control protein 45 homolog (CDC45) LDTP01213 C479(702.25)  LDD0209 
Cell division control protein 6 homolog (CDC6) LDTP10967 C156(0.72)  LDD0531 
Cell division cycle-associated 7-like protein (CDCA7L) LDTP10355 C422(1.17); C372(1.15); C373(1.15)  LDD0078 
Cell division cycle-associated protein 2 (CDCA2) LDTP07345 C315(1.35); C790(1.13); C792(1.13); C660(0.96)  LDD0078 
Cell division cycle-associated protein 4 (CDCA4) LDTP11392 C102(0.81); C207(1.28); C224(1.28)  LDD0531 
Cell division cycle-associated protein 7 (CDCA7) LDTP11337 C418(3.76)  LDD3352 
Cell growth regulator with RING finger domain protein 1 (CGRRF1) LDTP10938 C295(1.25); C298(1.25)  LDD0531 
Cellular retinoic acid-binding protein 2 (CRABP2) LDTP03482 C82(0.95)  LDD0531 
Centlein (CNTLN) LDTP12779 C119(1.08)  LDD3373 
Centriolar coiled-coil protein of 110 kDa (CCP110) LDTP00737 C436(1.89)  LDD3325 
Centriole and centriolar satellite protein OFD1 (OFD1) LDTP01286 C503(0.94)  LDD0531 
Centriolin (CNTRL) LDTP08139 C639(1.37)  LDD0080 
Centrobin (CNTROB) LDTP08749 C533(2.40)  LDD3421 
Centromere protein C (CENPC) LDTP05399 C800(1.01)  LDD0547 
Centromere protein F (CENPF) LDTP04258 C2560(1.14); C1767(1.13); C2415(1.01); C1055(0.99)  LDD0078 
Centromere protein H (CENPH) LDTP11883 C35(1.17)  LDD0078 
Centromere protein I (CENPI) LDTP09839 C450(1.05)  LDD0078 
Centromere protein J (CENPJ) LDTP12220 C506(1.01); C510(1.01); C514(1.01)  LDD0078 
Centromere protein K (CENPK) LDTP11143 C28(1.86)  LDD0080 
Centromere protein L (CENPL) LDTP15388 C52(0.96)  LDD1492 
Centromere protein M (CENPM) LDTP16090 C40(4.11)  LDD0209 
Centromere protein N (CENPN) LDTP10373 C325(0.98)  LDD1492 
Centromere protein O (CENPO) LDTP11222 C234(1.16)  LDD0080 
Centromere protein P (CENPP) LDTP07419 C204(1.27)  LDD0080 
Centromere protein Q (CENPQ) LDTP07950 C121(4.52)  LDD3403 
Centromere protein R (ITGB3BP) LDTP05837 C127(0.93)  LDD1511 
Centromere protein S (CENPS) LDTP08810 C58(5.19)  LDD3341 
Centromere protein T (CENPT) LDTP10141 C550(2.68)  LDD3375 
Centromere protein U (CENPU) LDTP07900 C38(1.71)  LDD3315 
Centromere protein V (CENPV) LDTP08155 C152(1.08); C154(1.08); C216(0.94)  LDD0078 
Centromere protein V-like protein 1 (CENPVL1) LDTP18633 C154(1.18)  LDD3333 
Centromere protein V-like protein 2 (CENPVL2) LDTP19147 C281(0.67)  LDD3323 
Centromere protein V-like protein 3 (CENPVL3) LDTP18635 C40(2.53); C129(4.14)  LDD3423 
Centromere protein W (CENPW) LDTP06965 C63(1.02)  LDD0531 
Centromere/kinetochore protein zw10 homolog (ZW10) LDTP00720 C124(0.97); C588(0.94)  LDD0078 
Centrosomal AT-AC splicing factor (CENATAC) LDTP08249 C16(13.60)  LDD0209 
Centrosomal protein 43 (CEP43) LDTP01652 C244(1.05)  LDD1492 
Centrosomal protein kizuna (KIZ) LDTP06700 C207(0.90); C217(0.90)  LDD0078 
Centrosomal protein of 104 kDa (CEP104) LDTP00948 C833(1.56)  LDD3380 
Centrosomal protein of 112 kDa (CEP112) LDTP15454 C188(8.71)  LDD3342 
Centrosomal protein of 120 kDa (CEP120) LDTP08992 C572(1.22)  LDD0531 
Centrosomal protein of 126 kDa (CEP126) LDTP13051 C490(2.88)  LDD3439 
Centrosomal protein of 128 kDa (CEP128) LDTP07842 C989(1.21)  LDD0531 
Centrosomal protein of 131 kDa (CEP131) LDTP13699 C159(0.87); C181(1.09); C218(0.82)  LDD0531 
Centrosomal protein of 135 kDa (CEP135) LDTP07295 C473(1.26)  LDD0078 
Centrosomal protein of 152 kDa (CEP152) LDTP01481 C1168(1.01); C1171(1.01); C1390(0.94); C1391(0.94)  LDD0078 
Centrosomal protein of 162 kDa (CEP162) LDTP07173 C427(1.01); C1014(1.11)  LDD1507 
Centrosomal protein of 164 kDa (CEP164) LDTP13723 C781(3.01)  LDD3493 
Centrosomal protein of 170 kDa (CEP170) LDTP07071 C235(1.08); C967(1.01)  LDD0078 
Centrosomal protein of 170 kDa protein B (CEP170B) LDTP16282 C217(4.65)  LDD0080 
Centrosomal protein of 192 kDa (CEP192) LDTP09503 C1126(1.79); C1215(1.25); C1572(0.62); C1586(0.62)  LDD0531 
Centrosomal protein of 290 kDa (CEP290) LDTP00531 C383(1.61)  LDD3342 
Centrosomal protein of 295 kDa (CEP295) LDTP11603 C540(22.63)  LDD0209 
Centrosomal protein of 41 kDa (CEP41) LDTP11501 C171(8.63); C240(1.90)  LDD0080 
Centrosomal protein of 44 kDa (CEP44) LDTP11611 C355(43.71)  LDD0209 
Centrosomal protein of 55 kDa (CEP55) LDTP06886 C236(2.57); C159(2.40); C443(1.85)  LDD0080 
Centrosomal protein of 57 kDa (CEP57) LDTP08372 C252(12.18)  LDD0209 
Centrosomal protein of 63 kDa (CEP63) LDTP10598 C108(4.29)  LDD0209 
Centrosomal protein of 68 kDa (CEP68) LDTP07924 C465(1.00)  LDD1492 
Centrosomal protein of 70 kDa (CEP70) LDTP09257 C138(1.00)  LDD1512 
Centrosomal protein of 72 kDa (CEP72) LDTP13010 C274(27.62)  LDD0209 
Centrosomal protein of 76 kDa (CEP76) LDTP09308 C612(9.36)  LDD0204 
Centrosomal protein of 78 kDa (CEP78) LDTP07013 C670(1.09)  LDD3380 
Centrosomal protein of 85 kDa (CEP85) LDTP07522 C281(1.29); C286(1.29); C49(1.20); C64(1.20)  LDD0078 
Centrosomal protein of 85 kDa-like (CEP85L) LDTP07081 C777(0.92)  LDD1508 
Centrosomal protein of 95 kDa (CEP95) LDTP10347 C678(44.90)  LDD0209 
Centrosomal protein of 97 kDa (CEP97) LDTP08523 C568(5.80)  LDD0209 
Centrosomal protein POC5 (POC5) LDTP09021 C91(3.64)  LDD3487 
Centrosome and spindle pole-associated protein 1 (CSPP1) LDTP06676 C865(0.92)  LDD0533 
Centrosome-associated protein 350 (CEP350) LDTP07211 C2590(1.01)  LDD0078 
Centrosome-associated protein ALMS1 (ALMS1) LDTP09397 C336(1.05); C343(1.05)  LDD0078 
Centrosome-associated protein CEP250 (CEP250) LDTP11270 C2348(1.16)  LDD0531 
Ceramide-1-phosphate transfer protein (CPTP) LDTP07159 C163(37.92)  LDD0209 
Cerebellar degeneration-related protein 2 (CDR2) LDTP05319 C432(39.78)  LDD0209 
Cerebellar degeneration-related protein 2-like (CDR2L) LDTP08346 C160(0.96)  LDD0078 
Cerebral cavernous malformations 2 protein (CCM2) LDTP11166 C191(2.66)  LDD3318 
Cerebral cavernous malformations 2 protein-like (CCM2L) LDTP18468 C117(1.89)  LDD3478 
CGG triplet repeat-binding protein 1 (CGGBP1) LDTP13217 C92(1.09); C43(0.86); C46(0.86)  LDD0078 
Charged multivesicular body protein 1a (CHMP1A) LDTP12285 C44(0.87)  LDD3316 
Charged multivesicular body protein 3 (CHMP3) LDTP13990 C89(2.42)  LDD3314 
Charged multivesicular body protein 5 (CHMP5) LDTP12948 C20(1.01)  LDD0531 
Charged multivesicular body protein 6 (CHMP6) LDTP10324 C110(1.37)  LDD3312 
Charged multivesicular body protein 7 (CHMP7) LDTP09589 C355(1.02)  LDD1507 
Checkpoint protein HUS1 (HUS1) LDTP01085 C44(6.17); C253(9.30)  LDD0209 
Chimeric ERCC6-PGBD3 protein (ERCC6) LDTP02446 C806(1.99)  LDD3323 
Chondroadherin (CHAD) LDTP14445 C326(1.87)  LDD2268 
Chondroadherin-like protein (CHADL) LDTP07469 C396(2.93)  LDD2250 
Chondroitin sulfate proteoglycan 4 (CSPG4) LDTP07659 C1593(1.76)  LDD3311 
Chondroitin sulfate proteoglycan 5 (CSPG5) LDTP01521 C512(1.13)  LDD1492 
Chondrolectin (CHODL) LDTP12103 C31(1.03)  LDD2263 
Chordin (CHRD) LDTP11847 C121(0.90); C125(0.90); C902(0.92); C909(0.92)  LDD2171 
Chordin-like protein 2 (CHRDL2) LDTP07743 C201(3.03)  LDD3356 
Choriogonadotropin subunit beta variant 2 (CGB2) LDTP17358 C150(0.97)  LDD0078 
Chromatin assembly factor 1 subunit A (CHAF1A) LDTP05750 C878(1.25); C207(1.03); C190(1.02); C202(0.94)  LDD0078 
Chromatin assembly factor 1 subunit B (CHAF1B) LDTP05751 C6(1.09); C191(1.01)  LDD0080 
Chromatin complexes subunit BAP18 (BAP18) LDTP08604 C66(0.95)  LDD1492 
Chromatin remodeling regulator CECR2 (CECR2) LDTP11373 C1059(1.51); C1036(1.70)  LDD0080 
Chromobox protein homolog 1 (CBX1) LDTP05189 C156(1.16)  LDD3311 
Chromobox protein homolog 2 (CBX2) LDTP06209 C284(1.05)  LDD0078 
Chromobox protein homolog 3 (CBX3) LDTP05778 C177(1.19)  LDD0078 
Chromobox protein homolog 5 (CBX5) LDTP04073 C133(1.02)  LDD0078 
Chromobox protein homolog 6 (CBX6) LDTP01626 C386(0.99)  LDD1512 
Chromobox protein homolog 7 (CBX7) LDTP01716 C102(1.29); C107(1.29)  LDD2171 
Chromobox protein homolog 8 (CBX8) LDTP12216 C142(0.97); C261(0.97)  LDD0078 
Chromodomain Y-like protein 2 (CDYL2) LDTP15462 C247(2.94)  LDD3345 
Chromosome alignment-maintaining phosphoprotein 1 (CHAMP1) LDTP10476 C194(1.12); C119(0.99)  LDD0078 
Chromosome transmission fidelity protein 18 homolog (CHTF18) LDTP09603 C401(3.29)  LDD3310 
Chromosome transmission fidelity protein 8 homolog (CHTF8) LDTP14611 C83(1.34)  LDD0080 
Cilia- and flagella-associated protein 20 (CFAP20) LDTP14227 C119(1.27)  LDD0531 
Cilia- and flagella-associated protein 251 (CFAP251) LDTP09357 C814(5.45)  LDD3459 
Cilia- and flagella-associated protein 298 (CFAP298) LDTP04781 C83(0.67)  LDD0813 
Cilia- and flagella-associated protein 418 (CFAP418) LDTP10630 C17(1.69)  LDD3310 
Cilia- and flagella-associated protein 46 (CFAP46) LDTP15365 C549(2.68)  LDD3372 
Cilia- and flagella-associated protein 97 (CFAP97) LDTP18513 C504(0.63)  LDD0547 
Cilium assembly protein DZIP1L (DZIP1L) LDTP08681 C379(1.01)  LDD1510 
Cingulin (CGN) LDTP13067 C691(1.22)  LDD3312 
Cingulin-like protein 1 (CGNL1) LDTP05615 C427(1.79)  LDD3313 
Cip1-interacting zinc finger protein (CIZ1) LDTP13579 C524(3.74); C531(3.74)  LDD0080 
Claspin (CLSPN) LDTP12146 C207(1.14); C397(0.93)  LDD0078 
Cleavage and polyadenylation specificity factor subunit 1 (CPSF1) LDTP05626 C1044(1.09); C1126(0.88); C1135(0.88)  LDD0078 
Cleavage and polyadenylation specificity factor subunit 4 (CPSF4) LDTP01644 C41(0.94); C96(0.91)  LDD0078 
Cleavage and polyadenylation specificity factor subunit 6 (CPSF6) LDTP06584 C159(1.13)  LDD3310 
Cleavage and polyadenylation specificity factor subunit 7 (CPSF7) LDTP08922 C442(1.81)  LDD3312 
Cleavage stimulation factor subunit 1 (CSTF1) LDTP14812 C379(2.20); C380(2.20)  LDD0078 
Cleavage stimulation factor subunit 2 (CSTF2) LDTP03665 C150(3.00)  LDD0080 
Cleavage stimulation factor subunit 2 tau variant (CSTF2T) LDTP11718 C441(4.98); C150(149.39)  LDD0209 
Cleavage stimulation factor subunit 3 (CSTF3) LDTP05719 C103(0.85)  LDD0078 
CLIP-associating protein 1 (CLASP1) LDTP08062 C835(1.13)  LDD0078 
CLIP-associating protein 2 (CLASP2) LDTP01129 C633(24.61)  LDD0204 
Clustered mitochondria protein homolog (CLUH) LDTP14486 C1196(1.38); C333(1.09)  LDD0078 
Clusterin (CLU) LDTP02526 C365(2.74)  LDD3373 
Clusterin-associated protein 1 (CLUAP1) LDTP10084 C292(2.53)  LDD3310 
Coactosin-like protein (COTL1) LDTP06024 C52(1.77)  LDD3312 
Coatomer subunit alpha (COPA) LDTP04571 C245(0.96)  LDD0078 
Coatomer subunit beta (COPB1) LDTP04570 C888(1.24); C623(0.98)  LDD0078 
Coatomer subunit beta' (COPB2) LDTP03767 C351(0.88)  LDD0078 
Coatomer subunit delta (ARCN1) LDTP04181 C94(1.48); C441(1.26)  LDD0080 
Coatomer subunit epsilon (COPE) LDTP00376 C212(1.58); C225(1.58)  LDD0080 
Coatomer subunit gamma-1 (COPG1) LDTP14216 C169(1.09); C722(1.01); C726(1.01); C516(1.01)  LDD0078 
Coatomer subunit gamma-2 (COPG2) LDTP13110 C230(1.11)  LDD0078 
Cobalamin trafficking protein CblD (MMADHC) LDTP11871 C212(15.50)  LDD0209 
Codanin-1 (CDAN1) LDTP08572 C1213(2.06)  LDD0080 
Coenzyme Q-binding protein COQ10 homolog A, mitochondrial (COQ10A) LDTP18207 C85(4.81)  LDD3352 
Coenzyme Q-binding protein COQ10 homolog B, mitochondrial (COQ10B) LDTP18417 C108(0.84)  LDD0531 
Cofilin-1 (CFL1) LDTP03244 C39(1.27); C139(1.88)  LDD0080 
Cofilin-2 (CFL2) LDTP13827 C80(1.54)  LDD3310 
Cohesin subunit SA-1 (STAG1) LDTP09614 C179(1.12); C644(1.07); C716(1.07); C776(0.98)  LDD0531 
Cohesin subunit SA-2 (STAG2) LDTP08842 C347(4.80); C535(2.00); C640(2.03)  LDD3311 
Coiled-coil alpha-helical rod protein 1 (CCHCR1) LDTP09417 C724(1.11)  LDD1492 
Coiled-coil and C2 domain-containing protein 1A (CC2D1A) LDTP07513 C252(0.78); C80(0.98)  LDD0531 
Coiled-coil and C2 domain-containing protein 1B (CC2D1B) LDTP07085 C86(1.04)  LDD0078 
Coiled-coil domain-containing protein 102A (CCDC102A) LDTP19844 C214(1.18)  LDD0078 
Coiled-coil domain-containing protein 102B (CCDC102B) LDTP07322 C98(0.88)  LDD0531 
Coiled-coil domain-containing protein 106 (CCDC106) LDTP11320 C108(1.06)  LDD0078 
Coiled-coil domain-containing protein 115 (CCDC115) LDTP10635 C68(0.97)  LDD1492 
Coiled-coil domain-containing protein 117 (CCDC117) LDTP08536 C81(239.02); C81(52.12); C81(31.56)  LDD0209 
Coiled-coil domain-containing protein 120 (CCDC120) LDTP10382 C353(2.58)  LDD3358 
Coiled-coil domain-containing protein 127 (CCDC127) LDTP20361 C174(0.82)  LDD0531 
Coiled-coil domain-containing protein 134 (CCDC134) LDTP11979 C147(1.00)  LDD1509 
Coiled-coil domain-containing protein 138 (CCDC138) LDTP15781 C28(0.98)  LDD0078 
Coiled-coil domain-containing protein 14 (CCDC14) LDTP06829 C826(1.08); C831(1.08); C880(0.97); C886(0.97)  LDD0078 
Coiled-coil domain-containing protein 142 (CCDC142) LDTP19246 C538(1.91)  LDD3410 
Coiled-coil domain-containing protein 177 (CCDC177) LDTP19987 C58(2.11)  LDD3343 
Coiled-coil domain-containing protein 18 (CCDC18) LDTP17238 C430(0.97); C433(0.97); C434(0.97)  LDD0532 
Coiled-coil domain-containing protein 181 (CCDC181) LDTP15023 C301(1.27)  LDD1507 
Coiled-coil domain-containing protein 186 (CCDC186) LDTP17535 C27(1.01); C145(0.94); C618(0.85); C627(0.85)  LDD0078 
Coiled-coil domain-containing protein 25 (CCDC25) LDTP08339 C83(1.01)  LDD0078 
Coiled-coil domain-containing protein 28A (CCDC28A) LDTP15344 C201(1.00)  LDD1492 
Coiled-coil domain-containing protein 28B (CCDC28B) LDTP11244 C114(3.45)  LDD3410 
Coiled-coil domain-containing protein 34 (CCDC34) LDTP10392 C248(1.04)  LDD0531 
Coiled-coil domain-containing protein 50 (CCDC50) LDTP08507 C85(0.67)  LDD3342 
Coiled-coil domain-containing protein 6 (CCDC6) LDTP06515 C319(2.00)  LDD3407 
Coiled-coil domain-containing protein 71 (CCDC71) LDTP19642 C76(1.24)  LDD0531 
Coiled-coil domain-containing protein 71L (CCDC71L) LDTP19760 C104(1.01)  LDD0078 
Coiled-coil domain-containing protein 77 (CCDC77) LDTP18296 C184(1.44)  LDD0080 
Coiled-coil domain-containing protein 8 (CCDC8) LDTP11736 C256(4.08)  LDD3323 
Coiled-coil domain-containing protein 80 (CCDC80) LDTP07922 C771(2.18)  LDD3441 
Coiled-coil domain-containing protein 82 (CCDC82) LDTP17708 C190(61.07)  LDD0209 
Coiled-coil domain-containing protein 85A (CCDC85A) LDTP18236 C265(1.11); C180(0.85)  LDD3364 
Coiled-coil domain-containing protein 85B (CCDC85B) LDTP06488 C82(0.84)  LDD0078 
Coiled-coil domain-containing protein 85C (CCDC85C) LDTP16650 C389(1.16)  LDD0078 
Coiled-coil domain-containing protein 86 (CCDC86) LDTP16005 C127(1.08)  LDD0078 
Coiled-coil domain-containing protein 88B (CCDC88B) LDTP00083 C1222(17.33); C1382(46.37)  LDD0209 
Coiled-coil domain-containing protein 89 (CCDC89) LDTP17760 C197(2.46); C202(2.46)  LDD0080 
Coiled-coil domain-containing protein 9 (CCDC9) LDTP16279 C233(1.08)  LDD0078 
Coiled-coil domain-containing protein 91 (CCDC91) LDTP08114 C424(1.01)  LDD0078 
Coiled-coil domain-containing protein 92 (CCDC92) LDTP06912 C88(1.46)  LDD3367 
Coiled-coil domain-containing protein 97 (CCDC97) LDTP19860 C17(0.96)  LDD0078 
Coiled-coil domain-containing protein 9B (CCDC9B) LDTP17499 C276(0.90)  LDD0078 
Coiled-coil domain-containing protein R3HCC1L (R3HCC1L) LDTP08095 C665(1.77)  LDD0080 
Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (CHCHD10) LDTP09743 C112(7.59); C122(7.59)  LDD0080 
Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (CHCHD2) LDTP14251 C134(4.08); C124(2.45)  LDD0080 
Coiled-coil-helix-coiled-coil-helix domain-containing protein 5 (CHCHD5) LDTP18304 C58(2.55); C68(2.55)  LDD0080 
Coilin (COIL) LDTP03853 C170(1.52); C126(1.08)  LDD0078 
Cold shock domain-containing protein E1 (CSDE1) LDTP01252 C680(1,106.74); C733(433.79); C645(36.86)  LDD0209 
Collagen alpha-1(I) chain (COL1A1) LDTP01924 C1265(1.66)  LDD3310 
Collagen alpha-1(II) chain (COL2A1) LDTP01925 C1289(1.04); C1306(0.90)  LDD1492 
Collagen alpha-1(III) chain (COL3A1) LDTP01926 C1417(1.68)  LDD3323 
Collagen alpha-1(IV) chain (COL4A1) LDTP01927 C31(0.85); C36(0.85)  LDD0078 
Collagen alpha-1(V) chain (COL5A1) LDTP03089 C1645(0.92); C1662(0.92)  LDD0078 
Collagen alpha-1(VI) chain (COL6A1) LDTP02605 C247(0.96); C248(0.96); C252(0.96); C604(0.95)  LDD0078 
Collagen alpha-1(VII) chain (COL7A1) LDTP05351 C2912(1.55); C1048(1.11)  LDD0078 
Collagen alpha-1(XI) chain (COL11A1) LDTP02604 C1815(1.88); C1769(2.55)  LDD3410 
Collagen alpha-1(XII) chain (COL12A1) LDTP10955 C431(2.01)  LDD3318 
Collagen alpha-1(XIII) chain (COL13A1) LDTP07170 C213(2.84)  LDD2367 
Collagen alpha-1(XIV) chain (COL14A1) LDTP05463 C1261(2.90); C973(5.51); C1624(5.62)  LDD3401 
Collagen alpha-1(XIX) chain (COL19A1) LDTP06247 C70(3.05)  LDD3410 
Collagen alpha-1(XV) chain (COL15A1) LDTP03866 C1369(6.84)  LDD3401 
Collagen alpha-1(XVI) chain (COL16A1) LDTP05513 C156(2.27)  LDD3434 
Collagen alpha-1(XVII) chain (COL17A1) LDTP13613 C328(1.77)  LDD2370 
Collagen alpha-1(XVIII) chain (COL18A1) LDTP03867 C1706(1.61)  LDD0602 
Collagen alpha-1(XXI) chain (COL21A1) LDTP10655 C797(2.60)  LDD3318 
Collagen alpha-1(XXV) chain (COL25A1) LDTP11404 C27(0.87)  LDD1492 
Collagen alpha-2(I) chain (COL1A2) LDTP02246 C1317(3.42); C1186(1.81)  LDD3410 
Collagen alpha-2(IV) chain (COL4A2) LDTP02282 C1537(1.39); C1658(1.45)  LDD3316 
Collagen alpha-2(VI) chain (COL6A2) LDTP02606 C605(2.02)  LDD0078 
Collagen alpha-2(XI) chain (COL11A2) LDTP02701 C54(1.96)  LDD3410 
Collagen alpha-3(VI) chain (COL6A3) LDTP02607 C775(1.23)  LDD3376 
Collagen alpha-4(IV) chain (COL4A4) LDTP04562 C928(0.14)  LDD2236 
Collagen alpha-5(IV) chain (COL4A5) LDTP03486 C1515(2.99)  LDD3311 
Collectin-11 (COLEC11) LDTP11333 C96(1.61)  LDD3376 
Collectin-12 (COLEC12) LDTP07031 C27(1.24); C371(1.82)  LDD3360 
Colorectal mutant cancer protein (MCC) LDTP03238 C58(19.17)  LDD0209 
COMM domain-containing protein 1 (COMMD1) LDTP08919 C160(1.00)  LDD1492 
COMM domain-containing protein 10 (COMMD10) LDTP14249 C132(2.77)  LDD3310 
COMM domain-containing protein 3 (COMMD3) LDTP13118 C101(2.78)  LDD3312 
COMM domain-containing protein 4 (COMMD4) LDTP11692 C107(1.31)  LDD0080 
COMM domain-containing protein 5 (COMMD5) LDTP15941 C64(1.05)  LDD0531 
COMM domain-containing protein 6 (COMMD6) LDTP08067 C60(0.74)  LDD0613 
COMM domain-containing protein 7 (COMMD7) LDTP15294 C198(1.27); C200(1.33)  LDD0531 
COMM domain-containing protein 8 (COMMD8) LDTP16123 C32(0.97)  LDD0533 
COMM domain-containing protein 9 (COMMD9) LDTP12949 C160(2.02)  LDD3332 
Complement C1q tumor necrosis factor-related protein 2 (C1QTNF2) LDTP11385 C9(1.74)  LDD3424 
Complement C1q tumor necrosis factor-related protein 6 (C1QTNF6) LDTP11380 C56(3.03)  LDD3311 
Complement C1q-like protein 4 (C1QL4) LDTP08429 C32(2.10)  LDD3427 
Complement C3 (C3) LDTP01815 C693(0.95)  LDD0531 
Complement C4-A (C4A) LDTP02388 C736(0.31)  LDD0531 
Complement C4-B (C4B; C4B_2) LDTP02389 C567(1.67)  LDD3316 
Complement component C1q receptor (CD93) LDTP12384 C104(1.25)  LDD3335 
Complement component C7 (C7) LDTP02510 C165(1.15); C91(1.55); C96(1.62)  LDD0531 
Complement component C8 beta chain (C8B) LDTP02201 C122(0.89); C127(0.89)  LDD0078 
Complement decay-accelerating factor (CD55) LDTP02253 C98(1.45); C163(3.42)  LDD3310 
Complement factor H-related protein 5 (CFHR5) LDTP11403 C359(2.08)  LDD3335 
Complement receptor type 2 (CR2) LDTP03025 C721(1.83)  LDD3311 
Complex I assembly factor TIMMDC1, mitochondrial (TIMMDC1) LDTP12379 C78(0.86)  LDD0531 
Complex I intermediate-associated protein 30, mitochondrial (NDUFAF1) LDTP13954 C183(1.25)  LDD0533 
Complex III assembly factor LYRM7 (LYRM7) LDTP07200 C97(1.36)  LDD0080 
Complexin-1 (CPLX1) LDTP00445 C105(1.03)  LDD1492 
Complexin-2 (CPLX2) LDTP07613 C90(2.09)  LDD3342 
Condensin complex subunit 1 (NCAPD2) LDTP06281 C439(1.25); C766(1.07); C767(1.07); C1045(1.03)  LDD0078 
Condensin complex subunit 2 (NCAPH) LDTP06268 C397(1.02); C402(1.02)  LDD0078 
Condensin complex subunit 3 (NCAPG) LDTP11040 C610(4.28); C611(4.28); C835(2.92); C843(2.92)  LDD0080 
Condensin-2 complex subunit D3 (NCAPD3) LDTP03994 C588(1.16); C330(1.13); C1484(1.08); C541(1.08)  LDD0078 
Condensin-2 complex subunit G2 (NCAPG2) LDTP08359 C826(71.36); C184(4.91); C964(18.95); C964(19.34)  LDD0209 
Condensin-2 complex subunit H2 (NCAPH2) LDTP07405 C230(4.66); C342(5.00)  LDD0209 
Connector enhancer of kinase suppressor of ras 1 (CNKSR1) LDTP10001 C500(3.50)  LDD3312 
Connector enhancer of kinase suppressor of ras 2 (CNKSR2) LDTP09705 C573(2.02)  LDD3410 
Connector enhancer of kinase suppressor of ras 3 (CNKSR3) LDTP07556 C526(1.24)  LDD3319 
Conserved oligomeric Golgi complex subunit 1 (COG1) LDTP09549 C87(1.10); C72(1.07); C618(0.92); C625(0.92)  LDD0078 
Conserved oligomeric Golgi complex subunit 2 (COG2) LDTP06201 C287(0.91)  LDD0078 
Conserved oligomeric Golgi complex subunit 3 (COG3) LDTP10452 C697(0.93); C363(0.85)  LDD0078 
Conserved oligomeric Golgi complex subunit 4 (COG4) LDTP12094 C25(1.43)  LDD0080 
Conserved oligomeric Golgi complex subunit 5 (COG5) LDTP13689 C664(10.79)  LDD0209 
Conserved oligomeric Golgi complex subunit 6 (COG6) LDTP13918 C621(1.36)  LDD0080 
Conserved oligomeric Golgi complex subunit 7 (COG7) LDTP05185 C505(1.03); C174(0.86)  LDD0078 
Conserved oligomeric Golgi complex subunit 8 (COG8) LDTP10603 C96(1.19); C595(1.17); C125(0.94)  LDD0078 
Consortin (CNST) LDTP07603 C439(0.94)  LDD0078 
Constitutive coactivator of peroxisome proliferator-activated receptor gamma (FAM120B) LDTP15717 C637(2.65); C644(2.65); C392(1.78); C356(2.53)  LDD0080 
Constitutive coactivator of PPAR-gamma-like protein 1 (FAM120A) LDTP12883 C1088(14.21); C1103(14.21)  LDD0204 
Constitutive coactivator of PPAR-gamma-like protein 2 (FAM120C) LDTP18481 C354(1.66); C720(3.05); C1056(3.39)  LDD3311 
Contactin-associated protein 1 (CNTNAP1) LDTP05105 C831(1.03); C585(0.89)  LDD0078 
Contactin-associated protein-like 3 (CNTNAP3) LDTP15920 C1167(0.44)  LDD2236 
Contactin-associated protein-like 3B (CNTNAP3B) LDTP15798 C1203(2.93)  LDD3383 
COP9 signalosome complex subunit 1 (GPS1) LDTP05746 C228(5.27); C238(1.87); C67(2.33)  LDD3311 
COP9 signalosome complex subunit 2 (COPS2) LDTP04906 C399(5.39)  LDD3314 
COP9 signalosome complex subunit 7a (COPS7A) LDTP13170 C110(1.24)  LDD0080 
COP9 signalosome complex subunit 7b (COPS7B) LDTP12106 C110(0.94); C157(1.55); C178(0.50); C181(0.50)  LDD0531 
COP9 signalosome complex subunit 8 (COPS8) LDTP10927 C20(1.01)  LDD1508 
Copine-2 (CPNE2) LDTP10312 C14(1.72)  LDD3315 
Copine-4 (CPNE4) LDTP15685 C88(1.66)  LDD3312 
Copine-7 (CPNE7) LDTP13127 C20(1.25); C293(0.96); C295(0.96); C631(1.44)  LDD0531 
Copine-8 (CPNE8) LDTP17607 C155(0.86); C156(0.86)  LDD0078 
Copper transport protein ATOX1 (ATOX1) LDTP00229 C12(2.18); C15(2.18)  LDD0080 
Cordon-bleu protein-like 1 (COBLL1) LDTP17155 C686(1.85)  LDD0080 
Core histone macro-H2A.1 (MACROH2A1) LDTP01195 C276(0.84); C297(0.83)  LDD0531 
Core histone macro-H2A.2 (MACROH2A2) LDTP12971 C297(1.25)  LDD0531 
Corepressor interacting with RBPJ 1 (CIR1) LDTP08354 C299(23.04)  LDD0204 
Corneodesmosin (CDSN) LDTP06403 C391(0.94)  LDD2265 
Cornifin-A (SPRR1A) LDTP03732 C73(1.60)  LDD3489 
Cornifin-B (SPRR1B) LDTP03177 C57(2.61)  LDD3312 
Cornulin (CRNN) LDTP13115 C425(2.62)  LDD2465 
Coronin-1A (CORO1A) LDTP03573 C40(1.51)  LDD3310 
Coronin-1B (CORO1B) LDTP11101 C25(1.61)  LDD0531 
Coronin-1C (CORO1C) LDTP13580 C243(2.12); C92(1.99)  LDD3310 
Coronin-2A (CORO2A) LDTP15667 C335(1.23); C474(1.17)  LDD0080 
Coronin-2B (CORO2B) LDTP13740 C335(1.62); C46(1.36); C220(1.46)  LDD3332 
Coronin-6 (CORO6) LDTP15136 C396(2.48)  LDD3311 
Coronin-7 (CORO7) LDTP04798 C34(235.67)  LDD0209 
Cortactin-binding protein 2 (CTTNBP2) LDTP09753 C1225(0.97)  LDD0547 
Costars family protein ABRACL (ABRACL) LDTP20008 C39(0.88)  LDD0078 
COX assembly mitochondrial protein 2 homolog (CMC2) LDTP18462 C37(1.23)  LDD0080 
COX assembly mitochondrial protein homolog (CMC1) LDTP17566 C77(0.93)  LDD0532 
CRACD-like protein (CRACDL) LDTP19490 C118(3.43)  LDD3493 
CREB-regulated transcription coactivator 1 (CRTC1) LDTP07657 C131(1.39)  LDD1507 
CREB-regulated transcription coactivator 2 (CRTC2) LDTP06884 C515(0.96)  LDD0078 
Crk-like protein (CRKL) LDTP04092 C249(1.08); C44(1.03)  LDD0078 
Crooked neck-like protein 1 (CRNKL1) LDTP11540 C640(0.64)  LDD0531 
Cryptic family protein 1B (CFC1B) LDTP16894 C114(3.08)  LDD2243 
CST complex subunit CTC1 (CTC1) LDTP06711 C584(0.82); C1100(0.80); C1181(0.93); C424(1.00)  LDD0531 
CST complex subunit STN1 (STN1) LDTP11972 C322(0.98); C330(0.98)  LDD0532 
CST complex subunit TEN1 (TEN1) LDTP08343 C33(1.17)  LDD0531 
cTAGE family member 2 (CTAGE1) LDTP18264 C548(14.01)  LDD0204 
cTAGE family member 4 (CTAGE4) LDTP17635 C755(1.46)  LDD3323 
CTTNBP2 N-terminal-like protein (CTTNBP2NL) LDTP13035 C352(0.86)  LDD0078 
CUB and sushi domain-containing protein 1 (CSMD1) LDTP10711 C3181(2.16)  LDD3376 
CUB domain-containing protein 1 (CDCP1) LDTP11963 C599(0.85)  LDD0078 
CUE domain-containing protein 1 (CUEDC1) LDTP18480 C68(2.38)  LDD3360 
CUGBP Elav-like family member 1 (CELF1) LDTP09913 C150(4.03)  LDD0204 
CUGBP Elav-like family member 2 (CELF2) LDTP01563 C174(1.37)  LDD3310 
CUGBP Elav-like family member 4 (CELF4) LDTP11522 C63(2.16)  LDD3340 
Cullin-7 (CUL7) LDTP06251 C646(2.34); C1497(1.76)  LDD3312 
Cullin-9 (CUL9) LDTP08555 C1340(16.63)  LDD0209 
CWF19-like protein 1 (CWF19L1) LDTP15066 C141(1.36); C160(1.47)  LDD0080 
CWF19-like protein 2 (CWF19L2) LDTP06730 C299(1.05)  LDD0531 
Cx9C motif-containing protein 4 (CMC4) LDTP14715 C12(2.72)  LDD3337 
CXXC motif containing zinc binding protein (CZIB) LDTP16121 C33(1.89); C36(1.89)  LDD0080 
CXXC-type zinc finger protein 5 (CXXC5) LDTP07987 C291(1.46)  LDD3310 
Cyclin-A1 (CCNA1) LDTP05121 C97(1.50)  LDD3333 
Cyclin-A2 (CCNA2) LDTP03039 C327(1.73)  LDD3397 
Cyclin-C (CCNC) LDTP03295 C90(1.96)  LDD3410 
Cyclin-D1-binding protein 1 (CCNDBP1) LDTP01552 C89(0.86)  LDD0531 
Cyclin-dependent kinase 2-associated protein 2 (CDK2AP2) LDTP01367 C77(4.65)  LDD3331 
Cyclin-dependent kinase 2-interacting protein (CINP) LDTP11314 C81(5.69)  LDD0209 
Cyclin-dependent kinase 4 inhibitor B (CDKN2B) LDTP04002 C74(1.24)  LDD3384 
Cyclin-dependent kinase 4 inhibitor C (CDKN2C) LDTP04003 C141(1.20)  LDD3318 
Cyclin-dependent kinase inhibitor 1 (CDKN1A) LDTP03863 C13(1.26); C34(1.03); C41(1.03)  LDD0531 
Cyclin-dependent kinase inhibitor 1B (CDKN1B) LDTP04097 C29(0.06)  LDD2236 
Cyclin-dependent kinase inhibitor 2A (CDKN2A) LDTP04001 C76(5.54)  LDD3348 
Cyclin-F (CCNF) LDTP03914 C14(0.92); C16(0.92)  LDD0078 
Cyclin-G1 (CCNG1) LDTP04492 C217(17.68); C226(17.68)  LDD0080 
Cyclin-H (CCNH) LDTP04487 C244(1.13); C84(0.65)  LDD0531 
Cyclin-I (CCNI) LDTP14838 C272(3.73)  LDD3332 
Cyclin-I2 (CCNI2) LDTP17453 C124(1.93)  LDD3451 
Cyclin-K (CCNK) LDTP01348 C23(1.04); C98(0.98); C99(0.98)  LDD1492 
Cyclin-L1 (CCNL1) LDTP13428 C195(1.35); C87(1.47)  LDD0531 
Cyclin-L2 (CCNL2) LDTP10805 C82(1.06)  LDD0531 
Cyclin-T1 (CCNT1) LDTP01002 C111(1.45)  LDD0531 
Cyclin-T2 (CCNT2) LDTP01007 C26(0.90)  LDD0532 
Cyclin-Y (CCNY) LDTP09117 C39(2.22)  LDD3365 
Cyclin-Y-like protein 1 (CCNYL1) LDTP17743 C258(2.02)  LDD0080 
CYFIP-related Rac1 interactor A (CYRIA) LDTP19951 C83(4.29)  LDD3335 
CYFIP-related Rac1 interactor B (CYRIB) LDTP12642 C10(1.46); C223(0.80); C231(0.88)  LDD0531 
Cystatin-C (CST3) LDTP01818 C109(1.39)  LDD3318 
Cystatin-F (CST7) LDTP01404 C63(1.51)  LDD2412 
Cystatin-SA (CST2) LDTP02334 C104(1.57)  LDD2263 
Cysteine and glycine-rich protein 1 (CSRP1) LDTP03106 C34(1.01); C58(1.00); C37(0.94); C40(0.94)  LDD0078 
Cysteine and glycine-rich protein 2 (CSRP2) LDTP06542 C37(3.99); C40(3.97); C33(4.11); C167(1.06)  LDD0080 
Cysteine and glycine-rich protein 3 (CSRP3) LDTP04365 C168(0.93)  LDD3313 
Cysteine and histidine-rich domain-containing protein 1 (CHORDC1) LDTP13269 C59(1.30); C211(1.25)  LDD0080 
Cysteine-rich DPF motif domain-containing protein 1 (CDPF1) LDTP15099 C72(0.70); C77(0.70); C86(0.85); C89(0.85)  LDD0531 
Cysteine-rich hydrophobic domain-containing protein 2 (CHIC2) LDTP13458 C131(1.66)  LDD3315 
Cysteine-rich PDZ-binding protein (CRIPT) LDTP12952 C73(1.23); C76(1.23); C83(1.02); C86(1.02)  LDD0078 
Cysteine-rich protein 1 (CRIP1) LDTP04351 C28(0.85); C52(0.86); C56(0.86)  LDD0531 
Cysteine-rich protein 2 (CRIP2) LDTP16973 C200(1.12)  LDD3312 
Cysteine-rich protein 2-binding protein (KAT14) LDTP12054 C547(1.13)  LDD0078 
Cysteine-rich secretory protein 3 (CRISP3) LDTP04599 C239(5.92)  LDD3486 
Cysteine-rich secretory protein LCCL domain-containing 1 (CRISPLD1) LDTP15980 C413(1.00)  LDD1508 
Cytochrome b-245 chaperone 1 (CYBC1) LDTP11068 C165(1.70)  LDD3338 
Cytochrome c oxidase assembly factor 5 (COA5) LDTP15307 C57(2.36)  LDD0080 
Cytochrome c oxidase assembly factor 8 (COA8) LDTP10421 C65(1.07)  LDD1510 
Cytochrome c oxidase assembly protein COX11, mitochondrial (COX11) LDTP14277 C217(1.05); C219(1.03)  LDD0531 
Cytochrome c oxidase assembly protein COX19 (COX19) LDTP14927 C40(3.72); C51(3.72)  LDD0080 
Cytochrome c oxidase copper chaperone (COX17) LDTP06030 C23(3.33); C26(3.33); C24(3.33)  LDD0080 
Cytohesin-1 (CYTH1) LDTP06392 C94(2.74)  LDD3319 
Cytohesin-3 (CYTH3) LDTP00852 C327(2.07)  LDD3410 
Cytohesin-interacting protein (CYTIP) LDTP01045 C246(2.24)  LDD3411 
Cytoplasmic 60S subunit biogenesis factor ZNF622 (ZNF622) LDTP10027 C305(1.04); C308(1.04)  LDD0078 
Cytoplasmic dynein 1 heavy chain 1 (DYNC1H1) LDTP06083 C3940(1.03); C633(1.02); C2639(0.96); C2466(0.94)  LDD0078 
Cytoplasmic dynein 1 intermediate chain 1 (DYNC1I1) LDTP00374 C394(0.81)  LDD1509 
Cytoplasmic dynein 1 intermediate chain 2 (DYNC1I2) LDTP05855 C408(1.23)  LDD0531 
Cytoplasmic dynein 1 light intermediate chain 1 (DYNC1LI1) LDTP14250 C117(1.21); C247(0.98); C275(0.64)  LDD0531 
Cytoplasmic dynein 1 light intermediate chain 2 (DYNC1LI2) LDTP00712 C191(1.05)  LDD0078 
Cytoplasmic dynein 2 heavy chain 1 (DYNC2H1) LDTP09100 C3225(5.62); C4123(31.89)  LDD0209 
Cytoplasmic dynein 2 intermediate chain 2 (DYNC2I2) LDTP10281 C196(0.46); C362(1.05); C65(0.92)  LDD0531 
Cytoplasmic dynein 2 light intermediate chain 1 (DYNC2LI1) LDTP09401 C51(0.96)  LDD1492 
Cytoplasmic FMR1-interacting protein 1 (CYFIP1) LDTP07958 C346(1.10); C98(0.92); C428(0.88); C334(0.85)  LDD0078 
Cytoplasmic FMR1-interacting protein 2 (CYFIP2) LDTP10289 C427(1.04)  LDD0080 
Cytoplasmic polyadenylation element-binding protein 1 (CPEB1) LDTP11521 C50(6.50)  LDD0204 
Cytoplasmic polyadenylation element-binding protein 3 (CPEB3) LDTP09147 C850(1.96)  LDD3314 
Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) LDTP06668 C545(1.15)  LDD0812 
Cytoplasmic protein NCK2 (NCK2) LDTP00825 C144(1.08); C297(1.10)  LDD0531 
Cytoplasmic tRNA 2-thiolation protein 2 (CTU2) LDTP06735 C433(3.39); C434(3.39); C463(2.70); C466(2.70)  LDD0080 
Cytoskeleton-associated protein 2 (CKAP2) LDTP09652 C667(1.35); C674(1.35); C430(0.91); C438(0.91)  LDD0078 
Cytoskeleton-associated protein 2-like (CKAP2L) LDTP08634 C361(1.12); C367(1.12); C44(1.01)  LDD0078 
Cytoskeleton-associated protein 5 (CKAP5) LDTP06021 C1203(6.57); C1317(22.78); C1317(153.15); C1500(100.05)  LDD0209 
Cytosolic arginine sensor for mTORC1 subunit 2 (CASTOR2) LDTP14367 C223(1.47)  LDD3316 
Cytosolic Fe-S cluster assembly factor NUBP1 (NUBP1) LDTP04560 C25(1.03)  LDD0078 
Cytosolic Fe-S cluster assembly factor NUBP2 (NUBP2) LDTP14179 C54(1.04); C72(1.00); C196(0.97); C199(0.97)  LDD0078 
Cytosolic iron-sulfur assembly component 2A (CIAO2A) LDTP11965 C155(1.10)  LDD1492 
Cytosolic iron-sulfur assembly component 2B (CIAO2B) LDTP13979 C158(3.23)  LDD3314 
Cytospin-A (SPECC1L) LDTP07348 C162(1.15)  LDD0078 
Cytospin-B (SPECC1) LDTP07032 C805(1.01); C493(0.99)  LDD0078 
Cytotoxic granule associated RNA binding protein TIA1 (TIA1) LDTP03598 C214(0.44); C218(0.44)  LDD0531 
DALR anticodon-binding domain-containing protein 3 (DALRD3) LDTP06956 C130(54.09)  LDD0209 
Dapper homolog 3 (DACT3) LDTP10107 C473(4.18)  LDD3433 
DAZ-associated protein 1 (DAZAP1) LDTP10271 C85(0.43); C124(1.22)  LDD0531 
DBF4-type zinc finger-containing protein 2 (ZDBF2) LDTP18443 C1575(2.35); C1597(2.36)  LDD0080 
DBIRD complex subunit ZNF326 (ZNF326) LDTP06952 C314(0.45); C317(0.45)  LDD0533 
DCC-interacting protein 13-alpha (APPL1) LDTP13451 C549(2.45); C551(2.45)  LDD0080 
DCC-interacting protein 13-beta (APPL2) LDTP09175 C412(1.03); C368(1.02); C341(1.04); C606(1.08)  LDD1492 
DDB1- and CUL4-associated factor 10 (DCAF10) LDTP07050 C504(1.04); C510(1.04)  LDD0078 
DDB1- and CUL4-associated factor 12 (DCAF12) LDTP07131 C380(1.02)  LDD0532 
DDB1- and CUL4-associated factor 12-like protein 1 (DCAF12L1) LDTP19435 C113(2.00)  LDD3352 
DDB1- and CUL4-associated factor 13 (DCAF13) LDTP12652 C120(0.90)  LDD0078 
DDB1- and CUL4-associated factor 15 (DCAF15) LDTP07296 C193(1.50); C196(1.50)  LDD0080 
DDB1- and CUL4-associated factor 16 (DCAF16) LDTP16129 C173(1.42); C178(1.26)  LDD0531 
DDB1- and CUL4-associated factor 17 (DCAF17) LDTP06984 C20(22.33)  LDD0209 
DDB1- and CUL4-associated factor 4 (DCAF4) LDTP09591 C88(1.04)  LDD0531 
DDB1- and CUL4-associated factor 7 (DCAF7) LDTP04947 C109(1.67); C61(1.63)  LDD0080 
Death domain-associated protein 6 (DAXX) LDTP13199 C664(1.66)  LDD0080 
Death effector domain-containing protein (DEDD) LDTP01276 C110(1.92)  LDD3314 
Death-inducer obliterator 1 (DIDO1) LDTP11192 C397(1.19); C402(1.19); C403(1.19); C1665(1.17)  LDD0078 
Decorin (DCN) LDTP02214 C67(2.73)  LDD2361 
Dedicator of cytokinesis protein 1 (DOCK1) LDTP06072 C595(1.77)  LDD0080 
Dedicator of cytokinesis protein 10 (DOCK10) LDTP10146 C2164(0.99); C1508(0.96); C1510(0.96)  LDD0078 
Dedicator of cytokinesis protein 11 (DOCK11) LDTP14977 C160(6.10); C1190(5.48); C1878(2.71); C1883(2.71)  LDD0080 
Dedicator of cytokinesis protein 2 (DOCK2) LDTP09815 C730(17.22)  LDD0209 
Dedicator of cytokinesis protein 3 (DOCK3) LDTP08695 C1823(0.83); C1640(0.90)  LDD1514 
Dedicator of cytokinesis protein 4 (DOCK4) LDTP08775 C1190(1.70)  LDD3312 
Dedicator of cytokinesis protein 5 (DOCK5) LDTP12022 C1223(1.02); C508(0.96)  LDD0078 
Dedicator of cytokinesis protein 6 (DOCK6) LDTP10395 C1243(1.03); C595(0.91)  LDD0078 
Dedicator of cytokinesis protein 7 (DOCK7) LDTP10613 C2125(1.10); C193(1.03); C388(1.00); C1944(0.98)  LDD0078 
Dedicator of cytokinesis protein 8 (DOCK8) LDTP09189 C197(1.41); C685(1.27)  LDD3319 
Dedicator of cytokinesis protein 9 (DOCK9) LDTP11514 C667(2.04); C468(1.70); C628(2.06)  LDD3312 
Deleted in azoospermia protein 2 (DAZ2) LDTP05755 C738(3.91)  LDD3351 
Delphilin (GRID2IP) LDTP16580 C503(2.42); C1002(6.14)  LDD3403 
Delta and Notch-like epidermal growth factor-related receptor (DNER) LDTP09220 C540(2.84)  LDD2252 
Delta-like protein 1 (DLL1) LDTP00307 C696(1.77)  LDD3345 
Delta-like protein 4 (DLL4) LDTP12479 C653(1.32)  LDD3380 
Delta-sarcoglycan (SGCD) LDTP09830 C221(1.30)  LDD3332 
Dematin (DMTN) LDTP05565 C194(1.10)  LDD3402 
DENN domain-containing protein 10 (DENND10) LDTP09380 C47(5.84); C48(5.84)  LDD0080 
DENN domain-containing protein 11 (DENND11) LDTP16577 C271(1.24)  LDD0531 
DENN domain-containing protein 1A (DENND1A) LDTP09498 C201(1.04)  LDD1507 
DENN domain-containing protein 1B (DENND1B) LDTP07527 C412(30.01); C52(45.20)  LDD0209 
DENN domain-containing protein 1C (DENND1C) LDTP08483 C412(102.22)  LDD0209 
DENN domain-containing protein 2A (DENND2A) LDTP16234 C673(2.75)  LDD3365 
DENN domain-containing protein 2B (DENND2B) LDTP05135 C804(23.91)  LDD0209 
DENN domain-containing protein 2C (DENND2C) LDTP15063 C599(2.10)  LDD3346 
DENN domain-containing protein 2D (DENND2D) LDTP18400 C104(38.94)  LDD0209 
DENN domain-containing protein 3 (DENND3) LDTP14335 C499(4.00)  LDD0209 
DENN domain-containing protein 4B (DENND4B) LDTP14484 C576(13.74)  LDD0209 
DENN domain-containing protein 4C (DENND4C) LDTP07258 C1045(22.35)  LDD0209 
DENN domain-containing protein 5A (DENND5A) LDTP07425 C271(0.99)  LDD0531 
DENN domain-containing protein 5B (DENND5B) LDTP15197 C768(2.33)  LDD3339 
Density-regulated protein (DENR) LDTP00808 C37(2.75); C34(1.57); C44(1.57); C132(1.09)  LDD0080 
Denticleless protein homolog (DTL) LDTP12905 C544(1.20); C438(0.98); C454(0.98); C450(0.97)  LDD0078 
Deoxynucleotidyltransferase terminal-interacting protein 2 (DNTTIP2) LDTP07047 C116(1.11); C618(1.01)  LDD0078 
DEP domain-containing mTOR-interacting protein (DEPTOR) LDTP09327 C284(10.44); C304(10.44)  LDD0080 
DEP domain-containing protein 1A (DEPDC1) LDTP07172 C722(4.88)  LDD0080 
DEP domain-containing protein 1B (DEPDC1B) LDTP18084 C249(7.17); C256(7.17)  LDD0080 
DEP domain-containing protein 7 (DEPDC7) LDTP18238 C452(3.49)  LDD0080 
Desmin (DES) LDTP02913 C333(1.82)  LDD3401 
Desmoglein-2 (DSG2) LDTP06042 C840(0.90)  LDD0531 
Desmoglein-3 (DSG3) LDTP03654 C503(1.76); C967(1.33)  LDD3352 
Destrin (DSTN) LDTP04887 C23(1.18); C163(1.09); C46(0.96); C135(0.93)  LDD0078 
DET1- and DDB1-associated protein 1 (DDA1) LDTP11312 C25(1.13)  LDD0078 
Dickkopf-related protein 1 (DKK1) LDTP01457 C189(1.53)  LDD3316 
Dickkopf-related protein 4 (DKK4) LDTP13157 C145(2.09)  LDD2319 
Differentially expressed in FDCP 6 homolog (DEF6) LDTP11920 C266(1.02); C267(1.02)  LDD0531 
Differentially expressed in FDCP 8 homolog (DEF8) LDTP15181 C451(0.97); C454(0.97)  LDD0078 
Diphthamide biosynthesis protein 3 (DPH3) LDTP10319 C66(0.95)  LDD0531 
Disabled homolog 1 (DAB1) LDTP01253 C61(2.02)  LDD3423 
Disabled homolog 2 (DAB2) LDTP05211 C138(3.30)  LDD3325 
Disabled homolog 2-interacting protein (DAB2IP) LDTP07244 C487(43.71)  LDD0209 
Disco-interacting protein 2 homolog B (DIP2B) LDTP16173 C1019(0.89); C592(0.98)  LDD0531 
Disco-interacting protein 2 homolog C (DIP2C) LDTP18563 C1282(1.80)  LDD3310 
Discoidin, CUB and LCCL domain-containing protein 1 (DCBLD1) LDTP17755 C580(0.78); C702(1.03)  LDD1492 
Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) LDTP10670 C739(1.22)  LDD3312 
Disheveled-associated activator of morphogenesis 1 (DAAM1) LDTP14045 C87(0.87)  LDD1514 
Disheveled-associated activator of morphogenesis 2 (DAAM2) LDTP08187 C87(2.56)  LDD3375 
Disks large homolog 3 (DLG3) LDTP09877 C519(0.91)  LDD1492 
Disks large homolog 5 (DLG5) LDTP09441 C1094(1.06); C1240(1.05); C1917(0.96)  LDD0078 
Disks large-associated protein 1 (DLGAP1) LDTP00345 C309(1.49)  LDD2363 
Disks large-associated protein 2 (DLGAP2) LDTP12998 C96(3.08)  LDD3398 
Disks large-associated protein 3 (DLGAP3) LDTP01708 C98(1.86)  LDD3310 
Disks large-associated protein 4 (DLGAP4) LDTP13865 C726(1.02)  LDD0078 
Disks large-associated protein 5 (DLGAP5) LDTP06378 C801(1.15); C811(1.15); C381(1.03); C129(0.98)  LDD0078 
DISP complex protein LRCH3 (LRCH3) LDTP10417 C236(2.76)  LDD3310 
Disrupted in schizophrenia 1 protein (DISC1) LDTP12513 C86(0.89)  LDD1507 
Divergent protein kinase domain 1A (DIPK1A) LDTP17237 C6(1.05)  LDD1510 
Divergent protein kinase domain 1B (DIPK1B) LDTP17270 C334(1.09)  LDD1575 
Divergent protein kinase domain 2A (DIPK2A) LDTP09143 C236(1.04)  LDD0531 
DmX-like protein 1 (DMXL1) LDTP18576 C2532(1.07); C2916(1.40)  LDD0080 
DNA damage-binding protein 1 (DDB1) LDTP06543 C87(1.06)  LDD0080 
DNA damage-binding protein 2 (DDB2) LDTP09760 C48(20.00); C52(20.00); C322(1.32); C254(1.27)  LDD0080 
DNA damage-inducible transcript 4 protein (DDIT4) LDTP12751 C140(0.94)  LDD0531 
DNA excision repair protein ERCC-8 (ERCC8) LDTP05788 C84(2.12)  LDD0080 
DNA fragmentation factor subunit alpha (DFFA) LDTP00239 C38(1.01)  LDD0078 
DNA mismatch repair protein Mlh1 (MLH1) LDTP03902 C256(1.00)  LDD0078 
DNA mismatch repair protein Mlh3 (MLH3) LDTP13263 C1031(0.96); C1040(0.96); C1041(0.96)  LDD0078 
DNA mismatch repair protein Msh2 (MSH2) LDTP04028 C843(1.00)  LDD0078 
DNA mismatch repair protein Msh3 (MSH3) LDTP03056 C252(1.81); C141(1.53); C142(1.53); C166(1.52)  LDD0080 
DNA mismatch repair protein Msh6 (MSH6) LDTP04518 C615(1.10); C1337(1.10); C1269(1.04); C1275(1.04)  LDD0078 
DNA polymerase delta subunit 3 (POLD3) LDTP06300 C137(0.98)  LDD0078 
DNA polymerase epsilon subunit 3 (POLE3) LDTP12506 C51(0.88)  LDD0531 
DNA repair protein complementing XP-A cells (XPA) LDTP03204 C126(0.99); C129(0.99); C105(1.08); C108(1.08)  LDD0080 
DNA repair protein complementing XP-C cells (XPC) LDTP05317 C544(0.87); C558(0.87)  LDD0078 
DNA repair protein RAD51 homolog 1 (RAD51) LDTP05497 C31(1.08)  LDD3339 
DNA repair protein RAD51 homolog 2 (RAD51B) LDTP00607 C54(2.85)  LDD3407 
DNA repair protein RAD51 homolog 3 (RAD51C) LDTP00781 C124(1.25)  LDD0080 
DNA repair protein RAD52 homolog (RAD52) LDTP04035 C64(3.02)  LDD3310 
DNA repair protein XRCC1 (XRCC1) LDTP02973 C615(0.91)  LDD0532 
DNA repair protein XRCC2 (XRCC2) LDTP00797 C179(1.04)  LDD1508 
DNA repair protein XRCC3 (XRCC3) LDTP00796 C221(0.97)  LDD0078 
DNA repair protein XRCC4 (XRCC4) LDTP05865 C128(1.10)  LDD0080 
DNA repair-scaffolding protein (SPIDR) LDTP06061 C398(1.75); C402(1.75)  LDD0080 
DNA replication complex GINS protein PSF1 (GINS1) LDTP06187 C75(0.69)  LDD0531 
DNA replication complex GINS protein PSF3 (GINS3) LDTP11139 C227(1.86)  LDD3319 
DNA replication complex GINS protein SLD5 (GINS4) LDTP11134 C53(0.95)  LDD1492 
DNA replication factor Cdt1 (CDT1) LDTP11785 C441(1.10); C151(0.84); C163(0.84)  LDD0078 
DNA topoisomerase 2-binding protein 1 (TOPBP1) LDTP09791 C1299(0.85); C1304(0.85)  LDD0078 
DNA-directed RNA polymerase II subunit GRINL1A, isoforms 4/5 (POLR2M) LDTP19477 C28(0.96)  LDD1492 
DNA/RNA-binding protein KIN17 (KIN) LDTP01068 C212(0.95)  LDD0078 
DnaJ homolog subfamily A member 1 (DNAJA1) LDTP03606 C177(0.94); C180(0.94); C302(0.87)  LDD0078 
DnaJ homolog subfamily A member 2 (DNAJA2) LDTP01073 C308(0.88)  LDD0078 
DnaJ homolog subfamily A member 3, mitochondrial (DNAJA3) LDTP10282 C289(0.59); C292(0.59)  LDD0532 
DnaJ homolog subfamily A member 4 (DNAJA4) LDTP09634 C164(1.21)  LDD3338 
DnaJ homolog subfamily B member 1 (DNAJB1) LDTP03325 C179(1.41)  LDD0080 
DnaJ homolog subfamily B member 11 (DNAJB11) LDTP13152 C193(0.95); C196(0.95)  LDD0078 
DnaJ homolog subfamily B member 4 (DNAJB4) LDTP13193 C7(1.02)  LDD0078 
DnaJ homolog subfamily B member 5 (DNAJB5) LDTP14510 C292(1.14)  LDD1492 
DnaJ homolog subfamily B member 6 (DNAJB6) LDTP01158 C275(1.43)  LDD3310 
DnaJ homolog subfamily C member 11 (DNAJC11) LDTP12677 C235(1.07); C241(1.07)  LDD0078 
DnaJ homolog subfamily C member 12 (DNAJC12) LDTP16219 C129(11.49)  LDD0209 
DnaJ homolog subfamily C member 13 (DNAJC13) LDTP01149 C2181(0.92)  LDD0078 
DnaJ homolog subfamily C member 14 (DNAJC14) LDTP17450 C559(0.99); C562(0.99)  LDD0078 
DnaJ homolog subfamily C member 16 (DNAJC16) LDTP13863 C171(0.99); C174(0.96); C744(0.89)  LDD0531 
DnaJ homolog subfamily C member 17 (DNAJC17) LDTP18473 C38(1.05)  LDD1511 
DnaJ homolog subfamily C member 18 (DNAJC18) LDTP18411 C115(1.13)  LDD1575 
DnaJ homolog subfamily C member 21 (DNAJC21) LDTP06967 C489(1.77)  LDD3316 
DnaJ homolog subfamily C member 24 (DNAJC24) LDTP07528 C55(2.79)  LDD3408 
DnaJ homolog subfamily C member 3 (DNAJC3) LDTP05789 C197(13.72)  LDD0209 
DnaJ homolog subfamily C member 30, mitochondrial (DNAJC30) LDTP10554 C43(1.18)  LDD0078 
DnaJ homolog subfamily C member 7 (DNAJC7) LDTP10920 C58(0.90); C175(0.89)  LDD0078 
DnaJ homolog subfamily C member 9 (DNAJC9) LDTP09721 C7(0.97)  LDD3332 
DNL-type zinc finger protein (DNLZ) LDTP14995 C75(1.32)  LDD3365 
Docking protein 1 (DOK1) LDTP10948 C115(1.01); C389(0.97); C463(0.97)  LDD0078 
Docking protein 2 (DOK2) LDTP00985 C65(14.68)  LDD0209 
Docking protein 3 (DOK3) LDTP07960 C493(2.10)  LDD3334 
Double C2-like domain-containing protein alpha (DOC2A) LDTP06070 C138(60.56)  LDD0209 
Double zinc ribbon and ankyrin repeat-containing protein 1 (DZANK1) LDTP18474 C193(0.88)  LDD1507 
Double-strand-break repair protein rad21 homolog (RAD21) LDTP00911 C585(1.09)  LDD0078 
Double-stranded RNA-binding protein Staufen homolog 1 (STAU1) LDTP01677 C574(0.99)  LDD0078 
Double-stranded RNA-binding protein Staufen homolog 2 (STAU2) LDTP12631 C491(1.85)  LDD0080 
Drebrin (DBN1) LDTP06588 C70(1.98)  LDD3310 
Drebrin-like protein (DBNL) LDTP13399 C67(1.77)  LDD3310 
Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide (DAPP1) LDTP13637 C54(1.76)  LDD3439 
Dymeclin (DYM) LDTP08000 C207(0.95)  LDD0532 
Dynactin subunit 1 (DCTN1) LDTP06082 C1252(1.23); C888(1.04); C677(0.90)  LDD0078 
Dynactin subunit 2 (DCTN2) LDTP05922 C240(0.95); C256(1.04); C240(0.97); C256(0.97)  LDD1492 
Dynactin subunit 3 (DCTN3) LDTP01359 C140(2.33)  LDD3312 
Dynactin subunit 4 (DCTN4) LDTP13402 C30(1.20); C425(1.49); C265(2.94)  LDD3312 
Dynactin subunit 5 (DCTN5) LDTP11196 C46(1.15)  LDD0531 
Dynactin subunit 6 (DCTN6) LDTP00261 C18(3.62)  LDD3312 
Dynamin-binding protein (DNMBP) LDTP07755 C1434(1.74)  LDD0080 
Dynein axonemal assembly factor 10 (DNAAF10) LDTP15788 C70(0.92); C167(0.90)  LDD0078 
Dynein axonemal assembly factor 5 (DNAAF5) LDTP08387 C555(1.06); C173(1.03); C612(0.95)  LDD0078 
Dynein axonemal assembly factor 9 (DNAAF9) LDTP17242 C29(0.83)  LDD3424 
Dynein axonemal light chain 1 (DNAL1) LDTP06860 C141(1.09)  LDD1492 
Dynein light chain 1, cytoplasmic (DYNLL1) LDTP05049 C24(2.05)  LDD3323 
Dynein light chain 2, cytoplasmic (DYNLL2) LDTP10308 C56(2.20)  LDD3310 
Dynein light chain Tctex-type 1 (DYNLT1) LDTP05050 C83(1.19)  LDD0080 
Dynein light chain Tctex-type 3 (DYNLT3) LDTP04467 C8(1.14)  LDD0531 
Dynein light chain Tctex-type protein 2B (DYNLT2B) LDTP09637 C47(1.79)  LDD3376 
Dynein regulatory complex subunit 4 (GAS8) LDTP01738 C309(11.37)  LDD0209 
Dysbindin (DTNBP1) LDTP10279 C302(0.94)  LDD0531 
Dyslexia-associated protein KIAA0319-like protein (KIAA0319L) LDTP08689 C904(1.10)  LDD1507 
Dystonin (DST) LDTP05386 C179(1.31); C884(1.39); C6799(1.11)  LDD0080 
Dystrophia myotonica WD repeat-containing protein (DMWD) LDTP17017 C140(1.00); C141(1.00)  LDD0078 
E2F-associated phosphoprotein (EAPP) LDTP06931 C210(1.82)  LDD3342 
E3 ubiquitin-protein ligase RNFT2 (RNFT2) LDTP15719 C161(14.60)  LDD0204 
Early endosome antigen 1 (EEA1) LDTP06310 C1382(1.01); C1385(1.01); C346(0.88)  LDD0078 
Early estrogen-induced gene 1 protein (EEIG1) LDTP15013 C151(1.62)  LDD3337 
Early placenta insulin-like peptide (INSL4) LDTP14847 C6(3.33)  LDD3440 
EARP and GARP complex-interacting protein 1 (EIPR1) LDTP06913 C95(1.07)  LDD0080 
Echinoderm microtubule-associated protein-like 1 (EML1) LDTP00271 C789(1.72)  LDD3316 
Echinoderm microtubule-associated protein-like 2 (EML2) LDTP01690 C53(0.89)  LDD3310 
Echinoderm microtubule-associated protein-like 3 (EML3) LDTP06752 C816(0.84)  LDD0533 
Echinoderm microtubule-associated protein-like 4 (EML4) LDTP12214 C820(4.20); C82(1.70); C311(1.09)  LDD0080 
Echinoderm microtubule-associated protein-like 5 (EML5) LDTP17010 C363(1.79); C1972(1.97)  LDD3340 
Ecotropic viral integration site 5 protein homolog (EVI5) LDTP00971 C198(1.02)  LDD0531 
Ectoderm-neural cortex protein 1 (ENC1) LDTP00406 C464(1.27); C468(1.27)  LDD0078 
Ectodysplasin-A receptor-associated adapter protein (EDARADD) LDTP09675 C57(3.62); C64(3.62)  LDD0080 
Ectopic P granules protein 5 homolog (EPG5) LDTP12232 C472(1.87); C1861(1.32); C187(1.08); C201(1.08)  LDD0078 
EEIG family member 2 (EEIG2) LDTP19405 C222(1.56)  LDD3333 
EF-hand and coiled-coil domain-containing protein 1 (EFCC1) LDTP18428 C83(1.73); C472(1.31)  LDD2470 
EF-hand calcium-binding domain-containing protein 4A (CRACR2B) LDTP08880 C185(2.90)  LDD3314 
EF-hand calcium-binding domain-containing protein 4B (CRACR2A) LDTP11172 C291(1.87)  LDD3314 
EF-hand calcium-binding domain-containing protein 7 (EFCAB7) LDTP14390 C524(2.81)  LDD0080 
EF-hand domain-containing family member B (EFHB) LDTP08967 C810(2.40)  LDD3336 
EF-hand domain-containing protein D2 (EFHD2) LDTP15701 C172(1.04); C53(0.95)  LDD0078 
EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) LDTP05656 C159(0.99); C184(0.99); C377(0.95); C379(0.95)  LDD0078 
EH domain-binding protein 1 (EHBP1) LDTP09128 C672(1.61)  LDD3337 
EH domain-binding protein 1-like protein 1 (EHBP1L1) LDTP15411 C422(1.08); C1364(1.03); C346(0.92)  LDD0078 
EKC/KEOPS complex subunit GON7 (GON7) LDTP11418 C21(2.98)  LDD3338 
EKC/KEOPS complex subunit LAGE3 (LAGE3) LDTP06171 C113(1.11)  LDD1514 
EKC/KEOPS complex subunit TPRKB (TPRKB) LDTP13974 C206(1.30)  LDD3312 
ELKS/Rab6-interacting/CAST family member 1 (ERC1) LDTP08448 C258(2.25)  LDD3320 
ELL-associated factor 1 (EAF1) LDTP10458 C15(1.66)  LDD3310 
ELL-associated factor 2 (EAF2) LDTP10174 C29(0.92)  LDD0532 
ELMO domain-containing protein 1 (ELMOD1) LDTP17691 C322(2.02)  LDD3404 
ELMO domain-containing protein 2 (ELMOD2) LDTP17659 C285(1.21)  LDD0080 
Elongation factor 1-beta (EEF1B2) LDTP03283 C50(1.02)  LDD0078 
Elongation factor 1-delta (EEF1D) LDTP03499 C613(0.96)  LDD3310 
Elongation factor 1-gamma (EEF1G) LDTP03367 C194(1.62); C266(1.20)  LDD0080 
Elongation factor Ts, mitochondrial (TSFM) LDTP04064 C71(0.82); C149(1.81); C261(1.48)  LDD3311 
Elongator complex protein 1 (ELP1) LDTP01511 C453(0.90); C456(0.90)  LDD0078 
Elongator complex protein 2 (ELP2) LDTP07400 C811(1.79)  LDD3310 
Elongator complex protein 4 (ELP4) LDTP10252 C218(17.81)  LDD0209 
Elongator complex protein 5 (ELP5) LDTP09469 C52(0.97); C151(1.04)  LDD1492 
Elongator complex protein 6 (ELP6) LDTP05607 C218(1.08)  LDD0078 
Elongin BC and Polycomb repressive complex 2-associated protein (EPOP) LDTP14365 C140(2.29)  LDD3407 
Elongin-A (ELOA) LDTP06090 C568(408.93); C610(7.93)  LDD0209 
Elongin-B (ELOB) LDTP06369 C60(1.80)  LDD3310 
Elongin-C (ELOC) LDTP06368 C74(0.89)  LDD0078 
Embryonal Fyn-associated substrate (EFS) LDTP00724 C402(2.36)  LDD3341 
Emerin (EMD) LDTP04356 C147(1.31)  LDD3323 
EMILIN-1 (EMILIN1) LDTP14233 C734(1.35)  LDD3338 
EMILIN-2 (EMILIN2) LDTP11422 C691(1.07)  LDD3333 
EMILIN-3 (EMILIN3) LDTP12598 C521(1.41)  LDD1507 
Endogenous retroviral envelope protein HEMO (ERVMER34-1) LDTP12100 C352(1.13); C364(1.11); C543(1.37)  LDD0531 
Endogenous retrovirus group FC1 member 1 Env polyprotein (ERVFC1-1) LDTP14756 C132(0.91)  LDD1492 
Endonuclease/exonuclease/phosphatase family domain-containing protein 1 (EEPD1) LDTP15220 C28(0.77)  LDD0531 
Endophilin-A1 (SH3GL2) LDTP11020 C108(110.93)  LDD0209 
Endophilin-A2 (SH3GL1) LDTP11019 C277(0.89)  LDD0078 
Endophilin-B2 (SH3GLB2) LDTP12474 C271(4.83)  LDD3310 
Endoplasmic reticulum lectin 1 (ERLEC1) LDTP10237 C113(3.34)  LDD3310 
Endoplasmic reticulum resident protein 29 (ERP29) LDTP03509 C157(1.06)  LDD0531 
Endoplasmic reticulum resident protein 44 (ERP44) LDTP11144 C92(0.70)  LDD0532 
Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ERGIC1) LDTP10046 C70(3.37)  LDD3310 
Endoplasmic reticulum-Golgi intermediate compartment protein 2 (ERGIC2) LDTP10775 C344(0.81); C345(0.81)  LDD1095 
Endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3) LDTP13828 C182(0.97)  LDD3312 
Endoplasmin (HSP90B1) LDTP02734 C645(1.71)  LDD0080 
Endosialin (CD248) LDTP12270 C753(1.36)  LDD3364 
Endosomal transmembrane epsin interactor 1 (ENTREP1) LDTP06498 C292(1.07)  LDD1571 
Endosome-associated-trafficking regulator 1 (ENTR1) LDTP10164 C33(1.09); C39(1.09)  LDD0078 
Endosome/lysosome-associated apoptosis and autophagy regulator 1 (ELAPOR1) LDTP07705 C739(1.96)  LDD3395 
Endothelial cell-specific chemotaxis regulator (ECSCR) LDTP06671 C172(1.47)  LDD3478 
Endothelial protein C receptor (PROCR) LDTP13669 C186(1.53)  LDD3380 
Endothelin-1 (EDN1) LDTP02105 C155(19.70)  LDD2236 
Engulfment and cell motility protein 1 (ELMO1) LDTP09794 C726(1.12)  LDD0078 
Engulfment and cell motility protein 2 (ELMO2) LDTP10469 C404(1.02); C550(0.79)  LDD0531 
Engulfment and cell motility protein 3 (ELMO3) LDTP18127 C597(1.18)  LDD3310 
Enhancer of filamentation 1 (NEDD9) LDTP06131 C281(2.05)  LDD3367 
Enhancer of mRNA-decapping protein 3 (EDC3) LDTP10299 C137(1.10)  LDD0078 
Enhancer of mRNA-decapping protein 4 (EDC4) LDTP07521 C384(1.01)  LDD0078 
Enhancer of polycomb homolog 1 (EPC1) LDTP11817 C566(1.31)  LDD0078 
Enhancer of polycomb homolog 2 (EPC2) LDTP14941 C626(2.39)  LDD0080 
Enkurin domain-containing protein 1 (ENKD1) LDTP11713 C58(0.84)  LDD1507 
Ensconsin (MAP7) LDTP06092 C275(3.55)  LDD3364 
Envoplakin (EVPL) LDTP09884 C130(1.27); C1592(0.97)  LDD0531 
Ephexin-1 (NGEF) LDTP08908 C454(3.34)  LDD3322 
Ephrin-A5 (EFNA5) LDTP04536 C164(1.97)  LDD3360 
Ephrin-B1 (EFNB1) LDTP05222 C314(2.24)  LDD3317 
Ephrin-B2 (EFNB2) LDTP04535 C301(0.78)  LDD0593 
Ephrin-B3 (EFNB3) LDTP06466 C308(1.22)  LDD3346 
Epidermal growth factor receptor kinase substrate 8 (EPS8) LDTP05696 C767(1.16)  LDD0531 
Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8L1) LDTP09481 C124(4.48)  LDD3364 
Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8L2) LDTP11998 C317(1.03); C369(0.85); C543(1.32)  LDD0531 
Epidermal growth factor receptor kinase substrate 8-like protein 3 (EPS8L3) LDTP09480 C37(1.62)  LDD3330 
Epidermal growth factor receptor substrate 15 (EPS15) LDTP03982 C657(1.05); C586(0.90)  LDD0078 
Epidermal growth factor receptor substrate 15-like 1 (EPS15L1) LDTP13097 C470(1.61)  LDD3312 
Epidermal growth factor-like protein 7 (EGFL7) LDTP13276 C102(4.84); C111(4.84)  LDD0080 
Epidermal growth factor-like protein 8 (EGFL8) LDTP11013 C38(2.34)  LDD2253 
Epiplakin (EPPK1) LDTP04809 C406(1.10); C927(0.91)  LDD0078 
Epithelial cell adhesion molecule (EPCAM) LDTP02847 C135(0.97); C38(1.28); C46(1.54); C48(1.57)  LDD0531 
Epithelial splicing regulatory protein 1 (ESRP1) LDTP07487 C547(1.08); C215(1.09); C258(1.24)  LDD0531 
Epithelial splicing regulatory protein 2 (ESRP2) LDTP11999 C86(2.41)  LDD3311 
EPM2A-interacting protein 1 (EPM2AIP1) LDTP07972 C465(0.99)  LDD0078 
Epsilon-sarcoglycan (SGCE) LDTP00799 C235(1.32)  LDD1508 
Epsin-1 (EPN1) LDTP14256 C96(2.05)  LDD3332 
Epsin-2 (EPN2) LDTP01527 C96(3.54)  LDD3325 
Epsin-3 (EPN3) LDTP11783 C96(1.95)  LDD3320 
ER lumen protein-retaining receptor 2 (KDELR2) LDTP03678 C29(1.22)  LDD0531 
ERBB receptor feedback inhibitor 1 (ERRFI1) LDTP13388 C80(1.46); C378(1.30); C124(1.26); C142(0.85)  LDD0078 
Erbin (ERBIN) LDTP10782 C1316(2.25)  LDD3314 
Ergosterol biosynthetic protein 28 homolog (ERG28) LDTP13478 C65(0.96); C67(0.96)  LDD0531 
Erythroid differentiation-related factor 1 (EDRF1) LDTP06756 C1019(150.83); C465(5.29)  LDD0209 
ESF1 homolog (ESF1) LDTP15997 C353(1.00); C453(1.04); C462(1.04)  LDD0531 
Espin (ESPN) LDTP00160 C526(0.89)  LDD0531 
Espin-like protein (ESPNL) LDTP15200 C882(1.00)  LDD1492 
Eukaryotic peptide chain release factor subunit 1 (ETF1) LDTP04993 C302(1.79); C335(1.22); C127(1.21)  LDD0080 
Eukaryotic translation elongation factor 1 epsilon-1 (EEF1E1) LDTP00750 C147(0.93)  LDD0078 
Eukaryotic translation initiation factor 1 (EIF1) LDTP03953 C69(0.88)  LDD0531 
Eukaryotic translation initiation factor 1A, X-chromosomal (EIF1AX) LDTP04129 C51(1.30)  LDD0080 
Eukaryotic translation initiation factor 1b (EIF1B) LDTP16815 C94(0.92)  LDD3332 
Eukaryotic translation initiation factor 2 subunit 1 (EIF2S1) LDTP02101 C199(1.00); C70(0.89)  LDD0078 
Eukaryotic translation initiation factor 2 subunit 2 (EIF2S2) LDTP03027 C226(0.92); C302(0.89); C305(0.89); C309(0.89)  LDD0078 
Eukaryotic translation initiation factor 2A (EIF2A) LDTP11436 C142(4.49)  LDD0209 
Eukaryotic translation initiation factor 2D (EIF2D) LDTP03928 C489(1.25)  LDD0078 
Eukaryotic translation initiation factor 3 subunit A (EIF3A) LDTP06055 C478(0.92); C58(0.88)  LDD0078 
Eukaryotic translation initiation factor 3 subunit B (EIF3B) LDTP04718 C384(1.45)  LDD3310 
Eukaryotic translation initiation factor 3 subunit C (EIF3C) LDTP10919 C443(1.05)  LDD0078 
Eukaryotic translation initiation factor 3 subunit C-like protein (EIF3CL) LDTP16728 C444(0.95); C620(0.85)  LDD0078 
Eukaryotic translation initiation factor 3 subunit D (EIF3D) LDTP00619 C19(0.97)  LDD0078 
Eukaryotic translation initiation factor 3 subunit E (EIF3E) LDTP04853 C350(1.09)  LDD0078 
Eukaryotic translation initiation factor 3 subunit G (EIF3G) LDTP01319 C139(1.14); C25(1.06)  LDD0078 
Eukaryotic translation initiation factor 3 subunit H (EIF3H) LDTP00620 C327(2.55)  LDD0080 
Eukaryotic translation initiation factor 3 subunit I (EIF3I) LDTP05834 C76(1.19); C81(1.08)  LDD0078 
Eukaryotic translation initiation factor 3 subunit J (EIF3J) LDTP01320 C207(1.16)  LDD0531 
Eukaryotic translation initiation factor 3 subunit K (EIF3K) LDTP13143 C85(2.33); C87(1.87); C190(1.07)  LDD0080 
Eukaryotic translation initiation factor 3 subunit L (EIF3L) LDTP13813 C417(0.71)  LDD0531 
Eukaryotic translation initiation factor 3 subunit M (EIF3M) LDTP07947 C134(1.02); C175(1.00)  LDD0078 
Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) LDTP05421 C662(13.37); C821(840.93)  LDD0209 
Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) LDTP05098 C282(0.99)  LDD0078 
Eukaryotic translation initiation factor 4 gamma 3 (EIF4G3) LDTP00766 C982(14.07)  LDD0204 
Eukaryotic translation initiation factor 4B (EIF4B) LDTP03247 C457(1.48)  LDD3319 
Eukaryotic translation initiation factor 4E (EIF4E) LDTP02156 C201(1.55)  LDD3310 
Eukaryotic translation initiation factor 4E type 3 (EIF4E3) LDTP17722 C69(2.19)  LDD3318 
Eukaryotic translation initiation factor 4E-binding protein 2 (EIF4EBP2) LDTP05916 C35(1.96)  LDD3401 
Eukaryotic translation initiation factor 4E-binding protein 3 (EIF4EBP3) LDTP14475 C19(10.38)  LDD0209 
Eukaryotic translation initiation factor 4H (EIF4H) LDTP06301 C85(1.08)  LDD0531 
Eukaryotic translation initiation factor 5 (EIF5) LDTP04652 C320(0.99); C122(0.89)  LDD0078 
Eukaryotic translation initiation factor 6 (EIF6) LDTP04743 C11(0.91); C15(0.91)  LDD0078 
EVI5-like protein (EVI5L) LDTP10178 C648(1.40)  LDD3323 
Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (ECSIT) LDTP11065 C85(2.12)  LDD3310 
Ewing's tumor-associated antigen 1 (ETAA1) LDTP12812 C536(30.73)  LDD0209 
Exocyst complex component 3-like protein 2 (EXOC3L2) LDTP17076 C130(1.44)  LDD2324 
Exocyst complex component 6B (EXOC6B) LDTP13851 C32(0.91)  LDD0078 
Exophilin-5 (EXPH5) LDTP09178 C149(2.24); C1492(2.31)  LDD3314 
Exosome complex component RRP4 (EXOSC2) LDTP05993 C240(1.82)  LDD3310 
Exosome complex component RRP40 (EXOSC3) LDTP12434 C215(0.99)  LDD0078 
Exportin-6 (XPO6) LDTP10749 C299(1.32); C547(0.89)  LDD0078 
Extracellular matrix organizing protein FRAS1 (FRAS1) LDTP08376 C3971(4.46)  LDD3365 
Extracellular matrix protein 1 (ECM1) LDTP06572 C311(2.94)  LDD3401 
EZH inhibitory protein (EZHIP) LDTP08350 C238(0.89)  LDD3323 
Ezrin (EZR) LDTP02779 C117(1.05); C284(0.92)  LDD0531 
F-actin-capping protein subunit alpha-1 (CAPZA1) LDTP04544 C124(1.22)  LDD0531 
F-actin-capping protein subunit alpha-2 (CAPZA2) LDTP04126 C141(0.86)  LDD0593 
F-actin-capping protein subunit beta (CAPZB) LDTP04127 C206(1.85)  LDD0080 
F-actin-uncapping protein LRRC16A (CARMIL1) LDTP07261 C1106(1.00); C235(1.17); C464(1.18); C51(0.65)  LDD0531 
F-BAR and double SH3 domains protein 1 (FCHSD1) LDTP08336 C471(1.42)  LDD3314 
F-BAR and double SH3 domains protein 2 (FCHSD2) LDTP01443 C49(4.25)  LDD3310 
F-BAR domain only protein 1 (FCHO1) LDTP00363 C371(5.13); C571(9.05)  LDD0209 
F-BAR domain only protein 2 (FCHO2) LDTP05605 C679(1.10)  LDD0532 
F-box only protein 21 (FBXO21) LDTP16836 C66(0.81)  LDD0532 
F-box only protein 22 (FBXO22) LDTP09187 C228(0.92)  LDD0078 
F-box only protein 24 (FBXO24) LDTP16821 C506(4.32)  LDD3311 
F-box only protein 28 (FBXO28) LDTP12674 C166(0.78); C167(0.78); C98(0.97)  LDD0531 
F-box only protein 3 (FBXO3) LDTP13436 C403(1.14)  LDD0532 
F-box only protein 30 (FBXO30) LDTP15582 C555(1.30); C562(1.30); C60(1.23); C67(1.23)  LDD0078 
F-box only protein 33 (FBXO33) LDTP17558 C101(0.78)  LDD1093 
F-box only protein 38 (FBXO38) LDTP07588 C750(0.88); C773(0.88)  LDD0078 
F-box only protein 4 (FBXO4) LDTP13482 C147(391.15)  LDD0209 
F-box only protein 40 (FBXO40) LDTP18532 C25(1.09)  LDD2171 
F-box only protein 42 (FBXO42) LDTP15111 C341(1.24); C345(1.24)  LDD0531 
F-box only protein 46 (FBXO46) LDTP17395 C545(8.46)  LDD0209 
F-box only protein 5 (FBXO5) LDTP13481 C401(1.08); C49(1.05); C53(1.05)  LDD0078 
F-box only protein 7 (FBXO7) LDTP13993 C286(0.93); C36(0.89)  LDD0078 
F-box only protein 9 (FBXO9) LDTP13435 C226(1.11)  LDD0532 
F-box-like/WD repeat-containing protein TBL1X (TBL1X) LDTP01082 C571(18.86)  LDD0209 
F-box-like/WD repeat-containing protein TBL1XR1 (TBL1XR1) LDTP11544 C367(0.90); C490(1.34)  LDD0531 
F-box-like/WD repeat-containing protein TBL1Y (TBL1Y) LDTP11062 C553(1.58)  LDD3410 
F-box/LRR-repeat protein 14 (FBXL14) LDTP08768 C127(23.62); C382(42.55)  LDD0209 
F-box/LRR-repeat protein 15 (FBXL15) LDTP11902 C139(0.89)  LDD0078 
F-box/LRR-repeat protein 16 (FBXL16) LDTP15417 C356(0.87)  LDD0532 
F-box/LRR-repeat protein 20 (FBXL20) LDTP15743 C116(1.77)  LDD0531 
F-box/LRR-repeat protein 4 (FBXL4) LDTP13438 C257(1.30)  LDD0080 
F-box/LRR-repeat protein 7 (FBXL7) LDTP13396 C253(1.26)  LDD2268 
F-box/WD repeat-containing protein 11 (FBXW11) LDTP13442 C393(0.48)  LDD0533 
F-box/WD repeat-containing protein 1A (BTRC) LDTP13838 C87(1.20); C94(1.20)  LDD0078 
F-box/WD repeat-containing protein 2 (FBXW2) LDTP13484 C327(0.91)  LDD0531 
F-box/WD repeat-containing protein 4 (FBXW4) LDTP14725 C64(9.89)  LDD0080 
F-box/WD repeat-containing protein 5 (FBXW5) LDTP10034 C503(3.09)  LDD3470 
F-box/WD repeat-containing protein 8 (FBXW8) LDTP08844 C575(1.38)  LDD3382 
F-box/WD repeat-containing protein 9 (FBXW9) LDTP17296 C407(1.01)  LDD0533 
Fanconi anemia core complex-associated protein 100 (FAAP100) LDTP05616 C852(1.05); C860(1.05)  LDD0078 
Fanconi anemia group A protein (FANCA) LDTP00618 C622(0.86); C625(0.86)  LDD0078 
Fanconi anemia group B protein (FANCB) LDTP09045 C189(1.16); C196(1.16); C190(0.93)  LDD0078 
Fanconi anemia group C protein (FANCC) LDTP05250 C241(1.11)  LDD1509 
Fanconi anemia group D2 protein (FANCD2) LDTP11421 C1369(1.14); C729(0.85)  LDD0078 
Fanconi anemia group E protein (FANCE) LDTP12167 C222(1.07)  LDD0078 
Fanconi anemia group G protein (FANCG) LDTP00600 C499(1.05); C503(1.05)  LDD0078 
Fanconi anemia group I protein (FANCI) LDTP12680 C419(3.61); C1184(1.21); C875(1.80); C165(1.31)  LDD0080 
Far upstream element-binding protein 1 (FUBP1) LDTP10078 C148(1.51)  LDD3310 
Far upstream element-binding protein 2 (KHSRP) LDTP09938 C176(0.95)  LDD0078 
Far upstream element-binding protein 3 (FUBP3) LDTP10408 C460(1.02); C109(0.89); C366(0.88)  LDD0078 
Fas apoptotic inhibitory molecule 1 (FAIM) LDTP16110 C156(1.29)  LDD3339 
FAS-associated death domain protein (FADD) LDTP05772 C27(2.42)  LDD3310 
FAS-associated factor 1 (FAF1) LDTP13668 C428(2.03)  LDD0080 
FAS-associated factor 2 (FAF2) LDTP10185 C32(1.35)  LDD0080 
Fasciculation and elongation protein zeta-2 (FEZ2) LDTP13315 C61(1.86)  LDD3413 
Fascin (FSCN1) LDTP06598 C334(1.14)  LDD0078 
Fatty acid-binding protein, adipocyte (FABP4) LDTP02763 C118(8.62)  LDD3345 
Fer-1-like protein 6 (FER1L6) LDTP17090 C1728(1.72)  LDD3338 
FERM and PDZ domain-containing protein 3 (FRMPD3) LDTP19359 C1198(2.97)  LDD3342 
FERM and PDZ domain-containing protein 4 (FRMPD4) LDTP06257 C1191(1.64)  LDD3373 
FERM domain-containing protein 3 (FRMD3) LDTP00043 C33(2.12); C62(1.41)  LDD3383 
FERM domain-containing protein 4A (FRMD4A) LDTP13074 C980(2.85)  LDD3332 
FERM domain-containing protein 4B (FRMD4B) LDTP16265 C527(2.30)  LDD3319 
FERM domain-containing protein 5 (FRMD5) LDTP08123 C91(1.10)  LDD0531 
FERM domain-containing protein 6 (FRMD6) LDTP10624 C306(1.04)  LDD0531 
FERM domain-containing protein 8 (FRMD8) LDTP11515 C206(3.20); C168(1.98); C176(1.98)  LDD0080 
FERM, ARHGEF and pleckstrin domain-containing protein 1 (FARP1) LDTP14052 C522(2.15)  LDD3312 
FERM, ARHGEF and pleckstrin domain-containing protein 2 (FARP2) LDTP01450 C313(1.75)  LDD3310 
Fermitin family homolog 2 (FERMT2) LDTP10076 C426(2.16)  LDD3310 
Fermitin family homolog 3 (FERMT3) LDTP08263 C439(2.26); C407(4.06)  LDD3333 
Ferritin heavy polypeptide-like 17 (FTHL17) LDTP18329 C82(1.62)  LDD2356 
FGFR1 oncogene partner 2 (FGFR1OP2) LDTP16108 C198(0.98)  LDD0078 
FH1/FH2 domain-containing protein 1 (FHOD1) LDTP14195 C502(1.10); C43(0.97); C373(0.93)  LDD0078 
FH1/FH2 domain-containing protein 3 (FHOD3) LDTP06732 C111(2.13)  LDD3369 
FHF complex subunit HOOK interacting protein 2A (FHIP2A) LDTP17289 C304(1.09); C306(1.09)  LDD0078 
FHF complex subunit HOOK-interacting protein 1A (FHIP1A) LDTP17011 C430(0.96)  LDD0532 
FHF complex subunit HOOK-interacting protein 1B (FHIP1B) LDTP08915 C522(1.13); C399(1.04); C967(1.26)  LDD1492 
FHF complex subunit HOOK-interacting protein 2B (FHIP2B) LDTP17580 C298(0.96)  LDD0078 
Fibrillin-1 (FBN1) LDTP03757 C617(1.12); C623(1.12); C59(1.12); C1971(1.11)  LDD0078 
Fibrillin-2 (FBN2) LDTP03758 C898(4.37); C821(5.06); C826(5.06); C808(6.61)  LDD0080 
Fibrillin-3 (FBN3) LDTP07911 C500(1.35)  LDD0637 
Fibrinogen beta chain (FGB) LDTP01942 C437(1.14)  LDD0531 
Fibrinogen C domain-containing protein 1 (FIBCD1) LDTP08882 C77(3.98)  LDD3458 
Fibrinogen gamma chain (FGG) LDTP01943 C34(1.91)  LDD0532 
Fibroblast growth factor receptor substrate 2 (FRS2) LDTP09557 C415(1.90)  LDD3337 
Fibroblast growth factor receptor substrate 3 (FRS3) LDTP00801 C80(2.93)  LDD3311 
Fibroblast growth factor-binding protein 1 (FGFBP1) LDTP06132 C197(1.45)  LDD2284 
Fibroblast growth factor-binding protein 3 (FGFBP3) LDTP09313 C80(2.95); C90(3.41)  LDD2460 
Fibroleukin (FGL2) LDTP06102 C39(2.47)  LDD3366 
Fibronectin (FN1) LDTP01957 C135(1.89); C401(2.04)  LDD3311 
Fibrous sheath-interacting protein 1 (FSIP1) LDTP17772 C476(3.80)  LDD3319 
Fibrous sheath-interacting protein 2 (FSIP2) LDTP06955 C2120(0.92)  LDD2331 
Fibulin-1 (FBLN1) LDTP03208 C186(1.99)  LDD3311 
Fibulin-2 (FBLN2) LDTP05213 C798(2.29); C1103(2.30); C837(3.08); C489(2.66)  LDD3410 
Fibulin-7 (FBLN7) LDTP14949 C196(2.77)  LDD2337 
Ficolin-1 (FCN1) LDTP00322 C111(1.14)  LDD3336 
FIGNL1-interacting regulator of recombination and mitosis (FIRRM) LDTP19992 C559(1.11)  LDD0078 
Filamin A-interacting protein 1-like (FILIP1L) LDTP06857 C849(0.89)  LDD0078 
Filamin-A-interacting protein 1 (FILIP1) LDTP08141 C404(0.67)  LDD3421 
Filamin-binding LIM protein 1 (FBLIM1) LDTP09582 C35(1.05); C208(0.98); C211(0.98); C183(0.87)  LDD0078 
FK506-binding protein-like (FKBPL) LDTP16206 C261(0.91); C275(0.91)  LDD0078 
Flotillin-2 (FLOT2) LDTP06096 C88(7.62)  LDD3312 
FLYWCH family member 2 (FLYWCH2) LDTP19852 C64(0.97)  LDD0531 
FLYWCH-type zinc finger-containing protein 1 (FLYWCH1) LDTP06867 C740(2.74)  LDD3310 
FMR1-interacting protein NUFIP1 (NUFIP1) LDTP13291 C199(1.43); C204(1.43)  LDD0080 
FMR1-interacting protein NUFIP2 (NUFIP2) LDTP08054 C234(1.06)  LDD0078 
Focadhesin (FOCAD) LDTP07235 C1058(1.21); C55(0.85); C56(0.85)  LDD0078 
Folate receptor beta (FOLR2) LDTP02714 C129(1.48)  LDD3332 
Folate receptor gamma (FOLR3) LDTP03951 C152(1.31)  LDD3368 
Folliculin (FLCN) LDTP09201 C131(0.90); C134(0.90); C335(0.85)  LDD0078 
Folliculin-interacting protein 1 (FNIP1) LDTP09523 C281(1.18); C87(1.13); C88(1.13); C887(1.11)  LDD0078 
Folliculin-interacting protein 2 (FNIP2) LDTP13027 C235(3.03)  LDD3418 
Follistatin (FST) LDTP03021 C132(3.82)  LDD3365 
Follistatin-related protein 1 (FSTL1) LDTP05666 C233(5.61); C250(5.61); C84(2.45)  LDD0080 
Follistatin-related protein 3 (FSTL3) LDTP01643 C229(3.23)  LDD3440 
Formin-1 (FMN1) LDTP07324 C804(0.99)  LDD0078 
Formin-2 (FMN2) LDTP12876 C1555(1.75)  LDD3345 
Formin-binding protein 1 (FNBP1) LDTP10786 C511(0.98); C130(0.85)  LDD0078 
Formin-binding protein 1-like (FNBP1L) LDTP07088 C129(1.81)  LDD0080 
Formin-binding protein 4 (FNBP4) LDTP15413 C675(1.81)  LDD3314 
Formin-like protein 1 (FMNL1) LDTP01611 C787(8.19); C787(199.02); C300(14.46)  LDD0209 
Formin-like protein 2 (FMNL2) LDTP10707 C69(1.77)  LDD3310 
Formin-like protein 3 (FMNL3) LDTP08494 C735(2.54)  LDD3319 
Four and a half LIM domains protein 1 (FHL1) LDTP05961 C87(0.86)  LDD3311 
Four and a half LIM domains protein 2 (FHL2) LDTP06077 C209(3.10); C212(2.21); C214(2.06); C251(1.99)  LDD0080 
Four and a half LIM domains protein 3 (FHL3) LDTP05962 C129(1.34); C132(1.34); C10(1.03); C254(0.96)  LDD0078 
Fragile X messenger ribonucleoprotein 1 (FMR1) LDTP05501 C584(1.07); C77(0.97)  LDD0078 
FRAS1-related extracellular matrix protein 2 (FREM2) LDTP07080 C914(0.80)  LDD1492 
FYVE, RhoGEF and PH domain-containing protein 1 (FGD1) LDTP05223 C756(0.84); C761(0.84)  LDD0078 
FYVE, RhoGEF and PH domain-containing protein 2 (FGD2) LDTP08122 C622(2.53)  LDD3310 
FYVE, RhoGEF and PH domain-containing protein 3 (FGD3) LDTP07006 C655(52.44)  LDD0209 
FYVE, RhoGEF and PH domain-containing protein 4 (FGD4) LDTP10577 C102(0.99); C234(1.06); C614(1.12); C88(0.99)  LDD0531 
FYVE, RhoGEF and PH domain-containing protein 5 (FGD5) LDTP07799 C851(3.17)  LDD3487 
FYVE, RhoGEF and PH domain-containing protein 6 (FGD6) LDTP07851 C330(1.05); C350(1.05)  LDD0078 
G antigen 1 (GAGE1) LDTP19158 C117(1.72)  LDD3373 
G kinase-anchoring protein 1 (GKAP1) LDTP07210 C365(1.65)  LDD3440 
G patch domain and ankyrin repeat-containing protein 1 (GPANK1) LDTP01705 C149(0.90)  LDD1492 
G patch domain-containing protein 1 (GPATCH1) LDTP15867 C839(2.77)  LDD3331 
G patch domain-containing protein 11 (GPATCH11) LDTP15466 C69(0.99)  LDD0078 
G patch domain-containing protein 2 (GPATCH2) LDTP12707 C296(2.34)  LDD0080 
G patch domain-containing protein 2-like (GPATCH2L) LDTP12722 C205(0.95)  LDD1514 
G patch domain-containing protein 4 (GPATCH4) LDTP17229 C338(1.59)  LDD3311 
G patch domain-containing protein 8 (GPATCH8) LDTP16223 C795(1.13); C569(1.09); C882(0.98); C639(0.94)  LDD0078 
G protein-regulated inducer of neurite outgrowth 1 (GPRIN1) LDTP15235 C93(0.96); C98(0.96)  LDD0078 
G protein-regulated inducer of neurite outgrowth 3 (GPRIN3) LDTP17503 C228(2.66)  LDD2412 
G-patch domain and KOW motifs-containing protein (GPKOW) LDTP09930 C137(0.65)  LDD0531 
G-protein-signaling modulator 1 (GPSM1) LDTP08410 C128(14.31); C129(14.31)  LDD0080 
G-protein-signaling modulator 2 (GPSM2) LDTP05167 C614(2.13)  LDD3375 
G-protein-signaling modulator 3 (GPSM3) LDTP14060 C160(0.94)  LDD3403 
G-rich sequence factor 1 (GRSF1) LDTP05668 C476(1.02); C29(0.98); C15(0.91); C22(0.91)  LDD0078 
G1/S-specific cyclin-D2 (CCND2) LDTP03527 C41(8.50)  LDD0080 
G1/S-specific cyclin-D3 (CCND3) LDTP03528 C47(1.44)  LDD0078 
G1/S-specific cyclin-E1 (CCNE1) LDTP03296 C322(1.06)  LDD0532 
G1/S-specific cyclin-E2 (CCNE2) LDTP01757 C109(1.06); C57(0.67); C69(0.67)  LDD0531 
G2 and S phase-expressed protein 1 (GTSE1) LDTP12865 C436(2.08)  LDD0080 
GA-binding protein subunit beta-1 (GABPB1) LDTP05495 C331(1.68)  LDD3314 
Galectin-1 (LGALS1) LDTP02341 C43(1.05); C61(0.93)  LDD0078 
Galectin-12 (LGALS12) LDTP15711 C515(4.80)  LDD3344 
Galectin-2 (LGALS2) LDTP02093 C57(0.94)  LDD3487 
Galectin-3-binding protein (LGALS3BP) LDTP05558 C561(0.74)  LDD0531 
Galectin-9 (LGALS9) LDTP00205 C259(1.65)  LDD3451 
Galectin-9B (LGALS9B) LDTP14905 C102(0.96)  LDD3310 
Galectin-related protein (LGALSL) LDTP17117 C101(2.29)  LDD0080 
Gametocyte-specific factor 1 (GTSF1) LDTP18094 C100(2.03); C103(2.03); C76(1.74)  LDD0080 
Gametogenetin-binding protein 2 (GGNBP2) LDTP15986 C461(1.30); C466(1.30); C687(1.12); C385(1.03)  LDD0078 
Gamma-aminobutyric acid receptor-associated protein-like 2 (GABARAPL2) LDTP04871 C15(1.54)  LDD3311 
Gamma-crystallin D (CRYGD) LDTP02194 C111(1.03)  LDD0080 
Gamma-parvin (PARVG) LDTP12183 C314(49.13)  LDD0204 
Gamma-soluble NSF attachment protein (NAPG) LDTP10969 C193(1.32); C312(1.31)  LDD0531 
Gamma-taxilin (TXLNG) LDTP12640 C127(1.55); C56(1.17); C71(1.17); C101(1.04)  LDD0078 
Gamma-tubulin complex component 2 (TUBGCP2) LDTP11159 C469(4.41); C648(9.45); C463(5.52); C469(5.52)  LDD0209 
Gamma-tubulin complex component 3 (TUBGCP3) LDTP10191 C17(0.90); C18(0.89); C274(0.86)  LDD0078 
Gamma-tubulin complex component 4 (TUBGCP4) LDTP13230 C162(1.38)  LDD0080 
Gamma-tubulin complex component 5 (TUBGCP5) LDTP10784 C670(2.39); C574(4.66); C580(4.66)  LDD0080 
Gamma-tubulin complex component 6 (TUBGCP6) LDTP10783 C995(1.17)  LDD0078 
Ganglioside GM2 activator (GM2A) LDTP02927 C138(1.15)  LDD0531 
Ganglioside-induced differentiation-associated protein 1 (GDAP1) LDTP09324 C51(1.02)  LDD1492 
Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1L1) LDTP19897 C72(1.86)  LDD3340 
Ganglioside-induced differentiation-associated protein 2 (GDAP2) LDTP18486 C348(1.19)  LDD0078 
GAS2-like protein 1 (GAS2L1) LDTP10880 C577(1.02)  LDD0078 
GAS2-like protein 3 (GAS2L3) LDTP08360 C132(0.79)  LDD0533 
GATOR1 complex protein DEPDC5 (DEPDC5) LDTP01135 C416(1.00)  LDD0531 
GATOR1 complex protein NPRL2 (NPRL2) LDTP09550 C67(0.94); C70(0.94)  LDD0078 
GATOR1 complex protein NPRL3 (NPRL3) LDTP05714 C80(5.65)  LDD0080 
GATOR2 complex protein MIOS (MIOS) LDTP12775 C788(0.84); C799(0.84)  LDD0078 
GATOR2 complex protein WDR59 (WDR59) LDTP07600 C791(1.00); C902(0.97); C905(0.97)  LDD0078 
GDNF family receptor alpha-1 (GFRA1) LDTP04724 C36(3.95); C52(5.99)  LDD3345 
GDNF family receptor alpha-3 (GFRA3) LDTP01010 C44(1.91)  LDD3333 
Gelsolin (GSN) LDTP02145 C331(0.94); C672(1.18)  LDD0531 
Gem-associated protein 2 (GEMIN2) LDTP00465 C63(57.73)  LDD0209 
Gem-associated protein 4 (GEMIN4) LDTP04790 C683(0.90)  LDD0078 
Gem-associated protein 5 (GEMIN5) LDTP09504 C1503(1.08); C1507(1.07); C1415(1.01); C1421(1.01)  LDD0078 
Gem-associated protein 6 (GEMIN6) LDTP09690 C91(1.06)  LDD0078 
Gem-associated protein 7 (GEMIN7) LDTP12047 C44(1.65)  LDD3323 
Gem-associated protein 8 (GEMIN8) LDTP12746 C180(1.78)  LDD3323 
GEM-interacting protein (GMIP) LDTP12993 C529(0.95); C537(0.95)  LDD0078 
General transcription factor 3C polypeptide 1 (GTF3C1) LDTP05648 C431(1.35); C544(1.10); C853(1.02); C317(0.99)  LDD0078 
General transcription factor 3C polypeptide 2 (GTF3C2) LDTP09565 C828(1.47)  LDD0080 
General transcription factor 3C polypeptide 3 (GTF3C3) LDTP14148 C607(1.02)  LDD0078 
General transcription factor 3C polypeptide 5 (GTF3C5) LDTP14147 C242(8.53); C242(128.52)  LDD0209 
General transcription factor 3C polypeptide 6 (GTF3C6) LDTP09991 C178(0.99)  LDD1492 
General transcription factor IIE subunit 1 (GTF2E1) LDTP03465 C129(1.19); C132(1.19)  LDD1093 
General transcription factor IIF subunit 1 (GTF2F1) LDTP03729 C130(1.71)  LDD3337 
General transcription factor IIF subunit 2 (GTF2F2) LDTP02703 C116(2.21)  LDD3311 
General transcription factor IIH subunit 1 (GTF2H1) LDTP03651 C506(0.99)  LDD0078 
General transcription factor IIH subunit 2 (GTF2H2) LDTP06001 C299(1.85)  LDD0080 
General transcription factor IIH subunit 2-like protein (GTF2H2C; GTF2H2C_2) LDTP15107 C308(0.98)  LDD3312 
General transcription factor IIH subunit 3 (GTF2H3) LDTP06002 C142(1.11); C255(1.19); C257(0.98)  LDD0531 
General transcription factor IIH subunit 4 (GTF2H4) LDTP09861 C16(4.74)  LDD0209 
General vesicular transport factor p115 (USO1) LDTP01048 C307(5.04)  LDD3310 
Genetic suppressor element 1 (GSE1) LDTP06184 C272(0.84)  LDD0078 
Gephyrin (GPHN) LDTP12448 C26(2.65)  LDD3312 
GH3 domain-containing protein (GHDC) LDTP08795 C377(1.49)  LDD0532 
Gigaxonin (GAN) LDTP11810 C134(1.46); C296(1.27); C415(1.12)  LDD0531 
Girdin (CCDC88A) LDTP06804 C1244(1.45)  LDD0080 
Glia maturation factor gamma (GMFG) LDTP14467 C96(1.11)  LDD1508 
Glia-derived nexin (SERPINE2) LDTP02173 C162(2.02)  LDD3332 
Glial fibrillary acidic protein (GFAP) LDTP02710 C294(1.31)  LDD2333 
Glucocorticoid-induced transcript 1 protein (GLCCI1) LDTP19626 C207(1.12)  LDD0078 
Glucokinase regulatory protein (GCKR) LDTP06114 C559(1.61)  LDD3346 
Glucose-induced degradation protein 4 homolog (GID4) LDTP08517 C90(0.92)  LDD1507 
Glucose-induced degradation protein 8 homolog (GID8) LDTP12735 C139(1.17)  LDD0531 
Glutamate-rich protein 3 (ERICH3) LDTP17206 C509(1.24)  LDD3372 
Glutamate-rich WD repeat-containing protein 1 (GRWD1) LDTP11058 C11(1.14)  LDD0078 
Glutamine and serine-rich protein 1 (QSER1) LDTP17071 C283(0.91)  LDD0078 
Glutaredoxin-2, mitochondrial (GLRX2) LDTP12555 C77(61.81)  LDD0209 
Glutathione S-transferase C-terminal domain-containing protein (GSTCD) LDTP17802 C140(1.00)  LDD0078 
Glycine cleavage system H protein, mitochondrial (GCSH) LDTP03227 C138(1.46)  LDD3312 
Glycogen debranching enzyme (AGL) LDTP03762 C399(10.95)  LDD0205 
Glycolipid transfer protein (GLTP) LDTP12891 C36(1.52)  LDD3314 
Glycoprotein integral membrane protein 1 (GINM1) LDTP19994 C88(4.05)  LDD3314 
Glycosylphosphatidylinositol anchor attachment 1 protein (GPAA1) LDTP00729 C266(1.25)  LDD0531 
Glypican-1 (GPC1) LDTP03704 C268(1.02)  LDD0531 
Glypican-2 (GPC2) LDTP08758 C32(3.41)  LDD2275 
Glypican-3 (GPC3) LDTP04439 C372(1.12); C65(2.47)  LDD3424 
Glypican-4 (GPC4) LDTP01237 C244(1.43)  LDD3310 
Glypican-5 (GPC5) LDTP05095 C358(1.18)  LDD1492 
Glypican-6 (GPC6) LDTP14204 C266(17.83); C270(17.83)  LDD0080 
Golgi apparatus protein 1 (GLG1) LDTP09920 C734(3.54); C385(4.52); C324(2.65); C203(3.09)  LDD3311 
Golgi integral membrane protein 4 (GOLIM4) LDTP00281 C6(0.98)  LDD1509 
Golgi membrane protein 1 (GOLM1) LDTP09054 C159(2.13)  LDD3310 
Golgi phosphoprotein 3 (GOLPH3) LDTP11911 C84(1.14); C108(0.99)  LDD0078 
Golgi phosphoprotein 3-like (GOLPH3L) LDTP11910 C84(1.81)  LDD3310 
Golgi reassembly-stacking protein 2 (GORASP2) LDTP12073 C173(1.19)  LDD0080 
Golgi SNAP receptor complex member 2 (GOSR2) LDTP00397 C18(1.26)  LDD3310 
Golgi to ER traffic protein 4 homolog (GET4) LDTP07964 C160(1.56)  LDD0078 
Golgi-associated kinase 1A (GASK1A) LDTP13216 C242(0.96)  LDD1508 
Golgi-associated plant pathogenesis-related protein 1 (GLIPR2) LDTP11924 C63(1.73)  LDD0531 
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (GBF1) LDTP09783 C661(1.01)  LDD0078 
Golgin subfamily A member 2 (GOLGA2) LDTP05557 C139(0.99); C144(0.99); C984(0.97); C794(0.93)  LDD0078 
Golgin subfamily A member 3 (GOLGA3) LDTP05556 C1431(1.88)  LDD0080 
Golgin subfamily A member 4 (GOLGA4) LDTP05872 C1362(1.82)  LDD3310 
Golgin subfamily A member 6-like protein 22 (GOLGA6L22) LDTP18987 C773(1.19)  LDD2257 
Golgin subfamily A member 7B (GOLGA7B) LDTP14893 C33(1.47)  LDD3314 
Golgin subfamily A member 8O (GOLGA8O) LDTP16590 C201(2.20)  LDD3334 
Golgin subfamily B member 1 (GOLGB1) LDTP06210 C980(1.48)  LDD3311 
GON-4-like protein (GON4L) LDTP14919 C1278(1.12); C1288(1.12); C896(0.99); C897(0.99)  LDD0078 
GPI transamidase component PIG-S (PIGS) LDTP10799 C408(1.52)  LDD3312 
GPI transamidase component PIG-T (PIGT) LDTP10015 C78(1.28)  LDD3312 
GRAM domain-containing protein 2B (GRAMD2B) LDTP10390 C27(3.60)  LDD3323 
GRAM domain-containing protein 4 (GRAMD4) LDTP07406 C463(0.84)  LDD1511 
Grancalcin (GCA) LDTP03448 C181(0.85); C182(0.85); C76(0.92); C94(0.92)  LDD0531 
Granule associated Rac and RHOG effector protein 1 (GARRE1) LDTP14439 C245(4.28); C259(4.28)  LDD0080 
GRB10-interacting GYF protein 1 (GIGYF1) LDTP01214 C261(0.98)  LDD0078 
GRB10-interacting GYF protein 2 (GIGYF2) LDTP07758 C594(1.20)  LDD3311 
GRB2-associated and regulator of MAPK protein 1 (GAREM1) LDTP12008 C595(1.03); C598(1.03)  LDD0078 
GRB2-associated-binding protein 1 (GAB1) LDTP05888 C213(1.15)  LDD3323 
GRB2-associated-binding protein 2 (GAB2) LDTP13757 C303(3.44)  LDD3332 
GRB2-related adapter protein (GRAP) LDTP05935 C161(5.31)  LDD3339 
GRB2-related adapter protein 2 (GRAP2) LDTP01310 C244(1.78)  LDD3397 
GREB1-like protein (GREB1L) LDTP11588 C234(1.90)  LDD3395 
Gremlin-1 (GREM1) LDTP01003 C67(2.55)  LDD3318 
GRIP and coiled-coil domain-containing protein 1 (GCC1) LDTP10180 C570(2.22)  LDD3312 
GRIP and coiled-coil domain-containing protein 2 (GCC2) LDTP08543 C284(1.04); C817(0.84); C826(0.84)  LDD0078 
GRIP1-associated protein 1 (GRIPAP1) LDTP06864 C744(1.22)  LDD0078 
Growth arrest-specific protein 1 (GAS1) LDTP14711 C179(14.90)  LDD0209 
Growth arrest-specific protein 2 (GAS2) LDTP00898 C68(1.22)  LDD3372 
Growth arrest-specific protein 6 (GAS6) LDTP06113 C513(2.27)  LDD3380 
Growth arrest-specific protein 7 (GAS7) LDTP01066 C318(2.71); C424(1.46)  LDD3331 
Growth factor receptor-bound protein 10 (GRB10) LDTP05825 C321(0.91)  LDD0078 
Growth factor receptor-bound protein 14 (GRB14) LDTP06122 C360(2.92)  LDD0080 
Growth factor receptor-bound protein 2 (GRB2) LDTP05035 C32(0.94)  LDD0078 
Growth factor receptor-bound protein 7 (GRB7) LDTP06123 C544(1.73)  LDD3310 
Growth hormone-regulated TBC protein 1 (GRTP1) LDTP17241 C54(2.50)  LDD3319 
Growth/differentiation factor 15 (GDF15) LDTP11031 C108(1.58); C222(0.91)  LDD3311 
Growth/differentiation factor 9 (GDF9) LDTP00964 C120(4.83)  LDD2268 
GrpE protein homolog 1, mitochondrial (GRPEL1) LDTP12144 C124(1.06)  LDD0531 
GrpE protein homolog 2, mitochondrial (GRPEL2) LDTP15573 C126(1.82)  LDD0080 
GSK3B-interacting protein (GSKIP) LDTP12977 C77(1.61)  LDD3325 
GTPase-activating protein and VPS9 domain-containing protein 1 (GAPVD1) LDTP06255 C176(4.71); C293(12.72); C176(92.05); C1396(26.86)  LDD0209 
GTPase-activating Rap/Ran-GAP domain-like protein 3 (GARNL3) LDTP15040 C152(2.57)  LDD3340 
Guanine nucleotide exchange factor C9orf72 (C9orf72) LDTP10560 C321(0.96)  LDD3312 
Guanine nucleotide exchange factor DBS (MCF2L) LDTP00528 C951(1.33)  LDD0531 
Guanine nucleotide exchange factor for Rab-3A (RAB3IL1) LDTP09353 C200(0.92); C204(0.92)  LDD0078 
Guanine nucleotide exchange factor MSS4 (RABIF) LDTP04122 C23(0.97)  LDD3314 
Guanine nucleotide exchange factor subunit RIC1 (RIC1) LDTP06836 C434(0.90)  LDD0531 
Guanine nucleotide exchange factor VAV3 (VAV3) LDTP13493 C83(5.11)  LDD0209 
Guanine nucleotide exchange protein SMCR8 (SMCR8) LDTP09511 C350(1.34)  LDD3338 
Guanine nucleotide-binding protein G(i) subunit alpha-1 (GNAI1) LDTP05041 C139(0.88)  LDD0531 
Guanine nucleotide-binding protein G(i) subunit alpha-2 (GNAI2) LDTP02059 C287(1.08); C255(1.90)  LDD3310 
Guanine nucleotide-binding protein G(i) subunit alpha-3 (GNAI3) LDTP02306 C139(0.99); C286(0.53); C305(0.53)  LDD0531 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 (GNG11) LDTP04944 C36(0.23)  LDD2236 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 (GNG12) LDTP13120 C43(1.32)  LDD3311 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (GNG2) LDTP14747 C41(1.31)  LDD2253 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 (GNG3) LDTP14777 C30(1.69)  LDD3340 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 (GNG4) LDTP04343 C28(1.12)  LDD3331 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 (GNG5) LDTP05054 C39(1.02)  LDD1492 
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 (GNG7) LDTP14469 C39(1.12)  LDD1508 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (GNB3) LDTP02857 C25(0.82)  LDD3344 
Guanine nucleotide-binding protein G(o) subunit alpha (GNAO1) LDTP02348 C108(1.11)  LDD3312 
Guanine nucleotide-binding protein G(q) subunit alpha (GNAQ) LDTP04342 C330(2.26)  LDD3312 
Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (GNAS) LDTP07022 C817(0.92)  LDD0649 
Guanine nucleotide-binding protein G(t) subunit alpha-3 (GNAT3) LDTP00139 C139(2.88)  LDD3465 
Guanine nucleotide-binding protein G(z) subunit alpha (GNAZ) LDTP02979 C66(0.86); C287(0.92); C140(1.01)  LDD1492 
Guanine nucleotide-binding protein subunit alpha-12 (GNA12) LDTP05393 C334(4.80)  LDD3310 
Guanine nucleotide-binding protein subunit alpha-13 (GNA13) LDTP06109 C329(0.48)  LDD0533 
Guanine nucleotide-binding protein subunit alpha-14 (GNA14) LDTP01692 C99(2.29)  LDD3314 
Guanine nucleotide-binding protein subunit alpha-15 (GNA15) LDTP03555 C196(1.31)  LDD3315 
Guanine nucleotide-binding protein subunit beta-4 (GNB4) LDTP12141 C148(6.77); C149(6.77); C204(2.38)  LDD0080 
Guanine nucleotide-binding protein subunit beta-5 (GNB5) LDTP00429 C110(1.36); C114(1.36)  LDD0531 
Guanine nucleotide-binding protein subunit beta-like protein 1 (GNB1L) LDTP18337 C109(1.26)  LDD0080 
Guanylyl cyclase-activating protein 3 (GUCA1C) LDTP01693 C183(0.88)  LDD3370 
H/ACA ribonucleoprotein complex subunit 1 (GAR1) LDTP12796 C88(1.45)  LDD0080 
H/ACA ribonucleoprotein complex subunit 2 (NHP2) LDTP12754 C18(1.11)  LDD0078 
H/ACA ribonucleoprotein complex subunit 3 (NOP10) LDTP12350 C28(2.85)  LDD3311 
Hamartin (TSC1) LDTP09805 C306(1.55); C572(0.97); C586(0.97)  LDD0078 
HAUS augmin-like complex subunit 1 (HAUS1) LDTP10184 C156(1.03)  LDD0531 
HAUS augmin-like complex subunit 2 (HAUS2) LDTP12700 C200(1.01); C43(0.89)  LDD0078 
HAUS augmin-like complex subunit 3 (HAUS3) LDTP07318 C271(1.04); C44(0.83)  LDD0531 
HAUS augmin-like complex subunit 4 (HAUS4) LDTP11978 C241(9.41)  LDD0209 
HAUS augmin-like complex subunit 5 (HAUS5) LDTP01466 C533(1.05)  LDD0078 
HAUS augmin-like complex subunit 6 (HAUS6) LDTP08069 C699(1.11); C926(1.00)  LDD0078 
HAUS augmin-like complex subunit 7 (HAUS7) LDTP10996 C119(4.67)  LDD0209 
HAUS augmin-like complex subunit 8 (HAUS8) LDTP11180 C354(1.46)  LDD0078 
HCLS1-binding protein 3 (HS1BP3) LDTP14950 C287(1.13)  LDD1492 
Headcase protein homolog (HECA) LDTP18519 C398(1.09); C401(1.09)  LDD0613 
HEAT repeat-containing protein 1 (HEATR1) LDTP11948 C1138(0.90)  LDD0078 
HEAT repeat-containing protein 3 (HEATR3) LDTP15253 C585(1.07); C20(1.03); C109(0.99); C115(0.99)  LDD0078 
HEAT repeat-containing protein 5A (HEATR5A) LDTP17596 C841(1.51)  LDD0080 
HEAT repeat-containing protein 5B (HEATR5B) LDTP13038 C810(7.01)  LDD0204 
HEAT repeat-containing protein 6 (HEATR6) LDTP17313 C846(19.63); C651(5.91); C1065(5.10)  LDD0209 
Heat shock 70 kDa protein 12A (HSPA12A) LDTP14451 C564(1.13)  LDD0531 
Heat shock 70 kDa protein 13 (HSPA13) LDTP04207 C43(1.77)  LDD3365 
Heat shock 70 kDa protein 14 (HSPA14) LDTP14819 C335(32.33)  LDD0209 
Heat shock 70 kDa protein 1B (HSPA1B) LDTP02435 C17(1.65)  LDD3311 
Heat shock 70 kDa protein 4 (HSPA4) LDTP03695 C34(0.89); C38(0.88)  LDD0078 
Heat shock 70 kDa protein 4L (HSPA4L) LDTP14545 C34(1.40); C540(1.77); C589(1.05); C421(1.40)  LDD0080 
Heat shock 70 kDa protein 6 (HSPA6) LDTP02884 C308(1.13)  LDD2171 
Heat shock protein 105 kDa (HSPH1) LDTP09811 C658(1.14); C650(1.06); C845(1.01); C516(0.98)  LDD0078 
Heat shock protein 75 kDa, mitochondrial (TRAP1) LDTP05697 C573(1.02); C501(0.93)  LDD0078 
Heat shock protein beta-6 (HSPB6) LDTP00370 C46(1.89)  LDD3340 
Heat shock protein beta-7 (HSPB7) LDTP13181 C131(1.14)  LDD2361 
Heat shock protein beta-8 (HSPB8) LDTP13413 C99(1.39)  LDD3314 
Heat shock-related 70 kDa protein 2 (HSPA2) LDTP04621 C606(1.48)  LDD3314 
Hedgehog-interacting protein (HHIP) LDTP10750 C639(1.17)  LDD1573 
Hematopoietic lineage cell-specific protein (HCLS1) LDTP02720 C470(1.46)  LDD3377 
Hematopoietic SH2 domain-containing protein (HSH2D) LDTP10490 C269(3.43); C299(3.46)  LDD3372 
Heme-binding protein 1 (HEBP1) LDTP16078 C36(1.88)  LDD3314 
Hemogen (HEMGN) LDTP15907 C233(2.54)  LDD3408 
Hemoglobin subunit delta (HBD) LDTP01921 C94(1.76)  LDD2324 
Hemoglobin subunit epsilon (HBE1) LDTP01922 C94(1.33)  LDD1507 
Hemoglobin subunit gamma-2 (HBG2) LDTP05083 C94(2.72)  LDD3335 
Hemoglobin subunit zeta (HBZ) LDTP01920 C105(1.90)  LDD3335 
Hemojuvelin (HJV) LDTP07857 C95(1.29)  LDD3413 
Heparin cofactor 2 (SERPIND1) LDTP02120 C292(1.16)  LDD3368 
Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) LDTP00490 C185(1.02); C190(1.02)  LDD0078 
Hepatoma-derived growth factor (HDGF) LDTP04483 C12(0.99)  LDD0078 
Hepatoma-derived growth factor-related protein 2 (HDGFL2) LDTP08081 C496(1.38)  LDD3311 
Hepatoma-derived growth factor-related protein 3 (HDGFL3) LDTP13987 C171(1.01)  LDD1492 
HERV-H_2q24.3 provirus ancestral Env polyprotein LDTP12295 C185(0.80)  LDD1492 
Heterochromatin protein 1-binding protein 3 (HP1BP3) LDTP07068 C359(0.85)  LDD0078 
Heterogeneous nuclear ribonucleoprotein A0 (HNRNPA0) LDTP05768 C49(0.44)  LDD0533 
Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) LDTP02364 C43(1.30); C175(1.43)  LDD0080 
Heterogeneous nuclear ribonucleoprotein A1-like 2 (HNRNPA1L2) LDTP17097 C43(1.06)  LDD0532 
Heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3) LDTP04495 C85(0.99); C94(0.99)  LDD0078 
Heterogeneous nuclear ribonucleoprotein D-like (HNRNPDL) LDTP00500 C177(1.69)  LDD0080 
Heterogeneous nuclear ribonucleoprotein D0 (HNRNPD) LDTP06032 C226(1.15)  LDD0531 
Heterogeneous nuclear ribonucleoprotein F (HNRNPF) LDTP04514 C267(1.06); C122(0.85)  LDD0078 
Heterogeneous nuclear ribonucleoprotein H (HNRNPH1) LDTP03615 C22(1.53); C290(1.14)  LDD0080 
Heterogeneous nuclear ribonucleoprotein H2 (HNRNPH2) LDTP04714 C267(4.01); C122(1.90); C22(1.92)  LDD0080 
Heterogeneous nuclear ribonucleoprotein K (HNRNPK) LDTP04952 C132(7.58); C145(4.48)  LDD0209 
Heterogeneous nuclear ribonucleoprotein L (HNRNPL) LDTP02750 C452(1.10); C472(0.94)  LDD0078 
Heterogeneous nuclear ribonucleoprotein L-like (HNRNPLL) LDTP09626 C405(1.10); C505(0.92)  LDD0078 
Heterogeneous nuclear ribonucleoprotein M (HNRNPM) LDTP04500 C676(1.00); C114(0.98); C653(0.91)  LDD0078 
Heterogeneous nuclear ribonucleoprotein Q (SYNCRIP) LDTP00991 C237(1.09)  LDD0078 
Heterogeneous nuclear ribonucleoprotein R (HNRNPR) LDTP00756 C214(2.85); C240(1.37); C226(2.86)  LDD3310 
Heterogeneous nuclear ribonucleoprotein U (HNRNPU) LDTP05259 C594(1.09); C607(0.97); C562(0.88)  LDD0078 
Heterogeneous nuclear ribonucleoprotein U-like protein 1 (HNRNPUL1) LDTP11238 C487(3.17)  LDD0080 
Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2) LDTP17065 C57(1.03); C405(0.99); C602(0.93)  LDD0078 
Heterogeneous nuclear ribonucleoproteins A2/B1 (HNRNPA2B1) LDTP03182 C50(2.14)  LDD0531 
HHIP-like protein 2 (HHIPL2) LDTP17426 C169(0.92); C472(0.87)  LDD0078 
Hippocalcin-like protein 1 (HPCAL1) LDTP03841 C185(1.10)  LDD0078 
Hippocalcin-like protein 4 (HPCAL4) LDTP13604 C87(0.97)  LDD0532 
HIRA-interacting protein 3 (HIRIP3) LDTP11315 C449(1.55); C450(1.55)  LDD0080 
Histone chaperone ASF1A (ASF1A) LDTP13835 C203(1.19)  LDD0080 
Histone chaperone ASF1B (ASF1B) LDTP12689 C172(0.91); C178(0.91)  LDD0078 
Histone deacetylase complex subunit SAP30 (SAP30) LDTP01224 C184(1.12)  LDD0078 
Histone deacetylase complex subunit SAP30L (SAP30L) LDTP12126 C38(1.19)  LDD3383 
Histone H2B type 1-C/E/F/G/I (H2BC4; H2BC6; H2BC7; H2BC8; H2BC10) LDTP05005 C73(1.50)  LDD2245 
Histone H2B type 2-F (H2BC18) LDTP07049 C84(1.21)  LDD2408 
Histone H3-7 (H3-7) LDTP15019 C111(0.79)  LDD1492 
Histone H3.1 (H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12) LDTP05079 C111(0.65); C97(0.65)  LDD0531 
Histone H3.2 (H3C15; H3C14; H3C13) LDTP07899 C111(0.91)  LDD0602 
Histone H3.3 (H3-3A; H3-3B) LDTP05198 C111(1.00)  LDD0533 
Histone RNA hairpin-binding protein (SLBP) LDTP06126 C15(1.28)  LDD3397 
Histone-binding protein RBBP4 (RBBP4) LDTP05590 C138(1.25)  LDD0080 
Histone-binding protein RBBP7 (RBBP7) LDTP06562 C97(1.08)  LDD0078 
Holliday junction recognition protein (HJURP) LDTP09090 C194(1.11); C348(1.01)  LDD0078 
Homer protein homolog 1 (HOMER1) LDTP08407 C234(1.77)  LDD3342 
Homer protein homolog 2 (HOMER2) LDTP12580 C218(2.29)  LDD3493 
Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (HERPUD1) LDTP06274 C68(1.07)  LDD0531 
Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein (HERPUD2) LDTP11154 C86(2.67); C28(1.00)  LDD3358 
Homologous recombination OB-fold protein (HROB) LDTP08834 C324(3.07)  LDD3397 
Homologous-pairing protein 2 homolog (PSMC3IP) LDTP13083 C107(0.98)  LDD0531 
Host cell factor 1 (HCFC1) LDTP04434 C1166(8.03); C1139(20.67)  LDD0209 
Host cell factor 2 (HCFC2) LDTP14188 C345(1.69); C346(1.69); C278(2.32)  LDD0080 
Hsc70-interacting protein (ST13) LDTP04367 C209(1.03)  LDD0078 
Hsp70-binding protein 1 (HSPBP1) LDTP12914 C204(1.06)  LDD0078 
Hsp90 co-chaperone Cdc37-like 1 (CDC37L1) LDTP07951 C124(1.12); C35(1.00); C54(1.00)  LDD0078 
Huntingtin-interacting protein 1-related protein (HIP1R) LDTP01139 C105(0.88); C211(0.87); C240(0.88); C650(0.94)  LDD0531 
HUWE1-associated protein modifying stress responses 1 (HAPSTR1) LDTP06263 C148(0.82)  LDD0531 
Hyaluronan mediated motility receptor (HMMR) LDTP01177 C243(0.96)  LDD3331 
Hyccin (HYCC1) LDTP11463 C211(0.93); C213(0.93)  LDD0078 
Hyccin 2 (HYCC2) LDTP15350 C7(1.33)  LDD3323 
Hypocretin neuropeptide precursor (HCRT) LDTP00818 C410(1.62); C183(2.80)  LDD3312 
IgGFc-binding protein (FCGBP) LDTP14292 C432(3.22); C354(2.55); C228(1.34)  LDD3319 
Immediate early response gene 2 protein (IER2) LDTP11202 C188(1.21); C200(1.21)  LDD0531 
Immediate early response gene 5 protein (IER5) LDTP07251 C176(1.08); C178(1.08); C220(1.08); C231(1.08)  LDD0078 
Immediate early response gene 5-like protein (IER5L) LDTP19407 C137(9.97)  LDD0079 
Immunoglobulin-binding protein 1 (IGBP1) LDTP05089 C118(1.05)  LDD1510 
Inactive cell surface hyaluronidase CEMIP2 (CEMIP2) LDTP13298 C1192(1.09); C1195(1.09)  LDD0078 
InaD-like protein (PATJ) LDTP09280 C71(1.99)  LDD0080 
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) LDTP05530 C16(1.48)  LDD0078 
Influenza virus NS1A-binding protein (IVNS1ABP) LDTP14309 C143(1.04); C274(0.89)  LDD0078 
Inhibin beta E chain (INHBE) LDTP14727 C139(1.54)  LDD3377 
Inhibitor of Bruton tyrosine kinase (IBTK) LDTP13036 C407(19.88)  LDD0209 
Inhibitor of growth protein 1 (ING1) LDTP13426 C216(0.50)  LDD0531 
Inhibitor of growth protein 2 (ING2) LDTP11748 C164(0.97); C173(0.97)  LDD0078 
Inhibitor of growth protein 3 (ING3) LDTP12789 C187(1.36)  LDD0580 
Innate immunity activator protein (INAVA) LDTP06764 C638(3.05)  LDD3440 
Inner centromere protein (INCENP) LDTP12432 C24(1.21)  LDD0078 
Inner nuclear membrane protein Man1 (LEMD3) LDTP13913 C754(1.15)  LDD0078 
INO80 complex subunit B (INO80B) LDTP11587 C309(0.73); C314(0.73); C330(1.07); C334(1.07)  LDD0533 
INO80 complex subunit D (INO80D) LDTP06924 C667(0.99); C416(0.96)  LDD1507 
INO80 complex subunit E (INO80E) LDTP09073 C179(2.10)  LDD3339 
Inositol 1,4,5-triphosphate receptor associated 1 (IRAG1) LDTP14244 C891(2.46)  LDD2361 
Insulin receptor substrate 1 (IRS1) LDTP03761 C1191(1.20); C1195(1.20); C923(1.06); C436(0.96)  LDD0078 
Insulin receptor substrate 2 (IRS2) LDTP14059 C816(1.30); C801(1.06); C802(1.06)  LDD0078 
Insulin receptor substrate 4 (IRS4) LDTP00398 C1054(6.91); C332(2.58); C1065(3.47); C1055(3.60)  LDD0080 
Insulin-like 3 (INSL3) LDTP04416 C1300(1.04)  LDD3319 
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) LDTP12904 C337(105.23)  LDD0209 
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) LDTP14272 C255(0.79)  LDD0533 
Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) LDTP00272 C257(0.84)  LDD0078 
Insulin-like growth factor-binding protein 2 (IGFBP2) LDTP02937 C285(0.66); C86(1.11)  LDD0531 
Insulin-like growth factor-binding protein 3 (IGFBP3) LDTP02930 C219(0.73)  LDD3317 
Insulin-like growth factor-binding protein 4 (IGFBP4) LDTP03187 C215(1.39)  LDD3402 
Insulin-like growth factor-binding protein 5 (IGFBP5) LDTP03288 C219(1.75)  LDD3345 
Insulin-like growth factor-binding protein 6 (IGFBP6) LDTP03287 C190(2.53)  LDD2236 
Integral membrane protein DGCR2/IDD (DGCR2) LDTP05214 C271(1.45)  LDD3316 
Integral membrane protein GPR180 (GPR180) LDTP19625 C132(2.81)  LDD3337 
Integrator complex subunit 1 (INTS1) LDTP08785 C2098(2.68); C2099(2.68); C1755(2.77)  LDD0080 
Integrator complex subunit 10 (INTS10) LDTP16111 C122(1.05); C387(0.97)  LDD0078 
Integrator complex subunit 12 (INTS12) LDTP10166 C379(0.98)  LDD0078 
Integrator complex subunit 13 (INTS13) LDTP12685 C406(1.27); C349(1.13)  LDD0078 
Integrator complex subunit 14 (INTS14) LDTP15834 C156(1.26); C171(1.26)  LDD0531 
Integrator complex subunit 15 (INTS15) LDTP18217 C157(2.71); C158(2.71)  LDD0080 
Integrator complex subunit 2 (INTS2) LDTP11710 C988(2.21)  LDD0080 
Integrator complex subunit 3 (INTS3) LDTP07333 C80(0.94)  LDD0078 
Integrator complex subunit 4 (INTS4) LDTP10402 C44(1.10)  LDD0078 
Integrator complex subunit 5 (INTS5) LDTP07551 C245(12.01)  LDD0209 
Integrator complex subunit 7 (INTS7) LDTP12678 C618(7.01)  LDD0208 
Integrator complex subunit 8 (INTS8) LDTP07912 C250(0.44); C253(0.44); C381(1.08); C385(1.11)  LDD0531 
Integrin alpha-10 (ITGA10) LDTP01261 C867(2.52)  LDD2252 
Integrin alpha-2 (ITGA2) LDTP02893 C83(1.17); C92(1.17)  LDD0078 
Integrin alpha-3 (ITGA3) LDTP03342 C621(1.09); C140(1.03); C94(0.91)  LDD0078 
Integrin alpha-4 (ITGA4) LDTP02669 C183(2.87)  LDD3333 
Integrin alpha-9 (ITGA9) LDTP05984 C142(4.19)  LDD3374 
Integrin alpha-IIb (ITGA2B) LDTP02277 C87(2.12); C161(2.99)  LDD3334 
Integrin alpha-M (ITGAM) LDTP02551 C495(3.07); C722(2.06)  LDD3334 
Integrin beta-2 (ITGB2) LDTP02077 C564(0.97); C573(0.97); C575(0.97)  LDD0078 
Integrin beta-3 (ITGB3) LDTP02076 C521(1.35)  LDD3310 
Integrin beta-4 (ITGB4) LDTP02829 C742(1.18); C748(1.18); C749(1.18); C288(0.93)  LDD0078 
Integrin beta-5 (ITGB5) LDTP02941 C498(1.05); C500(1.05); C513(1.05); C528(1.00)  LDD0078 
Integrin beta-6 (ITGB6) LDTP02957 C426(1.35)  LDD3360 
Integrin beta-7 (ITGB7) LDTP03343 C428(1.87)  LDD3333 
Integrin beta-8 (ITGB8) LDTP03344 C601(1.96); C738(4.76)  LDD3332 
Inter-alpha-trypsin inhibitor heavy chain H2 (ITIH2) LDTP03014 C717(2.71)  LDD3380 
Inter-alpha-trypsin inhibitor heavy chain H5 (ITIH5) LDTP08261 C71(1.73)  LDD3413 
Interactor protein for cytohesin exchange factors 1 (IPCEF1) LDTP09658 C191(4.60)  LDD3388 
Interferon-induced 35 kDa protein (IFI35) LDTP05158 C107(1.00); C195(2.34)  LDD3310 
Interferon-induced protein 44 (IFI44) LDTP18058 C250(2.73)  LDD3311 
Interferon-induced protein 44-like (IFI44L) LDTP14944 C286(2.28)  LDD3310 
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) LDTP02379 C294(4.36); C94(2.45)  LDD3316 
Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2) LDTP02378 C54(3.48); C149(4.92); C73(2.62)  LDD3311 
Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) LDTP00463 C283(0.97); C284(0.97); C39(0.90)  LDD0078 
Interferon-induced protein with tetratricopeptide repeats 5 (IFIT5) LDTP05828 C476(0.97); C137(0.88); C142(0.88)  LDD0078 
Interferon-induced transmembrane protein 10 (IFITM10) LDTP18853 C125(4.80)  LDD3337 
Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PRKRA) LDTP01259 C54(0.96); C106(0.90)  LDD0078 
Interferon-related developmental regulator 1 (IFRD1) LDTP14420 C277(37.02); C367(8.80); C178(10.71)  LDD0209 
Interferon-related developmental regulator 2 (IFRD2) LDTP17026 C511(1.91)  LDD3364 
Interleukin enhancer-binding factor 2 (ILF2) LDTP05688 C311(1.01)  LDD0078 
Interleukin enhancer-binding factor 3 (ILF3) LDTP05689 C203(12.89); C116(2.24); C255(6.41); C226(4.31)  LDD3311 
Interleukin-15 receptor subunit alpha (IL15RA) LDTP05807 C59(1.72)  LDD2260 
Interleukin-17 receptor A (IL17RA) LDTP10296 C185(2.16)  LDD3333 
Interleukin-17 receptor C (IL17RC) LDTP09025 C6(2.42)  LDD3333 
Interleukin-17 receptor D (IL17RD) LDTP09211 C720(1.23)  LDD3393 
Interleukin-2 receptor subunit alpha (IL2RA) LDTP01874 C168(1.65)  LDD3397 
Interleukin-32 (IL32) LDTP03264 C227(3.77)  LDD3331 
Intermembrane lipid transfer protein VPS13C (VPS13C) LDTP07872 C1094(1.07); C1098(1.07)  LDD0078 
Intermembrane lipid transfer protein VPS13D (VPS13D) LDTP07192 C2824(1.23); C1570(2.83); C1581(2.83)  LDD0080 
Intersectin-1 (ITSN1) LDTP06478 C1698(1.64)  LDD3395 
Intersectin-2 (ITSN2) LDTP12917 C1305(0.93); C1307(0.81)  LDD0531 
Intracellular hyaluronan-binding protein 4 (HABP4) LDTP07021 C236(0.95)  LDD0078 
Intraflagellar transport protein 140 homolog (IFT140) LDTP10790 C331(0.98); C333(0.98)  LDD0078 
Intraflagellar transport protein 172 homolog (IFT172) LDTP13218 C198(7.04); C215(7.04)  LDD0080 
Intraflagellar transport protein 25 homolog (IFT25) LDTP14088 C52(1.06)  LDD3420 
Intraflagellar transport protein 52 homolog (IFT52) LDTP13952 C276(1.18)  LDD3365 
Intraflagellar transport protein 70A (IFT70A) LDTP17593 C93(1.03)  LDD0531 
Intraflagellar transport protein 70B (IFT70B) LDTP15421 C589(12.83)  LDD0205 
Intraflagellar transport protein 80 homolog (IFT80) LDTP13052 C106(1.52)  LDD0080 
Intron Large complex component GCFC2 (GCFC2) LDTP02841 C320(5.87)  LDD0080 
Inversin (INVS) LDTP13829 C702(2.44); C63(3.20)  LDD3332 
Inverted formin-2 (INF2) LDTP06681 C1029(1.13); C38(0.99); C104(0.92); C758(0.88)  LDD0078 
Involucrin (IVL) LDTP02207 C44(1.81)  LDD3325 
IQ calmodulin-binding motif-containing protein 1 (IQCB1) LDTP06298 C299(7.59)  LDD0080 
IQ domain-containing protein C (IQCC) LDTP17136 C217(0.78)  LDD1492 
IQ motif and SEC7 domain-containing protein 1 (IQSEC1) LDTP07373 C890(2.14); C359(1.75)  LDD0080 
IQ motif and SEC7 domain-containing protein 2 (IQSEC2) LDTP07016 C157(2.18)  LDD2243 
Iron-sulfur cluster assembly 1 homolog, mitochondrial (ISCA1) LDTP11232 C57(1.36)  LDD0080 
Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2) LDTP08212 C144(0.91); C146(0.91); C79(0.89)  LDD0078 
Iron-sulfur cluster assembly enzyme ISCU (ISCU) LDTP11771 C69(0.87)  LDD0078 
Iron-sulfur cluster co-chaperone protein HscB (HSCB) LDTP08547 C28(3.20)  LDD3331 
Iron-sulfur cluster transfer protein NUBPL (NUBPL) LDTP09325 C244(1.28)  LDD3315 
Islet cell autoantigen 1 (ICA1) LDTP05445 C85(9.30)  LDD0209 
Islet cell autoantigen 1-like protein (ICA1L) LDTP09127 C63(1.06)  LDD1492 
IST1 homolog (IST1) LDTP04593 C138(2.22)  LDD3310 
Janus kinase and microtubule-interacting protein 1 (JAKMIP1) LDTP10607 C489(3.57)  LDD3420 
Jerky protein homolog (JRK) LDTP01258 C503(3.06); C513(3.06)  LDD0080 
Jerky protein homolog-like (JRKL) LDTP18577 C102(3.28)  LDD3369 
JNK1/MAPK8-associated membrane protein (JKAMP) LDTP16159 C196(0.86)  LDD1155 
Jouberin (AHI1) LDTP08757 C469(0.94)  LDD0078 
Junction plakoglobin (JUP) LDTP02756 C381(2.78); C573(1.53); C511(1.24); C341(1.31)  LDD3310 
Junction-mediating and -regulatory protein (JMY) LDTP08997 C46(1.02)  LDD0531 
Junctional cadherin 5-associated protein (JCAD) LDTP13021 C946(1.19); C552(1.17); C810(1.16); C1347(0.98)  LDD0078 
Junctional sarcoplasmic reticulum protein 1 (JSRP1) LDTP10584 C18(0.98)  LDD3404 
Jupiter microtubule associated homolog 2 (JPT2) LDTP12077 C118(1.33)  LDD0080 
Kanadaptin (SLC4A1AP) LDTP15899 C125(1.17); C730(0.98)  LDD0078 
KAT8 regulatory NSL complex subunit 1 (KANSL1) LDTP08028 C208(0.82)  LDD0533 
KAT8 regulatory NSL complex subunit 2 (KANSL2) LDTP12101 C302(2.46)  LDD3365 
KAT8 regulatory NSL complex subunit 3 (KANSL3) LDTP13070 C103(0.68); C301(1.00)  LDD0531 
Katanin p80 WD40 repeat-containing subunit B1 (KATNB1) LDTP11276 C244(0.92); C245(0.92); C250(0.92)  LDD0078 
KATNB1-like protein 1 (KATNBL1) LDTP11684 C95(3.33)  LDD0080 
Kazrin (KAZN) LDTP07303 C348(1.24)  LDD1507 
Kelch domain-containing protein 10 (KLHDC10) LDTP07585 C254(1.10)  LDD1513 
Kelch domain-containing protein 2 (KLHDC2) LDTP13914 C223(2.41)  LDD3311 
Kelch domain-containing protein 3 (KLHDC3) LDTP11064 C213(0.99)  LDD0078 
Kelch domain-containing protein 4 (KLHDC4) LDTP15584 C373(1.10)  LDD0531 
Kelch domain-containing protein 7A (KLHDC7A) LDTP17265 C389(2.59); C500(1.42); C474(2.34)  LDD3314 
Kelch domain-containing protein 7B (KLHDC7B) LDTP10333 C448(3.05); C258(4.51)  LDD3444 
Kelch domain-containing protein 8B (KLHDC8B) LDTP08613 C20(1.15)  LDD3376 
Kelch domain-containing protein 9 (KLHDC9) LDTP17809 C182(1.22)  LDD3318 
Kelch repeat and BTB domain-containing protein 11 (KBTBD11) LDTP16834 C485(0.88)  LDD0078 
Kelch repeat and BTB domain-containing protein 2 (KBTBD2) LDTP15355 C349(1.92); C524(1.14)  LDD0080 
Kelch repeat and BTB domain-containing protein 3 (KBTBD3) LDTP19767 C350(1.11)  LDD2268 
Kelch repeat and BTB domain-containing protein 4 (KBTBD4) LDTP16114 C471(1.87)  LDD3312 
Kelch repeat and BTB domain-containing protein 6 (KBTBD6) LDTP08276 C375(1.05); C93(1.06)  LDD0531 
Kelch repeat and BTB domain-containing protein 7 (KBTBD7) LDTP09631 C160(2.18)  LDD3332 
Kelch repeat and BTB domain-containing protein 8 (KBTBD8) LDTP09232 C276(2.73)  LDD0080 
Kelch-like ECH-associated protein 1 (KEAP1) LDTP06051 C624(1.00)  LDD0078 
Kelch-like protein 11 (KLHL11) LDTP18475 C708(1.01); C570(0.98)  LDD0078 
Kelch-like protein 12 (KLHL12) LDTP06895 C511(10.42)  LDD0209 
Kelch-like protein 13 (KLHL13) LDTP13071 C134(0.98)  LDD1492 
Kelch-like protein 14 (KLHL14) LDTP13048 C290(1.32)  LDD3339 
Kelch-like protein 15 (KLHL15) LDTP10576 C444(1.59)  LDD3331 
Kelch-like protein 18 (KLHL18) LDTP14520 C253(51.01)  LDD0209 
Kelch-like protein 20 (KLHL20) LDTP13892 C182(1.09)  LDD0531 
Kelch-like protein 21 (KLHL21) LDTP13390 C351(0.91)  LDD0078 
Kelch-like protein 22 (KLHL22) LDTP06904 C72(1.03)  LDD0580 
Kelch-like protein 23 (KLHL23) LDTP19773 C431(0.99)  LDD0532 
Kelch-like protein 24 (KLHL24) LDTP07645 C494(1.26)  LDD3331 
Kelch-like protein 25 (KLHL25) LDTP11711 C478(23.38)  LDD0209 
Kelch-like protein 26 (KLHL26) LDTP14946 C383(0.87)  LDD0078 
Kelch-like protein 29 (KLHL29) LDTP18139 C728(3.69)  LDD3383 
Kelch-like protein 36 (KLHL36) LDTP08871 C523(1.29)  LDD0080 
Kelch-like protein 4 (KLHL4) LDTP18351 C711(1.48)  LDD3373 
Kelch-like protein 40 (KLHL40) LDTP06729 C403(1.70); C145(4.05)  LDD3401 
Kelch-like protein 41 (KLHL41) LDTP01019 C147(2.37)  LDD3344 
Kelch-like protein 42 (KLHL42) LDTP13061 C15(2.85)  LDD3331 
Kelch-like protein 5 (KLHL5) LDTP15810 C677(2.74)  LDD3314 
Kelch-like protein 6 (KLHL6) LDTP15652 C508(1.51)  LDD3334 
Kelch-like protein 7 (KLHL7) LDTP08609 C133(0.92)  LDD0532 
Kelch-like protein 8 (KLHL8) LDTP13050 C590(2.38)  LDD0080 
Kelch-like protein 9 (KLHL9) LDTP13055 C487(0.94); C489(0.94)  LDD0531 
Keratin, type I cuticular Ha3-I (KRT33A) LDTP14515 C393(2.12)  LDD3331 
Keratin, type I cuticular Ha3-II (KRT33B) LDTP06137 C142(3.45)  LDD3331 
Keratin, type I cuticular Ha5 (KRT35) LDTP09862 C310(1.79)  LDD3345 
Keratin, type I cytoskeletal 10 (KRT10) LDTP02674 C427(1.83)  LDD3410 
Keratin, type I cytoskeletal 13 (KRT13) LDTP02675 C383(0.92)  LDD3320 
Keratin, type I cytoskeletal 14 (KRT14) LDTP01930 C367(1.11)  LDD3365 
Keratin, type I cytoskeletal 15 (KRT15) LDTP02974 C355(1.40); C380(1.34)  LDD3314 
Keratin, type I cytoskeletal 16 (KRT16) LDTP02308 C391(1.88); C18(3.99); C40(5.27)  LDD3321 
Keratin, type I cytoskeletal 17 (KRT17) LDTP05424 C336(4.59); C40(2.42)  LDD3313 
Keratin, type I cytoskeletal 20 (KRT20) LDTP03791 C141(6.81)  LDD3319 
Keratin, type I cytoskeletal 23 (KRT23) LDTP15928 C413(1.02)  LDD3323 
Keratin, type I cytoskeletal 24 (KRT24) LDTP06698 C486(1.15)  LDD3465 
Keratin, type II cuticular Hb3 (KRT83) LDTP05118 C389(1.37)  LDD3311 
Keratin, type II cuticular Hb5 (KRT85) LDTP05119 C290(7.77)  LDD3346 
Keratin, type II cuticular Hb6 (KRT86) LDTP00868 C470(1.39)  LDD2262 
Keratin, type II cytoskeletal 1 (KRT1) LDTP02031 C49(26.03)  LDD3319 
Keratin, type II cytoskeletal 4 (KRT4) LDTP02975 C17(2.47)  LDD3352 
Keratin, type II cytoskeletal 5 (KRT5) LDTP02676 C494(5.31)  LDD3312 
Keratin, type II cytoskeletal 6B (KRT6B) LDTP02030 C77(1.17)  LDD3323 
Keratin, type II cytoskeletal 75 (KRT75) LDTP01651 C388(1.02)  LDD3314 
Keratin, type II cytoskeletal 78 (KRT78) LDTP08780 C394(1.90); C47(5.51)  LDD3360 
Keratin, type II cytoskeletal 80 (KRT80) LDTP07437 C231(1.87)  LDD3313 
Keratin-associated protein 13-2 (KRTAP13-2) LDTP06878 C83(2.49)  LDD3332 
Keratin-associated protein 2-3 (KRTAP2-3) LDTP14599 C36(1.23); C41(1.23); C50(1.20); C55(1.20)  LDD0531 
Keratin-like protein KRT222 (KRT222) LDTP08764 C153(3.12)  LDD0080 
Keratinocyte differentiation factor 1 (KDF1) LDTP09034 C187(1.02); C188(1.13)  LDD0531 
Keratinocyte-associated protein 3 (KRTCAP3) LDTP17151 C132(1.14); C152(1.14)  LDD0532 
KH domain-containing RNA-binding protein QKI (QKI) LDTP10700 C35(0.89)  LDD0078 
KH domain-containing, RNA-binding, signal transduction-associated protein 1 (KHDRBS1) LDTP05525 C264(1.58)  LDD3323 
KH homology domain-containing protein 4 (KHDC4) LDTP08147 C280(1.12)  LDD0078 
KICSTOR complex protein ITFG2 (ITFG2) LDTP10024 C140(2.62)  LDD3319 
KICSTOR complex protein kaptin (KPTN) LDTP14211 C221(2.50)  LDD3335 
KICSTOR complex protein SZT2 (SZT2) LDTP07083 C3273(3.90)  LDD3310 
KICSTOR subunit 2 (KICS2) LDTP10581 C130(0.97)  LDD1508 
KIF-binding protein (KIFBP) LDTP10263 C371(1.42); C265(1.10)  LDD0080 
Killer cell lectin-like receptor subfamily G member 2 (KLRG2) LDTP16576 C218(4.64); C219(4.64); C90(1.35)  LDD0080 
Kinectin (KTN1) LDTP08238 C1105(0.91)  LDD0078 
Kinesin light chain 1 (KLC1) LDTP05533 C621(1.35)  LDD3310 
Kinesin light chain 2 (KLC2) LDTP11695 C474(1.14)  LDD0080 
Kinesin light chain 3 (KLC3) LDTP07541 C365(1.39); C252(1.60)  LDD3310 
Kinesin light chain 4 (KLC4) LDTP12591 C318(80.11)  LDD0209 
Kinesin-associated protein 3 (KIFAP3) LDTP09902 C78(36.23)  LDD0204 
Kinetochore protein NDC80 homolog (NDC80) LDTP00431 C528(1.39)  LDD0080 
Kinetochore protein Nuf2 (NUF2) LDTP11525 C377(0.86)  LDD0078 
Kinetochore protein Spc24 (SPC24) LDTP09069 C155(1.16)  LDD0080 
Kinetochore protein Spc25 (SPC25) LDTP12192 C27(0.98)  LDD0078 
Kinetochore scaffold 1 (KNL1) LDTP09242 C919(1.32); C935(1.32); C688(1.05); C701(1.05)  LDD0078 
Kinetochore-associated protein 1 (KNTC1) LDTP04382 C683(0.88); C563(0.86); C1168(0.85); C1173(0.85)  LDD0078 
Kinetochore-associated protein DSN1 homolog (DSN1) LDTP11896 C65(2.17)  LDD0080 
Kinetochore-associated protein NSL1 homolog (NSL1) LDTP10433 C136(0.99); C53(0.82)  LDD0531 
Kininogen-1 (KNG1) LDTP01822 C328(1.70)  LDD3318 
KN motif and ankyrin repeat domain-containing protein 1 (KANK1) LDTP06178 C317(1.26); C630(0.87); C640(0.87)  LDD0078 
KN motif and ankyrin repeat domain-containing protein 2 (KANK2) LDTP07287 C562(5.20)  LDD0209 
KN motif and ankyrin repeat domain-containing protein 3 (KANK3) LDTP15105 C684(1.53)  LDD3382 
KN motif and ankyrin repeat domain-containing protein 4 (KANK4) LDTP07143 C755(1.74)  LDD3472 
Kremen protein 1 (KREMEN1) LDTP10600 C431(1.02)  LDD1507 
Krev interaction trapped protein 1 (KRIT1) LDTP00303 C228(1.28)  LDD0078 
KRR1 small subunit processome component homolog (KRR1) LDTP05939 C102(0.97); C75(0.97)  LDD0531 
La-related protein 1 (LARP1) LDTP07605 C864(1.08); C238(1.04)  LDD0078 
La-related protein 1B (LARP1B) LDTP07294 C838(1.73)  LDD0080 
La-related protein 4 (LARP4) LDTP07903 C130(69.11); C224(490.60); C199(11.67)  LDD0209 
La-related protein 4B (LARP4B) LDTP09820 C633(2.04); C167(1.54); C654(1.74); C679(1.16)  LDD0080 
La-related protein 6 (LARP6) LDTP11130 C406(42.95)  LDD0209 
La-related protein 7 (LARP7) LDTP06838 C155(2.07)  LDD3312 
Ladinin-1 (LAD1) LDTP14421 C428(0.96)  LDD0531 
Laforin, isoform 9 (EPM2A) LDTP14405 C86(2.82)  LDD3331 
Lamin tail domain-containing protein 2 (LMNTD2) LDTP08614 C601(2.17)  LDD2236 
Lamin-B1 (LMNB1) LDTP03065 C198(1.15)  LDD0080 
Lamin-B2 (LMNB2) LDTP05400 C192(1.11)  LDD0531 
Lamina-associated polypeptide 2, isoform alpha (TMPO) LDTP03967 C341(1.12); C684(1.02); C518(1.01); C330(1.00)  LDD0078 
Lamina-associated polypeptide 2, isoforms beta/gamma (TMPO) LDTP03968 C363(0.99)  LDD0078 
Laminin subunit alpha-1 (LAMA1) LDTP03320 C2481(4.01)  LDD3419 
Laminin subunit alpha-2 (LAMA2) LDTP03265 C886(2.85)  LDD3397 
Laminin subunit alpha-3 (LAMA3) LDTP06629 C628(1.12); C631(1.12)  LDD0078 
Laminin subunit alpha-4 (LAMA4) LDTP06528 C1727(2.59)  LDD3345 
Laminin subunit alpha-5 (LAMA5) LDTP00579 C758(1.20); C773(1.20); C605(1.10); C607(1.10)  LDD0078 
Laminin subunit beta-1 (LAMB1) LDTP02230 C1425(3.84); C1430(3.84)  LDD0080 
Laminin subunit beta-2 (LAMB2) LDTP04691 C321(1.04); C324(1.04)  LDD0078 
Laminin subunit beta-3 (LAMB3) LDTP05974 C584(0.89)  LDD0078 
Laminin subunit beta-4 (LAMB4) LDTP00058 C28(2.50); C991(2.37)  LDD3409 
Laminin subunit gamma-1 (LAMC1) LDTP02535 C1600(0.97); C1028(0.92); C1031(0.92); C1034(0.92)  LDD0078 
Laminin subunit gamma-2 (LAMC2) LDTP05975 C575(1.49); C585(1.49); C81(0.96); C84(0.96)  LDD0078 
LanC-like protein 2 (LANCL2) LDTP12571 C169(1.38)  LDD0078 
LanC-like protein 3 (LANCL3) LDTP19585 C103(1.58)  LDD2351 
Large proline-rich protein BAG6 (BAG6) LDTP04094 C856(1.00); C349(0.99)  LDD1492 
Large ribosomal subunit protein bL12m (MRPL12) LDTP04537 C45(1.01)  LDD1492 
Large ribosomal subunit protein bL17m (MRPL17) LDTP16079 C129(1.29)  LDD0080 
Large ribosomal subunit protein bL19m (MRPL19) LDTP14696 C137(0.97); C248(1.13)  LDD0531 
Large ribosomal subunit protein bL20m (MRPL20) LDTP15914 C93(1.04)  LDD0531 
Large ribosomal subunit protein bL21m (MRPL21) LDTP15237 C203(0.66)  LDD0532 
Large ribosomal subunit protein bL27m (MRPL27) LDTP16162 C88(0.86)  LDD0078 
Large ribosomal subunit protein bL28m (MRPL28) LDTP05741 C154(525.89); C21(1,746.96)  LDD0209 
Large ribosomal subunit protein bL32m (MRPL32) LDTP15913 C123(0.99); C126(0.99); C110(0.99); C113(0.99)  LDD0078 
Large ribosomal subunit protein bL33m (MRPL33) LDTP14495 C29(1.22)  LDD0080 
Large ribosomal subunit protein bL35m (MRPL35) LDTP12894 C119(1.04)  LDD0078 
Large ribosomal subunit protein bL36m (MRPL36) LDTP16160 C92(1.19)  LDD3412 
Large ribosomal subunit protein bL9m (MRPL9) LDTP15916 C221(1.34)  LDD0563 
Large ribosomal subunit protein eL13 (RPL13) LDTP03354 C186(1.85)  LDD2356 
Large ribosomal subunit protein eL14 (RPL14) LDTP04389 C42(0.93)  LDD0078 
Large ribosomal subunit protein eL15 (RPL15) LDTP04919 C220(1.16)  LDD3330 
Large ribosomal subunit protein eL18 (RPL18) LDTP05509 C134(1.41)  LDD0080 
Large ribosomal subunit protein eL20 (RPL18A) LDTP05360 C22(0.92); C109(0.86)  LDD0078 
Large ribosomal subunit protein eL21 (RPL21) LDTP04107 C56(1.04)  LDD1510 
Large ribosomal subunit protein eL22 (RPL22) LDTP03728 C25(0.88)  LDD3310 
Large ribosomal subunit protein eL24 (RPL24) LDTP05186 C6(1.15); C36(1.07)  LDD0078 
Large ribosomal subunit protein eL28 (RPL28) LDTP04108 C13(9.24)  LDD0209 
Large ribosomal subunit protein eL30 (RPL30) LDTP05021 C92(0.99)  LDD0078 
Large ribosomal subunit protein eL32 (RPL32) LDTP05025 C91(2.03); C96(1.40)  LDD0080 
Large ribosomal subunit protein eL33 (RPL35A) LDTP02940 C47(2.70)  LDD2260 
Large ribosomal subunit protein eL34 (RPL34) LDTP04233 C83(1.09); C46(0.90); C49(0.90)  LDD0078 
Large ribosomal subunit protein eL36 (RPL36) LDTP14012 C48(1.22)  LDD0078 
Large ribosomal subunit protein eL37 (RPL37) LDTP04943 C19(2.75)  LDD3318 
Large ribosomal subunit protein eL42 (RPL36A) LDTP05188 C77(2.53); C72(2.51)  LDD0080 
Large ribosomal subunit protein eL43 (RPL37A) LDTP04926 C57(1.02); C60(1.02); C39(0.87); C42(0.87)  LDD0078 
Large ribosomal subunit protein eL6 (RPL6) LDTP05378 C44(1.64)  LDD0547 
Large ribosomal subunit protein eL8 (RPL7A) LDTP04990 C182(8.03); C182(11.87); C199(9.00)  LDD0209 
Large ribosomal subunit protein mL37 (MRPL37) LDTP15922 C203(1.77)  LDD0080 
Large ribosomal subunit protein mL38 (MRPL38) LDTP10232 C143(0.92)  LDD0078 
Large ribosomal subunit protein mL41 (MRPL41) LDTP08605 C88(1.48)  LDD3311 
Large ribosomal subunit protein mL42 (MRPL42) LDTP14248 C45(1.70)  LDD0080 
Large ribosomal subunit protein mL43 (MRPL43) LDTP08994 C70(1.88); C71(1.88)  LDD0080 
Large ribosomal subunit protein mL45 (MRPL45) LDTP15863 C168(15.74)  LDD0209 
Large ribosomal subunit protein mL46 (MRPL46) LDTP15976 C210(1.16)  LDD3312 
Large ribosomal subunit protein mL50 (MRPL50) LDTP15429 C52(1.07)  LDD0078 
Large ribosomal subunit protein mL53 (MRPL53) LDTP10266 C21(1.26)  LDD0080 
Large ribosomal subunit protein mL54 (MRPL54) LDTP17370 C62(1.52)  LDD3314 
Large ribosomal subunit protein mL64 (GADD45GIP1) LDTP09297 C124(1.70)  LDD0080 
Large ribosomal subunit protein mL65 (MRPS30) LDTP16055 C204(0.93)  LDD0078 
Large ribosomal subunit protein mL66 (MRPS18A) LDTP16113 C108(12.23); C186(721.19)  LDD0209 
Large ribosomal subunit protein P1 (RPLP1) LDTP02107 C61(0.92)  LDD0078 
Large ribosomal subunit protein uL1 (RPL10A) LDTP05024 C164(0.86)  LDD0078 
Large ribosomal subunit protein uL10 (RPLP0) LDTP02109 C27(4.34); C119(1.35)  LDD0080 
Large ribosomal subunit protein uL10m (MRPL10) LDTP08154 C190(3.30)  LDD3310 
Large ribosomal subunit protein uL11 (RPL12) LDTP03517 C17(1.31)  LDD0080 
Large ribosomal subunit protein uL11m (MRPL11) LDTP13971 C50(1.91)  LDD0080 
Large ribosomal subunit protein uL13 (RPL13A) LDTP03899 C38(8.00)  LDD0209 
Large ribosomal subunit protein uL13m (MRPL13) LDTP15915 C53(1.06)  LDD1492 
Large ribosomal subunit protein uL14 (RPL23) LDTP05008 C28(1.09)  LDD0078 
Large ribosomal subunit protein uL14m (MRPL14) LDTP15108 C57(9.65)  LDD0209 
Large ribosomal subunit protein uL15 (RPL27A) LDTP04105 C144(1.15); C70(1.14)  LDD0078 
Large ribosomal subunit protein uL15m (MRPL15) LDTP16157 C188(1.17)  LDD0531 
Large ribosomal subunit protein uL16 (RPL10) LDTP03395 C105(1.77); C49(1.34); C195(1.04)  LDD0078 
Large ribosomal subunit protein uL16m (MRPL16) LDTP16124 C167(1.01)  LDD0531 
Large ribosomal subunit protein uL18 (RPL5) LDTP04106 C100(0.92)  LDD0078 
Large ribosomal subunit protein uL18m (MRPL18) LDTP11734 C125(1.28)  LDD0531 
Large ribosomal subunit protein uL1m (MRPL1) LDTP18338 C279(1.77)  LDD3310 
Large ribosomal subunit protein uL2 (RPL8) LDTP05027 C90(1.05)  LDD0078 
Large ribosomal subunit protein uL22 (RPL17) LDTP02961 C144(4.68)  LDD0204 
Large ribosomal subunit protein uL22m (MRPL22) LDTP12736 C70(1.31)  LDD0080 
Large ribosomal subunit protein uL24m (MRPL24) LDTP15687 C190(1.04)  LDD0531 
Large ribosomal subunit protein uL29m (MRPL47) LDTP16049 C87(1.37)  LDD0080 
Large ribosomal subunit protein uL2m (MRPL2) LDTP15007 C213(0.59)  LDD0531 
Large ribosomal subunit protein uL3 (RPL3) LDTP03865 C253(1.09); C114(1.03)  LDD0078 
Large ribosomal subunit protein uL30 (RPL7) LDTP02944 C186(0.97)  LDD0078 
Large ribosomal subunit protein uL30m (MRPL30) LDTP15598 C168(1.24)  LDD3323 
Large ribosomal subunit protein uL3m (MRPL3) LDTP14589 C127(1.24)  LDD0580 
Large ribosomal subunit protein uL4 (RPL4) LDTP03815 C125(1.03); C96(1.02); C208(0.85)  LDD0078 
Large ribosomal subunit protein uL4m (MRPL4) LDTP15917 C311(1.47)  LDD3439 
Large ribosomal subunit protein uL5 (RPL11) LDTP05026 C72(1.13)  LDD0078 
Large ribosomal subunit protein uL6 (RPL9; RPL9P7; RPL9P8; RPL9P9) LDTP03658 C134(0.93)  LDD0078 
Late secretory pathway protein AVL9 homolog (AVL9) LDTP15478 C409(8.72)  LDD0206 
Latent-transforming growth factor beta-binding protein 2 (LTBP2) LDTP06206 C742(2.14)  LDD3310 
Latent-transforming growth factor beta-binding protein 3 (LTBP3) LDTP12554 C614(1.01); C620(1.01); C379(0.96); C381(0.96)  LDD0078 
Latent-transforming growth factor beta-binding protein 4 (LTBP4) LDTP08806 C367(0.92); C372(0.92)  LDD0078 
Lateral signaling target protein 2 homolog (ZFYVE28) LDTP12229 C49(1.26)  LDD0531 
Layilin (LAYN) LDTP07690 C184(5.92)  LDD3310 
Lck-interacting transmembrane adapter 1 (LIME1) LDTP11895 C270(1.10); C280(1.10)  LDD0532 
Lebercilin (LCA5) LDTP08297 C321(3.01); C329(3.01)  LDD0080 
Leiomodin-1 (LMOD1) LDTP03494 C72(4.43)  LDD3363 
LEM domain-containing protein 2 (LEMD2) LDTP09082 C253(1.15); C261(1.10)  LDD0078 
Leptin receptor gene-related protein (LEPROT) LDTP00585 C66(1.17)  LDD0078 
Leptin receptor overlapping transcript-like 1 (LEPROTL1) LDTP01529 C66(0.80)  LDD1492 
Lethal(2) giant larvae protein homolog 1 (LLGL1) LDTP06361 C855(1.01); C725(1.01); C505(0.91); C697(0.85)  LDD0078 
Lethal(3)malignant brain tumor-like protein 2 (L3MBTL2) LDTP10023 C90(1.92); C93(1.92); C408(1.44)  LDD0080 
Lethal(3)malignant brain tumor-like protein 3 (L3MBTL3) LDTP10477 C233(4.15)  LDD0080 
Lethal(3)malignant brain tumor-like protein 4 (L3MBTL4) LDTP15474 C379(0.78); C384(0.78)  LDD1125 
Leucine zipper protein 1 (LUZP1) LDTP08273 C560(1.11); C594(1.08); C969(0.98)  LDD0078 
Leucine zipper putative tumor suppressor 2 (LZTS2) LDTP11115 C212(0.84); C376(0.74)  LDD0531 
Leucine zipper putative tumor suppressor 3 (LZTS3) LDTP14471 C154(1.19)  LDD1507 
Leucine-rich melanocyte differentiation-associated protein (LRMDA) LDTP18382 C106(1.38)  LDD3334 
Leucine-rich PPR motif-containing protein, mitochondrial (LRPPRC) LDTP03997 C863(0.94); C113(0.87)  LDD0078 
Leucine-rich repeat and calponin homology domain-containing protein 1 (LRCH1) LDTP13889 C251(2.48)  LDD3321 
Leucine-rich repeat and calponin homology domain-containing protein 2 (LRCH2) LDTP17272 C307(2.74); C306(2.51); C265(1.64)  LDD0080 
Leucine-rich repeat and calponin homology domain-containing protein 4 (LRCH4) LDTP01216 C224(4.66); C213(18.48)  LDD0209 
Leucine-rich repeat and coiled-coil domain-containing protein 1 (LRRCC1) LDTP15929 C985(3.15)  LDD3423 
Leucine-rich repeat and WD repeat-containing protein 1 (LRWD1) LDTP13210 C522(1.12); C76(0.86); C88(0.86)  LDD0078 
Leucine-rich repeat protein 1 (LRR1) LDTP10529 C114(0.94)  LDD0531 
Leucine-rich repeat protein SHOC-2 (SHOC2) LDTP13743 C306(2.08)  LDD3332 
Leucine-rich repeat transmembrane protein FLRT2 (FLRT2) LDTP00690 C648(1.07); C658(1.07)  LDD0078 
Leucine-rich repeat-containing protein 1 (LRRC1) LDTP15885 C413(0.78); C425(0.78)  LDD0531 
Leucine-rich repeat-containing protein 14 (LRRC14) LDTP14853 C147(11.21)  LDD0209 
Leucine-rich repeat-containing protein 14B (LRRC14B) LDTP18811 C86(2.12); C420(4.88)  LDD3339 
Leucine-rich repeat-containing protein 17 (LRRC17) LDTP17735 C67(3.95)  LDD3401 
Leucine-rich repeat-containing protein 28 (LRRC28) LDTP19630 C92(14.92); C104(14.92)  LDD0209 
Leucine-rich repeat-containing protein 34 (LRRC34) LDTP17655 C303(45.49)  LDD0209 
Leucine-rich repeat-containing protein 40 (LRRC40) LDTP19976 C54(1.04)  LDD0078 
Leucine-rich repeat-containing protein 41 (LRRC41) LDTP06362 C123(0.96)  LDD0078 
Leucine-rich repeat-containing protein 42 (LRRC42) LDTP20035 C373(0.99)  LDD0078 
Leucine-rich repeat-containing protein 45 (LRRC45) LDTP10179 C83(2.42)  LDD3409 
Leucine-rich repeat-containing protein 57 (LRRC57) LDTP17764 C128(0.92)  LDD0078 
Leucine-rich repeat-containing protein 58 (LRRC58) LDTP19853 C296(4.43); C119(9.85); C319(4.86)  LDD0209 
Leucine-rich repeat-containing protein 7 (LRRC7) LDTP10640 C68(2.32)  LDD2336 
Leukocyte antigen CD37 (CD37) LDTP02536 C217(1.53)  LDD3372 
Leukocyte cell-derived chemotaxin 1 (CNMD) LDTP01322 C283(0.94); C286(0.94)  LDD0531 
Leukocyte receptor cluster member 8 (LENG8) LDTP10703 C643(7.24); C695(47.94); C566(6.18)  LDD0209 
Leukocyte receptor cluster member 9 (LENG9) LDTP19850 C127(2.49); C46(1.18)  LDD3377 
Leupaxin (LPXN) LDTP01036 C204(0.92)  LDD3310 
Ligand of Numb protein X 2 (LNX2) LDTP08854 C684(1.80)  LDD3339 
Ligand-dependent nuclear receptor-interacting factor 1 (LRIF1) LDTP07108 C524(1.35); C23(1.26); C27(1.26)  LDD0078 
LIM and calponin homology domains-containing protein 1 (LIMCH1) LDTP13705 C1067(1.19); C1070(1.19); C140(0.98); C669(0.86)  LDD0078 
LIM and cysteine-rich domains protein 1 (LMCD1) LDTP12940 C335(0.91); C338(0.91); C356(0.89); C359(0.89)  LDD0078 
LIM and senescent cell antigen-like-containing domain protein 1 (LIMS1) LDTP04156 C219(0.97); C138(0.92); C300(1.04); C97(1.06)  LDD1492 
LIM and senescent cell antigen-like-containing domain protein 2 (LIMS2) LDTP08071 C362(0.94); C72(1.13)  LDD3310 
LIM and senescent cell antigen-like-containing domain protein 3 (LIMS3) LDTP19110 C200(1.28)  LDD3325 
LIM and SH3 domain protein 1 (LASP1) LDTP06220 C5(1.40)  LDD3311 
LIM domain and actin-binding protein 1 (LIMA1) LDTP13260 C316(0.72)  LDD3311 
LIM domain only protein 3 (LMO3) LDTP09307 C81(1.01)  LDD3358 
LIM domain only protein 7 (LMO7) LDTP09650 C228(1.46); C261(1.17); C1646(1.04); C1648(1.04)  LDD0078 
LIM domain transcription factor LMO4 (LMO4) LDTP04950 C115(1.57); C118(1.57)  LDD0080 
LIM domain-binding protein 1 (LDB1) LDTP08215 C233(0.95)  LDD0531 
LIM domain-binding protein 2 (LDB2) LDTP00834 C246(1.38)  LDD3310 
LIM domain-containing protein 1 (LIMD1) LDTP13241 C305(0.95)  LDD0078 
LIM domain-containing protein 2 (LIMD2) LDTP11179 C40(1.07); C43(1.07)  LDD0078 
LIM domain-containing protein ajuba (AJUBA) LDTP10416 C158(0.85)  LDD0078 
Limb region 1 protein homolog (LMBR1) LDTP09619 C391(1.15)  LDD1492 
Linker for activation of T-cells family member 2 (LAT2) LDTP11669 C160(2.33)  LDD3333 
Lipase maturation factor 1 (LMF1) LDTP10791 C443(1.08)  LDD1507 
Lipase maturation factor 2 (LMF2) LDTP15887 C696(1.16)  LDD0078 
Lipid droplet-regulating VLDL assembly factor AUP1 (AUP1) LDTP14217 C70(1.72)  LDD0531 
Lipoma-preferred partner (LPP) LDTP09969 C569(1.07); C572(1.07); C584(1.07); C593(1.02)  LDD0078 
Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) LDTP04385 C2655(1.03)  LDD0078 
Liprin-alpha-1 (PPFIA1) LDTP05763 C1019(1.02); C1023(1.02)  LDD0078 
Liprin-alpha-2 (PPFIA2) LDTP01178 C143(0.94)  LDD0078 
Liprin-alpha-3 (PPFIA3) LDTP01138 C250(1.71)  LDD0080 
Liprin-beta-1 (PPFIBP1) LDTP08321 C788(0.99)  LDD0078 
Liprin-beta-2 (PPFIBP2) LDTP09115 C386(9.45)  LDD0209 
LisH domain-containing protein ARMC9 (ARMC9) LDTP08032 C270(0.78)  LDD0532 
Little elongation complex subunit 2 (ICE2) LDTP07293 C780(1.02); C792(1.02)  LDD0078 
LLGL scribble cell polarity complex component 2 (LLGL2) LDTP07512 C280(0.93); C456(1.14); C933(1.10)  LDD0531 
Low affinity immunoglobulin epsilon Fc receptor (FCER2) LDTP02160 C174(0.62); C282(1.34)  LDD3372 
Low density lipoprotein receptor adapter protein 1 (LDLRAP1) LDTP07072 C119(1.05)  LDD0531 
Low-density lipoprotein receptor class A domain-containing protein 3 (LDLRAD3) LDTP08398 C49(1.06)  LDD1492 
Low-density lipoprotein receptor-related protein 10 (LRP10) LDTP08066 C80(0.91)  LDD0531 
Low-density lipoprotein receptor-related protein 11 (LRP11) LDTP08309 C310(1.11)  LDD1492 
Low-density lipoprotein receptor-related protein 12 (LRP12) LDTP14090 C232(2.85)  LDD3413 
Low-density lipoprotein receptor-related protein 1B (LRP1B) LDTP12933 C2069(3.12)  LDD3310 
Low-density lipoprotein receptor-related protein 5 (LRP5) LDTP01161 C1543(1.12); C1548(1.12)  LDD0078 
Low-density lipoprotein receptor-related protein 6 (LRP6) LDTP01262 C1532(1.01); C1537(1.01); C1333(0.94); C1338(0.94)  LDD0078 
Low-density lipoprotein receptor-related protein 8 (LRP8) LDTP06036 C360(1.08); C362(1.08)  LDD0078 
LRP chaperone MESD (MESD) LDTP06191 C180(1.68)  LDD3311 
Luc7-like protein 3 (LUC7L3) LDTP01534 C192(2.14); C195(2.14); C35(1.57); C58(1.36)  LDD0080 
Lupus La protein (SSB) LDTP02116 C245(0.94)  LDD0078 
Ly6/PLAUR domain-containing protein 4 (LYPD4) LDTP17418 C191(0.47)  LDD2236 
Lymphocyte antigen 6D (LY6D) LDTP06086 C38(1.66)  LDD2418 
Lymphocyte antigen 6K (LY6K) LDTP14877 C43(1.43); C46(1.43); C85(1.19); C89(1.19)  LDD0078 
Lymphocyte antigen 75 (LY75) LDTP00972 C951(1.79); C477(1.89)  LDD3311 
Lymphocyte function-associated antigen 3 (CD58) LDTP02988 C161(1.02)  LDD1510 
Lymphocyte-specific protein 1 (LSP1) LDTP03666 C47(1.96)  LDD3339 
Lysine-rich coiled-coil protein 1 (KRCC1) LDTP18454 C184(1.91)  LDD3369 
Lysine-rich nucleolar protein 1 (KNOP1) LDTP17064 C78(0.99); C184(0.99); C172(0.87)  LDD0078 
LysM and putative peptidoglycan-binding domain-containing protein 1 (LYSMD1) LDTP15825 C32(1.03)  LDD0078 
LysM and putative peptidoglycan-binding domain-containing protein 2 (LYSMD2) LDTP17622 C106(0.99)  LDD0078 
LysM and putative peptidoglycan-binding domain-containing protein 3 (LYSMD3) LDTP15240 C122(1.06); C83(0.85)  LDD1507 
LysM and putative peptidoglycan-binding domain-containing protein 4 (LYSMD4) LDTP17293 C93(2.21)  LDD3380 
Lysosomal-trafficking regulator (LYST) LDTP10946 C3505(2.26)  LDD3325 
Lysosome-associated membrane glycoprotein 3 (LAMP3) LDTP13772 C408(1.63)  LDD3349 
M-phase phosphoprotein 6 (MPHOSPH6) LDTP10892 C432(4.03)  LDD3312 
M-phase phosphoprotein 8 (MPHOSPH8) LDTP10893 C753(2.61)  LDD3310 
Macrophage colony-stimulating factor 1 (CSF1) LDTP02360 C258(1.17)  LDD3389 
Macrophage immunometabolism regulator (MACIR) LDTP10363 C36(1.05); C41(1.05)  LDD0078 
Macrophage mannose receptor 1 (MRC1) LDTP03202 C74(2.41)  LDD3409 
Macrophage-capping protein (CAPG) LDTP03877 C77(1.01)  LDD3310 
MAD2L1-binding protein (MAD2L1BP) LDTP06276 C124(17.44)  LDD0204 
Maestro heat-like repeat-containing protein family member 1 (MROH1) LDTP17791 C1376(287.34)  LDD0209 
Maestro heat-like repeat-containing protein family member 6 (MROH6) LDTP18799 C281(0.92)  LDD0531 
MAGUK p55 subfamily member 2 (MPP2) LDTP06068 C256(1.74); C270(2.29)  LDD0080 
MAGUK p55 subfamily member 7 (MPP7) LDTP07106 C462(1.22)  LDD0531 
Major centromere autoantigen B (CENPB) LDTP02182 C135(1.31); C259(1.14)  LDD0078 
Major facilitator superfamily domain-containing protein 1 (MFSD1) LDTP11891 C34(1.15)  LDD1507 
Male-specific lethal 3 homolog (MSL3) LDTP08909 C188(1.07)  LDD0078 
Malectin (MLEC) LDTP06066 C206(1.94)  LDD3310 
Malignant fibrous histiocytoma-amplified sequence 1 (MFHAS1) LDTP14042 C629(1.12)  LDD0531 
Malignant T-cell-amplified sequence 1 (MCTS1) LDTP13532 C114(1.23)  LDD3310 
Malignant T-cell-amplified sequence 2 (MCTS2) LDTP18707 C14(0.84)  LDD1492 
MAM domain-containing protein 2 (MAMDC2) LDTP17532 C475(2.13)  LDD2253 
Mammalian ependymin-related protein 1 (EPDR1) LDTP13606 C88(3.21)  LDD3314 
Mannose-P-dolichol utilization defect 1 protein (MPDU1) LDTP14491 C22(1.25)  LDD1093 
MAP kinase-activating death domain protein (MADD) LDTP09699 C1489(1.23)  LDD0078 
MAP3K12-binding inhibitory protein 1 (MBIP) LDTP12567 C183(1.05); C194(1.05)  LDD0078 
MAP7 domain-containing protein 1 (MAP7D1) LDTP14910 C382(0.97); C251(0.95)  LDD0078 
MAP7 domain-containing protein 2 (MAP7D2) LDTP18273 C244(4.81); C615(2.95)  LDD3342 
MAP7 domain-containing protein 3 (MAP7D3) LDTP08535 C494(1.10)  LDD0078 
MAPK regulated corepressor interacting protein 2 (MCRIP2) LDTP15892 C34(1.79)  LDD3355 
MARCKS-related protein (MARCKSL1) LDTP04224 C134(0.86)  LDD0078 
Marginal zone B- and B1-cell-specific protein (MZB1) LDTP09558 C51(1.07)  LDD3431 
MARVEL domain-containing protein 1 (MARVELD1) LDTP18303 C126(0.83)  LDD1492 
Mastermind-like domain-containing protein 1 (MAMLD1) LDTP05896 C477(1.73)  LDD2470 
Mastermind-like protein 1 (MAML1) LDTP09809 C525(0.88)  LDD0531 
Mastermind-like protein 2 (MAML2) LDTP08706 C275(1.52)  LDD2469 
Matrilin-2 (MATN2) LDTP00256 C633(1.59)  LDD2469 
Matrin-3 (MATR3) LDTP04027 C552(1.92); C806(1.53)  LDD0080 
Matrix Gla protein (MGP) LDTP02276 C98(1.62)  LDD2270 
Maturin (MTURN) LDTP08829 C14(0.51)  LDD1507 
MAU2 chromatid cohesion factor homolog (MAU2) LDTP14304 C364(0.99); C367(0.99); C47(0.96); C50(0.96)  LDD0078 
MBT domain-containing protein 1 (MBTD1) LDTP05471 C54(1.57); C57(1.57); C168(1.07)  LDD0080 
Mdm2-binding protein (MTBP) LDTP15714 C789(5.43); C797(5.43)  LDD0080 
Mediator of DNA damage checkpoint protein 1 (MDC1) LDTP06176 C26(1.03)  LDD0078 
Mediator of RNA polymerase II transcription subunit 1 (MED1) LDTP06434 C800(0.94); C373(0.92)  LDD0078 
Mediator of RNA polymerase II transcription subunit 11 (MED11) LDTP12955 C90(1.09)  LDD1509 
Mediator of RNA polymerase II transcription subunit 12 (MED12) LDTP09973 C481(62.63); C541(9.47); C444(15.81); C83(45.56)  LDD0209 
Mediator of RNA polymerase II transcription subunit 12-like protein (MED12L) LDTP08424 C1488(5.76)  LDD3373 
Mediator of RNA polymerase II transcription subunit 13 (MED13) LDTP13307 C1878(1.04); C244(1.02); C245(1.02)  LDD0078 
Mediator of RNA polymerase II transcription subunit 13-like (MED13L) LDTP07901 C423(0.94); C425(0.94)  LDD0078 
Mediator of RNA polymerase II transcription subunit 14 (MED14) LDTP00925 C1433(0.98)  LDD0078 
Mediator of RNA polymerase II transcription subunit 15 (MED15) LDTP10771 C660(1.16)  LDD0078 
Mediator of RNA polymerase II transcription subunit 16 (MED16) LDTP13924 C253(4.12)  LDD0204 
Mediator of RNA polymerase II transcription subunit 17 (MED17) LDTP12669 C304(1.18); C488(1.07)  LDD0531 
Mediator of RNA polymerase II transcription subunit 18 (MED18) LDTP11231 C105(1.82)  LDD3332 
Mediator of RNA polymerase II transcription subunit 19 (MED19) LDTP00016 C62(1.65)  LDD0080 
Mediator of RNA polymerase II transcription subunit 22 (MED22) LDTP06405 C112(1.22)  LDD0531 
Mediator of RNA polymerase II transcription subunit 23 (MED23) LDTP13559 C225(1.46); C1069(1.48); C238(1.62); C1090(1.51)  LDD0080 
Mediator of RNA polymerase II transcription subunit 24 (MED24) LDTP01225 C218(89.79)  LDD0209 
Mediator of RNA polymerase II transcription subunit 25 (MED25) LDTP07906 C429(2.04)  LDD3312 
Mediator of RNA polymerase II transcription subunit 26 (MED26) LDTP01590 C356(1.26); C340(1.06)  LDD0078 
Mediator of RNA polymerase II transcription subunit 27 (MED27) LDTP07518 C281(1.13)  LDD0078 
Mediator of RNA polymerase II transcription subunit 28 (MED28) LDTP11784 C93(2.95)  LDD0080 
Mediator of RNA polymerase II transcription subunit 29 (MED29) LDTP12766 C126(1.03); C131(1.03)  LDD0078 
Mediator of RNA polymerase II transcription subunit 30 (MED30) LDTP10396 C34(1.12)  LDD0532 
Mediator of RNA polymerase II transcription subunit 31 (MED31) LDTP13977 C93(1.23)  LDD0531 
Mediator of RNA polymerase II transcription subunit 4 (MED4) LDTP12377 C162(0.88)  LDD0531 
Mediator of RNA polymerase II transcription subunit 6 (MED6) LDTP01264 C45(0.83)  LDD0563 
Mediator of RNA polymerase II transcription subunit 7 (MED7) LDTP00787 C197(0.92)  LDD0078 
Mediator of RNA polymerase II transcription subunit 8 (MED8) LDTP10330 C147(7.54)  LDD0209 
Mediator of RNA polymerase II transcription subunit 9 (MED9) LDTP16117 C139(0.77)  LDD0531 
Megakaryocyte and platelet inhibitory receptor G6b (MPIG6B) LDTP01701 C53(1.56)  LDD2324 
Meiosis regulator and mRNA stability factor 1 (MARF1) LDTP14053 C193(16.26); C194(16.26); C271(3.37); C274(3.37)  LDD0080 
Meiotic nuclear division protein 1 homolog (MND1) LDTP18320 C115(1.99)  LDD3331 
Melanocyte protein PMEL (PMEL) LDTP03913 C475(3.32)  LDD3332 
Melanoma antigen preferentially expressed in tumors (PRAME) LDTP05120 C487(1.71); C490(1.71)  LDD0533 
Melanoma antigen recognized by T-cells 1 (MLANA) LDTP06596 C93(1.94); C68(4.92)  LDD3332 
Melanoma-associated antigen 1 (MAGEA1) LDTP04038 C139(1.75)  LDD3364 
Melanoma-associated antigen 11 (MAGEA11) LDTP04044 C381(1.04)  LDD3364 
Melanoma-associated antigen 2 (MAGEA2; MAGEA2B) LDTP04039 C143(1.21); C268(0.93)  LDD0531 
Melanoma-associated antigen 3 (MAGEA3) LDTP04040 C10(2.99)  LDD3373 
Melanoma-associated antigen 4 (MAGEA4) LDTP04041 C147(2.77)  LDD3331 
Melanoma-associated antigen 9 (MAGEA9; MAGEA9B) LDTP16961 C299(1.07)  LDD3351 
Melanoma-associated antigen B2 (MAGEB2) LDTP00648 C301(1.06)  LDD0531 
Melanoma-associated antigen B3 (MAGEB3) LDTP19013 C148(1.40)  LDD3376 
Melanoma-associated antigen B6 (MAGEB6) LDTP08970 C200(1.04)  LDD1511 
Melanoma-associated antigen C1 (MAGEC1) LDTP16814 C1066(1.00)  LDD3351 
Melanoma-associated antigen D1 (MAGED1) LDTP14165 C517(4.67)  LDD0209 
Melanoma-associated antigen D2 (MAGED2) LDTP13657 C516(1.49)  LDD0080 
Melanoma-associated antigen D4 (MAGED4; MAGED4B) LDTP10464 C484(0.97)  LDD1507 
Melanoma-associated antigen E1 (MAGEE1) LDTP12244 C429(1.08)  LDD1507 
Melanophilin (MLPH) LDTP11263 C81(0.86); C84(0.86); C89(0.86)  LDD0078 
Melanoregulin (MREG) LDTP08886 C198(3.26)  LDD3320 
Melanotransferrin (MELTF) LDTP02287 C199(1.23); C369(1.09); C186(1.02); C532(0.94)  LDD0078 
Membralin (TMEM259) LDTP14939 C129(1.34)  LDD0080 
Membrane cofactor protein (CD46) LDTP02795 C228(2.92); C94(2.56)  LDD3311 
Membrane protein BRI3 (BRI3) LDTP01595 C78(2.52); C81(2.52)  LDD0080 
Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (MAGI1) LDTP10752 C1065(1.04)  LDD0531 
Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (MAGI3) LDTP07179 C1304(1.00)  LDD0078 
Menin (MEN1) LDTP00232 C359(1.05)  LDD0080 
Merlin (NF2) LDTP03720 C300(1.45)  LDD3312 
Mesencephalic astrocyte-derived neurotrophic factor (MANF) LDTP04676 C117(1.18)  LDD0532 
Mesothelin (MSLN) LDTP05860 C190(1.42)  LDD3360 
Metalloproteinase inhibitor 1 (TIMP1) LDTP01817 C93(1.26)  LDD0078 
Metalloproteinase inhibitor 2 (TIMP2) LDTP02820 C152(0.86); C154(0.86)  LDD0531 
Metalloproteinase inhibitor 3 (TIMP3) LDTP03773 C118(1.70)  LDD0080 
Metallothionein-1E (MT1E) LDTP02050 C15(0.97); C19(0.96); C7(0.96); C13(0.96)  LDD0078 
Metallothionein-1F (MT1F) LDTP02051 C44(1.71); C48(1.71); C33(1.70); C41(1.70)  LDD0080 
Metallothionein-1G (MT1G) LDTP02673 C45(1.45); C49(1.45); C37(1.51); C42(1.51)  LDD0080 
Metallothionein-1L (MT1L) LDTP18119 C44(0.85); C48(0.89); C50(0.87); C34(0.84)  LDD0531 
Metallothionein-1M (MT1M) LDTP15409 C60(1.25); C33(0.98); C36(0.98); C34(0.94)  LDD0078 
Metallothionein-2 (MT2A) LDTP01975 C34(1.04); C33(0.97); C15(0.96); C7(0.96)  LDD0078 
Metastasis-associated in colon cancer protein 1 (MACC1) LDTP15180 C104(0.97)  LDD0531 
Methyl-CpG-binding domain protein 2 (MBD2) LDTP13092 C10(0.92); C11(0.92)  LDD0078 
Methyl-CpG-binding domain protein 3 (MBD3) LDTP01731 C215(1.37)  LDD0080 
Methyl-CpG-binding domain protein 3-like 2B (MBD3L2B) LDTP18663 C159(1.42)  LDD3423 
Methyl-CpG-binding domain protein 6 (MBD6) LDTP15710 C60(1.67)  LDD0080 
Methyl-CpG-binding protein 2 (MECP2) LDTP04433 C441(1.68)  LDD3312 
Methylosome protein WDR77 (WDR77) LDTP11066 C53(1.00); C26(0.96); C65(0.87); C73(0.87)  LDD0078 
Methyltransferase-like 26 (METTL26) LDTP18266 C118(12.07)  LDD0209 
MICAL-like protein 1 (MICALL1) LDTP08830 C214(1.13); C218(1.13); C194(0.87)  LDD0078 
MICAL-like protein 2 (MICALL2) LDTP08623 C271(1.08)  LDD0078 
MICOS complex subunit MIC13 (MICOS13) LDTP07274 C60(0.87)  LDD0531 
MICOS complex subunit MIC19 (CHCHD3) LDTP12764 C112(1.83)  LDD0080 
MICOS complex subunit MIC25 (CHCHD6) LDTP11123 C218(1.04)  LDD1492 
MICOS complex subunit MIC27 (APOOL) LDTP07718 C74(0.96)  LDD0078 
Microcephalin (MCPH1) LDTP09162 C776(0.80); C782(0.80)  LDD0531 
Microfibrillar-associated protein 2 (MFAP2) LDTP04650 C142(4.38)  LDD3469 
Microfibrillar-associated protein 5 (MFAP5) LDTP05840 C140(2.18)  LDD3383 
Microprocessor complex subunit DGCR8 (DGCR8) LDTP09744 C128(1.98); C769(1.29)  LDD0080 
Microspherule protein 1 (MCRS1) LDTP10287 C97(1.69); C202(8.01)  LDD3311 
Microtubule cross-linking factor 1 (MTCL1) LDTP14037 C729(1.02)  LDD0078 
Microtubule cross-linking factor 2 (MTCL2) LDTP01473 C754(8.85); C1068(17.13); C726(62.23)  LDD0209 
Microtubule cross-linking factor 3 (MTCL3) LDTP17245 C527(10.56); C254(2.61)  LDD3340 
Microtubule nucleation factor SSNA1 (SSNA1) LDTP00871 C18(1.65); C23(1.65)  LDD0080 
Microtubule organization protein AKNA (AKNA) LDTP08087 C651(2.86)  LDD3339 
Microtubule-actin cross-linking factor 1, isoforms 6/7 (MACF1) LDTP14519 C80(1.15); C571(0.95); C500(0.88); C510(0.88)  LDD0078 
Microtubule-associated protein 10 (MAP10) LDTP13049 C54(1.97)  LDD3344 
Microtubule-associated protein 1A (MAP1A) LDTP05146 C2191(1.47)  LDD3310 
Microtubule-associated protein 1B (MAP1B) LDTP04112 C2041(1.18); C2065(1.06); C963(1.01); C382(0.99)  LDD0078 
Microtubule-associated protein 1S (MAP1S) LDTP07297 C588(1.03); C598(1.03); C738(0.99); C743(0.99)  LDD0078 
Microtubule-associated protein 2 (MAP2) LDTP02540 C758(1.50)  LDD3311 
Microtubule-associated protein 4 (MAP4) LDTP03404 C635(1.71); C535(1.26)  LDD0080 
Microtubule-associated protein 6 (MAP6) LDTP10461 C137(1.26)  LDD3340 
Microtubule-associated protein 9 (MAP9) LDTP06833 C108(1.32)  LDD3310 
Microtubule-associated protein RP/EB family member 1 (MAPRE1) LDTP06444 C228(0.94); C39(1.08); C45(1.08)  LDD0531 
Microtubule-associated protein RP/EB family member 2 (MAPRE2) LDTP06413 C279(1.66)  LDD3331 
Microtubule-associated protein RP/EB family member 3 (MAPRE3) LDTP13736 C182(0.89)  LDD0078 
Microtubule-associated protein tau (MAPT) LDTP02509 C657(3.65)  LDD3423 
Microtubule-associated tumor suppressor 1 (MTUS1) LDTP13537 C492(2.71)  LDD0080 
Mid1-interacting protein 1 (MID1IP1) LDTP16056 C62(5.77)  LDD0209 
Midasin (MDN1) LDTP12619 C1394(1.19); C4041(1.15); C1332(1.15); C1011(1.10)  LDD0078 
Midkine (MDK) LDTP03128 C37(2.68); C45(2.68); C84(2.06)  LDD0080 
Midnolin (MIDN) LDTP14940 C332(2.95); C336(2.95)  LDD0078 
MIF4G domain-containing protein (MIF4GD) LDTP00155 C90(3.04)  LDD3325 
Migration and invasion enhancer 1 (MIEN1) LDTP11132 C30(0.74); C33(0.68)  LDD0812 
Migration and invasion-inhibitory protein (MIIP) LDTP07024 C213(1.39); C215(1.39)  LDD0531 
Mini-chromosome maintenance complex-binding protein (MCMBP) LDTP11197 C636(1.07); C325(1.06); C200(1.00); C249(0.97)  LDD0078 
Mis18-binding protein 1 (MIS18BP1) LDTP07500 C550(1.02); C554(1.02)  LDD0078 
MIT domain-containing protein 1 (MITD1) LDTP09599 C138(65.62)  LDD0209 
Mitochondria-eating protein (SPATA18) LDTP09373 C512(1.64)  LDD3310 
Mitochondrial antiviral-signaling protein (MAVS) LDTP08058 C283(1.99)  LDD0531 
Mitochondrial assembly of ribosomal large subunit protein 1 (MALSU1) LDTP10261 C110(1.08)  LDD1507 
Mitochondrial dynamics protein MID49 (MIEF2) LDTP10153 C378(3.34)  LDD3325 
Mitochondrial dynamics protein MIEF1 (MIEF1) LDTP12418 C251(1.28); C359(0.98)  LDD0531 
Mitochondrial fission 1 protein (FIS1) LDTP13982 C41(0.90)  LDD0078 
Mitochondrial fission factor (MFF) LDTP11670 C209(3.49)  LDD3321 
Mitochondrial fission process protein 1 (MTFP1) LDTP16192 C104(4.78)  LDD3383 
Mitochondrial fission regulator 1 (MTFR1) LDTP14857 C89(0.85)  LDD0078 
Mitochondrial fission regulator 1-like (MTFR1L) LDTP15947 C222(0.96); C230(0.96)  LDD0078 
Mitochondrial fission regulator 2 (MTFR2) LDTP15112 C50(3.19)  LDD3439 
Mitochondrial import inner membrane translocase subunit Tim13 (TIMM13) LDTP14136 C65(1.37); C69(1.37)  LDD2171 
Mitochondrial import inner membrane translocase subunit Tim29 (TIMM29) LDTP15874 C46(0.85)  LDD0078 
Mitochondrial import inner membrane translocase subunit Tim9 (TIMM9) LDTP14126 C48(1.28)  LDD1571 
Mitochondrial import receptor subunit TOM20 homolog (TOMM20) LDTP06373 C100(2.17)  LDD3312 
Mitochondrial import receptor subunit TOM34 (TOMM34) LDTP06473 C236(0.68); C250(0.71)  LDD0531 
Mitochondrial import receptor subunit TOM40B (TOMM40L) LDTP15674 C270(3.14)  LDD3312 
Mitochondrial import receptor subunit TOM70 (TOMM70) LDTP01432 C475(1.08); C544(0.97)  LDD0078 
Mitochondrial nucleoid-associated protein 1 (MTNAP1) LDTP15880 C332(1.35)  LDD0078 
Mitochondrial potassium channel (CCDC51) LDTP10275 C316(1.59)  LDD0080 
Mitochondrial protein C2orf69 (C2orf69) LDTP15461 C219(0.97)  LDD0078 
Mitochondrial ribosome and complex I assembly factor AltMIEF1 (MIEF1) LDTP00183 C251(4.97)  LDD3310 
Mitochondrial translation release factor in rescue (MTRFR) LDTP11868 C81(2.81)  LDD3337 
Mitogen-activated protein kinase-binding protein 1 (MAPKBP1) LDTP00955 C408(1.22); C417(1.22)  LDD1094 
Mitotic checkpoint protein BUB3 (BUB3) LDTP00838 C129(0.96); C101(0.96); C105(0.96)  LDD0078 
Mitotic interactor and substrate of PLK1 (MISP) LDTP08514 C491(0.91)  LDD0078 
Mitotic spindle assembly checkpoint protein MAD1 (MAD1L1) LDTP14239 C134(1.04)  LDD0080 
Mitotic spindle assembly checkpoint protein MAD2A (MAD2L1) LDTP05805 C106(1.03)  LDD0078 
Mitotic spindle assembly checkpoint protein MAD2B (MAD2L2) LDTP13333 C133(1.65); C144(1.65)  LDD0080 
Mitotic-spindle organizing protein 1 (MZT1) LDTP05583 C51(5.47)  LDD3332 
Mitotic-spindle organizing protein 2A (MZT2A) LDTP15117 C80(1.15)  LDD0532 
Mitotic-spindle organizing protein 2B (MZT2B) LDTP15106 C80(49.34)  LDD0209 
MKI67 FHA domain-interacting nucleolar phosphoprotein (NIFK) LDTP11457 C237(1.19); C269(1.16)  LDD0078 
MMS19 nucleotide excision repair protein homolog (MMS19) LDTP10843 C549(117.82); C819(8.55); C502(955.58); C361(6.95)  LDD0209 
MOB kinase activator 2 (MOB2) LDTP07886 C136(1.52)  LDD3338 
MOB kinase activator 3A (MOB3A) LDTP18131 C83(0.86); C88(0.86)  LDD0531 
MOB kinase activator 3B (MOB3B) LDTP15279 C79(0.87); C82(0.87)  LDD1093 
MOB kinase activator 3C (MOB3C) LDTP07887 C82(0.85); C87(0.85)  LDD0547 
MOB-like protein phocein (MOB4) LDTP13964 C119(1.06); C134(0.83); C51(1.13)  LDD0531 
Modulator of smoothened protein (MOSMO) LDTP18039 C46(1.60)  LDD3413 
Moesin (MSN) LDTP03346 C117(1.67)  LDD3312 
Molybdenum cofactor biosynthesis protein 1 (MOCS1) LDTP12884 C84(0.91); C87(0.91)  LDD0813 
MORC family CW-type zinc finger protein 3 (MORC3) LDTP06053 C694(0.94)  LDD0078 
MORC family CW-type zinc finger protein 4 (MORC4) LDTP09483 C324(0.84)  LDD0531 
MORF4 family associated protein 1 like 2 (MRFAP1L2) LDTP18918 C89(10.43)  LDD0205 
MORF4 family-associated protein 1-like 1 (MRFAP1L1) LDTP10400 C97(52.48)  LDD0209 
Mortality factor 4-like protein 1 (MORF4L1) LDTP13162 C19(0.92)  LDD0593 
Mortality factor 4-like protein 2 (MORF4L2) LDTP06277 C165(0.93)  LDD0078 
Motile sperm domain-containing protein 1 (MOSPD1) LDTP16210 C54(1.98)  LDD3319 
Motile sperm domain-containing protein 2 (MOSPD2) LDTP09255 C471(0.95)  LDD0531 
MRG/MORF4L-binding protein (MRGBP) LDTP12658 C170(0.96)  LDD0078 
MRN complex-interacting protein (MRNIP) LDTP07465 C195(3.59); C203(3.59)  LDD0080 
mRNA decay activator protein ZFP36 (ZFP36) LDTP03368 C249(2.39); C250(2.39); C253(2.39)  LDD2171 
mRNA decay activator protein ZFP36L1 (ZFP36L1) LDTP05520 C34(1.13)  LDD0078 
mRNA decay activator protein ZFP36L2 (ZFP36L2) LDTP04143 C159(0.92); C168(0.92)  LDD0078 
mRNA turnover protein 4 homolog (MRTO4) LDTP16220 C176(0.84)  LDD0531 
Mth938 domain-containing protein (AAMDC) LDTP16011 C122(1.28)  LDD0080 
MTOR-associated protein MEAK7 (MEAK7) LDTP07550 C387(2.64); C13(1.72)  LDD3314 
Mucin-16 (MUC16) LDTP09708 C13395(1.33)  LDD3312 
Mucin-17 (MUC17) LDTP07306 C4353(5.43)  LDD3440 
Mucin-2 (MUC2) LDTP05374 C712(3.43)  LDD3312 
Mucin-4 (MUC4) LDTP10853 C325(2.42)  LDD3319 
Mucin-5AC (MUC5AC) LDTP05212 C1831(1.05); C1448(0.90); C1456(0.90); C953(0.85)  LDD0078 
Mucin-5B (MUC5B) LDTP12222 C597(0.68); C5344(1.43); C1071(1.12); C2399(1.49)  LDD3312 
Mucin-6 (MUC6) LDTP07739 C773(0.92)  LDD3342 
Muellerian-inhibiting factor (AMH) LDTP01993 C411(0.98)  LDD3395 
Multifunctional methyltransferase subunit TRM112-like protein (TRMT112) LDTP13323 C33(1.06)  LDD0078 
Multimerin-1 (MMRN1) LDTP05783 C486(0.96)  LDD3380 
Multiple epidermal growth factor-like domains protein 10 (MEGF10) LDTP10502 C234(1.12)  LDD3310 
Multiple epidermal growth factor-like domains protein 11 (MEGF11) LDTP00080 C779(1.26)  LDD2469 
Multiple epidermal growth factor-like domains protein 6 (MEGF6) LDTP14485 C906(1.17)  LDD3311 
Multiple epidermal growth factor-like domains protein 8 (MEGF8) LDTP08157 C1072(1.01); C1078(1.01)  LDD0078 
Multiple epidermal growth factor-like domains protein 9 (MEGF9) LDTP15965 C283(1.25)  LDD3310 
Multiple myeloma tumor-associated protein 2 (MMTAG2) LDTP11223 C179(0.88)  LDD0078 
Multiple PDZ domain protein (MPDZ) LDTP01370 C990(4.59); C994(4.59); C1620(4.08); C1626(4.08)  LDD0080 
Multivesicular body subunit 12A (MVB12A) LDTP10284 C33(0.97); C90(1.02)  LDD0531 
Multivesicular body subunit 12B (MVB12B) LDTP12031 C267(3.62)  LDD3314 
Muscleblind-like protein 1 (MBNL1) LDTP12478 C53(1.06); C19(1.06); C185(1.03); C27(1.02)  LDD0078 
Muscleblind-like protein 2 (MBNL2) LDTP07260 C53(0.80)  LDD3310 
Muscleblind-like protein 3 (MBNL3) LDTP12630 C99(0.80)  LDD3310 
Musculoskeletal embryonic nuclear protein 1 (MUSTN1) LDTP17626 C47(1.76)  LDD3404 
Muskelin (MKLN1) LDTP13525 C560(0.93); C582(0.87)  LDD0078 
Myb-binding protein 1A (MYBBP1A) LDTP11079 C968(5.60); C338(6.32)  LDD0209 
Myb/SANT-like DNA-binding domain-containing protein 7 (MSANTD7) LDTP20092 C163(0.90); C210(1.26)  LDD1492 
Myc box-dependent-interacting protein 1 (BIN1) LDTP00296 C47(2.86)  LDD0080 
Myc target protein 1 (MYCT1) LDTP17726 C131(1.14)  LDD3388 
Myelin expression factor 2 (MYEF2) LDTP13060 C143(1.27)  LDD3310 
Myeloid differentiation primary response protein MyD88 (MYD88) LDTP10992 C274(4.92); C280(4.92)  LDD0080 
MYND-type zinc finger-containing chromatin reader ZMYND8 (ZMYND8) LDTP13575 CAmbiguous(12.92)  LDD0209 
Myomegalin (PDE4DIP) LDTP07221 C434(1.34)  LDD3311 
Myosin light chain 4 (MYL4) LDTP02633 C78(0.52)  LDD3334 
Myosin light chain 6B (MYL6B) LDTP02736 C89(1.23)  LDD0531 
Myosin light polypeptide 6 (MYL6) LDTP04875 C138(1.33)  LDD3332 
Myosin phosphatase Rho-interacting protein (MPRIP) LDTP07741 C831(1.23); C724(1.54)  LDD3311 
Myosin regulatory light chain 11 (MYL11) LDTP10058 C128(7.47); C157(6.35)  LDD3401 
Myosin regulatory light chain 12B (MYL12B) LDTP00487 C109(1.88)  LDD0080 
Myosin regulatory light chain 2, atrial isoform (MYL7) LDTP05290 C164(2.24)  LDD2282 
Myosin regulatory light polypeptide 9 (MYL9) LDTP03293 C109(1.02)  LDD0531 
Myotrophin (MTPN) LDTP04819 C45(1.01)  LDD3377 
N-acetylglucosamine-1-phosphotransferase subunit gamma (GNPTG) LDTP13386 C142(1.02)  LDD0078 
N-alpha-acetyltransferase 38, NatC auxiliary subunit (NAA38) LDTP11102 C66(1.28)  LDD0080 
N-chimaerin (CHN1) LDTP02810 C35(1.52); C37(1.52)  LDD0580 
N-glycosylase/DNA lyase (OGG1) LDTP00667 C163(2.88)  LDD3360 
N-myc-interactor (NMI) LDTP05815 C230(0.74)  LDD0533 
N6-adenosine-methyltransferase non-catalytic subunit (METTL14) LDTP12234 C210(1.64); C235(1.34); C256(1.23); C260(1.23)  LDD0531 
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 (NHERF4) LDTP08247 C484(1.28)  LDD2499 
NACHT, LRR and PYD domains-containing protein 10 (NLRP10) LDTP08314 C540(3.48); C414(3.68)  LDD2284 
NACHT, LRR and PYD domains-containing protein 2 (NLRP2) LDTP12748 C247(0.78); C1008(1.03); C143(1.12); C256(1.02)  LDD0531 
NACHT, LRR and PYD domains-containing protein 4 (NLRP4) LDTP10592 C479(3.72)  LDD3331 
NACHT, LRR and PYD domains-containing protein 7 (NLRP7) LDTP09681 C575(0.96)  LDD3313 
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (NDUFAF6) LDTP06753 C216(1.02)  LDD0531 
NADH dehydrogenase 1 alpha subcomplex assembly factor 3 (NDUFAF3) LDTP11221 C150(0.93); C157(0.93)  LDD0532 
NADH dehydrogenase 1 alpha subcomplex assembly factor 4 (NDUFAF4) LDTP12953 C87(1.43)  LDD0080 
NADPH oxidase organizer 1 (NOXO1) LDTP09194 C243(2.52)  LDD3439 
NALCN channel auxiliary factor 2 (NALF2) LDTP16828 C67(1.70)  LDD3345 
Nanos homolog 1 (NANOS1) LDTP09726 C241(2.09)  LDD3493 
NBAS subunit of NRZ tethering complex (NBAS) LDTP00046 C1453(1.00); C802(0.93); C807(0.93)  LDD0078 
Nck-associated protein 1 (NCKAP1) LDTP13839 C562(2.13)  LDD3310 
Nck-associated protein 1-like (NCKAP1L) LDTP04678 C982(6.43); C338(3.52)  LDD3333 
Nck-associated protein 5 (NCKAP5) LDTP14425 C1642(0.61)  LDD3344 
Nck-associated protein 5-like (NCKAP5L) LDTP12241 C787(2.62)  LDD3419 
NCK-interacting protein with SH3 domain (NCKIPSD) LDTP12929 C331(0.98)  LDD0078 
Nebulette (NEBL) LDTP01385 C53(1.11)  LDD3312 
Nebulin (NEB) LDTP03091 C4034(1.02)  LDD3374 
NEDD4 family-interacting protein 2 (NDFIP2) LDTP12664 C213(1.08); C266(1.20)  LDD1492 
NEDD4-binding protein 2-like 2 (N4BP2L2) LDTP09880 C193(0.82)  LDD0533 
NEDD4-binding protein 3 (N4BP3) LDTP00519 C442(0.69); C447(0.69)  LDD0563 
NEDD8 ultimate buster 1 (NUB1) LDTP14104 C51(13.45); C52(13.45); C267(2.87); C270(3.37)  LDD0080 
Negative elongation factor A (NELFA) LDTP11876 C131(10.12); C141(10.12); C471(1.33)  LDD0080 
Negative elongation factor B (NELFB) LDTP09679 C235(1.05)  LDD0078 
Negative elongation factor C/D (NELFCD) LDTP08594 C397(4.79); C398(4.79)  LDD0080 
Negative elongation factor E (NELFE) LDTP02960 C297(1.85)  LDD0080 
NELL2-interacting cell ontogeny regulator 1 (NICOL1) LDTP19331 C69(2.62)  LDD3413 
Nephrocystin-3 (NPHP3) LDTP08065 C933(2.31); C941(2.31)  LDD0080 
Nephrocystin-4 (NPHP4) LDTP01147 C1174(1.37); C1181(1.37)  LDD0532 
Nephronectin (NPNT) LDTP07711 C86(1.92)  LDD3373 
Nesprin-1 (SYNE1) LDTP09191 C8196(0.62)  LDD0533 
Nesprin-2 (SYNE2) LDTP09702 C90(198.84); C1844(21.06); C2520(39.68)  LDD0209 
Nesprin-3 (SYNE3) LDTP07781 C51(3.42); C246(1.95)  LDD3332 
Nestin (NES) LDTP04206 C157(2.35)  LDD3312 
Netrin-4 (NTN4) LDTP12161 C362(1.05); C371(1.05); C329(1.00)  LDD0078 
Neuferricin (CYB5D2) LDTP15623 C17(1.54)  LDD2469 
Neurabin-1 (PPP1R9A) LDTP13557 C980(1.46)  LDD3310 
Neurabin-2 (PPP1R9B) LDTP10808 C270(0.92)  LDD0078 
Neural proliferation differentiation and control protein 1 (NPDC1) LDTP12450 C260(1.85)  LDD3493 
Neurexin-2-beta (NRXN2) LDTP04816 C431(3.18)  LDD3409 
Neurexophilin-4 (NXPH4) LDTP16842 C233(6.07)  LDD3342 
Neurobeachin (NBEA) LDTP09214 C457(2.25)  LDD3312 
Neurobeachin-like protein 1 (NBEAL1) LDTP17486 C250(18.64)  LDD0209 
Neurobeachin-like protein 2 (NBEAL2) LDTP07797 C121(1.15); C1814(0.97); C1661(0.95)  LDD0078 
Neuroblast differentiation-associated protein AHNAK (AHNAK) LDTP05597 C108(1.06); C2806(1.02); C5502(0.97); C1833(0.95)  LDD0078 
Neuroblastoma suppressor of tumorigenicity 1 (NBL1) LDTP03948 C70(1.92)  LDD3484 
Neurocalcin-delta (NCALD) LDTP04930 C185(10.63)  LDD3344 
Neurochondrin (NCDN) LDTP13093 C98(297.53)  LDD0209 
Neuroendocrine secretory protein 55 (GNAS) LDTP01612 C443(2.06)  LDD3310 
Neuroepithelial cell-transforming gene 1 protein (NET1) LDTP08110 C267(1.66)  LDD0080 
Neurofibromin (NF1) LDTP03108 C124(1.10); C673(1.09); C680(1.09); C118(0.92)  LDD0078 
Neurofilament heavy polypeptide (NEFH) LDTP02600 C227(2.72); C265(7.62)  LDD3340 
Neurofilament light polypeptide (NEFL) LDTP02180 C322(1.71)  LDD0080 
Neurogenic locus notch homolog protein 2 (NOTCH2) LDTP05425 C412(0.89); C419(0.89); C1235(0.86); C1241(0.86)  LDD0078 
Neurogenic locus notch homolog protein 3 (NOTCH3) LDTP13608 C579(0.85); C586(0.85)  LDD0078 
Neuron navigator 1 (NAV1) LDTP09181 C337(1.09)  LDD0078 
Neuron navigator 3 (NAV3) LDTP08502 C1228(1.17)  LDD0533 
Neuron-specific vesicular protein calcyon (CALY) LDTP12859 C6(2.28)  LDD2252 
Neuronal calcium sensor 1 (NCS1) LDTP04961 C38(1.47)  LDD3337 
Neuronal membrane glycoprotein M6-a (GPM6A) LDTP04444 C192(1.04)  LDD1507 
Neuronal membrane glycoprotein M6-b (GPM6B) LDTP05894 C261(1.13)  LDD1507 
Neuronal migration protein doublecortin (DCX) LDTP00814 C127(1.51)  LDD3340 
Neuronal vesicle trafficking-associated protein 1 (NSG1) LDTP04006 C112(0.92)  LDD1509 
Neuropeptide W (NPW) LDTP15437 C159(1.81)  LDD3423 
Neutrophil cytosol factor 2 (NCF2) LDTP03020 C291(1.56)  LDD3334 
Neutrophil cytosol factor 4 (NCF4) LDTP06313 C84(1.98)  LDD3334 
Neutrophil gelatinase-associated lipocalin (LCN2) LDTP05156 C195(1.24)  LDD3312 
Next to BRCA1 gene 1 protein (NBR1) LDTP06159 C433(10.28)  LDD0204 
NF-kappa-B essential modulator (IKBKG) LDTP14268 C415(1.73)  LDD3311 
NF-kappa-B-activating protein (NKAP) LDTP08895 C349(1.25)  LDD0080 
NFATC2-interacting protein (NFATC2IP) LDTP09093 C232(1.43)  LDD0532 
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (NFU1) LDTP13622 C210(1.09); C213(1.09)  LDD0078 
NGFI-A-binding protein 1 (NAB1) LDTP05901 C111(1.28); C379(1.08); C130(0.98); C135(0.98)  LDD0078 
NGFI-A-binding protein 2 (NAB2) LDTP06456 C499(1.88)  LDD3311 
NHL repeat-containing protein 2 (NHLRC2) LDTP09049 C716(1.80)  LDD0080 
NHP2-like protein 1 (SNU13) LDTP04708 C30(1.01)  LDD0080 
NHS-like protein 1 (NHSL1) LDTP17217 C268(0.96)  LDD0078 
NHS-like protein 2 (NHSL2) LDTP06991 C679(1.74)  LDD3340 
NHS-like protein 3 (NHSL3) LDTP16169 C380(1.21)  LDD3323 
Nibrin (NBN) LDTP01090 C478(1.00); C487(0.96)  LDD0078 
Nicastrin (NCSTN) LDTP09787 C140(1.15); C159(1.15)  LDD0533 
Nicolin-1 (NICN1) LDTP15878 C8(2.18)  LDD3407 
Nidogen-1 (NID1) LDTP02728 C695(20.00); C697(20.00)  LDD0080 
Nidogen-2 (NID2) LDTP06035 C940(2.22)  LDD3311 
Ninein (NIN) LDTP08861 C701(1.61)  LDD3318 
Ninein-like protein (NINL) LDTP13872 C853(0.99)  LDD1509 
Nipped-B-like protein (NIPBL) LDTP07438 C304(1.00); C2035(0.99); C2045(0.99); C2151(0.85)  LDD0078 
Nischarin (NISCH) LDTP13870 C884(0.95); C887(0.95); C185(0.90)  LDD0078 
NKAP-like protein (NKAPL) LDTP14986 C336(0.76)  LDD1571 
NLR family member X1 (NLRX1) LDTP08248 C331(1.08)  LDD0078 
NMDA receptor synaptonuclear signaling and neuronal migration factor (NSMF) LDTP07746 C154(4.83)  LDD3457 
Non-homologous end-joining factor 1 (NHEJ1) LDTP12107 C202(0.92); C253(1.03); C74(1.08); C99(1.03)  LDD1492 
Non-structural maintenance of chromosomes element 3 homolog (NSMCE3) LDTP10585 C283(3.34)  LDD0080 
Non-structural maintenance of chromosomes element 4 homolog A (NSMCE4A) LDTP12795 C226(0.96)  LDD1492 
Nonsense-mediated mRNA decay factor SMG5 (SMG5) LDTP13712 C109(1.02)  LDD0078 
Nonsense-mediated mRNA decay factor SMG7 (SMG7) LDTP09785 C345(51.83)  LDD0209 
Nonsense-mediated mRNA decay factor SMG8 (SMG8) LDTP09112 C157(6.84)  LDD0204 
Nonsense-mediated mRNA decay factor SMG9 (SMG9) LDTP11737 C380(606.28); C380(4.77)  LDD0209 
NOP protein chaperone 1 (NOPCHAP1) LDTP17717 C13(2.61)  LDD0080 
Norrin (NDP) LDTP05251 C65(49.05); C69(49.05)  LDD0209 
Nostrin (NOSTRIN) LDTP08500 C8(0.83)  LDD3342 
Notch homolog 2 N-terminal-like protein A (NOTCH2NLA) LDTP08039 C170(2.26)  LDD3369 
Notchless protein homolog 1 (NLE1) LDTP12701 C280(0.96)  LDD0078 
NTF2-related export protein 2 (NXT2) LDTP12378 C70(2.51)  LDD3310 
Nuclear apoptosis-inducing factor 1 (NAIF1) LDTP07346 C266(14.95)  LDD0209 
Nuclear autoantigenic sperm protein (NASP) LDTP04241 C708(0.97)  LDD0078 
Nuclear cap-binding protein subunit 3 (NCBP3) LDTP06887 C131(0.96)  LDD1507 
Nuclear distribution protein nudE homolog 1 (NDE1) LDTP12786 C321(143.29)  LDD0209 
Nuclear distribution protein nudE-like 1 (NDEL1) LDTP11628 C203(1.41)  LDD1492 
Nuclear envelope integral membrane protein 2 (NEMP2) LDTP18787 C34(2.17)  LDD3413 
Nuclear envelope phosphatase-regulatory subunit 1 (CNEP1R1) LDTP08996 C23(0.89); C110(1.09)  LDD1492 
Nuclear exosome regulator NRDE2 (NRDE2) LDTP12038 C777(1.05); C781(1.05); C733(1.01); C203(0.91)  LDD0078 
Nuclear factor related to kappa-B-binding protein (NFRKB) LDTP07538 C29(5.68)  LDD0209 
Nuclear migration protein nudC (NUDC) LDTP13817 C188(0.92)  LDD0078 
Nuclear mitotic apparatus protein 1 (NUMA1) LDTP06244 C1937(1.38); C2009(1.22); C1930(1.06); C658(1.01)  LDD0078 
Nuclear protein AMMECR1 (AMMECR1) LDTP14076 C175(9.25)  LDD0080 
Nuclear protein MDM1 (MDM1) LDTP09362 C405(2.51)  LDD3408 
Nuclear receptor 2C2-associated protein (NR2C2AP) LDTP08338 C76(0.81)  LDD0532 
Nuclear receptor coactivator 4 (NCOA4) LDTP05979 C384(2.48)  LDD3311 
Nuclear receptor coactivator 5 (NCOA5) LDTP12230 C266(0.77)  LDD0532 
Nuclear receptor coactivator 6 (NCOA6) LDTP06183 C1427(1.12)  LDD0080 
Nuclear receptor-binding factor 2 (NRBF2) LDTP10292 C155(1.93)  LDD0080 
Nuclear RNA export factor 2 (NXF2; NXF2B) LDTP11668 C165(2.40)  LDD3331 
Nuclear RNA export factor 3 (NXF3) LDTP11918 C320(1.96)  LDD3334 
Nuclear RNA export factor 5 (NXF5) LDTP11757 C333(0.93)  LDD3331 
Nuclear speckle splicing regulatory protein 1 (NSRP1) LDTP11709 C232(0.95)  LDD0078 
Nuclear transport factor 2 (NUTF2) LDTP04951 C114(1.47); C38(1.03)  LDD0080 
Nucleolar and spindle-associated protein 1 (NUSAP1) LDTP11408 C256(1.17)  LDD0078 
Nucleolar complex protein 2 homolog (NOC2L) LDTP14011 C585(1.07)  LDD0078 
Nucleolar complex protein 3 homolog (NOC3L) LDTP09545 C381(0.88); C382(0.88)  LDD0531 
Nucleolar complex protein 4 homolog (NOC4L) LDTP11287 C99(4.00); C100(4.00)  LDD0209 
Nucleolar MIF4G domain-containing protein 1 (NOM1) LDTP06954 C332(1.06)  LDD0078 
Nucleolar pre-ribosomal-associated protein 1 (URB1) LDTP16802 C136(0.99); C1801(0.96); C1805(0.96); C541(0.92)  LDD0078 
Nucleolar protein 10 (NOL10) LDTP18301 C79(0.98)  LDD0078 
Nucleolar protein 11 (NOL11) LDTP16017 C557(1.27); C560(1.08)  LDD0078 
Nucleolar protein 14 (NOP14) LDTP05087 C687(0.77)  LDD0531 
Nucleolar protein 16 (NOP16) LDTP16278 C36(1.23)  LDD0078 
Nucleolar protein 3 (NOL3) LDTP01091 C73(0.96)  LDD3328 
Nucleolar protein 4-like (NOL4L) LDTP18215 C148(1.70)  LDD3314 
Nucleolar protein 56 (NOP56) LDTP00313 C142(1.12)  LDD0078 
Nucleolar protein 58 (NOP58) LDTP13925 C439(1.03); C205(0.95)  LDD0078 
Nucleolar protein 6 (NOL6) LDTP11993 C1034(0.91)  LDD0078 
Nucleolar protein 8 (NOL8) LDTP07918 C418(1.09); C424(1.09); C1020(1.05); C517(1.03)  LDD0078 
Nucleolar protein 9 (NOP9) LDTP15283 C141(0.94); C557(0.91)  LDD0078 
Nucleolin (NCL) LDTP02990 C543(0.93)  LDD0078 
Nucleolus and neural progenitor protein (NEPRO) LDTP15100 C316(1.05)  LDD0078 
Nucleolysin TIAR (TIAL1) LDTP05274 C35(1.25)  LDD3377 
Nucleophosmin (NPM1) LDTP02164 C275(0.98)  LDD0532 
Nucleoplasmin-2 (NPM2) LDTP08162 C50(1.62)  LDD2243 
Nucleoplasmin-3 (NPM3) LDTP01272 C79(1.83)  LDD0080 
Nucleosome assembly protein 1-like 1 (NAP1L1) LDTP04684 C388(0.93); C88(0.88)  LDD0078 
Nucleosome assembly protein 1-like 4 (NAP1L4) LDTP10965 C77(1.68)  LDD3311 
Nucleosome-remodeling factor subunit BPTF (BPTF) LDTP05661 C1241(1.58); C1266(1.24); C1460(1.00); C1471(1.00)  LDD0078 
Nucleotide exchange factor SIL1 (SIL1) LDTP11754 C408(3.94)  LDD3310 
Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) LDTP13795 C676(15.99)  LDD0204 
NudC domain-containing protein 1 (NUDCD1) LDTP10781 C513(2.29); C376(0.99)  LDD0078 
NudC domain-containing protein 2 (NUDCD2) LDTP09609 C99(1.12)  LDD0078 
NudC domain-containing protein 3 (NUDCD3) LDTP08489 C260(1.12)  LDD0531 
Numb-like protein (NUMBL) LDTP14289 C206(6.88)  LDD0209 
NXPE family member 1 (NXPE1) LDTP17689 C244(0.80)  LDD1492 
NXPE family member 3 (NXPE3) LDTP18121 C407(0.93)  LDD1507 
OCIA domain-containing protein 1 (OCIAD1) LDTP12755 C38(0.86)  LDD0078 
OCIA domain-containing protein 2 (OCIAD2) LDTP17157 C27(1.31); C106(0.95); C130(0.88); C134(0.88)  LDD0078 
Olfactomedin-like protein 1 (OLFML1) LDTP17427 C49(1.99)  LDD2288 
Olfactomedin-like protein 2A (OLFML2A) LDTP15061 C8(0.85)  LDD3314 
Olfactomedin-like protein 2B (OLFML2B) LDTP15062 C79(2.25)  LDD3401 
Olfactomedin-like protein 3 (OLFML3) LDTP16075 C347(2.47); C44(1.16)  LDD3423 
Oligodendrocyte-myelin glycoprotein (OMG) LDTP03241 C41(1.31)  LDD2253 
Oligophrenin-1 (OPHN1) LDTP01076 C24(1.01)  LDD0531 
Oncoprotein-induced transcript 3 protein (OIT3) LDTP09678 C513(0.94)  LDD0531 
Opioid growth factor receptor (OGFR) LDTP16155 C330(1.09); C443(1.00); C417(0.95)  LDD0078 
Optic atrophy 3 protein (OPA3) LDTP16006 C164(1.21)  LDD0078 
Origin recognition complex subunit 1 (ORC1) LDTP05857 C253(1.07); C93(0.91); C98(0.91)  LDD0078 
Origin recognition complex subunit 2 (ORC2) LDTP05858 C520(0.54)  LDD0532 
Origin recognition complex subunit 3 (ORC3) LDTP13104 C639(6.86); C141(160.58)  LDD0209 
Origin recognition complex subunit 4 (ORC4) LDTP00909 C421(0.85)  LDD0078 
Origin recognition complex subunit 5 (ORC5) LDTP00900 C409(4.60)  LDD0204 
Origin recognition complex subunit 6 (ORC6) LDTP14139 C82(1.32)  LDD0080 
Ornithine decarboxylase antizyme 1 (OAZ1) LDTP04616 C175(1.16)  LDD0814 
Ornithine decarboxylase antizyme 2 (OAZ2) LDTP14530 C138(1.45)  LDD0531 
Osteoclast-stimulating factor 1 (OSTF1) LDTP09914 C114(1.48); C185(1.55)  LDD3312 
Otoancorin (OTOA) LDTP08007 C653(0.96)  LDD3380 
Otogelin (OTOG) LDTP07812 C2655(4.88)  LDD0209 
Outer dense fiber protein 2 (ODF2) LDTP06946 C136(2.93)  LDD0080 
Outer dynein arm-docking complex subunit 2 (ODAD2) LDTP07105 C863(1.02); C865(1.02); C235(1.03); C610(0.85)  LDD0531 
Outer dynein arm-docking complex subunit 4 (ODAD4) LDTP10625 C26(2.05)  LDD3331 
Oxidation resistance protein 1 (OXR1) LDTP08888 C471(1.47)  LDD0080 
Oxidative stress-induced growth inhibitor 2 (OSGIN2) LDTP18560 C483(1.83)  LDD3373 
Oxidative stress-responsive serine-rich protein 1 (OSER1) LDTP20003 C56(1.86)  LDD3390 
Oxidized low-density lipoprotein receptor 1 (OLR1) LDTP05114 C172(3.19)  LDD3440 
Oxysterol-binding protein 1 (OSBP) LDTP03151 C224(0.95); C343(0.86)  LDD0078 
Oxysterol-binding protein 2 (OSBP2) LDTP10022 C859(1.06); C865(1.06)  LDD0078 
Oxysterol-binding protein-related protein 1 (OSBPL1A) LDTP11420 C520(1.14); C297(1.12)  LDD0078 
Oxysterol-binding protein-related protein 10 (OSBPL10) LDTP11368 C33(6.27)  LDD3311 
Oxysterol-binding protein-related protein 11 (OSBPL11) LDTP11367 C34(1.07)  LDD0078 
Oxysterol-binding protein-related protein 2 (OSBPL2) LDTP11774 C122(1.34); C402(1.79)  LDD0080 
Oxysterol-binding protein-related protein 3 (OSBPL3) LDTP11930 C203(1.30); C24(1.11); C337(0.96)  LDD0078 
Oxysterol-binding protein-related protein 6 (OSBPL6) LDTP11533 C404(1.81)  LDD3376 
Oxysterol-binding protein-related protein 7 (OSBPL7) LDTP11532 C197(0.65); C204(0.65)  LDD0533 
Oxysterol-binding protein-related protein 9 (OSBPL9) LDTP10825 C8(2.17); C730(0.97)  LDD3310 
P antigen family member 4 (PAGE4) LDTP01058 C63(1.03)  LDD2297 
P-selectin (SELP) LDTP02826 C150(1.58)  LDD2324 
p21-activated protein kinase-interacting protein 1 (PAK1IP1) LDTP12731 C232(1.29); C239(1.29)  LDD0547 
p53 and DNA damage-regulated protein 1 (PDRG1) LDTP16099 C60(1.13)  LDD1507 
PABIR family member 2 (PABIR2) LDTP17533 C193(3.59)  LDD3311 
Paired amphipathic helix protein Sin3a (SIN3A) LDTP10823 C551(1.82)  LDD0080 
Paired amphipathic helix protein Sin3b (SIN3B) LDTP01156 C1052(1.08); C1056(1.08)  LDD0078 
PALM2-AKAP2 fusion protein (PALM2AKAP2) LDTP16261 C148(1.50)  LDD3401 
Palmdelphin (PALMD) LDTP12314 C388(0.87)  LDD3376 
Pancreatic progenitor cell differentiation and proliferation factor (PPDPF) LDTP19958 C30(1.21); C35(1.21)  LDD0533 
Pancreatic secretory granule membrane major glycoprotein GP2 (GP2) LDTP04688 C85(2.53)  LDD2267 
Parafibromin (CDC73) LDTP07506 C145(1.05)  LDD0078 
Paralemmin-3 (PALM3) LDTP00087 C231(1.32)  LDD3321 
Paraneoplastic antigen Ma1 (PNMA1) LDTP09119 C30(0.84)  LDD1511 
Paraneoplastic antigen Ma2 (PNMA2) LDTP13517 C310(1.30)  LDD0080 
Paraneoplastic antigen Ma3 (PNMA3) LDTP13516 C130(1.10)  LDD3310 
Paraneoplastic antigen-like protein 5 (PNMA5) LDTP10702 C47(2.06); C30(1.12); C314(2.02); C227(0.72)  LDD3331 
Paraneoplastic antigen-like protein 6A (PNMA6A) LDTP19112 C152(1.21)  LDD1507 
Paraneoplastic antigen-like protein 8A (PNMA8A) LDTP19624 C14(3.12)  LDD3401 
Partitioning defective 3 homolog (PARD3) LDTP09512 C16(5.13); C323(330.03); C921(5.82)  LDD0209 
Partitioning defective 3 homolog B (PARD3B) LDTP09514 C921(2.37)  LDD3310 
Partitioning defective 6 homolog alpha (PARD6A) LDTP12337 C304(0.82); C311(0.82)  LDD1093 
Partitioning defective 6 homolog beta (PARD6B) LDTP11459 C13(1.02)  LDD0531 
Partitioning defective 6 homolog gamma (PARD6G) LDTP11458 C16(1.89)  LDD0080 
Partner and localizer of BRCA2 (PALB2) LDTP08394 C755(0.92); C756(0.92)  LDD0078 
PAX-interacting protein 1 (PAXIP1) LDTP07860 C740(1.17); C985(0.91); C648(0.85); C653(0.85)  LDD0078 
PAX3- and PAX7-binding protein 1 (PAXBP1) LDTP14107 C621(0.97); C831(1.03); C870(0.83)  LDD0531 
Paxillin (PXN) LDTP04226 C561(1.19); C564(1.19); C443(1.11); C446(1.11)  LDD0078 
PC4 and SFRS1-interacting protein (PSIP1) LDTP01233 C204(0.99)  LDD0078 
PCI domain-containing protein 2 (PCID2) LDTP07019 C148(1.14); C399(1.05); C50(0.78); C68(0.93)  LDD0531 
PCNA-associated factor (PCLAF) LDTP06269 C99(0.90)  LDD0078 
PDZ and LIM domain protein 1 (PDLIM1) LDTP00193 C73(1.06); C263(0.92); C286(0.86); C289(0.86)  LDD0078 
PDZ and LIM domain protein 2 (PDLIM2) LDTP10489 C539(1.61)  LDD3311 
PDZ and LIM domain protein 3 (PDLIM3) LDTP06898 C297(1.70)  LDD3331 
PDZ and LIM domain protein 4 (PDLIM4) LDTP04366 C255(0.88)  LDD3310 
PDZ and LIM domain protein 5 (PDLIM5) LDTP10383 C467(1.27); C470(1.12); C73(1.03); C213(1.00)  LDD0078 
PDZ and LIM domain protein 7 (PDLIM7) LDTP12461 C367(0.99); C370(0.99); C388(0.95); C332(0.86)  LDD0078 
PDZ domain-containing protein GIPC1 (GIPC1) LDTP00472 C100(0.84)  LDD0532 
PDZ domain-containing protein GIPC3 (GIPC3) LDTP15618 C79(1.14)  LDD1508 
PDZ domain-containing RING finger protein 4 (PDZRN4) LDTP17452 C436(1.26)  LDD3344 
Pecanex-like protein 1 (PCNX1) LDTP15822 C1621(1.14)  LDD0078 
Pecanex-like protein 3 (PCNX3) LDTP16002 C301(1.17); C1409(0.84)  LDD0078 
Pecanex-like protein 4 (PCNX4) LDTP17298 C947(0.87)  LDD1512 
Peflin (PEF1) LDTP13167 C247(1.10)  LDD3325 
Pentatricopeptide repeat-containing protein 1, mitochondrial (PTCD1) LDTP01130 C695(2.11)  LDD0080 
Pentatricopeptide repeat-containing protein 2, mitochondrial (PTCD2) LDTP15631 C242(0.60)  LDD0533 
Peptidase inhibitor 16 (PI16) LDTP07702 C74(3.24)  LDD2361 
Peptide chain release factor 1, mitochondrial (MTRF1) LDTP14499 C200(0.78); C216(1.12)  LDD0531 
Peptide chain release factor 1-like, mitochondrial (MTRF1L) LDTP13223 C103(1.49)  LDD3346 
Pericentrin (PCNT) LDTP01637 C75(1.18); C93(1.18); C64(1.01); C70(1.01)  LDD0078 
Perilipin-2 (PLIN2) LDTP10889 C84(1.68)  LDD0080 
Perilipin-3 (PLIN3) LDTP01021 C60(1.14)  LDD0078 
Perilipin-4 (PLIN4) LDTP10714 C456(3.54)  LDD3319 
Period circadian protein homolog 1 (PER1) LDTP00672 C623(1.40); C630(1.40)  LDD0078 
Period circadian protein homolog 2 (PER2) LDTP00521 C579(1.26); C586(1.26)  LDD0078 
Periodic tryptophan protein 1 homolog (PWP1) LDTP05942 C329(1.02)  LDD0078 
Periodic tryptophan protein 2 homolog (PWP2) LDTP06345 C716(1.12)  LDD0078 
Periostin (POSTN) LDTP06306 C44(0.95)  LDD0531 
Periphilin-1 (PPHLN1) LDTP09183 C309(2.60)  LDD0080 
Periplakin (PPL) LDTP00969 C1693(1.14); C694(1.04); C788(0.87)  LDD0531 
Peroxiredoxin-like 2A (PRXL2A) LDTP11140 C85(3.72)  LDD0078 
Peroxisomal membrane protein 11B (PEX11B) LDTP01750 C153(1.22)  LDD0078 
Peroxisomal membrane protein 11C (PEX11G) LDTP10381 C106(0.86)  LDD1508 
Peroxisomal targeting signal 1 receptor (PEX5) LDTP04369 C438(2.87)  LDD3310 
Peroxisome proliferator-activated receptor gamma coactivator 1-beta (PPARGC1B) LDTP08408 C316(0.99)  LDD1511 
Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PPRC1) LDTP07229 C1369(0.95); C1383(0.95)  LDD0078 
Pescadillo homolog (PES1) LDTP00306 C272(1.23); C361(1.06); C391(0.97)  LDD0078 
PEX5-related protein (PEX5L) LDTP08638 C386(3.25)  LDD3344 
PH and SEC7 domain-containing protein 1 (PSD) LDTP00075 C773(2.18)  LDD2243 
PH and SEC7 domain-containing protein 2 (PSD2) LDTP15855 C679(1.10)  LDD2279 
PH and SEC7 domain-containing protein 3 (PSD3) LDTP12831 C284(21.41)  LDD0204 
PH and SEC7 domain-containing protein 4 (PSD4) LDTP09139 C435(25.42)  LDD0209 
PH-interacting protein (PHIP) LDTP09660 C79(1.13); C1612(1.08)  LDD0078 
Phagosome assembly factor 1 (PHAF1) LDTP11169 C222(0.82); C345(0.84)  LDD0531 
PHD and RING finger domain-containing protein 1 (PHRF1) LDTP16167 C585(0.92)  LDD0078 
PHD finger protein 11 (PHF11) LDTP13357 C135(23.29)  LDD0209 
PHD finger protein 12 (PHF12) LDTP10747 C613(0.96)  LDD0078 
PHD finger protein 13 (PHF13) LDTP08402 C274(1.25)  LDD3323 
PHD finger protein 20 (PHF20) LDTP11286 C555(0.86); C557(0.86)  LDD0078 
PHD finger protein 20-like protein 1 (PHF20L1) LDTP00146 C751(1.01)  LDD0531 
PHD finger protein 21A (PHF21A) LDTP10120 C533(1.36)  LDD3383 
PHD finger protein 23 (PHF23) LDTP11240 C381(0.95)  LDD0078 
PHD finger protein 24 (PHF24) LDTP13724 C158(1.94)  LDD2250 
PHD finger protein 3 (PHF3) LDTP18116 C561(1.12); C402(1.11); C1616(1.06); C885(1.05)  LDD0078 
PHD finger protein 6 (PHF6) LDTP08552 C280(4.23); C283(4.23); C292(3.35); C212(2.91)  LDD0080 
Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1) LDTP05981 C25(1.04)  LDD1492 
Phosducin-like protein (PDCL) LDTP05846 C291(7.99)  LDD0204 
Phosducin-like protein 3 (PDCL3) LDTP11825 C154(2.26)  LDD0080 
Phosphatidylcholine transfer protein (PCTP) LDTP13465 C207(1.08)  LDD0532 
Phosphatidylethanolamine-binding protein 1 (PEBP1) LDTP03520 C133(6.44)  LDD0208 
Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein (PREX1) LDTP09399 C37(2.57); C936(1.27)  LDD3332 
Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein (PREX2) LDTP07894 C26(1.52)  LDD3323 
Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1) LDTP03408 C146(2.34)  LDD3310 
Phosphatidylinositol 3-kinase regulatory subunit beta (PIK3R2) LDTP00280 C50(1.78)  LDD0080 
Phosphatidylinositol 3-kinase regulatory subunit gamma (PIK3R3) LDTP09802 C230(1.47)  LDD3403 
Phosphatidylinositol glycan anchor biosynthesis class U protein (PIGU) LDTP11906 C154(1.48)  LDD3365 
Phosphatidylinositol-binding clathrin assembly protein (PICALM) LDTP05895 C48(1.60)  LDD3337 
Phosphatidylinositol-glycan biosynthesis class X protein (PIGX) LDTP15587 C43(2.47)  LDD3311 
Phosphofurin acidic cluster sorting protein 1 (PACS1) LDTP07736 C116(332.77)  LDD0209 
Phosphoinositide 3-kinase adapter protein 1 (PIK3AP1) LDTP07844 C103(2.64); C358(2.11)  LDD3339 
Phosphoinositide 3-kinase regulatory subunit 6 (PIK3R6) LDTP07204 C593(1.53)  LDD2412 
Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) LDTP12723 C355(1.63)  LDD0080 
Phostensin (PPP1R18) LDTP07493 C276(1.08); C396(1.07); C397(1.07); C611(1.07)  LDD0078 
Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL) LDTP15721 C32(1.76); C370(1.59)  LDD3333 
PI-PLC X domain-containing protein 1 (PLCXD1) LDTP19998 C288(1.67)  LDD3330 
PiggyBac transposable element-derived protein 1 (PGBD1) LDTP10485 C384(3.90)  LDD3340 
PiggyBac transposable element-derived protein 2 (PGBD2) LDTP19506 C563(1.05); C566(1.05)  LDD0580 
PiggyBac transposable element-derived protein 3 (PGBD3) LDTP17690 C167(1.92)  LDD0080 
PiggyBac transposable element-derived protein 4 (PGBD4) LDTP19856 C379(2.17)  LDD3321 
PIH1 domain-containing protein 1 (PIH1D1) LDTP12726 C117(0.90)  LDD0531 
Pikachurin (EGFLAM) LDTP07285 C453(1.58)  LDD3363 
PIN2/TERF1-interacting telomerase inhibitor 1 (PINX1) LDTP10129 C265(0.96)  LDD0078 
Pituitary tumor-transforming gene 1 protein-interacting protein (PTTG1IP) LDTP04586 C66(1.03); C81(1.03); C48(0.89); C51(0.89)  LDD0078 
Plakophilin-1 (PKP1) LDTP05990 C290(2.57)  LDD3348 
Plakophilin-2 (PKP2) LDTP11018 C381(1.13); C647(1.07)  LDD0531 
Plakophilin-3 (PKP3) LDTP14017 C569(1.02); C347(0.87)  LDD0078 
Plakophilin-4 (PKP4) LDTP10898 C492(1.35)  LDD0078 
Plasma protease C1 inhibitor (SERPING1) LDTP02089 C210(5.15)  LDD3368 
Plasminogen activator inhibitor 2 (SERPINB2) LDTP02084 C79(1.07)  LDD0078 
Plastin-1 (PLS1) LDTP06167 C142(1.25); C166(0.81)  LDD0531 
Plastin-2 (LCP1) LDTP02691 C42(1.42)  LDD0080 
Plastin-3 (PLS3) LDTP02692 C33(1.02); C143(1.02)  LDD0078 
Platelet endothelial aggregation receptor 1 (PEAR1) LDTP07252 C725(1.11); C734(1.11)  LDD0078 
Platelet glycoprotein Ib beta chain (GP1BB) LDTP02648 C323(3.02)  LDD3335 
Platelet-activating factor acetylhydrolase IB subunit beta (PAFAH1B1) LDTP04015 C226(1.41); C184(1.44)  LDD0080 
Platelet-derived growth factor C (PDGFC) LDTP12491 C274(0.97)  LDD1573 
Pleckstrin (PLEK) LDTP02280 C102(1.01)  LDD3333 
Pleckstrin homology domain-containing family A member 1 (PLEKHA1) LDTP12157 C11(1.16)  LDD3312 
Pleckstrin homology domain-containing family A member 2 (PLEKHA2) LDTP12155 C191(1.02)  LDD0078 
Pleckstrin homology domain-containing family A member 3 (PLEKHA3) LDTP12156 C94(22.81)  LDD0209 
Pleckstrin homology domain-containing family A member 4 (PLEKHA4) LDTP11933 C438(1.54)  LDD3383 
Pleckstrin homology domain-containing family A member 5 (PLEKHA5) LDTP12137 C249(3.96)  LDD3310 
Pleckstrin homology domain-containing family A member 6 (PLEKHA6) LDTP18565 C996(1.67)  LDD3314 
Pleckstrin homology domain-containing family A member 7 (PLEKHA7) LDTP07424 C699(1.57)  LDD3319 
Pleckstrin homology domain-containing family A member 8 (PLEKHA8) LDTP10450 C295(2.80); C299(2.80)  LDD0080 
Pleckstrin homology domain-containing family B member 1 (PLEKHB1) LDTP13205 C90(2.36)  LDD3402 
Pleckstrin homology domain-containing family B member 2 (PLEKHB2) LDTP10186 C53(0.98); C81(0.78)  LDD1492 
Pleckstrin homology domain-containing family D member 1 (PLEKHD1) LDTP18768 C406(2.41)  LDD2267 
Pleckstrin homology domain-containing family F member 2 (PLEKHF2) LDTP12068 C183(1.15); C186(1.15); C178(1.02)  LDD0078 
Pleckstrin homology domain-containing family G member 1 (PLEKHG1) LDTP18551 C1145(3.88)  LDD3408 
Pleckstrin homology domain-containing family G member 2 (PLEKHG2) LDTP12032 C193(1.81)  LDD3347 
Pleckstrin homology domain-containing family G member 3 (PLEKHG3) LDTP00035 C159(1.82); C169(1.82)  LDD0080 
Pleckstrin homology domain-containing family G member 4B (PLEKHG4B) LDTP15812 C956(1.53)  LDD2260 
Pleckstrin homology domain-containing family G member 5 (PLEKHG5) LDTP01433 C551(5.58)  LDD3310 
Pleckstrin homology domain-containing family H member 1 (PLEKHH1) LDTP18552 C728(2.32)  LDD3413 
Pleckstrin homology domain-containing family H member 2 (PLEKHH2) LDTP08490 C772(2.54); C692(4.17)  LDD3369 
Pleckstrin homology domain-containing family H member 3 (PLEKHH3) LDTP17563 C151(1.29)  LDD0531 
Pleckstrin homology domain-containing family M member 1 (PLEKHM1) LDTP14056 C489(1.08); C498(1.08)  LDD0078 
Pleckstrin homology domain-containing family M member 2 (PLEKHM2) LDTP08539 C427(1.16); C901(1.00); C905(1.00)  LDD0078 
Pleckstrin homology domain-containing family M member 3 (PLEKHM3) LDTP15204 C722(1.17)  LDD3393 
Pleckstrin homology domain-containing family N member 1 (PLEKHN1) LDTP06815 C238(1.18); C247(1.18)  LDD0078 
Pleckstrin homology domain-containing family O member 2 (PLEKHO2) LDTP18061 C388(36.47)  LDD0209 
Pleckstrin homology domain-containing family S member 1 (PLEKHS1) LDTP07075 C22(1.81)  LDD2267 
Pleckstrin homology-like domain family A member 1 (PHLDA1) LDTP09594 C148(1.07); C171(0.92); C172(0.92)  LDD0078 
Pleckstrin homology-like domain family A member 2 (PHLDA2) LDTP06896 C84(0.95); C89(0.95)  LDD0531 
Pleckstrin homology-like domain family A member 3 (PHLDA3) LDTP14124 C63(1.20)  LDD3315 
Pleckstrin homology-like domain family B member 1 (PHLDB1) LDTP08251 C553(0.99); C557(0.99); C691(0.99)  LDD0078 
Pleckstrin homology-like domain family B member 2 (PHLDB2) LDTP08172 C522(0.96); C805(0.85)  LDD0078 
Pleckstrin homology-like domain family B member 3 (PHLDB3) LDTP17355 C327(2.40)  LDD3432 
Pleckstrin-2 (PLEK2) LDTP18496 C87(1.02)  LDD0078 
Plectin (PLEC) LDTP06330 C3110(1.02); C3493(0.99); C3295(0.95); C317(0.89)  LDD0078 
Pleiotrophin (PTN) LDTP03102 C99(3.80)  LDD3376 
Pleiotropic regulator 1 (PLRG1) LDTP00827 C264(1.92); C272(1.42); C468(1.15)  LDD0531 
Plexin-A1 (PLXNA1) LDTP13365 C104(0.89); C95(0.89)  LDD0078 
Plexin-A2 (PLXNA2) LDTP01106 C192(3.22)  LDD3312 
Plexin-A3 (PLXNA3) LDTP04466 C820(1.74)  LDD3427 
Plexin-A4 (PLXNA4) LDTP12255 C1542(2.08)  LDD3340 
Plexin-B1 (PLXNB1) LDTP00692 C1852(1.15)  LDD3312 
Plexin-B2 (PLXNB2) LDTP00513 C779(0.91); C782(0.91); C767(0.85); C770(0.85)  LDD0078 
Plexin-B3 (PLXNB3) LDTP13561 C163(1.20)  LDD3316 
Plexin-C1 (PLXNC1) LDTP00980 C703(2.98)  LDD3332 
Plexin-D1 (PLXND1) LDTP14047 C1363(1.10)  LDD0078 
PML-RARA-regulated adapter molecule 1 (PRAM1) LDTP10739 C658(2.30)  LDD2414 
PMS1 protein homolog 1 (PMS1) LDTP04609 C725(5.01)  LDD0209 
POC1 centriolar protein homolog A (POC1A) LDTP09068 C394(0.94)  LDD1508 
POC1 centriolar protein homolog B (POC1B) LDTP09370 C388(5.37); C401(5.37)  LDD0080 
Podocalyxin-like protein 2 (PODXL2) LDTP12875 C487(0.85)  LDD0078 
Pogo transposable element with KRAB domain (POGK) LDTP18509 C310(1.18)  LDD0078 
Poly(rC)-binding protein 1 (PCBP1) LDTP06366 C194(1.06)  LDD0078 
Poly(rC)-binding protein 2 (PCBP2) LDTP06367 C301(9.42); C158(142.17)  LDD0209 
Poly(rC)-binding protein 3 (PCBP3) LDTP04793 C141(31.62); C86(14.72)  LDD0209 
Poly(rC)-binding protein 4 (PCBP4) LDTP14721 C58(61.85)  LDD0209 
Poly(U)-binding-splicing factor PUF60 (PUF60) LDTP13311 C129(1.40)  LDD0531 
Polyadenylate-binding protein 1 (PABPC1) LDTP02595 C132(0.83)  LDD1507 
Polyadenylate-binding protein 1-like (PABPC1L) LDTP17141 C339(1.40)  LDD3310 
Polyadenylate-binding protein 2 (PABPN1) LDTP08213 C222(0.98); C232(1.02)  LDD3310 
Polyadenylate-binding protein 3 (PABPC3) LDTP11862 C132(1.07)  LDD3310 
Polyadenylate-binding protein 4 (PABPC4) LDTP05821 C472(1.13)  LDD0078 
Polyadenylate-binding protein-interacting protein 1 (PAIP1) LDTP11682 C470(1.26)  LDD0080 
Polyadenylate-binding protein-interacting protein 2 (PAIP2) LDTP11044 C60(1.03)  LDD0531 
Polyadenylate-binding protein-interacting protein 2B (PAIP2B) LDTP16240 C60(1.10)  LDD3377 
Polyamine-modulated factor 1 (PMF1) LDTP07508 C61(4.70)  LDD0209 
Polycomb group protein ASXL1 (ASXL1) LDTP08599 C387(1.01)  LDD1492 
Polycomb protein EED (EED) LDTP01249 C324(1.27)  LDD0531 
Polycomb protein SCMH1 (SCMH1) LDTP10345 C38(1.08); C46(1.08)  LDD0531 
Polycomb protein SUZ12 (SUZ12) LDTP06282 C494(1.06); C46(0.95); C450(0.88); C453(0.88)  LDD0078 
Polyglutamine-binding protein 1 (PQBP1) LDTP01057 C60(0.84)  LDD3312 
Polyhomeotic-like protein 1 (PHC1) LDTP05109 C831(1.00)  LDD3380 
Polyhomeotic-like protein 2 (PHC2) LDTP08600 C673(4.22)  LDD0209 
Polyhomeotic-like protein 3 (PHC3) LDTP09141 C828(3.20)  LDD3332 
Polymerase delta-interacting protein 2 (POLDIP2) LDTP13906 C143(43.14)  LDD0209 
Polymerase delta-interacting protein 3 (POLDIP3) LDTP11443 C338(1.10); C346(0.89)  LDD0531 
Polypyrimidine tract-binding protein 1 (PTBP1) LDTP03364 C251(3.81)  LDD3337 
Polypyrimidine tract-binding protein 2 (PTBP2) LDTP13441 C247(1.07)  LDD1492 
Polypyrimidine tract-binding protein 3 (PTBP3) LDTP01669 C248(53.33); C55(195.45)  LDD0209 
POM121 and ZP3 fusion protein (POMZP3) LDTP17396 C3(1.02)  LDD1512 
Post-GPI attachment to proteins factor 4 (PGAP4) LDTP11126 C356(2.16)  LDD3380 
POTE ankyrin domain family member B2 (POTEB2) LDTP18996 C197(1.90)  LDD3466 
POTE ankyrin domain family member E (POTEE) LDTP07634 C917(0.89)  LDD0531 
POTE ankyrin domain family member F (POTEF) LDTP14342 C957(5.64); C965(5.64); C972(5.64)  LDD0209 
POTE ankyrin domain family member I (POTEI) LDTP16895 C917(1.13)  LDD3330 
POTE ankyrin domain family member J (POTEJ) LDTP16896 C700(2.19)  LDD3403 
PPP2R1A-PPP2R2A-interacting phosphatase regulator 1 (PABIR1) LDTP10241 C206(0.95); C193(0.95)  LDD1492 
Pre-B-cell leukemia transcription factor-interacting protein 1 (PBXIP1) LDTP10091 C588(1.00); C594(1.00)  LDD0078 
pre-mRNA 3' end processing protein WDR33 (WDR33) LDTP11620 C120(1.13); C220(1.41); C249(1.35)  LDD0531 
Pre-mRNA 3'-end-processing factor FIP1 (FIP1L1) LDTP07655 C216(1.09)  LDD0532 
Pre-mRNA cleavage complex 2 protein Pcf11 (PCF11) LDTP14522 C102(1.15); C1518(1.10)  LDD0531 
Pre-mRNA-processing factor 17 (CDC40) LDTP00993 C29(2.68)  LDD0080 
Pre-mRNA-processing factor 39 (PRPF39) LDTP15284 C413(0.79); C450(0.83); C552(1.06)  LDD0531 
Pre-mRNA-processing factor 40 homolog A (PRPF40A) LDTP01208 C39(1.10)  LDD0078 
Pre-mRNA-processing factor 40 homolog B (PRPF40B) LDTP07485 C137(1.60)  LDD0080 
Pre-mRNA-processing factor 6 (PRPF6) LDTP01456 C913(0.84)  LDD0078 
Pre-mRNA-processing-splicing factor 8 (PRPF8) LDTP07526 C547(1.05); C435(1.00); C1228(0.96)  LDD0078 
Pre-mRNA-splicing factor 18 (PRPF18) LDTP10928 C336(1.41)  LDD0080 
Pre-mRNA-splicing factor 38A (PRPF38A) LDTP09033 C116(0.87)  LDD0078 
Pre-mRNA-splicing factor 38B (PRPF38B) LDTP17266 C113(0.93)  LDD0078 
Pre-mRNA-splicing factor CWC22 homolog (CWC22) LDTP12240 C490(0.86); C496(0.88); C497(0.86); C253(1.25)  LDD0531 
Pre-mRNA-splicing factor CWC25 homolog (CWC25) LDTP12777 C107(2.22)  LDD3339 
Pre-mRNA-splicing factor ISY1 homolog (ISY1) LDTP13570 C36(1.80)  LDD3319 
Pre-mRNA-splicing factor RBM22 (RBM22) LDTP12706 C71(0.95); C74(0.95)  LDD0078 
Pre-mRNA-splicing factor SLU7 (SLU7) LDTP01582 C120(1.37); C123(1.37)  LDD0080 
Pre-mRNA-splicing factor SPF27 (BCAS2) LDTP01358 C106(2.14); C132(1.35)  LDD0080 
Pre-mRNA-splicing factor SYF1 (XAB2) LDTP12269 C676(0.87)  LDD0078 
Pre-mRNA-splicing regulator WTAP (WTAP) LDTP06272 C90(76.70)  LDD0209 
Pre-rRNA-processing protein TSR2 homolog (TSR2) LDTP09989 C114(0.85)  LDD0078 
Prefoldin subunit 3 (VBP1) LDTP04935 C113(1.54)  LDD0080 
Prefoldin subunit 5 (PFDN5) LDTP10873 C49(1.14)  LDD0080 
Prelamin-A/C (LMNA) LDTP01932 C588(0.97); C591(0.97)  LDD0078 
PRELI domain-containing protein 1, mitochondrial (PRELID1) LDTP13807 C112(1.06)  LDD0814 
Prickle planar cell polarity protein 3 (PRICKLE3) LDTP00897 C27(1.83); C30(1.83)  LDD0080 
Prickle-like protein 1 (PRICKLE1) LDTP10596 C302(0.94)  LDD0078 
Prickle-like protein 2 (PRICKLE2) LDTP15242 C465(2.26)  LDD3311 
PRKC apoptosis WT1 regulator protein (PAWR) LDTP10435 C173(0.94)  LDD0078 
PRKCA-binding protein (PICK1) LDTP12499 C348(1.23)  LDD0531 
PRKCH upstream open reading frame 2 (PRKCH) LDTP14410 C301(1.48)  LDD3403 
Pro-interleukin-16 (IL16) LDTP06020 C975(1.72)  LDD3370 
Probable cytosolic iron-sulfur protein assembly protein CIAO1 (CIAO1) LDTP01392 C243(1.16); C245(1.16); C123(1.16); C234(0.94)  LDD0078 
Probable ribosome biogenesis protein RLP24 (RSL24D1) LDTP16197 C6(1.22); C9(1.22)  LDD0078 
Probable RNA polymerase II nuclear localization protein SLC7A6OS (SLC7A6OS) LDTP15704 C27(1.46)  LDD0080 
Probable RNA-binding protein 18 (RBM18) LDTP19868 C88(0.96)  LDD1511 
Probable RNA-binding protein 19 (RBM19) LDTP14044 C77(1.16)  LDD0080 
Probable RNA-binding protein 23 (RBM23) LDTP08210 C316(1.06)  LDD0532 
Probable RNA-binding protein 46 (RBM46) LDTP15591 C368(2.04)  LDD2266 
Probable RNA-binding protein EIF1AD (EIF1AD) LDTP09008 C89(1.89)  LDD0080 
Probable rRNA-processing protein EBP2 (EBNA1BP2) LDTP10993 C56(1.12)  LDD0531 
Probable splicing factor YJU2B (YJU2B) LDTP02705 C56(0.52); C59(0.52)  LDD1093 
Probable U3 small nucleolar RNA-associated protein 11 (UTP11) LDTP13963 C201(1.15)  LDD0531 
Proepiregulin (EREG) LDTP00484 C94(1.36)  LDD0531 
Profilin-1 (PFN1) LDTP02218 C128(0.84)  LDD0078 
Profilin-2 (PFN2) LDTP03706 C84(2.12)  LDD3323 
Progesterone-induced-blocking factor 1 (PIBF1) LDTP09719 C199(2.02)  LDD0080 
Programmed cell death 6-interacting protein (PDCD6IP) LDTP09580 C90(5.86)  LDD0209 
Programmed cell death protein 2 (PDCD2) LDTP06525 C89(2.62); C90(2.62); C281(1.63); C283(1.63)  LDD0080 
Programmed cell death protein 2-like (PDCD2L) LDTP19919 C100(0.96)  LDD0078 
Programmed cell death protein 4 (PDCD4) LDTP06881 C288(0.85)  LDD0078 
Programmed cell death protein 7 (PDCD7) LDTP17750 C159(1.94)  LDD0080 
Progranulin (GRN) LDTP03453 C164(0.86); C165(0.86); C171(0.86)  LDD0078 
Prolactin-inducible protein (PIP) LDTP02615 C123(1.88)  LDD2268 
Proliferating cell nuclear antigen (PCNA) LDTP02596 C81(1.01)  LDD0080 
Proliferation marker protein Ki-67 (MKI67) LDTP04078 C1373(1.29); C1981(1.22); C3199(1.17); C958(1.14)  LDD0078 
Proline and serine-rich protein 1 (PROSER1) LDTP15317 C518(1.10)  LDD0532 
Proline and serine-rich protein 2 (PROSER2) LDTP17591 C367(1.20); C21(1.09)  LDD0078 
Proline-, glutamic acid- and leucine-rich protein 1 (PELP1) LDTP08707 C536(2.75); C645(0.99)  LDD3310 
Proline-rich AKT1 substrate 1 (AKT1S1) LDTP10111 C61(6.20)  LDD0209 
Proline-rich protein 11 (PRR11) LDTP15734 C120(1.12)  LDD0078 
Proline-rich protein 12 (PRR12) LDTP16239 C1626(2.37)  LDD3319 
Proline-rich protein 14 (PRR14) LDTP11332 C111(1.24); C113(1.24)  LDD0078 
Proline-rich protein 25 (PRR25) LDTP19910 C42(1.96)  LDD2347 
Proline-rich protein 3 (PRR3) LDTP05151 C143(2.22)  LDD3332 
Proline-rich protein 5 (PRR5) LDTP05203 C341(1.67)  LDD3383 
Proline-rich transmembrane protein 3 (PRRT3) LDTP14963 C720(7.70)  LDD3365 
Proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) LDTP00809 C13(1.28); C305(2.75); C259(0.90)  LDD2412 
Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2) LDTP18420 C221(1.21)  LDD0080 
Proline/serine-rich coiled-coil protein 1 (PSRC1) LDTP07573 C91(1.68)  LDD0080 
Prostate tumor-overexpressed gene 1 protein (PTOV1) LDTP08396 C121(6.49); C359(191.70)  LDD0209 
Prostate-associated microseminoprotein (MSMP) LDTP14878 C100(2.00)  LDD3373 
Proteasomal ATPase-associated factor 1 (PAAF1) LDTP15864 C139(1.12); C140(1.12)  LDD0532 
Proteasomal ubiquitin receptor ADRM1 (ADRM1) LDTP06514 C88(0.95)  LDD0078 
Proteasome activator complex subunit 1 (PSME1) LDTP05484 C22(41.81); C22(90.86)  LDD0209 
Proteasome activator complex subunit 2 (PSME2) LDTP13519 C91(0.93)  LDD0078 
Proteasome activator complex subunit 3 (PSME3) LDTP04917 C92(4.26)  LDD0209 
Proteasome activator complex subunit 4 (PSME4) LDTP06250 C1001(1.51); C710(1.15); C1227(0.92); C1232(0.92)  LDD0078 
Proteasome adapter and scaffold protein ECM29 (ECPAS) LDTP07255 C1594(2.33); C1599(2.33); C1420(1.87)  LDD0080 
Proteasome assembly chaperone 1 (PSMG1) LDTP01608 C169(1.02); C106(0.99); C157(0.89)  LDD0078 
Proteasome assembly chaperone 2 (PSMG2) LDTP10035 C168(0.92); C178(0.92)  LDD0078 
Proteasome assembly chaperone 4 (PSMG4) LDTP17190 C55(1.15)  LDD3310 
Proteasome inhibitor PI31 subunit (PSMF1) LDTP09779 C185(0.93)  LDD0547 
Protection of telomeres protein 1 (POT1) LDTP12650 C349(2.06)  LDD3342 
Protein AAR2 homolog (AAR2) LDTP18567 C156(0.68)  LDD0531 
Protein Abitram (ABITRAM) LDTP16125 C74(1.10)  LDD0078 
Protein AF-9 (MLLT3) LDTP03983 C320(1.02)  LDD1492 
Protein AHNAK2 (AHNAK2) LDTP08491 C225(1.40); C5415(1.08); C5425(1.08); C5136(0.97)  LDD0078 
Protein AMBP (AMBP) LDTP01959 C53(3.38)  LDD3418 
Protein AMN1 homolog (AMN1) LDTP19664 C230(1.00)  LDD0531 
Protein angel homolog 1 (ANGEL1) LDTP16249 C27(0.94)  LDD0531 
Protein angel homolog 2 (ANGEL2) LDTP17263 C139(1.91); C158(1.68)  LDD0080 
Protein APCDD1 (APCDD1) LDTP08726 C300(1.77)  LDD3402 
Protein APCDD1-like (APCDD1L) LDTP17784 C37(1.03)  LDD2473 
Protein argonaute-1 (AGO1) LDTP13510 C453(1.03)  LDD3339 
Protein argonaute-4 (AGO4) LDTP12251 C262(0.97); C482(1.19); C484(1.12)  LDD0531 
Protein associated with UVRAG as autophagy enhancer (RUBCNL) LDTP12010 C764(3.54)  LDD3428 
Protein asteroid homolog 1 (ASTE1) LDTP19259 C653(8.79); C293(1.49); C294(1.49)  LDD0080 
Protein BANP (BANP) LDTP09007 C48(24.06)  LDD0209 
Protein bassoon (BSN) LDTP13691 C190(1.09); C193(1.09)  LDD0080 
Protein BCAP (ODF2L) LDTP13554 C493(1.37)  LDD3427 
Protein BEX2 (BEX2) LDTP11424 C47(0.89)  LDD1575 
Protein bicaudal C homolog 1 (BICC1) LDTP11974 C164(1.80)  LDD3369 
Protein bicaudal D homolog 2 (BICD2) LDTP09410 C437(6.45)  LDD0209 
Protein Bop (RTL10) LDTP07952 C72(3.16)  LDD3397 
Protein BRICK1 (BRK1) LDTP09587 C43(2.62)  LDD3333 
Protein BTG2 (BTG2) LDTP05141 C29(0.97)  LDD0637 
Protein BTG3 (BTG3) LDTP14839 C238(1.08)  LDD1508 
Protein BUD31 homolog (BUD31) LDTP03935 C117(1.12); C119(1.12); C101(0.95); C102(0.95)  LDD0078 
Protein C10 (C12orf57) LDTP10923 C44(1.62)  LDD0078 
Protein C12orf4 (C12orf4) LDTP18456 C55(1.09)  LDD0078 
Protein C19orf12 (C19orf12) LDTP12592 C24(7.80)  LDD0204 
Protein C1orf43 (C1orf43) LDTP11330 C97(1.02)  LDD0078 
Protein C3orf33 (C3orf33) LDTP15110 C275(1.20)  LDD1507 
Protein canopy homolog 2 (CNPY2) LDTP13841 C28(1.45)  LDD0531 
Protein canopy homolog 3 (CNPY3) LDTP11176 C104(1.79)  LDD3312 
Protein CASP (CUX1) LDTP06010 C421(0.92)  LDD1507 
Protein CBFA2T1 (RUNX1T1) LDTP05490 C279(1.13)  LDD3332 
Protein CBFA2T2 (CBFA2T2) LDTP00768 C583(1.40)  LDD3367 
Protein CBFA2T3 (CBFA2T3) LDTP01117 C250(1.06)  LDD0078 
Protein Churchill (CHURC1) LDTP15622 C92(1.27)  LDD3329 
Protein CIP2A (CIP2A) LDTP09383 C92(1.17)  LDD0078 
Protein CLEC16A (CLEC16A) LDTP06691 C579(0.95)  LDD0625 
Protein CMSS1 (CMSS1) LDTP18287 C55(1.04)  LDD0078 
Protein cordon-bleu (COBL) LDTP01131 C736(2.05)  LDD3321 
Protein CutA (CUTA) LDTP01075 C96(1.19)  LDD3433 
Protein Daple (CCDC88C) LDTP13013 C134(0.99)  LDD0531 
Protein DBF4 homolog A (DBF4) LDTP13161 C135(1.40)  LDD0532 
Protein DBF4 homolog B (DBF4B) LDTP09219 C213(4.06)  LDD2236 
Protein DEK (DEK) LDTP03778 C161(1.10)  LDD0532 
Protein delta homolog 2 (DLK2) LDTP15167 C171(0.49)  LDD1508 
Protein DENND6A (DENND6A) LDTP15343 C108(3.54)  LDD0080 
Protein DGCR6L (DGCR6L) LDTP11431 C107(1.02)  LDD1514 
Protein diaphanous homolog 1 (DIAPH1) LDTP01011 C1227(2.32); C796(3.02)  LDD0080 
Protein diaphanous homolog 2 (DIAPH2) LDTP01069 C775(1.20)  LDD0080 
Protein diaphanous homolog 3 (DIAPH3) LDTP12596 C687(4.29); C688(2.25); C1125(1.77)  LDD0080 
Protein dispatched homolog 1 (DISP1) LDTP10297 C1476(1.40); C1483(1.40)  LDD2171 
Protein Dok-7 (DOK7) LDTP06669 C134(1.27)  LDD3458 
Protein dopey-1 (DOP1A) LDTP17198 C1652(0.99); C1654(0.99)  LDD0613 
Protein dopey-2 (DOP1B) LDTP14008 C1329(0.83)  LDD0532 
Protein downstream neighbor of Son (DONSON) LDTP12840 C190(9.06)  LDD0209 
Protein DPCD (DPCD) LDTP18315 C200(1.05)  LDD0531 
Protein Dr1 (DR1) LDTP05306 C94(0.92)  LDD0078 
Protein ecdysoneless homolog (ECD) LDTP01711 C267(1.98)  LDD3323 
Protein ECT2 (ECT2) LDTP12067 C221(4.04)  LDD0209 
Protein EFR3 homolog A (EFR3A) LDTP06059 C237(0.95); C819(0.82)  LDD0531 
Protein EFR3 homolog B (EFR3B) LDTP13858 C763(4.56); C533(3.39)  LDD3413 
Protein enabled homolog (ENAH) LDTP08984 C62(0.76)  LDD0531 
Protein ENL (MLLT1) LDTP05391 C42(0.83)  LDD0531 
Protein ENTREP3 (ENTREP3) LDTP05169 C436(3.08)  LDD3419 
Protein EOLA2 (EOLA2) LDTP19855 C5(1.03)  LDD1514 
Protein EURL homolog (EURL) LDTP12836 C73(1.20)  LDD0078 
Protein FAM110A (FAM110A) LDTP11063 C97(1.06)  LDD1508 
Protein FAM110B (FAM110B) LDTP15596 C248(2.14)  LDD3401 
Protein FAM110C (FAM110C) LDTP06679 C300(18.04)  LDD0209 
Protein FAM114A2 (FAM114A2) LDTP16080 C425(1.03)  LDD0532 
Protein FAM117A (FAM117A) LDTP19945 C70(2.15)  LDD3335 
Protein FAM117B (FAM117B) LDTP07509 C474(1.01)  LDD0078 
Protein FAM118A (FAM118A) LDTP12728 C327(0.87); C330(0.87)  LDD0078 
Protein FAM118B (FAM118B) LDTP15852 C319(6.95)  LDD0209 
Protein FAM124A (FAM124A) LDTP08272 C474(2.01)  LDD2337 
Protein FAM131B (FAM131B) LDTP15313 C318(1.64)  LDD3412 
Protein FAM135A (FAM135A) LDTP18515 C938(0.80); C948(0.80)  LDD0533 
Protein FAM136A (FAM136A) LDTP18132 C35(12.61); C40(12.61); C39(12.61)  LDD0080 
Protein FAM13A (FAM13A) LDTP14523 C172(1.04); C569(0.95)  LDD1492 
Protein FAM156A/FAM156B (FAM156A; FAM156B) LDTP15499 C131(1.51)  LDD3339 
Protein FAM167A (FAM167A) LDTP15763 C157(2.94)  LDD3310 
Protein FAM168A (FAM168A) LDTP09801 C75(1.07)  LDD0813 
Protein FAM171A1 (FAM171A1) LDTP07224 C815(1.00)  LDD0531 
Protein FAM171A2 (FAM171A2) LDTP16702 C742(0.82)  LDD1508 
Protein FAM177A1 (FAM177A1) LDTP15398 C137(3.42)  LDD3312 
Protein FAM185A (FAM185A) LDTP19675 C106(0.78)  LDD3313 
Protein FAM193A (FAM193A) LDTP14781 C202(4.11); C205(4.11)  LDD0080 
Protein FAM193B (FAM193B) LDTP10704 C130(1.62); C133(1.62)  LDD0080 
Protein FAM199X (FAM199X) LDTP19513 C235(1.05)  LDD1492 
Protein FAM200C (FAM200C) LDTP17656 C561(17.46)  LDD0209 
Protein FAM204A (FAM204A) LDTP19974 C192(1.92)  LDD3320 
Protein FAM210B, mitochondrial (FAM210B) LDTP10519 C77(1.42)  LDD0080 
Protein FAM216A (FAM216A) LDTP19828 C54(1.06)  LDD0814 
Protein FAM219A (FAM219A) LDTP17631 C32(1.01)  LDD1492 
Protein FAM221A (FAM221A) LDTP00060 C66(1.75)  LDD3344 
Protein FAM234B (FAM234B) LDTP18732 C475(1.03)  LDD3312 
Protein FAM3A (FAM3A) LDTP14800 C59(0.97); C65(0.97)  LDD0813 
Protein FAM3C (FAM3C) LDTP09773 C185(1.37)  LDD0080 
Protein FAM47A (FAM47A) LDTP17186 C650(2.40)  LDD3439 
Protein FAM50B (FAM50B) LDTP13801 C119(1.63)  LDD3332 
Protein FAM53B (FAM53B) LDTP06056 C195(1.11); C204(1.11)  LDD0078 
Protein FAM53C (FAM53C) LDTP18492 C276(0.85)  LDD0078 
Protein FAM72A (FAM72A) LDTP15024 C12(0.88)  LDD0532 
Protein FAM76A (FAM76A) LDTP18047 C26(1.09)  LDD3339 
Protein FAM76B (FAM76B) LDTP06987 C103(0.96); C106(0.96)  LDD0531 
Protein FAM83A (FAM83A) LDTP08264 C205(1.95)  LDD3312 
Protein FAM83B (FAM83B) LDTP07090 C197(0.96); C281(1.17)  LDD0531 
Protein FAM83C (FAM83C) LDTP18290 C371(2.03)  LDD2365 
Protein FAM83D (FAM83D) LDTP11925 C148(0.89)  LDD0531 
Protein FAM83E (FAM83E) LDTP17074 C221(1.02)  LDD3346 
Protein FAM83F (FAM83F) LDTP17803 C333(1.16)  LDD0531 
Protein FAM83G (FAM83G) LDTP00086 C219(0.89); C223(1.11)  LDD0532 
Protein FAM83H (FAM83H) LDTP07816 C789(1.55); C218(0.86)  LDD0078 
Protein FAM91A1 (FAM91A1) LDTP15056 C141(0.88)  LDD0078 
Protein FAM98A (FAM98A) LDTP09086 C126(1.05); C46(1.00)  LDD0531 
Protein FAM98B (FAM98B) LDTP06879 C52(4.06); C93(2.22)  LDD3312 
Protein FAM98C (FAM98C) LDTP14876 C301(20.00); C302(20.00); C36(20.00)  LDD0080 
Protein FAN (NSMAF) LDTP09833 C466(3.61)  LDD3331 
Protein fantom (RPGRIP1L) LDTP07316 C798(0.75); C799(0.75)  LDD0533 
Protein fem-1 homolog B (FEM1B) LDTP13431 C459(0.92); C465(0.92)  LDD0078 
Protein fem-1 homolog C (FEM1C) LDTP10480 C205(44.22)  LDD0209 
Protein flightless-1 homolog (FLII) LDTP05734 C46(1.00); C1257(0.95); C1265(0.95)  LDD0078 
Protein FMC1 homolog (FMC1) LDTP15735 C68(1.70)  LDD3314 
Protein FRG1 (FRG1) LDTP06107 C205(0.98)  LDD0078 
Protein furry homolog (FRY) LDTP07174 C420(3.63)  LDD3333 
Protein furry homolog-like (FRYL) LDTP01460 C2369(1.01)  LDD0080 
Protein GREB1 (GREB1) LDTP06870 C200(1.84)  LDD3340 
Protein HEG homolog 1 (HEG1) LDTP13552 C1360(0.90)  LDD0078 
Protein HEXIM1 (HEXIM1) LDTP01484 C79(2.53); C84(2.53)  LDD0080 
Protein HEXIM2 (HEXIM2) LDTP10587 C240(1.11); C246(1.11)  LDD0078 
Protein HGH1 homolog (HGH1) LDTP18309 C227(1.44); C228(1.44); C51(0.93)  LDD0078 
Protein HID1 (HID1) LDTP08480 C70(1.67)  LDD3314 
Protein Hikeshi (HIKESHI) LDTP06892 C4(1.27)  LDD0547 
Protein hinderin (KIAA1328) LDTP08189 C82(0.53)  LDD0814 
Protein HIRA (HIRA) LDTP04602 C745(0.91); C752(0.91)  LDD0078 
Protein Hook homolog 1 (HOOK1) LDTP13383 C652(1.54)  LDD0080 
Protein Hook homolog 2 (HOOK2) LDTP10255 C121(0.90); C125(0.90); C423(1.00)  LDD0531 
Protein Hook homolog 3 (HOOK3) LDTP08301 C58(1.45)  LDD3332 
Protein ILRUN (ILRUN) LDTP11984 C18(2.18)  LDD0080 
Protein IMPACT (IMPACT) LDTP13088 C284(0.84)  LDD0531 
Protein inturned (INTU) LDTP13540 C622(1.08); C250(1.13); C653(0.67)  LDD1507 
Protein ITPRID2 (ITPRID2) LDTP03426 C305(4.32)  LDD0209 
Protein IWS1 homolog (IWS1) LDTP10822 C749(0.82)  LDD0531 
Protein jagged-1 (JAG1) LDTP05132 C844(0.96); C846(0.96)  LDD0078 
Protein jagged-2 (JAG2) LDTP13778 C1151(0.89)  LDD0078 
Protein JTB (JTB) LDTP01403 C85(0.93)  LDD1492 
Protein KIBRA (WWC1) LDTP08579 C940(2.07)  LDD3346 
Protein kinase C and casein kinase substrate in neurons protein 1 (PACSIN1) LDTP11427 C39(1.03); C45(1.03)  LDD0532 
Protein kinase C and casein kinase substrate in neurons protein 2 (PACSIN2) LDTP13656 C163(1.10)  LDD0080 
Protein kinase C and casein kinase substrate in neurons protein 3 (PACSIN3) LDTP13479 C421(0.96)  LDD0078 
Protein kinase C-binding protein NELL1 (NELL1) LDTP09892 C304(1.60); C273(1.81)  LDD3413 
Protein kinase C-binding protein NELL2 (NELL2) LDTP10861 C413(1.18)  LDD1510 
Protein kintoun (DNAAF2) LDTP12690 C762(0.94); C508(0.85)  LDD0078 
Protein KPLCE (KPLCE) LDTP19403 C62(0.92)  LDD0813 
Protein KRBA1 (KRBA1) LDTP16583 C549(17.45)  LDD0209 
Protein KRI1 homolog (KRI1) LDTP17765 C667(3.69)  LDD0080 
Protein KTI12 homolog (KTI12) LDTP19858 C103(1.04); C107(1.04)  LDD0531 
Protein LDOC1 (LDOC1) LDTP01667 C35(3.45)  LDD3352 
Protein LIAT1 (LIAT1) LDTP07807 C429(2.33); C433(2.33)  LDD0080 
Protein lin-28 homolog A (LIN28A) LDTP12114 C44(1.32)  LDD3383 
Protein lin-28 homolog B (LIN28B) LDTP07784 C201(1.78); C187(1.83)  LDD0080 
Protein lin-37 homolog (LIN37) LDTP10369 C176(2.98)  LDD3343 
Protein lin-54 homolog (LIN54) LDTP07450 C525(1.37); C527(1.37)  LDD0531 
Protein lin-7 homolog A (LIN7A) LDTP00473 C62(2.27)  LDD3456 
Protein lin-7 homolog C (LIN7C) LDTP12638 C47(1.92)  LDD0080 
Protein lin-9 homolog (LIN9) LDTP07195 C192(2.55)  LDD3395 
Protein Lines homolog 1 (LINS1) LDTP15523 C5(0.94); C75(1.11)  LDD1507 
Protein LLP homolog (LLPH) LDTP15868 C64(2.03)  LDD3332 
Protein LRATD1 (LRATD1) LDTP10510 C197(1.68)  LDD3440 
Protein LRATD2 (LRATD2) LDTP15761 C91(1.02)  LDD0625 
Protein LSM12 (LSM12) LDTP06780 C20(701.72)  LDD0209 
Protein LSM14 homolog A (LSM14A) LDTP09116 C361(4.09)  LDD0209 
Protein LSM14 homolog B (LSM14B) LDTP11350 C310(0.96)  LDD0078 
Protein LTO1 homolog (LTO1) LDTP15628 C65(12.94); C70(12.94)  LDD0080 
Protein LTV1 homolog (LTV1) LDTP15727 C350(1.15); C354(1.15)  LDD0078 
Protein LZIC (LZIC) LDTP18112 C33(0.88)  LDD1492 
Protein mago nashi homolog 2 (MAGOHB) LDTP10071 C133(1.12)  LDD0078 
Protein MAK16 homolog (MAK16) LDTP18333 C44(0.83); C61(0.96)  LDD0531 
Protein MCM10 homolog (MCM10) LDTP07959 C515(0.74); C528(0.99)  LDD0533 
Protein Mdm4 (MDM4) LDTP00554 C334(0.98)  LDD0531 
Protein MEMO1 (MEMO1) LDTP13942 C91(1.58)  LDD3311 
Protein MGARP (MGARP) LDTP09423 C139(1.46)  LDD3330 
Protein MIS12 homolog (MIS12) LDTP11685 C53(865.64); C69(400.53)  LDD0209 
Protein Mis18-alpha (MIS18A) LDTP12842 C112(1.18); C115(1.18); C85(1.02); C88(1.02)  LDD0078 
Protein Mis18-beta (OIP5) LDTP00775 C171(0.85); C21(0.84)  LDD0531 
Protein misato homolog 1 (MSTO1) LDTP11239 C411(0.88)  LDD0078 
Protein MIX23 (MIX23) LDTP19309 C53(2.36)  LDD3370 
Protein MMP24OS (MMP24OS) LDTP18636 C67(2.92)  LDD3315 
Protein MMS22-like (MMS22L) LDTP07814 C288(1.01); C290(1.01); C292(1.01)  LDD0078 
Protein MON2 homolog (MON2) LDTP08041 C1454(0.88)  LDD0078 
Protein moonraker (KIAA0753) LDTP06688 C155(0.86); C157(0.86)  LDD0078 
Protein MTO1 homolog, mitochondrial (MTO1) LDTP13936 C315(26.97)  LDD0209 
Protein MTSS 1 (MTSS1) LDTP00742 C74(3.24)  LDD3334 
Protein MTSS 2 (MTSS2) LDTP07916 C365(0.86); C371(0.86); C276(0.85)  LDD0078 
Protein naked cuticle homolog 1 (NKD1) LDTP09999 C43(1.11)  LDD3333 
Protein naked cuticle homolog 2 (NKD2) LDTP09992 C229(1.16)  LDD3371 
Protein NATD1 (NATD1) LDTP17731 C92(1.09)  LDD0080 
Protein NCBP2AS2 (NCBP2AS2) LDTP19472 C63(16.86)  LDD3473 
Protein NDNF (NDNF) LDTP09331 C462(1.09)  LDD1511 
Protein NEDD1 (NEDD1) LDTP09266 C66(1.97)  LDD0080 
Protein Niban 1 (NIBAN1) LDTP11559 C891(1.64)  LDD0080 
Protein Niban 2 (NIBAN2) LDTP10847 C405(3.69)  LDD0080 
Protein Niban 3 (NIBAN3) LDTP15319 C579(2.14); C93(1.39)  LDD3339 
Protein NipSnap homolog 1 (NIPSNAP1) LDTP19912 C138(1.04)  LDD0078 
Protein NipSnap homolog 2 (NIPSNAP2) LDTP01174 C85(8.29); C108(16.11); C93(5.02)  LDD0209 
Protein NipSnap homolog 3A (NIPSNAP3A) LDTP18525 C135(1.14)  LDD3312 
Protein Njmu-R1 (C17orf75) LDTP16028 C182(25.60); C182(18.80)  LDD0209 
Protein NLRC5 (NLRC5) LDTP08333 C1736(1.25)  LDD3338 
Protein NOXP20 (FAM114A1) LDTP08537 C34(0.49)  LDD3337 
Protein NPAT (NPAT) LDTP06084 C978(0.97)  LDD0547 
Protein numb homolog (NUMB) LDTP04295 C165(0.88); C160(0.86)  LDD0078 
Protein odr-4 homolog (ODR4) LDTP17214 C141(1.07)  LDD0078 
Protein PALS1 (PALS1) LDTP08840 C366(1.06)  LDD0078 
Protein PALS2 (PALS2) LDTP16156 C298(0.97)  LDD0078 
Protein PAT1 homolog 1 (PATL1) LDTP08192 C563(1.58)  LDD0080 
Protein PAXX (PAXX) LDTP11235 C180(0.80); C22(1.41); C24(1.64)  LDD0531 
Protein PBDC1 (PBDC1) LDTP19924 C125(1.06)  LDD0531 
Protein pelota homolog (PELO) LDTP11138 C258(1.01)  LDD0078 
Protein phosphatase 1 regulatory subunit 12A (PPP1R12A) LDTP00495 C553(2.56)  LDD3323 
Protein phosphatase 1 regulatory subunit 12B (PPP1R12B) LDTP00918 C779(2.04)  LDD3401 
Protein phosphatase 1 regulatory subunit 12C (PPP1R12C) LDTP11547 C211(0.92)  LDD0078 
Protein phosphatase 1 regulatory subunit 14A (PPP1R14A) LDTP15682 C73(1.48)  LDD3331 
Protein phosphatase 1 regulatory subunit 14B (PPP1R14B) LDTP18135 C659(0.95)  LDD3331 
Protein phosphatase 1 regulatory subunit 15B (PPP1R15B) LDTP07073 C703(0.69)  LDD0531 
Protein phosphatase 1 regulatory subunit 16A (PPP1R16A) LDTP10411 C497(1.03)  LDD1492 
Protein phosphatase 1 regulatory subunit 21 (PPP1R21) LDTP07768 C368(1.01); C373(1.01)  LDD0531 
Protein phosphatase 1 regulatory subunit 29 (ELFN2) LDTP07052 C551(0.94)  LDD0532 
Protein phosphatase 1 regulatory subunit 35 (PPP1R35) LDTP09309 C142(0.96)  LDD1492 
Protein phosphatase 1 regulatory subunit 37 (PPP1R37) LDTP01330 C660(1.22); C668(1.22)  LDD0078 
Protein phosphatase 1 regulatory subunit 3A (PPP1R3A) LDTP06637 C289(1.95)  LDD3364 
Protein phosphatase 1 regulatory subunit 3B (PPP1R3B) LDTP15316 C264(0.86)  LDD0812 
Protein phosphatase 1 regulatory subunit 3C (PPP1R3C) LDTP13763 C76(0.49)  LDD2236 
Protein phosphatase 1 regulatory subunit 3D (PPP1R3D) LDTP14543 C93(1.46); C97(1.46)  LDD0078 
Protein phosphatase 1 regulatory subunit 3E (PPP1R3E) LDTP18406 C131(7.51)  LDD3340 
Protein phosphatase 1 regulatory subunit 3F (PPP1R3F) LDTP07827 C715(0.95)  LDD1507 
Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) LDTP16731 C225(1.48)  LDD3319 
Protein phosphatase 1 regulatory subunit 7 (PPP1R7) LDTP06389 C69(1.33)  LDD3311 
Protein PIMREG (PIMREG) LDTP11160 C104(3.29)  LDD3358 
Protein PMS2CL (PMS2CL) LDTP19470 C165(0.97); C174(0.97)  LDD0078 
Protein POF1B (POF1B) LDTP09624 C496(1.68)  LDD3314 
Protein POLR1D, isoform 2 (POLR1D) LDTP16934 C37(91.47)  LDD0209 
Protein preY, mitochondrial (PYURF) LDTP10407 C60(1.07)  LDD1492 
Protein PRR14L (PRR14L) LDTP17253 C1483(1.22); C1487(1.22); C972(1.14); C982(1.14)  LDD0078 
Protein PRRC1 (PRRC1) LDTP15778 C348(0.94)  LDD1510 
Protein PRRC2A (PRRC2A) LDTP04199 C437(2.72)  LDD3321 
Protein PRRC2B (PRRC2B) LDTP14978 C1101(1.13); C1212(1.05); C819(1.00); C246(0.97)  LDD0078 
Protein PRRC2C (PRRC2C) LDTP14085 C486(4.54)  LDD3311 
Protein RCC2 (RCC2) LDTP13020 C144(1.25); C428(1.00)  LDD0078 
Protein RRP5 homolog (PDCD11) LDTP06186 C1154(0.93)  LDD0078 
Protein RUFY3 (RUFY3) LDTP07933 C29(3.46); C58(3.84)  LDD3344 
Protein S100-A11 (S100A11) LDTP03620 C13(0.98)  LDD0532 
Protein S100-A14 (S100A14) LDTP12277 C62(0.97); C74(1.15)  LDD0531 
Protein S100-A2 (S100A2) LDTP03463 C22(1.54)  LDD0531 
Protein S100-A3 (S100A3) LDTP03674 C68(1.23); C30(1.34); C99(1.30)  LDD0531 
Protein S100-A6 (S100A6) LDTP02153 C3(1.05)  LDD3337 
Protein S100-A7A (S100A7A) LDTP08167 C47(2.75); C96(3.28)  LDD2268 
Protein S100-A8 (S100A8) LDTP02079 C42(1.88)  LDD2274 
Protein SAAL1 (SAAL1) LDTP18152 C366(1.56); C25(1.20)  LDD0080 
Protein salvador homolog 1 (SAV1) LDTP11915 C266(0.82)  LDD0531 
Protein SCAF11 (SCAF11) LDTP10909 C450(1.34); C433(1.03); C446(1.03); C542(1.02)  LDD0078 
Protein SCAI (SCAI) LDTP09010 C477(1.70)  LDD3332 
Protein scribble homolog (SCRIB) LDTP06062 C864(111.75)  LDD0209 
Protein SDA1 homolog (SDAD1) LDTP12694 C206(1.08)  LDD0531 
Protein sel-1 homolog 3 (SEL1L3) LDTP17306 C87(1.94)  LDD3312 
Protein SERAC1 (SERAC1) LDTP10487 C433(1.25)  LDD0531 
Protein SFI1 homolog (SFI1) LDTP00133 C77(0.85)  LDD0531 
Protein SGT1 homolog (SUGT1) LDTP13935 C49(1.06); C54(1.04); C62(1.04); C88(0.91)  LDD0078 
Protein SHQ1 homolog (SHQ1) LDTP07580 C572(1.13)  LDD0080 
Protein Shroom1 (SHROOM1) LDTP14884 C242(1.01); C247(1.01); C222(1.01)  LDD0078 
Protein Shroom2 (SHROOM2) LDTP05983 C1605(0.96)  LDD0531 
Protein Shroom3 (SHROOM3) LDTP09533 C1403(2.14); C1104(2.27)  LDD3337 
Protein Shroom4 (SHROOM4) LDTP13562 C719(1.43)  LDD3388 
Protein SLX4IP (SLX4IP) LDTP17281 C274(0.89); C276(0.89); C282(0.89)  LDD0078 
Protein Smaug homolog 1 (SAMD4A) LDTP13722 C20(56.05)  LDD0209 
Protein Smaug homolog 2 (SAMD4B) LDTP07042 C20(3.77)  LDD3365 
Protein Spindly (SPDL1) LDTP10251 C490(1.02); C467(0.92)  LDD0078 
Protein spire homolog 1 (SPIRE1) LDTP05580 C747(1.63)  LDD3406 
Protein spire homolog 2 (SPIRE2) LDTP09653 C62(2.67)  LDD3332 
Protein SPMIP1 (SPMIP1) LDTP20075 C367(5.27)  LDD3310 
Protein sprouty homolog 1 (SPRY1) LDTP00816 C305(2.28); C181(1.16); C184(1.16)  LDD0080 
Protein sprouty homolog 2 (SPRY2) LDTP00812 C300(4.43); C301(4.43)  LDD0080 
Protein sprouty homolog 3 (SPRY3) LDTP00817 C270(1.01)  LDD3323 
Protein sprouty homolog 4 (SPRY4) LDTP11577 C159(1.30); C162(1.30)  LDD0078 
Protein SPT2 homolog (SPTY2D1) LDTP07320 C535(1.00)  LDD0078 
Protein SREK1IP1 (SREK1IP1) LDTP09009 C18(0.82); C28(0.82)  LDD0533 
Protein SSX2 (SSX2; SSX2B) LDTP06530 C140(1.89)  LDD3351 
Protein SSXT (SS18) LDTP06406 C34(1.11)  LDD0080 
Protein strawberry notch homolog 1 (SBNO1) LDTP14337 C425(0.48); C438(0.48); C445(0.90)  LDD0531 
Protein strawberry notch homolog 2 (SBNO2) LDTP13864 C501(1.51)  LDD0531 
Protein TALPID3 (KIAA0586) LDTP11303 C225(1.03)  LDD1514 
Protein TANC1 (TANC1) LDTP11604 C800(1.23); C1594(1.19)  LDD0078 
Protein TANC2 (TANC2) LDTP12231 C1365(1.97)  LDD3352 
Protein TASOR (TASOR) LDTP13430 C690(0.97); C886(0.94); C889(0.94)  LDD0078 
Protein TASOR 2 (TASOR2) LDTP07241 C902(0.93); C914(0.93)  LDD0078 
Protein TFG (TFG) LDTP09851 C80(0.94)  LDD0828 
Protein THEM6 (THEM6) LDTP19831 C168(1.01)  LDD0078 
Protein THEMIS (THEMIS) LDTP08776 C413(3.37); C450(4.17)  LDD3397 
Protein THEMIS2 (THEMIS2) LDTP07187 C290(0.89)  LDD0531 
Protein timeless homolog (TIMELESS) LDTP13674 C1126(3.11)  LDD0080 
Protein TMED8 (TMED8) LDTP07608 C161(0.92)  LDD0078 
Protein TMEPAI (PMEPA1) LDTP10042 C206(0.95); C218(0.95)  LDD0078 
Protein Tob2 (TOB2) LDTP06033 C120(1.83)  LDD1492 
Protein transport protein Sec16A (SEC16A) LDTP00512 CAmbiguous(11.06); C1293(49.02)  LDD0209 
Protein transport protein Sec23A (SEC23A) LDTP06390 C432(1.04); C180(0.93)  LDD0078 
Protein transport protein Sec23B (SEC23B) LDTP06391 C767(0.98); C434(0.89)  LDD0078 
Protein transport protein Sec24A (SEC24A) LDTP01620 C388(1.00); C928(1.25)  LDD0531 
Protein transport protein Sec24B (SEC24B) LDTP01621 C87(1.05); C1103(1.12); C555(1.29); C562(0.93)  LDD0531 
Protein transport protein Sec24C (SEC24C) LDTP04594 C1083(1.57); C78(1.12)  LDD0078 
Protein transport protein Sec24D (SEC24D) LDTP01440 C820(2.86); C781(4.45); C849(3.07)  LDD3310 
Protein unc-119 homolog A (UNC119) LDTP05868 C77(0.94)  LDD0547 
Protein unc-119 homolog B (UNC119B) LDTP00105 C193(0.68)  LDD0531 
Protein unc-13 homolog A (UNC13A) LDTP13729 C595(2.08); C603(2.08)  LDD0080 
Protein unc-13 homolog B (UNC13B) LDTP00439 C1542(1.65)  LDD0080 
Protein unc-13 homolog C (UNC13C) LDTP09042 C1139(0.77); C1147(0.77)  LDD0533 
Protein unc-13 homolog D (UNC13D) LDTP07888 C439(38.82); C276(4.42)  LDD0209 
Protein unc-45 homolog A (UNC45A) LDTP11890 C426(1.09)  LDD0078 
Protein unc-45 homolog B (UNC45B) LDTP08569 C636(2.73); C344(2.02)  LDD3401 
Protein VAC14 homolog (VAC14) LDTP05586 C516(1.16); C619(0.88); C620(0.88)  LDD0078 
Protein virilizer homolog (VIRMA) LDTP07347 C1559(0.91); C1560(0.91)  LDD0078 
Protein Wnt-11 (WNT11) LDTP01752 C157(3.31)  LDD3364 
Protein Wnt-16 (WNT16) LDTP13165 C223(0.77); C230(0.77); C355(1.03); C364(1.03)  LDD0533 
Protein Wnt-2 (WNT2) LDTP02357 C96(3.62)  LDD3443 
Protein Wnt-2b (WNT2B) LDTP09981 C107(0.93)  LDD1573 
Protein Wnt-5a (WNT5A) LDTP03933 C252(1.25); C240(1.05); C247(1.05); C182(1.01)  LDD0078 
Protein Wnt-5b (WNT5B) LDTP11769 C349(0.19); C358(0.19); C161(0.30)  LDD1093 
Protein Wnt-7a (WNT7A) LDTP00339 C214(2.23)  LDD2282 
Protein WWC2 (WWC2) LDTP07353 C1061(101.94); C1050(48.73)  LDD0209 
Protein WWC3 (WWC3) LDTP13542 C158(2.48)  LDD3312 
Protein XRP2 (RP2) LDTP01296 C110(0.61); C114(0.61)  LDD0533 
Protein YAE1 homolog (YAE1) LDTP16071 C180(1.12); C185(1.12); C186(1.12)  LDD0078 
Protein YIPF4 (YIPF4) LDTP11167 C94(1.04)  LDD0531 
Protein zer-1 homolog (ZER1) LDTP15272 C577(3.45)  LDD3345 
Protein ZNRD2 (ZNRD2) LDTP00916 C70(1.19); C73(1.19); C53(1.00); C56(1.00)  LDD0078 
Protein zwilch homolog (ZWILCH) LDTP12074 C7(1.08)  LDD0078 
Protein zyg-11 homolog A (ZYG11A) LDTP19539 C428(1.13)  LDD1507 
Protein zyg-11 homolog B (ZYG11B) LDTP15931 C457(1.25); C735(0.49)  LDD0531 
Proto-oncogene vav (VAV1) LDTP02789 C71(31.85)  LDD0209 
Protocadherin beta-11 (PCDHB11) LDTP14114 C383(1.45)  LDD3312 
Protocadherin beta-8 (PCDHB8) LDTP16244 C384(1.51)  LDD3344 
Protocadherin Fat 1 (FAT1) LDTP06134 C4512(1.21); C3738(0.98); C3743(0.98); C3826(0.94)  LDD0078 
Protocadherin Fat 2 (FAT2) LDTP12846 C4312(2.51); C3974(1.40)  LDD3365 
Protocadherin Fat 4 (FAT4) LDTP07726 C4166(2.15)  LDD3370 
Protocadherin gamma-A8 (PCDHGA8) LDTP16307 C96(1.41)  LDD3323 
Protocadherin gamma-C3 (PCDHGC3) LDTP16246 C336(3.21)  LDD3314 
Protocadherin-1 (PCDH1) LDTP05547 C432(1.69)  LDD3452 
Protocadherin-10 (PCDH10) LDTP16177 C953(1.37)  LDD3342 
Protocadherin-16 (DCHS1) LDTP10483 C639(1.83)  LDD3340 
Protocadherin-18 (PCDH18) LDTP16045 C931(2.76)  LDD3398 
Protocadherin-19 (PCDH19) LDTP09289 C997(1.63)  LDD3310 
Protocadherin-9 (PCDH9) LDTP16041 C401(1.62)  LDD3332 
Protransforming growth factor alpha (TGFA) LDTP01831 C153(0.92); C154(0.92)  LDD0531 
PSME3-interacting protein (PSME3IP1) LDTP11654 C187(1.12)  LDD0078 
PTB domain-containing engulfment adapter protein 1 (GULP1) LDTP13141 C101(1.22); C115(1.12); C93(1.12)  LDD0531 
PTB-containing, cubilin and LRP1-interacting protein (PID1) LDTP08020 C91(2.60)  LDD3404 
Pulmonary surfactant-associated protein A2 (SFTPA2) LDTP08545 C170(0.99)  LDD3323 
Pumilio homolog 1 (PUM1) LDTP06174 C234(15.63)  LDD0209 
Pumilio homolog 2 (PUM2) LDTP09330 C813(0.45)  LDD0533 
Pumilio homolog 3 (PUM3) LDTP06377 C185(0.96)  LDD0078 
Puratrophin-1 (PLEKHG4) LDTP06938 C26(1.13)  LDD0078 
Putative annexin A2-like protein (ANXA2P2) LDTP00114 C353(4.39); C151(6.91)  LDD3312 
Putative caspase recruitment domain-containing protein 17P (CARD17P) LDTP07276 C45(1.28)  LDD2412 
Putative cleavage and polyadenylation specificity factor subunit 4-like protein (CPSF4L) LDTP18855 C96(1.21)  LDD3310 
Putative coiled-coil domain-containing protein 144B (CCDC144BP) LDTP19283 C388(2.77)  LDD3332 
Putative coiled-coil-helix-coiled-coil-helix domain-containing protein CHCHD2P9, mitochondrial (CHCHD2P9) LDTP17224 C124(2.75)  LDD3338 
Putative DENN domain-containing protein 10 B (DENND10P1) LDTP17356 C135(2.88)  LDD3330 
Putative EP400-like protein (EP400P1) LDTP17492 C151(1.01)  LDD1507 
Putative fatty acid-binding protein 5-like protein 3 (FABP5P3) LDTP18887 C87(1.28)  LDD3333 
Putative FERM domain-containing protein FRMD8P1 (FRMD8P1) LDTP19938 C206(2.72)  LDD3310 
Putative FK506-binding protein 9-like protein (FKBP9P1) LDTP19595 C9(1.98)  LDD3312 
Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (GATD3B) LDTP16462 C244(0.96)  LDD3310 
Putative heat shock protein HSP 90-alpha A4 (HSP90AA4P) LDTP14957 C178(1.17)  LDD3323 
Putative heat shock protein HSP 90-alpha A5 (HSP90AA5P) LDTP17160 C694(4.13)  LDD3314 
Putative heat shock protein HSP 90-beta 2 (HSP90AB2P) LDTP14956 C564(8.71)  LDD3314 
Putative heat shock protein HSP 90-beta-3 (HSP90AB3P) LDTP14955 C521(7.23)  LDD3312 
Putative HLA class I histocompatibility antigen, alpha chain H (HLA-H) LDTP01914 C283(2.03)  LDD3310 
Putative KHDC1-like protein (KHDC1L) LDTP19353 C46(1.66)  LDD3331 
Putative male-specific lethal-3 protein-like 2 (MSL3P1) LDTP16886 C283(1.07)  LDD3427 
Putative methyl-CpG-binding domain protein 3-like 4 (MBD3L4) LDTP18764 C207(1.95)  LDD3423 
Putative neutrophil cytosol factor 1B (NCF1B) LDTP16632 C87(2.00); C197(2.62)  LDD3333 
Putative neutrophil cytosol factor 1C (NCF1C) LDTP16701 C98(1.61)  LDD3334 
Putative PDZ domain-containing protein PDZK1P1 (PDZK1P1) LDTP16695 C455(1.05)  LDD2268 
Putative peripheral benzodiazepine receptor-related protein (TSPO) LDTP16716 C19(1.88)  LDD3345 
Putative Polycomb group protein ASXL2 (ASXL2) LDTP07920 C1166(1.62)  LDD0080 
Putative Polycomb group protein ASXL3 (ASXL3) LDTP11610 C2226(0.95); C2230(0.95); C2234(0.95)  LDD0078 
Putative protein FAM10A4 (ST13P4) LDTP17664 C209(1.15)  LDD3310 
Putative protein PLEKHA9 (PLEKHA8P1) LDTP19027 C43(2.00)  LDD2260 
Putative protein SSX8 (SSX8P) LDTP17522 C72(4.75)  LDD3351 
Putative rhophilin-2-like protein RHPN2P1 (RHPN2P1) LDTP18877 C359(18.40)  LDD0204 
Putative ribosomal protein eL43-like (RPL37AP8) LDTP18837 C43(1.59)  LDD3317 
Putative ribosomal protein eS26-like (RPS26P11) LDTP19348 C77(2.30); C74(2.47)  LDD0080 
Putative ribosomal protein uL10-like (RPLP0P6) LDTP18040 C27(5.04)  LDD3312 
Putative ribosome-binding factor A, mitochondrial (RBFA) LDTP08729 C136(1.12); C338(0.71)  LDD0531 
Putative RNA-binding protein 15B (RBM15B) LDTP09134 C859(2.48)  LDD0080 
Putative RNA-binding protein Luc7-like 1 (LUC7L) LDTP12388 C43(0.97); C44(0.97)  LDD0078 
Putative RNA-binding protein Luc7-like 2 (LUC7L2) LDTP13956 C348(0.96); C43(0.95); C44(0.95)  LDD0078 
Putative segment polarity protein dishevelled homolog DVL1P1 (DVL1P1) LDTP14709 C80(1.67)  LDD3339 
Putative STAG3-like protein 1 (STAG3L1) LDTP19107 C457(3.75)  LDD3343 
Putative testis-specific Y-encoded-like protein 3 (TSPY26P) LDTP19960 C82(1.69)  LDD3436 
Putative TGFB1-induced anti-apoptotic factor 1 (MYO18A) LDTP14537 C73(5.23); C868(2.46)  LDD3311 
Putative transmembrane protein 183BP (TMEM183BP) LDTP17063 C33(2.10)  LDD3311 
Putative uncharacterized protein encoded by BRWD1-AS2 (BRWD1-AS2) LDTP19189 C98(3.21)  LDD3373 
Putative uncharacterized protein encoded by LINC00612 (LINC00612) LDTP20328 C398(2.66)  LDD3311 
Putative uncharacterized protein FER1L6-AS1 (FER1L6-AS1) LDTP20345 C95(0.80)  LDD1575 
Putative uncharacterized protein LINC02693 (LINC02693) LDTP18874 C23(0.72)  LDD1509 
PWWP domain-containing DNA repair factor 3A (PWWP3A) LDTP06723 C155(5.66); C166(5.66); C359(3.58); C362(3.58)  LDD0080 
PX domain-containing protein 1 (PXDC1) LDTP19418 C115(2.45)  LDD3314 
Pygopus homolog 1 (PYGO1) LDTP14015 C317(1.47)  LDD3410 
Pygopus homolog 2 (PYGO2) LDTP11121 C346(0.89); C350(0.89)  LDD0078 
Pyridoxal phosphate homeostasis protein (PLPBP) LDTP14521 C15(1.20); C86(1.03)  LDD0531 
R3H and coiled-coil domain-containing protein 1 (R3HCC1) LDTP18574 C94(19.00); C100(38.15)  LDD0209 
R3H domain-containing protein 1 (R3HDM1) LDTP17044 C1031(12.10); C1032(12.10); C858(2.40)  LDD0080 
R3H domain-containing protein 2 (R3HDM2) LDTP13883 C45(1.59)  LDD3332 
R3H domain-containing protein 4 (R3HDM4) LDTP19854 C29(1.64)  LDD3310 
Rab effector Noc2 (RPH3AL) LDTP13654 C123(1.61)  LDD3420 
Rab GDP dissociation inhibitor alpha (GDI1) LDTP03574 C317(0.95)  LDD0531 
Rab GDP dissociation inhibitor beta (GDI2) LDTP04355 C202(1.69)  LDD0080 
Rab GTPase-activating protein 1 (RABGAP1) LDTP14000 C155(1.08); C1026(0.88)  LDD0078 
Rab GTPase-activating protein 1-like (RABGAP1L) LDTP07051 C554(67.83); C330(13.18)  LDD0209 
Rab GTPase-activating protein 1-like, isoform 10 (RABGAP1L) LDTP16730 C139(2.59); C202(3.61)  LDD3310 
Rab GTPase-binding effector protein 1 (RABEP1) LDTP06347 C533(1.01); C536(1.01)  LDD0078 
Rab GTPase-binding effector protein 2 (RABEP2) LDTP11958 C422(0.84); C423(0.84)  LDD0078 
Rab proteins geranylgeranyltransferase component A 1 (CHM) LDTP03275 C364(1.06); C564(0.88); C580(0.88)  LDD0078 
Rab proteins geranylgeranyltransferase component A 2 (CHML) LDTP03355 C320(0.96); C278(0.91); C582(0.86)  LDD0078 
Rab-3A-interacting protein (RAB3IP) LDTP10736 C334(176.03)  LDD0209 
Rab11 family-interacting protein 1 (RAB11FIP1) LDTP07742 C1028(1.02)  LDD0078 
Rab11 family-interacting protein 2 (RAB11FIP2) LDTP07976 C296(1.02)  LDD1509 
Rab11 family-interacting protein 5 (RAB11FIP5) LDTP11374 C66(0.88)  LDD0078 
RAB11-binding protein RELCH (RELCH) LDTP16172 C526(3.89)  LDD3325 
Rab3 GTPase-activating protein catalytic subunit (RAB3GAP1) LDTP06292 C858(1.21); C678(1.31)  LDD0080 
Rab3 GTPase-activating protein non-catalytic subunit (RAB3GAP2) LDTP11833 C1336(1.40); C67(1.50)  LDD0080 
RAB6-interacting golgin (GORAB) LDTP07147 C354(2.26); C367(2.77); C380(2.77)  LDD0080 
RAB6A-GEF complex partner protein 2 (RGP1) LDTP09790 C101(7.49)  LDD0204 
RAB7A-interacting MON1-CCZ1 complex subunit 1 (RIMOC1) LDTP14351 C244(1.00); C225(0.90); C120(0.88); C130(0.88)  LDD0078 
Rab9 effector protein with kelch motifs (RABEPK) LDTP08130 C29(1.16); C80(0.87)  LDD0078 
Rabankyrin-5 (ANKFY1) LDTP13075 C1102(3.83); C791(3.41); C541(3.74)  LDD3310 
Rabenosyn-5 (RBSN) LDTP11770 C182(0.92); C187(0.92)  LDD0078 
Rabphilin-3A (RPH3A) LDTP13876 C126(1.34)  LDD3362 
Rac GTPase-activating protein 1 (RACGAP1) LDTP11712 C331(2.01); C335(2.01)  LDD0080 
RAD50-interacting protein 1 (RINT1) LDTP07476 C720(1.03)  LDD0078 
RAD51-associated protein 1 (RAD51AP1) LDTP10105 C254(0.92)  LDD0531 
Radixin (RDX) LDTP03721 C284(2.15)  LDD3310 
Raftlin (RFTN1) LDTP06193 C551(9.96)  LDD0204 
Raftlin-2 (RFTN2) LDTP17145 C128(2.13)  LDD3424 
Ragulator complex protein LAMTOR2 (LAMTOR2) LDTP13901 C76(1.52)  LDD3310 
Ragulator complex protein LAMTOR3 (LAMTOR3) LDTP13257 C73(0.98)  LDD0532 
Ragulator complex protein LAMTOR5 (LAMTOR5) LDTP00782 C23(2.36); C33(2.36)  LDD0080 
Ral GTPase-activating protein subunit alpha-1 (RALGAPA1) LDTP07393 C1712(4.94)  LDD0209 
Ral GTPase-activating protein subunit alpha-2 (RALGAPA2) LDTP06716 C1662(24.44)  LDD0209 
Ral GTPase-activating protein subunit beta (RALGAPB) LDTP15308 C327(3.50)  LDD0080 
Ral guanine nucleotide dissociation stimulator-like 2 (RGL2) LDTP00572 C620(1.09); C649(1.09)  LDD0078 
RalBP1-associated Eps domain-containing protein 1 (REPS1) LDTP10203 C21(0.96)  LDD0531 
RalBP1-associated Eps domain-containing protein 2 (REPS2) LDTP09205 C380(1.34)  LDD0531 
Ran-binding protein 10 (RANBP10) LDTP07733 C243(1.34)  LDD0080 
Ran-binding protein 3 (RANBP3) LDTP12006 C249(1.10)  LDD0078 
Ran-binding protein 9 (RANBP9) LDTP10802 C610(1.08)  LDD0078 
Ran-specific GTPase-activating protein (RANBP1) LDTP04049 C132(0.89)  LDD0078 
RANBP2-like and GRIP domain-containing protein 1 (RGPD1) LDTP16909 C82(3.22); C101(1.98); C2381(3.08); C206(2.69)  LDD3311 
RANBP2-like and GRIP domain-containing protein 2 (RGPD2) LDTP16910 C1432(3.50)  LDD3392 
RanBP2-like and GRIP domain-containing protein 3 (RGPD3) LDTP16655 C84(2.44)  LDD3323 
RanBP2-like and GRIP domain-containing protein 4 (RGPD4) LDTP17537 C1167(0.86)  LDD3360 
RANBP2-like and GRIP domain-containing protein 5/6 (RGPD5; RGPD6) LDTP15842 C1431(1.05); C349(0.83)  LDD0531 
RANBP2-like and GRIP domain-containing protein 8 (RGPD8) LDTP16786 C815(1.82)  LDD3403 
Rap guanine nucleotide exchange factor 1 (RAPGEF1) LDTP06005 C474(47.77)  LDD0209 
Rap guanine nucleotide exchange factor 2 (RAPGEF2) LDTP14058 C194(3.77)  LDD3318 
Rap guanine nucleotide exchange factor 3 (RAPGEF3) LDTP01587 C70(1.90)  LDD3365 
Rap guanine nucleotide exchange factor 4 (RAPGEF4) LDTP09756 C443(1.41)  LDD2254 
Rap guanine nucleotide exchange factor 6 (RAPGEF6) LDTP09509 C93(4.05)  LDD0209 
Rap guanine nucleotide exchange factor-like 1 (RAPGEFL1) LDTP16203 C506(5.85)  LDD3312 
Rap1 GTPase-activating protein 1 (RAP1GAP) LDTP04125 C83(17.44)  LDD0209 
Rap1 GTPase-activating protein 2 (RAP1GAP2) LDTP07305 C228(8.49)  LDD0209 
Rap1 GTPase-GDP dissociation stimulator 1 (RAP1GDS1) LDTP04504 C85(5.69)  LDD0209 
Ras and Rab interactor 1 (RIN1) LDTP05964 C733(1.41); C639(0.98); C101(0.86); C105(0.86)  LDD0078 
Ras and Rab interactor 2 (RIN2) LDTP09741 C187(2.05)  LDD3319 
Ras and Rab interactor 3 (RIN3) LDTP09323 C906(0.83); C909(0.83)  LDD0531 
Ras and Rab interactor-like protein (RINL) LDTP17485 C421(1.04)  LDD0531 
Ras association domain-containing protein 1 (RASSF1) LDTP12556 C341(0.95)  LDD0531 
Ras association domain-containing protein 10 (RASSF10) LDTP00111 C28(4.28)  LDD3444 
Ras association domain-containing protein 2 (RASSF2) LDTP04383 C251(2.62)  LDD3338 
Ras association domain-containing protein 3 (RASSF3) LDTP08331 C156(0.97)  LDD0531 
Ras association domain-containing protein 5 (RASSF5) LDTP09668 C225(4.06)  LDD0209 
Ras association domain-containing protein 7 (RASSF7) LDTP05376 C122(1.11)  LDD0078 
Ras association domain-containing protein 8 (RASSF8) LDTP15565 C159(2.66)  LDD3410 
Ras association domain-containing protein 9 (RASSF9) LDTP14508 C41(3.01)  LDD3380 
Ras GTPase-activating protein 1 (RASA1) LDTP03094 C906(17.33)  LDD0209 
Ras GTPase-activating protein 2 (RASA2) LDTP06348 C567(1.08)  LDD0078 
Ras GTPase-activating protein 3 (RASA3) LDTP06166 C206(0.88)  LDD0078 
Ras GTPase-activating protein 4 (RASA4) LDTP00754 C434(0.87)  LDD1573 
Ras GTPase-activating protein 4B (RASA4B) LDTP16741 C705(1.68)  LDD3310 
Ras GTPase-activating protein nGAP (RASAL2) LDTP13385 C508(2.16); C591(3.64)  LDD3311 
Ras GTPase-activating protein-binding protein 2 (G3BP2) LDTP13647 C73(1.20)  LDD0531 
Ras GTPase-activating-like protein IQGAP1 (IQGAP1) LDTP04117 C781(1.01); C494(0.89)  LDD0078 
Ras GTPase-activating-like protein IQGAP2 (IQGAP2) LDTP05932 C628(4.56)  LDD0209 
Ras GTPase-activating-like protein IQGAP3 (IQGAP3) LDTP08288 C919(0.94)  LDD0078 
RAS guanyl-releasing protein 1 (RASGRP1) LDTP01550 C166(4.37)  LDD0204 
RAS guanyl-releasing protein 2 (RASGRP2) LDTP07986 C296(7.45); C11(19.01); C76(4.10)  LDD0209 
RAS guanyl-releasing protein 4 (RASGRP4) LDTP09432 C532(2.43); C33(1.92)  LDD2324 
RAS protein activator like-3 (RASAL3) LDTP08418 C605(48.74); C546(44.85)  LDD0209 
Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) LDTP07878 C1045(1.32)  LDD0080 
Ras-associating and dilute domain-containing protein (RADIL) LDTP10467 C379(1.93); C671(4.10)  LDD3340 
Ras-interacting protein 1 (RASIP1) LDTP07202 C463(1.97)  LDD3345 
Ras-related protein Rab-34, isoform NARR (RAB34) LDTP02417 C94(2.16); C19(1.89)  LDD3311 
Ras-specific guanine nucleotide-releasing factor 2 (RASGRF2) LDTP00450 C505(2.92)  LDD3323 
Ras-specific guanine nucleotide-releasing factor RalGPS2 (RALGPS2) LDTP15310 C489(1.00)  LDD0080 
RasGAP-activating-like protein 1 (RASAL1) LDTP01557 C386(9.20)  LDD0209 
RB1-inducible coiled-coil protein 1 (RB1CC1) LDTP09466 C783(1.04); C379(0.96)  LDD0078 
RBBP8 N-terminal-like protein (RBBP8NL) LDTP17782 C76(1.16)  LDD3323 
RBPJ-interacting and tubulin-associated protein 1 (RITA1) LDTP10494 C80(2.01)  LDD3436 
RCC1 and BTB domain-containing protein 1 (RCBTB1) LDTP09131 C459(0.94); C72(1.14)  LDD1492 
RCC1 and BTB domain-containing protein 2 (RCBTB2) LDTP14531 C488(1.40)  LDD3332 
RCC1 domain-containing protein 1 (RCCD1) LDTP00091 C42(1.54)  LDD0080 
RCC1-like G exchanging factor-like protein (RCC1L) LDTP10412 C401(1.72); C425(1.55)  LDD0080 
Receptor expression-enhancing protein 4 (REEP4) LDTP11981 C7(1.20)  LDD0593 
Receptor expression-enhancing protein 5 (REEP5) LDTP05257 C18(1.22)  LDD0078 
Receptor-binding cancer antigen expressed on SiSo cells (EBAG9) LDTP00309 C12(0.75)  LDD1509 
Receptor-transporting protein 4 (RTP4) LDTP10236 C37(1.26)  LDD2337 
RecQ-mediated genome instability protein 1 (RMI1) LDTP12088 C366(0.98)  LDD0078 
RecQ-mediated genome instability protein 2 (RMI2) LDTP10243 C95(4.80)  LDD3325 
Refilin-A (RFLNA) LDTP15192 C26(1.90)  LDD3353 
Refilin-B (RFLNB) LDTP17721 C186(0.93)  LDD0078 
Regulating synaptic membrane exocytosis protein 1 (RIMS1) LDTP08245 C907(2.47)  LDD3339 
Regulating synaptic membrane exocytosis protein 3 (RIMS3) LDTP13384 C28(2.77)  LDD3339 
Regulation of nuclear pre-mRNA domain-containing protein 1A (RPRD1A) LDTP10651 C220(1.19)  LDD0080 
Regulation of nuclear pre-mRNA domain-containing protein 1B (RPRD1B) LDTP12417 C100(1.22)  LDD0078 
Regulation of nuclear pre-mRNA domain-containing protein 2 (RPRD2) LDTP07213 C903(1.12)  LDD0078 
Regulator of chromosome condensation (RCC1) LDTP02964 C383(1.23); C93(1.04); C229(0.98)  LDD3310 
Regulator of G-protein signaling 1 (RGS1) LDTP05544 C170(1.52)  LDD3419 
Regulator of G-protein signaling 12 (RGS12) LDTP00476 C683(1.18); C701(1.18)  LDD0078 
Regulator of G-protein signaling 14 (RGS14) LDTP00803 C496(34.48)  LDD0209 
Regulator of G-protein signaling 17 (RGS17) LDTP13222 C70(1.03)  LDD1492 
Regulator of G-protein signaling 19 (RGS19) LDTP04311 C73(3.98); C76(3.98)  LDD0080 
Regulator of G-protein signaling 2 (RGS2) LDTP03932 C199(0.99)  LDD1492 
Regulator of G-protein signaling 3 (RGS3) LDTP04312 C1159(0.84); C563(1.26); C632(0.69); C767(1.15)  LDD0531 
Regulator of G-protein signaling 6 (RGS6) LDTP04296 C70(1.45)  LDD2412 
Regulator of microtubule dynamics protein 1 (RMDN1) LDTP10209 C37(0.91)  LDD0533 
Regulator of microtubule dynamics protein 2 (RMDN2) LDTP10567 C491(2.44)  LDD3314 
Regulator of microtubule dynamics protein 3 (RMDN3) LDTP10849 C128(1.19)  LDD0078 
Regulator of MON1-CCZ1 complex (RMC1) LDTP10218 C635(25.02)  LDD0209 
Regulator of nonsense transcripts 2 (UPF2) LDTP12139 C944(1.02)  LDD0078 
Regulator of nonsense transcripts 3A (UPF3A) LDTP11767 C315(1.44)  LDD3325 
Regulator of nonsense transcripts 3B (UPF3B) LDTP11539 C319(1.10); C453(1.06)  LDD0078 
Regulatory-associated protein of mTOR (RPTOR) LDTP08744 C713(0.97)  LDD0078 
RELT-like protein 1 (RELL1) LDTP08468 C176(1.42)  LDD3310 
Remodeling and spacing factor 1 (RSF1) LDTP10831 C562(1.26)  LDD0078 
Repetin (RPTN) LDTP15173 C352(1.54)  LDD3373 
Replication factor C subunit 1 (RFC1) LDTP03727 C750(1.07); C752(1.07); C822(1.05); C118(1.04)  LDD0078 
Replication protein A 14 kDa subunit (RPA3) LDTP03723 C81(0.77)  LDD0531 
Replication protein A 30 kDa subunit (RPA4) LDTP05771 C212(1.09)  LDD2526 
Replication protein A 32 kDa subunit (RPA2) LDTP02816 C307(1.10)  LDD3311 
Replication protein A 70 kDa DNA-binding subunit (RPA1) LDTP03397 C503(1.05); C476(1.02); C486(1.02); C481(1.00)  LDD0078 
Replication termination factor 2 (RTF2) LDTP11434 C262(2.33); C139(1.40)  LDD0080 
Repressor of RNA polymerase III transcription MAF1 homolog (MAF1) LDTP11681 C34(1.38)  LDD0080 
Repulsive guidance molecule A (RGMA) LDTP10115 C145(1.07)  LDD1510 
Repulsive guidance molecule B (RGMB) LDTP07484 C226(1.01)  LDD1492 
Required for meiotic nuclear division protein 1 homolog (RMND1) LDTP12729 C390(1.07)  LDD0531 
Reticulon-3 (RTN3) LDTP01522 C582(1.23); C390(1.35)  LDD3310 
Reticulon-4 (RTN4) LDTP12412 C1101(1.77)  LDD0078 
Reticulon-4 receptor (RTN4R) LDTP11560 C419(0.97)  LDD1492 
Reticulophagy regulator 2 (RETREG2) LDTP09080 C187(1.05)  LDD0531 
Reticulophagy regulator 3 (RETREG3) LDTP08300 C268(0.97)  LDD1492 
Retinaldehyde-binding protein 1 (RLBP1) LDTP02613 C138(1.19)  LDD3410 
Retinitis pigmentosa 9 protein (RP9) LDTP09287 C120(0.98)  LDD3310 
Retinoblastoma-associated protein (RB1) LDTP02146 C438(2.76)  LDD0080 
Retinoblastoma-binding protein 5 (RBBP5) LDTP06351 C212(1.11)  LDD0078 
Retinoblastoma-like protein 1 (RBL1) LDTP03452 C1047(1.01)  LDD0078 
Retinoblastoma-like protein 2 (RBL2) LDTP05578 C1118(5.88); C368(156.50)  LDD0209 
Retinoic acid receptor responder protein 2 (RARRES2) LDTP11025 C135(3.52); C77(3.44)  LDD3380 
Retinoid-binding protein 7 (RBP7) LDTP18243 C122(1.67); C127(1.67)  LDD0531 
Retinol-binding protein 1 (RBP1) LDTP02345 C127(0.84)  LDD0531 
Retroelement silencing factor 1 (RESF1) LDTP12254 C483(1.05); C494(1.05)  LDD0078 
Retrotransposon Gag-like protein 5 (RTL5) LDTP19346 C98(0.86)  LDD1507 
Retrotransposon-derived protein PEG10 (PEG10) LDTP08195 C119(0.79)  LDD0531 
Retrotransposon-like protein 1 (RTL1) LDTP16652 C1246(2.55)  LDD3340 
Reversion-inducing cysteine-rich protein with Kazal motifs (RECK) LDTP01730 C581(2.86)  LDD2361 
Rho GDP-dissociation inhibitor 1 (ARHGDIA) LDTP04510 C79(1.01)  LDD3361 
Rho GDP-dissociation inhibitor 2 (ARHGDIB) LDTP04511 C76(1.65)  LDD3334 
Rho GTPase-activating protein 1 (ARHGAP1) LDTP05540 C91(0.55)  LDD0531 
Rho GTPase-activating protein 10 (ARHGAP10) LDTP00024 C402(0.92)  LDD0531 
Rho GTPase-activating protein 11A (ARHGAP11A) LDTP15116 C690(1.12); C108(1.05); C115(1.05); C876(0.99)  LDD0078 
Rho GTPase-activating protein 12 (ARHGAP12) LDTP08566 C199(1.06); C441(0.88)  LDD0531 
Rho GTPase-activating protein 15 (ARHGAP15) LDTP14948 C197(1.56); C301(2.01)  LDD3334 
Rho GTPase-activating protein 17 (ARHGAP17) LDTP07335 C272(2.06)  LDD3316 
Rho GTPase-activating protein 18 (ARHGAP18) LDTP08822 C377(1.46); C637(0.83)  LDD0531 
Rho GTPase-activating protein 19 (ARHGAP19) LDTP06256 C359(10.68)  LDD0204 
Rho GTPase-activating protein 20 (ARHGAP20) LDTP13045 C32(2.80)  LDD2469 
Rho GTPase-activating protein 21 (ARHGAP21) LDTP07124 C264(0.95); C266(0.95)  LDD0078 
Rho GTPase-activating protein 22 (ARHGAP22) LDTP08091 C89(1.66)  LDD3335 
Rho GTPase-activating protein 23 (ARHGAP23) LDTP18510 C1261(1.77)  LDD3369 
Rho GTPase-activating protein 24 (ARHGAP24) LDTP08788 C560(1.18); C571(1.18)  LDD0078 
Rho GTPase-activating protein 25 (ARHGAP25) LDTP03977 C184(1.95)  LDD3333 
Rho GTPase-activating protein 26 (ARHGAP26) LDTP13650 C142(0.88); C71(0.83); C82(0.83)  LDD0531 
Rho GTPase-activating protein 27 (ARHGAP27) LDTP07845 C697(0.98); C703(0.98); C830(1.01)  LDD0531 
Rho GTPase-activating protein 28 (ARHGAP28) LDTP13068 C9(0.97)  LDD3380 
Rho GTPase-activating protein 29 (ARHGAP29) LDTP06880 C1066(3.94); C518(1.88)  LDD0080 
Rho GTPase-activating protein 30 (ARHGAP30) LDTP08120 C954(2.54)  LDD3339 
Rho GTPase-activating protein 31 (ARHGAP31) LDTP06696 C1424(1.18); C509(1.03); C76(0.91)  LDD0078 
Rho GTPase-activating protein 32 (ARHGAP32) LDTP00123 C93(2.15)  LDD3348 
Rho GTPase-activating protein 35 (ARHGAP35) LDTP12547 C559(0.97); C565(0.97)  LDD0078 
Rho GTPase-activating protein 39 (ARHGAP39) LDTP15933 C1079(1.11)  LDD3321 
Rho GTPase-activating protein 4 (ARHGAP4) LDTP05221 C34(28.49)  LDD0209 
Rho GTPase-activating protein 42 (ARHGAP42) LDTP14368 C653(0.91)  LDD0580 
Rho GTPase-activating protein 44 (ARHGAP44) LDTP06662 C367(1.14)  LDD1509 
Rho GTPase-activating protein 45 (ARHGAP45) LDTP09823 C324(136.80); C739(44.22)  LDD0209 
Rho GTPase-activating protein 5 (ARHGAP5) LDTP05726 C557(3.68); C563(3.68)  LDD0080 
Rho GTPase-activating protein 6 (ARHGAP6) LDTP00703 C819(2.50); C867(1.40)  LDD3335 
Rho GTPase-activating protein 7 (DLC1) LDTP10729 C1106(0.53)  LDD1094 
Rho GTPase-activating protein 8 (ARHGAP8) LDTP05202 C41(1.27)  LDD0531 
Rho GTPase-activating protein 9 (ARHGAP9) LDTP11128 C562(4.40)  LDD0204 
Rho GTPase-activating protein SYDE1 (SYDE1) LDTP07859 C360(1.20)  LDD0602 
Rho GTPase-activating protein SYDE2 (SYDE2) LDTP15028 C856(3.34)  LDD3310 
Rho guanine nucleotide exchange factor 1 (ARHGEF1) LDTP09917 C815(4.49)  LDD0204 
Rho guanine nucleotide exchange factor 10 (ARHGEF10) LDTP00506 C1335(0.99); C950(0.95)  LDD0531 
Rho guanine nucleotide exchange factor 10-like protein (ARHGEF10L) LDTP12235 C444(0.70)  LDD0531 
Rho guanine nucleotide exchange factor 11 (ARHGEF11) LDTP00535 C442(1.23)  LDD3347 
Rho guanine nucleotide exchange factor 12 (ARHGEF12) LDTP12924 C369(1.02); C371(1.02)  LDD0078 
Rho guanine nucleotide exchange factor 16 (ARHGEF16) LDTP07226 C438(0.79); C465(0.87)  LDD0531 
Rho guanine nucleotide exchange factor 17 (ARHGEF17) LDTP15805 C1134(3.08); C1479(6.17)  LDD3310 
Rho guanine nucleotide exchange factor 18 (ARHGEF18) LDTP07828 C699(1.04)  LDD0078 
Rho guanine nucleotide exchange factor 2 (ARHGEF2) LDTP09950 C715(1.56); C342(2.08); C68(1.61); C71(1.61)  LDD0080 
Rho guanine nucleotide exchange factor 26 (ARHGEF26) LDTP10225 C850(2.34)  LDD0080 
Rho guanine nucleotide exchange factor 28 (ARHGEF28) LDTP08784 C559(2.10)  LDD3314 
Rho guanine nucleotide exchange factor 3 (ARHGEF3) LDTP12483 C548(1.39)  LDD3313 
Rho guanine nucleotide exchange factor 35 (ARHGEF35) LDTP18745 C186(1.33)  LDD3360 
Rho guanine nucleotide exchange factor 38 (ARHGEF38) LDTP16133 C447(1.84)  LDD2268 
Rho guanine nucleotide exchange factor 39 (ARHGEF39) LDTP15423 C274(15.67); C10(4.52)  LDD0209 
Rho guanine nucleotide exchange factor 4 (ARHGEF4) LDTP12482 C646(3.00); C307(1.41); C587(2.62)  LDD2469 
Rho guanine nucleotide exchange factor 40 (ARHGEF40) LDTP09507 C1282(2.32)  LDD0080 
Rho guanine nucleotide exchange factor 5 (ARHGEF5) LDTP05645 C548(1.30); C1509(0.70); C1517(0.70)  LDD0531 
Rho guanine nucleotide exchange factor 6 (ARHGEF6) LDTP06299 C182(1.38)  LDD0080 
Rho guanine nucleotide exchange factor 7 (ARHGEF7) LDTP06058 C721(0.85)  LDD0078 
Rho guanine nucleotide exchange factor TIAM1 (TIAM1) LDTP05723 C226(1.15)  LDD0531 
Rho guanine nucleotide exchange factor TIAM2 (TIAM2) LDTP08493 C8(1.78)  LDD2469 
Rhombotin-1 (LMO1) LDTP03335 C334(1.77)  LDD3423 
Rhombotin-2 (LMO2) LDTP03334 C199(2.69)  LDD3334 
Rhophilin-1 (RHPN1) LDTP09402 C22(0.88); C30(0.88)  LDD0078 
Rhophilin-2 (RHPN2) LDTP08445 C346(1.04)  LDD0078 
Rhotekin (RTKN) LDTP11168 C424(2.19); C425(2.19)  LDD0080 
Rhotekin-2 (RTKN2) LDTP08690 C22(4.24)  LDD3364 
Ribonuclease inhibitor (RNH1) LDTP02656 C220(0.95); C96(0.93); C102(0.93); C95(0.93)  LDD0078 
Ribonucleoprotein PTB-binding 1 (RAVER1) LDTP15356 C251(4.60); C161(1.77); C297(1.08); C239(1.13)  LDD0080 
Ribonucleoprotein PTB-binding 2 (RAVER2) LDTP18440 C631(0.98); C82(1.03)  LDD0531 
Ribosomal L1 domain-containing protein 1 (RSL1D1) LDTP01379 C211(0.96); C47(0.93)  LDD0078 
Ribosomal protein eL42-like (RPL36AL) LDTP15677 C77(1.86)  LDD3429 
Ribosomal protein eS27-like (RPS27L) LDTP07909 C77(4.94)  LDD0080 
Ribosomal protein uL16-like (RPL10L) LDTP10525 C195(3.49)  LDD3312 
Ribosomal protein uL3-like (RPL3L) LDTP15668 C253(4.24)  LDD3310 
Ribosomal protein uL30-like (RPL7L1) LDTP17320 C193(1.21)  LDD3310 
Ribosomal RNA processing protein 1 homolog A (RRP1) LDTP04729 C274(0.89)  LDD0078 
Ribosomal RNA processing protein 1 homolog B (RRP1B) LDTP06182 C155(1.27); C628(1.09); C286(0.99)  LDD0078 
Ribosomal RNA processing protein 36 homolog (RRP36) LDTP10277 C87(1.03)  LDD0078 
Ribosomal RNA-processing protein 7 homolog A (RRP7A) LDTP13965 C8(5.78)  LDD0209 
Ribosome biogenesis inhibitor MINAS-60 (RBM10) LDTP14628 C284(1.87)  LDD3312 
Ribosome biogenesis protein BOP1 (BOP1) LDTP06046 C373(1.52); C108(1.00); C404(0.97)  LDD0078 
Ribosome biogenesis protein BRX1 homolog (BRIX1) LDTP15609 C52(1.13)  LDD0078 
Ribosome biogenesis protein NSA2 homolog (NSA2) LDTP16846 C193(1.09)  LDD0080 
Ribosome biogenesis protein WDR12 (WDR12) LDTP11625 C302(1.07); C309(1.07)  LDD0078 
Ribosome biogenesis regulatory protein homolog (RRS1) LDTP06297 C52(0.92)  LDD0078 
Ribosome maturation protein SBDS (SBDS) LDTP13966 C31(0.88)  LDD0078 
Ribosome production factor 1 (RPF1) LDTP16024 C187(1.08)  LDD0531 
Ribosome production factor 2 homolog (RPF2) LDTP12019 C87(0.54)  LDD0533 
Ribosome quality control complex subunit NEMF (NEMF) LDTP00997 C663(1.15)  LDD0078 
Ribosome-binding protein 1 (RRBP1) LDTP13044 C933(1.04); C1216(0.99); C1038(0.95); C1128(0.85)  LDD0078 
Ribosome-recycling factor, mitochondrial (MRRF) LDTP10242 C154(1.12)  LDD3330 
RILP-like protein 1 (RILPL1) LDTP06962 C47(1.13)  LDD0078 
RILP-like protein 2 (RILPL2) LDTP10043 C161(1.74)  LDD3334 
RING finger and SPRY domain-containing protein 1 (RSPRY1) LDTP15712 C167(4.68)  LDD3312 
RING finger protein 11 (RNF11) LDTP13975 C125(0.94)  LDD1509 
RING finger protein 113B (RNF113B) LDTP19671 C202(1.18)  LDD3310 
RING finger protein 141 (RNF141) LDTP09606 C169(1.22); C174(1.22)  LDD0080 
RING finger protein 214 (RNF214) LDTP19787 C696(0.98); C699(0.98); C658(0.93); C661(0.93)  LDD0078 
RING finger protein 24 (RNF24) LDTP13783 C115(0.86); C118(1.04)  LDD1492 
RING finger protein unkempt homolog (UNK) LDTP11594 C788(0.95); C791(0.95)  LDD0078 
RING1 and YY1-binding protein (RYBP) LDTP08857 C41(1.48); C44(1.48)  LDD0080 
RISC-loading complex subunit TARBP2 (TARBP2) LDTP06428 C282(0.95); C295(0.95); C263(0.91)  LDD0078 
RNA binding motif protein, X-linked-like-1 (RBMXL1) LDTP18146 C338(1.18)  LDD0078 
RNA polymerase I-specific transcription initiation factor RRN3 (RRN3) LDTP12853 C224(35.58)  LDD0209 
RNA polymerase II elongation factor ELL (ELL) LDTP04682 C264(1.08); C14(0.97)  LDD0078 
RNA polymerase II elongation factor ELL2 (ELL2) LDTP00288 C308(1.06)  LDD0078 
RNA polymerase II elongation factor ELL3 (ELL3) LDTP12162 C15(1.25)  LDD0593 
RNA polymerase II-associated factor 1 homolog (PAF1) LDTP08965 C36(2.12)  LDD0080 
RNA polymerase II-associated protein 1 (RPAP1) LDTP11327 C1039(1.00); C1049(1.00)  LDD0078 
RNA polymerase II-associated protein 3 (RPAP3) LDTP12000 C519(1.07)  LDD0078 
RNA polymerase-associated protein CTR9 homolog (CTR9) LDTP07563 C196(1.03); C707(0.99); C363(0.91); C136(0.89)  LDD0078 
RNA polymerase-associated protein RTF1 homolog (RTF1) LDTP09786 C373(2.82)  LDD0080 
RNA transcription, translation and transport factor protein (RTRAF) LDTP13782 C19(0.93)  LDD0078 
RNA-binding motif protein, X-linked 2 (RBMX2) LDTP13958 C80(0.77); C83(0.77)  LDD0531 
RNA-binding motif protein, Y chromosome, family 1 member B (RBMY1B) LDTP00088 C85(1.26)  LDD3399 
RNA-binding motif, single-stranded-interacting protein 1 (RBMS1) LDTP03495 C194(1.85)  LDD3312 
RNA-binding motif, single-stranded-interacting protein 2 (RBMS2) LDTP17046 C188(1.90)  LDD3312 
RNA-binding motif, single-stranded-interacting protein 3 (RBMS3) LDTP07748 C101(0.81)  LDD3353 
RNA-binding protein 10 (RBM10) LDTP05224 C222(0.96)  LDD1492 
RNA-binding protein 12 (RBM12) LDTP16096 C545(1.78)  LDD3409 
RNA-binding protein 12B (RBM12B) LDTP17640 C204(1.18); C837(1.14); C919(1.01)  LDD0078 
RNA-binding protein 14 (RBM14) LDTP10684 C90(0.88)  LDD0078 
RNA-binding protein 15 (RBM15) LDTP10832 C926(1.82)  LDD0080 
RNA-binding protein 20 (RBM20) LDTP07113 C523(2.46); C530(2.46); C1024(1.75)  LDD0080 
RNA-binding protein 25 (RBM25) LDTP04294 C132(2.48)  LDD0080 
RNA-binding protein 26 (RBM26) LDTP15012 C25(1.09)  LDD0080 
RNA-binding protein 27 (RBM27) LDTP18517 C801(4.43)  LDD3311 
RNA-binding protein 28 (RBM28) LDTP12703 C97(1.28); C71(1.06)  LDD0078 
RNA-binding protein 33 (RBM33) LDTP18155 C1093(0.87); C1098(0.87)  LDD0078 
RNA-binding protein 34 (RBM34) LDTP14680 C196(1.78)  LDD3310 
RNA-binding protein 39 (RBM39) LDTP06128 C478(1.64); C303(1.46)  LDD0080 
RNA-binding protein 4 (RBM4) LDTP11324 C162(1.04)  LDD0531 
RNA-binding protein 41 (RBM41) LDTP10437 C136(3.38)  LDD3419 
RNA-binding protein 42 (RBM42) LDTP11195 C385(1.02)  LDD1094 
RNA-binding protein 43 (RBM43) LDTP19567 C313(8.32)  LDD0204 
RNA-binding protein 45 (RBM45) LDTP08454 C149(0.74)  LDD3312 
RNA-binding protein 47 (RBM47) LDTP00009 C349(1.05)  LDD0078 
RNA-binding protein 48 (RBM48) LDTP07055 C258(2.83)  LDD0080 
RNA-binding protein 4B (RBM4B) LDTP11046 C107(1.56); C31(1.34)  LDD3312 
RNA-binding protein 5 (RBM5) LDTP04527 C191(1.02)  LDD0078 
RNA-binding protein 6 (RBM6) LDTP05094 C556(1.11); C1057(1.10); C277(0.96)  LDD0078 
RNA-binding protein EWS (EWSR1) LDTP05318 C389(1.92)  LDD3324 
RNA-binding protein FUS (FUS) LDTP03775 C444(1.85); C447(1.85); C433(1.94); C428(1.47)  LDD0080 
RNA-binding protein FXR1 (FXR1) LDTP04395 C77(1.12)  LDD0078 
RNA-binding protein FXR2 (FXR2) LDTP04396 C87(1.09); C151(1.00)  LDD0078 
RNA-binding protein MEX3A (MEX3A) LDTP14330 C341(6.52); C345(6.52)  LDD0080 
RNA-binding protein MEX3B (MEX3B) LDTP07782 C69(1.28); C438(0.97)  LDD1492 
RNA-binding protein Musashi homolog 1 (MSI1) LDTP14453 C167(0.93)  LDD1492 
RNA-binding protein Musashi homolog 2 (MSI2) LDTP10216 C64(1.24)  LDD3310 
RNA-binding protein Nova-1 (NOVA1) LDTP04419 C100(0.96)  LDD1510 
RNA-binding protein Nova-2 (NOVA2) LDTP13680 C21(0.99)  LDD1510 
RNA-binding protein Raly (RALY) LDTP13467 C51(2.51)  LDD3333 
RNA-binding protein RO60 (RO60) LDTP02480 C71(1.03)  LDD0078 
RNA-binding Raly-like protein (RALYL) LDTP08161 C64(2.75)  LDD3323 
RNA-binding region-containing protein 3 (RNPC3) LDTP10561 C420(0.99)  LDD0078 
Rootletin (CROCC) LDTP07196 C1759(1.34)  LDD3314 
Rotatin (RTTN) LDTP08303 C1819(1.48); C1820(1.48); C1109(1.11); C1113(1.11)  LDD0078 
RPA-interacting protein (RPAIN) LDTP08218 C122(1.06); C175(0.99); C154(0.88); C156(0.88)  LDD1492 
RPA-related protein RADX (RADX) LDTP07458 C793(2.76); C108(2.75)  LDD0080 
rRNA-processing protein FCF1 homolog (FCF1) LDTP13944 C154(0.86)  LDD0078 
rRNA-processing protein UTP23 homolog (UTP23) LDTP11135 C207(1.01)  LDD0078 
RRP12-like protein (RRP12) LDTP14980 C839(4.22)  LDD0080 
RRP15-like protein (RRP15) LDTP18570 C146(1.88)  LDD0080 
RUN and FYVE domain-containing protein 1 (RUFY1) LDTP10834 C81(1.09); C8(0.95)  LDD0078 
RUN and FYVE domain-containing protein 2 (RUFY2) LDTP09682 C595(2.25)  LDD3319 
Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (RUBCN) LDTP09826 C486(42.43); C739(5.62)  LDD0209 
RUN domain-containing protein 1 (RUNDC1) LDTP18133 C559(0.85)  LDD0531 
RUN domain-containing protein 3A (RUNDC3A) LDTP06942 C108(1.27)  LDD3344 
RUS family member 1 (RUSF1) LDTP10357 C201(6.62)  LDD0209 
S phase cyclin A-associated protein in the endoplasmic reticulum (SCAPER) LDTP11428 C71(1.95)  LDD0080 
S-arrestin (SAG) LDTP02498 C67(4.29)  LDD3338 
S1 RNA-binding domain-containing protein 1 (SRBD1) LDTP17715 C165(1.38); C571(1.02); C502(1.00)  LDD0078 
S100P-binding protein (S100PBP) LDTP15699 C156(1.57)  LDD3332 
SAC3 domain-containing protein 1 (SAC3D1) LDTP14373 C84(1.64)  LDD0080 
Sacsin (SACS) LDTP12906 C2514(1.17); C360(1.06); C2976(0.99); C1889(0.97)  LDD0078 
SAFB-like transcription modulator (SLTM) LDTP12717 C107(1.29)  LDD0080 
SAGA-associated factor 29 (SGF29) LDTP10276 C243(1.68)  LDD0080 
SAM and SH3 domain-containing protein 1 (SASH1) LDTP01448 C1170(2.08)  LDD0080 
SAM and SH3 domain-containing protein 3 (SASH3) LDTP01373 C351(1.14)  LDD3449 
SAM domain-containing protein SAMSN-1 (SAMSN1) LDTP12590 C28(1.43)  LDD3325 
SAP domain-containing ribonucleoprotein (SARNP) LDTP05179 C20(1.01)  LDD3310 
Sarcolemmal membrane-associated protein (SLMAP) LDTP06254 C644(1.71); C641(1.34); C406(0.99); C415(0.99)  LDD0078 
SAYSvFN domain-containing protein 1 (SAYSD1) LDTP19983 C159(1.02)  LDD1492 
Scaffold attachment factor B1 (SAFB) LDTP06385 C448(1.44)  LDD3310 
Scaffold attachment factor B2 (SAFB2) LDTP06054 C361(1.08); C224(1.04)  LDD0078 
SCAN domain-containing protein 1 (SCAND1) LDTP04785 C35(1.00)  LDD1576 
SCAN domain-containing protein 3 (SCAND3) LDTP15137 C59(1.74)  LDD0078 
Scavenger receptor class A member 3 (SCARA3) LDTP07354 C14(0.87); C32(0.87)  LDD0531 
Scavenger receptor class F member 1 (SCARF1) LDTP06064 C797(1.32)  LDD3376 
Scavenger receptor class F member 2 (SCARF2) LDTP10356 C314(9.50); C327(9.50); C318(9.50); C251(4.81)  LDD0080 
Sciellin (SCEL) LDTP01516 C678(1.18)  LDD3317 
Scinderin (SCIN) LDTP14295 C619(2.23)  LDD3409 
SCL-interrupting locus protein (STIL) LDTP06397 C134(1.03)  LDD1492 
Sclerostin domain-containing protein 1 (SOSTDC1) LDTP07745 C99(1.14)  LDD2343 
Scm-like with four MBT domains protein 1 (SFMBT1) LDTP13288 C528(1.65); C534(1.65); C623(1.74); C627(1.74)  LDD0080 
Scm-like with four MBT domains protein 2 (SFMBT2) LDTP07225 C537(3.48)  LDD3311 
SCRIB overlapping open reading frame protein (SCRIB) LDTP18939 C1082(0.97); C864(4.68)  LDD3310 
Sec1 family domain-containing protein 1 (SCFD1) LDTP09615 C623(0.91)  LDD0078 
Sec1 family domain-containing protein 2 (SCFD2) LDTP18079 C492(1.07)  LDD0078 
SEC14 domain and spectrin repeat-containing protein 1 (SESTD1) LDTP08304 C112(1.27)  LDD0078 
SEC14-like protein 2 (SEC14L2) LDTP01387 C176(0.84)  LDD1492 
Secretagogin (SCGN) LDTP16831 C269(13.39)  LDD3340 
Secretoglobin family 1D member 2 (SCGB1D2) LDTP16852 C65(2.61)  LDD2268 
Segment polarity protein dishevelled homolog DVL-1 (DVL1) LDTP00391 C338(1.04)  LDD0078 
Segment polarity protein dishevelled homolog DVL-2 (DVL2) LDTP00392 C354(1.00)  LDD0078 
Segment polarity protein dishevelled homolog DVL-3 (DVL3) LDTP09960 C336(1.11)  LDD0078 
Selenocysteine insertion sequence-binding protein 2 (SECISBP2) LDTP10830 C291(0.97)  LDD0078 
Selenocysteine insertion sequence-binding protein 2-like (SECISBP2L) LDTP15671 C678(1.21); C683(1.21); C736(0.93); C743(0.93)  LDD0078 
Selenoprotein F (SELENOF) LDTP01012 C70(4.70); C71(4.70)  LDD0080 
Selenoprotein S (SELENOS) LDTP11075 C174(1.16)  LDD0078 
Selenoprotein W (SELENOW) LDTP17000 C37(1.21)  LDD1492 
Semaphorin-4A (SEMA4A) LDTP11884 C379(2.72)  LDD3333 
Semaphorin-4B (SEMA4B) LDTP12382 C816(1.03)  LDD0532 
Semaphorin-4F (SEMA4F) LDTP01668 C273(1.16); C384(0.97)  LDD1513 
Semaphorin-5A (SEMA5A) LDTP05936 C242(2.55)  LDD3321 
Semaphorin-5B (SEMA5B) LDTP13028 C364(2.13); C745(2.24)  LDD3434 
Semaphorin-6A (SEMA6A) LDTP11815 C258(2.44)  LDD3383 
Semaphorin-6B (SEMA6B) LDTP11889 C486(2.87)  LDD3345 
Semaphorin-6D (SEMA6D) LDTP09231 C118(1.57)  LDD2253 
Sequestosome-1 (SQSTM1) LDTP05898 C44(1.24); C142(1.08); C145(1.08); C289(1.07)  LDD0078 
Serine incorporator 1 (SERINC1) LDTP12544 C72(2.39)  LDD3312 
Serine incorporator 2 (SERINC2) LDTP18269 C205(1.62)  LDD3410 
Serine-rich coiled-coil domain-containing protein 2 (CCSER2) LDTP16014 C193(1.89)  LDD3374 
Serine-threonine kinase receptor-associated protein (STRAP) LDTP13991 C305(1.26)  LDD0080 
Serine/arginine repetitive matrix protein 2 (SRRM2) LDTP13746 C956(1.03); C785(0.99); C1029(0.97); C1036(0.97)  LDD0078 
Serine/arginine-rich splicing factor 1 (SRSF1) LDTP05539 C16(0.86); C148(0.91)  LDD3310 
Serine/arginine-rich splicing factor 10 (SRSF10) LDTP01239 C77(1.48)  LDD3397 
Serine/arginine-rich splicing factor 11 (SRSF11) LDTP05458 C455(1.25)  LDD3312 
Serine/arginine-rich splicing factor 12 (SRSF12) LDTP09693 C104(1.23)  LDD1507 
Serine/arginine-rich splicing factor 3 (SRSF3) LDTP05197 C10(1.03); C6(1.03)  LDD0078 
Serine/arginine-rich splicing factor 4 (SRSF4) LDTP05546 C115(1.03)  LDD0078 
Serine/arginine-rich splicing factor 6 (SRSF6) LDTP05802 C121(1.13)  LDD3313 
Serine/arginine-rich splicing factor 7 (SRSF7) LDTP06583 C109(1.13); C106(1.00); C119(0.94)  LDD0078 
Serine/arginine-rich splicing factor 8 (SRSF8) LDTP11117 C141(1.29)  LDD3332 
Serine/arginine-rich splicing factor 9 (SRSF9) LDTP05800 C80(1.03); C138(0.86)  LDD0078 
Serine/threonine-protein kinase 11-interacting protein (STK11IP) LDTP08770 C633(1.05)  LDD0078 
Serine/threonine-protein phosphatase 1 regulatory subunit 10 (PPP1R10) LDTP10730 C463(1.03); C48(1.11)  LDD0531 
Serine/threonine-protein phosphatase 4 regulatory subunit 1 (PPP4R1) LDTP15616 C566(0.94); C281(0.88); C284(0.88)  LDD0078 
Serine/threonine-protein phosphatase 4 regulatory subunit 2 (PPP4R2) LDTP12800 C377(0.98); C134(0.95)  LDD0078 
Serine/threonine-protein phosphatase 4 regulatory subunit 4 (PPP4R4) LDTP07475 C551(0.97)  LDD1512 
Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (ANKRD28) LDTP00534 C520(4.52); C505(2.89)  LDD3311 
Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (ANKRD44) LDTP15452 C565(2.28)  LDD3332 
Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (ANKRD52) LDTP17779 C1049(1.19); C1058(1.19)  LDD0078 
Serine/threonine-protein phosphatase 6 regulatory subunit 1 (PPP6R1) LDTP13701 C172(1.01); C795(1.00); C455(0.92)  LDD0078 
Serine/threonine-protein phosphatase 6 regulatory subunit 2 (PPP6R2) LDTP01151 C511(453.32)  LDD0209 
Serine/threonine-protein phosphatase 6 regulatory subunit 3 (PPP6R3) LDTP06983 C850(1.50); C836(1.34)  LDD3311 
Serologically defined colon cancer antigen 8 (SDCCAG8) LDTP08176 C283(4.80)  LDD0209 
Serotransferrin (TF) LDTP01970 C469(1.01)  LDD3314 
Serpin B4 (SERPINB4) LDTP04197 C279(1.12)  LDD3325 
Serpin B5 (SERPINB5) LDTP03825 C214(1.12); C205(0.93); C287(1.41)  LDD0531 
Serpin B6 (SERPINB6) LDTP03719 C350(1.20)  LDD0078 
Serpin B7 (SERPINB7) LDTP14501 C193(1.26)  LDD3337 
Serpin B8 (SERPINB8) LDTP04361 C98(2.32)  LDD3310 
Serpin B9 (SERPINB9) LDTP04362 C341(1.25); C342(1.25); C335(1.07); C98(0.87)  LDD0078 
Serpin H1 (SERPINH1) LDTP04363 C156(1.55)  LDD0078 
Serrate RNA effector molecule homolog (SRRT) LDTP11398 C421(1.92); C715(2.07); C441(1.61); C490(1.44)  LDD0080 
Serum response factor-binding protein 1 (SRFBP1) LDTP15509 C300(2.52)  LDD3332 
Sesquipedalian-1 (PHETA1) LDTP08860 C14(0.99)  LDD1508 
Sesquipedalian-2 (PHETA2) LDTP07408 C157(4.32)  LDD3352 
Sex comb on midleg-like protein 1 (SCML1) LDTP18554 C276(1.05)  LDD1507 
Sex comb on midleg-like protein 2 (SCML2) LDTP13770 C559(2.11); C51(2.04); C688(1.46)  LDD0080 
Sex comb on midleg-like protein 4 (SCML4) LDTP17684 C324(2.60)  LDD3419 
SH2 domain-containing adapter protein B (SHB) LDTP06394 C215(0.95); C204(0.94)  LDD0078 
SH2 domain-containing protein 1A (SH2D1A) LDTP01070 C124(1.19)  LDD3397 
SH2 domain-containing protein 2A (SH2D2A) LDTP12299 C6(1.36)  LDD3397 
SH2 domain-containing protein 3A (SH2D3A) LDTP11109 C51(2.06)  LDD3354 
SH2 domain-containing protein 3C (SH2D3C) LDTP08898 C317(1.91)  LDD3370 
SH2 domain-containing protein 4A (SH2D4A) LDTP12015 C391(0.75)  LDD0533 
SH2 domain-containing protein 5 (SH2D5) LDTP17501 C253(42.33)  LDD0209 
SH2/SH3 adapter protein NCK1 (NCK1) LDTP02840 C266(1.20)  LDD0078 
SH2B adapter protein 1 (SH2B1) LDTP12504 C30(2.03); C323(1.23)  LDD3310 
SH2B adapter protein 2 (SH2B2) LDTP00346 C186(1.53)  LDD2257 
SH2B adapter protein 3 (SH2B3) LDTP13769 C254(1.88)  LDD3369 
SH3 and cysteine-rich domain-containing protein 2 (STAC2) LDTP07777 C96(0.29)  LDD2236 
SH3 and cysteine-rich domain-containing protein 3 (STAC3) LDTP10582 C92(0.99)  LDD3401 
SH3 and multiple ankyrin repeat domains protein 2 (SHANK2) LDTP13732 C648(2.54)  LDD3314 
SH3 and PX domain-containing protein 2A (SH3PXD2A) LDTP07183 C749(1.16)  LDD3312 
SH3 and PX domain-containing protein 2B (SH3PXD2B) LDTP00039 C664(0.99); C598(0.97)  LDD0078 
SH3 domain and tetratricopeptide repeat-containing protein 1 (SH3TC1) LDTP19823 C345(2.13)  LDD3332 
SH3 domain and tetratricopeptide repeat-containing protein 2 (SH3TC2) LDTP09521 C78(2.50)  LDD3331 
SH3 domain-binding glutamic acid-rich-like protein 2 (SH3BGRL2) LDTP18537 C76(2.54)  LDD3368 
SH3 domain-binding glutamic acid-rich-like protein 3 (SH3BGRL3) LDTP11804 C71(0.73)  LDD3345 
SH3 domain-binding protein 1 (SH3BP1) LDTP13994 C102(0.90); C388(0.87); C56(0.86)  LDD0531 
SH3 domain-binding protein 2 (SH3BP2) LDTP05086 C317(2.48)  LDD3314 
SH3 domain-binding protein 4 (SH3BP4) LDTP12985 C730(1.40); C748(1.40)  LDD0532 
SH3 domain-binding protein 5 (SH3BP5) LDTP00920 C438(3.30)  LDD3332 
SH3 domain-binding protein 5-like (SH3BP5L) LDTP07978 C201(0.84)  LDD0531 
SH3 domain-containing kinase-binding protein 1 (SH3KBP1) LDTP10117 C301(1.26)  LDD0531 
SH3 domain-containing protein 19 (SH3D19) LDTP06989 C455(1.70)  LDD0080 
SH3 domain-containing YSC84-like protein 1 (SH3YL1) LDTP15736 C57(2.27)  LDD2268 
SH3KBP1-binding protein 1 (SHKBP1) LDTP09337 C667(7.37)  LDD0209 
Sharpin (SHARPIN) LDTP11707 C140(1.87)  LDD3369 
SHC SH2 domain-binding protein 1 (SHCBP1) LDTP17808 C43(1.34); C46(1.34)  LDD0078 
SHC-transforming protein 1 (SHC1) LDTP03479 C86(1.57)  LDD3310 
SHC-transforming protein 3 (SHC3) LDTP09778 C477(1.34)  LDD2469 
SHC-transforming protein 4 (SHC4) LDTP07633 C199(1.23)  LDD0547 
Shiftless antiviral inhibitor of ribosomal frameshifting protein (SHFL) LDTP12632 C155(1.03)  LDD3427 
Shootin-1 (SHTN1) LDTP00019 C565(1.76); C550(1.62); C135(7.33); C140(7.33)  LDD0080 
Shugoshin 1 (SGO1) LDTP06968 C199(1.26); C203(1.26)  LDD0078 
Shugoshin 2 (SGO2) LDTP06927 C681(2.02)  LDD0080 
Sialate:O-sulfotransferase 1 (WSCD1) LDTP17304 C519(2.42)  LDD2469 
Sialate:O-sulfotransferase 2 (WSCD2) LDTP17086 C207(3.48)  LDD2359 
Sickle tail protein homolog (KIAA1217) LDTP07123 C1693(0.99)  LDD0078 
Sideroflexin-3 (SFXN3) LDTP11331 C234(2.11)  LDD3310 
Sideroflexin-5 (SFXN5) LDTP09413 C214(1.06)  LDD1492 
Signal peptide, CUB and EGF-like domain-containing protein 2 (SCUBE2) LDTP12391 C177(1.82)  LDD2269 
Signal peptide, CUB and EGF-like domain-containing protein 3 (SCUBE3) LDTP08587 C299(2.82)  LDD3310 
Signal recognition particle receptor subunit alpha (SRPRA) LDTP02263 C253(1.03)  LDD0078 
Signal recognition particle receptor subunit beta (SRPRB) LDTP16323 C179(1.13); C73(1.09); C100(1.08); C246(1.03)  LDD0078 
Signal transducing adapter molecule 1 (STAM) LDTP09870 C85(1.15)  LDD0531 
Signal transducing adapter molecule 2 (STAM2) LDTP01339 C85(4.03)  LDD3312 
Signal-induced proliferation-associated 1-like protein 1 (SIPA1L1) LDTP00695 C1031(1.15); C105(0.98); C745(0.92); C750(0.92)  LDD0078 
Signal-induced proliferation-associated 1-like protein 2 (SIPA1L2) LDTP16178 C1034(1.20); C1038(1.20); C741(1.13); C746(1.13)  LDD0078 
Signal-induced proliferation-associated 1-like protein 3 (SIPA1L3) LDTP00940 C438(1.17); C1549(0.97)  LDD0078 
Signal-induced proliferation-associated protein 1 (SIPA1) LDTP10314 C632(0.55); C634(0.55)  LDD0531 
Signal-transducing adaptor protein 1 (STAP1) LDTP13596 C178(1.55); C269(1.91); C76(0.71)  LDD3339 
Signal-transducing adaptor protein 2 (STAP2) LDTP13231 C172(1.33)  LDD3337 
Signaling threshold-regulating transmembrane adapter 1 (SIT1) LDTP13999 C173(4.02)  LDD0209 
Sin3 histone deacetylase corepressor complex component SDS3 (SUDS3) LDTP12028 C287(1.93)  LDD3352 
SIN3-HDAC complex-associated factor (SINHCAF) LDTP12300 C173(0.86); C174(0.86)  LDD0078 
Sine oculis-binding protein homolog (SOBP) LDTP00126 C826(1.10)  LDD1507 
Single-stranded DNA-binding protein 2 (SSBP2) LDTP14786 C82(1.69)  LDD3316 
Single-stranded DNA-binding protein 3 (SSBP3) LDTP11344 C80(1.72)  LDD3314 
Single-stranded DNA-binding protein 4 (SSBP4) LDTP18318 C81(0.60)  LDD0531 
Sister chromatid cohesion protein DCC1 (DSCC1) LDTP11279 C98(1.06)  LDD0080 
Sister chromatid cohesion protein PDS5 homolog A (PDS5A) LDTP06684 C532(1.23); C430(0.86)  LDD0078 
Sister chromatid cohesion protein PDS5 homolog B (PDS5B) LDTP12605 C943(1.05); C946(1.05)  LDD0078 
Ski oncogene (SKI) LDTP02629 C435(20.81)  LDD0209 
Ski-like protein (SKIL) LDTP02630 C615(3.22); C617(3.22)  LDD0080 
SKI/DACH domain-containing protein 1 (SKIDA1) LDTP17068 C219(2.53)  LDD3373 
SLAIN motif-containing protein 1 (SLAIN1) LDTP09118 C67(2.59)  LDD3434 
SLAIN motif-containing protein 2 (SLAIN2) LDTP13023 C306(1.17); C152(1.13); C165(0.88)  LDD0078 
SLIT and NTRK-like protein 5 (SLITRK5) LDTP01483 C760(1.10); C882(1.17)  LDD1492 
SLIT-ROBO Rho GTPase-activating protein 1 (SRGAP1) LDTP08115 C34(0.89); C603(1.00)  LDD0531 
SLIT-ROBO Rho GTPase-activating protein 2 (SRGAP2) LDTP01105 C34(0.85); C39(0.85)  LDD0078 
SLIT-ROBO Rho GTPase-activating protein 2B (SRGAP2B) LDTP16913 C98(4.80)  LDD3331 
SLIT-ROBO Rho GTPase-activating protein 2C (SRGAP2C) LDTP02425 C357(1.29)  LDD3410 
SLIT-ROBO Rho GTPase-activating protein 3 (SRGAP3) LDTP00732 C370(3.01)  LDD3311 
Smad nuclear-interacting protein 1 (SNIP1) LDTP09295 C299(2.12)  LDD3373 
Small EDRK-rich factor 1 (SERF1A; SERF1B) LDTP01354 C65(0.98)  LDD1512 
Small G protein signaling modulator 2 (SGSM2) LDTP00685 C488(1.00)  LDD1507 
Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) LDTP00862 C129(0.92)  LDD0078 
Small glutamine-rich tetratricopeptide repeat-containing protein beta (SGTB) LDTP10273 C67(1.46); C123(1.09)  LDD0080 
Small integral membrane protein 10 (SMIM10) LDTP19869 C43(1.04)  LDD1508 
Small integral membrane protein 10-like protein 1 (SMIM10L1) LDTP20198 C28(0.98)  LDD1508 
Small integral membrane protein 11 (SMIM11) LDTP16980 C24(1.06)  LDD1492 
Small kinetochore-associated protein (KNSTRN) LDTP14018 C296(1.06)  LDD0531 
Small nuclear ribonucleoprotein E (SNRPE) LDTP04976 C46(1.46)  LDD0080 
Small nuclear ribonucleoprotein F (SNRPF) LDTP04977 C66(1.08)  LDD0078 
Small nuclear ribonucleoprotein G (SNRPG) LDTP04978 C45(1.04)  LDD3349 
Small nuclear ribonucleoprotein Sm D2 (SNRPD2) LDTP04982 C46(0.88)  LDD0078 
Small nuclear ribonucleoprotein Sm D3 (SNRPD3) LDTP04983 C20(1.14); C41(1.29)  LDD0531 
Small nuclear ribonucleoprotein-associated protein N (SNRPN) LDTP05047 C23(2.14)  LDD3311 
Small nuclear ribonucleoprotein-associated proteins B and B' (SNRPB) LDTP02741 C19(6.58); C43(4.66); C45(4.66)  LDD0209 
Small proline-rich protein 2D (SPRR2D) LDTP14655 C63(1.39)  LDD3413 
Small proline-rich protein 2G (SPRR2G) LDTP18339 C23(1.68); C27(1.68)  LDD0080 
Small proline-rich protein 3 (SPRR3) LDTP13101 C153(2.14)  LDD3364 
Small ribosomal subunit protein bS16m (MRPS16) LDTP13981 C26(1.01)  LDD0531 
Small ribosomal subunit protein bS18m (MRPS18C) LDTP18571 C90(1.20)  LDD0078 
Small ribosomal subunit protein bS21m (MRPS21) LDTP14791 C87(1.10)  LDD0080 
Small ribosomal subunit protein bS6m (MRPS6) LDTP05178 C105(0.98)  LDD0078 
Small ribosomal subunit protein eS1 (RPS3A) LDTP04913 C201(1.16); C139(1.02); C96(0.89)  LDD0078 
Small ribosomal subunit protein eS12 (RPS12) LDTP03321 C69(1.06); C50(1.01); C56(1.01); C92(0.94)  LDD0078 
Small ribosomal subunit protein eS17 (RPS17) LDTP02302 C35(15.35)  LDD0209 
Small ribosomal subunit protein eS21 (RPS21) LDTP05055 C56(1.03)  LDD0078 
Small ribosomal subunit protein eS25 (RPS25) LDTP05013 C59(0.18)  LDD2236 
Small ribosomal subunit protein eS26 (RPS26) LDTP05014 C74(1.24); C77(1.24)  LDD0078 
Small ribosomal subunit protein eS27 (RPS27) LDTP03987 C77(1.51)  LDD0078 
Small ribosomal subunit protein eS28 (RPS28) LDTP05015 C27(2.02)  LDD0080 
Small ribosomal subunit protein eS4, X isoform (RPS4X) LDTP04997 C41(1.01)  LDD0078 
Small ribosomal subunit protein eS4, Y isoform 1 (RPS4Y1) LDTP14653 C41(7.91)  LDD0209 
Small ribosomal subunit protein eS4, Y isoform 2 (RPS4Y2) LDTP19820 C41(5.67)  LDD3332 
Small ribosomal subunit protein eS6 (RPS6) LDTP05002 C12(1.09); C100(0.90)  LDD0078 
Small ribosomal subunit protein eS8 (RPS8) LDTP04964 C174(1.23); C182(1.19); C71(1.09); C72(1.09)  LDD0078 
Small ribosomal subunit protein mS22 (MRPS22) LDTP05175 C231(0.54)  LDD0532 
Small ribosomal subunit protein mS25 (MRPS25) LDTP14787 C139(4.39); C149(4.39); C141(4.39)  LDD0080 
Small ribosomal subunit protein mS27 (MRPS27) LDTP09793 C101(1.07)  LDD0080 
Small ribosomal subunit protein mS29 (DAP3) LDTP04412 C139(1.07); C145(1.07)  LDD0078 
Small ribosomal subunit protein mS31 (MRPS31) LDTP09836 C356(1.02)  LDD0078 
Small ribosomal subunit protein mS34 (MRPS34) LDTP05177 C93(0.99)  LDD0531 
Small ribosomal subunit protein mS35 (MRPS35) LDTP14788 C130(0.97)  LDD0531 
Small ribosomal subunit protein mS39 (PTCD3) LDTP10285 C260(0.86); C423(1.07)  LDD0531 
Small ribosomal subunit protein mS40 (MRPS18B) LDTP14215 C105(1.82); C108(1.82)  LDD0080 
Small ribosomal subunit protein uS10 (RPS20) LDTP04880 C70(13.96); C70(75.50); C36(12.34)  LDD0209 
Small ribosomal subunit protein uS10m (MRPS10) LDTP17001 C142(1.01)  LDD1492 
Small ribosomal subunit protein uS11 (RPS14) LDTP04970 C31(2.88)  LDD3491 
Small ribosomal subunit protein uS11m (MRPS11) LDTP05176 C112(0.99)  LDD0078 
Small ribosomal subunit protein uS12 (RPS23) LDTP04971 C90(1.11)  LDD0078 
Small ribosomal subunit protein uS12m (MRPS12) LDTP14443 C64(1.06); C132(0.98)  LDD0078 
Small ribosomal subunit protein uS14 (RPS29) LDTP04973 C39(1.40)  LDD3312 
Small ribosomal subunit protein uS14m (MRPS14) LDTP01050 C83(5.56)  LDD0209 
Small ribosomal subunit protein uS15m (MRPS15) LDTP14790 C182(1.51)  LDD3460 
Small ribosomal subunit protein uS17 (RPS11) LDTP04975 C116(1.16); C131(1.05); C60(1.01)  LDD0078 
Small ribosomal subunit protein uS17m (MRPS17) LDTP16269 C58(1.43)  LDD3310 
Small ribosomal subunit protein uS2 (RPSA) LDTP02312 C148(4.59); C163(25.06)  LDD0209 
Small ribosomal subunit protein uS2B (RPSA2) LDTP14323 C163(2.78)  LDD3311 
Small ribosomal subunit protein uS2m (MRPS2) LDTP13961 C162(1.28)  LDD0531 
Small ribosomal subunit protein uS3m (MRPS24) LDTP18151 C103(1.04); C120(1.18)  LDD0531 
Small ribosomal subunit protein uS4 (RPS9) LDTP04109 C169(1.61)  LDD3432 
Small ribosomal subunit protein uS5 (RPS2) LDTP02809 C229(1.11); C188(1.02)  LDD0078 
Small ribosomal subunit protein uS5m (MRPS5) LDTP14789 C211(1.40)  LDD0080 
Small ribosomal subunit protein uS7 (RPS5) LDTP04110 C66(3.46); C155(1.19)  LDD0080 
Small ribosomal subunit protein uS7m (MRPS7) LDTP16270 C191(1.43)  LDD0080 
Small ribosomal subunit protein uS8 (RPS15A) LDTP04965 C30(1.07)  LDD0078 
Small ribosomal subunit protein uS9 (RPS16) LDTP04966 C25(1.04)  LDD0078 
Small ribosomal subunit protein uS9m (MRPS9) LDTP14792 C233(1.35)  LDD0080 
Small subunit processome component 20 homolog (UTP20) LDTP01294 C618(1.03)  LDD0078 
Small ubiquitin-related modifier 1 (SUMO1) LDTP05048 C52(1.00)  LDD3330 
Small vasohibin-binding protein (SVBP) LDTP08811 C58(1.36)  LDD3423 
SMC5-SMC6 complex localization factor protein 1 (SLF1) LDTP11086 C815(1.94)  LDD3401 
SMC5-SMC6 complex localization factor protein 2 (SLF2) LDTP08586 C511(1.17)  LDD3342 
Smoothelin (SMTN) LDTP04590 C410(7.74)  LDD0209 
Smoothelin-like protein 1 (SMTNL1) LDTP00142 C185(1.54)  LDD3401 
snRNA-activating protein complex subunit 1 (SNAPC1) LDTP06544 C43(1.58)  LDD0080 
snRNA-activating protein complex subunit 3 (SNAPC3) LDTP09947 CAmbiguous(7.59)  LDD0209 
SNW domain-containing protein 1 (SNW1) LDTP05930 C250(8.32)  LDD0080 
Sodium channel and clathrin linker 1 (SCLT1) LDTP10629 C292(2.51)  LDD3410 
Soluble lamin-associated protein of 75 kDa (FAM169A) LDTP18592 C225(1.29)  LDD0531 
Solute carrier family 66 member 3 (SLC66A3) LDTP19719 C135(1.41)  LDD0531 
Something about silencing protein 10 (UTP3) LDTP12453 C359(1.05)  LDD0580 
Son of sevenless homolog 1 (SOS1) LDTP05535 C440(0.93); C441(0.93)  LDD0533 
Son of sevenless homolog 2 (SOS2) LDTP05536 C348(1.00)  LDD1507 
Sorbin and SH3 domain-containing protein 2 (SORBS2) LDTP01445 C978(0.96)  LDD3314 
Sorcin (SRI) LDTP03554 C57(0.92); C75(0.92)  LDD0078 
Sororin (CDCA5) LDTP10304 C165(0.62); C185(0.62)  LDD0531 
Sorting nexin-9 (SNX9) LDTP14172 C427(0.84); C502(0.97)  LDD0531 
SOSS complex subunit B1 (NABP2) LDTP11047 C81(0.92); C99(0.91)  LDD0078 
SOSS complex subunit B2 (NABP1) LDTP10082 C23(2.02)  LDD3313 
SPARC-related modular calcium-binding protein 1 (SMOC1) LDTP11922 C227(2.47)  LDD3354 
Spartin (SPART) LDTP08735 C499(7.27); C504(7.27)  LDD0080 
Spatacsin (SPG11) LDTP10468 C1424(3.37)  LDD0080 
SPATS2-like protein (SPATS2L) LDTP16102 C533(7.49); C536(7.49); C111(1.27)  LDD0080 
Specifically androgen-regulated gene protein (SARG) LDTP11307 C212(1.18)  LDD3316 
Spectrin alpha chain, erythrocytic 1 (SPTA1) LDTP01933 C773(1.36); C965(1.79); C1879(2.37)  LDD3334 
Spectrin alpha chain, non-erythrocytic 1 (SPTAN1) LDTP05985 C1935(0.87); C956(1.43); C1444(1.14)  LDD3310 
Spectrin beta chain, erythrocytic (SPTB) LDTP02561 C735(4.31); C603(2.88); C618(2.85)  LDD3314 
Spectrin beta chain, non-erythrocytic 2 (SPTBN2) LDTP00510 C186(1.95); C115(3.79); C2030(1.84); C231(3.14)  LDD0080 
Spectrin beta chain, non-erythrocytic 4 (SPTBN4) LDTP11796 C190(0.96)  LDD0531 
Spectrin beta chain, non-erythrocytic 5 (SPTBN5) LDTP12496 C2657(1.96)  LDD2324 
Speedy protein C (SPDYC) LDTP14989 C130(1.10)  LDD1508 
Sperm mitochondrial-associated cysteine-rich protein (SMCP) LDTP04326 C99(2.30)  LDD3492 
Sperm protein associated with the nucleus on the X chromosome A (SPANXA1; SPANXA2) LDTP16082 C16(1.43)  LDD3462 
Sperm protein associated with the nucleus on the X chromosome B1 (SPANXB1) LDTP16081 C16(3.09)  LDD3414 
Sperm protein associated with the nucleus on the X chromosome D (SPANXD) LDTP18327 C16(1.67)  LDD3465 
Sperm-associated antigen 1 (SPAG1) LDTP05522 C657(6.97)  LDD0209 
Sperm-associated antigen 5 (SPAG5) LDTP10753 C1003(1.15); C544(1.06); C545(1.06); C1035(0.96)  LDD0078 
Sperm-associated antigen 7 (SPAG7) LDTP19024 C191(0.92)  LDD0078 
Sperm-associated microtubule inner protein 4 (SPMIP4) LDTP08973 C365(1.23)  LDD3381 
Spermatid perinuclear RNA-binding protein (STRBP) LDTP10815 C142(0.85)  LDD0078 
Spermatogenesis-associated protein 13 (SPATA13) LDTP10618 C599(3.98); C986(2.61)  LDD3332 
Spermatogenesis-associated protein 2 (SPATA2) LDTP13612 C41(0.69)  LDD0531 
Spermatogenesis-associated protein 2-like protein (SPATA2L) LDTP08467 C26(1.01)  LDD0531 
Spermatogenesis-associated protein 20 (SPATA20) LDTP18050 C637(0.96)  LDD3332 
Spermatogenesis-associated protein 24 (SPATA24) LDTP08318 C127(1.04)  LDD1507 
Spermatogenesis-associated protein 33 (SPATA33) LDTP15789 C102(2.09)  LDD3373 
Spermatogenesis-associated protein 7 (SPATA7) LDTP12990 C308(0.89)  LDD1511 
Spermatogenesis-associated serine-rich protein 2 (SPATS2) LDTP17603 C384(1.06); C406(1.06); C61(1.00)  LDD0078 
Spermatogenesis-defective protein 39 homolog (VIPAS39) LDTP12091 C170(4.99)  LDD3310 
Spindle and centriole-associated protein 1 (SPICE1) LDTP08737 C796(2.91)  LDD3339 
Spindle and kinetochore-associated protein 1 (SKA1) LDTP10122 C29(2.58); C142(2.10)  LDD0080 
Spindle and kinetochore-associated protein 2 (SKA2) LDTP09612 C79(3.32)  LDD3310 
Spindle and kinetochore-associated protein 3 (SKA3) LDTP08588 C20(1.83)  LDD0080 
Spindle assembly abnormal protein 6 homolog (SASS6) LDTP07658 C156(35.28)  LDD0209 
Spindlin interactor and repressor of chromatin-binding protein (SPINDOC) LDTP11226 C12(1.40)  LDD0532 
Spindlin-1 (SPIN1) LDTP14208 C96(1.06)  LDD0531 
Spindlin-2A (SPIN2A) LDTP15848 C56(1.16)  LDD3395 
Splicing factor 1 (SF1) LDTP06429 C279(0.85); C292(0.92); C282(0.99)  LDD1507 
Splicing factor 3A subunit 1 (SF3A1) LDTP06393 C244(1.01)  LDD0078 
Splicing factor 3A subunit 2 (SF3A2) LDTP06387 C59(1.58)  LDD3314 
Splicing factor 3A subunit 3 (SF3A3) LDTP05677 C145(0.89)  LDD0078 
Splicing factor 3B subunit 1 (SF3B1) LDTP01251 C1250(1.18); C1244(0.92)  LDD0078 
Splicing factor 3B subunit 2 (SF3B2) LDTP05870 C661(0.98)  LDD1492 
Splicing factor 3B subunit 3 (SF3B3) LDTP06376 C1054(1.21)  LDD0080 
Splicing factor 3B subunit 4 (SF3B4) LDTP06386 C168(1.26)  LDD1492 
Splicing factor 3B subunit 5 (SF3B5) LDTP11328 C76(1.82)  LDD0531 
Splicing factor 3B subunit 6 (SF3B6) LDTP13970 C74(0.85); C83(0.85)  LDD0532 
Splicing factor 45 (RBM17) LDTP10409 C385(1.33)  LDD0080 
Splicing factor C9orf78 (C9orf78) LDTP12877 C145(0.94)  LDD0078 
Splicing factor Cactin (CACTIN) LDTP09583 C699(1.91)  LDD3312 
Splicing factor ESS-2 homolog (ESS2) LDTP10214 C263(1.51)  LDD0532 
Splicing factor U2AF 26 kDa subunit (U2AF1L4) LDTP09562 C90(1.21)  LDD3310 
Splicing factor U2AF 35 kDa subunit (U2AF1) LDTP05272 C163(0.88)  LDD0078 
Splicing factor U2AF 65 kDa subunit (U2AF2) LDTP03352 C464(0.98)  LDD0078 
Splicing factor YJU2 (YJU2) LDTP11317 C275(0.85)  LDD0078 
Splicing factor, suppressor of white-apricot homolog (SFSWAP) LDTP14822 C220(1.38)  LDD3312 
Splicing regulator ARVCF (ARVCF) LDTP00209 C292(3.66)  LDD3340 
Splicing regulator RBM11 (RBM11) LDTP04772 C56(2.24)  LDD3342 
Splicing regulator SDE2 (SDE2) LDTP07426 C150(0.98); C160(0.98)  LDD0078 
Splicing regulatory glutamine/lysine-rich protein 1 (SREK1) LDTP09684 C610(1.56)  LDD3312 
SPOC domain-containing protein 1 (SPOCD1) LDTP15179 C933(1.91)  LDD3311 
Spondin-1 (SPON1) LDTP12226 C340(3.77); C770(3.43); C595(2.12); C44(3.55)  LDD3365 
Spondin-2 (SPON2) LDTP11230 C171(1.22)  LDD3314 
Sprouty-related, EVH1 domain-containing protein 1 (SPRED1) LDTP08112 C55(1.26)  LDD0531 
Sprouty-related, EVH1 domain-containing protein 2 (SPRED2) LDTP08111 C326(1.33)  LDD3427 
SPRY domain-containing protein 3 (SPRYD3) LDTP19781 C429(1.24)  LDD0080 
SPRY domain-containing protein 4 (SPRYD4) LDTP19833 C114(1.61)  LDD3313 
SPRY domain-containing protein 7 (SPRYD7) LDTP07269 C49(0.85); C54(0.85)  LDD0078 
Squamous cell carcinoma antigen recognized by T-cells 3 (SART3) LDTP06280 C472(0.93); C670(0.92)  LDD0078 
SR-related and CTD-associated factor 4 (SCAF4) LDTP01499 C545(0.97)  LDD0078 
SR-related and CTD-associated factor 8 (SCAF8) LDTP13700 C475(0.80); C514(1.03); C518(1.04)  LDD0531 
SRA stem-loop-interacting RNA-binding protein, mitochondrial (SLIRP) LDTP11645 C48(0.96)  LDD0531 
SRC kinase signaling inhibitor 1 (SRCIN1) LDTP11616 C950(3.07)  LDD3340 
Src kinase-associated phosphoprotein 1 (SKAP1) LDTP08342 C177(3.81)  LDD3397 
Src substrate cortactin (CTTN) LDTP06094 C246(1.61); C112(1.78)  LDD3311 
Src-like-adapter (SLA) LDTP05798 C93(2.47)  LDD2412 
SRR1-like protein (SRRD) LDTP18531 C137(0.96)  LDD1507 
SS18-like protein 2 (SS18L2) LDTP20020 C34(3.36)  LDD3352 
Stabilizer of axonemal microtubules 5 (SAXO5) LDTP17775 C237(2.31)  LDD3395 
STAGA complex 65 subunit gamma (SUPT7L) LDTP01442 C105(3.77); C120(3.77)  LDD0080 
Stalled ribosome sensor GCN1 (GCN1) LDTP09821 C939(0.99); C55(0.98); C1275(0.93); C907(0.85)  LDD0078 
Stanniocalcin-1 (STC1) LDTP04538 C98(3.46); C45(2.19); C66(2.64)  LDD2268 
Stanniocalcin-2 (STC2) LDTP01388 C146(0.85)  LDD0531 
StAR-related lipid transfer protein 13 (STARD13) LDTP13997 C303(1.02); C319(1.02); C13(0.96); C215(0.94)  LDD0078 
StAR-related lipid transfer protein 4 (STARD4) LDTP10223 C75(3.08)  LDD3332 
StAR-related lipid transfer protein 5 (STARD5) LDTP18466 C156(0.43); C158(0.43); C160(0.43)  LDD0533 
StAR-related lipid transfer protein 8 (STARD8) LDTP09767 C980(2.23)  LDD3381 
START domain-containing protein 10 (STARD10) LDTP13951 C181(2.29)  LDD3368 
Stathmin domain-containing protein 1 (STMND1) LDTP16770 C245(0.96)  LDD1513 
Stathmin-4 (STMN4) LDTP11751 C85(1.34)  LDD3434 
Sterile alpha motif domain-containing protein 1 (SAMD1) LDTP07638 C383(0.95)  LDD0078 
Sterile alpha motif domain-containing protein 5 (SAMD5) LDTP19416 C99(0.94)  LDD3341 
Sterile alpha motif domain-containing protein 9 (SAMD9) LDTP07029 C975(1.19); C979(1.19); C161(1.15); C1538(1.10)  LDD0078 
Sterile alpha motif domain-containing protein 9-like (SAMD9L) LDTP08495 C228(3.23); C316(1.99)  LDD3311 
Steroid receptor RNA activator 1 (SRA1) LDTP12278 C134(0.90)  LDD1508 
Steroid receptor-associated and regulated protein (SRARP) LDTP09167 C102(3.58)  LDD2268 
Sterol regulatory element-binding protein cleavage-activating protein (SCAP) LDTP05643 C914(1.08)  LDD0812 
STING ER exit protein (STEEP1) LDTP11964 C11(0.91)  LDD0078 
Stomatin-like protein 1 (STOML1) LDTP13119 C32(0.91)  LDD1492 
Stonin-1 (STON1) LDTP14285 C707(1.43)  LDD3333 
Stonin-2 (STON2) LDTP09692 C479(1.81)  LDD3334 
Storkhead-box protein 1 (STOX1) LDTP07852 C843(1.17)  LDD1513 
Storkhead-box protein 2 (STOX2) LDTP18516 C170(0.81); C185(0.81)  LDD0531 
Stress-70 protein, mitochondrial (HSPA9) LDTP03860 C317(1.03)  LDD0078 
Stress-induced-phosphoprotein 1 (STIP1) LDTP03619 C417(1.75); C420(1.75); C471(1.72); C26(1.13)  LDD0080 
Striatin (STRN) LDTP00875 C765(1.01)  LDD0078 
Striatin-3 (STRN3) LDTP05731 C621(1.61); C623(1.61)  LDD0531 
Striatin-4 (STRN4) LDTP12519 C337(0.95); C713(1.11)  LDD0531 
Striatin-interacting protein 1 (STRIP1) LDTP07207 C798(2.42)  LDD0080 
Striatin-interacting protein 2 (STRIP2) LDTP13568 C222(1.21)  LDD0078 
Stromal cell-derived factor 2 (SDF2) LDTP18279 C88(4.32); C80(2.15)  LDD3311 
Stromal cell-derived factor 2-like protein 1 (SDF2L1) LDTP16047 C92(1.01)  LDD0532 
Stromal membrane-associated protein 1 (SMAP1) LDTP08639 C33(4.01); C36(4.01)  LDD0080 
Stromal membrane-associated protein 2 (SMAP2) LDTP09563 C28(0.87); C31(0.87)  LDD0078 
Structural maintenance of chromosomes protein 1A (SMC1A) LDTP06181 C1210(1.00); C1180(0.96)  LDD0078 
Structural maintenance of chromosomes protein 1B (SMC1B) LDTP09136 C133(1.73)  LDD2337 
Structural maintenance of chromosomes protein 2 (SMC2) LDTP01567 C326(1.05); C1174(0.94)  LDD0078 
Structural maintenance of chromosomes protein 3 (SMC3) LDTP13760 C650(0.95)  LDD0531 
Structural maintenance of chromosomes protein 4 (SMC4) LDTP12606 C110(0.94)  LDD0078 
Structural maintenance of chromosomes protein 5 (SMC5) LDTP08618 C881(1.00)  LDD0078 
Structural maintenance of chromosomes protein 6 (SMC6) LDTP10810 C411(1.04)  LDD3312 
Structure-specific endonuclease subunit SLX4 (SLX4) LDTP08632 C808(2.20); C296(1.35); C299(1.35)  LDD0080 
Succinate dehydrogenase assembly factor 2, mitochondrial (SDHAF2) LDTP12753 C83(1.04)  LDD1507 
Succinate dehydrogenase assembly factor 3, mitochondrial (SDHAF3) LDTP19990 C80(1.21)  LDD0531 
SUMO-interacting motif-containing protein 1 (SIMC1) LDTP09142 C665(0.88)  LDD0531 
SUN domain-containing ossification factor (SUCO) LDTP13155 C592(1.65)  LDD3314 
Superkiller complex protein 3 (SKIC3) LDTP07574 C715(8.89)  LDD0080 
Superkiller complex protein 8 (SKIC8) LDTP11643 C266(1.84)  LDD3323 
Supervillin (SVIL) LDTP01597 C178(1.01); C1854(0.94); C1858(0.94); C1101(0.85)  LDD0078 
Suppressor APC domain-containing protein 2 (SAPCD2) LDTP08220 C162(2.55); C170(2.55)  LDD0080 
Suppressor of cytokine signaling 2 (SOCS2) LDTP00352 C174(0.84)  LDD0533 
Suppressor of cytokine signaling 6 (SOCS6) LDTP00368 C342(0.87); C471(0.86)  LDD0531 
Suppressor of cytokine signaling 7 (SOCS7) LDTP00354 C342(4.78)  LDD3383 
Suppressor of fused homolog (SUFU) LDTP13627 C292(1.60)  LDD0531 
Suppressor of IKBKE 1 (SIKE1) LDTP11137 C150(4.22)  LDD3367 
Suppressor of SWI4 1 homolog (PPAN) LDTP12396 C73(1.58)  LDD3310 
Suppressor of tumorigenicity 7 protein (ST7) LDTP12495 C133(1.36); C489(0.97)  LDD0078 
Suppressyn (ERVH48-1) LDTP14414 C95(1.57)  LDD3376 
Surfactant-associated protein 2 (SFTA2) LDTP17411 C76(4.00)  LDD3472 
Surfeit locus protein 1 (SURF1) LDTP06404 C125(0.98)  LDD0080 
Surfeit locus protein 2 (SURF2) LDTP17048 C29(0.95); C38(0.95)  LDD0078 
Surfeit locus protein 6 (SURF6) LDTP14502 C19(1.03)  LDD0078 
SURP and G-patch domain-containing protein 1 (SUGP1) LDTP08577 C78(1.17); C353(0.98)  LDD1492 
SURP and G-patch domain-containing protein 2 (SUGP2) LDTP08578 C656(16.17); C540(3.64); C417(4.85); C947(1.36)  LDD0080 
Survival motor neuron protein (SMN1; SMN2) LDTP06587 C60(1.60); C107(1.07)  LDD0080 
Survival of motor neuron-related-splicing factor 30 (SMNDC1) LDTP01362 C214(0.99)  LDD0531 
Sushi domain-containing protein 2 (SUSD2) LDTP13246 C683(1.44); C689(1.44)  LDD0531 
Sushi domain-containing protein 5 (SUSD5) LDTP14470 C81(1.02)  LDD1507 
Sushi repeat-containing protein SRPX (SRPX) LDTP05139 C367(1.06)  LDD3316 
Sushi repeat-containing protein SRPX2 (SRPX2) LDTP01032 C319(1.91); C105(1.87)  LDD3310 
Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (SVEP1) LDTP06859 C2770(0.92); C2775(0.92)  LDD1507 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1) LDTP05660 C167(4.04)  LDD0209 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (SMARCD1) LDTP10353 C492(1.32); C460(0.88)  LDD0078 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (SMARCD2) LDTP09933 C355(3.37)  LDD0080 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 (SMARCD3) LDTP07639 C317(1.14)  LDD0531 
Switch-associated protein 70 (SWAP70) LDTP13252 C40(0.82); C94(0.87); C98(0.83)  LDD0531 
Symplekin (SYMPK) LDTP09878 C578(1.14); C969(0.91); C645(0.88)  LDD0078 
Synapse-associated protein 1 (SYAP1) LDTP10062 C283(1.28)  LDD0080 
Synaptic plasticity regulator PANTS (C22orf39) LDTP07545 C105(0.95)  LDD1492 
Synaptic vesicle glycoprotein 2A (SV2A) LDTP07934 C438(1.31)  LDD1492 
Synaptogyrin-2 (SYNGR2) LDTP00859 C59(0.84)  LDD0531 
Synaptogyrin-3 (SYNGR3) LDTP00860 C59(1.01)  LDD1512 
Synaptophysin-like protein 1 (SYPL1) LDTP06557 C193(0.96)  LDD0531 
Synaptophysin-like protein 2 (SYPL2) LDTP15044 C96(1.00)  LDD1507 
Synaptopodin (SYNPO) LDTP08843 C396(2.89)  LDD3312 
Synaptopodin-2 (SYNPO2) LDTP13624 C8(2.12); C152(2.08); C290(2.10)  LDD3340 
Synaptosomal-associated protein 47 (SNAP47) LDTP07061 C51(0.96); C57(0.96)  LDD0078 
Synaptotagmin-10 (SYT10) LDTP07753 C409(1.81)  LDD2285 
Synaptotagmin-11 (SYT11) LDTP11189 C415(1.25)  LDD3316 
Synaptotagmin-17 (SYT17) LDTP11173 C298(1.54)  LDD3337 
Synaptotagmin-2 (SYT2) LDTP09001 C290(1.99)  LDD3433 
Synaptotagmin-4 (SYT4) LDTP11808 C423(1.41)  LDD3344 
Synaptotagmin-5 (SYT5) LDTP00277 C278(1.44)  LDD3339 
Synaptotagmin-6 (SYT6) LDTP07146 C407(1.40)  LDD3423 
Synaptotagmin-7 (SYT7) LDTP00807 C543(1.84)  LDD3493 
Synaptotagmin-like protein 1 (SYTL1) LDTP08656 C448(1.92); C290(3.11)  LDD3314 
Synaptotagmin-like protein 3 (SYTL3) LDTP14938 C528(0.84); C585(0.97)  LDD0531 
Syncoilin (SYNC) LDTP12021 C182(1.21)  LDD3455 
Syndetin (VPS50) LDTP10463 C518(0.97); C472(0.86); C313(0.84); C324(0.84)  LDD0078 
Synembryn-A (RIC8A) LDTP12381 C341(3.59)  LDD3312 
Synembryn-B (RIC8B) LDTP12686 C7(2.44)  LDD3473 
Synemin (SYNM) LDTP00524 C27(1.06)  LDD0078 
Synergin gamma (SYNRG) LDTP13635 C1134(0.94); C1194(1.06); C1250(1.01)  LDD0531 
Syntabulin (SYBU) LDTP12770 C36(1.99)  LDD3416 
Syntaphilin (SNPH) LDTP00532 C268(2.68)  LDD3419 
Syntaxin-10 (STX10) LDTP00986 C29(1.51)  LDD0533 
Syntaxin-11 (STX11) LDTP01256 C102(1.05)  LDD1513 
Syntaxin-12 (STX12) LDTP08389 C29(1.02)  LDD1492 
Syntaxin-16 (STX16) LDTP00401 C279(1.45); C150(1.31)  LDD0080 
Syntaxin-18 (STX18) LDTP13086 C107(2.64)  LDD3319 
Syntaxin-2 (STX2) LDTP03652 C11(0.83)  LDD0531 
Syntaxin-7 (STX7) LDTP00632 C28(0.73)  LDD3312 
Syntaxin-8 (STX8) LDTP13664 C14(0.98)  LDD3332 
Syntaxin-binding protein 2 (STXBP2) LDTP06487 C45(51.43)  LDD0209 
Syntaxin-binding protein 3 (STXBP3) LDTP00206 C498(0.89); C501(0.89)  LDD0078 
Syntaxin-binding protein 4 (STXBP4) LDTP07864 C411(1.13); C544(0.97)  LDD0078 
Syntaxin-binding protein 5 (STXBP5) LDTP07122 C933(2.68)  LDD3325 
Syntaxin-binding protein 5-like (STXBP5L) LDTP13886 C530(0.95); C609(0.92)  LDD1507 
Syntaxin-binding protein 6 (STXBP6) LDTP09230 C144(2.88)  LDD3343 
Syntenin-2 (SDCBP2) LDTP11755 C27(1.62)  LDD3439 
T-cell activation inhibitor, mitochondrial (TCAIM) LDTP17695 C392(0.89)  LDD1511 
T-cell immunomodulatory protein (ITFG1) LDTP15583 C449(1.01); C453(1.01)  LDD0078 
T-cell surface glycoprotein CD3 gamma chain (CD3G) LDTP02370 C87(3.83)  LDD3397 
T-complex protein 1 subunit alpha (TCP1) LDTP02934 C397(1.12); C147(1.03); C357(1.00); C385(0.97)  LDD0078 
T-complex protein 1 subunit beta (CCT2) LDTP05113 C535(1.05); C289(1.02)  LDD0078 
T-complex protein 1 subunit epsilon (CCT5) LDTP04201 C440(1.21); C253(1.04); C407(1.04)  LDD0078 
T-complex protein 1 subunit eta (CCT7) LDTP10990 C158(0.98); C370(0.90); C29(0.89)  LDD0078 
T-complex protein 1 subunit gamma (CCT3) LDTP04249 C173(1.02); C455(1.00); C213(0.92); C475(0.90)  LDD0078 
T-complex protein 1 subunit theta (CCT8) LDTP04390 C244(1.02); C149(0.91)  LDD0078 
T-complex protein 1 subunit zeta (CCT6A) LDTP03888 C282(1.63); C328(1.24); C343(1.24); C406(1.02)  LDD0531 
T-complex protein 1 subunit zeta-2 (CCT6B) LDTP09777 C508(4.56)  LDD3313 
T-complex protein 11-like protein 1 (TCP11L1) LDTP12629 C495(1.86)  LDD0080 
T-complex protein 11-like protein 2 (TCP11L2) LDTP17709 C451(7.79)  LDD0209 
t-SNARE domain-containing protein 1 (TSNARE1) LDTP18221 C177(0.94)  LDD0533 
TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L (TAF5L) LDTP01248 C15(3.57); C188(2.50)  LDD0080 
TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) LDTP14263 C81(1.29)  LDD0078 
Talin rod domain-containing protein 1 (TLNRD1) LDTP18375 C164(1.09)  LDD1510 
Tandem C2 domains nuclear protein (TC2N) LDTP17766 C324(3.81)  LDD3354 
TANK-binding kinase 1-binding protein 1 (TBKBP1) LDTP00124 C360(3.58); C363(3.58)  LDD0080 
Taperin (TPRN) LDTP06854 C536(1.42)  LDD3320 
TAR DNA-binding protein 43 (TARDBP) LDTP05767 C50(1.10)  LDD0078 
Target of EGR1 protein 1 (TOE1) LDTP10354 C80(1.00)  LDD0078 
Target of rapamycin complex 2 subunit MAPKAP1 (MAPKAP1) LDTP11045 C149(4.39)  LDD0209 
Target of rapamycin complex subunit LST8 (MLST8) LDTP11280 C298(0.97); C34(0.95); C107(0.90); C238(0.85)  LDD0078 
Targeting protein for Xklp2 (TPX2) LDTP13583 C594(45.81)  LDD0209 
Tastin (TROAP) LDTP05658 C718(0.92); C724(0.92)  LDD0532 
TATA box-binding protein-associated factor RNA polymerase I subunit B (TAF1B) LDTP06922 C189(1.98); C13(1.53); C16(1.53)  LDD0080 
TATA element modulatory factor (TMF1) LDTP05172 C158(1.05)  LDD3310 
TATA-binding protein-associated factor 2N (TAF15) LDTP09881 C360(1.01); C365(1.01)  LDD0078 
Tax1-binding protein 1 (TAX1BP1) LDTP08294 C350(2.39)  LDD0080 
TBC1 domain family member 10A (TBC1D10A) LDTP11379 C381(5.38)  LDD0209 
TBC1 domain family member 10B (TBC1D10B) LDTP06853 C573(0.97)  LDD0078 
TBC1 domain family member 12 (TBC1D12) LDTP16806 C682(1.10)  LDD0531 
TBC1 domain family member 13 (TBC1D13) LDTP16107 C282(1.13)  LDD0078 
TBC1 domain family member 14 (TBC1D14) LDTP13066 C601(0.89)  LDD0532 
TBC1 domain family member 15 (TBC1D15) LDTP09363 C197(1.21); C686(0.91)  LDD0078 
TBC1 domain family member 16 (TBC1D16) LDTP15589 C290(11.99); C296(11.99)  LDD0080 
TBC1 domain family member 17 (TBC1D17) LDTP12117 C112(0.90)  LDD1492 
TBC1 domain family member 22A (TBC1D22A) LDTP09566 C151(1.84)  LDD3378 
TBC1 domain family member 22B (TBC1D22B) LDTP12618 C144(102.19)  LDD0209 
TBC1 domain family member 23 (TBC1D23) LDTP12651 C399(0.90)  LDD0532 
TBC1 domain family member 24 (TBC1D24) LDTP13567 C29(0.91)  LDD0078 
TBC1 domain family member 25 (TBC1D25) LDTP06781 C43(1.47)  LDD3410 
TBC1 domain family member 2A (TBC1D2) LDTP11506 C469(1.07)  LDD0078 
TBC1 domain family member 2B (TBC1D2B) LDTP13721 C554(2.30)  LDD0080 
TBC1 domain family member 30 (TBC1D30) LDTP13875 C306(1.07); C310(1.16)  LDD0531 
TBC1 domain family member 31 (TBC1D31) LDTP10221 C197(4.75); C202(4.75)  LDD0080 
TBC1 domain family member 7 (TBC1D7) LDTP12974 C43(72.51)  LDD0209 
TBC1 domain family member 8 (TBC1D8) LDTP14546 C1040(15.44)  LDD0209 
TBC1 domain family member 8B (TBC1D8B) LDTP05604 C1048(0.95); C150(0.89); C468(0.78)  LDD0531 
TBC1 domain family member 9 (TBC1D9) LDTP17491 C166(1.10)  LDD0593 
TBC1 domain family member 9B (TBC1D9B) LDTP15057 C876(0.86)  LDD0078 
TBCC domain-containing protein 1 (TBCCD1) LDTP16112 C298(78.90)  LDD0209 
Tectonic-2 (TCTN2) LDTP10366 C202(1.65); C219(1.65)  LDD1093 
Tectonic-3 (TCTN3) LDTP07478 C121(1.89)  LDD0080 
Tectonin beta-propeller repeat-containing protein 1 (TECPR1) LDTP08129 C821(1.31)  LDD3316 
Tectonin beta-propeller repeat-containing protein 2 (TECPR2) LDTP00515 C226(1.27)  LDD0078 
Tektin-5 (TEKT5) LDTP10570 C462(2.48)  LDD3345 
TELO2-interacting protein 1 homolog (TTI1) LDTP00691 C185(3.68); C187(3.68)  LDD0080 
TELO2-interacting protein 2 (TTI2) LDTP15103 C484(179.60); C484(174.17); C36(141.68)  LDD0209 
Telomerase Cajal body protein 1 (WRAP53) LDTP11249 C284(0.99); C294(0.99)  LDD0078 
Telomere length regulation protein TEL2 homolog (TELO2) LDTP14072 C141(2.38)  LDD0080 
Telomere-associated protein RIF1 (RIF1) LDTP07205 C880(1.25); C2450(1.10); C1718(1.02); C2169(1.00)  LDD0078 
Telomeric repeat-binding factor 1 (TERF1) LDTP04608 C126(1.27)  LDD0531 
Telomeric repeat-binding factor 2 (TERF2) LDTP06412 C148(27.15)  LDD0204 
Tenascin (TNC) LDTP03292 C64(1.62)  LDD3313 
Tenascin-N (TNN) LDTP13767 C1237(1.31)  LDD3430 
Teneurin-3 (TENM3) LDTP13025 C2521(2.09)  LDD3332 
Teneurin-4 (TENM4) LDTP07453 C1217(2.65); C1220(2.65)  LDD0080 
TERF1-interacting nuclear factor 2 (TINF2) LDTP11158 C332(3.32)  LDD3311 
Testican-1 (SPOCK1) LDTP05569 C166(1.60)  LDD3314 
Testican-2 (SPOCK2) LDTP09798 C101(2.62)  LDD3365 
Testican-3 (SPOCK3) LDTP11048 C139(1.05)  LDD1507 
Testin (TES) LDTP13227 C412(1.03); C416(1.03); C196(1.02); C361(0.94)  LDD0078 
Testis-expressed protein 10 (TEX10) LDTP16128 C454(1.84)  LDD0080 
Testis-expressed protein 11 (TEX11) LDTP08647 C609(24.64); C736(2.56)  LDD3386 
Testis-expressed protein 13D (TEX13D) LDTP18630 C619(1.04)  LDD3364 
Testis-expressed protein 15 (TEX15) LDTP11411 C709(3.37)  LDD3380 
Testis-expressed protein 2 (TEX2) LDTP15342 C790(3.18)  LDD3311 
Testis-expressed protein 264 (TEX264) LDTP14259 C68(1.33)  LDD0080 
Testis-expressed protein 30 (TEX30) LDTP19358 C166(4.59)  LDD0209 
Testis-specific Y-encoded protein 10 (TSPY10) LDTP16907 C283(4.83)  LDD3364 
Testis-specific Y-encoded-like protein 1 (TSPYL1) LDTP15956 C135(1.90)  LDD0080 
Testis-specific Y-encoded-like protein 5 (TSPYL5) LDTP08308 C79(22.48); C85(8.99); C315(6.34)  LDD0209 
Tether containing UBX domain for GLUT4 (ASPSCR1) LDTP11530 C32(1.22)  LDD3323 
Tetranectin (CLEC3B) LDTP02115 C173(1.39); C98(1.28)  LDD0531 
Tetraspanin-11 (TSPAN11) LDTP18722 C208(1.44)  LDD3380 
Tetraspanin-13 (TSPAN13) LDTP16851 C128(1.01); C129(1.01)  LDD0580 
Tetraspanin-31 (TSPAN31) LDTP14827 C157(4.20); C160(4.20)  LDD0080 
Tetraspanin-4 (TSPAN4) LDTP00448 C190(1.23)  LDD0531 
Tetraspanin-6 (TSPAN6) LDTP14458 C197(2.16)  LDD3314 
Tetraspanin-8 (TSPAN8) LDTP02978 C194(1.65)  LDD3364 
Tetratricopeptide repeat protein 1 (TTC1) LDTP15840 C62(0.99); C66(0.99); C149(0.92)  LDD0078 
Tetratricopeptide repeat protein 12 (TTC12) LDTP12053 C163(3.67)  LDD3378 
Tetratricopeptide repeat protein 13 (TTC13) LDTP19774 C110(2.85)  LDD3380 
Tetratricopeptide repeat protein 14 (TTC14) LDTP18220 C634(1.12)  LDD0078 
Tetratricopeptide repeat protein 17 (TTC17) LDTP10079 C823(1.03)  LDD0078 
Tetratricopeptide repeat protein 19, mitochondrial (TTC19) LDTP07368 C239(1.07); C243(1.07)  LDD0531 
Tetratricopeptide repeat protein 21B (TTC21B) LDTP08073 C833(9.49)  LDD0204 
Tetratricopeptide repeat protein 22 (TTC22) LDTP19409 C368(0.73)  LDD0532 
Tetratricopeptide repeat protein 23 (TTC23) LDTP07270 C321(0.94)  LDD1508 
Tetratricopeptide repeat protein 27 (TTC27) LDTP19505 C749(0.86)  LDD0078 
Tetratricopeptide repeat protein 28 (TTC28) LDTP10102 C678(20.00); C726(1.36)  LDD0080 
Tetratricopeptide repeat protein 31 (TTC31) LDTP19297 C107(1.12)  LDD0531 
Tetratricopeptide repeat protein 33 (TTC33) LDTP17392 C55(2.28)  LDD3319 
Tetratricopeptide repeat protein 38 (TTC38) LDTP19372 C53(1.01)  LDD0547 
Tetratricopeptide repeat protein 39A (TTC39A) LDTP17208 C341(0.91); C342(0.91); C92(1.11)  LDD0531 
Tetratricopeptide repeat protein 39B (TTC39B) LDTP15031 C139(1.05); C203(1.02)  LDD1509 
Tetratricopeptide repeat protein 39C (TTC39C) LDTP17713 C87(3.02)  LDD3331 
Tetratricopeptide repeat protein 4 (TTC4) LDTP01678 C174(1.24); C321(1.03)  LDD0080 
Tetratricopeptide repeat protein 5 (TTC5) LDTP08738 C29(1.05)  LDD0080 
Tetratricopeptide repeat protein 7A (TTC7A) LDTP13572 C458(2.68)  LDD3314 
Tetratricopeptide repeat protein 7B (TTC7B) LDTP08207 C616(1.53); C21(1.48)  LDD3332 
Tetratricopeptide repeat protein 9A (TTC9) LDTP19840 C30(2.82)  LDD3337 
TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (TAB2) LDTP12833 C31(0.99); C42(0.99); C43(0.99); C608(0.94)  LDD0078 
TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (TAB3) LDTP08892 C635(1.71)  LDD0080 
Thioredoxin domain-containing protein 15 (TXNDC15) LDTP10442 C114(1.06)  LDD0532 
Thioredoxin domain-containing protein 9 (TXNDC9) LDTP00365 C135(1.00)  LDD0593 
Thioredoxin-related transmembrane protein 4 (TMX4) LDTP18373 C326(1.04)  LDD1492 
THO complex subunit 3 (THOC3) LDTP10440 C65(1.65); C306(1.10)  LDD0080 
Thrombomodulin (THBD) LDTP02185 C323(1.24); C336(1.24)  LDD0078 
Thrombospondin type-1 domain-containing protein 1 (THSD1) LDTP12562 C688(0.55)  LDD3380 
Thrombospondin type-1 domain-containing protein 7A (THSD7A) LDTP13738 C1204(1.40)  LDD2260 
Thrombospondin type-1 domain-containing protein 7B (THSD7B) LDTP11618 C959(0.90)  LDD1508 
Thrombospondin-1 (THBS1) LDTP02238 C813(1.05)  LDD0078 
Thrombospondin-2 (THBS2) LDTP03743 C266(2.73)  LDD3332 
Thrombospondin-3 (THBS3) LDTP04287 C921(2.28); C519(1.70)  LDD3331 
Thrombospondin-4 (THBS4) LDTP03744 C461(1.31)  LDD0547 
THUMP domain-containing protein 1 (THUMPD1) LDTP12780 C31(2.26)  LDD0080 
Thymocyte nuclear protein 1 (THYN1) LDTP18504 C89(1.48)  LDD0080 
Thymosin beta-15A (TMSB15A) LDTP14614 C668(1.00)  LDD3332 
Thyroid hormone receptor-associated protein 3 (THRAP3) LDTP13919 C476(1.54)  LDD2248 
Thyroid receptor-interacting protein 11 (TRIP11) LDTP06431 C212(1.06); C726(1.02)  LDD0078 
Thyroid receptor-interacting protein 6 (TRIP6) LDTP06439 C328(1.06); C331(1.06); C310(1.04); C47(1.03)  LDD0078 
Tigger transposable element-derived protein 2 (TIGD2) LDTP19312 C202(1.19)  LDD0532 
Tigger transposable element-derived protein 5 (TIGD5) LDTP17148 C476(1.13)  LDD0531 
Tigger transposable element-derived protein 7 (TIGD7) LDTP17357 C170(1.05)  LDD1573 
Tight junction protein ZO-2 (TJP2) LDTP13192 C945(1.66)  LDD3312 
Tight junction-associated protein 1 (TJAP1) LDTP07010 C350(1.12); C196(1.04)  LDD0078 
TIMELESS-interacting protein (TIPIN) LDTP11305 C139(0.98)  LDD0547 
TIP41-like protein (TIPRL) LDTP01285 C14(0.94)  LDD0078 
TIR domain-containing adapter molecule 1 (TICAM1) LDTP08446 C192(1.50)  LDD0547 
Tissue factor pathway inhibitor (TFPI) LDTP02513 C63(1.28)  LDD3316 
Tissue factor pathway inhibitor 2 (TFPI2) LDTP04172 C183(1.47); C191(1.47); C145(1.26); C149(1.26)  LDD0078 
TLE family member 5 (TLE5) LDTP05545 C93(2.03)  LDD3323 
TLR adapter interacting with SLC15A4 on the lysosome (TASL) LDTP12125 C58(2.21)  LDD3403 
TM2 domain-containing protein 1 (TM2D1) LDTP11358 C58(0.93)  LDD1509 
TM2 domain-containing protein 3 (TM2D3) LDTP18298 C166(2.48)  LDD3369 
TNF receptor-associated factor 1 (TRAF1) LDTP05740 C57(1.33)  LDD3323 
TNF receptor-associated factor 5 (TRAF5) LDTP00283 C521(1.39)  LDD0531 
TNFAIP3-interacting protein 1 (TNIP1) LDTP06284 C212(0.95)  LDD0531 
TNFAIP3-interacting protein 2 (TNIP2) LDTP09236 C21(1.36)  LDD1507 
TNFAIP3-interacting protein 3 (TNIP3) LDTP10515 C93(2.37)  LDD3329 
Toll-interacting protein (TOLLIP) LDTP11702 C229(1.38)  LDD0080 
Toll-like receptor 10 (TLR10) LDTP11402 C764(1.49)  LDD3372 
Toll-like receptor 9 (TLR9) LDTP12487 C279(3.17)  LDD3408 
TOM1-like protein 2 (TOM1L2) LDTP07856 C77(0.85)  LDD1507 
Torsin-1A-interacting protein 1 (TOR1AIP1) LDTP07012 C424(0.89); C496(1.02)  LDD0531 
Torsin-1A-interacting protein 2 (TOR1AIP2) LDTP09215 C47(1.15)  LDD0078 
Torsin-1A-interacting protein 2, isoform IFRG15 (TOR1AIP2) LDTP19961 C49(0.94); C52(0.94)  LDD0078 
Torsin-2A (TOR2A) LDTP14982 C271(1.64)  LDD3338 
Torsin-3A (TOR3A) LDTP11908 C385(33.10)  LDD0209 
Torsin-4A (TOR4A) LDTP18484 C230(0.98)  LDD0078 
TP53-binding protein 1 (TP53BP1) LDTP05682 C1164(1.27); C1183(1.12); C324(1.22)  LDD3311 
TPA-induced transmembrane protein (TTMP) LDTP06953 C119(1.26)  LDD1507 
TPR and ankyrin repeat-containing protein 1 (TRANK1) LDTP16789 C646(3.81)  LDD3310 
TraB domain-containing protein (TRABD) LDTP19963 C287(2.77)  LDD0080 
TRAF family member-associated NF-kappa-B activator (TANK) LDTP09901 C177(1.21); C183(1.21); C318(1.01)  LDD0078 
TRAF-interacting protein with FHA domain-containing protein B (TIFAB) LDTP07798 C83(3.47)  LDD3333 
TRAF-type zinc finger domain-containing protein 1 (TRAFD1) LDTP14426 C476(1.03); C482(1.03); C116(0.88); C119(0.88)  LDD0078 
TRAF3-interacting JNK-activating modulator (TRAF3IP3) LDTP13786 C380(1.56)  LDD3333 
TRAF3-interacting protein 1 (TRAF3IP1) LDTP09450 C641(1.62)  LDD0080 
Trafficking kinesin-binding protein 1 (TRAK1) LDTP13725 C713(0.93); C875(1.14); C98(0.89)  LDD1492 
Trafficking protein particle complex subunit 1 (TRAPPC1) LDTP14153 C115(2.64)  LDD3312 
Trafficking protein particle complex subunit 10 (TRAPPC10) LDTP04195 C696(1.06)  LDD0078 
Trafficking protein particle complex subunit 11 (TRAPPC11) LDTP08026 C162(1.19)  LDD0080 
Trafficking protein particle complex subunit 13 (TRAPPC13) LDTP14344 C32(1.99)  LDD3312 
Trafficking protein particle complex subunit 14 (TRAPPC14) LDTP09621 C369(0.72); C376(0.97)  LDD0531 
Trafficking protein particle complex subunit 2-like protein (TRAPPC2L) LDTP13514 C140(1.31)  LDD0637 
Trafficking protein particle complex subunit 3 (TRAPPC3) LDTP00822 C31(1.59)  LDD3310 
Trafficking protein particle complex subunit 4 (TRAPPC4) LDTP13837 C195(0.85)  LDD0532 
Trafficking protein particle complex subunit 5 (TRAPPC5) LDTP15333 C139(3.39)  LDD3314 
Trafficking protein particle complex subunit 6A (TRAPPC6A) LDTP01331 C138(5.12)  LDD3338 
Trafficking protein particle complex subunit 6B (TRAPPC6B) LDTP08182 C95(5.12)  LDD3312 
Trafficking protein particle complex subunit 8 (TRAPPC8) LDTP13888 C978(1.14); C265(1.01)  LDD0078 
Trafficking protein particle complex subunit 9 (TRAPPC9) LDTP10713 C935(23.70); C1035(18.96)  LDD0209 
Transcription cofactor vestigial-like protein 1 (VGLL1) LDTP11032 C177(4.25)  LDD3319 
Transcription cofactor vestigial-like protein 2 (VGLL2) LDTP15456 C117(3.81)  LDD3401 
Transcription cofactor vestigial-like protein 3 (VGLL3) LDTP00144 C277(1.68)  LDD3399 
Transcription cofactor vestigial-like protein 4 (VGLL4) LDTP06045 C211(2.47)  LDD3358 
Transcription elongation factor 1 homolog (ELOF1) LDTP19195 C26(1.25); C29(1.25)  LDD0533 
Transcription elongation factor A protein 1 (TCEA1) LDTP03209 C291(0.89); C294(0.89)  LDD0078 
Transcription elongation factor A protein 2 (TCEA2) LDTP06414 C263(1.42)  LDD3312 
Transcription elongation factor A protein 3 (TCEA3) LDTP14506 C318(2.18); C310(1.59)  LDD3319 
Transcription elongation factor A protein-like 1 (TCEAL1) LDTP06335 C90(3.42)  LDD3358 
Transcription elongation factor A protein-like 4 (TCEAL4) LDTP18149 C34(0.82)  LDD3310 
Transcription elongation factor A protein-like 5 (TCEAL5) LDTP19342 C149(1.62)  LDD3310 
Transcription elongation factor A protein-like 8 (TCEAL8) LDTP15360 C5(1.79)  LDD3401 
Transcription elongation factor SPT4 (SUPT4H1) LDTP05061 C16(0.87); C19(0.87)  LDD0078 
Transcription elongation factor SPT5 (SUPT5H) LDTP00236 C626(1.08)  LDD0078 
Transcription elongation factor SPT6 (SUPT6H) LDTP07928 C336(0.96)  LDD0078 
Transcription elongation factor, mitochondrial (TEFM) LDTP10735 C130(1.09); C135(0.95); C50(0.96)  LDD0531 
Transcription elongation regulator 1 (TCERG1) LDTP00430 C535(0.91)  LDD0078 
Transcription factor Gibbin (AHDC1) LDTP07190 C791(1.03)  LDD0078 
Transcription factor IIIB 50 kDa subunit (BRF2) LDTP12145 C245(37.41)  LDD0209 
Transcription factor IIIB 90 kDa subunit (BRF1) LDTP09958 C184(0.96)  LDD0078 
Transcription factor SPT20 homolog (SUPT20H) LDTP09163 C138(1.86); C289(1.38)  LDD0080 
Transcription factor TFIIIB component B'' homolog (BDP1) LDTP00081 C578(0.92); C587(0.92)  LDD0078 
Transcription initiation factor IIA subunit 2 (GTF2A2) LDTP04517 C68(1.25); C98(1.50)  LDD0531 
Transcription initiation factor IIE subunit beta (GTF2E2) LDTP03466 C208(1.90)  LDD0080 
Transcription initiation factor TFIID subunit 10 (TAF10) LDTP05707 C174(0.85)  LDD0078 
Transcription initiation factor TFIID subunit 11 (TAF11) LDTP06409 C173(1.01)  LDD1507 
Transcription initiation factor TFIID subunit 12 (TAF12) LDTP06537 C143(1.94)  LDD0080 
Transcription initiation factor TFIID subunit 2 (TAF2) LDTP07517 C767(1.27)  LDD0080 
Transcription initiation factor TFIID subunit 3 (TAF3) LDTP07238 C431(1.94)  LDD3342 
Transcription initiation factor TFIID subunit 4 (TAF4) LDTP00237 C1022(13.76)  LDD0209 
Transcription initiation factor TFIID subunit 4B (TAF4B) LDTP09857 C160(1.01); C274(0.83)  LDD1492 
Transcription initiation factor TFIID subunit 5 (TAF5) LDTP06407 C227(0.97); C231(0.97); C273(1.07); C632(1.11)  LDD0531 
Transcription initiation factor TFIID subunit 6 (TAF6) LDTP04321 C235(41.76)  LDD0209 
Transcription initiation factor TFIID subunit 7 (TAF7) LDTP06410 C72(2.57)  LDD3339 
Transcription initiation factor TFIID subunit 7-like (TAF7L) LDTP06982 C26(2.66)  LDD3358 
Transcription initiation factor TFIID subunit 8 (TAF8) LDTP08144 C80(2.94)  LDD3310 
Transcription initiation factor TFIID subunit 9 (TAF9) LDTP06568 C121(1.18)  LDD0078 
Transcription initiation factor TFIID subunit 9B (TAF9B) LDTP12193 C121(4.57)  LDD3311 
Transcription initiation protein SPT3 homolog (SUPT3H) LDTP01236 C268(3.67)  LDD0080 
Transcription termination factor 1 (TTF1) LDTP06364 C887(1.09); C892(1.09)  LDD0078 
Transcription termination factor 1, mitochondrial (MTERF1) LDTP10895 C305(1.83)  LDD3346 
Transcription termination factor 2, mitochondrial (MTERF2) LDTP06831 C259(4.32); C101(1.52); C107(1.52)  LDD0080 
Transcription termination factor 3, mitochondrial (MTERF3) LDTP10246 C399(2.41)  LDD3337 
Transcription termination factor 4, mitochondrial (MTERF4) LDTP08132 C69(1.10)  LDD0078 
Transcriptional adapter 1 (TADA1) LDTP10132 C139(1.32)  LDD0531 
Transcriptional coactivator YAP1 (YAP1) LDTP04115 C347(4.25)  LDD3314 
Transcriptional regulator SEHBP (ZNF689) LDTP14409 C484(1.47)  LDD3317 
Transducin beta-like protein 2 (TBL2) LDTP16285 C335(1.25); C240(1.16); C44(0.98)  LDD0078 
Transducin beta-like protein 3 (TBL3) LDTP05647 C613(1.02); C41(0.87); C43(0.87)  LDD0078 
Transducin-like enhancer protein 1 (TLE1) LDTP05426 C89(1.07)  LDD1492 
Transducin-like enhancer protein 2 (TLE2) LDTP05427 C499(15.98); C718(14.84); C261(11.60)  LDD0209 
Transducin-like enhancer protein 3 (TLE3) LDTP05428 C26(1.24); C528(1.06)  LDD0531 
Transducin-like enhancer protein 4 (TLE4) LDTP05429 C561(1.77)  LDD3310 
Transformer-2 protein homolog alpha (TRA2A) LDTP05937 C19(1.70)  LDD3312 
Transformer-2 protein homolog beta (TRA2B) LDTP05036 C118(1.18)  LDD0078 
Transforming acidic coiled-coil-containing protein 1 (TACC1) LDTP01210 C587(3.56); C597(3.56); C467(2.48)  LDD0080 
Transforming acidic coiled-coil-containing protein 2 (TACC2) LDTP01569 C2859(1.16)  LDD0078 
Transforming acidic coiled-coil-containing protein 3 (TACC3) LDTP14228 C749(1.09); C224(1.07); C20(1.01); C426(0.94)  LDD0078 
Transforming growth factor beta regulator 1 (TBRG1) LDTP06806 C232(0.47); C236(0.47)  LDD0533 
Transforming growth factor beta-1-induced transcript 1 protein (TGFB1I1) LDTP00731 C275(1.30); C278(1.30)  LDD0532 
Transforming growth factor beta-3 proprotein (TGFB3) LDTP02503 C307(4.81)  LDD3493 
Transforming growth factor-beta receptor-associated protein 1 (TGFBRAP1) LDTP09574 C818(1.28); C821(1.53); C826(1.09)  LDD0531 
Transforming growth factor-beta-induced protein ig-h3 (TGFBI) LDTP06420 C49(3.02)  LDD3310 
Transgelin (TAGLN) LDTP14802 C38(1.59)  LDD3368 
Transgelin-2 (TAGLN2) LDTP03846 C124(1.05)  LDD0078 
Transgelin-3 (TAGLN3) LDTP18533 C38(1.83)  LDD3344 
Translation initiation factor eIF2 assembly protein (CDC123) LDTP16826 C289(0.86)  LDD0078 
Translation initiation factor eIF2B subunit alpha (EIF2B1) LDTP06088 C218(1.37)  LDD0080 
Translation initiation factor eIF2B subunit beta (EIF2B2) LDTP04304 C194(1.96); C198(1.96)  LDD0080 
Translation initiation factor eIF2B subunit delta (EIF2B4) LDTP13318 C69(1.25)  LDD0080 
Translation initiation factor eIF2B subunit epsilon (EIF2B5) LDTP05765 C196(0.98)  LDD0078 
Translation initiation factor eIF2B subunit gamma (EIF2B3) LDTP12476 C281(1.22); C285(1.22); C64(1.08)  LDD0078 
Translation initiation factor IF-3, mitochondrial (MTIF3) LDTP11827 C238(3.25)  LDD3311 
Translation machinery-associated protein 16 (TMA16) LDTP10283 C75(1.73); C162(1.17)  LDD0080 
Translational activator of cytochrome c oxidase 1 (TACO1) LDTP11157 C42(1.36)  LDD0531 
Translationally-controlled tumor protein (TPT1) LDTP02683 C28(0.80)  LDD3310 
Translin-associated protein X (TSNAX) LDTP10914 C257(1.17)  LDD0080 
Transmembrane and coiled-coil domain-containing protein 4 (TMCO4) LDTP17252 C460(0.85)  LDD0531 
Transmembrane and coiled-coil domain-containing protein 6 (TMCO6) LDTP18140 C14(2.46)  LDD3321 
Transmembrane and coiled-coil domains protein 2 (TMCC2) LDTP01112 C554(1.85)  LDD3351 
Transmembrane and ubiquitin-like domain-containing protein 2 (TMUB2) LDTP07904 C166(1.46)  LDD3319 
Transmembrane anterior posterior transformation protein 1 homolog (TAPT1) LDTP07491 C562(1.15)  LDD0080 
Transmembrane emp24 domain-containing protein 5 (TMED5) LDTP13967 C47(1.05)  LDD0080 
Transmembrane glycoprotein NMB (GPNMB) LDTP06237 C369(1.43)  LDD3314 
Transmembrane protein 11, mitochondrial (TMEM11) LDTP02887 C80(0.78)  LDD0531 
Transmembrane protein 115 (TMEM115) LDTP05685 C156(0.97)  LDD0828 
Transmembrane protein 120B (TMEM120B) LDTP00022 C43(0.71)  LDD3339 
Transmembrane protein 121B (TMEM121B) LDTP19930 C475(1.11)  LDD1511 
Transmembrane protein 131 (TMEM131) LDTP18115 C1747(1.04)  LDD0078 
Transmembrane protein 131-like (TMEM131L) LDTP00055 C1241(38.74)  LDD0209 
Transmembrane protein 132C (TMEM132C) LDTP17697 C1086(2.11)  LDD2469 
Transmembrane protein 135 (TMEM135) LDTP15286 C234(2.78)  LDD3427 
Transmembrane protein 138 (TMEM138) LDTP12368 C131(0.88)  LDD1094 
Transmembrane protein 143 (TMEM143) LDTP10087 C408(0.92)  LDD3313 
Transmembrane protein 154 (TMEM154) LDTP15120 C164(1.78)  LDD3373 
Transmembrane protein 156 (TMEM156) LDTP19712 C185(1.43)  LDD3483 
Transmembrane protein 161A (TMEM161A) LDTP12762 C33(1.11)  LDD0078 
Transmembrane protein 161B (TMEM161B) LDTP17796 C33(1.08)  LDD0533 
Transmembrane protein 177 (TMEM177) LDTP17153 C244(1.16)  LDD0080 
Transmembrane protein 178B (TMEM178B) LDTP18993 C294(0.93)  LDD1492 
Transmembrane protein 183A (TMEM183A) LDTP17642 C242(0.95)  LDD0531 
Transmembrane protein 185B (TMEM185B) LDTP19972 C279(1.01)  LDD1514 
Transmembrane protein 186 (TMEM186) LDTP15695 C156(1.01)  LDD1508 
Transmembrane protein 198 (TMEM198) LDTP15059 C353(0.83)  LDD1512 
Transmembrane protein 200A (TMEM200A) LDTP17588 C201(1.61)  LDD0532 
Transmembrane protein 209 (TMEM209) LDTP18272 C301(1.38); C295(1.18); C158(1.09); C422(1.05)  LDD0078 
Transmembrane protein 216 (TMEM216) LDTP12972 C83(3.65)  LDD3456 
Transmembrane protein 231 (TMEM231) LDTP11985 C70(1.48)  LDD3334 
Transmembrane protein 248 (TMEM248) LDTP12712 C305(2.78)  LDD3312 
Transmembrane protein 252 (TMEM252) LDTP19715 C112(2.24)  LDD3418 
Transmembrane protein 256 (TMEM256) LDTP19689 C61(1.13)  LDD1492 
Transmembrane protein 267 (TMEM267) LDTP19227 C168(0.97)  LDD0531 
Transmembrane protein 39B (TMEM39B) LDTP18362 C264(1.17); C265(1.17)  LDD0078 
Transmembrane protein 45A (TMEM45A) LDTP16119 C255(8.22)  LDD3473 
Transmembrane protein 53 (TMEM53) LDTP07523 C46(0.95)  LDD1508 
Transmembrane protein 54 (TMEM54) LDTP10010 C177(1.10)  LDD1508 
Transmembrane protein 98 (TMEM98) LDTP13932 C177(1.00)  LDD1492 
Transmembrane protein 9B (TMEM9B) LDTP16061 C66(0.93); C68(0.93)  LDD0531 
Transmembrane protein adipocyte-associated 1 (TPRA1) LDTP15298 C30(0.95)  LDD0531 
Transport and Golgi organization protein 2 homolog (TANGO2) LDTP07410 C231(12.24)  LDD0209 
Transport and Golgi organization protein 6 homolog (TANGO6) LDTP18348 C286(0.99)  LDD0078 
Treacle protein (TCOF1) LDTP05867 C38(2.85); C1334(2.38)  LDD3331 
Treslin (TICRR) LDTP08022 C1317(1.89); C1694(1.10)  LDD0080 
Trichohyalin (TCHH) LDTP05516 C196(2.26)  LDD2435 
Trinucleotide repeat-containing gene 6A protein (TNRC6A) LDTP09137 C822(2.00); C225(1.41)  LDD0080 
Trinucleotide repeat-containing gene 6B protein (TNRC6B) LDTP13710 C557(1.03); C245(1.03); C254(1.03)  LDD0078 
Trinucleotide repeat-containing gene 6C protein (TNRC6C) LDTP12246 C868(1.02)  LDD1492 
TRIO and F-actin-binding protein (TRIOBP) LDTP11814 C2271(1.07); C2233(0.84)  LDD0078 
tRNA (32-2'-O)-methyltransferase regulator THADA (THADA) LDTP07761 C635(1.20); C683(0.93)  LDD0078 
tRNA (34-2'-O)-methyltransferase regulator WDR6 (WDR6) LDTP12296 C688(1.06)  LDD0078 
tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (TRMT6) LDTP13381 C73(2.53)  LDD3312 
tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 (WDR4) LDTP04783 C137(1.06)  LDD0078 
tRNA selenocysteine 1-associated protein 1 (TRNAU1AP) LDTP12750 C48(1.41)  LDD3375 
tRNA-splicing endonuclease subunit Sen15 (TSEN15) LDTP09632 C13(1.04)  LDD0531 
Trophoblast glycoprotein (TPBG) LDTP05960 C323(2.84)  LDD3313 
Tropomodulin-3 (TMOD3) LDTP18494 C231(0.96)  LDD0078 
Tropomyosin alpha-1 chain (TPM1) LDTP02351 C190(1.86)  LDD3337 
Tropomyosin alpha-3 chain (TPM3) LDTP02165 C170(2.70)  LDD3313 
Tropomyosin alpha-4 chain (TPM4) LDTP05068 C247(1.30)  LDD0078 
Tropomyosin beta chain (TPM2) LDTP02234 C190(1.32)  LDD0532 
Troponin I, slow skeletal muscle (TNNI1) LDTP02987 C87(3.31); C29(1.73)  LDD3401 
TRPM8 channel-associated factor 1 (TCAF1) LDTP14041 C487(1.03); C488(1.03)  LDD0078 
TRPM8 channel-associated factor 2 (TCAF2) LDTP00094 C597(1.01)  LDD0531 
Tsukushi (TSKU) LDTP09567 C339(2.44)  LDD3348 
Tubby protein homolog (TUB) LDTP04378 C426(1.19)  LDD3395 
Tuberin (TSC2) LDTP04316 C189(0.89)  LDD0078 
Tubulin beta 8B (TUBB8B) LDTP00119 C127(1.03); C129(1.15); C127(0.98); C129(0.98)  LDD1492 
Tubulin beta chain (TUBB) LDTP02205 C127(2.14); C129(2.14)  LDD0080 
Tubulin beta-2A chain (TUBB2A) LDTP05998 C127(1.11); C129(1.11)  LDD0078 
Tubulin beta-2B chain (TUBB2B) LDTP11277 C127(1.42); C129(1.42)  LDD0078 
Tubulin beta-3 chain (TUBB3) LDTP05904 C303(1.14); C354(1.09)  LDD0078 
Tubulin beta-4B chain (TUBB4B) LDTP05076 C239(1.19); C12(1.07); C127(1.05); C129(1.05)  LDD0078 
Tubulin beta-6 chain (TUBB6) LDTP11233 C124(1.10); C127(1.10); C129(1.10); C303(1.08)  LDD0078 
Tubulin beta-8 chain (TUBB8) LDTP06809 C406(1.32)  LDD3314 
Tubulin delta chain (TUBD1) LDTP13394 C93(1.04); C95(1.04)  LDD0078 
Tubulin epsilon and delta complex protein 1 (TEDC1) LDTP15278 C417(1.02); C87(0.88)  LDD0078 
Tubulin epsilon and delta complex protein 2 (TEDC2) LDTP15215 C331(0.95); C343(0.95)  LDD0078 
Tubulin epsilon chain (TUBE1) LDTP18540 C205(1.00)  LDD1492 
Tubulin gamma-2 chain (TUBG2) LDTP12512 C201(1.19)  LDD0531 
Tubulin polyglutamylase complex subunit 1 (TPGS1) LDTP15195 C126(0.88)  LDD0531 
Tubulin-folding cofactor B (TBCB) LDTP10860 C83(1.21)  LDD0078 
Tubulin-specific chaperone A (TBCA) LDTP01184 C67(1.17)  LDD0080 
Tubulin-specific chaperone C (TBCC) LDTP06480 C284(1.77); C184(1.25)  LDD0080 
Tubulin-specific chaperone cofactor E-like protein (TBCEL) LDTP14990 C121(1.38); C14(0.91)  LDD0531 
Tubulin-specific chaperone D (TBCD) LDTP11212 C899(2.50); C234(1.68); C1192(1.14)  LDD0080 
Tubulin-specific chaperone E (TBCE) LDTP06479 C137(6.72); C141(2.51); C522(1.00)  LDD0080 
Tudor and KH domain-containing protein (TDRKH) LDTP13922 C109(1.15)  LDD0078 
Tudor domain-containing protein 1 (TDRD1) LDTP11410 C62(3.94)  LDD3310 
Tudor domain-containing protein 3 (TDRD3) LDTP12024 C98(2.72)  LDD3310 
Tudor domain-containing protein 7 (TDRD7) LDTP09264 C714(1.93); C1029(3.54)  LDD0080 
Tuftelin-interacting protein 11 (TFIP11) LDTP13094 C445(5.58); C391(1.25); C400(1.25)  LDD0080 
Tumor necrosis factor alpha-induced protein 8 (TNFAIP8) LDTP01577 C198(3.61)  LDD3370 
Tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD) LDTP06425 C135(0.86); C138(0.86)  LDD0078 
Tumor protein D54 (TPD52L2) LDTP00759 C74(1.44)  LDD3339 
Tumor protein p53-inducible nuclear protein 1 (TP53INP1) LDTP10064 C234(2.81)  LDD3339 
Tumor protein p53-inducible nuclear protein 2 (TP53INP2) LDTP08593 C214(4.47)  LDD0080 
Tumor protein p63-regulated gene 1-like protein (TPRG1L) LDTP07084 C207(0.94)  LDD0625 
Tumor suppressor ARF (CDKN2A) LDTP08957 C100(0.95)  LDD0078 
Tumor-associated calcium signal transducer 2 (TACSTD2) LDTP02371 C44(1.25)  LDD3311 
Twinfilin-1 (TWF1) LDTP05650 C6(2.21); C67(2.50)  LDD3310 
Twinfilin-2 (TWF2) LDTP07404 C67(0.69)  LDD0531 
Twisted gastrulation protein homolog 1 (TWSG1) LDTP11667 C31(2.58)  LDD3342 
U1 small nuclear ribonucleoprotein 70 kDa (SNRNP70) LDTP02292 C39(0.99)  LDD0078 
U1 small nuclear ribonucleoprotein C (SNRPC) LDTP02335 C25(1.92)  LDD3316 
U11/U12 small nuclear ribonucleoprotein 48 kDa protein (SNRNP48) LDTP07413 C292(2.05); C26(1.32)  LDD0080 
U2 small nuclear ribonucleoprotein A' (SNRPA1) LDTP02365 C89(0.66)  LDD1508 
U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1 (ZRSR2P1) LDTP14864 C331(1.99)  LDD3310 
U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (ZRSR2) LDTP06445 C326(0.98)  LDD0078 
U2 snRNP-associated SURP motif-containing protein (U2SURP) LDTP00517 C320(1.19); C65(1.10); C624(1.02)  LDD0078 
U3 small nucleolar ribonucleoprotein protein IMP3 (IMP3) LDTP12656 C98(9.22); C107(9.22)  LDD0080 
U3 small nucleolar ribonucleoprotein protein IMP4 (IMP4) LDTP10328 C165(1.00)  LDD1492 
U3 small nucleolar ribonucleoprotein protein MPP10 (MPHOSPH10) LDTP00312 C27(1.27)  LDD0078 
U3 small nucleolar RNA-associated protein 14 homolog A (UTP14A) LDTP11288 C522(1.10); C380(0.96)  LDD0078 
U3 small nucleolar RNA-associated protein 14 homolog C (UTP14C) LDTP07168 C520(1.04)  LDD1492 
U3 small nucleolar RNA-associated protein 15 homolog (UTP15) LDTP09494 C85(1.90)  LDD0531 
U3 small nucleolar RNA-associated protein 18 homolog (UTP18) LDTP14122 C241(1.15); C442(1.23); C446(1.23)  LDD0531 
U3 small nucleolar RNA-associated protein 25 homolog (UTP25) LDTP07315 C642(1.41)  LDD0080 
U3 small nucleolar RNA-associated protein 4 homolog (UTP4) LDTP10047 C401(2.18)  LDD0080 
U3 small nucleolar RNA-associated protein 6 homolog (UTP6) LDTP12830 C328(1.10); C333(1.10); C370(1.02); C309(0.86)  LDD0078 
U3 small nucleolar RNA-associated protein NOL7 (NOL7) LDTP13633 C149(0.89)  LDD0532 
U3 small nucleolar RNA-interacting protein 2 (RRP9) LDTP00876 C296(0.88); C297(0.88)  LDD0078 
U4/U6 small nuclear ribonucleoprotein Prp3 (PRPF3) LDTP00757 C630(0.92)  LDD0533 
U4/U6 small nuclear ribonucleoprotein Prp31 (PRPF31) LDTP09671 C247(0.97)  LDD0078 
U4/U6 small nuclear ribonucleoprotein Prp4 (PRPF4) LDTP00698 C399(1.00); C263(0.91)  LDD0078 
U4/U6.U5 tri-snRNP-associated protein 1 (SART1) LDTP00727 C560(1.00)  LDD0078 
U5 small nuclear ribonucleoprotein 40 kDa protein (SNRNP40) LDTP10217 C168(1.25); C291(1.28)  LDD0531 
U5 small nuclear ribonucleoprotein TSSC4 (TSSC4) LDTP14160 C99(0.98)  LDD0531 
U6 snRNA-associated Sm-like protein LSm2 (LSM2) LDTP13946 C26(1.33)  LDD3314 
U6 snRNA-associated Sm-like protein LSm4 (LSM4) LDTP14081 C59(2.33)  LDD0080 
U6 snRNA-associated Sm-like protein LSm6 (LSM6) LDTP04980 C36(0.94)  LDD1492 
U6 snRNA-associated Sm-like protein LSm7 (LSM7) LDTP13425 C76(1.06)  LDD0080 
U7 snRNA-associated Sm-like protein LSm11 (LSM11) LDTP05184 C52(1.04)  LDD1492 
Ubinuclein-1 (UBN1) LDTP12360 C420(1.38); C467(1.08)  LDD0078 
Ubinuclein-2 (UBN2) LDTP17493 C562(1.01); C141(0.94); C152(0.94); C966(0.91)  LDD0078 
Ubiquinol-cytochrome c reductase complex assembly factor 1 (UQCC1) LDTP12666 C124(0.91)  LDD0547 
Ubiquinol-cytochrome c reductase complex assembly factor 2 (UQCC2) LDTP11131 C13(1.08)  LDD1492 
Ubiquinone biosynthesis protein COQ9, mitochondrial (COQ9) LDTP01163 C153(3.33)  LDD3312 
Ubiquitin domain-containing protein UBFD1 (UBFD1) LDTP16782 C185(1.64)  LDD3340 
Ubiquitin recognition factor in ER-associated degradation protein 1 (UFD1) LDTP09919 C25(1.88)  LDD3311 
Ubiquitin-associated and SH3 domain-containing protein A (UBASH3A) LDTP04780 C262(23.88)  LDD0209 
Ubiquitin-associated domain-containing protein 1 (UBAC1) LDTP11164 C322(1.17)  LDD0080 
Ubiquitin-associated protein 1 (UBAP1) LDTP12869 C161(14.63)  LDD0209 
Ubiquitin-associated protein 1-like (UBAP1L) LDTP18974 C143(0.83)  LDD1508 
Ubiquitin-associated protein 2 (UBAP2) LDTP07132 C208(0.97)  LDD0078 
Ubiquitin-fold modifier-conjugating enzyme 1 (UFC1) LDTP13978 C69(3.07)  LDD0080 
Ubiquitin-like protein 4A (UBL4A) LDTP02570 C13(1.15)  LDD1492 
Ubiquitin-like protein 5 (UBL5) LDTP11545 C18(1.39)  LDD0613 
Ubiquitin-like protein 7 (UBL7) LDTP15824 C66(1.57)  LDD0080 
Ubiquitin-like protein ISG15 (ISG15) LDTP02092 C78(0.92)  LDD0531 
Ubiquitin-ribosomal protein eL40 fusion protein (UBA52) LDTP05034 C115(0.68)  LDD0531 
Ubiquitin-ribosomal protein eS31 fusion protein (RPS27A) LDTP05033 C144(1.05); C149(1.05); C121(1.03); C126(1.03)  LDD0078 
UBX domain-containing protein 1 (UBXN1) LDTP05418 C214(1.48)  LDD3410 
UBX domain-containing protein 2A (UBXN2A) LDTP14779 C51(3.04)  LDD3342 
UBX domain-containing protein 2B (UBXN2B) LDTP06260 C127(48.14)  LDD0209 
UBX domain-containing protein 4 (UBXN4) LDTP09806 C144(1.08)  LDD0078 
UBX domain-containing protein 6 (UBXN6) LDTP11564 C347(29.47); C210(11.97)  LDD0209 
UBX domain-containing protein 7 (UBXN7) LDTP01451 C160(0.91)  LDD0078 
UBX domain-containing protein 8 (UBXN8) LDTP00187 C174(0.81); C198(1.01)  LDD0531 
UL16-binding protein 1 (ULBP1) LDTP11554 C127(1.28)  LDD3314 
UL16-binding protein 2 (ULBP2) LDTP11553 C34(1.36)  LDD3375 
UL16-binding protein 3 (ULBP3) LDTP11552 C51(0.85)  LDD0580 
UNC5C-like protein (UNC5CL) LDTP08481 C184(1.85)  LDD3314 
Uncharacterized bromodomain-containing protein 10 (BRD10) LDTP19344 C400(2.70)  LDD3484 
Uncharacterized membrane protein C3orf80 (C3orf80) LDTP18975 C177(1.39)  LDD1509 
Uncharacterized protein C11orf96 (C11orf96) LDTP19610 C420(2.74); C402(3.88)  LDD3340 
Uncharacterized protein C14orf119 (C14orf119) LDTP12724 C41(0.98)  LDD0078 
Uncharacterized protein C14orf93 (C14orf93) LDTP18422 C522(2.76); C523(2.76)  LDD0080 
Uncharacterized protein C15orf39 (C15orf39) LDTP17481 C139(1.12); C145(1.12); C417(1.10); C426(1.10)  LDD0078 
Uncharacterized protein C15orf61 (C15orf61) LDTP18863 C84(1.19)  LDD0531 
Uncharacterized protein C17orf100 (C17orf100) LDTP20136 C98(0.79)  LDD1509 
Uncharacterized protein C19orf44 (C19orf44) LDTP16009 C79(0.99)  LDD1514 
Uncharacterized protein C19orf47 (C19orf47) LDTP17763 C56(2.63)  LDD3365 
Uncharacterized protein C1orf122 (C1orf122) LDTP19568 C61(0.96)  LDD0078 
Uncharacterized protein C1orf131 (C1orf131) LDTP09123 C100(0.97)  LDD1492 
Uncharacterized protein C1orf198 (C1orf198) LDTP18394 C228(1.04)  LDD0531 
Uncharacterized protein C1orf21 (C1orf21) LDTP19956 C3(1.03)  LDD1492 
Uncharacterized protein C1orf50 (C1orf50) LDTP15893 C144(1.56)  LDD3331 
Uncharacterized protein C2orf42 (C2orf42) LDTP20001 C115(0.55); C120(0.55); C286(0.67); C295(0.67)  LDD0533 
Uncharacterized protein C2orf72 (C2orf72) LDTP20112 C244(2.58)  LDD0080 
Uncharacterized protein C3orf38 (C3orf38) LDTP17182 C259(1.12)  LDD0078 
Uncharacterized protein C4orf19 (C4orf19) LDTP19663 C147(1.22)  LDD3440 
Uncharacterized protein C4orf54 (C4orf54) LDTP16759 C346(1.79)  LDD3318 
Uncharacterized protein C5orf34 (C5orf34) LDTP20377 C315(4.73)  LDD0080 
Uncharacterized protein C6orf132 (C6orf132) LDTP19390 C479(0.90)  LDD0531 
Uncharacterized protein C7orf50 (C7orf50) LDTP19918 C107(1.04)  LDD0078 
Uncharacterized protein C8orf88 (C8orf88) LDTP19126 C93(2.08)  LDD3392 
Uncharacterized protein C9orf40 (C9orf40) LDTP20311 C22(0.98)  LDD1492 
Uncharacterized protein CXorf49 (CXorf49; CXorf49B) LDTP18904 C340(1.29)  LDD0533 
Uncharacterized protein KIAA0513 (KIAA0513) LDTP16801 C317(1.13)  LDD0078 
Uncharacterized protein KIAA0825 (KIAA0825) LDTP17619 C1052(1.01); C1054(1.01)  LDD1511 
Uncharacterized protein KIAA0930 (KIAA0930) LDTP17325 C19(1.07); C23(1.07)  LDD0078 
Uncharacterized protein KIAA1671 (KIAA1671) LDTP19933 C585(0.96); C1590(0.95); C1454(0.89)  LDD0078 
Uncharacterized protein KIAA1755 (KIAA1755) LDTP19363 C337(1.37)  LDD3430 
Uncharacterized protein KIAA1958 (KIAA1958) LDTP15458 C73(70.83)  LDD0209 
Uncharacterized protein KIAA2013 (KIAA2013) LDTP17652 C185(2.15)  LDD3310 
Uncharacterized protein MISP3 (MISP3) LDTP19863 C139(3.05)  LDD3358 
Uncharacterized protein ZSWIM9 (ZSWIM9) LDTP19634 C260(0.93); C261(0.93)  LDD0078 
Unhealthy ribosome biogenesis protein 2 homolog (URB2) LDTP17034 C35(1.04); C702(1.03); C931(0.96); C1380(0.91)  LDD0078 
UPF0235 protein C15orf40 (C15orf40) LDTP19830 C62(0.99)  LDD1492 
UPF0415 protein C7orf25 (C7orf25) LDTP19913 C8(1.91)  LDD3332 
UPF0461 protein C5orf24 (C5orf24) LDTP19608 C158(1.94)  LDD0080 
UPF0488 protein C8orf33 (C8orf33) LDTP12025 C50(1.05); C44(1.01)  LDD1492 
UPF0489 protein C5orf22 (C5orf22) LDTP17129 C195(0.90)  LDD0078 
UPF0538 protein C2orf76 (C2orf76) LDTP19272 C111(0.66)  LDD3331 
UPF0547 protein C16orf87 (C16orf87) LDTP17389 C16(0.95); C19(0.95); C27(0.95)  LDD0078 
UPF0598 protein C8orf82 (C8orf82) LDTP19499 C98(1.34)  LDD0080 
UPF0606 protein KIAA1549 (KIAA1549) LDTP12256 C1748(1.13)  LDD0078 
UPF0669 protein C6orf120 (C6orf120) LDTP17546 C99(0.88)  LDD1492 
UPF0688 protein C1orf174 (C1orf174) LDTP17648 C124(1.20); C92(1.20)  LDD0078 
UPF0696 protein C11orf68 (C11orf68) LDTP11866 C264(1.77)  LDD3310 
UPF0711 protein C18orf21 (C18orf21) LDTP19266 C175(1.10)  LDD0078 
UPF0729 protein C18orf32 (C18orf32) LDTP15599 C71(1.09)  LDD0078 
Urokinase plasminogen activator surface receptor (PLAUR) LDTP05404 C117(1.42); C120(1.42); C127(1.42)  LDD0078 
Uroplakin-3b-like protein 2 (UPK3BL2) LDTP18959 C151(3.98)  LDD3412 
USP6 N-terminal-like protein (USP6NL) LDTP09854 C154(4.38)  LDD3319 
UV excision repair protein RAD23 homolog A (RAD23A) LDTP04626 C344(0.84)  LDD3377 
UV excision repair protein RAD23 homolog B (RAD23B) LDTP04627 C390(0.74)  LDD3331 
UV radiation resistance-associated gene protein (UVRAG) LDTP13090 C186(0.96)  LDD0078 
UV-stimulated scaffold protein A (UVSSA) LDTP06740 C252(1.09); C253(1.09); C231(1.06); C238(1.06)  LDD0078 
Uveal autoantigen with coiled-coil domains and ankyrin repeats (UACA) LDTP11534 C408(1.15)  LDD0078 
Vacuolar fusion protein CCZ1 homolog (CCZ1) LDTP14797 C471(0.88); C65(0.90)  LDD0531 
Vacuolar fusion protein CCZ1 homolog B (CCZ1B) LDTP17004 C471(3.47); C141(1.63)  LDD3312 
Vacuolar fusion protein MON1 homolog A (MON1A) LDTP08307 C110(12.51); C392(6.20)  LDD0209 
Vacuolar fusion protein MON1 homolog B (MON1B) LDTP15214 C297(1.10)  LDD0625 
Vacuolar protein sorting-associated protein 11 homolog (VPS11) LDTP11801 C317(1.05)  LDD0078 
Vacuolar protein sorting-associated protein 16 homolog (VPS16) LDTP11800 C490(1.15); C255(1.02); C259(1.02)  LDD0078 
Vacuolar protein sorting-associated protein 18 homolog (VPS18) LDTP13019 C776(3.23); C780(3.23)  LDD0080 
Vacuolar protein sorting-associated protein 26C (VPS26C) LDTP00494 C221(0.93)  LDD0078 
Vacuolar protein sorting-associated protein 28 homolog (VPS28) LDTP13424 C103(7.65)  LDD0209 
Vacuolar protein sorting-associated protein 33A (VPS33A) LDTP10097 C121(1.35); C411(0.85); C416(0.85)  LDD0531 
Vacuolar protein sorting-associated protein 33B (VPS33B) LDTP11799 C259(0.98); C546(0.91)  LDD0531 
Vacuolar protein sorting-associated protein 37A (VPS37A) LDTP09184 C325(1.11)  LDD0533 
Vacuolar protein sorting-associated protein 41 homolog (VPS41) LDTP04292 C332(1.30)  LDD0080 
Vacuolar protein sorting-associated protein 45 (VPS45) LDTP12541 C70(1.97)  LDD3323 
Vacuolar protein sorting-associated protein 51 homolog (VPS51) LDTP13338 C421(1.01); C190(0.97); C226(0.91); C764(0.89)  LDD0078 
Vacuolar protein sorting-associated protein 52 homolog (VPS52) LDTP08766 C220(135.22)  LDD0209 
Vacuolar protein sorting-associated protein 53 homolog (VPS53) LDTP07206 C424(2.25); C365(2.63); C667(2.72)  LDD3312 
Vacuolar protein sorting-associated protein 54 (VPS54) LDTP12999 C547(2.07); C557(2.07)  LDD0080 
Vacuolar protein sorting-associated protein VTA1 homolog (VTA1) LDTP12317 C38(1.46)  LDD0080 
Vacuolar protein-sorting-associated protein 25 (VPS25) LDTP11108 C34(1.37); C41(1.37)  LDD1109 
Vacuolar protein-sorting-associated protein 36 (VPS36) LDTP08293 C291(0.68)  LDD0532 
Vacuolar-sorting protein SNF8 (SNF8) LDTP10372 C72(0.96)  LDD0531 
Vam6/Vps39-like protein (VPS39) LDTP10457 C681(6.38)  LDD0209 
Vang-like protein 2 (VANGL2) LDTP13560 C103(1.11)  LDD1492 
Vasculin (GPBP1) LDTP08337 C439(0.88)  LDD1507 
Vasculin-like protein 1 (GPBP1L1) LDTP18437 C130(0.95)  LDD1492 
Vasodilator-stimulated phosphoprotein (VASP) LDTP04372 C334(1.07)  LDD0078 
Vasorin (VASN) LDTP07381 C304(1.06)  LDD1095 
Ventricular zone-expressed PH domain-containing protein homolog 1 (VEPH1) LDTP06266 C237(1.85)  LDD3311 
Very large A-kinase anchor protein (CRYBG3) LDTP07330 C677(1.11); C998(1.21)  LDD0531 
Very low-density lipoprotein receptor (VLDLR) LDTP05215 C338(3.62); C344(3.62)  LDD0080 
Vesicle transport protein SEC20 (BNIP1) LDTP05715 C12(1.50)  LDD3316 
Vesicle transport protein SFT2A (SFT2D1) LDTP09592 C153(1.06)  LDD0547 
Vesicle transport protein SFT2B (SFT2D2) LDTP01630 C158(1.07)  LDD1507 
Vesicle transport protein SFT2C (SFT2D3) LDTP19324 C67(1.03)  LDD1492 
Vesicle transport protein USE1 (USE1) LDTP12872 C17(0.64)  LDD0593 
Vesicle-associated membrane protein 5 (VAMP5) LDTP01519 C9(0.94)  LDD0078 
Vesicle-associated membrane protein 7 (VAMP7) LDTP04468 C21(1.94)  LDD3312 
Vesicle-trafficking protein SEC22a (SEC22A) LDTP10431 C33(1.26); C156(1.25); C172(1.25); C111(1.10)  LDD0078 
Vesicle-trafficking protein SEC22b (SEC22B) LDTP01206 C52(1.04)  LDD1511 
Vigilin (HDLBP) LDTP05239 C940(1.02); C948(1.01)  LDD0078 
Villin-1 (VIL1) LDTP02339 C562(1.25)  LDD3333 
Villin-like protein (VILL) LDTP00566 C397(0.74)  LDD3321 
Vimentin (VIM) LDTP02297 C328(1.04)  LDD0078 
Vinculin (VCL) LDTP02946 C85(0.97)  LDD0078 
Vinexin (SORBS3) LDTP00990 C482(2.91); C521(1.58)  LDD0080 
VIP36-like protein (LMAN2L) LDTP11735 C66(1.89)  LDD3310 
Visinin-like protein 1 (VSNL1) LDTP05003 C187(1.05); C87(1.16)  LDD0531 
Vitamin D-binding protein (GC) LDTP01965 C141(2.05)  LDD3316 
Vitamin K-dependent protein S (PROS1) LDTP02187 C666(3.80)  LDD3311 
Vitelline membrane outer layer protein 1 homolog (VMO1) LDTP17552 C174(4.52)  LDD2275 
von Willebrand factor (VWF) LDTP02033 C372(1.45)  LDD0812 
von Willebrand factor A domain-containing protein 1 (VWA1) LDTP07557 C420(0.86)  LDD1492 
von Willebrand factor A domain-containing protein 2 (VWA2) LDTP06973 C290(0.98)  LDD3310 
von Willebrand factor A domain-containing protein 5A (VWA5A) LDTP14422 C743(1.47); C112(2.20)  LDD3311 
von Willebrand factor A domain-containing protein 5B2 (VWA5B2) LDTP19692 C946(1.31)  LDD0533 
von Willebrand factor A domain-containing protein 8 (VWA8) LDTP00057 C416(1.12); C162(1.00)  LDD0078 
von Willebrand factor D and EGF domain-containing protein (VWDE) LDTP15407 C168(0.85); C179(0.85)  LDD0531 
VPS10 domain-containing receptor SorCS2 (SORCS2) LDTP10693 C210(2.03)  LDD3487 
VPS35 endosomal protein-sorting factor-like (VPS35L) LDTP08035 C315(1.75); C588(1.12)  LDD0080 
WAP four-disulfide core domain protein 1 (WFDC1) LDTP18438 C66(12.21); C78(4.32); C83(3.78); C89(2.35)  LDD2236 
WAP four-disulfide core domain protein 8 (WFDC8) LDTP17609 C68(4.90)  LDD3310 
WAS/WASL-interacting protein family member 2 (WIPF2) LDTP09534 C45(2.10)  LDD3358 
WAS/WASL-interacting protein family member 3 (WIPF3) LDTP14358 C221(0.81)  LDD1508 
WASH complex subunit 5 (WASHC5) LDTP05641 C1064(2.12); C969(3.68); C385(9.24)  LDD0080 
WASP homolog-associated protein with actin, membranes and microtubules (WHAMM) LDTP09522 C609(1.12); C612(1.12)  LDD0078 
WD repeat and coiled-coil-containing protein (WDCP) LDTP11995 C713(1.16); C714(1.16); C574(0.96); C161(0.93)  LDD0078 
WD repeat and FYVE domain-containing protein 1 (WDFY1) LDTP08534 C142(1.37); C290(1.08); C344(1.06); C347(1.06)  LDD0078 
WD repeat and FYVE domain-containing protein 2 (WDFY2) LDTP10658 C290(0.89)  LDD0078 
WD repeat and FYVE domain-containing protein 3 (WDFY3) LDTP08713 C3460(1.40); C3463(1.40); C1945(0.90)  LDD0078 
WD repeat and HMG-box DNA-binding protein 1 (WDHD1) LDTP01299 C285(1.17); C277(1.06)  LDD0078 
WD repeat and SOCS box-containing protein 1 (WSB1) LDTP14258 C126(1.88)  LDD3376 
WD repeat domain phosphoinositide-interacting protein 1 (WIPI1) LDTP07038 C318(3.39)  LDD3310 
WD repeat domain phosphoinositide-interacting protein 2 (WIPI2) LDTP14069 C328(1.03)  LDD0078 
WD repeat domain phosphoinositide-interacting protein 3 (WDR45B) LDTP07037 C63(1.08)  LDD0078 
WD repeat domain phosphoinositide-interacting protein 4 (WDR45) LDTP14029 C166(0.90)  LDD1571 
WD repeat domain-containing protein 83 (WDR83) LDTP11141 C253(11.71)  LDD0204 
WD repeat, SAM and U-box domain-containing protein 1 (WDSUB1) LDTP19757 C316(1.30)  LDD0531 
WD repeat- and FYVE domain-containing protein 4 (WDFY4) LDTP15189 C2510(4.28)  LDD3333 
WD repeat-containing protein 1 (WDR1) LDTP01118 C325(1.08); C170(0.90); C438(0.87); C225(0.85)  LDD0078 
WD repeat-containing protein 11 (WDR11) LDTP11538 C715(1.56); C411(1.40)  LDD0080 
WD repeat-containing protein 13 (WDR13) LDTP18379 C423(0.99); C432(0.99)  LDD0078 
WD repeat-containing protein 17 (WDR17) LDTP19673 C46(10.17)  LDD0209 
WD repeat-containing protein 18 (WDR18) LDTP11264 C384(0.85)  LDD0533 
WD repeat-containing protein 19 (WDR19) LDTP09185 C78(1.17)  LDD0078 
WD repeat-containing protein 20 (WDR20) LDTP09359 C545(2.05)  LDD3310 
WD repeat-containing protein 25 (WDR25) LDTP07291 C255(2.39)  LDD3409 
WD repeat-containing protein 26 (WDR26) LDTP12023 C238(1.11); C656(0.90)  LDD0078 
WD repeat-containing protein 3 (WDR3) LDTP13681 C625(1.34); C44(1.20)  LDD0080 
WD repeat-containing protein 36 (WDR36) LDTP09281 C866(0.88)  LDD0078 
WD repeat-containing protein 37 (WDR37) LDTP13874 C146(0.94)  LDD0078 
WD repeat-containing protein 41 (WDR41) LDTP12123 C131(1.08)  LDD0078 
WD repeat-containing protein 43 (WDR43) LDTP06305 C380(1.17); C341(1.08); C307(1.01); C158(0.85)  LDD0078 
WD repeat-containing protein 44 (WDR44) LDTP07005 C140(1.08); C147(1.08)  LDD0078 
WD repeat-containing protein 46 (WDR46) LDTP00574 C515(1.24); C172(1.20)  LDD0078 
WD repeat-containing protein 48 (WDR48) LDTP09298 C342(1.61); C350(1.61)  LDD0080 
WD repeat-containing protein 5 (WDR5) LDTP04948 C205(1.09)  LDD0531 
WD repeat-containing protein 53 (WDR53) LDTP19607 C63(1.22)  LDD3332 
WD repeat-containing protein 54 (WDR54) LDTP12081 C295(1.18); C299(1.18); C306(1.18)  LDD0078 
WD repeat-containing protein 55 (WDR55) LDTP18402 C258(5.58); C268(5.58); C306(1.44)  LDD0080 
WD repeat-containing protein 5B (WDR5B) LDTP19627 C261(2.06)  LDD3352 
WD repeat-containing protein 62 (WDR62) LDTP00755 C1119(11.34)  LDD0209 
WD repeat-containing protein 7 (WDR7) LDTP18579 C1103(9.31)  LDD0209 
WD repeat-containing protein 70 (WDR70) LDTP18478 C229(0.88)  LDD0078 
WD repeat-containing protein 73 (WDR73) LDTP07536 C227(0.96); C251(0.97)  LDD0531 
WD repeat-containing protein 74 (WDR74) LDTP07628 C134(4.60); C83(6.76)  LDD0209 
WD repeat-containing protein 75 (WDR75) LDTP08529 C100(1.24); C12(0.93); C444(0.88); C451(0.88)  LDD0078 
WD repeat-containing protein 76 (WDR76) LDTP16022 C527(1.00); C81(0.89)  LDD0078 
WD repeat-containing protein 81 (WDR81) LDTP06926 C198(1.10)  LDD0078 
WD repeat-containing protein 89 (WDR89) LDTP19864 C82(1.31)  LDD0078 
WD repeat-containing protein 90 (WDR90) LDTP10522 C240(0.94); C257(0.94)  LDD0531 
WD repeat-containing protein 91 (WDR91) LDTP00063 C246(2.32)  LDD0080 
WD repeat-containing protein 97 (WDR97) LDTP16606 C560(2.38)  LDD2236 
WD repeat-containing protein WRAP73 (WRAP73) LDTP13079 C122(0.79); C14(1.05); C288(0.91); C391(0.80)  LDD0531 
WD40 repeat-containing protein SMU1 (SMU1) LDTP06726 C298(1.13)  LDD0078 
Whirlin (WHRN) LDTP13009 C855(0.88)  LDD3493 
Wilms tumor protein 1-interacting protein (WTIP) LDTP00106 C732(2.32)  LDD3316 
Wings apart-like protein homolog (WAPL) LDTP08094 C1190(21.22)  LDD0204 
WW domain-binding protein 1 (WBP1) LDTP18158 C102(1.05)  LDD1492 
WW domain-binding protein 4 (WBP4) LDTP01254 C18(1.65)  LDD0532 
WW domain-containing adapter protein with coiled-coil (WAC) LDTP11191 C615(0.70)  LDD0531 
WW domain-containing transcription regulator protein 1 (WWTR1) LDTP11658 C262(1.28)  LDD0078 
X antigen family member 1 (XAGE1A; XAGE1B) LDTP16050 C43(2.50)  LDD3316 
X antigen family member 2 (XAGE2) LDTP18162 C82(1.11)  LDD2260 
XIAP-associated factor 1 (XAF1) LDTP07389 C50(1.90)  LDD3310 
Xin actin-binding repeat-containing protein 1 (XIRP1) LDTP07871 C993(2.24); C120(2.50); C675(4.99); C832(15.53)  LDD3401 
YEATS domain-containing protein 2 (YEATS2) LDTP13564 C420(1.10); C434(1.10); C1005(0.86); C996(0.86)  LDD0078 
YEATS domain-containing protein 4 (YEATS4) LDTP01638 C210(1.82)  LDD0080 
YLP motif-containing protein 1 (YLPM1) LDTP04290 C1967(2.01)  LDD3312 
YTH domain-containing family protein 2 (YTHDF2) LDTP14105 C482(1.08)  LDD0078 
YTH domain-containing family protein 3 (YTHDF3) LDTP08136 C439(1.35)  LDD0531 
YTH domain-containing protein 1 (YTHDC1) LDTP10599 C449(6.52)  LDD3409 
YY1-associated protein 1 (YY1AP1) LDTP12050 C789(1.93)  LDD3320 
Z-DNA-binding protein 1 (ZBP1) LDTP11752 C327(2.54)  LDD3377 
Zinc finger and BTB domain-containing protein 10 (ZBTB10) LDTP10229 C335(8.77); C347(8.77); C394(2.08); C248(2.35)  LDD0080 
Zinc finger and SCAN domain-containing protein 18 (ZSCAN18) LDTP09339 C173(1.32)  LDD3313 
Zinc finger C3H1 domain-containing protein (ZFC3H1) LDTP00941 C1864(19.59)  LDD0209 
Zinc finger C3HC-type protein 1 (ZC3HC1) LDTP08325 C502(1.04); C208(0.93)  LDD0078 
Zinc finger CCCH domain-containing protein 10 (ZC3H10) LDTP10497 C92(1.12)  LDD1507 
Zinc finger CCCH domain-containing protein 11A (ZC3H11A) LDTP01143 C27(0.97); C37(0.97)  LDD0078 
Zinc finger CCCH domain-containing protein 11B (ZC3H11B) LDTP18644 C22(1.88)  LDD3313 
Zinc finger CCCH domain-containing protein 13 (ZC3H13) LDTP07099 C1591(1.06); C1592(1.06); C51(0.99); C57(0.99)  LDD0078 
Zinc finger CCCH domain-containing protein 14 (ZC3H14) LDTP07602 C634(0.89); C641(0.89)  LDD0078 
Zinc finger CCCH domain-containing protein 18 (ZC3H18) LDTP08292 C232(1.06); C238(1.06)  LDD0532 
Zinc finger CCCH domain-containing protein 3 (ZC3H3) LDTP08616 C183(0.94); C192(0.94)  LDD0078 
Zinc finger CCCH domain-containing protein 7A (ZC3H7A) LDTP15345 C594(1.10); C907(1.09); C915(1.03); C921(1.03)  LDD0078 
Zinc finger CCCH domain-containing protein 7B (ZC3H7B) LDTP13245 C785(1.15); C791(1.15); C956(1.13); C606(0.86)  LDD0078 
Zinc finger CCCH-type antiviral protein 1 (ZC3HAV1) LDTP08018 C15(1.72); C82(2.12); C78(1.90); C88(1.90)  LDD0080 
Zinc finger CCCH-type antiviral protein 1-like (ZC3HAV1L) LDTP18166 C121(1.02); C125(1.02); C182(0.93); C15(0.85)  LDD0078 
Zinc finger CCHC domain-containing protein 14 (ZCCHC14) LDTP15651 C362(2.12)  LDD3369 
Zinc finger CCHC domain-containing protein 17 (ZCCHC17) LDTP12308 C133(1.05); C146(1.13)  LDD0080 
Zinc finger CCHC domain-containing protein 2 (ZCCHC2) LDTP18349 C133(0.93)  LDD0531 
Zinc finger CCHC domain-containing protein 24 (ZCCHC24) LDTP19687 C227(1.18)  LDD3332 
Zinc finger CCHC domain-containing protein 3 (ZCCHC3) LDTP12623 C373(1.37); C376(1.37)  LDD0080 
Zinc finger CCHC domain-containing protein 7 (ZCCHC7) LDTP08847 C524(1.02); C278(0.98); C286(0.98); C296(0.96)  LDD0078 
Zinc finger CCHC domain-containing protein 8 (ZCCHC8) LDTP07496 C262(1.82); C157(1.16); C393(0.96)  LDD0078 
Zinc finger CCHC domain-containing protein 9 (ZCCHC9) LDTP17712 C213(1.27)  LDD0080 
Zinc finger CCHC-type and RNA-binding motif-containing protein 1 (ZCRB1) LDTP15586 C67(1.61)  LDD0532 
Zinc finger FYVE domain-containing protein 1 (ZFYVE1) LDTP12174 C628(1.78); C631(1.78); C740(2.00); C748(2.00)  LDD0080 
Zinc finger FYVE domain-containing protein 21 (ZFYVE21) LDTP11049 C88(0.95); C99(0.86); C53(0.93); C96(1.04)  LDD1492 
Zinc finger FYVE domain-containing protein 26 (ZFYVE26) LDTP07328 C1843(1.00); C1846(1.00); C1871(0.91)  LDD0078 
Zinc finger FYVE domain-containing protein 9 (ZFYVE9) LDTP01591 C136(3.99); C141(3.99); C515(1.44)  LDD0080 
Zinc finger HIT domain-containing protein 1 (ZNHIT1) LDTP00719 C140(1.44)  LDD3312 
Zinc finger HIT domain-containing protein 2 (ZNHIT2) LDTP16202 C57(1.06); C25(1.00); C30(1.00)  LDD0078 
Zinc finger HIT domain-containing protein 3 (ZNHIT3) LDTP06435 C14(0.96); C6(0.96); C42(0.87)  LDD0078 
Zinc finger matrin-type protein 2 (ZMAT2) LDTP10623 C87(0.95)  LDD1492 
Zinc finger matrin-type protein 3 (ZMAT3) LDTP12115 C107(1.53)  LDD3419 
Zinc finger matrin-type protein 4 (ZMAT4) LDTP16016 C55(2.38)  LDD3344 
Zinc finger matrin-type protein 5 (ZMAT5) LDTP13190 C10(0.91); C7(0.91)  LDD0078 
Zinc finger MYND domain-containing protein 10 (ZMYND10) LDTP01313 C280(66.12)  LDD0209 
Zinc finger MYND domain-containing protein 11 (ZMYND11) LDTP06358 C463(1.08); C467(1.08)  LDD0078 
Zinc finger MYND domain-containing protein 19 (ZMYND19) LDTP10247 C187(0.91)  LDD0531 
Zinc finger protein 106 (ZNF106) LDTP11851 C1307(1.02)  LDD0078 
Zinc finger protein 185 (ZNF185) LDTP00580 C564(2.59); C647(2.52)  LDD3310 
Zinc finger protein 318 (ZNF318) LDTP07223 C1071(2.95); C1075(2.95); C1860(3.53); C475(2.37)  LDD0080 
Zinc finger protein 330 (ZNF330) LDTP14010 C192(1.34); C194(1.34); C186(0.94)  LDD0078 
Zinc finger protein 346 (ZNF346) LDTP13515 C68(0.67); C135(0.90); C79(1.04)  LDD1492 
Zinc finger protein 385B (ZNF385B) LDTP06929 C210(1.46)  LDD0532 
Zinc finger protein 385C (ZNF385C) LDTP15058 C82(4.05)  LDD3410 
Zinc finger protein 428 (ZNF428) LDTP19849 C114(1.49); C115(1.49)  LDD0080 
Zinc finger protein 503 (ZNF503) LDTP10295 C219(0.93)  LDD0531 
Zinc finger protein 608 (ZNF608) LDTP18549 C65(2.34)  LDD3403 
Zinc finger protein 609 (ZNF609) LDTP00507 C944(1.25); C489(0.99); C497(0.99); C502(0.99)  LDD0078 
Zinc finger protein 638 (ZNF638) LDTP06240 C652(1.02)  LDD0078 
Zinc finger protein 703 (ZNF703) LDTP12033 C376(1.24)  LDD0080 
Zinc finger protein 704 (ZNF704) LDTP17470 C55(4.21)  LDD3342 
Zinc finger protein 706 (ZNF706) LDTP20038 C44(0.99)  LDD0533 
Zinc finger protein 830 (ZNF830) LDTP10622 C314(1.45)  LDD0080 
Zinc finger protein DPF3 (DPF3) LDTP09871 C79(1.32)  LDD3404 
Zinc finger protein neuro-d4 (DPF1) LDTP09869 C122(138.31)  LDD0209 
Zinc finger protein ubi-d4 (DPF2) LDTP09872 C53(2.95); C374(1.14); C295(2.07); C298(2.07)  LDD0080 
Zinc finger protein ZPR1 (ZPR1) LDTP01171 C288(1.11); C291(1.11)  LDD0532 
Zinc finger protein-like 1 (ZFPL1) LDTP01510 C56(0.96); C24(0.91); C27(0.91)  LDD0078 
Zinc finger Ran-binding domain-containing protein 2 (ZRANB2) LDTP01530 C88(1.25); C74(1.13); C71(0.99); C85(0.94)  LDD0078 
Zinc finger RNA-binding protein (ZFR) LDTP15762 C844(0.85); C856(0.85)  LDD0078 
Zinc finger SWIM domain-containing protein 1 (ZSWIM1) LDTP19916 C421(0.99)  LDD1507 
Zinc finger SWIM domain-containing protein 6 (ZSWIM6) LDTP18441 C970(0.94)  LDD1508 
Zinc finger SWIM domain-containing protein 8 (ZSWIM8) LDTP00121 C1453(2.55); C507(3.51)  LDD3310 
Zinc finger TRAF-type-containing protein 1 (ZFTRAF1) LDTP16945 C299(1.71)  LDD3310 
Zinc finger ZZ-type and EF-hand domain-containing protein 1 (ZZEF1) LDTP00687 C2312(1.11); C612(1.04); C364(1.00); C369(1.00)  LDD0078 
Zona pellucida sperm-binding protein 3 (ZP3) LDTP03129 C327(1.27)  LDD2250 
ZW10 interactor (ZWINT) LDTP01532 C54(11.79)  LDD0209 
Zyxin (ZYX) LDTP06507 C537(1.10); C540(1.10); C553(1.10); C384(0.94)  LDD0078 
ZZ-type zinc finger-containing protein 3 (ZZZ3) LDTP08649 C823(1.21); C826(1.21); C441(1.01); C442(1.01)  LDD0078 
------------------------------------------------------------------------------------
⏷ Show the Full List of 4808 Other

Competitor(s) Related To This Probe

Competitor ID Name Concentration Cell-system Ref
 LDCM0020  ARS-1620 5 uM Human lung adenocarcinoma cells (HCC44) [1]
 LDCM0021  THZ1 5 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0022  KB02 500 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0023  KB03 500 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0024  KB05 500 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0102  BDHI 8 50 mM Human T acute lymphoblastic leukemia cell lysate (Jurkat) [3]
 LDCM0103  BDHI 10 50 mM Human T acute lymphoblastic leukemia cell lysate (Jurkat) [3]
 LDCM0104  BDHI 13 50 mM Human T acute lymphoblastic leukemia cell lysate (Jurkat) [3]
 LDCM0105  BDHI 14 50 mM Human T acute lymphoblastic leukemia cell lysate (Jurkat) [3]
 LDCM0106  BDHI 18 50 mM Human T acute lymphoblastic leukemia cell lysate (Jurkat) [3]
 LDCM0214  AC1 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0215  AC10 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0216  AC100 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0217  AC101 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0218  AC102 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0219  AC103 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0220  AC104 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0221  AC105 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0222  AC106 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0223  AC107 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0224  AC108 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0225  AC109 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0226  AC11 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0227  AC110 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0228  AC111 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0229  AC112 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0230  AC113 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0231  AC114 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0232  AC115 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0233  AC116 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0234  AC117 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0235  AC118 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0236  AC119 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0237  AC12 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0238  AC120 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0239  AC121 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0240  AC122 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0241  AC123 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0242  AC124 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0243  AC125 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0244  AC126 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0245  AC127 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0246  AC128 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0247  AC129 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0248  AKOS034007472 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0249  AC130 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0250  AC131 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0251  AC132 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0252  AC133 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0253  AC134 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0254  AC135 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0255  AC136 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0256  AC137 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0257  AC138 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0258  AC139 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0259  AC14 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0260  AC140 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0261  AC141 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0262  AC142 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0263  AC143 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0264  AC144 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0265  AC145 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0266  AC146 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0267  AC147 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0268  AC148 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0269  AC149 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0270  AC15 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0271  AC150 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0272  AC151 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0273  AC152 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0274  AC153 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0275  AKOS034007705 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0276  AC17 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0277  AC18 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0278  AC19 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0279  AC2 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0280  AC20 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0281  AC21 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0282  AC22 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0283  AC23 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0284  AC24 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0285  AC25 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0286  AC26 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0287  AC27 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0288  AC28 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0289  AC29 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0290  AC3 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0291  AC30 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0292  AC31 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0293  AC32 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0294  AC33 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0295  AC34 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0296  AC35 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0297  AC36 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0298  AC37 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0299  AC38 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0300  AC39 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0301  AC4 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0302  AC40 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0303  AC41 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0304  AC42 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0305  AC43 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0306  AC44 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0307  AC45 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0308  AC46 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0309  AC47 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0310  AC48 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0311  AC49 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0312  AC5 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0313  AC50 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0314  AC51 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0315  AC52 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0316  AC53 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0317  AC54 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0318  AC55 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0319  AC56 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0320  AC57 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0321  AC58 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0322  AC59 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0323  AC6 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0324  AC60 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0325  AC61 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0326  AC62 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0327  AC63 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0328  AC64 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0329  AC65 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0330  AC66 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0331  AC67 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0332  AC68 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0333  AC69 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0334  AC7 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0335  AC70 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0336  AC71 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0337  AC72 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0338  AC73 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0339  AC74 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0340  AC75 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0341  AC76 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0342  AC77 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0343  AC78 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0344  AC79 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0345  AC8 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0346  AC80 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0347  AC81 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0348  AC82 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0349  AC83 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0350  AC84 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0351  AC85 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0352  AC86 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0353  AC87 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0354  AC88 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0355  AC89 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0356  AKOS034007680 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0357  AC90 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0358  AC91 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0359  AC92 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0360  AC93 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0361  AC94 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0362  AC95 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0363  AC96 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0364  AC97 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0365  AC98 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0366  AC99 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0367  CL1 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0368  CL10 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0369  CL100 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0370  CL101 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0371  CL102 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0372  CL103 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0373  CL104 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0374  CL105 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0375  CL106 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0376  CL107 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0377  CL108 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0378  CL109 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0379  CL11 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0380  CL110 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0381  CL111 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0382  CL112 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0383  CL113 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0384  CL114 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0385  CL115 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0386  CL116 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0387  CL117 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0388  CL118 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0389  CL119 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0390  CL12 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0391  CL120 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0392  CL121 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0393  CL122 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0394  CL123 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0395  CL124 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0396  CL125 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0397  CL126 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0398  CL127 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0399  CL128 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0400  CL13 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0401  CL14 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0402  CL15 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0403  CL16 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0404  CL17 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0405  CL18 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0406  CL19 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0407  CL2 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0408  CL20 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0409  CL21 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0410  CL22 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0411  CL23 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0412  CL24 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0413  CL25 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0414  CL26 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0415  CL27 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0416  CL28 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0417  CL29 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0418  CL3 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0419  CL30 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0420  CL31 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0421  CL32 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0422  CL33 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0423  CL34 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0424  CL35 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0425  CL36 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0426  CL37 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0427  Fragment51 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0428  CL39 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0429  CL4 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0430  CL40 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0431  CL41 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0432  CL42 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0433  CL43 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0434  CL44 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0435  CL45 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0436  CL46 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0437  CL47 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0438  CL48 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0439  CL49 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0440  CL5 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0441  CL50 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0442  CL51 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0443  CL52 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0444  CL53 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0445  CL54 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0446  CL55 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0447  CL56 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0448  CL57 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0449  CL58 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0450  CL59 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0451  CL6 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0452  CL60 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0453  CL61 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0454  CL62 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0455  CL63 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0456  CL64 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0457  CL65 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0458  CL66 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0459  CL67 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0460  CL68 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0461  CL69 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0462  CL7 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0463  CL70 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0464  CL71 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0465  CL72 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0466  CL73 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0467  CL74 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0468  Fragment33 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0469  CL76 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0470  CL77 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0471  CL78 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0472  CL79 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0473  CL8 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0474  CL80 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0475  CL81 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0476  CL82 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0477  CL83 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0478  CL84 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0479  CL85 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0480  CL86 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0481  CL87 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0482  CL88 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0483  CL89 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0484  CL9 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0485  CL90 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0486  CL91 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0487  CL92 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0488  CL93 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0489  CL94 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0490  CL95 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0491  CL96 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0492  CL97 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0493  CL98 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0494  CL99 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0495  E2913 50 uM Human normal cell lysate (HEK-293T) [4]
 LDCM0621  AC154 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0622  AC155 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0623  AC156 25 uM Human colon carcinoma cell lysate (HCT 116) [1]
 LDCM0624  AC157 25 uM Human colon carcinoma cell lysate (HCT 116) [1]

Full Information of The Labelling Profiles of This Probe

Quantification: Probe vs (Probe+Competitor)
  
Experiment 1 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
ARS-1620
 Competitor Info 
Competitor Concentration
5 uM
In Vitro Experiment Model
Model Type
Living cell
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cells (HCC44)
Interaction Atlas ID
 LDD0078 
Download The Altas
  
Experiment 2 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
THZ1
 Competitor Info 
Competitor Concentration
5 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0079 
Download The Altas
  
Experiment 3 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0080 
Download The Altas
  
Experiment 4 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0081 
Download The Altas
  
Experiment 5 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0082 
Download The Altas
  
Experiment 6 Reporting the Labelling Profiles of This Probe
REF [3]
Probe concentration
50 mM
Quantitative Method
TMT
Competitor Name
BDHI 8
 Competitor Info 
Competitor Concentration
50 mM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD0204 
Download The Altas
  
Experiment 7 Reporting the Labelling Profiles of This Probe
REF [3]
Probe concentration
50 mM
Quantitative Method
TMT
Competitor Name
BDHI 10
 Competitor Info 
Competitor Concentration
50 mM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD0205 
Download The Altas
  
Experiment 8 Reporting the Labelling Profiles of This Probe
REF [3]
Probe concentration
50 mM
Quantitative Method
TMT
Competitor Name
BDHI 13
 Competitor Info 
Competitor Concentration
50 mM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD0206 
Download The Altas
  
Experiment 9 Reporting the Labelling Profiles of This Probe
REF [3]
Probe concentration
50 mM
Quantitative Method
TMT
Competitor Name
BDHI 14
 Competitor Info 
Competitor Concentration
50 mM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD0207 
Download The Altas
  
Experiment 10 Reporting the Labelling Profiles of This Probe
REF [3]
Probe concentration
50 mM
Quantitative Method
TMT
Competitor Name
BDHI 18
 Competitor Info 
Competitor Concentration
50 mM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD0208 
Download The Altas
  
Experiment 11 Reporting the Labelling Profiles of This Probe
REF [3]
Probe concentration
50 mM
Quantitative Method
TMT
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
50 mM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD0209 
Download The Altas
  
Experiment 12 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Competitor Name
THZ1
 Competitor Info 
Competitor Concentration
1 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0458 
Download The Altas
  
Experiment 13 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Competitor Name
ARS-1620
 Competitor Info 
Competitor Concentration
1 uM
In Vitro Experiment Model
Model Type
Living cell
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cells (HCC44)
Interaction Atlas ID
 LDD0459 
Download The Altas
  
Experiment 14 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC1
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0531 
Download The Altas
  
Experiment 15 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC10
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0532 
Download The Altas
  
Experiment 16 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC100
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0533 
Download The Altas
  
Experiment 17 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC101
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0534 
Download The Altas
  
Experiment 18 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC102
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0535 
Download The Altas
  
Experiment 19 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC103
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0536 
Download The Altas
  
Experiment 20 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC104
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0537 
Download The Altas
  
Experiment 21 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC105
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0538 
Download The Altas
  
Experiment 22 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC106
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0539 
Download The Altas
  
Experiment 23 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC107
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0540 
Download The Altas
  
Experiment 24 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC108
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0541 
Download The Altas
  
Experiment 25 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC109
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0542 
Download The Altas
  
Experiment 26 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC11
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0543 
Download The Altas
  
Experiment 27 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC110
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0544 
Download The Altas
  
Experiment 28 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC111
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0545 
Download The Altas
  
Experiment 29 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC112
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0546 
Download The Altas
  
Experiment 30 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC113
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0547 
Download The Altas
  
Experiment 31 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC114
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0548 
Download The Altas
  
Experiment 32 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC115
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0549 
Download The Altas
  
Experiment 33 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC116
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0550 
Download The Altas
  
Experiment 34 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC117
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0551 
Download The Altas
  
Experiment 35 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC118
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0552 
Download The Altas
  
Experiment 36 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC119
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0553 
Download The Altas
  
Experiment 37 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC12
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0554 
Download The Altas
  
Experiment 38 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC120
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0555 
Download The Altas
  
Experiment 39 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC121
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0556 
Download The Altas
  
Experiment 40 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC122
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0557 
Download The Altas
  
Experiment 41 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC123
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0558 
Download The Altas
  
Experiment 42 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC124
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0559 
Download The Altas
  
Experiment 43 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC125
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0560 
Download The Altas
  
Experiment 44 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC126
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0561 
Download The Altas
  
Experiment 45 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC127
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0562 
Download The Altas
  
Experiment 46 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC128
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0563 
Download The Altas
  
Experiment 47 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC129
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0564 
Download The Altas
  
Experiment 48 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007472
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0565 
Download The Altas
  
Experiment 49 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC130
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0566 
Download The Altas
  
Experiment 50 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC131
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0567 
Download The Altas
  
Experiment 51 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC132
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0568 
Download The Altas
  
Experiment 52 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC133
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0569 
Download The Altas
  
Experiment 53 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC134
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0570 
Download The Altas
  
Experiment 54 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC135
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0571 
Download The Altas
  
Experiment 55 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC136
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0572 
Download The Altas
  
Experiment 56 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC137
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0573 
Download The Altas
  
Experiment 57 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC138
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0574 
Download The Altas
  
Experiment 58 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC139
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0575 
Download The Altas
  
Experiment 59 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC14
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0576 
Download The Altas
  
Experiment 60 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC140
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0577 
Download The Altas
  
Experiment 61 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC141
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0578 
Download The Altas
  
Experiment 62 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC142
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0579 
Download The Altas
  
Experiment 63 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC143
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0580 
Download The Altas
  
Experiment 64 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC144
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0581 
Download The Altas
  
Experiment 65 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC145
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0582 
Download The Altas
  
Experiment 66 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC146
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0583 
Download The Altas
  
Experiment 67 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC147
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0584 
Download The Altas
  
Experiment 68 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC148
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0585 
Download The Altas
  
Experiment 69 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC149
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0586 
Download The Altas
  
Experiment 70 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC15
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0587 
Download The Altas
  
Experiment 71 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC150
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0588 
Download The Altas
  
Experiment 72 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC151
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0589 
Download The Altas
  
Experiment 73 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC152
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0590 
Download The Altas
  
Experiment 74 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC153
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0591 
Download The Altas
  
Experiment 75 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007705
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0592 
Download The Altas
  
Experiment 76 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC17
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0593 
Download The Altas
  
Experiment 77 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC18
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0594 
Download The Altas
  
Experiment 78 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC19
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0595 
Download The Altas
  
Experiment 79 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC2
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0596 
Download The Altas
  
Experiment 80 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC20
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0597 
Download The Altas
  
Experiment 81 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC21
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0598 
Download The Altas
  
Experiment 82 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC22
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0599 
Download The Altas
  
Experiment 83 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC23
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0600 
Download The Altas
  
Experiment 84 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC24
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0601 
Download The Altas
  
Experiment 85 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC25
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0602 
Download The Altas
  
Experiment 86 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC26
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0603 
Download The Altas
  
Experiment 87 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC27
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0604 
Download The Altas
  
Experiment 88 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC28
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0605 
Download The Altas
  
Experiment 89 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC29
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0606 
Download The Altas
  
Experiment 90 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC3
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0607 
Download The Altas
  
Experiment 91 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC30
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0608 
Download The Altas
  
Experiment 92 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC31
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0609 
Download The Altas
  
Experiment 93 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC32
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0610 
Download The Altas
  
Experiment 94 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0611 
Download The Altas
  
Experiment 95 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC34
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0612 
Download The Altas
  
Experiment 96 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC35
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0613 
Download The Altas
  
Experiment 97 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC36
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0614 
Download The Altas
  
Experiment 98 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC37
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0615 
Download The Altas
  
Experiment 99 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC38
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0616 
Download The Altas
  
Experiment 100 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC39
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0617 
Download The Altas
  
Experiment 101 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC4
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0618 
Download The Altas
  
Experiment 102 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC40
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0619 
Download The Altas
  
Experiment 103 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC41
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0620 
Download The Altas
  
Experiment 104 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC42
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0621 
Download The Altas
  
Experiment 105 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC43
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0622 
Download The Altas
  
Experiment 106 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC44
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0623 
Download The Altas
  
Experiment 107 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC45
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0624 
Download The Altas
  
Experiment 108 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC46
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0625 
Download The Altas
  
Experiment 109 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC47
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0626 
Download The Altas
  
Experiment 110 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC48
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0627 
Download The Altas
  
Experiment 111 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC49
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0628 
Download The Altas
  
Experiment 112 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC5
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0629 
Download The Altas
  
Experiment 113 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC50
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0630 
Download The Altas
  
Experiment 114 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0631 
Download The Altas
  
Experiment 115 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC52
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0632 
Download The Altas
  
Experiment 116 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC53
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0633 
Download The Altas
  
Experiment 117 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC54
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0634 
Download The Altas
  
Experiment 118 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC55
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0635 
Download The Altas
  
Experiment 119 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC56
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0636 
Download The Altas
  
Experiment 120 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC57
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0637 
Download The Altas
  
Experiment 121 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC58
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0638 
Download The Altas
  
Experiment 122 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC59
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0639 
Download The Altas
  
Experiment 123 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC6
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0640 
Download The Altas
  
Experiment 124 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC60
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0641 
Download The Altas
  
Experiment 125 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC61
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0642 
Download The Altas
  
Experiment 126 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC62
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0643 
Download The Altas
  
Experiment 127 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC63
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0644 
Download The Altas
  
Experiment 128 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC64
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0645 
Download The Altas
  
Experiment 129 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC65
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0646 
Download The Altas
  
Experiment 130 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC66
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0647 
Download The Altas
  
Experiment 131 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC67
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0648 
Download The Altas
  
Experiment 132 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC68
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0649 
Download The Altas
  
Experiment 133 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC69
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0650 
Download The Altas
  
Experiment 134 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC7
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0651 
Download The Altas
  
Experiment 135 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC70
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0652 
Download The Altas
  
Experiment 136 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC71
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0653 
Download The Altas
  
Experiment 137 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC72
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0654 
Download The Altas
  
Experiment 138 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC73
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0655 
Download The Altas
  
Experiment 139 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC74
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0656 
Download The Altas
  
Experiment 140 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC75
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0657 
Download The Altas
  
Experiment 141 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC76
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0658 
Download The Altas
  
Experiment 142 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC77
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0659 
Download The Altas
  
Experiment 143 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC78
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0660 
Download The Altas
  
Experiment 144 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC79
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0661 
Download The Altas
  
Experiment 145 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC8
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0662 
Download The Altas
  
Experiment 146 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC80
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0663 
Download The Altas
  
Experiment 147 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC81
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0664 
Download The Altas
  
Experiment 148 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC82
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0665 
Download The Altas
  
Experiment 149 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC83
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0666 
Download The Altas
  
Experiment 150 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC84
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0667 
Download The Altas
  
Experiment 151 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC85
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0668 
Download The Altas
  
Experiment 152 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC86
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0669 
Download The Altas
  
Experiment 153 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC87
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0670 
Download The Altas
  
Experiment 154 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC88
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0671 
Download The Altas
  
Experiment 155 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC89
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0672 
Download The Altas
  
Experiment 156 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007680
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0673 
Download The Altas
  
Experiment 157 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC90
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0674 
Download The Altas
  
Experiment 158 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC91
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0675 
Download The Altas
  
Experiment 159 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC92
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0676 
Download The Altas
  
Experiment 160 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC93
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0677 
Download The Altas
  
Experiment 161 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC94
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0678 
Download The Altas
  
Experiment 162 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC95
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0679 
Download The Altas
  
Experiment 163 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC96
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0680 
Download The Altas
  
Experiment 164 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC97
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0681 
Download The Altas
  
Experiment 165 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC98
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0682 
Download The Altas
  
Experiment 166 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC99
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0683 
Download The Altas
  
Experiment 167 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL1
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0684 
Download The Altas
  
Experiment 168 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL10
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0685 
Download The Altas
  
Experiment 169 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL100
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0686 
Download The Altas
  
Experiment 170 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL101
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0687 
Download The Altas
  
Experiment 171 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL102
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0688 
Download The Altas
  
Experiment 172 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL103
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0689 
Download The Altas
  
Experiment 173 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL104
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0690 
Download The Altas
  
Experiment 174 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL105
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0691 
Download The Altas
  
Experiment 175 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL106
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0692 
Download The Altas
  
Experiment 176 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL107
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0693 
Download The Altas
  
Experiment 177 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL108
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0694 
Download The Altas
  
Experiment 178 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL109
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0695 
Download The Altas
  
Experiment 179 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL11
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0696 
Download The Altas
  
Experiment 180 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL110
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0697 
Download The Altas
  
Experiment 181 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL111
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0698 
Download The Altas
  
Experiment 182 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL112
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0699 
Download The Altas
  
Experiment 183 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL113
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0700 
Download The Altas
  
Experiment 184 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL114
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0701 
Download The Altas
  
Experiment 185 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL115
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0702 
Download The Altas
  
Experiment 186 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL116
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0703 
Download The Altas
  
Experiment 187 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL117
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0704 
Download The Altas
  
Experiment 188 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL118
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0705 
Download The Altas
  
Experiment 189 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL119
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0706 
Download The Altas
  
Experiment 190 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL12
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0707 
Download The Altas
  
Experiment 191 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL120
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0708 
Download The Altas
  
Experiment 192 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL121
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0709 
Download The Altas
  
Experiment 193 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL122
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0710 
Download The Altas
  
Experiment 194 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL123
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0711 
Download The Altas
  
Experiment 195 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL124
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0712 
Download The Altas
  
Experiment 196 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL125
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0713 
Download The Altas
  
Experiment 197 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL126
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0714 
Download The Altas
  
Experiment 198 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL127
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0715 
Download The Altas
  
Experiment 199 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL128
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0716 
Download The Altas
  
Experiment 200 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL13
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0717 
Download The Altas
  
Experiment 201 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL14
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0718 
Download The Altas
  
Experiment 202 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL15
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0719 
Download The Altas
  
Experiment 203 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL16
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0720 
Download The Altas
  
Experiment 204 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL17
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0721 
Download The Altas
  
Experiment 205 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL18
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0722 
Download The Altas
  
Experiment 206 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL19
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0723 
Download The Altas
  
Experiment 207 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL2
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0724 
Download The Altas
  
Experiment 208 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL20
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0725 
Download The Altas
  
Experiment 209 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL21
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0726 
Download The Altas
  
Experiment 210 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL22
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0727 
Download The Altas
  
Experiment 211 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL23
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0728 
Download The Altas
  
Experiment 212 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL24
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0729 
Download The Altas
  
Experiment 213 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL25
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0730 
Download The Altas
  
Experiment 214 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL26
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0731 
Download The Altas
  
Experiment 215 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL27
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0732 
Download The Altas
  
Experiment 216 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL28
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0733 
Download The Altas
  
Experiment 217 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL29
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0734 
Download The Altas
  
Experiment 218 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL3
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0735 
Download The Altas
  
Experiment 219 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL30
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0736 
Download The Altas
  
Experiment 220 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL31
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0737 
Download The Altas
  
Experiment 221 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL32
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0738 
Download The Altas
  
Experiment 222 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0739 
Download The Altas
  
Experiment 223 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL34
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0740 
Download The Altas
  
Experiment 224 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL35
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0741 
Download The Altas
  
Experiment 225 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL36
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0742 
Download The Altas
  
Experiment 226 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL37
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0743 
Download The Altas
  
Experiment 227 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0744 
Download The Altas
  
Experiment 228 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL39
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0745 
Download The Altas
  
Experiment 229 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL4
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0746 
Download The Altas
  
Experiment 230 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL40
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0747 
Download The Altas
  
Experiment 231 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL41
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0748 
Download The Altas
  
Experiment 232 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL42
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0749 
Download The Altas
  
Experiment 233 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL43
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0750 
Download The Altas
  
Experiment 234 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL44
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0751 
Download The Altas
  
Experiment 235 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL45
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0752 
Download The Altas
  
Experiment 236 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL46
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0753 
Download The Altas
  
Experiment 237 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL47
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0754 
Download The Altas
  
Experiment 238 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL48
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0755 
Download The Altas
  
Experiment 239 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL49
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0756 
Download The Altas
  
Experiment 240 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL5
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0757 
Download The Altas
  
Experiment 241 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL50
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0758 
Download The Altas
  
Experiment 242 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0759 
Download The Altas
  
Experiment 243 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL52
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0760 
Download The Altas
  
Experiment 244 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL53
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0761 
Download The Altas
  
Experiment 245 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL54
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0762 
Download The Altas
  
Experiment 246 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL55
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0763 
Download The Altas
  
Experiment 247 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL56
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0764 
Download The Altas
  
Experiment 248 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL57
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0765 
Download The Altas
  
Experiment 249 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL58
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0766 
Download The Altas
  
Experiment 250 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL59
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0767 
Download The Altas
  
Experiment 251 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL6
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0768 
Download The Altas
  
Experiment 252 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL60
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0769 
Download The Altas
  
Experiment 253 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL61
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0770 
Download The Altas
  
Experiment 254 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL62
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0771 
Download The Altas
  
Experiment 255 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL63
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0772 
Download The Altas
  
Experiment 256 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL64
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0773 
Download The Altas
  
Experiment 257 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL65
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0774 
Download The Altas
  
Experiment 258 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL66
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0775 
Download The Altas
  
Experiment 259 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL67
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0776 
Download The Altas
  
Experiment 260 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL68
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0777 
Download The Altas
  
Experiment 261 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL69
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0778 
Download The Altas
  
Experiment 262 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL7
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0779 
Download The Altas
  
Experiment 263 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL70
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0780 
Download The Altas
  
Experiment 264 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL71
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0781 
Download The Altas
  
Experiment 265 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL72
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0782 
Download The Altas
  
Experiment 266 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL73
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0783 
Download The Altas
  
Experiment 267 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL74
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0784 
Download The Altas
  
Experiment 268 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0785 
Download The Altas
  
Experiment 269 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL76
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0786 
Download The Altas
  
Experiment 270 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL77
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0787 
Download The Altas
  
Experiment 271 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL78
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0788 
Download The Altas
  
Experiment 272 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL79
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0789 
Download The Altas
  
Experiment 273 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL8
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0790 
Download The Altas
  
Experiment 274 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL80
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0791 
Download The Altas
  
Experiment 275 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL81
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0792 
Download The Altas
  
Experiment 276 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL82
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0793 
Download The Altas
  
Experiment 277 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL83
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0794 
Download The Altas
  
Experiment 278 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL84
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0795 
Download The Altas
  
Experiment 279 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL85
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0796 
Download The Altas
  
Experiment 280 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL86
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0797 
Download The Altas
  
Experiment 281 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL87
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0798 
Download The Altas
  
Experiment 282 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL88
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0799 
Download The Altas
  
Experiment 283 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL89
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0800 
Download The Altas
  
Experiment 284 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL9
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0801 
Download The Altas
  
Experiment 285 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL90
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0802 
Download The Altas
  
Experiment 286 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL91
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0803 
Download The Altas
  
Experiment 287 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL92
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0804 
Download The Altas
  
Experiment 288 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL93
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0805 
Download The Altas
  
Experiment 289 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL94
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0806 
Download The Altas
  
Experiment 290 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL95
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0807 
Download The Altas
  
Experiment 291 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL96
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0808 
Download The Altas
  
Experiment 292 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL97
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0809 
Download The Altas
  
Experiment 293 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL98
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0810 
Download The Altas
  
Experiment 294 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL99
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD0811 
Download The Altas
  
Experiment 295 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC1
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0812 
Download The Altas
  
Experiment 296 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC10
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0813 
Download The Altas
  
Experiment 297 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC100
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0814 
Download The Altas
  
Experiment 298 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC101
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0815 
Download The Altas
  
Experiment 299 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC102
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0816 
Download The Altas
  
Experiment 300 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC103
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0817 
Download The Altas
  
Experiment 301 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC104
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0818 
Download The Altas
  
Experiment 302 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC105
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0819 
Download The Altas
  
Experiment 303 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC106
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0820 
Download The Altas
  
Experiment 304 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC107
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0821 
Download The Altas
  
Experiment 305 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC108
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0822 
Download The Altas
  
Experiment 306 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC109
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0823 
Download The Altas
  
Experiment 307 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC11
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0824 
Download The Altas
  
Experiment 308 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC110
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0825 
Download The Altas
  
Experiment 309 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC111
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0826 
Download The Altas
  
Experiment 310 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC112
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0827 
Download The Altas
  
Experiment 311 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC113
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0828 
Download The Altas
  
Experiment 312 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC114
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0829 
Download The Altas
  
Experiment 313 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC115
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0830 
Download The Altas
  
Experiment 314 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC116
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0831 
Download The Altas
  
Experiment 315 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC117
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0832 
Download The Altas
  
Experiment 316 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC118
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0833 
Download The Altas
  
Experiment 317 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC119
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0834 
Download The Altas
  
Experiment 318 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC12
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0835 
Download The Altas
  
Experiment 319 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC120
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0836 
Download The Altas
  
Experiment 320 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC121
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0837 
Download The Altas
  
Experiment 321 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC122
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0838 
Download The Altas
  
Experiment 322 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC123
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0839 
Download The Altas
  
Experiment 323 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC124
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0840 
Download The Altas
  
Experiment 324 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC125
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0841 
Download The Altas
  
Experiment 325 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC126
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0842 
Download The Altas
  
Experiment 326 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC127
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0843 
Download The Altas
  
Experiment 327 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC128
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0844 
Download The Altas
  
Experiment 328 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC129
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0845 
Download The Altas
  
Experiment 329 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007472
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0846 
Download The Altas
  
Experiment 330 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC130
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0847 
Download The Altas
  
Experiment 331 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC131
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0848 
Download The Altas
  
Experiment 332 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC132
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0849 
Download The Altas
  
Experiment 333 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC133
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0850 
Download The Altas
  
Experiment 334 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC134
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0851 
Download The Altas
  
Experiment 335 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC135
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0852 
Download The Altas
  
Experiment 336 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC136
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0853 
Download The Altas
  
Experiment 337 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC137
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0854 
Download The Altas
  
Experiment 338 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC138
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0855 
Download The Altas
  
Experiment 339 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC139
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0856 
Download The Altas
  
Experiment 340 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC14
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0857 
Download The Altas
  
Experiment 341 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC140
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0858 
Download The Altas
  
Experiment 342 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC141
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0859 
Download The Altas
  
Experiment 343 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC142
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0860 
Download The Altas
  
Experiment 344 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC143
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0861 
Download The Altas
  
Experiment 345 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC144
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0862 
Download The Altas
  
Experiment 346 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC145
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0863 
Download The Altas
  
Experiment 347 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC146
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0864 
Download The Altas
  
Experiment 348 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC147
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0865 
Download The Altas
  
Experiment 349 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC148
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0866 
Download The Altas
  
Experiment 350 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC149
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0867 
Download The Altas
  
Experiment 351 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC15
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0868 
Download The Altas
  
Experiment 352 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC150
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0869 
Download The Altas
  
Experiment 353 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC151
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0870 
Download The Altas
  
Experiment 354 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC152
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0871 
Download The Altas
  
Experiment 355 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC153
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0872 
Download The Altas
  
Experiment 356 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007705
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0873 
Download The Altas
  
Experiment 357 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC17
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0874 
Download The Altas
  
Experiment 358 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC18
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0875 
Download The Altas
  
Experiment 359 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC19
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0876 
Download The Altas
  
Experiment 360 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC2
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0877 
Download The Altas
  
Experiment 361 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC20
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0878 
Download The Altas
  
Experiment 362 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC21
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0879 
Download The Altas
  
Experiment 363 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC22
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0880 
Download The Altas
  
Experiment 364 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC23
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0881 
Download The Altas
  
Experiment 365 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC24
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0882 
Download The Altas
  
Experiment 366 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC25
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0883 
Download The Altas
  
Experiment 367 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC26
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0884 
Download The Altas
  
Experiment 368 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC27
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0885 
Download The Altas
  
Experiment 369 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC28
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0886 
Download The Altas
  
Experiment 370 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC29
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0887 
Download The Altas
  
Experiment 371 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC3
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0888 
Download The Altas
  
Experiment 372 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC30
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0889 
Download The Altas
  
Experiment 373 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC31
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0890 
Download The Altas
  
Experiment 374 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC32
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0891 
Download The Altas
  
Experiment 375 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0892 
Download The Altas
  
Experiment 376 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC34
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0893 
Download The Altas
  
Experiment 377 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC35
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0894 
Download The Altas
  
Experiment 378 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC36
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0895 
Download The Altas
  
Experiment 379 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC37
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0896 
Download The Altas
  
Experiment 380 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC38
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0897 
Download The Altas
  
Experiment 381 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC39
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0898 
Download The Altas
  
Experiment 382 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC4
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0899 
Download The Altas
  
Experiment 383 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC40
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0900 
Download The Altas
  
Experiment 384 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC41
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0901 
Download The Altas
  
Experiment 385 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC42
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0902 
Download The Altas
  
Experiment 386 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC43
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0903 
Download The Altas
  
Experiment 387 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC44
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0904 
Download The Altas
  
Experiment 388 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC45
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0905 
Download The Altas
  
Experiment 389 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC46
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0906 
Download The Altas
  
Experiment 390 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC47
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0907 
Download The Altas
  
Experiment 391 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC48
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0908 
Download The Altas
  
Experiment 392 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC49
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0909 
Download The Altas
  
Experiment 393 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC5
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0910 
Download The Altas
  
Experiment 394 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC50
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0911 
Download The Altas
  
Experiment 395 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0912 
Download The Altas
  
Experiment 396 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC52
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0913 
Download The Altas
  
Experiment 397 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC53
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0914 
Download The Altas
  
Experiment 398 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC54
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0915 
Download The Altas
  
Experiment 399 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC55
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0916 
Download The Altas
  
Experiment 400 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC56
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0917 
Download The Altas
  
Experiment 401 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC57
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0918 
Download The Altas
  
Experiment 402 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC58
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0919 
Download The Altas
  
Experiment 403 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC59
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0920 
Download The Altas
  
Experiment 404 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC6
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0921 
Download The Altas
  
Experiment 405 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC60
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0922 
Download The Altas
  
Experiment 406 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC61
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0923 
Download The Altas
  
Experiment 407 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC62
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0924 
Download The Altas
  
Experiment 408 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC63
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0925 
Download The Altas
  
Experiment 409 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC64
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0926 
Download The Altas
  
Experiment 410 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC65
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0927 
Download The Altas
  
Experiment 411 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC66
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0928 
Download The Altas
  
Experiment 412 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC67
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0929 
Download The Altas
  
Experiment 413 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC68
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0930 
Download The Altas
  
Experiment 414 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC69
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0931 
Download The Altas
  
Experiment 415 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC7
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0932 
Download The Altas
  
Experiment 416 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC70
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0933 
Download The Altas
  
Experiment 417 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC71
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0934 
Download The Altas
  
Experiment 418 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC72
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0935 
Download The Altas
  
Experiment 419 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC73
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0936 
Download The Altas
  
Experiment 420 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC74
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0937 
Download The Altas
  
Experiment 421 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC75
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0938 
Download The Altas
  
Experiment 422 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC76
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0939 
Download The Altas
  
Experiment 423 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC77
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0940 
Download The Altas
  
Experiment 424 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC78
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0941 
Download The Altas
  
Experiment 425 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC79
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0942 
Download The Altas
  
Experiment 426 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC8
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0943 
Download The Altas
  
Experiment 427 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC80
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0944 
Download The Altas
  
Experiment 428 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC81
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0945 
Download The Altas
  
Experiment 429 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC82
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0946 
Download The Altas
  
Experiment 430 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC83
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0947 
Download The Altas
  
Experiment 431 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC84
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0948 
Download The Altas
  
Experiment 432 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC85
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0949 
Download The Altas
  
Experiment 433 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC86
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0950 
Download The Altas
  
Experiment 434 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC87
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0951 
Download The Altas
  
Experiment 435 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC88
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0952 
Download The Altas
  
Experiment 436 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC89
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0953 
Download The Altas
  
Experiment 437 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007680
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0954 
Download The Altas
  
Experiment 438 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC90
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0955 
Download The Altas
  
Experiment 439 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC91
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0956 
Download The Altas
  
Experiment 440 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC92
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0957 
Download The Altas
  
Experiment 441 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC93
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0958 
Download The Altas
  
Experiment 442 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC94
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0959 
Download The Altas
  
Experiment 443 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC95
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0960 
Download The Altas
  
Experiment 444 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC96
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0961 
Download The Altas
  
Experiment 445 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC97
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0962 
Download The Altas
  
Experiment 446 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC98
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0963 
Download The Altas
  
Experiment 447 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC99
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0964 
Download The Altas
  
Experiment 448 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL1
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0965 
Download The Altas
  
Experiment 449 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL10
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0966 
Download The Altas
  
Experiment 450 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL100
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0967 
Download The Altas
  
Experiment 451 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL101
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0968 
Download The Altas
  
Experiment 452 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL102
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0969 
Download The Altas
  
Experiment 453 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL103
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0970 
Download The Altas
  
Experiment 454 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL104
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0971 
Download The Altas
  
Experiment 455 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL105
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0972 
Download The Altas
  
Experiment 456 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL106
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0973 
Download The Altas
  
Experiment 457 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL107
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0974 
Download The Altas
  
Experiment 458 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL108
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0975 
Download The Altas
  
Experiment 459 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL109
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0976 
Download The Altas
  
Experiment 460 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL11
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0977 
Download The Altas
  
Experiment 461 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL110
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0978 
Download The Altas
  
Experiment 462 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL111
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0979 
Download The Altas
  
Experiment 463 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL112
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0980 
Download The Altas
  
Experiment 464 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL113
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0981 
Download The Altas
  
Experiment 465 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL114
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0982 
Download The Altas
  
Experiment 466 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL115
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0983 
Download The Altas
  
Experiment 467 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL116
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0984 
Download The Altas
  
Experiment 468 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL117
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0985 
Download The Altas
  
Experiment 469 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL118
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0986 
Download The Altas
  
Experiment 470 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL119
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0987 
Download The Altas
  
Experiment 471 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL12
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0988 
Download The Altas
  
Experiment 472 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL120
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0989 
Download The Altas
  
Experiment 473 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL121
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0990 
Download The Altas
  
Experiment 474 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL122
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0991 
Download The Altas
  
Experiment 475 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL123
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0992 
Download The Altas
  
Experiment 476 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL124
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0993 
Download The Altas
  
Experiment 477 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL125
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0994 
Download The Altas
  
Experiment 478 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL126
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0995 
Download The Altas
  
Experiment 479 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL127
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0996 
Download The Altas
  
Experiment 480 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL128
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0997 
Download The Altas
  
Experiment 481 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL13
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0998 
Download The Altas
  
Experiment 482 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL14
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD0999 
Download The Altas
  
Experiment 483 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL15
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1000 
Download The Altas
  
Experiment 484 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL16
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1001 
Download The Altas
  
Experiment 485 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL17
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1002 
Download The Altas
  
Experiment 486 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL18
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1003 
Download The Altas
  
Experiment 487 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL19
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1004 
Download The Altas
  
Experiment 488 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL2
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1005 
Download The Altas
  
Experiment 489 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL20
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1006 
Download The Altas
  
Experiment 490 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL21
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1007 
Download The Altas
  
Experiment 491 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL22
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1008 
Download The Altas
  
Experiment 492 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL23
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1009 
Download The Altas
  
Experiment 493 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL24
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1010 
Download The Altas
  
Experiment 494 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL25
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1011 
Download The Altas
  
Experiment 495 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL26
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1012 
Download The Altas
  
Experiment 496 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL27
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1013 
Download The Altas
  
Experiment 497 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL28
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1014 
Download The Altas
  
Experiment 498 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL29
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1015 
Download The Altas
  
Experiment 499 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL3
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1016 
Download The Altas
  
Experiment 500 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL30
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1017 
Download The Altas
  
Experiment 501 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL31
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1018 
Download The Altas
  
Experiment 502 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL32
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1019 
Download The Altas
  
Experiment 503 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1020 
Download The Altas
  
Experiment 504 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL34
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1021 
Download The Altas
  
Experiment 505 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL35
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1022 
Download The Altas
  
Experiment 506 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL36
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1023 
Download The Altas
  
Experiment 507 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL37
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1024 
Download The Altas
  
Experiment 508 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1025 
Download The Altas
  
Experiment 509 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL39
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1026 
Download The Altas
  
Experiment 510 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL4
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1027 
Download The Altas
  
Experiment 511 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL40
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1028 
Download The Altas
  
Experiment 512 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL41
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1029 
Download The Altas
  
Experiment 513 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL42
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1030 
Download The Altas
  
Experiment 514 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL43
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1031 
Download The Altas
  
Experiment 515 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL44
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1032 
Download The Altas
  
Experiment 516 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL45
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1033 
Download The Altas
  
Experiment 517 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL46
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1034 
Download The Altas
  
Experiment 518 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL47
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1035 
Download The Altas
  
Experiment 519 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL48
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1036 
Download The Altas
  
Experiment 520 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL49
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1037 
Download The Altas
  
Experiment 521 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL5
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1038 
Download The Altas
  
Experiment 522 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL50
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1039 
Download The Altas
  
Experiment 523 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1040 
Download The Altas
  
Experiment 524 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL52
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1041 
Download The Altas
  
Experiment 525 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL53
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1042 
Download The Altas
  
Experiment 526 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL54
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1043 
Download The Altas
  
Experiment 527 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL55
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1044 
Download The Altas
  
Experiment 528 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL56
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1045 
Download The Altas
  
Experiment 529 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL57
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1046 
Download The Altas
  
Experiment 530 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL58
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1047 
Download The Altas
  
Experiment 531 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL59
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1048 
Download The Altas
  
Experiment 532 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL6
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1049 
Download The Altas
  
Experiment 533 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL60
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1050 
Download The Altas
  
Experiment 534 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL61
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1051 
Download The Altas
  
Experiment 535 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL62
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1052 
Download The Altas
  
Experiment 536 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL63
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1053 
Download The Altas
  
Experiment 537 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL64
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1054 
Download The Altas
  
Experiment 538 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL65
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1055 
Download The Altas
  
Experiment 539 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL66
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1056 
Download The Altas
  
Experiment 540 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL67
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1057 
Download The Altas
  
Experiment 541 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL68
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1058 
Download The Altas
  
Experiment 542 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL69
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1059 
Download The Altas
  
Experiment 543 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL7
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1060 
Download The Altas
  
Experiment 544 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL70
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1061 
Download The Altas
  
Experiment 545 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL71
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1062 
Download The Altas
  
Experiment 546 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL72
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1063 
Download The Altas
  
Experiment 547 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL73
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1064 
Download The Altas
  
Experiment 548 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL74
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1065 
Download The Altas
  
Experiment 549 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1066 
Download The Altas
  
Experiment 550 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL76
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1067 
Download The Altas
  
Experiment 551 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL77
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1068 
Download The Altas
  
Experiment 552 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL78
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1069 
Download The Altas
  
Experiment 553 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL79
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1070 
Download The Altas
  
Experiment 554 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL8
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1071 
Download The Altas
  
Experiment 555 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL80
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1072 
Download The Altas
  
Experiment 556 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL81
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1073 
Download The Altas
  
Experiment 557 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL82
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1074 
Download The Altas
  
Experiment 558 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL83
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1075 
Download The Altas
  
Experiment 559 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL84
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1076 
Download The Altas
  
Experiment 560 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL85
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1077 
Download The Altas
  
Experiment 561 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL86
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1078 
Download The Altas
  
Experiment 562 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL87
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1079 
Download The Altas
  
Experiment 563 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL88
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1080 
Download The Altas
  
Experiment 564 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL89
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1081 
Download The Altas
  
Experiment 565 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL9
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1082 
Download The Altas
  
Experiment 566 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL90
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1083 
Download The Altas
  
Experiment 567 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL91
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1084 
Download The Altas
  
Experiment 568 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL92
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1085 
Download The Altas
  
Experiment 569 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL93
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1086 
Download The Altas
  
Experiment 570 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL94
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1087 
Download The Altas
  
Experiment 571 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL95
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1088 
Download The Altas
  
Experiment 572 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL96
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1089 
Download The Altas
  
Experiment 573 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL97
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1090 
Download The Altas
  
Experiment 574 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL98
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1091 
Download The Altas
  
Experiment 575 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL99
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1092 
Download The Altas
  
Experiment 576 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC1
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1093 
Download The Altas
  
Experiment 577 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC10
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1094 
Download The Altas
  
Experiment 578 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC100
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1095 
Download The Altas
  
Experiment 579 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC101
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1096 
Download The Altas
  
Experiment 580 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC102
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1097 
Download The Altas
  
Experiment 581 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC103
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1098 
Download The Altas
  
Experiment 582 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC104
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1099 
Download The Altas
  
Experiment 583 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC105
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1100 
Download The Altas
  
Experiment 584 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC106
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1101 
Download The Altas
  
Experiment 585 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC107
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1102 
Download The Altas
  
Experiment 586 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC108
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1103 
Download The Altas
  
Experiment 587 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC109
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1104 
Download The Altas
  
Experiment 588 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC11
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1105 
Download The Altas
  
Experiment 589 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC110
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1106 
Download The Altas
  
Experiment 590 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC111
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1107 
Download The Altas
  
Experiment 591 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC112
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1108 
Download The Altas
  
Experiment 592 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC113
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1109 
Download The Altas
  
Experiment 593 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC114
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1110 
Download The Altas
  
Experiment 594 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC115
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1111 
Download The Altas
  
Experiment 595 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC116
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1112 
Download The Altas
  
Experiment 596 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC117
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1113 
Download The Altas
  
Experiment 597 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC118
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1114 
Download The Altas
  
Experiment 598 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC119
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1115 
Download The Altas
  
Experiment 599 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC12
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1116 
Download The Altas
  
Experiment 600 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC120
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1117 
Download The Altas
  
Experiment 601 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC121
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1118 
Download The Altas
  
Experiment 602 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC122
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1119 
Download The Altas
  
Experiment 603 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC123
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1120 
Download The Altas
  
Experiment 604 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC124
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1121 
Download The Altas
  
Experiment 605 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC125
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1122 
Download The Altas
  
Experiment 606 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC126
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1123 
Download The Altas
  
Experiment 607 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC127
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1124 
Download The Altas
  
Experiment 608 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC128
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1125 
Download The Altas
  
Experiment 609 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC129
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1126 
Download The Altas
  
Experiment 610 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007472
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1127 
Download The Altas
  
Experiment 611 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC130
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1128 
Download The Altas
  
Experiment 612 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC131
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1129 
Download The Altas
  
Experiment 613 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC132
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1130 
Download The Altas
  
Experiment 614 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC133
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1131 
Download The Altas
  
Experiment 615 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC134
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1132 
Download The Altas
  
Experiment 616 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC135
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1133 
Download The Altas
  
Experiment 617 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC136
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1134 
Download The Altas
  
Experiment 618 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC137
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1135 
Download The Altas
  
Experiment 619 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC138
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1136 
Download The Altas
  
Experiment 620 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC139
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1137 
Download The Altas
  
Experiment 621 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC14
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1138 
Download The Altas
  
Experiment 622 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC140
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1139 
Download The Altas
  
Experiment 623 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC141
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1140 
Download The Altas
  
Experiment 624 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC142
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1141 
Download The Altas
  
Experiment 625 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC143
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1142 
Download The Altas
  
Experiment 626 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC144
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1143 
Download The Altas
  
Experiment 627 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC145
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1144 
Download The Altas
  
Experiment 628 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC146
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1145 
Download The Altas
  
Experiment 629 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC147
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1146 
Download The Altas
  
Experiment 630 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC148
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1147 
Download The Altas
  
Experiment 631 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC149
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1148 
Download The Altas
  
Experiment 632 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC15
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1149 
Download The Altas
  
Experiment 633 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC150
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1150 
Download The Altas
  
Experiment 634 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC151
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1151 
Download The Altas
  
Experiment 635 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC152
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1152 
Download The Altas
  
Experiment 636 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC153
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1153 
Download The Altas
  
Experiment 637 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007705
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1154 
Download The Altas
  
Experiment 638 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC17
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1155 
Download The Altas
  
Experiment 639 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC18
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1156 
Download The Altas
  
Experiment 640 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC19
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1157 
Download The Altas
  
Experiment 641 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC2
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1158 
Download The Altas
  
Experiment 642 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC20
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1159 
Download The Altas
  
Experiment 643 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC21
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1160 
Download The Altas
  
Experiment 644 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC22
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1161 
Download The Altas
  
Experiment 645 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC23
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1162 
Download The Altas
  
Experiment 646 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC24
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1163 
Download The Altas
  
Experiment 647 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC25
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1164 
Download The Altas
  
Experiment 648 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC26
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1165 
Download The Altas
  
Experiment 649 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC27
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1166 
Download The Altas
  
Experiment 650 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC28
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1167 
Download The Altas
  
Experiment 651 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC29
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1168 
Download The Altas
  
Experiment 652 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC3
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1169 
Download The Altas
  
Experiment 653 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC30
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1170 
Download The Altas
  
Experiment 654 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC31
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1171 
Download The Altas
  
Experiment 655 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC32
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1172 
Download The Altas
  
Experiment 656 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1173 
Download The Altas
  
Experiment 657 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC34
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1174 
Download The Altas
  
Experiment 658 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC35
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1175 
Download The Altas
  
Experiment 659 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC36
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1176 
Download The Altas
  
Experiment 660 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC37
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1177 
Download The Altas
  
Experiment 661 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC38
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1178 
Download The Altas
  
Experiment 662 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC39
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1179 
Download The Altas
  
Experiment 663 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC4
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1180 
Download The Altas
  
Experiment 664 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC40
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1181 
Download The Altas
  
Experiment 665 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC41
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1182 
Download The Altas
  
Experiment 666 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC42
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1183 
Download The Altas
  
Experiment 667 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC43
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1184 
Download The Altas
  
Experiment 668 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC44
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1185 
Download The Altas
  
Experiment 669 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC45
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1186 
Download The Altas
  
Experiment 670 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC46
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1187 
Download The Altas
  
Experiment 671 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC47
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1188 
Download The Altas
  
Experiment 672 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC48
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1189 
Download The Altas
  
Experiment 673 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC49
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1190 
Download The Altas
  
Experiment 674 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC5
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1191 
Download The Altas
  
Experiment 675 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC50
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1192 
Download The Altas
  
Experiment 676 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1193 
Download The Altas
  
Experiment 677 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC52
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1194 
Download The Altas
  
Experiment 678 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC53
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1195 
Download The Altas
  
Experiment 679 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC54
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1196 
Download The Altas
  
Experiment 680 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC55
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1197 
Download The Altas
  
Experiment 681 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC56
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1198 
Download The Altas
  
Experiment 682 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC57
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1199 
Download The Altas
  
Experiment 683 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC58
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1200 
Download The Altas
  
Experiment 684 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC59
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1201 
Download The Altas
  
Experiment 685 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC6
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1202 
Download The Altas
  
Experiment 686 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC60
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1203 
Download The Altas
  
Experiment 687 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC61
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1204 
Download The Altas
  
Experiment 688 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC62
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1205 
Download The Altas
  
Experiment 689 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC63
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1206 
Download The Altas
  
Experiment 690 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC64
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1207 
Download The Altas
  
Experiment 691 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC65
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1208 
Download The Altas
  
Experiment 692 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC66
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1209 
Download The Altas
  
Experiment 693 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC67
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1210 
Download The Altas
  
Experiment 694 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC68
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1211 
Download The Altas
  
Experiment 695 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC69
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1212 
Download The Altas
  
Experiment 696 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC7
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1213 
Download The Altas
  
Experiment 697 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC70
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1214 
Download The Altas
  
Experiment 698 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC71
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1215 
Download The Altas
  
Experiment 699 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC72
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1216 
Download The Altas
  
Experiment 700 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC73
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1217 
Download The Altas
  
Experiment 701 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC74
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1218 
Download The Altas
  
Experiment 702 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC75
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1219 
Download The Altas
  
Experiment 703 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC76
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1220 
Download The Altas
  
Experiment 704 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC77
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1221 
Download The Altas
  
Experiment 705 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC78
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1222 
Download The Altas
  
Experiment 706 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC79
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1223 
Download The Altas
  
Experiment 707 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC8
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1224 
Download The Altas
  
Experiment 708 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC80
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1225 
Download The Altas
  
Experiment 709 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC81
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1226 
Download The Altas
  
Experiment 710 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC82
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1227 
Download The Altas
  
Experiment 711 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC83
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1228 
Download The Altas
  
Experiment 712 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC84
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1229 
Download The Altas
  
Experiment 713 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC85
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1230 
Download The Altas
  
Experiment 714 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC86
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1231 
Download The Altas
  
Experiment 715 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC87
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1232 
Download The Altas
  
Experiment 716 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC88
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1233 
Download The Altas
  
Experiment 717 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC89
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1234 
Download The Altas
  
Experiment 718 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007680
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1235 
Download The Altas
  
Experiment 719 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC90
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1236 
Download The Altas
  
Experiment 720 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC91
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1237 
Download The Altas
  
Experiment 721 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC92
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1238 
Download The Altas
  
Experiment 722 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC93
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1239 
Download The Altas
  
Experiment 723 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC94
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1240 
Download The Altas
  
Experiment 724 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC95
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1241 
Download The Altas
  
Experiment 725 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC96
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1242 
Download The Altas
  
Experiment 726 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC97
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1243 
Download The Altas
  
Experiment 727 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC98
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1244 
Download The Altas
  
Experiment 728 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC99
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1245 
Download The Altas
  
Experiment 729 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL1
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1246 
Download The Altas
  
Experiment 730 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL10
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1247 
Download The Altas
  
Experiment 731 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL100
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1248 
Download The Altas
  
Experiment 732 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL101
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1249 
Download The Altas
  
Experiment 733 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL102
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1250 
Download The Altas
  
Experiment 734 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL103
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1251 
Download The Altas
  
Experiment 735 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL104
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1252 
Download The Altas
  
Experiment 736 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL105
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1253 
Download The Altas
  
Experiment 737 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL106
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1254 
Download The Altas
  
Experiment 738 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL107
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1255 
Download The Altas
  
Experiment 739 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL108
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1256 
Download The Altas
  
Experiment 740 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL109
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1257 
Download The Altas
  
Experiment 741 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL11
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1258 
Download The Altas
  
Experiment 742 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL110
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1259 
Download The Altas
  
Experiment 743 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL111
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1260 
Download The Altas
  
Experiment 744 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL112
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1261 
Download The Altas
  
Experiment 745 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL113
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1262 
Download The Altas
  
Experiment 746 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL114
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1263 
Download The Altas
  
Experiment 747 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL115
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1264 
Download The Altas
  
Experiment 748 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL116
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1265 
Download The Altas
  
Experiment 749 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL117
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1266 
Download The Altas
  
Experiment 750 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL118
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1267 
Download The Altas
  
Experiment 751 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL119
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1268 
Download The Altas
  
Experiment 752 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL12
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1269 
Download The Altas
  
Experiment 753 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL120
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1270 
Download The Altas
  
Experiment 754 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL121
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1271 
Download The Altas
  
Experiment 755 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL122
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1272 
Download The Altas
  
Experiment 756 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL123
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1273 
Download The Altas
  
Experiment 757 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL124
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1274 
Download The Altas
  
Experiment 758 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL125
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1275 
Download The Altas
  
Experiment 759 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL126
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1276 
Download The Altas
  
Experiment 760 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL127
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1277 
Download The Altas
  
Experiment 761 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL128
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1278 
Download The Altas
  
Experiment 762 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL13
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1279 
Download The Altas
  
Experiment 763 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL14
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1280 
Download The Altas
  
Experiment 764 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL15
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1281 
Download The Altas
  
Experiment 765 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL16
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1282 
Download The Altas
  
Experiment 766 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL17
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1283 
Download The Altas
  
Experiment 767 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL18
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1284 
Download The Altas
  
Experiment 768 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL19
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1285 
Download The Altas
  
Experiment 769 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL2
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1286 
Download The Altas
  
Experiment 770 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL20
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1287 
Download The Altas
  
Experiment 771 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL21
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1288 
Download The Altas
  
Experiment 772 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL22
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1289 
Download The Altas
  
Experiment 773 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL23
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1290 
Download The Altas
  
Experiment 774 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL24
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1291 
Download The Altas
  
Experiment 775 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL25
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1292 
Download The Altas
  
Experiment 776 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL26
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1293 
Download The Altas
  
Experiment 777 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL27
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1294 
Download The Altas
  
Experiment 778 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL28
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1295 
Download The Altas
  
Experiment 779 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL29
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1296 
Download The Altas
  
Experiment 780 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL3
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1297 
Download The Altas
  
Experiment 781 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL30
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1298 
Download The Altas
  
Experiment 782 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL31
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1299 
Download The Altas
  
Experiment 783 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL32
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1300 
Download The Altas
  
Experiment 784 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1301 
Download The Altas
  
Experiment 785 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL34
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1302 
Download The Altas
  
Experiment 786 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL35
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1303 
Download The Altas
  
Experiment 787 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL36
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1304 
Download The Altas
  
Experiment 788 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL37
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1305 
Download The Altas
  
Experiment 789 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1306 
Download The Altas
  
Experiment 790 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL39
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1307 
Download The Altas
  
Experiment 791 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL4
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1308 
Download The Altas
  
Experiment 792 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL40
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1309 
Download The Altas
  
Experiment 793 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL41
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1310 
Download The Altas
  
Experiment 794 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL42
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1311 
Download The Altas
  
Experiment 795 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL43
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1312 
Download The Altas
  
Experiment 796 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL44
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1313 
Download The Altas
  
Experiment 797 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL45
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1314 
Download The Altas
  
Experiment 798 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL46
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1315 
Download The Altas
  
Experiment 799 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL47
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1316 
Download The Altas
  
Experiment 800 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL48
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1317 
Download The Altas
  
Experiment 801 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL49
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1318 
Download The Altas
  
Experiment 802 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL5
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1319 
Download The Altas
  
Experiment 803 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL50
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1320 
Download The Altas
  
Experiment 804 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL51
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1321 
Download The Altas
  
Experiment 805 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL52
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1322 
Download The Altas
  
Experiment 806 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL53
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1323 
Download The Altas
  
Experiment 807 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL54
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1324 
Download The Altas
  
Experiment 808 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL55
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1325 
Download The Altas
  
Experiment 809 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL56
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1326 
Download The Altas
  
Experiment 810 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL57
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1327 
Download The Altas
  
Experiment 811 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL58
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1328 
Download The Altas
  
Experiment 812 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL59
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1329 
Download The Altas
  
Experiment 813 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL6
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1330 
Download The Altas
  
Experiment 814 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL60
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1331 
Download The Altas
  
Experiment 815 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL61
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1332 
Download The Altas
  
Experiment 816 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL62
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1333 
Download The Altas
  
Experiment 817 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL63
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1334 
Download The Altas
  
Experiment 818 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL64
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1335 
Download The Altas
  
Experiment 819 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL65
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1336 
Download The Altas
  
Experiment 820 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL66
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1337 
Download The Altas
  
Experiment 821 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL67
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1338 
Download The Altas
  
Experiment 822 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL68
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1339 
Download The Altas
  
Experiment 823 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL69
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1340 
Download The Altas
  
Experiment 824 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL7
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1341 
Download The Altas
  
Experiment 825 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL70
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1342 
Download The Altas
  
Experiment 826 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL71
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1343 
Download The Altas
  
Experiment 827 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL72
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1344 
Download The Altas
  
Experiment 828 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL73
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1345 
Download The Altas
  
Experiment 829 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL74
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1346 
Download The Altas
  
Experiment 830 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment33
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1347 
Download The Altas
  
Experiment 831 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL76
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1348 
Download The Altas
  
Experiment 832 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL77
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1349 
Download The Altas
  
Experiment 833 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL78
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1350 
Download The Altas
  
Experiment 834 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL79
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1351 
Download The Altas
  
Experiment 835 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL8
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1352 
Download The Altas
  
Experiment 836 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL80
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1353 
Download The Altas
  
Experiment 837 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL81
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1354 
Download The Altas
  
Experiment 838 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL82
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1355 
Download The Altas
  
Experiment 839 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL83
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1356 
Download The Altas
  
Experiment 840 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL84
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1357 
Download The Altas
  
Experiment 841 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL85
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1358 
Download The Altas
  
Experiment 842 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL86
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1359 
Download The Altas
  
Experiment 843 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL87
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1360 
Download The Altas
  
Experiment 844 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL88
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1361 
Download The Altas
  
Experiment 845 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL89
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1362 
Download The Altas
  
Experiment 846 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL9
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1363 
Download The Altas
  
Experiment 847 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL90
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1364 
Download The Altas
  
Experiment 848 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL91
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1365 
Download The Altas
  
Experiment 849 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL92
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1366 
Download The Altas
  
Experiment 850 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL93
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1367 
Download The Altas
  
Experiment 851 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL94
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1368 
Download The Altas
  
Experiment 852 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL95
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1369 
Download The Altas
  
Experiment 853 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL96
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1370 
Download The Altas
  
Experiment 854 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL97
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1371 
Download The Altas
  
Experiment 855 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL98
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1372 
Download The Altas
  
Experiment 856 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL99
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD1373 
Download The Altas
  
Experiment 857 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
10 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1492 
Download The Altas
  
Experiment 858 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
20 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1493 
Download The Altas
  
Experiment 859 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1494 
Download The Altas
  
Experiment 860 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
100 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1495 
Download The Altas
  
Experiment 861 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
200 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1496 
Download The Altas
  
Experiment 862 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
10 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1497 
Download The Altas
  
Experiment 863 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
20 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1498 
Download The Altas
  
Experiment 864 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1499 
Download The Altas
  
Experiment 865 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
100 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1500 
Download The Altas
  
Experiment 866 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
200 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1501 
Download The Altas
  
Experiment 867 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
10 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1502 
Download The Altas
  
Experiment 868 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
20 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1503 
Download The Altas
  
Experiment 869 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1504 
Download The Altas
  
Experiment 870 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
100 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1505 
Download The Altas
  
Experiment 871 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
200 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1506 
Download The Altas
  
Experiment 872 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC1
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1507 
Download The Altas
  
Experiment 873 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC10
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1508 
Download The Altas
  
Experiment 874 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC11
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1509 
Download The Altas
  
Experiment 875 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC12
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1510 
Download The Altas
  
Experiment 876 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007472
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1511 
Download The Altas
  
Experiment 877 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC14
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1512 
Download The Altas
  
Experiment 878 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC15
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1513 
Download The Altas
  
Experiment 879 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007705
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1514 
Download The Altas
  
Experiment 880 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC17
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1515 
Download The Altas
  
Experiment 881 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC18
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1516 
Download The Altas
  
Experiment 882 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC19
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1517 
Download The Altas
  
Experiment 883 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC2
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1518 
Download The Altas
  
Experiment 884 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC20
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1519 
Download The Altas
  
Experiment 885 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC21
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1520 
Download The Altas
  
Experiment 886 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC22
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1521 
Download The Altas
  
Experiment 887 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC23
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1522 
Download The Altas
  
Experiment 888 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC24
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1523 
Download The Altas
  
Experiment 889 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC25
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1524 
Download The Altas
  
Experiment 890 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC26
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1525 
Download The Altas
  
Experiment 891 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC27
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1526 
Download The Altas
  
Experiment 892 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC28
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1527 
Download The Altas
  
Experiment 893 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC29
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1528 
Download The Altas
  
Experiment 894 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC3
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1529 
Download The Altas
  
Experiment 895 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC30
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1530 
Download The Altas
  
Experiment 896 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC31
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1531 
Download The Altas
  
Experiment 897 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC32
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1532 
Download The Altas
  
Experiment 898 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC33
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1533 
Download The Altas
  
Experiment 899 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC34
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1534 
Download The Altas
  
Experiment 900 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC35
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1535 
Download The Altas
  
Experiment 901 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC36
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1536 
Download The Altas
  
Experiment 902 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC37
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1537 
Download The Altas
  
Experiment 903 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC38
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1538 
Download The Altas
  
Experiment 904 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC39
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1539 
Download The Altas
  
Experiment 905 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC4
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1540 
Download The Altas
  
Experiment 906 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC40
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1541 
Download The Altas
  
Experiment 907 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC41
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1542 
Download The Altas
  
Experiment 908 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC42
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1543 
Download The Altas
  
Experiment 909 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC43
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1544 
Download The Altas
  
Experiment 910 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC44
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1545 
Download The Altas
  
Experiment 911 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC45
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1546 
Download The Altas
  
Experiment 912 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC46
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1547 
Download The Altas
  
Experiment 913 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC47
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1548 
Download The Altas
  
Experiment 914 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC48
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1549 
Download The Altas
  
Experiment 915 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC49
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1550 
Download The Altas
  
Experiment 916 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC5
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1551 
Download The Altas
  
Experiment 917 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC50
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1552 
Download The Altas
  
Experiment 918 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC51
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1553 
Download The Altas
  
Experiment 919 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC52
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1554 
Download The Altas
  
Experiment 920 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC53
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1555 
Download The Altas
  
Experiment 921 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC54
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1556 
Download The Altas
  
Experiment 922 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC55
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1557 
Download The Altas
  
Experiment 923 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC56
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1558 
Download The Altas
  
Experiment 924 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC57
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1559 
Download The Altas
  
Experiment 925 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC58
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1560 
Download The Altas
  
Experiment 926 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC59
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1561 
Download The Altas
  
Experiment 927 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC6
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1562 
Download The Altas
  
Experiment 928 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC60
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1563 
Download The Altas
  
Experiment 929 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC61
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1564 
Download The Altas
  
Experiment 930 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC62
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1565 
Download The Altas
  
Experiment 931 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC63
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1566 
Download The Altas
  
Experiment 932 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC64
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1567 
Download The Altas
  
Experiment 933 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC7
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1568 
Download The Altas
  
Experiment 934 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC8
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1569 
Download The Altas
  
Experiment 935 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AKOS034007680
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1570 
Download The Altas
  
Experiment 936 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL1
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1571 
Download The Altas
  
Experiment 937 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL10
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1572 
Download The Altas
  
Experiment 938 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL100
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1573 
Download The Altas
  
Experiment 939 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL101
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1574 
Download The Altas
  
Experiment 940 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL102
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1575 
Download The Altas
  
Experiment 941 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL103
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1576 
Download The Altas
  
Experiment 942 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL104
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1577 
Download The Altas
  
Experiment 943 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL105
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1578 
Download The Altas
  
Experiment 944 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL106
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1579 
Download The Altas
  
Experiment 945 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL107
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1580 
Download The Altas
  
Experiment 946 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL108
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1581 
Download The Altas
  
Experiment 947 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL109
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1582 
Download The Altas
  
Experiment 948 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL11
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1583 
Download The Altas
  
Experiment 949 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL110
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1584 
Download The Altas
  
Experiment 950 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL111
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1585 
Download The Altas
  
Experiment 951 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL112
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1586 
Download The Altas
  
Experiment 952 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL113
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1587 
Download The Altas
  
Experiment 953 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL114
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1588 
Download The Altas
  
Experiment 954 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL115
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1589 
Download The Altas
  
Experiment 955 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL116
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1590 
Download The Altas
  
Experiment 956 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL117
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1591 
Download The Altas
  
Experiment 957 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL118
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1592 
Download The Altas
  
Experiment 958 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL119
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1593 
Download The Altas
  
Experiment 959 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL12
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1594 
Download The Altas
  
Experiment 960 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL120
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1595 
Download The Altas
  
Experiment 961 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL121
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1596 
Download The Altas
  
Experiment 962 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL122
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1597 
Download The Altas
  
Experiment 963 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL123
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1598 
Download The Altas
  
Experiment 964 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL124
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1599 
Download The Altas
  
Experiment 965 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL125
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1600 
Download The Altas
  
Experiment 966 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL126
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1601 
Download The Altas
  
Experiment 967 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL127
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1602 
Download The Altas
  
Experiment 968 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL128
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1603 
Download The Altas
  
Experiment 969 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL13
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1604 
Download The Altas
  
Experiment 970 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL14
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1605 
Download The Altas
  
Experiment 971 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL15
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1606 
Download The Altas
  
Experiment 972 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL16
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1607 
Download The Altas
  
Experiment 973 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL17
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1608 
Download The Altas
  
Experiment 974 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL18
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1609 
Download The Altas
  
Experiment 975 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL19
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1610 
Download The Altas
  
Experiment 976 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL2
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1611 
Download The Altas
  
Experiment 977 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL20
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1612 
Download The Altas
  
Experiment 978 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL21
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1613 
Download The Altas
  
Experiment 979 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL22
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1614 
Download The Altas
  
Experiment 980 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL23
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1615 
Download The Altas
  
Experiment 981 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL24
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1616 
Download The Altas
  
Experiment 982 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL25
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1617 
Download The Altas
  
Experiment 983 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL26
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1618 
Download The Altas
  
Experiment 984 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL27
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1619 
Download The Altas
  
Experiment 985 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL28
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1620 
Download The Altas
  
Experiment 986 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL29
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1621 
Download The Altas
  
Experiment 987 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL3
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1622 
Download The Altas
  
Experiment 988 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL30
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1623 
Download The Altas
  
Experiment 989 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL31
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1624 
Download The Altas
  
Experiment 990 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL32
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1625 
Download The Altas
  
Experiment 991 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL33
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1626 
Download The Altas
  
Experiment 992 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL34
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1627 
Download The Altas
  
Experiment 993 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL35
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1628 
Download The Altas
  
Experiment 994 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL36
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1629 
Download The Altas
  
Experiment 995 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL37
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1630 
Download The Altas
  
Experiment 996 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment51
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1631 
Download The Altas
  
Experiment 997 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL39
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1632 
Download The Altas
  
Experiment 998 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL4
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1633 
Download The Altas
  
Experiment 999 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL40
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1634 
Download The Altas
  
Experiment 1000 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL41
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1635 
Download The Altas
  
Experiment 1001 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL42
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1636 
Download The Altas
  
Experiment 1002 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL43
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1637 
Download The Altas
  
Experiment 1003 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL44
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1638 
Download The Altas
  
Experiment 1004 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL45
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1639 
Download The Altas
  
Experiment 1005 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL46
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1640 
Download The Altas
  
Experiment 1006 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL47
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1641 
Download The Altas
  
Experiment 1007 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL48
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1642 
Download The Altas
  
Experiment 1008 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL49
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1643 
Download The Altas
  
Experiment 1009 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL5
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1644 
Download The Altas
  
Experiment 1010 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL50
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1645 
Download The Altas
  
Experiment 1011 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL52
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1646 
Download The Altas
  
Experiment 1012 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL53
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1647 
Download The Altas
  
Experiment 1013 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL54
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1648 
Download The Altas
  
Experiment 1014 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL55
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1649 
Download The Altas
  
Experiment 1015 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL56
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1650 
Download The Altas
  
Experiment 1016 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL57
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1651 
Download The Altas
  
Experiment 1017 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL58
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1652 
Download The Altas
  
Experiment 1018 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL59
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1653 
Download The Altas
  
Experiment 1019 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL6
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1654 
Download The Altas
  
Experiment 1020 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL60
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1655 
Download The Altas
  
Experiment 1021 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL61
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1656 
Download The Altas
  
Experiment 1022 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL62
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1657 
Download The Altas
  
Experiment 1023 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL63
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1658 
Download The Altas
  
Experiment 1024 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL64
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1659 
Download The Altas
  
Experiment 1025 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL65
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1660 
Download The Altas
  
Experiment 1026 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL66
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1661 
Download The Altas
  
Experiment 1027 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL67
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1662 
Download The Altas
  
Experiment 1028 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL68
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1663 
Download The Altas
  
Experiment 1029 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL69
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1664 
Download The Altas
  
Experiment 1030 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL7
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1665 
Download The Altas
  
Experiment 1031 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL70
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1666 
Download The Altas
  
Experiment 1032 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL71
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1667 
Download The Altas
  
Experiment 1033 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL72
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1668 
Download The Altas
  
Experiment 1034 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL73
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1669 
Download The Altas
  
Experiment 1035 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL74
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1670 
Download The Altas
  
Experiment 1036 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
Fragment33
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1671 
Download The Altas
  
Experiment 1037 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL76
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1672 
Download The Altas
  
Experiment 1038 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL77
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1673 
Download The Altas
  
Experiment 1039 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL78
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1674 
Download The Altas
  
Experiment 1040 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL79
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1675 
Download The Altas
  
Experiment 1041 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL8
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1676 
Download The Altas
  
Experiment 1042 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL80
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1677 
Download The Altas
  
Experiment 1043 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL81
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1678 
Download The Altas
  
Experiment 1044 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL82
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1679 
Download The Altas
  
Experiment 1045 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL83
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1680 
Download The Altas
  
Experiment 1046 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL84
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1681 
Download The Altas
  
Experiment 1047 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL85
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1682 
Download The Altas
  
Experiment 1048 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL86
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1683 
Download The Altas
  
Experiment 1049 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL87
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1684 
Download The Altas
  
Experiment 1050 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL88
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1685 
Download The Altas
  
Experiment 1051 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL89
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1686 
Download The Altas
  
Experiment 1052 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL9
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1687 
Download The Altas
  
Experiment 1053 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL90
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1688 
Download The Altas
  
Experiment 1054 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL91
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1689 
Download The Altas
  
Experiment 1055 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL92
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1690 
Download The Altas
  
Experiment 1056 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL93
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1691 
Download The Altas
  
Experiment 1057 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL94
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1692 
Download The Altas
  
Experiment 1058 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL95
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1693 
Download The Altas
  
Experiment 1059 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL96
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1694 
Download The Altas
  
Experiment 1060 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL97
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1695 
Download The Altas
  
Experiment 1061 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL98
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1696 
Download The Altas
  
Experiment 1062 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
CL99
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1697 
Download The Altas
  
Experiment 1063 Reporting the Labelling Profiles of This Probe
REF [4]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
E2913
 Competitor Info 
Competitor Concentration
50 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD1698 
Download The Altas
  
Experiment 1064 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC154
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD2158 
Download The Altas
  
Experiment 1065 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC155
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD2159 
Download The Altas
  
Experiment 1066 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC156
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD2160 
Download The Altas
  
Experiment 1067 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC157
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD2161 
Download The Altas
  
Experiment 1068 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC154
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD2162 
Download The Altas
  
Experiment 1069 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC155
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD2163 
Download The Altas
  
Experiment 1070 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC156
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD2164 
Download The Altas
  
Experiment 1071 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC157
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (HEK-293T)
Interaction Atlas ID
 LDD2165 
Download The Altas
  
Experiment 1072 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC154
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD2166 
Download The Altas
  
Experiment 1073 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC155
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD2167 
Download The Altas
  
Experiment 1074 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC156
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD2168 
Download The Altas
  
Experiment 1075 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
AC157
 Competitor Info 
Competitor Concentration
25 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD2169 
Download The Altas
  
Experiment 1076 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
ARS-1620
 Competitor Info 
Competitor Concentration
1 uM
In Vitro Experiment Model
Model Type
Living cell
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cells (HCC44)
Interaction Atlas ID
 LDD2171 
Download The Altas
  
Experiment 1077 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
ARS-1620
 Competitor Info 
Competitor Concentration
0.2 uM
In Vitro Experiment Model
Model Type
Living cell
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cells (HCC44)
Interaction Atlas ID
 LDD2172 
Download The Altas
  
Experiment 1078 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
THZ1
 Competitor Info 
Competitor Concentration
1 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD2173 
Download The Altas
  
Experiment 1079 Reporting the Labelling Profiles of This Probe
REF [1]
Probe concentration
500 uM
Quantitative Method
TMT
Experiment Method
SLC ABPP
Competitor Name
THZ1
 Competitor Info 
Competitor Concentration
0.2 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HCT 116)
Interaction Atlas ID
 LDD2174 
Download The Altas
  
Experiment 1080 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (22RV1)
Interaction Atlas ID
 LDD2243 
Download The Altas
  
Experiment 1081 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (42-MG-BA)
Interaction Atlas ID
 LDD2244 
Download The Altas
  
Experiment 1082 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (697)
Interaction Atlas ID
 LDD2245 
Download The Altas
  
Experiment 1083 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (769-P)
Interaction Atlas ID
 LDD2246 
Download The Altas
  
Experiment 1084 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (786-O)
Interaction Atlas ID
 LDD2247 
Download The Altas
  
Experiment 1085 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (8305C)
Interaction Atlas ID
 LDD2248 
Download The Altas
  
Experiment 1086 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (8505C)
Interaction Atlas ID
 LDD2249 
Download The Altas
  
Experiment 1087 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (A101D)
Interaction Atlas ID
 LDD2250 
Download The Altas
  
Experiment 1088 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (A-172)
Interaction Atlas ID
 LDD2251 
Download The Altas
  
Experiment 1089 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (A204)
Interaction Atlas ID
 LDD2252 
Download The Altas
  
Experiment 1090 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (A2058)
Interaction Atlas ID
 LDD2253 
Download The Altas
  
Experiment 1091 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (A2780)
Interaction Atlas ID
 LDD2254 
Download The Altas
  
Experiment 1092 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (A-375)
Interaction Atlas ID
 LDD2255 
Download The Altas
  
Experiment 1093 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (A375.S2)
Interaction Atlas ID
 LDD2256 
Download The Altas
  
Experiment 1094 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (A3-KAW)
Interaction Atlas ID
 LDD2257 
Download The Altas
  
Experiment 1095 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Skin squamous cell carcinoma [ICD-11:2C31]
Model Name
Human skin squamous cell carcinoma cell lysate (A431)
Interaction Atlas ID
 LDD2258 
Download The Altas
  
Experiment 1096 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cancer [ICD11: 2C90]
Model Name
Human renal cancer cell lysate (A498)
Interaction Atlas ID
 LDD2259 
Download The Altas
  
Experiment 1097 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (A-549)
Interaction Atlas ID
 LDD2260 
Download The Altas
  
Experiment 1098 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (A673)
Interaction Atlas ID
 LDD2261 
Download The Altas
  
Experiment 1099 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (ABC-1)
Interaction Atlas ID
 LDD2262 
Download The Altas
  
Experiment 1100 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (AGS)
Interaction Atlas ID
 LDD2263 
Download The Altas
  
Experiment 1101 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (AN3-CA)
Interaction Atlas ID
 LDD2264 
Download The Altas
  
Experiment 1102 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (AU565)
Interaction Atlas ID
 LDD2265 
Download The Altas
  
Experiment 1103 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (BICR-22)
Interaction Atlas ID
 LDD2266 
Download The Altas
  
Experiment 1104 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX142)
Interaction Atlas ID
 LDD2267 
Download The Altas
  
Experiment 1105 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX211)
Interaction Atlas ID
 LDD2268 
Download The Altas
  
Experiment 1106 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX250)
Interaction Atlas ID
 LDD2269 
Download The Altas
  
Experiment 1107 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX29)
Interaction Atlas ID
 LDD2270 
Download The Altas
  
Experiment 1108 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX330)
Interaction Atlas ID
 LDD2271 
Download The Altas
  
Experiment 1109 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX390)
Interaction Atlas ID
 LDD2273 
Download The Altas
  
Experiment 1110 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX394)
Interaction Atlas ID
 LDD2274 
Download The Altas
  
Experiment 1111 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX401)
Interaction Atlas ID
 LDD2275 
Download The Altas
  
Experiment 1112 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX50)
Interaction Atlas ID
 LDD2276 
Download The Altas
  
Experiment 1113 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX68)
Interaction Atlas ID
 LDD2277 
Download The Altas
  
Experiment 1114 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX82)
Interaction Atlas ID
 LDD2278 
Download The Altas
  
Experiment 1115 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (BT-549)
Interaction Atlas ID
 LDD2279 
Download The Altas
  
Experiment 1116 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (BxPC-3)
Interaction Atlas ID
 LDD2280 
Download The Altas
  
Experiment 1117 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (C32)
Interaction Atlas ID
 LDD2281 
Download The Altas
  
Experiment 1118 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (C-4-II)
Interaction Atlas ID
 LDD2282 
Download The Altas
  
Experiment 1119 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (Caki-1)
Interaction Atlas ID
 LDD2283 
Download The Altas
  
Experiment 1120 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-120)
Interaction Atlas ID
 LDD2284 
Download The Altas
  
Experiment 1121 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-148)
Interaction Atlas ID
 LDD2285 
Download The Altas
  
Experiment 1122 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral cancer [ICD11: 2B6E]
Model Name
Human oral cancer cell lysate (CAL-27)
Interaction Atlas ID
 LDD2286 
Download The Altas
  
Experiment 1123 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (CAL-33)
Interaction Atlas ID
 LDD2287 
Download The Altas
  
Experiment 1124 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-51)
Interaction Atlas ID
 LDD2288 
Download The Altas
  
Experiment 1125 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (CAL-62)
Interaction Atlas ID
 LDD2289 
Download The Altas
  
Experiment 1126 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (CAL-72)
Interaction Atlas ID
 LDD2290 
Download The Altas
  
Experiment 1127 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Chondrosarcoma [ICD11: 2B50]
Model Name
Human chondrosarcoma cell lysate (CAL-78)
Interaction Atlas ID
 LDD2291 
Download The Altas
  
Experiment 1128 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (Calu-1)
Interaction Atlas ID
 LDD2292 
Download The Altas
  
Experiment 1129 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (Calu-6)
Interaction Atlas ID
 LDD2293 
Download The Altas
  
Experiment 1130 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (CAMA-1)
Interaction Atlas ID
 LDD2294 
Download The Altas
  
Experiment 1131 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (Caov-3)
Interaction Atlas ID
 LDD2295 
Download The Altas
  
Experiment 1132 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (Ca-Ski)
Interaction Atlas ID
 LDD2296 
Download The Altas
  
Experiment 1133 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (CCK-81)
Interaction Atlas ID
 LDD2297 
Download The Altas
  
Experiment 1134 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (CC-LP-1)
Interaction Atlas ID
 LDD2298 
Download The Altas
  
Experiment 1135 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (CC-SW-1 )
Interaction Atlas ID
 LDD2299 
Download The Altas
  
Experiment 1136 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (CFPAC-1)
Interaction Atlas ID
 LDD2300 
Download The Altas
  
Experiment 1137 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (CHL-1)
Interaction Atlas ID
 LDD2301 
Download The Altas
  
Experiment 1138 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
.
Disease Model
Down syndrome [ICD11: LD40]
Model Name
Human down syndrome cell lysate (CMK)
Interaction Atlas ID
 LDD2302 
Download The Altas
  
Experiment 1139 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (COLO 320)
Interaction Atlas ID
 LDD2303 
Download The Altas
  
Experiment 1140 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (COLO-678)
Interaction Atlas ID
 LDD2304 
Download The Altas
  
Experiment 1141 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-679)
Interaction Atlas ID
 LDD2305 
Download The Altas
  
Experiment 1142 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (COLO-792)
Interaction Atlas ID
 LDD2306 
Download The Altas
  
Experiment 1143 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-800)
Interaction Atlas ID
 LDD2307 
Download The Altas
  
Experiment 1144 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-829)
Interaction Atlas ID
 LDD2308 
Download The Altas
  
Experiment 1145 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO 853)
Interaction Atlas ID
 LDD2309 
Download The Altas
  
Experiment 1146 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (COR-L23)
Interaction Atlas ID
 LDD2310 
Download The Altas
  
Experiment 1147 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (COR-L88)
Interaction Atlas ID
 LDD2311 
Download The Altas
  
Experiment 1148 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (D283 Med)
Interaction Atlas ID
 LDD2312 
Download The Altas
  
Experiment 1149 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic cancer [ICD11: 2C10]
Model Name
Human pancreatic cancer cell lysate (DAN-G)
Interaction Atlas ID
 LDD2313 
Download The Altas
  
Experiment 1150 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (Daoy)
Interaction Atlas ID
 LDD2314 
Download The Altas
  
Experiment 1151 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Anaplastic large cell lymphoma [ICD11: 2A90]
Model Name
Human anaplastic large cell lymphoma cell lysate (DEL)
Interaction Atlas ID
 LDD2315 
Download The Altas
  
Experiment 1152 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Pharyngeal squamous cell carcinoma [ICD11: 2B6D]
Model Name
Human pharyngeal squamous cell carcinoma cell lysate (Detroit 562)
Interaction Atlas ID
 LDD2316 
Download The Altas
  
Experiment 1153 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (DoTc2-4510)
Interaction Atlas ID
 LDD2317 
Download The Altas
  
Experiment 1154 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (DU145)
Interaction Atlas ID
 LDD2318 
Download The Altas
  
Experiment 1155 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (DU-4475)
Interaction Atlas ID
 LDD2319 
Download The Altas
  
Experiment 1156 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (ECC2)
Interaction Atlas ID
 LDD2320 
Download The Altas
  
Experiment 1157 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (EFO-21)
Interaction Atlas ID
 LDD2321 
Download The Altas
  
Experiment 1158 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian mucinous adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian mucinous adenocarcinoma cell lysate (EFO-27)
Interaction Atlas ID
 LDD2322 
Download The Altas
  
Experiment 1159 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (EGI-1)
Interaction Atlas ID
 LDD2323 
Download The Altas
  
Experiment 1160 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Chronic eosinophilic leukaemia [ICD11: 2A20]
Model Name
Human chronic eosinophilic leukaemia cell lysate (EoL-1)
Interaction Atlas ID
 LDD2324 
Download The Altas
  
Experiment 1161 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (ETK-1)
Interaction Atlas ID
 LDD2325 
Download The Altas
  
Experiment 1162 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Hypopharyngeal squamous cell carcinoma [ICD11: 2B6D.0]
Model Name
Human hypopharyngeal squamous cell carcinoma cell lysate (FaDu)
Interaction Atlas ID
 LDD2326 
Download The Altas
  
Experiment 1163 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland follicular carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland follicular carcinoma cell lysate (FTC-133)
Interaction Atlas ID
 LDD2327 
Download The Altas
  
Experiment 1164 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (FU-OV-1)
Interaction Atlas ID
 LDD2328 
Download The Altas
  
Experiment 1165 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (G-361)
Interaction Atlas ID
 LDD2329 
Download The Altas
  
Experiment 1166 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Wilms tumor [ICD11: 2C90]
Model Name
Human wilms tumor cell lysate (G-401)
Interaction Atlas ID
 LDD2330 
Download The Altas
  
Experiment 1167 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Kidney cancer [ICD11: 2C90]
Model Name
Human kidney cancer cell lysate (G-402)
Interaction Atlas ID
 LDD2331 
Download The Altas
  
Experiment 1168 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (G-415)
Interaction Atlas ID
 LDD2332 
Download The Altas
  
Experiment 1169 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GAMG)
Interaction Atlas ID
 LDD2333 
Download The Altas
  
Experiment 1170 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GB-1)
Interaction Atlas ID
 LDD2334 
Download The Altas
  
Experiment 1171 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GB-2)
Interaction Atlas ID
 LDD2335 
Download The Altas
  
Experiment 1172 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1143)
Interaction Atlas ID
 LDD2336 
Download The Altas
  
Experiment 1173 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1187)
Interaction Atlas ID
 LDD2337 
Download The Altas
  
Experiment 1174 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1395)
Interaction Atlas ID
 LDD2338 
Download The Altas
  
Experiment 1175 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1419)
Interaction Atlas ID
 LDD2339 
Download The Altas
  
Experiment 1176 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (HCC15)
Interaction Atlas ID
 LDD2340 
Download The Altas
  
Experiment 1177 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (HCC1806)
Interaction Atlas ID
 LDD2341 
Download The Altas
  
Experiment 1178 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1937)
Interaction Atlas ID
 LDD2342 
Download The Altas
  
Experiment 1179 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1954)
Interaction Atlas ID
 LDD2343 
Download The Altas
  
Experiment 1180 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (HCC44)
Interaction Atlas ID
 LDD2344 
Download The Altas
  
Experiment 1181 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC70)
Interaction Atlas ID
 LDD2345 
Download The Altas
  
Experiment 1182 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (HCC827 CDX model (CDX: HA1; Afatinib resistant))
Interaction Atlas ID
 LDD2346 
Download The Altas
  
Experiment 1183 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (HCT 15)
Interaction Atlas ID
 LDD2347 
Download The Altas
  
Experiment 1184 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (HD-MY-Z)
Interaction Atlas ID
 LDD2348 
Download The Altas
  
Experiment 1185 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HDQ-P1)
Interaction Atlas ID
 LDD2349 
Download The Altas
  
Experiment 1186 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (HEC-1)
Interaction Atlas ID
 LDD2350 
Download The Altas
  
Experiment 1187 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (HEL)
Interaction Atlas ID
 LDD2351 
Download The Altas
  
Experiment 1188 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (HEL 92.1.7)
Interaction Atlas ID
 LDD2352 
Download The Altas
  
Experiment 1189 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (Hep 3B2.1-7)
Interaction Atlas ID
 LDD2353 
Download The Altas
  
Experiment 1190 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatoblastoma [ICD-11:DB91]
Model Name
Human hepatoblastoma cell lysate (Hep-G2)
Interaction Atlas ID
 LDD2354 
Download The Altas
  
Experiment 1191 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Chronic lymphocytic leukemia [ICD11: 2A82]
Model Name
Human chronic lymphocytic leukemia cell lysate (HG-3)
Interaction Atlas ID
 LDD2355 
Download The Altas
  
Experiment 1192 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (HGC-27)
Interaction Atlas ID
 LDD2356 
Download The Altas
  
Experiment 1193 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (HKGZ-CC)
Interaction Atlas ID
 LDD2357 
Download The Altas
  
Experiment 1194 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (HLF)
Interaction Atlas ID
 LDD2358 
Download The Altas
  
Experiment 1195 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (HMCB)
Interaction Atlas ID
 LDD2359 
Download The Altas
  
Experiment 1196 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (Hs 578T)
Interaction Atlas ID
 LDD2360 
Download The Altas
  
Experiment 1197 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (Hs 839.T)
Interaction Atlas ID
 LDD2361 
Download The Altas
  
Experiment 1198 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD2362 
Download The Altas
  
Experiment 1199 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD2363 
Download The Altas
  
Experiment 1200 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (HSC-3)
Interaction Atlas ID
 LDD2364 
Download The Altas
  
Experiment 1201 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (HSC-4)
Interaction Atlas ID
 LDD2365 
Download The Altas
  
Experiment 1202 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (HT)
Interaction Atlas ID
 LDD2366 
Download The Altas
  
Experiment 1203 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Fibrosarcoma [ICD11: 2B53]
Model Name
Human fibrosarcoma cell lysate (HT-1080 (FAP expression))
Interaction Atlas ID
 LDD2367 
Download The Altas
  
Experiment 1204 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HT115)
Interaction Atlas ID
 LDD2368 
Download The Altas
  
Experiment 1205 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (HT-1197)
Interaction Atlas ID
 LDD2369 
Download The Altas
  
Experiment 1206 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (HT-1376)
Interaction Atlas ID
 LDD2370 
Download The Altas
  
Experiment 1207 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon cancer [ICD11: 2C82]
Model Name
Human colon cancer cell lysate (HT29)
Interaction Atlas ID
 LDD2371 
Download The Altas
  
Experiment 1208 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (HT-3)
Interaction Atlas ID
 LDD2372 
Download The Altas
  
Experiment 1209 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Liver bile duct carcinoma [ICD11: 2C12]
Model Name
Human liver bile duct carcinoma cell lysate (HuCCT-1)
Interaction Atlas ID
 LDD2373 
Download The Altas
  
Experiment 1210 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (HuH-1)
Interaction Atlas ID
 LDD2374 
Download The Altas
  
Experiment 1211 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (HuH-28)
Interaction Atlas ID
 LDD2375 
Download The Altas
  
Experiment 1212 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (Huh-7)
Interaction Atlas ID
 LDD2376 
Download The Altas
  
Experiment 1213 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (HuP-T3)
Interaction Atlas ID
 LDD2377 
Download The Altas
  
Experiment 1214 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (HuP-T4)
Interaction Atlas ID
 LDD2378 
Download The Altas
  
Experiment 1215 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC10)
Interaction Atlas ID
 LDD2379 
Download The Altas
  
Experiment 1216 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC106)
Interaction Atlas ID
 LDD2380 
Download The Altas
  
Experiment 1217 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC108)
Interaction Atlas ID
 LDD2381 
Download The Altas
  
Experiment 1218 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC11)
Interaction Atlas ID
 LDD2382 
Download The Altas
  
Experiment 1219 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC12)
Interaction Atlas ID
 LDD2383 
Download The Altas
  
Experiment 1220 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC13-7)
Interaction Atlas ID
 LDD2384 
Download The Altas
  
Experiment 1221 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC18)
Interaction Atlas ID
 LDD2385 
Download The Altas
  
Experiment 1222 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC19)
Interaction Atlas ID
 LDD2386 
Download The Altas
  
Experiment 1223 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC20)
Interaction Atlas ID
 LDD2387 
Download The Altas
  
Experiment 1224 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC21)
Interaction Atlas ID
 LDD2388 
Download The Altas
  
Experiment 1225 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC24)
Interaction Atlas ID
 LDD2389 
Download The Altas
  
Experiment 1226 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC26)
Interaction Atlas ID
 LDD2390 
Download The Altas
  
Experiment 1227 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC3)
Interaction Atlas ID
 LDD2391 
Download The Altas
  
Experiment 1228 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC4)
Interaction Atlas ID
 LDD2392 
Download The Altas
  
Experiment 1229 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC8)
Interaction Atlas ID
 LDD2393 
Download The Altas
  
Experiment 1230 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC9)
Interaction Atlas ID
 LDD2394 
Download The Altas
  
Experiment 1231 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (IGR-1)
Interaction Atlas ID
 LDD2395 
Download The Altas
  
Experiment 1232 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (IGR-37)
Interaction Atlas ID
 LDD2396 
Download The Altas
  
Experiment 1233 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (IGR-39)
Interaction Atlas ID
 LDD2397 
Download The Altas
  
Experiment 1234 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (IGROV-1)
Interaction Atlas ID
 LDD2398 
Download The Altas
  
Experiment 1235 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (IM95)
Interaction Atlas ID
 LDD2399 
Download The Altas
  
Experiment 1236 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (IPC-298)
Interaction Atlas ID
 LDD2400 
Download The Altas
  
Experiment 1237 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (Ishikawa (Heraklio) 02 ER-)
Interaction Atlas ID
 LDD2401 
Download The Altas
  
Experiment 1238 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (J82)
Interaction Atlas ID
 LDD2402 
Download The Altas
  
Experiment 1239 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Mantle cell lymphoma [ICD11: 2A85]
Model Name
Human mantle cell lymphoma cell lysate (JeKo-1)
Interaction Atlas ID
 LDD2403 
Download The Altas
  
Experiment 1240 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-1)
Interaction Atlas ID
 LDD2404 
Download The Altas
  
Experiment 1241 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-4)
Interaction Atlas ID
 LDD2405 
Download The Altas
  
Experiment 1242 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-6)
Interaction Atlas ID
 LDD2406 
Download The Altas
  
Experiment 1243 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-7)
Interaction Atlas ID
 LDD2407 
Download The Altas
  
Experiment 1244 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (JM-1)
Interaction Atlas ID
 LDD2408 
Download The Altas
  
Experiment 1245 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD2409 
Download The Altas
  
Experiment 1246 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Chronic myelogenous leukemia [ICD11: 2A20]
Model Name
Human chronic myelogenous leukemia cell lysate (JURL-MK1)
Interaction Atlas ID
 LDD2410 
Download The Altas
  
Experiment 1247 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B-cell prolymphocytic leukemia [ICD11: 2A70]
Model Name
Human b-cell prolymphocytic leukemia cell lysate (JVM-3)
Interaction Atlas ID
 LDD2411 
Download The Altas
  
Experiment 1248 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Anaplastic large cell lymphoma [ICD11: 2A90]
Model Name
Human anaplastic large cell lymphoma cell lysate (Karpas-299)
Interaction Atlas ID
 LDD2412 
Download The Altas
  
Experiment 1249 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (Karpas-422)
Interaction Atlas ID
 LDD2413 
Download The Altas
  
Experiment 1250 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Myeloid leukaemia [ICD11: 2B33]
Model Name
Human myeloid leukaemia cell lysate (Kasumi-1)
Interaction Atlas ID
 LDD2414 
Download The Altas
  
Experiment 1251 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (Kasumi-2)
Interaction Atlas ID
 LDD2415 
Download The Altas
  
Experiment 1252 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric signet ring cell adenocarcinoma [ICD11: 2B72]
Model Name
Human gastric signet ring cell adenocarcinoma cell lysate (KATO III)
Interaction Atlas ID
 LDD2416 
Download The Altas
  
Experiment 1253 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (Kelly)
Interaction Atlas ID
 LDD2417 
Download The Altas
  
Experiment 1254 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Liver cancer [ICD11: 2C12]
Model Name
Human liver cancer cell lysate (KMCH-1)
Interaction Atlas ID
 LDD2418 
Download The Altas
  
Experiment 1255 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC-1)
Interaction Atlas ID
 LDD2419 
Download The Altas
  
Experiment 1256 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC-20)
Interaction Atlas ID
 LDD2420 
Download The Altas
  
Experiment 1257 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC3)
Interaction Atlas ID
 LDD2421 
Download The Altas
  
Experiment 1258 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS11)
Interaction Atlas ID
 LDD2422 
Download The Altas
  
Experiment 1259 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS-12-BM)
Interaction Atlas ID
 LDD2423 
Download The Altas
  
Experiment 1260 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS-27)
Interaction Atlas ID
 LDD2424 
Download The Altas
  
Experiment 1261 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (KNS-42)
Interaction Atlas ID
 LDD2425 
Download The Altas
  
Experiment 1262 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (KNS-81-FD)
Interaction Atlas ID
 LDD2426 
Download The Altas
  
Experiment 1263 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Adult acute myeloid leukemia [ICD11: 2A60]
Model Name
Human adult acute myeloid leukemia cell lysate (K052)
Interaction Atlas ID
 LDD2427 
Download The Altas
  
Experiment 1264 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic cancer [ICD11: 2C10]
Model Name
Human pancreatic cancer cell lysate (KP-4)
Interaction Atlas ID
 LDD2428 
Download The Altas
  
Experiment 1265 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (KPL-1)
Interaction Atlas ID
 LDD2429 
Download The Altas
  
Experiment 1266 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Adrenal cancer [ICD11: 2D11]
Model Name
Human adrenal gland neuroblastoma cell lysate (KP-N-YN)
Interaction Atlas ID
 LDD2430 
Download The Altas
  
Experiment 1267 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (KU-19-19)
Interaction Atlas ID
 LDD2431 
Download The Altas
  
Experiment 1268 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (KURAMOCHI)
Interaction Atlas ID
 LDD2432 
Download The Altas
  
Experiment 1269 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Embryo
Disease Model
Embryonal rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human embryonal rhabdomyosarcoma cell lysate (KYM-1)
Interaction Atlas ID
 LDD2433 
Download The Altas
  
Experiment 1270 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-150)
Interaction Atlas ID
 LDD2434 
Download The Altas
  
Experiment 1271 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-180)
Interaction Atlas ID
 LDD2435 
Download The Altas
  
Experiment 1272 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-30)
Interaction Atlas ID
 LDD2436 
Download The Altas
  
Experiment 1273 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-410)
Interaction Atlas ID
 LDD2437 
Download The Altas
  
Experiment 1274 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-510)
Interaction Atlas ID
 LDD2438 
Download The Altas
  
Experiment 1275 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Hodgkin lymphoma [ICD11: 2B30]
Model Name
Human hodgkin lymphoma cell lysate (L-428)
Interaction Atlas ID
 LDD2439 
Download The Altas
  
Experiment 1276 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (LN-18)
Interaction Atlas ID
 LDD2440 
Download The Altas
  
Experiment 1277 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (LN-229)
Interaction Atlas ID
 LDD2441 
Download The Altas
  
Experiment 1278 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (LNCaP-Clone-FGC)
Interaction Atlas ID
 LDD2442 
Download The Altas
  
Experiment 1279 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (LOX IMVI)
Interaction Atlas ID
 LDD2443 
Download The Altas
  
Experiment 1280 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (LS-123)
Interaction Atlas ID
 LDD2444 
Download The Altas
  
Experiment 1281 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (LS180)
Interaction Atlas ID
 LDD2445 
Download The Altas
  
Experiment 1282 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Cecum adenocarcinoma [ICD-11:2B90]
Model Name
Human cecum adenocarcinoma cell lysate (LS-513)
Interaction Atlas ID
 LDD2446 
Download The Altas
  
Experiment 1283 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung giant cell carcinoma [ICD11: 2C25]
Model Name
Human lung giant cell carcinoma cell lysate (Lu-65)
Interaction Atlas ID
 LDD2447 
Download The Altas
  
Experiment 1284 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (LUDLU-1)
Interaction Atlas ID
 LDD2448 
Download The Altas
  
Experiment 1285 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian mucinous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian mucinous cystadenocarcinoma cell lysate (MCAS)
Interaction Atlas ID
 LDD2449 
Download The Altas
  
Experiment 1286 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Merkel cell carcinoma [ICD11: 2C34]
Model Name
Human merkel cell carcinoma cell lysate (MCC13)
Interaction Atlas ID
 LDD2450 
Download The Altas
  
Experiment 1287 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Merkel cell carcinoma [ICD11: 2C34]
Model Name
Human merkel cell carcinoma cell lysate (MCC26)
Interaction Atlas ID
 LDD2451 
Download The Altas
  
Experiment 1288 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Invasive breast carcinoma [ICD-11:2C60]
Model Name
Human invasive breast carcinoma cell lysate (MCF-7)
Interaction Atlas ID
 LDD2452 
Download The Altas
  
Experiment 1289 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (MDA-MB-157)
Interaction Atlas ID
 LDD2453 
Download The Altas
  
Experiment 1290 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-231)
Interaction Atlas ID
 LDD2454 
Download The Altas
  
Experiment 1291 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Ductal carcinoma [ICD11: 2C61]
Model Name
Human ductal carcinoma cell lysate (MDA-MB-436)
Interaction Atlas ID
 LDD2455 
Download The Altas
  
Experiment 1292 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-453)
Interaction Atlas ID
 LDD2456 
Download The Altas
  
Experiment 1293 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-468)
Interaction Atlas ID
 LDD2457 
Download The Altas
  
Experiment 1294 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (MDST8)
Interaction Atlas ID
 LDD2458 
Download The Altas
  
Experiment 1295 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Chronic lymphocytic leukemia [ICD11: 2A82]
Model Name
Human chronic lymphocytic leukemia cell lysate (MEC-1)
Interaction Atlas ID
 LDD2459 
Download The Altas
  
Experiment 1296 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (CHL1)
Interaction Atlas ID
 LDD2460 
Download The Altas
  
Experiment 1297 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (COLO792)
Interaction Atlas ID
 LDD2461 
Download The Altas
  
Experiment 1298 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (MEL-HO)
Interaction Atlas ID
 LDD2462 
Download The Altas
  
Experiment 1299 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (MEL-JUSO)
Interaction Atlas ID
 LDD2463 
Download The Altas
  
Experiment 1300 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (MeWo)
Interaction Atlas ID
 LDD2464 
Download The Altas
  
Experiment 1301 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (MFE-280)
Interaction Atlas ID
 LDD2465 
Download The Altas
  
Experiment 1302 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (MFE-296)
Interaction Atlas ID
 LDD2466 
Download The Altas
  
Experiment 1303 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial cancer [ICD11: 2C76]
Model Name
Human endometrial cancer cell lysate (MFE-319)
Interaction Atlas ID
 LDD2467 
Download The Altas
  
Experiment 1304 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (MG984)
Interaction Atlas ID
 LDD2468 
Download The Altas
  
Experiment 1305 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG123)
Interaction Atlas ID
 LDD2469 
Download The Altas
  
Experiment 1306 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG23)
Interaction Atlas ID
 LDD2470 
Download The Altas
  
Experiment 1307 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG75)
Interaction Atlas ID
 LDD2471 
Download The Altas
  
Experiment 1308 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (DM93)
Interaction Atlas ID
 LDD2472 
Download The Altas
  
Experiment 1309 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (A101D)
Interaction Atlas ID
 LDD2473 
Download The Altas
  
Experiment 1310 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (A2058)
Interaction Atlas ID
 LDD2474 
Download The Altas
  
Experiment 1311 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (CHL1)
Interaction Atlas ID
 LDD2475 
Download The Altas
  
Experiment 1312 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (COLO792)
Interaction Atlas ID
 LDD2476 
Download The Altas
  
Experiment 1313 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (G361)
Interaction Atlas ID
 LDD2477 
Download The Altas
  
Experiment 1314 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (HMCB)
Interaction Atlas ID
 LDD2478 
Download The Altas
  
Experiment 1315 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD2479 
Download The Altas
  
Experiment 1316 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (IGR37)
Interaction Atlas ID
 LDD2480 
Download The Altas
  
Experiment 1317 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (IGR39)
Interaction Atlas ID
 LDD2481 
Download The Altas
  
Experiment 1318 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEL167)
Interaction Atlas ID
 LDD2482 
Download The Altas
  
Experiment 1319 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEL182)
Interaction Atlas ID
 LDD2483 
Download The Altas
  
Experiment 1320 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MELHO)
Interaction Atlas ID
 LDD2484 
Download The Altas
  
Experiment 1321 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEWO)
Interaction Atlas ID
 LDD2485 
Download The Altas
  
Experiment 1322 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (RVH421)
Interaction Atlas ID
 LDD2486 
Download The Altas
  
Experiment 1323 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SH4)
Interaction Atlas ID
 LDD2487 
Download The Altas
  
Experiment 1324 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL2)
Interaction Atlas ID
 LDD2488 
Download The Altas
  
Experiment 1325 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL24)
Interaction Atlas ID
 LDD2489 
Download The Altas
  
Experiment 1326 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL3)
Interaction Atlas ID
 LDD2490 
Download The Altas
  
Experiment 1327 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (UACC257)
Interaction Atlas ID
 LDD2491 
Download The Altas
  
Experiment 1328 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (UACC62)
Interaction Atlas ID
 LDD2492 
Download The Altas
  
Experiment 1329 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (WM115)
Interaction Atlas ID
 LDD2493 
Download The Altas
  
Experiment 1330 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (WM266-4 )
Interaction Atlas ID
 LDD2494 
Download The Altas
  
Experiment 1331 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (RAW264.7)
Interaction Atlas ID
 LDD2495 
Download The Altas
  
Experiment 1332 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (MIA PaCa-2)
Interaction Atlas ID
 LDD2496 
Download The Altas
  
Experiment 1333 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (MKN-1)
Interaction Atlas ID
 LDD2497 
Download The Altas
  
Experiment 1334 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (MKN45)
Interaction Atlas ID
 LDD2498 
Download The Altas
  
Experiment 1335 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (MOLM-13)
Interaction Atlas ID
 LDD2499 
Download The Altas
  
Experiment 1336 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Adult acute myeloid leukemia [ICD11: 2A60]
Model Name
Human adult acute myeloid leukemia cell lysate (MOLM-16)
Interaction Atlas ID
 LDD2500 
Download The Altas
  
Experiment 1337 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MONO-MAC-6)
Interaction Atlas ID
 LDD2501 
Download The Altas
  
Experiment 1338 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MONO-MAC-6)
Interaction Atlas ID
 LDD2502 
Download The Altas
  
Experiment 1339 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pleural effusion
Disease Model
Pleural biphasic mesothelioma [ICD11: 2C26]
Model Name
Human pleural biphasic mesothelioma cell lysate (MSTO-211H)
Interaction Atlas ID
 LDD2503 
Download The Altas
  
Experiment 1340 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MV4-11)
Interaction Atlas ID
 LDD2504 
Download The Altas
  
Experiment 1341 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (NALM-6)
Interaction Atlas ID
 LDD2505 
Download The Altas
  
Experiment 1342 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (NB1)
Interaction Atlas ID
 LDD2506 
Download The Altas
  
Experiment 1343 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H1048)
Interaction Atlas ID
 LDD2507 
Download The Altas
  
Experiment 1344 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Lung large cell carcinoma [ICD-11:2C25]
Model Name
Human lung large cell carcinoma cell lysate (NCI-H1155)
Interaction Atlas ID
 LDD2508 
Download The Altas
  
Experiment 1345 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Lung large cell carcinoma [ICD-11:2C25]
Model Name
Human lung large cell carcinoma cell lysate (NCI-H1299)
Interaction Atlas ID
 LDD2509 
Download The Altas
  
Experiment 1346 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H146)
Interaction Atlas ID
 LDD2510 
Download The Altas
  
Experiment 1347 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1650)
Interaction Atlas ID
 LDD2511 
Download The Altas
  
Experiment 1348 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1666)
Interaction Atlas ID
 LDD2512 
Download The Altas
  
Experiment 1349 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H1703)
Interaction Atlas ID
 LDD2513 
Download The Altas
  
Experiment 1350 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1792)
Interaction Atlas ID
 LDD2514 
Download The Altas
  
Experiment 1351 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1793)
Interaction Atlas ID
 LDD2515 
Download The Altas
  
Experiment 1352 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCl-H1944)
Interaction Atlas ID
 LDD2516 
Download The Altas
  
Experiment 1353 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H196)
Interaction Atlas ID
 LDD2517 
Download The Altas
  
Experiment 1354 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1975)
Interaction Atlas ID
 LDD2518 
Download The Altas
  
Experiment 1355 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pleural effusion
Disease Model
Pleural mesothelioma [ICD11: 2C26]
Model Name
Human pleural mesothelioma cell lysate (NCI-H2052)
Interaction Atlas ID
 LDD2519 
Download The Altas
  
Experiment 1356 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H2122)
Interaction Atlas ID
 LDD2520 
Download The Altas
  
Experiment 1357 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H2170)
Interaction Atlas ID
 LDD2521 
Download The Altas
  
Experiment 1358 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung cancer cell lysate (NCI-H2172)
Interaction Atlas ID
 LDD2522 
Download The Altas
  
Experiment 1359 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H2286)
Interaction Atlas ID
 LDD2523 
Download The Altas
  
Experiment 1360 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H2291)
Interaction Atlas ID
 LDD2524 
Download The Altas
  
Experiment 1361 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H23)
Interaction Atlas ID
 LDD2525 
Download The Altas
  
Experiment 1362 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H3122)
Interaction Atlas ID
 LDD2526 
Download The Altas
  
Experiment 1363 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (NCI-H358)
Interaction Atlas ID
 LDD2527 
Download The Altas
  
Experiment 1364 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H446)
Interaction Atlas ID
 LDD2528 
Download The Altas
  
Experiment 1365 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H82)
Interaction Atlas ID
 LDD2529 
Download The Altas
  
Experiment 1366 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric tubular adenocarcinoma [ICD11: 2.00E+92]
Model Name
Human gastric tubular adenocarcinoma cell lysate (NCI-N87)
Interaction Atlas ID
 LDD2530 
Download The Altas
  
Experiment 1367 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-3)
Interaction Atlas ID
 LDD2531 
Download The Altas
  
Experiment 1368 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (NOMO-1)
Interaction Atlas ID
 LDD2532 
Download The Altas
  
Experiment 1369 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (NUGC-3)
Interaction Atlas ID
 LDD2533 
Download The Altas
  
Experiment 1370 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OAW-28)
Interaction Atlas ID
 LDD2534 
Download The Altas
  
Experiment 1371 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OAW-42)
Interaction Atlas ID
 LDD2535 
Download The Altas
  
Experiment 1372 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (OCI-AML-2)
Interaction Atlas ID
 LDD2536 
Download The Altas
  
Experiment 1373 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (OCI-AML-5)
Interaction Atlas ID
 LDD2537 
Download The Altas
  
Experiment 1374 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (OCI-Ly3)
Interaction Atlas ID
 LDD2538 
Download The Altas
  
Experiment 1375 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (OCUG-1)
Interaction Atlas ID
 LDD2539 
Download The Altas
  
Experiment 1376 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric signet ring cell adenocarcinoma [ICD11: 2B72]
Model Name
Human gastric signet ring cell adenocarcinoma cell lysate (OCUM-1)
Interaction Atlas ID
 LDD2540 
Download The Altas
  
Experiment 1377 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Barrett adenocarcinoma [ICD11: 2B70]
Model Name
Human barrett adenocarcinoma cell lysate (OE33)
Interaction Atlas ID
 LDD2541 
Download The Altas
  
Experiment 1378 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (ONS-76)
Interaction Atlas ID
 LDD2542 
Download The Altas
  
Experiment 1379 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (OPM-2)
Interaction Atlas ID
 LDD2543 
Download The Altas
  
Experiment 1380 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (OS-RC-2)
Interaction Atlas ID
 LDD2544 
Download The Altas
  
Experiment 1381 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OV56)
Interaction Atlas ID
 LDD2545 
Download The Altas
  
Experiment 1382 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OV-90)
Interaction Atlas ID
 LDD2546 
Download The Altas
  
Experiment 1383 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OVCA429)
Interaction Atlas ID
 LDD2547 
Download The Altas
  
Experiment 1384 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OVCAR-4)
Interaction Atlas ID
 LDD2548 
Download The Altas
  
Experiment 1385 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OVCAR-5)
Interaction Atlas ID
 LDD2549 
Download The Altas
  
Experiment 1386 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-8)
Interaction Atlas ID
 LDD2550 
Download The Altas
  
Experiment 1387 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (OVISE)
Interaction Atlas ID
 LDD2551 
Download The Altas
  
Experiment 1388 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (OVK-18)
Interaction Atlas ID
 LDD2552 
Download The Altas
  
Experiment 1389 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVKATE)
Interaction Atlas ID
 LDD2553 
Download The Altas
  
Experiment 1390 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (OVTOKO)
Interaction Atlas ID
 LDD2554 
Download The Altas
  
Experiment 1391 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (OZ)
Interaction Atlas ID
 LDD2555 
Download The Altas
  
Experiment 1392 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (P31-FUJ)
Interaction Atlas ID
 LDD2556 
Download The Altas
  
Experiment 1393 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (Panc 04.03)
Interaction Atlas ID
 LDD2557 
Download The Altas
  
Experiment 1394 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (PANC-1)
Interaction Atlas ID
 LDD2558 
Download The Altas
  
Experiment 1395 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD2559 
Download The Altas
  
Experiment 1396 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (PC-14)
Interaction Atlas ID
 LDD2560 
Download The Altas
  
Experiment 1397 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (PC-3)
Interaction Atlas ID
 LDD2561 
Download The Altas
  
Experiment 1398 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (PEO1)
Interaction Atlas ID
 LDD2562 
Download The Altas
  
Experiment 1399 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (PF-382)
Interaction Atlas ID
 LDD2563 
Download The Altas
  
Experiment 1400 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Neuroectodermal tumor [ICD11: 2A00]
Model Name
Human neuroectodermal tumor cell lysate (PFSK-1)
Interaction Atlas ID
 LDD2564 
Download The Altas
  
Experiment 1401 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (RBE)
Interaction Atlas ID
 LDD2565 
Download The Altas
  
Experiment 1402 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (RCC10RGB)
Interaction Atlas ID
 LDD2566 
Download The Altas
  
Experiment 1403 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (RD)
Interaction Atlas ID
 LDD2567 
Download The Altas
  
Experiment 1404 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Mantle cell lymphoma [ICD11: 2A85]
Model Name
Human mantle cell lymphoma cell lysate (REC-1)
Interaction Atlas ID
 LDD2568 
Download The Altas
  
Experiment 1405 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (Reh)
Interaction Atlas ID
 LDD2569 
Download The Altas
  
Experiment 1406 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Alveolar rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human alveolar rhabdomyosarcoma cell lysate (SJRH30)
Interaction Atlas ID
 LDD2570 
Download The Altas
  
Experiment 1407 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Alveolar rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human alveolar rhabdomyosarcoma cell lysate (Rh41)
Interaction Atlas ID
 LDD2571 
Download The Altas
  
Experiment 1408 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian leiomyosarcoma [ICD11: 2C73]
Model Name
Human ovarian leiomyosarcoma cell lysate (RKN)
Interaction Atlas ID
 LDD2572 
Download The Altas
  
Experiment 1409 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (RKO)
Interaction Atlas ID
 LDD2573 
Download The Altas
  
Experiment 1410 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (RL)
Interaction Atlas ID
 LDD2574 
Download The Altas
  
Experiment 1411 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial cancer [ICD11: 2C76]
Model Name
Human endometrial cancer cell lysate (RL95-2)
Interaction Atlas ID
 LDD2575 
Download The Altas
  
Experiment 1412 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD11: 2C30]
Model Name
Human melanoma cell lysate (RPMI-7951)
Interaction Atlas ID
 LDD2576 
Download The Altas
  
Experiment 1413 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (RPMI-8226)
Interaction Atlas ID
 LDD2577 
Download The Altas
  
Experiment 1414 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (RT-112)
Interaction Atlas ID
 LDD2578 
Download The Altas
  
Experiment 1415 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (RVH-421)
Interaction Atlas ID
 LDD2579 
Download The Altas
  
Experiment 1416 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (SAOS-2)
Interaction Atlas ID
 LDD2580 
Download The Altas
  
Experiment 1417 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SBC-5)
Interaction Atlas ID
 LDD2581 
Download The Altas
  
Experiment 1418 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Squamous carcinoma [ICD11: 2B6A]
Model Name
Human squamous carcinoma cell lysate (SCC-25)
Interaction Atlas ID
 LDD2582 
Download The Altas
  
Experiment 1419 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (SF-295)
Interaction Atlas ID
 LDD2583 
Download The Altas
  
Experiment 1420 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (SG231)
Interaction Atlas ID
 LDD2584 
Download The Altas
  
Experiment 1421 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SH-4)
Interaction Atlas ID
 LDD2585 
Download The Altas
  
Experiment 1422 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SHP-77)
Interaction Atlas ID
 LDD2586 
Download The Altas
  
Experiment 1423 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (SiSo)
Interaction Atlas ID
 LDD2587 
Download The Altas
  
Experiment 1424 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (SJSA-1)
Interaction Atlas ID
 LDD2588 
Download The Altas
  
Experiment 1425 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Ewing sarcoma [ICD11: 2B52]
Model Name
Human ewing sarcoma cell lysate (SK-ES1)
Interaction Atlas ID
 LDD2589 
Download The Altas
  
Experiment 1426 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatoma [ICD11: 2C12]
Model Name
Human hepatoma cell lysate (SK-HEP1)
Interaction Atlas ID
 LDD2590 
Download The Altas
  
Experiment 1427 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL-2)
Interaction Atlas ID
 LDD2591 
Download The Altas
  
Experiment 1428 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL-24)
Interaction Atlas ID
 LDD2592 
Download The Altas
  
Experiment 1429 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-28)
Interaction Atlas ID
 LDD2593 
Download The Altas
  
Experiment 1430 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL3)
Interaction Atlas ID
 LDD2594 
Download The Altas
  
Experiment 1431 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-30)
Interaction Atlas ID
 LDD2595 
Download The Altas
  
Experiment 1432 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-5)
Interaction Atlas ID
 LDD2596 
Download The Altas
  
Experiment 1433 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (SK-MM-2)
Interaction Atlas ID
 LDD2597 
Download The Altas
  
Experiment 1434 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Uterine corpus leiomyosarcoma [ICD11: 2.00E+86]
Model Name
Human uterine corpus leiomyosarcoma cell lysate (SKN)
Interaction Atlas ID
 LDD2598 
Download The Altas
  
Experiment 1435 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (SK-N-AS)
Interaction Atlas ID
 LDD2599 
Download The Altas
  
Experiment 1436 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Neuroepithelioma [ICD11: 2A00]
Model Name
Human neuroepithelioma cell lysate (SK-N-MC)
Interaction Atlas ID
 LDD2600 
Download The Altas
  
Experiment 1437 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (SK-OV-3)
Interaction Atlas ID
 LDD2601 
Download The Altas
  
Experiment 1438 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (SNG-M)
Interaction Atlas ID
 LDD2602 
Download The Altas
  
Experiment 1439 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (SNU-1)
Interaction Atlas ID
 LDD2603 
Download The Altas
  
Experiment 1440 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (SNU-1079)
Interaction Atlas ID
 LDD2604 
Download The Altas
  
Experiment 1441 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hilar cholangiocarcinoma [ICD11: 2C18]
Model Name
Human hilar cholangiocarcinoma cell lysate (SNU-1196)
Interaction Atlas ID
 LDD2605 
Download The Altas
  
Experiment 1442 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (SNU-245)
Interaction Atlas ID
 LDD2606 
Download The Altas
  
Experiment 1443 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (SNU-308)
Interaction Atlas ID
 LDD2607 
Download The Altas
  
Experiment 1444 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (SNU-423)
Interaction Atlas ID
 LDD2608 
Download The Altas
  
Experiment 1445 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (SNU-449)
Interaction Atlas ID
 LDD2609 
Download The Altas
  
Experiment 1446 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenocarcinoma cell lysate (SNU-478)
Interaction Atlas ID
 LDD2610 
Download The Altas
  
Experiment 1447 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (SNU-5)
Interaction Atlas ID
 LDD2611 
Download The Altas
  
Experiment 1448 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenocarcinoma cell lysate (SNU-869)
Interaction Atlas ID
 LDD2612 
Download The Altas
  
Experiment 1449 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (SSP-25)
Interaction Atlas ID
 LDD2613 
Download The Altas
  
Experiment 1450 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (SU-DHL-4)
Interaction Atlas ID
 LDD2614 
Download The Altas
  
Experiment 1451 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (SU-DHL-6)
Interaction Atlas ID
 LDD2615 
Download The Altas
  
Experiment 1452 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (SUIT-2)
Interaction Atlas ID
 LDD2616 
Download The Altas
  
Experiment 1453 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
T acute lymphoblastic leukemia [ICD11: 2A90]
Model Name
Human T lymphoblastic lymphoma cell lysate (SUP-T1)
Interaction Atlas ID
 LDD2617 
Download The Altas
  
Experiment 1454 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW1116)
Interaction Atlas ID
 LDD2618 
Download The Altas
  
Experiment 1455 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SW1271)
Interaction Atlas ID
 LDD2619 
Download The Altas
  
Experiment 1456 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (SW1573)
Interaction Atlas ID
 LDD2620 
Download The Altas
  
Experiment 1457 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Anaplastic astrocytoma [ICD11: 2A00]
Model Name
Human anaplastic astrocytoma cell lysate (SW1783)
Interaction Atlas ID
 LDD2621 
Download The Altas
  
Experiment 1458 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (SW1990)
Interaction Atlas ID
 LDD2622 
Download The Altas
  
Experiment 1459 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW403)
Interaction Atlas ID
 LDD2623 
Download The Altas
  
Experiment 1460 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW620)
Interaction Atlas ID
 LDD2624 
Download The Altas
  
Experiment 1461 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (SW756)
Interaction Atlas ID
 LDD2625 
Download The Altas
  
Experiment 1462 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Rectal cancer [ICD11: 2B92]
Model Name
Human rectal cancer cell lysate (SW837)
Interaction Atlas ID
 LDD2626 
Download The Altas
  
Experiment 1463 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW948)
Interaction Atlas ID
 LDD2627 
Download The Altas
  
Experiment 1464 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (T24)
Interaction Atlas ID
 LDD2628 
Download The Altas
  
Experiment 1465 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (T98G)
Interaction Atlas ID
 LDD2629 
Download The Altas
  
Experiment 1466 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Ewing sarcoma [ICD11: 2B52]
Model Name
Human ewing sarcoma cell lysate (TC-71)
Interaction Atlas ID
 LDD2630 
Download The Altas
  
Experiment 1467 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (TCCSUP)
Interaction Atlas ID
 LDD2631 
Download The Altas
  
Experiment 1468 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TF-1)
Interaction Atlas ID
 LDD2632 
Download The Altas
  
Experiment 1469 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-10)
Interaction Atlas ID
 LDD2633 
Download The Altas
  
Experiment 1470 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-11)
Interaction Atlas ID
 LDD2634 
Download The Altas
  
Experiment 1471 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE4)
Interaction Atlas ID
 LDD2635 
Download The Altas
  
Experiment 1472 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-8)
Interaction Atlas ID
 LDD2636 
Download The Altas
  
Experiment 1473 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (TF-1)
Interaction Atlas ID
 LDD2637 
Download The Altas
  
Experiment 1474 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (TFK-1)
Interaction Atlas ID
 LDD2638 
Download The Altas
  
Experiment 1475 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (TGBC1TKB)
Interaction Atlas ID
 LDD2639 
Download The Altas
  
Experiment 1476 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenosquamous carcinoma cell lysate (TGBC52TKB)
Interaction Atlas ID
 LDD2640 
Download The Altas
  
Experiment 1477 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (THP-1)
Interaction Atlas ID
 LDD2641 
Download The Altas
  
Experiment 1478 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (TKKK)
Interaction Atlas ID
 LDD2642 
Download The Altas
  
Experiment 1479 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (TOV-21G)
Interaction Atlas ID
 LDD2643 
Download The Altas
  
Experiment 1480 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (TYK-nu)
Interaction Atlas ID
 LDD2644 
Download The Altas
  
Experiment 1481 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Astrocytoma [ICD-11:2F36]
Model Name
Human astrocytoma cell lysate (U-118-MG)
Interaction Atlas ID
 LDD2645 
Download The Altas
  
Experiment 1482 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (U2OS)
Interaction Atlas ID
 LDD2646 
Download The Altas
  
Experiment 1483 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (U-87MG)
Interaction Atlas ID
 LDD2647 
Download The Altas
  
Experiment 1484 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (U-937)
Interaction Atlas ID
 LDD2648 
Download The Altas
  
Experiment 1485 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (UACC-257)
Interaction Atlas ID
 LDD2649 
Download The Altas
  
Experiment 1486 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (UACC-62)
Interaction Atlas ID
 LDD2650 
Download The Altas
  
Experiment 1487 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (UM-UC-3)
Interaction Atlas ID
 LDD2651 
Download The Altas
  
Experiment 1488 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (VCaP)
Interaction Atlas ID
 LDD2652 
Download The Altas
  
Experiment 1489 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (VMRC-RCW)
Interaction Atlas ID
 LDD2653 
Download The Altas
  
Experiment 1490 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (WM-115)
Interaction Atlas ID
 LDD2654 
Download The Altas
  
Experiment 1491 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (WM1552C)
Interaction Atlas ID
 LDD2655 
Download The Altas
  
Experiment 1492 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (WM 266-4)
Interaction Atlas ID
 LDD2656 
Download The Altas
  
Experiment 1493 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (WM793)
Interaction Atlas ID
 LDD2657 
Download The Altas
  
Experiment 1494 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (YSCCC)
Interaction Atlas ID
 LDD2658 
Download The Altas
  
Experiment 1495 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB02
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Invasive breast carcinoma [ICD-11:2C60]
Model Name
Human invasive breast carcinoma cell lysate (ZR-75-1)
Interaction Atlas ID
 LDD2659 
Download The Altas
  
Experiment 1496 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (22RV1)
Interaction Atlas ID
 LDD2660 
Download The Altas
  
Experiment 1497 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (42-MG-BA)
Interaction Atlas ID
 LDD2661 
Download The Altas
  
Experiment 1498 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (697)
Interaction Atlas ID
 LDD2662 
Download The Altas
  
Experiment 1499 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (769-P)
Interaction Atlas ID
 LDD2663 
Download The Altas
  
Experiment 1500 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (786-O)
Interaction Atlas ID
 LDD2664 
Download The Altas
  
Experiment 1501 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (8305C)
Interaction Atlas ID
 LDD2665 
Download The Altas
  
Experiment 1502 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (8505C)
Interaction Atlas ID
 LDD2666 
Download The Altas
  
Experiment 1503 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (A101D)
Interaction Atlas ID
 LDD2667 
Download The Altas
  
Experiment 1504 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (A-172)
Interaction Atlas ID
 LDD2668 
Download The Altas
  
Experiment 1505 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (A204)
Interaction Atlas ID
 LDD2669 
Download The Altas
  
Experiment 1506 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (A2058)
Interaction Atlas ID
 LDD2670 
Download The Altas
  
Experiment 1507 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (A2780)
Interaction Atlas ID
 LDD2671 
Download The Altas
  
Experiment 1508 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (A-375)
Interaction Atlas ID
 LDD2672 
Download The Altas
  
Experiment 1509 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (A375.S2)
Interaction Atlas ID
 LDD2673 
Download The Altas
  
Experiment 1510 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (A3-KAW)
Interaction Atlas ID
 LDD2674 
Download The Altas
  
Experiment 1511 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Skin squamous cell carcinoma [ICD-11:2C31]
Model Name
Human skin squamous cell carcinoma cell lysate (A431)
Interaction Atlas ID
 LDD2675 
Download The Altas
  
Experiment 1512 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cancer [ICD11: 2C90]
Model Name
Human renal cancer cell lysate (A498)
Interaction Atlas ID
 LDD2676 
Download The Altas
  
Experiment 1513 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (A-549)
Interaction Atlas ID
 LDD2677 
Download The Altas
  
Experiment 1514 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (A673)
Interaction Atlas ID
 LDD2678 
Download The Altas
  
Experiment 1515 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (ABC-1)
Interaction Atlas ID
 LDD2679 
Download The Altas
  
Experiment 1516 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (AGS)
Interaction Atlas ID
 LDD2680 
Download The Altas
  
Experiment 1517 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (AN3-CA)
Interaction Atlas ID
 LDD2681 
Download The Altas
  
Experiment 1518 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (AU565)
Interaction Atlas ID
 LDD2682 
Download The Altas
  
Experiment 1519 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (BICR-22)
Interaction Atlas ID
 LDD2683 
Download The Altas
  
Experiment 1520 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX142)
Interaction Atlas ID
 LDD2684 
Download The Altas
  
Experiment 1521 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX211)
Interaction Atlas ID
 LDD2685 
Download The Altas
  
Experiment 1522 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX250)
Interaction Atlas ID
 LDD2686 
Download The Altas
  
Experiment 1523 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX29)
Interaction Atlas ID
 LDD2687 
Download The Altas
  
Experiment 1524 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX330)
Interaction Atlas ID
 LDD2688 
Download The Altas
  
Experiment 1525 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX390)
Interaction Atlas ID
 LDD2690 
Download The Altas
  
Experiment 1526 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX394)
Interaction Atlas ID
 LDD2691 
Download The Altas
  
Experiment 1527 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX401)
Interaction Atlas ID
 LDD2692 
Download The Altas
  
Experiment 1528 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX50)
Interaction Atlas ID
 LDD2693 
Download The Altas
  
Experiment 1529 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX68)
Interaction Atlas ID
 LDD2694 
Download The Altas
  
Experiment 1530 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX82)
Interaction Atlas ID
 LDD2695 
Download The Altas
  
Experiment 1531 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (BT-549)
Interaction Atlas ID
 LDD2696 
Download The Altas
  
Experiment 1532 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (BxPC-3)
Interaction Atlas ID
 LDD2697 
Download The Altas
  
Experiment 1533 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (C32)
Interaction Atlas ID
 LDD2698 
Download The Altas
  
Experiment 1534 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (C-4-II)
Interaction Atlas ID
 LDD2699 
Download The Altas
  
Experiment 1535 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (Caki-1)
Interaction Atlas ID
 LDD2700 
Download The Altas
  
Experiment 1536 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-120)
Interaction Atlas ID
 LDD2701 
Download The Altas
  
Experiment 1537 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-148)
Interaction Atlas ID
 LDD2702 
Download The Altas
  
Experiment 1538 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral cancer [ICD11: 2B6E]
Model Name
Human oral cancer cell lysate (CAL-27)
Interaction Atlas ID
 LDD2703 
Download The Altas
  
Experiment 1539 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (CAL-33)
Interaction Atlas ID
 LDD2704 
Download The Altas
  
Experiment 1540 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-51)
Interaction Atlas ID
 LDD2705 
Download The Altas
  
Experiment 1541 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (CAL-62)
Interaction Atlas ID
 LDD2706 
Download The Altas
  
Experiment 1542 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (CAL-72)
Interaction Atlas ID
 LDD2707 
Download The Altas
  
Experiment 1543 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Chondrosarcoma [ICD11: 2B50]
Model Name
Human chondrosarcoma cell lysate (CAL-78)
Interaction Atlas ID
 LDD2708 
Download The Altas
  
Experiment 1544 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (Calu-1)
Interaction Atlas ID
 LDD2709 
Download The Altas
  
Experiment 1545 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (Calu-6)
Interaction Atlas ID
 LDD2710 
Download The Altas
  
Experiment 1546 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (CAMA-1)
Interaction Atlas ID
 LDD2711 
Download The Altas
  
Experiment 1547 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (Caov-3)
Interaction Atlas ID
 LDD2712 
Download The Altas
  
Experiment 1548 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (Ca-Ski)
Interaction Atlas ID
 LDD2713 
Download The Altas
  
Experiment 1549 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (CCK-81)
Interaction Atlas ID
 LDD2714 
Download The Altas
  
Experiment 1550 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (CC-LP-1)
Interaction Atlas ID
 LDD2715 
Download The Altas
  
Experiment 1551 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (CC-SW-1 )
Interaction Atlas ID
 LDD2716 
Download The Altas
  
Experiment 1552 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (CFPAC-1)
Interaction Atlas ID
 LDD2717 
Download The Altas
  
Experiment 1553 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (CHL-1)
Interaction Atlas ID
 LDD2718 
Download The Altas
  
Experiment 1554 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
.
Disease Model
Down syndrome [ICD11: LD40]
Model Name
Human down syndrome cell lysate (CMK)
Interaction Atlas ID
 LDD2719 
Download The Altas
  
Experiment 1555 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (COLO 320)
Interaction Atlas ID
 LDD2720 
Download The Altas
  
Experiment 1556 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (COLO-678)
Interaction Atlas ID
 LDD2721 
Download The Altas
  
Experiment 1557 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-679)
Interaction Atlas ID
 LDD2722 
Download The Altas
  
Experiment 1558 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (COLO-792)
Interaction Atlas ID
 LDD2723 
Download The Altas
  
Experiment 1559 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-800)
Interaction Atlas ID
 LDD2724 
Download The Altas
  
Experiment 1560 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-829)
Interaction Atlas ID
 LDD2725 
Download The Altas
  
Experiment 1561 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO 853)
Interaction Atlas ID
 LDD2726 
Download The Altas
  
Experiment 1562 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (COR-L23)
Interaction Atlas ID
 LDD2727 
Download The Altas
  
Experiment 1563 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (COR-L88)
Interaction Atlas ID
 LDD2728 
Download The Altas
  
Experiment 1564 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (D283 Med)
Interaction Atlas ID
 LDD2729 
Download The Altas
  
Experiment 1565 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic cancer [ICD11: 2C10]
Model Name
Human pancreatic cancer cell lysate (DAN-G)
Interaction Atlas ID
 LDD2730 
Download The Altas
  
Experiment 1566 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (Daoy)
Interaction Atlas ID
 LDD2731 
Download The Altas
  
Experiment 1567 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Anaplastic large cell lymphoma [ICD11: 2A90]
Model Name
Human anaplastic large cell lymphoma cell lysate (DEL)
Interaction Atlas ID
 LDD2732 
Download The Altas
  
Experiment 1568 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Pharyngeal squamous cell carcinoma [ICD11: 2B6D]
Model Name
Human pharyngeal squamous cell carcinoma cell lysate (Detroit 562)
Interaction Atlas ID
 LDD2733 
Download The Altas
  
Experiment 1569 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (DoTc2-4510)
Interaction Atlas ID
 LDD2734 
Download The Altas
  
Experiment 1570 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (DU145)
Interaction Atlas ID
 LDD2735 
Download The Altas
  
Experiment 1571 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (DU-4475)
Interaction Atlas ID
 LDD2736 
Download The Altas
  
Experiment 1572 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (ECC2)
Interaction Atlas ID
 LDD2737 
Download The Altas
  
Experiment 1573 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (EFO-21)
Interaction Atlas ID
 LDD2738 
Download The Altas
  
Experiment 1574 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian mucinous adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian mucinous adenocarcinoma cell lysate (EFO-27)
Interaction Atlas ID
 LDD2739 
Download The Altas
  
Experiment 1575 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (EGI-1)
Interaction Atlas ID
 LDD2740 
Download The Altas
  
Experiment 1576 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Chronic eosinophilic leukaemia [ICD11: 2A20]
Model Name
Human chronic eosinophilic leukaemia cell lysate (EoL-1)
Interaction Atlas ID
 LDD2741 
Download The Altas
  
Experiment 1577 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (ETK-1)
Interaction Atlas ID
 LDD2742 
Download The Altas
  
Experiment 1578 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Hypopharyngeal squamous cell carcinoma [ICD11: 2B6D.0]
Model Name
Human hypopharyngeal squamous cell carcinoma cell lysate (FaDu)
Interaction Atlas ID
 LDD2743 
Download The Altas
  
Experiment 1579 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland follicular carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland follicular carcinoma cell lysate (FTC-133)
Interaction Atlas ID
 LDD2744 
Download The Altas
  
Experiment 1580 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (FU-OV-1)
Interaction Atlas ID
 LDD2745 
Download The Altas
  
Experiment 1581 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (G-361)
Interaction Atlas ID
 LDD2746 
Download The Altas
  
Experiment 1582 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Wilms tumor [ICD11: 2C90]
Model Name
Human wilms tumor cell lysate (G-401)
Interaction Atlas ID
 LDD2747 
Download The Altas
  
Experiment 1583 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Kidney cancer [ICD11: 2C90]
Model Name
Human kidney cancer cell lysate (G-402)
Interaction Atlas ID
 LDD2748 
Download The Altas
  
Experiment 1584 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (G-415)
Interaction Atlas ID
 LDD2749 
Download The Altas
  
Experiment 1585 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GAMG)
Interaction Atlas ID
 LDD2750 
Download The Altas
  
Experiment 1586 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GB-1)
Interaction Atlas ID
 LDD2751 
Download The Altas
  
Experiment 1587 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GB-2)
Interaction Atlas ID
 LDD2752 
Download The Altas
  
Experiment 1588 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1143)
Interaction Atlas ID
 LDD2753 
Download The Altas
  
Experiment 1589 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1187)
Interaction Atlas ID
 LDD2754 
Download The Altas
  
Experiment 1590 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1395)
Interaction Atlas ID
 LDD2755 
Download The Altas
  
Experiment 1591 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1419)
Interaction Atlas ID
 LDD2756 
Download The Altas
  
Experiment 1592 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (HCC15)
Interaction Atlas ID
 LDD2757 
Download The Altas
  
Experiment 1593 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (HCC1806)
Interaction Atlas ID
 LDD2758 
Download The Altas
  
Experiment 1594 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1937)
Interaction Atlas ID
 LDD2759 
Download The Altas
  
Experiment 1595 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1954)
Interaction Atlas ID
 LDD2760 
Download The Altas
  
Experiment 1596 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (HCC44)
Interaction Atlas ID
 LDD2761 
Download The Altas
  
Experiment 1597 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC70)
Interaction Atlas ID
 LDD2762 
Download The Altas
  
Experiment 1598 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (HCC827 CDX model (CDX: HA1; Afatinib resistant))
Interaction Atlas ID
 LDD2763 
Download The Altas
  
Experiment 1599 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (HCT 15)
Interaction Atlas ID
 LDD2764 
Download The Altas
  
Experiment 1600 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (HD-MY-Z)
Interaction Atlas ID
 LDD2765 
Download The Altas
  
Experiment 1601 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HDQ-P1)
Interaction Atlas ID
 LDD2766 
Download The Altas
  
Experiment 1602 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (HEC-1)
Interaction Atlas ID
 LDD2767 
Download The Altas
  
Experiment 1603 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (HEL)
Interaction Atlas ID
 LDD2768 
Download The Altas
  
Experiment 1604 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (HEL 92.1.7)
Interaction Atlas ID
 LDD2769 
Download The Altas
  
Experiment 1605 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (Hep 3B2.1-7)
Interaction Atlas ID
 LDD2770 
Download The Altas
  
Experiment 1606 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatoblastoma [ICD-11:DB91]
Model Name
Human hepatoblastoma cell lysate (Hep-G2)
Interaction Atlas ID
 LDD2771 
Download The Altas
  
Experiment 1607 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Chronic lymphocytic leukemia [ICD11: 2A82]
Model Name
Human chronic lymphocytic leukemia cell lysate (HG-3)
Interaction Atlas ID
 LDD2772 
Download The Altas
  
Experiment 1608 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (HGC-27)
Interaction Atlas ID
 LDD2773 
Download The Altas
  
Experiment 1609 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (HKGZ-CC)
Interaction Atlas ID
 LDD2774 
Download The Altas
  
Experiment 1610 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (HLF)
Interaction Atlas ID
 LDD2775 
Download The Altas
  
Experiment 1611 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (HMCB)
Interaction Atlas ID
 LDD2776 
Download The Altas
  
Experiment 1612 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (Hs 578T)
Interaction Atlas ID
 LDD2777 
Download The Altas
  
Experiment 1613 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (Hs 839.T)
Interaction Atlas ID
 LDD2778 
Download The Altas
  
Experiment 1614 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD2779 
Download The Altas
  
Experiment 1615 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD2780 
Download The Altas
  
Experiment 1616 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (HSC-3)
Interaction Atlas ID
 LDD2781 
Download The Altas
  
Experiment 1617 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (HSC-4)
Interaction Atlas ID
 LDD2782 
Download The Altas
  
Experiment 1618 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (HT)
Interaction Atlas ID
 LDD2783 
Download The Altas
  
Experiment 1619 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Fibrosarcoma [ICD11: 2B53]
Model Name
Human fibrosarcoma cell lysate (HT-1080 (FAP expression))
Interaction Atlas ID
 LDD2784 
Download The Altas
  
Experiment 1620 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HT115)
Interaction Atlas ID
 LDD2785 
Download The Altas
  
Experiment 1621 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (HT-1197)
Interaction Atlas ID
 LDD2786 
Download The Altas
  
Experiment 1622 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (HT-1376)
Interaction Atlas ID
 LDD2787 
Download The Altas
  
Experiment 1623 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon cancer [ICD11: 2C82]
Model Name
Human colon cancer cell lysate (HT29)
Interaction Atlas ID
 LDD2788 
Download The Altas
  
Experiment 1624 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (HT-3)
Interaction Atlas ID
 LDD2789 
Download The Altas
  
Experiment 1625 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Liver bile duct carcinoma [ICD11: 2C12]
Model Name
Human liver bile duct carcinoma cell lysate (HuCCT-1)
Interaction Atlas ID
 LDD2790 
Download The Altas
  
Experiment 1626 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (HuH-1)
Interaction Atlas ID
 LDD2791 
Download The Altas
  
Experiment 1627 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (HuH-28)
Interaction Atlas ID
 LDD2792 
Download The Altas
  
Experiment 1628 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (Huh-7)
Interaction Atlas ID
 LDD2793 
Download The Altas
  
Experiment 1629 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (HuP-T3)
Interaction Atlas ID
 LDD2794 
Download The Altas
  
Experiment 1630 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (HuP-T4)
Interaction Atlas ID
 LDD2795 
Download The Altas
  
Experiment 1631 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC10)
Interaction Atlas ID
 LDD2796 
Download The Altas
  
Experiment 1632 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC106)
Interaction Atlas ID
 LDD2797 
Download The Altas
  
Experiment 1633 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC108)
Interaction Atlas ID
 LDD2798 
Download The Altas
  
Experiment 1634 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC11)
Interaction Atlas ID
 LDD2799 
Download The Altas
  
Experiment 1635 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC12)
Interaction Atlas ID
 LDD2800 
Download The Altas
  
Experiment 1636 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC13-7)
Interaction Atlas ID
 LDD2801 
Download The Altas
  
Experiment 1637 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC18)
Interaction Atlas ID
 LDD2802 
Download The Altas
  
Experiment 1638 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC19)
Interaction Atlas ID
 LDD2803 
Download The Altas
  
Experiment 1639 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC20)
Interaction Atlas ID
 LDD2804 
Download The Altas
  
Experiment 1640 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC21)
Interaction Atlas ID
 LDD2805 
Download The Altas
  
Experiment 1641 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC24)
Interaction Atlas ID
 LDD2806 
Download The Altas
  
Experiment 1642 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC26)
Interaction Atlas ID
 LDD2807 
Download The Altas
  
Experiment 1643 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC3)
Interaction Atlas ID
 LDD2808 
Download The Altas
  
Experiment 1644 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC4)
Interaction Atlas ID
 LDD2809 
Download The Altas
  
Experiment 1645 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC8)
Interaction Atlas ID
 LDD2810 
Download The Altas
  
Experiment 1646 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC9)
Interaction Atlas ID
 LDD2811 
Download The Altas
  
Experiment 1647 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (IGR-1)
Interaction Atlas ID
 LDD2812 
Download The Altas
  
Experiment 1648 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (IGR-37)
Interaction Atlas ID
 LDD2813 
Download The Altas
  
Experiment 1649 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (IGR-39)
Interaction Atlas ID
 LDD2814 
Download The Altas
  
Experiment 1650 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (IGROV-1)
Interaction Atlas ID
 LDD2815 
Download The Altas
  
Experiment 1651 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (IM95)
Interaction Atlas ID
 LDD2816 
Download The Altas
  
Experiment 1652 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (IPC-298)
Interaction Atlas ID
 LDD2817 
Download The Altas
  
Experiment 1653 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (Ishikawa (Heraklio) 02 ER-)
Interaction Atlas ID
 LDD2818 
Download The Altas
  
Experiment 1654 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (J82)
Interaction Atlas ID
 LDD2819 
Download The Altas
  
Experiment 1655 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Mantle cell lymphoma [ICD11: 2A85]
Model Name
Human mantle cell lymphoma cell lysate (JeKo-1)
Interaction Atlas ID
 LDD2820 
Download The Altas
  
Experiment 1656 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-1)
Interaction Atlas ID
 LDD2821 
Download The Altas
  
Experiment 1657 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-4)
Interaction Atlas ID
 LDD2822 
Download The Altas
  
Experiment 1658 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-6)
Interaction Atlas ID
 LDD2823 
Download The Altas
  
Experiment 1659 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-7)
Interaction Atlas ID
 LDD2824 
Download The Altas
  
Experiment 1660 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (JM-1)
Interaction Atlas ID
 LDD2825 
Download The Altas
  
Experiment 1661 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD2826 
Download The Altas
  
Experiment 1662 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Chronic myelogenous leukemia [ICD11: 2A20]
Model Name
Human chronic myelogenous leukemia cell lysate (JURL-MK1)
Interaction Atlas ID
 LDD2827 
Download The Altas
  
Experiment 1663 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B-cell prolymphocytic leukemia [ICD11: 2A70]
Model Name
Human b-cell prolymphocytic leukemia cell lysate (JVM-3)
Interaction Atlas ID
 LDD2828 
Download The Altas
  
Experiment 1664 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Anaplastic large cell lymphoma [ICD11: 2A90]
Model Name
Human anaplastic large cell lymphoma cell lysate (Karpas-299)
Interaction Atlas ID
 LDD2829 
Download The Altas
  
Experiment 1665 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (Karpas-422)
Interaction Atlas ID
 LDD2830 
Download The Altas
  
Experiment 1666 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Myeloid leukaemia [ICD11: 2B33]
Model Name
Human myeloid leukaemia cell lysate (Kasumi-1)
Interaction Atlas ID
 LDD2831 
Download The Altas
  
Experiment 1667 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (Kasumi-2)
Interaction Atlas ID
 LDD2832 
Download The Altas
  
Experiment 1668 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric signet ring cell adenocarcinoma [ICD11: 2B72]
Model Name
Human gastric signet ring cell adenocarcinoma cell lysate (KATO III)
Interaction Atlas ID
 LDD2833 
Download The Altas
  
Experiment 1669 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (Kelly)
Interaction Atlas ID
 LDD2834 
Download The Altas
  
Experiment 1670 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Liver cancer [ICD11: 2C12]
Model Name
Human liver cancer cell lysate (KMCH-1)
Interaction Atlas ID
 LDD2835 
Download The Altas
  
Experiment 1671 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC-1)
Interaction Atlas ID
 LDD2836 
Download The Altas
  
Experiment 1672 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC-20)
Interaction Atlas ID
 LDD2837 
Download The Altas
  
Experiment 1673 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC3)
Interaction Atlas ID
 LDD2838 
Download The Altas
  
Experiment 1674 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS11)
Interaction Atlas ID
 LDD2839 
Download The Altas
  
Experiment 1675 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS-12-BM)
Interaction Atlas ID
 LDD2840 
Download The Altas
  
Experiment 1676 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS-27)
Interaction Atlas ID
 LDD2841 
Download The Altas
  
Experiment 1677 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (KNS-42)
Interaction Atlas ID
 LDD2842 
Download The Altas
  
Experiment 1678 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (KNS-81-FD)
Interaction Atlas ID
 LDD2843 
Download The Altas
  
Experiment 1679 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Adult acute myeloid leukemia [ICD11: 2A60]
Model Name
Human adult acute myeloid leukemia cell lysate (K052)
Interaction Atlas ID
 LDD2844 
Download The Altas
  
Experiment 1680 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic cancer [ICD11: 2C10]
Model Name
Human pancreatic cancer cell lysate (KP-4)
Interaction Atlas ID
 LDD2845 
Download The Altas
  
Experiment 1681 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (KPL-1)
Interaction Atlas ID
 LDD2846 
Download The Altas
  
Experiment 1682 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Adrenal cancer [ICD11: 2D11]
Model Name
Human adrenal gland neuroblastoma cell lysate (KP-N-YN)
Interaction Atlas ID
 LDD2847 
Download The Altas
  
Experiment 1683 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (KU-19-19)
Interaction Atlas ID
 LDD2848 
Download The Altas
  
Experiment 1684 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (KURAMOCHI)
Interaction Atlas ID
 LDD2849 
Download The Altas
  
Experiment 1685 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Embryo
Disease Model
Embryonal rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human embryonal rhabdomyosarcoma cell lysate (KYM-1)
Interaction Atlas ID
 LDD2850 
Download The Altas
  
Experiment 1686 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-150)
Interaction Atlas ID
 LDD2851 
Download The Altas
  
Experiment 1687 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-180)
Interaction Atlas ID
 LDD2852 
Download The Altas
  
Experiment 1688 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-30)
Interaction Atlas ID
 LDD2853 
Download The Altas
  
Experiment 1689 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-410)
Interaction Atlas ID
 LDD2854 
Download The Altas
  
Experiment 1690 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-510)
Interaction Atlas ID
 LDD2855 
Download The Altas
  
Experiment 1691 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Hodgkin lymphoma [ICD11: 2B30]
Model Name
Human hodgkin lymphoma cell lysate (L-428)
Interaction Atlas ID
 LDD2856 
Download The Altas
  
Experiment 1692 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (LN-18)
Interaction Atlas ID
 LDD2857 
Download The Altas
  
Experiment 1693 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (LN-229)
Interaction Atlas ID
 LDD2858 
Download The Altas
  
Experiment 1694 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (LNCaP-Clone-FGC)
Interaction Atlas ID
 LDD2859 
Download The Altas
  
Experiment 1695 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (LOX IMVI)
Interaction Atlas ID
 LDD2860 
Download The Altas
  
Experiment 1696 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (LS-123)
Interaction Atlas ID
 LDD2861 
Download The Altas
  
Experiment 1697 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (LS180)
Interaction Atlas ID
 LDD2862 
Download The Altas
  
Experiment 1698 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Cecum adenocarcinoma [ICD-11:2B90]
Model Name
Human cecum adenocarcinoma cell lysate (LS-513)
Interaction Atlas ID
 LDD2863 
Download The Altas
  
Experiment 1699 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung giant cell carcinoma [ICD11: 2C25]
Model Name
Human lung giant cell carcinoma cell lysate (Lu-65)
Interaction Atlas ID
 LDD2864 
Download The Altas
  
Experiment 1700 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (LUDLU-1)
Interaction Atlas ID
 LDD2865 
Download The Altas
  
Experiment 1701 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian mucinous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian mucinous cystadenocarcinoma cell lysate (MCAS)
Interaction Atlas ID
 LDD2866 
Download The Altas
  
Experiment 1702 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Merkel cell carcinoma [ICD11: 2C34]
Model Name
Human merkel cell carcinoma cell lysate (MCC13)
Interaction Atlas ID
 LDD2867 
Download The Altas
  
Experiment 1703 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Merkel cell carcinoma [ICD11: 2C34]
Model Name
Human merkel cell carcinoma cell lysate (MCC26)
Interaction Atlas ID
 LDD2868 
Download The Altas
  
Experiment 1704 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Invasive breast carcinoma [ICD-11:2C60]
Model Name
Human invasive breast carcinoma cell lysate (MCF-7)
Interaction Atlas ID
 LDD2869 
Download The Altas
  
Experiment 1705 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (MDA-MB-157)
Interaction Atlas ID
 LDD2870 
Download The Altas
  
Experiment 1706 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-231)
Interaction Atlas ID
 LDD2871 
Download The Altas
  
Experiment 1707 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Ductal carcinoma [ICD11: 2C61]
Model Name
Human ductal carcinoma cell lysate (MDA-MB-436)
Interaction Atlas ID
 LDD2872 
Download The Altas
  
Experiment 1708 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-453)
Interaction Atlas ID
 LDD2873 
Download The Altas
  
Experiment 1709 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-468)
Interaction Atlas ID
 LDD2874 
Download The Altas
  
Experiment 1710 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (MDST8)
Interaction Atlas ID
 LDD2875 
Download The Altas
  
Experiment 1711 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Chronic lymphocytic leukemia [ICD11: 2A82]
Model Name
Human chronic lymphocytic leukemia cell lysate (MEC-1)
Interaction Atlas ID
 LDD2876 
Download The Altas
  
Experiment 1712 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (CHL1)
Interaction Atlas ID
 LDD2877 
Download The Altas
  
Experiment 1713 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (COLO792)
Interaction Atlas ID
 LDD2878 
Download The Altas
  
Experiment 1714 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (MEL-HO)
Interaction Atlas ID
 LDD2879 
Download The Altas
  
Experiment 1715 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (MEL-JUSO)
Interaction Atlas ID
 LDD2880 
Download The Altas
  
Experiment 1716 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (MeWo)
Interaction Atlas ID
 LDD2881 
Download The Altas
  
Experiment 1717 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (MFE-280)
Interaction Atlas ID
 LDD2882 
Download The Altas
  
Experiment 1718 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (MFE-296)
Interaction Atlas ID
 LDD2883 
Download The Altas
  
Experiment 1719 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial cancer [ICD11: 2C76]
Model Name
Human endometrial cancer cell lysate (MFE-319)
Interaction Atlas ID
 LDD2884 
Download The Altas
  
Experiment 1720 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (MG984)
Interaction Atlas ID
 LDD2885 
Download The Altas
  
Experiment 1721 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG123)
Interaction Atlas ID
 LDD2886 
Download The Altas
  
Experiment 1722 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG23)
Interaction Atlas ID
 LDD2887 
Download The Altas
  
Experiment 1723 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG75)
Interaction Atlas ID
 LDD2888 
Download The Altas
  
Experiment 1724 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (DM93)
Interaction Atlas ID
 LDD2889 
Download The Altas
  
Experiment 1725 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (A101D)
Interaction Atlas ID
 LDD2890 
Download The Altas
  
Experiment 1726 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (A2058)
Interaction Atlas ID
 LDD2891 
Download The Altas
  
Experiment 1727 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (CHL1)
Interaction Atlas ID
 LDD2892 
Download The Altas
  
Experiment 1728 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (COLO792)
Interaction Atlas ID
 LDD2893 
Download The Altas
  
Experiment 1729 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (G361)
Interaction Atlas ID
 LDD2894 
Download The Altas
  
Experiment 1730 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (HMCB)
Interaction Atlas ID
 LDD2895 
Download The Altas
  
Experiment 1731 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD2896 
Download The Altas
  
Experiment 1732 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (IGR37)
Interaction Atlas ID
 LDD2897 
Download The Altas
  
Experiment 1733 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (IGR39)
Interaction Atlas ID
 LDD2898 
Download The Altas
  
Experiment 1734 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEL167)
Interaction Atlas ID
 LDD2899 
Download The Altas
  
Experiment 1735 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEL182)
Interaction Atlas ID
 LDD2900 
Download The Altas
  
Experiment 1736 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MELHO)
Interaction Atlas ID
 LDD2901 
Download The Altas
  
Experiment 1737 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEWO)
Interaction Atlas ID
 LDD2902 
Download The Altas
  
Experiment 1738 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (RVH421)
Interaction Atlas ID
 LDD2903 
Download The Altas
  
Experiment 1739 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SH4)
Interaction Atlas ID
 LDD2904 
Download The Altas
  
Experiment 1740 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL2)
Interaction Atlas ID
 LDD2905 
Download The Altas
  
Experiment 1741 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL24)
Interaction Atlas ID
 LDD2906 
Download The Altas
  
Experiment 1742 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL3)
Interaction Atlas ID
 LDD2907 
Download The Altas
  
Experiment 1743 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (UACC257)
Interaction Atlas ID
 LDD2908 
Download The Altas
  
Experiment 1744 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (UACC62)
Interaction Atlas ID
 LDD2909 
Download The Altas
  
Experiment 1745 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (WM115)
Interaction Atlas ID
 LDD2910 
Download The Altas
  
Experiment 1746 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (WM266-4 )
Interaction Atlas ID
 LDD2911 
Download The Altas
  
Experiment 1747 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (RAW264.7)
Interaction Atlas ID
 LDD2912 
Download The Altas
  
Experiment 1748 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (MIA PaCa-2)
Interaction Atlas ID
 LDD2913 
Download The Altas
  
Experiment 1749 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (MKN-1)
Interaction Atlas ID
 LDD2914 
Download The Altas
  
Experiment 1750 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (MKN45)
Interaction Atlas ID
 LDD2915 
Download The Altas
  
Experiment 1751 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (MOLM-13)
Interaction Atlas ID
 LDD2916 
Download The Altas
  
Experiment 1752 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Adult acute myeloid leukemia [ICD11: 2A60]
Model Name
Human adult acute myeloid leukemia cell lysate (MOLM-16)
Interaction Atlas ID
 LDD2917 
Download The Altas
  
Experiment 1753 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MONO-MAC-6)
Interaction Atlas ID
 LDD2918 
Download The Altas
  
Experiment 1754 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MONO-MAC-6)
Interaction Atlas ID
 LDD2919 
Download The Altas
  
Experiment 1755 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pleural effusion
Disease Model
Pleural biphasic mesothelioma [ICD11: 2C26]
Model Name
Human pleural biphasic mesothelioma cell lysate (MSTO-211H)
Interaction Atlas ID
 LDD2920 
Download The Altas
  
Experiment 1756 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MV4-11)
Interaction Atlas ID
 LDD2921 
Download The Altas
  
Experiment 1757 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (NALM-6)
Interaction Atlas ID
 LDD2922 
Download The Altas
  
Experiment 1758 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (NB1)
Interaction Atlas ID
 LDD2923 
Download The Altas
  
Experiment 1759 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H1048)
Interaction Atlas ID
 LDD2924 
Download The Altas
  
Experiment 1760 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Lung large cell carcinoma [ICD-11:2C25]
Model Name
Human lung large cell carcinoma cell lysate (NCI-H1155)
Interaction Atlas ID
 LDD2925 
Download The Altas
  
Experiment 1761 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Lung large cell carcinoma [ICD-11:2C25]
Model Name
Human lung large cell carcinoma cell lysate (NCI-H1299)
Interaction Atlas ID
 LDD2926 
Download The Altas
  
Experiment 1762 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H146)
Interaction Atlas ID
 LDD2927 
Download The Altas
  
Experiment 1763 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1650)
Interaction Atlas ID
 LDD2928 
Download The Altas
  
Experiment 1764 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1666)
Interaction Atlas ID
 LDD2929 
Download The Altas
  
Experiment 1765 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H1703)
Interaction Atlas ID
 LDD2930 
Download The Altas
  
Experiment 1766 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1792)
Interaction Atlas ID
 LDD2931 
Download The Altas
  
Experiment 1767 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1793)
Interaction Atlas ID
 LDD2932 
Download The Altas
  
Experiment 1768 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCl-H1944)
Interaction Atlas ID
 LDD2933 
Download The Altas
  
Experiment 1769 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H196)
Interaction Atlas ID
 LDD2934 
Download The Altas
  
Experiment 1770 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1975)
Interaction Atlas ID
 LDD2935 
Download The Altas
  
Experiment 1771 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pleural effusion
Disease Model
Pleural mesothelioma [ICD11: 2C26]
Model Name
Human pleural mesothelioma cell lysate (NCI-H2052)
Interaction Atlas ID
 LDD2936 
Download The Altas
  
Experiment 1772 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H2122)
Interaction Atlas ID
 LDD2937 
Download The Altas
  
Experiment 1773 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H2170)
Interaction Atlas ID
 LDD2938 
Download The Altas
  
Experiment 1774 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung cancer cell lysate (NCI-H2172)
Interaction Atlas ID
 LDD2939 
Download The Altas
  
Experiment 1775 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H2286)
Interaction Atlas ID
 LDD2940 
Download The Altas
  
Experiment 1776 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H2291)
Interaction Atlas ID
 LDD2941 
Download The Altas
  
Experiment 1777 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H23)
Interaction Atlas ID
 LDD2942 
Download The Altas
  
Experiment 1778 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H3122)
Interaction Atlas ID
 LDD2943 
Download The Altas
  
Experiment 1779 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (NCI-H358)
Interaction Atlas ID
 LDD2944 
Download The Altas
  
Experiment 1780 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H446)
Interaction Atlas ID
 LDD2945 
Download The Altas
  
Experiment 1781 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H82)
Interaction Atlas ID
 LDD2946 
Download The Altas
  
Experiment 1782 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric tubular adenocarcinoma [ICD11: 2.00E+92]
Model Name
Human gastric tubular adenocarcinoma cell lysate (NCI-N87)
Interaction Atlas ID
 LDD2947 
Download The Altas
  
Experiment 1783 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-3)
Interaction Atlas ID
 LDD2948 
Download The Altas
  
Experiment 1784 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (NOMO-1)
Interaction Atlas ID
 LDD2949 
Download The Altas
  
Experiment 1785 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (NUGC-3)
Interaction Atlas ID
 LDD2950 
Download The Altas
  
Experiment 1786 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OAW-28)
Interaction Atlas ID
 LDD2951 
Download The Altas
  
Experiment 1787 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OAW-42)
Interaction Atlas ID
 LDD2952 
Download The Altas
  
Experiment 1788 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (OCI-AML-2)
Interaction Atlas ID
 LDD2953 
Download The Altas
  
Experiment 1789 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (OCI-AML-5)
Interaction Atlas ID
 LDD2954 
Download The Altas
  
Experiment 1790 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (OCI-Ly3)
Interaction Atlas ID
 LDD2955 
Download The Altas
  
Experiment 1791 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (OCUG-1)
Interaction Atlas ID
 LDD2956 
Download The Altas
  
Experiment 1792 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric signet ring cell adenocarcinoma [ICD11: 2B72]
Model Name
Human gastric signet ring cell adenocarcinoma cell lysate (OCUM-1)
Interaction Atlas ID
 LDD2957 
Download The Altas
  
Experiment 1793 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Barrett adenocarcinoma [ICD11: 2B70]
Model Name
Human barrett adenocarcinoma cell lysate (OE33)
Interaction Atlas ID
 LDD2958 
Download The Altas
  
Experiment 1794 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (ONS-76)
Interaction Atlas ID
 LDD2959 
Download The Altas
  
Experiment 1795 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (OPM-2)
Interaction Atlas ID
 LDD2960 
Download The Altas
  
Experiment 1796 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (OS-RC-2)
Interaction Atlas ID
 LDD2961 
Download The Altas
  
Experiment 1797 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OV56)
Interaction Atlas ID
 LDD2962 
Download The Altas
  
Experiment 1798 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OV-90)
Interaction Atlas ID
 LDD2963 
Download The Altas
  
Experiment 1799 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OVCA429)
Interaction Atlas ID
 LDD2964 
Download The Altas
  
Experiment 1800 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OVCAR-4)
Interaction Atlas ID
 LDD2965 
Download The Altas
  
Experiment 1801 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OVCAR-5)
Interaction Atlas ID
 LDD2966 
Download The Altas
  
Experiment 1802 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-8)
Interaction Atlas ID
 LDD2967 
Download The Altas
  
Experiment 1803 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (OVISE)
Interaction Atlas ID
 LDD2968 
Download The Altas
  
Experiment 1804 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (OVK-18)
Interaction Atlas ID
 LDD2969 
Download The Altas
  
Experiment 1805 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVKATE)
Interaction Atlas ID
 LDD2970 
Download The Altas
  
Experiment 1806 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (OVTOKO)
Interaction Atlas ID
 LDD2971 
Download The Altas
  
Experiment 1807 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (OZ)
Interaction Atlas ID
 LDD2972 
Download The Altas
  
Experiment 1808 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (P31-FUJ)
Interaction Atlas ID
 LDD2973 
Download The Altas
  
Experiment 1809 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (Panc 04.03)
Interaction Atlas ID
 LDD2974 
Download The Altas
  
Experiment 1810 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (PANC-1)
Interaction Atlas ID
 LDD2975 
Download The Altas
  
Experiment 1811 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD2976 
Download The Altas
  
Experiment 1812 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (PC-14)
Interaction Atlas ID
 LDD2977 
Download The Altas
  
Experiment 1813 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (PC-3)
Interaction Atlas ID
 LDD2978 
Download The Altas
  
Experiment 1814 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (PEO1)
Interaction Atlas ID
 LDD2979 
Download The Altas
  
Experiment 1815 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (PF-382)
Interaction Atlas ID
 LDD2980 
Download The Altas
  
Experiment 1816 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Neuroectodermal tumor [ICD11: 2A00]
Model Name
Human neuroectodermal tumor cell lysate (PFSK-1)
Interaction Atlas ID
 LDD2981 
Download The Altas
  
Experiment 1817 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (RBE)
Interaction Atlas ID
 LDD2982 
Download The Altas
  
Experiment 1818 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (RCC10RGB)
Interaction Atlas ID
 LDD2983 
Download The Altas
  
Experiment 1819 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (RD)
Interaction Atlas ID
 LDD2984 
Download The Altas
  
Experiment 1820 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Mantle cell lymphoma [ICD11: 2A85]
Model Name
Human mantle cell lymphoma cell lysate (REC-1)
Interaction Atlas ID
 LDD2985 
Download The Altas
  
Experiment 1821 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (Reh)
Interaction Atlas ID
 LDD2986 
Download The Altas
  
Experiment 1822 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Alveolar rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human alveolar rhabdomyosarcoma cell lysate (SJRH30)
Interaction Atlas ID
 LDD2987 
Download The Altas
  
Experiment 1823 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Alveolar rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human alveolar rhabdomyosarcoma cell lysate (Rh41)
Interaction Atlas ID
 LDD2988 
Download The Altas
  
Experiment 1824 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian leiomyosarcoma [ICD11: 2C73]
Model Name
Human ovarian leiomyosarcoma cell lysate (RKN)
Interaction Atlas ID
 LDD2989 
Download The Altas
  
Experiment 1825 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (RKO)
Interaction Atlas ID
 LDD2990 
Download The Altas
  
Experiment 1826 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (RL)
Interaction Atlas ID
 LDD2991 
Download The Altas
  
Experiment 1827 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial cancer [ICD11: 2C76]
Model Name
Human endometrial cancer cell lysate (RL95-2)
Interaction Atlas ID
 LDD2992 
Download The Altas
  
Experiment 1828 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD11: 2C30]
Model Name
Human melanoma cell lysate (RPMI-7951)
Interaction Atlas ID
 LDD2993 
Download The Altas
  
Experiment 1829 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (RPMI-8226)
Interaction Atlas ID
 LDD2994 
Download The Altas
  
Experiment 1830 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (RT-112)
Interaction Atlas ID
 LDD2995 
Download The Altas
  
Experiment 1831 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (RVH-421)
Interaction Atlas ID
 LDD2996 
Download The Altas
  
Experiment 1832 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (SAOS-2)
Interaction Atlas ID
 LDD2997 
Download The Altas
  
Experiment 1833 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SBC-5)
Interaction Atlas ID
 LDD2998 
Download The Altas
  
Experiment 1834 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Squamous carcinoma [ICD11: 2B6A]
Model Name
Human squamous carcinoma cell lysate (SCC-25)
Interaction Atlas ID
 LDD2999 
Download The Altas
  
Experiment 1835 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (SF-295)
Interaction Atlas ID
 LDD3000 
Download The Altas
  
Experiment 1836 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (SG231)
Interaction Atlas ID
 LDD3001 
Download The Altas
  
Experiment 1837 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SH-4)
Interaction Atlas ID
 LDD3002 
Download The Altas
  
Experiment 1838 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SHP-77)
Interaction Atlas ID
 LDD3003 
Download The Altas
  
Experiment 1839 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (SiSo)
Interaction Atlas ID
 LDD3004 
Download The Altas
  
Experiment 1840 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (SJSA-1)
Interaction Atlas ID
 LDD3005 
Download The Altas
  
Experiment 1841 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Ewing sarcoma [ICD11: 2B52]
Model Name
Human ewing sarcoma cell lysate (SK-ES1)
Interaction Atlas ID
 LDD3006 
Download The Altas
  
Experiment 1842 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatoma [ICD11: 2C12]
Model Name
Human hepatoma cell lysate (SK-HEP1)
Interaction Atlas ID
 LDD3007 
Download The Altas
  
Experiment 1843 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL-2)
Interaction Atlas ID
 LDD3008 
Download The Altas
  
Experiment 1844 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL-24)
Interaction Atlas ID
 LDD3009 
Download The Altas
  
Experiment 1845 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-28)
Interaction Atlas ID
 LDD3010 
Download The Altas
  
Experiment 1846 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL3)
Interaction Atlas ID
 LDD3011 
Download The Altas
  
Experiment 1847 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-30)
Interaction Atlas ID
 LDD3012 
Download The Altas
  
Experiment 1848 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-5)
Interaction Atlas ID
 LDD3013 
Download The Altas
  
Experiment 1849 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (SK-MM-2)
Interaction Atlas ID
 LDD3014 
Download The Altas
  
Experiment 1850 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Uterine corpus leiomyosarcoma [ICD11: 2.00E+86]
Model Name
Human uterine corpus leiomyosarcoma cell lysate (SKN)
Interaction Atlas ID
 LDD3015 
Download The Altas
  
Experiment 1851 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (SK-N-AS)
Interaction Atlas ID
 LDD3016 
Download The Altas
  
Experiment 1852 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Neuroepithelioma [ICD11: 2A00]
Model Name
Human neuroepithelioma cell lysate (SK-N-MC)
Interaction Atlas ID
 LDD3017 
Download The Altas
  
Experiment 1853 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (SK-OV-3)
Interaction Atlas ID
 LDD3018 
Download The Altas
  
Experiment 1854 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (SNG-M)
Interaction Atlas ID
 LDD3019 
Download The Altas
  
Experiment 1855 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (SNU-1)
Interaction Atlas ID
 LDD3020 
Download The Altas
  
Experiment 1856 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (SNU-1079)
Interaction Atlas ID
 LDD3021 
Download The Altas
  
Experiment 1857 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hilar cholangiocarcinoma [ICD11: 2C18]
Model Name
Human hilar cholangiocarcinoma cell lysate (SNU-1196)
Interaction Atlas ID
 LDD3022 
Download The Altas
  
Experiment 1858 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (SNU-245)
Interaction Atlas ID
 LDD3023 
Download The Altas
  
Experiment 1859 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (SNU-308)
Interaction Atlas ID
 LDD3024 
Download The Altas
  
Experiment 1860 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (SNU-423)
Interaction Atlas ID
 LDD3025 
Download The Altas
  
Experiment 1861 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (SNU-449)
Interaction Atlas ID
 LDD3026 
Download The Altas
  
Experiment 1862 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenocarcinoma cell lysate (SNU-478)
Interaction Atlas ID
 LDD3027 
Download The Altas
  
Experiment 1863 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (SNU-5)
Interaction Atlas ID
 LDD3028 
Download The Altas
  
Experiment 1864 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenocarcinoma cell lysate (SNU-869)
Interaction Atlas ID
 LDD3029 
Download The Altas
  
Experiment 1865 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (SSP-25)
Interaction Atlas ID
 LDD3030 
Download The Altas
  
Experiment 1866 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (SU-DHL-4)
Interaction Atlas ID
 LDD3031 
Download The Altas
  
Experiment 1867 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (SU-DHL-6)
Interaction Atlas ID
 LDD3032 
Download The Altas
  
Experiment 1868 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (SUIT-2)
Interaction Atlas ID
 LDD3033 
Download The Altas
  
Experiment 1869 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
T acute lymphoblastic leukemia [ICD11: 2A90]
Model Name
Human T lymphoblastic lymphoma cell lysate (SUP-T1)
Interaction Atlas ID
 LDD3034 
Download The Altas
  
Experiment 1870 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW1116)
Interaction Atlas ID
 LDD3035 
Download The Altas
  
Experiment 1871 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SW1271)
Interaction Atlas ID
 LDD3036 
Download The Altas
  
Experiment 1872 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (SW1573)
Interaction Atlas ID
 LDD3037 
Download The Altas
  
Experiment 1873 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Anaplastic astrocytoma [ICD11: 2A00]
Model Name
Human anaplastic astrocytoma cell lysate (SW1783)
Interaction Atlas ID
 LDD3038 
Download The Altas
  
Experiment 1874 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (SW1990)
Interaction Atlas ID
 LDD3039 
Download The Altas
  
Experiment 1875 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW403)
Interaction Atlas ID
 LDD3040 
Download The Altas
  
Experiment 1876 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW620)
Interaction Atlas ID
 LDD3041 
Download The Altas
  
Experiment 1877 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (SW756)
Interaction Atlas ID
 LDD3042 
Download The Altas
  
Experiment 1878 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Rectal cancer [ICD11: 2B92]
Model Name
Human rectal cancer cell lysate (SW837)
Interaction Atlas ID
 LDD3043 
Download The Altas
  
Experiment 1879 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW948)
Interaction Atlas ID
 LDD3044 
Download The Altas
  
Experiment 1880 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (T24)
Interaction Atlas ID
 LDD3045 
Download The Altas
  
Experiment 1881 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (T98G)
Interaction Atlas ID
 LDD3046 
Download The Altas
  
Experiment 1882 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Ewing sarcoma [ICD11: 2B52]
Model Name
Human ewing sarcoma cell lysate (TC-71)
Interaction Atlas ID
 LDD3047 
Download The Altas
  
Experiment 1883 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (TCCSUP)
Interaction Atlas ID
 LDD3048 
Download The Altas
  
Experiment 1884 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TF-1)
Interaction Atlas ID
 LDD3049 
Download The Altas
  
Experiment 1885 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-10)
Interaction Atlas ID
 LDD3050 
Download The Altas
  
Experiment 1886 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-11)
Interaction Atlas ID
 LDD3051 
Download The Altas
  
Experiment 1887 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE4)
Interaction Atlas ID
 LDD3052 
Download The Altas
  
Experiment 1888 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-8)
Interaction Atlas ID
 LDD3053 
Download The Altas
  
Experiment 1889 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (TF-1)
Interaction Atlas ID
 LDD3054 
Download The Altas
  
Experiment 1890 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (TFK-1)
Interaction Atlas ID
 LDD3055 
Download The Altas
  
Experiment 1891 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (TGBC1TKB)
Interaction Atlas ID
 LDD3056 
Download The Altas
  
Experiment 1892 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenosquamous carcinoma cell lysate (TGBC52TKB)
Interaction Atlas ID
 LDD3057 
Download The Altas
  
Experiment 1893 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (THP-1)
Interaction Atlas ID
 LDD3058 
Download The Altas
  
Experiment 1894 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (TKKK)
Interaction Atlas ID
 LDD3059 
Download The Altas
  
Experiment 1895 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (TOV-21G)
Interaction Atlas ID
 LDD3060 
Download The Altas
  
Experiment 1896 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (TYK-nu)
Interaction Atlas ID
 LDD3061 
Download The Altas
  
Experiment 1897 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Astrocytoma [ICD-11:2F36]
Model Name
Human astrocytoma cell lysate (U-118-MG)
Interaction Atlas ID
 LDD3062 
Download The Altas
  
Experiment 1898 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (U2OS)
Interaction Atlas ID
 LDD3063 
Download The Altas
  
Experiment 1899 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (U-87MG)
Interaction Atlas ID
 LDD3064 
Download The Altas
  
Experiment 1900 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (U-937)
Interaction Atlas ID
 LDD3065 
Download The Altas
  
Experiment 1901 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (UACC-257)
Interaction Atlas ID
 LDD3066 
Download The Altas
  
Experiment 1902 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (UACC-62)
Interaction Atlas ID
 LDD3067 
Download The Altas
  
Experiment 1903 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (UM-UC-3)
Interaction Atlas ID
 LDD3068 
Download The Altas
  
Experiment 1904 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (VCaP)
Interaction Atlas ID
 LDD3069 
Download The Altas
  
Experiment 1905 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (VMRC-RCW)
Interaction Atlas ID
 LDD3070 
Download The Altas
  
Experiment 1906 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (WM-115)
Interaction Atlas ID
 LDD3071 
Download The Altas
  
Experiment 1907 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (WM1552C)
Interaction Atlas ID
 LDD3072 
Download The Altas
  
Experiment 1908 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (WM 266-4)
Interaction Atlas ID
 LDD3073 
Download The Altas
  
Experiment 1909 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (WM793)
Interaction Atlas ID
 LDD3074 
Download The Altas
  
Experiment 1910 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (YSCCC)
Interaction Atlas ID
 LDD3075 
Download The Altas
  
Experiment 1911 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Invasive breast carcinoma [ICD-11:2C60]
Model Name
Human invasive breast carcinoma cell lysate (ZR-75-1)
Interaction Atlas ID
 LDD3076 
Download The Altas
  
Experiment 1912 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (22RV1)
Interaction Atlas ID
 LDD3077 
Download The Altas
  
Experiment 1913 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (42-MG-BA)
Interaction Atlas ID
 LDD3078 
Download The Altas
  
Experiment 1914 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (697)
Interaction Atlas ID
 LDD3079 
Download The Altas
  
Experiment 1915 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (769-P)
Interaction Atlas ID
 LDD3080 
Download The Altas
  
Experiment 1916 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (786-O)
Interaction Atlas ID
 LDD3081 
Download The Altas
  
Experiment 1917 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (8305C)
Interaction Atlas ID
 LDD3082 
Download The Altas
  
Experiment 1918 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB03
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (8505C)
Interaction Atlas ID
 LDD3083 
Download The Altas
  
Experiment 1919 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (A101D)
Interaction Atlas ID
 LDD3084 
Download The Altas
  
Experiment 1920 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (A-172)
Interaction Atlas ID
 LDD3085 
Download The Altas
  
Experiment 1921 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (A204)
Interaction Atlas ID
 LDD3086 
Download The Altas
  
Experiment 1922 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (A2058)
Interaction Atlas ID
 LDD3087 
Download The Altas
  
Experiment 1923 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (A2780)
Interaction Atlas ID
 LDD3088 
Download The Altas
  
Experiment 1924 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (A-375)
Interaction Atlas ID
 LDD3089 
Download The Altas
  
Experiment 1925 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (A375.S2)
Interaction Atlas ID
 LDD3090 
Download The Altas
  
Experiment 1926 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (A3-KAW)
Interaction Atlas ID
 LDD3091 
Download The Altas
  
Experiment 1927 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Skin squamous cell carcinoma [ICD-11:2C31]
Model Name
Human skin squamous cell carcinoma cell lysate (A431)
Interaction Atlas ID
 LDD3092 
Download The Altas
  
Experiment 1928 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cancer [ICD11: 2C90]
Model Name
Human renal cancer cell lysate (A498)
Interaction Atlas ID
 LDD3093 
Download The Altas
  
Experiment 1929 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (A-549)
Interaction Atlas ID
 LDD3094 
Download The Altas
  
Experiment 1930 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (A673)
Interaction Atlas ID
 LDD3095 
Download The Altas
  
Experiment 1931 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (ABC-1)
Interaction Atlas ID
 LDD3096 
Download The Altas
  
Experiment 1932 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (AGS)
Interaction Atlas ID
 LDD3097 
Download The Altas
  
Experiment 1933 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (AN3-CA)
Interaction Atlas ID
 LDD3098 
Download The Altas
  
Experiment 1934 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (AU565)
Interaction Atlas ID
 LDD3099 
Download The Altas
  
Experiment 1935 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (BICR-22)
Interaction Atlas ID
 LDD3100 
Download The Altas
  
Experiment 1936 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX142)
Interaction Atlas ID
 LDD3101 
Download The Altas
  
Experiment 1937 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX211)
Interaction Atlas ID
 LDD3102 
Download The Altas
  
Experiment 1938 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX250)
Interaction Atlas ID
 LDD3103 
Download The Altas
  
Experiment 1939 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX29)
Interaction Atlas ID
 LDD3104 
Download The Altas
  
Experiment 1940 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX330)
Interaction Atlas ID
 LDD3105 
Download The Altas
  
Experiment 1941 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX390)
Interaction Atlas ID
 LDD3107 
Download The Altas
  
Experiment 1942 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX394)
Interaction Atlas ID
 LDD3108 
Download The Altas
  
Experiment 1943 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX401)
Interaction Atlas ID
 LDD3109 
Download The Altas
  
Experiment 1944 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX50)
Interaction Atlas ID
 LDD3110 
Download The Altas
  
Experiment 1945 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX68)
Interaction Atlas ID
 LDD3111 
Download The Altas
  
Experiment 1946 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD-11:2C82]
Model Name
Human breast cancer cell lysate (BRX82)
Interaction Atlas ID
 LDD3112 
Download The Altas
  
Experiment 1947 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (BT-549)
Interaction Atlas ID
 LDD3113 
Download The Altas
  
Experiment 1948 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (BxPC-3)
Interaction Atlas ID
 LDD3114 
Download The Altas
  
Experiment 1949 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (C32)
Interaction Atlas ID
 LDD3115 
Download The Altas
  
Experiment 1950 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (C-4-II)
Interaction Atlas ID
 LDD3116 
Download The Altas
  
Experiment 1951 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (Caki-1)
Interaction Atlas ID
 LDD3117 
Download The Altas
  
Experiment 1952 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-120)
Interaction Atlas ID
 LDD3118 
Download The Altas
  
Experiment 1953 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-148)
Interaction Atlas ID
 LDD3119 
Download The Altas
  
Experiment 1954 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral cancer [ICD11: 2B6E]
Model Name
Human oral cancer cell lysate (CAL-27)
Interaction Atlas ID
 LDD3120 
Download The Altas
  
Experiment 1955 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (CAL-33)
Interaction Atlas ID
 LDD3121 
Download The Altas
  
Experiment 1956 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (CAL-51)
Interaction Atlas ID
 LDD3122 
Download The Altas
  
Experiment 1957 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland anaplastic carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland anaplastic carcinoma cell lysate (CAL-62)
Interaction Atlas ID
 LDD3123 
Download The Altas
  
Experiment 1958 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (CAL-72)
Interaction Atlas ID
 LDD3124 
Download The Altas
  
Experiment 1959 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Chondrosarcoma [ICD11: 2B50]
Model Name
Human chondrosarcoma cell lysate (CAL-78)
Interaction Atlas ID
 LDD3125 
Download The Altas
  
Experiment 1960 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (Calu-1)
Interaction Atlas ID
 LDD3126 
Download The Altas
  
Experiment 1961 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (Calu-6)
Interaction Atlas ID
 LDD3127 
Download The Altas
  
Experiment 1962 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (CAMA-1)
Interaction Atlas ID
 LDD3128 
Download The Altas
  
Experiment 1963 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (Caov-3)
Interaction Atlas ID
 LDD3129 
Download The Altas
  
Experiment 1964 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (Ca-Ski)
Interaction Atlas ID
 LDD3130 
Download The Altas
  
Experiment 1965 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (CCK-81)
Interaction Atlas ID
 LDD3131 
Download The Altas
  
Experiment 1966 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (CC-LP-1)
Interaction Atlas ID
 LDD3132 
Download The Altas
  
Experiment 1967 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (CC-SW-1 )
Interaction Atlas ID
 LDD3133 
Download The Altas
  
Experiment 1968 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (CFPAC-1)
Interaction Atlas ID
 LDD3134 
Download The Altas
  
Experiment 1969 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (CHL-1)
Interaction Atlas ID
 LDD3135 
Download The Altas
  
Experiment 1970 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
.
Disease Model
Down syndrome [ICD11: LD40]
Model Name
Human down syndrome cell lysate (CMK)
Interaction Atlas ID
 LDD3136 
Download The Altas
  
Experiment 1971 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (COLO 320)
Interaction Atlas ID
 LDD3137 
Download The Altas
  
Experiment 1972 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (COLO-678)
Interaction Atlas ID
 LDD3138 
Download The Altas
  
Experiment 1973 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-679)
Interaction Atlas ID
 LDD3139 
Download The Altas
  
Experiment 1974 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (COLO-792)
Interaction Atlas ID
 LDD3140 
Download The Altas
  
Experiment 1975 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-800)
Interaction Atlas ID
 LDD3141 
Download The Altas
  
Experiment 1976 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO-829)
Interaction Atlas ID
 LDD3142 
Download The Altas
  
Experiment 1977 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (COLO 853)
Interaction Atlas ID
 LDD3143 
Download The Altas
  
Experiment 1978 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (COR-L23)
Interaction Atlas ID
 LDD3144 
Download The Altas
  
Experiment 1979 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (COR-L88)
Interaction Atlas ID
 LDD3145 
Download The Altas
  
Experiment 1980 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (D283 Med)
Interaction Atlas ID
 LDD3146 
Download The Altas
  
Experiment 1981 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic cancer [ICD11: 2C10]
Model Name
Human pancreatic cancer cell lysate (DAN-G)
Interaction Atlas ID
 LDD3147 
Download The Altas
  
Experiment 1982 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (Daoy)
Interaction Atlas ID
 LDD3148 
Download The Altas
  
Experiment 1983 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Anaplastic large cell lymphoma [ICD11: 2A90]
Model Name
Human anaplastic large cell lymphoma cell lysate (DEL)
Interaction Atlas ID
 LDD3149 
Download The Altas
  
Experiment 1984 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Pharyngeal squamous cell carcinoma [ICD11: 2B6D]
Model Name
Human pharyngeal squamous cell carcinoma cell lysate (Detroit 562)
Interaction Atlas ID
 LDD3150 
Download The Altas
  
Experiment 1985 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (DoTc2-4510)
Interaction Atlas ID
 LDD3151 
Download The Altas
  
Experiment 1986 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (DU145)
Interaction Atlas ID
 LDD3152 
Download The Altas
  
Experiment 1987 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (DU-4475)
Interaction Atlas ID
 LDD3153 
Download The Altas
  
Experiment 1988 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (ECC2)
Interaction Atlas ID
 LDD3154 
Download The Altas
  
Experiment 1989 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (EFO-21)
Interaction Atlas ID
 LDD3155 
Download The Altas
  
Experiment 1990 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian mucinous adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian mucinous adenocarcinoma cell lysate (EFO-27)
Interaction Atlas ID
 LDD3156 
Download The Altas
  
Experiment 1991 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (EGI-1)
Interaction Atlas ID
 LDD3157 
Download The Altas
  
Experiment 1992 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Chronic eosinophilic leukaemia [ICD11: 2A20]
Model Name
Human chronic eosinophilic leukaemia cell lysate (EoL-1)
Interaction Atlas ID
 LDD3158 
Download The Altas
  
Experiment 1993 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (ETK-1)
Interaction Atlas ID
 LDD3159 
Download The Altas
  
Experiment 1994 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Hypopharyngeal squamous cell carcinoma [ICD11: 2B6D.0]
Model Name
Human hypopharyngeal squamous cell carcinoma cell lysate (FaDu)
Interaction Atlas ID
 LDD3160 
Download The Altas
  
Experiment 1995 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Thyroid
Disease Model
Thyroid gland follicular carcinoma [ICD11: 2D10]
Model Name
Human thyroid gland follicular carcinoma cell lysate (FTC-133)
Interaction Atlas ID
 LDD3161 
Download The Altas
  
Experiment 1996 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (FU-OV-1)
Interaction Atlas ID
 LDD3162 
Download The Altas
  
Experiment 1997 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (G-361)
Interaction Atlas ID
 LDD3163 
Download The Altas
  
Experiment 1998 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Wilms tumor [ICD11: 2C90]
Model Name
Human wilms tumor cell lysate (G-401)
Interaction Atlas ID
 LDD3164 
Download The Altas
  
Experiment 1999 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Kidney cancer [ICD11: 2C90]
Model Name
Human kidney cancer cell lysate (G-402)
Interaction Atlas ID
 LDD3165 
Download The Altas
  
Experiment 2000 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (G-415)
Interaction Atlas ID
 LDD3166 
Download The Altas
  
Experiment 2001 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GAMG)
Interaction Atlas ID
 LDD3167 
Download The Altas
  
Experiment 2002 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GB-1)
Interaction Atlas ID
 LDD3168 
Download The Altas
  
Experiment 2003 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (GB-2)
Interaction Atlas ID
 LDD3169 
Download The Altas
  
Experiment 2004 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1143)
Interaction Atlas ID
 LDD3170 
Download The Altas
  
Experiment 2005 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1187)
Interaction Atlas ID
 LDD3171 
Download The Altas
  
Experiment 2006 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1395)
Interaction Atlas ID
 LDD3172 
Download The Altas
  
Experiment 2007 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1419)
Interaction Atlas ID
 LDD3173 
Download The Altas
  
Experiment 2008 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (HCC15)
Interaction Atlas ID
 LDD3174 
Download The Altas
  
Experiment 2009 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (HCC1806)
Interaction Atlas ID
 LDD3175 
Download The Altas
  
Experiment 2010 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1937)
Interaction Atlas ID
 LDD3176 
Download The Altas
  
Experiment 2011 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC1954)
Interaction Atlas ID
 LDD3177 
Download The Altas
  
Experiment 2012 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (HCC44)
Interaction Atlas ID
 LDD3178 
Download The Altas
  
Experiment 2013 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HCC70)
Interaction Atlas ID
 LDD3179 
Download The Altas
  
Experiment 2014 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (HCC827 CDX model (CDX: HA1; Afatinib resistant))
Interaction Atlas ID
 LDD3180 
Download The Altas
  
Experiment 2015 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (HCT 15)
Interaction Atlas ID
 LDD3181 
Download The Altas
  
Experiment 2016 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (HD-MY-Z)
Interaction Atlas ID
 LDD3182 
Download The Altas
  
Experiment 2017 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast ductal carcinoma [ICD11: 2C61]
Model Name
Human breast ductal carcinoma cell lysate (HDQ-P1)
Interaction Atlas ID
 LDD3183 
Download The Altas
  
Experiment 2018 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (HEC-1)
Interaction Atlas ID
 LDD3184 
Download The Altas
  
Experiment 2019 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (HEL)
Interaction Atlas ID
 LDD3185 
Download The Altas
  
Experiment 2020 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (HEL 92.1.7)
Interaction Atlas ID
 LDD3186 
Download The Altas
  
Experiment 2021 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (Hep 3B2.1-7)
Interaction Atlas ID
 LDD3187 
Download The Altas
  
Experiment 2022 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatoblastoma [ICD-11:DB91]
Model Name
Human hepatoblastoma cell lysate (Hep-G2)
Interaction Atlas ID
 LDD3188 
Download The Altas
  
Experiment 2023 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Chronic lymphocytic leukemia [ICD11: 2A82]
Model Name
Human chronic lymphocytic leukemia cell lysate (HG-3)
Interaction Atlas ID
 LDD3189 
Download The Altas
  
Experiment 2024 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (HGC-27)
Interaction Atlas ID
 LDD3190 
Download The Altas
  
Experiment 2025 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (HKGZ-CC)
Interaction Atlas ID
 LDD3191 
Download The Altas
  
Experiment 2026 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (HLF)
Interaction Atlas ID
 LDD3192 
Download The Altas
  
Experiment 2027 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (HMCB)
Interaction Atlas ID
 LDD3193 
Download The Altas
  
Experiment 2028 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (Hs 578T)
Interaction Atlas ID
 LDD3194 
Download The Altas
  
Experiment 2029 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (Hs 839.T)
Interaction Atlas ID
 LDD3195 
Download The Altas
  
Experiment 2030 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD3196 
Download The Altas
  
Experiment 2031 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD3197 
Download The Altas
  
Experiment 2032 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (HSC-3)
Interaction Atlas ID
 LDD3198 
Download The Altas
  
Experiment 2033 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Oral squamous cell carcinoma [ICD11: 2B6E]
Model Name
Human oral squamous cell carcinoma cell lysate (HSC-4)
Interaction Atlas ID
 LDD3199 
Download The Altas
  
Experiment 2034 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (HT)
Interaction Atlas ID
 LDD3200 
Download The Altas
  
Experiment 2035 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Fibrosarcoma [ICD11: 2B53]
Model Name
Human fibrosarcoma cell lysate (HT-1080 (FAP expression))
Interaction Atlas ID
 LDD3201 
Download The Altas
  
Experiment 2036 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (HT115)
Interaction Atlas ID
 LDD3202 
Download The Altas
  
Experiment 2037 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (HT-1197)
Interaction Atlas ID
 LDD3203 
Download The Altas
  
Experiment 2038 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (HT-1376)
Interaction Atlas ID
 LDD3204 
Download The Altas
  
Experiment 2039 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon cancer [ICD11: 2C82]
Model Name
Human colon cancer cell lysate (HT29)
Interaction Atlas ID
 LDD3205 
Download The Altas
  
Experiment 2040 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (HT-3)
Interaction Atlas ID
 LDD3206 
Download The Altas
  
Experiment 2041 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Liver bile duct carcinoma [ICD11: 2C12]
Model Name
Human liver bile duct carcinoma cell lysate (HuCCT-1)
Interaction Atlas ID
 LDD3207 
Download The Altas
  
Experiment 2042 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (HuH-1)
Interaction Atlas ID
 LDD3208 
Download The Altas
  
Experiment 2043 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (HuH-28)
Interaction Atlas ID
 LDD3209 
Download The Altas
  
Experiment 2044 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (Huh-7)
Interaction Atlas ID
 LDD3210 
Download The Altas
  
Experiment 2045 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (HuP-T3)
Interaction Atlas ID
 LDD3211 
Download The Altas
  
Experiment 2046 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (HuP-T4)
Interaction Atlas ID
 LDD3212 
Download The Altas
  
Experiment 2047 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC10)
Interaction Atlas ID
 LDD3213 
Download The Altas
  
Experiment 2048 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC106)
Interaction Atlas ID
 LDD3214 
Download The Altas
  
Experiment 2049 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC108)
Interaction Atlas ID
 LDD3215 
Download The Altas
  
Experiment 2050 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC11)
Interaction Atlas ID
 LDD3216 
Download The Altas
  
Experiment 2051 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC12)
Interaction Atlas ID
 LDD3217 
Download The Altas
  
Experiment 2052 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC13-7)
Interaction Atlas ID
 LDD3218 
Download The Altas
  
Experiment 2053 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC18)
Interaction Atlas ID
 LDD3219 
Download The Altas
  
Experiment 2054 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC19)
Interaction Atlas ID
 LDD3220 
Download The Altas
  
Experiment 2055 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC20)
Interaction Atlas ID
 LDD3221 
Download The Altas
  
Experiment 2056 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC21)
Interaction Atlas ID
 LDD3222 
Download The Altas
  
Experiment 2057 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC24)
Interaction Atlas ID
 LDD3223 
Download The Altas
  
Experiment 2058 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC26)
Interaction Atlas ID
 LDD3224 
Download The Altas
  
Experiment 2059 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC3)
Interaction Atlas ID
 LDD3225 
Download The Altas
  
Experiment 2060 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC4)
Interaction Atlas ID
 LDD3226 
Download The Altas
  
Experiment 2061 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC8)
Interaction Atlas ID
 LDD3227 
Download The Altas
  
Experiment 2062 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (ICC9)
Interaction Atlas ID
 LDD3228 
Download The Altas
  
Experiment 2063 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (IGR-1)
Interaction Atlas ID
 LDD3229 
Download The Altas
  
Experiment 2064 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (IGR-37)
Interaction Atlas ID
 LDD3230 
Download The Altas
  
Experiment 2065 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (IGR-39)
Interaction Atlas ID
 LDD3231 
Download The Altas
  
Experiment 2066 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (IGROV-1)
Interaction Atlas ID
 LDD3232 
Download The Altas
  
Experiment 2067 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (IM95)
Interaction Atlas ID
 LDD3233 
Download The Altas
  
Experiment 2068 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (IPC-298)
Interaction Atlas ID
 LDD3234 
Download The Altas
  
Experiment 2069 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (Ishikawa (Heraklio) 02 ER-)
Interaction Atlas ID
 LDD3235 
Download The Altas
  
Experiment 2070 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (J82)
Interaction Atlas ID
 LDD3236 
Download The Altas
  
Experiment 2071 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Mantle cell lymphoma [ICD11: 2A85]
Model Name
Human mantle cell lymphoma cell lysate (JeKo-1)
Interaction Atlas ID
 LDD3237 
Download The Altas
  
Experiment 2072 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-1)
Interaction Atlas ID
 LDD3238 
Download The Altas
  
Experiment 2073 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-4)
Interaction Atlas ID
 LDD3239 
Download The Altas
  
Experiment 2074 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD11: 2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-6)
Interaction Atlas ID
 LDD3240 
Download The Altas
  
Experiment 2075 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (JHH-7)
Interaction Atlas ID
 LDD3241 
Download The Altas
  
Experiment 2076 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (JM-1)
Interaction Atlas ID
 LDD3242 
Download The Altas
  
Experiment 2077 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (Jurkat)
Interaction Atlas ID
 LDD3243 
Download The Altas
  
Experiment 2078 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Chronic myelogenous leukemia [ICD11: 2A20]
Model Name
Human chronic myelogenous leukemia cell lysate (JURL-MK1)
Interaction Atlas ID
 LDD3244 
Download The Altas
  
Experiment 2079 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B-cell prolymphocytic leukemia [ICD11: 2A70]
Model Name
Human b-cell prolymphocytic leukemia cell lysate (JVM-3)
Interaction Atlas ID
 LDD3245 
Download The Altas
  
Experiment 2080 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Anaplastic large cell lymphoma [ICD11: 2A90]
Model Name
Human anaplastic large cell lymphoma cell lysate (Karpas-299)
Interaction Atlas ID
 LDD3246 
Download The Altas
  
Experiment 2081 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (Karpas-422)
Interaction Atlas ID
 LDD3247 
Download The Altas
  
Experiment 2082 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Myeloid leukaemia [ICD11: 2B33]
Model Name
Human myeloid leukaemia cell lysate (Kasumi-1)
Interaction Atlas ID
 LDD3248 
Download The Altas
  
Experiment 2083 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (Kasumi-2)
Interaction Atlas ID
 LDD3249 
Download The Altas
  
Experiment 2084 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric signet ring cell adenocarcinoma [ICD11: 2B72]
Model Name
Human gastric signet ring cell adenocarcinoma cell lysate (KATO III)
Interaction Atlas ID
 LDD3250 
Download The Altas
  
Experiment 2085 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (Kelly)
Interaction Atlas ID
 LDD3251 
Download The Altas
  
Experiment 2086 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Liver cancer [ICD11: 2C12]
Model Name
Human liver cancer cell lysate (KMCH-1)
Interaction Atlas ID
 LDD3252 
Download The Altas
  
Experiment 2087 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC-1)
Interaction Atlas ID
 LDD3253 
Download The Altas
  
Experiment 2088 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC-20)
Interaction Atlas ID
 LDD3254 
Download The Altas
  
Experiment 2089 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (KMRC3)
Interaction Atlas ID
 LDD3255 
Download The Altas
  
Experiment 2090 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS11)
Interaction Atlas ID
 LDD3256 
Download The Altas
  
Experiment 2091 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS-12-BM)
Interaction Atlas ID
 LDD3257 
Download The Altas
  
Experiment 2092 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (KMS-27)
Interaction Atlas ID
 LDD3258 
Download The Altas
  
Experiment 2093 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (KNS-42)
Interaction Atlas ID
 LDD3259 
Download The Altas
  
Experiment 2094 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (KNS-81-FD)
Interaction Atlas ID
 LDD3260 
Download The Altas
  
Experiment 2095 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Adult acute myeloid leukemia [ICD11: 2A60]
Model Name
Human adult acute myeloid leukemia cell lysate (K052)
Interaction Atlas ID
 LDD3261 
Download The Altas
  
Experiment 2096 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic cancer [ICD11: 2C10]
Model Name
Human pancreatic cancer cell lysate (KP-4)
Interaction Atlas ID
 LDD3262 
Download The Altas
  
Experiment 2097 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast cancer [ICD11: 2C60-2C65]
Model Name
Human breast cancer cell lysate (KPL-1)
Interaction Atlas ID
 LDD3263 
Download The Altas
  
Experiment 2098 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Adrenal cancer [ICD11: 2D11]
Model Name
Human adrenal gland neuroblastoma cell lysate (KP-N-YN)
Interaction Atlas ID
 LDD3264 
Download The Altas
  
Experiment 2099 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (KU-19-19)
Interaction Atlas ID
 LDD3265 
Download The Altas
  
Experiment 2100 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (KURAMOCHI)
Interaction Atlas ID
 LDD3266 
Download The Altas
  
Experiment 2101 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Embryo
Disease Model
Embryonal rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human embryonal rhabdomyosarcoma cell lysate (KYM-1)
Interaction Atlas ID
 LDD3267 
Download The Altas
  
Experiment 2102 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-150)
Interaction Atlas ID
 LDD3268 
Download The Altas
  
Experiment 2103 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-180)
Interaction Atlas ID
 LDD3269 
Download The Altas
  
Experiment 2104 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-30)
Interaction Atlas ID
 LDD3270 
Download The Altas
  
Experiment 2105 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-410)
Interaction Atlas ID
 LDD3271 
Download The Altas
  
Experiment 2106 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (KYSE-510)
Interaction Atlas ID
 LDD3272 
Download The Altas
  
Experiment 2107 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Hodgkin lymphoma [ICD11: 2B30]
Model Name
Human hodgkin lymphoma cell lysate (L-428)
Interaction Atlas ID
 LDD3273 
Download The Altas
  
Experiment 2108 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (LN-18)
Interaction Atlas ID
 LDD3274 
Download The Altas
  
Experiment 2109 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (LN-229)
Interaction Atlas ID
 LDD3275 
Download The Altas
  
Experiment 2110 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (LNCaP-Clone-FGC)
Interaction Atlas ID
 LDD3276 
Download The Altas
  
Experiment 2111 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Amelanotic melanoma [ICD-11:2C30]
Model Name
Human amelanotic melanoma cell lysate (LOX IMVI)
Interaction Atlas ID
 LDD3277 
Download The Altas
  
Experiment 2112 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (LS-123)
Interaction Atlas ID
 LDD3278 
Download The Altas
  
Experiment 2113 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (LS180)
Interaction Atlas ID
 LDD3279 
Download The Altas
  
Experiment 2114 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Cecum adenocarcinoma [ICD-11:2B90]
Model Name
Human cecum adenocarcinoma cell lysate (LS-513)
Interaction Atlas ID
 LDD3280 
Download The Altas
  
Experiment 2115 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung giant cell carcinoma [ICD11: 2C25]
Model Name
Human lung giant cell carcinoma cell lysate (Lu-65)
Interaction Atlas ID
 LDD3281 
Download The Altas
  
Experiment 2116 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (LUDLU-1)
Interaction Atlas ID
 LDD3282 
Download The Altas
  
Experiment 2117 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian mucinous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian mucinous cystadenocarcinoma cell lysate (MCAS)
Interaction Atlas ID
 LDD3283 
Download The Altas
  
Experiment 2118 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Merkel cell carcinoma [ICD11: 2C34]
Model Name
Human merkel cell carcinoma cell lysate (MCC13)
Interaction Atlas ID
 LDD3284 
Download The Altas
  
Experiment 2119 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Merkel cell carcinoma [ICD11: 2C34]
Model Name
Human merkel cell carcinoma cell lysate (MCC26)
Interaction Atlas ID
 LDD3285 
Download The Altas
  
Experiment 2120 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Invasive breast carcinoma [ICD-11:2C60]
Model Name
Human invasive breast carcinoma cell lysate (MCF-7)
Interaction Atlas ID
 LDD3286 
Download The Altas
  
Experiment 2121 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast carcinoma [ICD-11:2C60]
Model Name
Human breast carcinoma cell lysate (MDA-MB-157)
Interaction Atlas ID
 LDD3287 
Download The Altas
  
Experiment 2122 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-231)
Interaction Atlas ID
 LDD3288 
Download The Altas
  
Experiment 2123 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Ductal carcinoma [ICD11: 2C61]
Model Name
Human ductal carcinoma cell lysate (MDA-MB-436)
Interaction Atlas ID
 LDD3289 
Download The Altas
  
Experiment 2124 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-453)
Interaction Atlas ID
 LDD3290 
Download The Altas
  
Experiment 2125 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Breast adenocarcinoma [ICD-11:2C60]
Model Name
Human breast adenocarcinoma cell lysate (MDA-MB-468)
Interaction Atlas ID
 LDD3291 
Download The Altas
  
Experiment 2126 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (MDST8)
Interaction Atlas ID
 LDD3292 
Download The Altas
  
Experiment 2127 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Chronic lymphocytic leukemia [ICD11: 2A82]
Model Name
Human chronic lymphocytic leukemia cell lysate (MEC-1)
Interaction Atlas ID
 LDD3293 
Download The Altas
  
Experiment 2128 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (CHL1)
Interaction Atlas ID
 LDD3294 
Download The Altas
  
Experiment 2129 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (COLO792)
Interaction Atlas ID
 LDD3295 
Download The Altas
  
Experiment 2130 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (MEL-HO)
Interaction Atlas ID
 LDD3296 
Download The Altas
  
Experiment 2131 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (MEL-JUSO)
Interaction Atlas ID
 LDD3297 
Download The Altas
  
Experiment 2132 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (MeWo)
Interaction Atlas ID
 LDD3298 
Download The Altas
  
Experiment 2133 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (MFE-280)
Interaction Atlas ID
 LDD3299 
Download The Altas
  
Experiment 2134 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (MFE-296)
Interaction Atlas ID
 LDD3300 
Download The Altas
  
Experiment 2135 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial cancer [ICD11: 2C76]
Model Name
Human endometrial cancer cell lysate (MFE-319)
Interaction Atlas ID
 LDD3301 
Download The Altas
  
Experiment 2136 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Normal
Model Name
Human normal cell lysate (MG984)
Interaction Atlas ID
 LDD3302 
Download The Altas
  
Experiment 2137 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG123)
Interaction Atlas ID
 LDD3303 
Download The Altas
  
Experiment 2138 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG23)
Interaction Atlas ID
 LDD3304 
Download The Altas
  
Experiment 2139 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (MGG75)
Interaction Atlas ID
 LDD3305 
Download The Altas
  
Experiment 2140 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (DM93)
Interaction Atlas ID
 LDD3306 
Download The Altas
  
Experiment 2141 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (A101D)
Interaction Atlas ID
 LDD3307 
Download The Altas
  
Experiment 2142 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (A2058)
Interaction Atlas ID
 LDD3308 
Download The Altas
  
Experiment 2143 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (CHL1)
Interaction Atlas ID
 LDD3309 
Download The Altas
  
Experiment 2144 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (COLO792)
Interaction Atlas ID
 LDD3310 
Download The Altas
  
Experiment 2145 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (G361)
Interaction Atlas ID
 LDD3311 
Download The Altas
  
Experiment 2146 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (HMCB)
Interaction Atlas ID
 LDD3312 
Download The Altas
  
Experiment 2147 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (Hs 936.T)
Interaction Atlas ID
 LDD3313 
Download The Altas
  
Experiment 2148 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (IGR37)
Interaction Atlas ID
 LDD3314 
Download The Altas
  
Experiment 2149 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (IGR39)
Interaction Atlas ID
 LDD3315 
Download The Altas
  
Experiment 2150 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEL167)
Interaction Atlas ID
 LDD3316 
Download The Altas
  
Experiment 2151 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEL182)
Interaction Atlas ID
 LDD3317 
Download The Altas
  
Experiment 2152 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MELHO)
Interaction Atlas ID
 LDD3318 
Download The Altas
  
Experiment 2153 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (MEWO)
Interaction Atlas ID
 LDD3319 
Download The Altas
  
Experiment 2154 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (RVH421)
Interaction Atlas ID
 LDD3320 
Download The Altas
  
Experiment 2155 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SH4)
Interaction Atlas ID
 LDD3321 
Download The Altas
  
Experiment 2156 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL2)
Interaction Atlas ID
 LDD3322 
Download The Altas
  
Experiment 2157 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL24)
Interaction Atlas ID
 LDD3323 
Download The Altas
  
Experiment 2158 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (SKMEL3)
Interaction Atlas ID
 LDD3324 
Download The Altas
  
Experiment 2159 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (UACC257)
Interaction Atlas ID
 LDD3325 
Download The Altas
  
Experiment 2160 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (UACC62)
Interaction Atlas ID
 LDD3326 
Download The Altas
  
Experiment 2161 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (WM115)
Interaction Atlas ID
 LDD3327 
Download The Altas
  
Experiment 2162 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (WM266-4 )
Interaction Atlas ID
 LDD3328 
Download The Altas
  
Experiment 2163 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung carcinoma cell lysate (RAW264.7)
Interaction Atlas ID
 LDD3329 
Download The Altas
  
Experiment 2164 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (MIA PaCa-2)
Interaction Atlas ID
 LDD3330 
Download The Altas
  
Experiment 2165 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (MKN-1)
Interaction Atlas ID
 LDD3331 
Download The Altas
  
Experiment 2166 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (MKN45)
Interaction Atlas ID
 LDD3332 
Download The Altas
  
Experiment 2167 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (MOLM-13)
Interaction Atlas ID
 LDD3333 
Download The Altas
  
Experiment 2168 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Adult acute myeloid leukemia [ICD11: 2A60]
Model Name
Human adult acute myeloid leukemia cell lysate (MOLM-16)
Interaction Atlas ID
 LDD3334 
Download The Altas
  
Experiment 2169 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MONO-MAC-6)
Interaction Atlas ID
 LDD3335 
Download The Altas
  
Experiment 2170 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MONO-MAC-6)
Interaction Atlas ID
 LDD3336 
Download The Altas
  
Experiment 2171 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pleural effusion
Disease Model
Pleural biphasic mesothelioma [ICD11: 2C26]
Model Name
Human pleural biphasic mesothelioma cell lysate (MSTO-211H)
Interaction Atlas ID
 LDD3337 
Download The Altas
  
Experiment 2172 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (MV4-11)
Interaction Atlas ID
 LDD3338 
Download The Altas
  
Experiment 2173 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (NALM-6)
Interaction Atlas ID
 LDD3339 
Download The Altas
  
Experiment 2174 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (NB1)
Interaction Atlas ID
 LDD3340 
Download The Altas
  
Experiment 2175 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H1048)
Interaction Atlas ID
 LDD3341 
Download The Altas
  
Experiment 2176 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Lung large cell carcinoma [ICD-11:2C25]
Model Name
Human lung large cell carcinoma cell lysate (NCI-H1155)
Interaction Atlas ID
 LDD3342 
Download The Altas
  
Experiment 2177 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Lung large cell carcinoma [ICD-11:2C25]
Model Name
Human lung large cell carcinoma cell lysate (NCI-H1299)
Interaction Atlas ID
 LDD3343 
Download The Altas
  
Experiment 2178 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H146)
Interaction Atlas ID
 LDD3344 
Download The Altas
  
Experiment 2179 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1650)
Interaction Atlas ID
 LDD3345 
Download The Altas
  
Experiment 2180 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1666)
Interaction Atlas ID
 LDD3346 
Download The Altas
  
Experiment 2181 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H1703)
Interaction Atlas ID
 LDD3347 
Download The Altas
  
Experiment 2182 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1792)
Interaction Atlas ID
 LDD3348 
Download The Altas
  
Experiment 2183 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1793)
Interaction Atlas ID
 LDD3349 
Download The Altas
  
Experiment 2184 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCl-H1944)
Interaction Atlas ID
 LDD3350 
Download The Altas
  
Experiment 2185 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H196)
Interaction Atlas ID
 LDD3351 
Download The Altas
  
Experiment 2186 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H1975)
Interaction Atlas ID
 LDD3352 
Download The Altas
  
Experiment 2187 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pleural effusion
Disease Model
Pleural mesothelioma [ICD11: 2C26]
Model Name
Human pleural mesothelioma cell lysate (NCI-H2052)
Interaction Atlas ID
 LDD3353 
Download The Altas
  
Experiment 2188 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H2122)
Interaction Atlas ID
 LDD3354 
Download The Altas
  
Experiment 2189 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H2170)
Interaction Atlas ID
 LDD3355 
Download The Altas
  
Experiment 2190 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Non-small cell lung cancer [ICD11: 2C25]
Model Name
Human non-small cell lung cancer cell lysate (NCI-H2172)
Interaction Atlas ID
 LDD3356 
Download The Altas
  
Experiment 2191 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung squamous cell carcinoma [ICD-11:2C25]
Model Name
Human lung squamous cell carcinoma cell lysate (NCI-H2286)
Interaction Atlas ID
 LDD3357 
Download The Altas
  
Experiment 2192 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H2291)
Interaction Atlas ID
 LDD3358 
Download The Altas
  
Experiment 2193 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H23)
Interaction Atlas ID
 LDD3359 
Download The Altas
  
Experiment 2194 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (NCI-H3122)
Interaction Atlas ID
 LDD3360 
Download The Altas
  
Experiment 2195 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (NCI-H358)
Interaction Atlas ID
 LDD3361 
Download The Altas
  
Experiment 2196 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H446)
Interaction Atlas ID
 LDD3362 
Download The Altas
  
Experiment 2197 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (NCI-H82)
Interaction Atlas ID
 LDD3363 
Download The Altas
  
Experiment 2198 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric tubular adenocarcinoma [ICD11: 2.00E+92]
Model Name
Human gastric tubular adenocarcinoma cell lysate (NCI-N87)
Interaction Atlas ID
 LDD3364 
Download The Altas
  
Experiment 2199 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-3)
Interaction Atlas ID
 LDD3365 
Download The Altas
  
Experiment 2200 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (NOMO-1)
Interaction Atlas ID
 LDD3366 
Download The Altas
  
Experiment 2201 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (NUGC-3)
Interaction Atlas ID
 LDD3367 
Download The Altas
  
Experiment 2202 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OAW-28)
Interaction Atlas ID
 LDD3368 
Download The Altas
  
Experiment 2203 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OAW-42)
Interaction Atlas ID
 LDD3369 
Download The Altas
  
Experiment 2204 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (OCI-AML-2)
Interaction Atlas ID
 LDD3370 
Download The Altas
  
Experiment 2205 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (OCI-AML-5)
Interaction Atlas ID
 LDD3371 
Download The Altas
  
Experiment 2206 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (OCI-Ly3)
Interaction Atlas ID
 LDD3372 
Download The Altas
  
Experiment 2207 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (OCUG-1)
Interaction Atlas ID
 LDD3373 
Download The Altas
  
Experiment 2208 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric signet ring cell adenocarcinoma [ICD11: 2B72]
Model Name
Human gastric signet ring cell adenocarcinoma cell lysate (OCUM-1)
Interaction Atlas ID
 LDD3374 
Download The Altas
  
Experiment 2209 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Barrett adenocarcinoma [ICD11: 2B70]
Model Name
Human barrett adenocarcinoma cell lysate (OE33)
Interaction Atlas ID
 LDD3375 
Download The Altas
  
Experiment 2210 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
Medulloblastoma [ICD11: 2A00]
Model Name
Human medulloblastoma cell lysate (ONS-76)
Interaction Atlas ID
 LDD3376 
Download The Altas
  
Experiment 2211 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (OPM-2)
Interaction Atlas ID
 LDD3377 
Download The Altas
  
Experiment 2212 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Clear cell renal cell carcinoma [ICD11: 2C90]
Model Name
Human clear cell renal cell carcinoma cell lysate (OS-RC-2)
Interaction Atlas ID
 LDD3378 
Download The Altas
  
Experiment 2213 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OV56)
Interaction Atlas ID
 LDD3379 
Download The Altas
  
Experiment 2214 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OV-90)
Interaction Atlas ID
 LDD3380 
Download The Altas
  
Experiment 2215 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OVCA429)
Interaction Atlas ID
 LDD3381 
Download The Altas
  
Experiment 2216 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (OVCAR-4)
Interaction Atlas ID
 LDD3382 
Download The Altas
  
Experiment 2217 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (OVCAR-5)
Interaction Atlas ID
 LDD3383 
Download The Altas
  
Experiment 2218 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-8)
Interaction Atlas ID
 LDD3384 
Download The Altas
  
Experiment 2219 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (OVISE)
Interaction Atlas ID
 LDD3385 
Download The Altas
  
Experiment 2220 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovary endometrioid adenocarcinoma [ICD11: 2C73]
Model Name
Human ovary endometrioid adenocarcinoma cell lysate (OVK-18)
Interaction Atlas ID
 LDD3386 
Download The Altas
  
Experiment 2221 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
High grade ovarian serous adenocarcinoma [ICD11: 2B5D]
Model Name
Human high grade ovarian serous adenocarcinoma cell lysate (OVKATE)
Interaction Atlas ID
 LDD3387 
Download The Altas
  
Experiment 2222 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (OVTOKO)
Interaction Atlas ID
 LDD3388 
Download The Altas
  
Experiment 2223 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (OZ)
Interaction Atlas ID
 LDD3389 
Download The Altas
  
Experiment 2224 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute myeloid leukemia [ICD-11:2A60]
Model Name
Human acute myeloid leukemia cell lysate (P31-FUJ)
Interaction Atlas ID
 LDD3390 
Download The Altas
  
Experiment 2225 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (Panc 04.03)
Interaction Atlas ID
 LDD3391 
Download The Altas
  
Experiment 2226 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (PANC-1)
Interaction Atlas ID
 LDD3392 
Download The Altas
  
Experiment 2227 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (PaTu 8988t)
Interaction Atlas ID
 LDD3393 
Download The Altas
  
Experiment 2228 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung adenocarcinoma [ICD-11:2C25]
Model Name
Human lung adenocarcinoma cell lysate (PC-14)
Interaction Atlas ID
 LDD3394 
Download The Altas
  
Experiment 2229 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (PC-3)
Interaction Atlas ID
 LDD3395 
Download The Altas
  
Experiment 2230 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian cancer [ICD11: 2C73]
Model Name
Human ovarian cancer cell lysate (PEO1)
Interaction Atlas ID
 LDD3396 
Download The Altas
  
Experiment 2231 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone marrow
Disease Model
T acute lymphoblastic leukemia [ICD-11:2A90]
Model Name
Human T acute lymphoblastic leukemia cell lysate (PF-382)
Interaction Atlas ID
 LDD3397 
Download The Altas
  
Experiment 2232 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Neuroectodermal tumor [ICD11: 2A00]
Model Name
Human neuroectodermal tumor cell lysate (PFSK-1)
Interaction Atlas ID
 LDD3398 
Download The Altas
  
Experiment 2233 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (RBE)
Interaction Atlas ID
 LDD3399 
Download The Altas
  
Experiment 2234 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (RCC10RGB)
Interaction Atlas ID
 LDD3400 
Download The Altas
  
Experiment 2235 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human rhabdomyosarcoma cell lysate (RD)
Interaction Atlas ID
 LDD3401 
Download The Altas
  
Experiment 2236 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Mantle cell lymphoma [ICD11: 2A85]
Model Name
Human mantle cell lymphoma cell lysate (REC-1)
Interaction Atlas ID
 LDD3402 
Download The Altas
  
Experiment 2237 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
B acute lymphoblastic leukemia [ICD11: 2B33]
Model Name
Human b acute lymphoblastic leukemia cell lysate (Reh)
Interaction Atlas ID
 LDD3403 
Download The Altas
  
Experiment 2238 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Alveolar rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human alveolar rhabdomyosarcoma cell lysate (SJRH30)
Interaction Atlas ID
 LDD3404 
Download The Altas
  
Experiment 2239 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Alveolar rhabdomyosarcoma [ICD11: 2B55]
Model Name
Human alveolar rhabdomyosarcoma cell lysate (Rh41)
Interaction Atlas ID
 LDD3405 
Download The Altas
  
Experiment 2240 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian leiomyosarcoma [ICD11: 2C73]
Model Name
Human ovarian leiomyosarcoma cell lysate (RKN)
Interaction Atlas ID
 LDD3406 
Download The Altas
  
Experiment 2241 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon carcinoma [ICD-11:2B90]
Model Name
Human colon carcinoma cell lysate (RKO)
Interaction Atlas ID
 LDD3407 
Download The Altas
  
Experiment 2242 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (RL)
Interaction Atlas ID
 LDD3408 
Download The Altas
  
Experiment 2243 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial cancer [ICD11: 2C76]
Model Name
Human endometrial cancer cell lysate (RL95-2)
Interaction Atlas ID
 LDD3409 
Download The Altas
  
Experiment 2244 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD11: 2C30]
Model Name
Human melanoma cell lysate (RPMI-7951)
Interaction Atlas ID
 LDD3410 
Download The Altas
  
Experiment 2245 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (RPMI-8226)
Interaction Atlas ID
 LDD3411 
Download The Altas
  
Experiment 2246 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (RT-112)
Interaction Atlas ID
 LDD3412 
Download The Altas
  
Experiment 2247 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (RVH-421)
Interaction Atlas ID
 LDD3413 
Download The Altas
  
Experiment 2248 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (SAOS-2)
Interaction Atlas ID
 LDD3414 
Download The Altas
  
Experiment 2249 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SBC-5)
Interaction Atlas ID
 LDD3415 
Download The Altas
  
Experiment 2250 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Squamous carcinoma [ICD11: 2B6A]
Model Name
Human squamous carcinoma cell lysate (SCC-25)
Interaction Atlas ID
 LDD3416 
Download The Altas
  
Experiment 2251 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (SF-295)
Interaction Atlas ID
 LDD3417 
Download The Altas
  
Experiment 2252 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (SG231)
Interaction Atlas ID
 LDD3418 
Download The Altas
  
Experiment 2253 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SH-4)
Interaction Atlas ID
 LDD3419 
Download The Altas
  
Experiment 2254 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SHP-77)
Interaction Atlas ID
 LDD3420 
Download The Altas
  
Experiment 2255 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (SiSo)
Interaction Atlas ID
 LDD3421 
Download The Altas
  
Experiment 2256 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (SJSA-1)
Interaction Atlas ID
 LDD3422 
Download The Altas
  
Experiment 2257 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Ewing sarcoma [ICD11: 2B52]
Model Name
Human ewing sarcoma cell lysate (SK-ES1)
Interaction Atlas ID
 LDD3423 
Download The Altas
  
Experiment 2258 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatoma [ICD11: 2C12]
Model Name
Human hepatoma cell lysate (SK-HEP1)
Interaction Atlas ID
 LDD3424 
Download The Altas
  
Experiment 2259 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL-2)
Interaction Atlas ID
 LDD3425 
Download The Altas
  
Experiment 2260 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL-24)
Interaction Atlas ID
 LDD3426 
Download The Altas
  
Experiment 2261 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-28)
Interaction Atlas ID
 LDD3427 
Download The Altas
  
Experiment 2262 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (SK-MEL3)
Interaction Atlas ID
 LDD3428 
Download The Altas
  
Experiment 2263 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-30)
Interaction Atlas ID
 LDD3429 
Download The Altas
  
Experiment 2264 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (SK-MEL-5)
Interaction Atlas ID
 LDD3430 
Download The Altas
  
Experiment 2265 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Plasma cell myeloma [ICD-11:2A83]
Model Name
Human plasma cell myeloma cell lysate (SK-MM-2)
Interaction Atlas ID
 LDD3431 
Download The Altas
  
Experiment 2266 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Uterine corpus leiomyosarcoma [ICD11: 2.00E+86]
Model Name
Human uterine corpus leiomyosarcoma cell lysate (SKN)
Interaction Atlas ID
 LDD3432 
Download The Altas
  
Experiment 2267 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Adrenal
Disease Model
Neuroblastoma [ICD-11:2D50]
Model Name
Human neuroblastoma cell lysate (SK-N-AS)
Interaction Atlas ID
 LDD3433 
Download The Altas
  
Experiment 2268 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Neuroepithelioma [ICD11: 2A00]
Model Name
Human neuroepithelioma cell lysate (SK-N-MC)
Interaction Atlas ID
 LDD3434 
Download The Altas
  
Experiment 2269 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (SK-OV-3)
Interaction Atlas ID
 LDD3435 
Download The Altas
  
Experiment 2270 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Endometrium
Disease Model
Endometrial adenocarcinoma [ICD-11:2C76]
Model Name
Human endometrial adenocarcinoma cell lysate (SNG-M)
Interaction Atlas ID
 LDD3436 
Download The Altas
  
Experiment 2271 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (SNU-1)
Interaction Atlas ID
 LDD3437 
Download The Altas
  
Experiment 2272 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (SNU-1079)
Interaction Atlas ID
 LDD3438 
Download The Altas
  
Experiment 2273 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hilar cholangiocarcinoma [ICD11: 2C18]
Model Name
Human hilar cholangiocarcinoma cell lysate (SNU-1196)
Interaction Atlas ID
 LDD3439 
Download The Altas
  
Experiment 2274 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (SNU-245)
Interaction Atlas ID
 LDD3440 
Download The Altas
  
Experiment 2275 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (SNU-308)
Interaction Atlas ID
 LDD3441 
Download The Altas
  
Experiment 2276 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (SNU-423)
Interaction Atlas ID
 LDD3442 
Download The Altas
  
Experiment 2277 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Hepatocellular carcinoma [ICD-11:2C12]
Model Name
Human hepatocellular carcinoma cell lysate (SNU-449)
Interaction Atlas ID
 LDD3443 
Download The Altas
  
Experiment 2278 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenocarcinoma cell lysate (SNU-478)
Interaction Atlas ID
 LDD3444 
Download The Altas
  
Experiment 2279 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gastric cancer [ICD11: 2B72]
Model Name
Human gastric cancer cell lysate (SNU-5)
Interaction Atlas ID
 LDD3445 
Download The Altas
  
Experiment 2280 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenocarcinoma cell lysate (SNU-869)
Interaction Atlas ID
 LDD3446 
Download The Altas
  
Experiment 2281 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (SSP-25)
Interaction Atlas ID
 LDD3447 
Download The Altas
  
Experiment 2282 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (SU-DHL-4)
Interaction Atlas ID
 LDD3448 
Download The Altas
  
Experiment 2283 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
Diffuse large B-cell lymphoma [ICD11: 2A81]
Model Name
Human diffuse large B-cell lymphoma cell lysate (SU-DHL-6)
Interaction Atlas ID
 LDD3449 
Download The Altas
  
Experiment 2284 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic ductal adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic ductal adenocarcinoma cell lysate (SUIT-2)
Interaction Atlas ID
 LDD3450 
Download The Altas
  
Experiment 2285 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lymph node
Disease Model
T acute lymphoblastic leukemia [ICD11: 2A90]
Model Name
Human T lymphoblastic lymphoma cell lysate (SUP-T1)
Interaction Atlas ID
 LDD3451 
Download The Altas
  
Experiment 2286 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW1116)
Interaction Atlas ID
 LDD3452 
Download The Altas
  
Experiment 2287 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Small cell lung cancer [ICD11: 2C25]
Model Name
Human small cell lung cancer cell lysate (SW1271)
Interaction Atlas ID
 LDD3453 
Download The Altas
  
Experiment 2288 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Lung
Disease Model
Lung cancer [ICD11: 2C25]
Model Name
Human lung cancer cell lysate (SW1573)
Interaction Atlas ID
 LDD3454 
Download The Altas
  
Experiment 2289 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Anaplastic astrocytoma [ICD11: 2A00]
Model Name
Human anaplastic astrocytoma cell lysate (SW1783)
Interaction Atlas ID
 LDD3455 
Download The Altas
  
Experiment 2290 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Pancreas
Disease Model
Pancreatic adenocarcinoma [ICD-11:2C10]
Model Name
Human pancreatic adenocarcinoma cell lysate (SW1990)
Interaction Atlas ID
 LDD3456 
Download The Altas
  
Experiment 2291 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW403)
Interaction Atlas ID
 LDD3457 
Download The Altas
  
Experiment 2292 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW620)
Interaction Atlas ID
 LDD3458 
Download The Altas
  
Experiment 2293 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Cervical cancer [ICD11: 2C77]
Model Name
Human cervical cancer cell lysate (SW756)
Interaction Atlas ID
 LDD3459 
Download The Altas
  
Experiment 2294 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Rectal cancer [ICD11: 2B92]
Model Name
Human rectal cancer cell lysate (SW837)
Interaction Atlas ID
 LDD3460 
Download The Altas
  
Experiment 2295 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Colon
Disease Model
Colon adenocarcinoma [ICD-11:2B90]
Model Name
Human colon adenocarcinoma cell lysate (SW948)
Interaction Atlas ID
 LDD3461 
Download The Altas
  
Experiment 2296 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (T24)
Interaction Atlas ID
 LDD3462 
Download The Altas
  
Experiment 2297 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (T98G)
Interaction Atlas ID
 LDD3463 
Download The Altas
  
Experiment 2298 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bone
Disease Model
Ewing sarcoma [ICD11: 2B52]
Model Name
Human ewing sarcoma cell lysate (TC-71)
Interaction Atlas ID
 LDD3464 
Download The Altas
  
Experiment 2299 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (TCCSUP)
Interaction Atlas ID
 LDD3465 
Download The Altas
  
Experiment 2300 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TF-1)
Interaction Atlas ID
 LDD3466 
Download The Altas
  
Experiment 2301 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-10)
Interaction Atlas ID
 LDD3467 
Download The Altas
  
Experiment 2302 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-11)
Interaction Atlas ID
 LDD3468 
Download The Altas
  
Experiment 2303 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE4)
Interaction Atlas ID
 LDD3469 
Download The Altas
  
Experiment 2304 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Oral
Disease Model
Esophageal squamous cell carcinoma [ICD11: 2B71]
Model Name
Human esophageal squamous cell carcinoma cell lysate (TE-8)
Interaction Atlas ID
 LDD3470 
Download The Altas
  
Experiment 2305 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Erythroleukemia [ICD11: 2A60]
Model Name
Human erythroleukemia cell lysate (TF-1)
Interaction Atlas ID
 LDD3471 
Download The Altas
  
Experiment 2306 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (TFK-1)
Interaction Atlas ID
 LDD3472 
Download The Altas
  
Experiment 2307 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Stomach
Disease Model
Gallbladder cancer [ICD11: 2C13]
Model Name
Human gallbladder cancer cell lysate (TGBC1TKB)
Interaction Atlas ID
 LDD3473 
Download The Altas
  
Experiment 2308 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Ampulla of vater adenocarcinoma [ICD11: 2C16]
Model Name
Human ampulla of Vater adenosquamous carcinoma cell lysate (TGBC52TKB)
Interaction Atlas ID
 LDD3474 
Download The Altas
  
Experiment 2309 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (THP-1)
Interaction Atlas ID
 LDD3475 
Download The Altas
  
Experiment 2310 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Intrahepatic cholangiocarcinoma [ICD11: 2C12]
Model Name
Human intrahepatic cholangiocarcinoma cell lysate (TKKK)
Interaction Atlas ID
 LDD3476 
Download The Altas
  
Experiment 2311 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian clear cell adenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian clear cell adenocarcinoma cell lysate (TOV-21G)
Interaction Atlas ID
 LDD3477 
Download The Altas
  
Experiment 2312 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Ovarian serous cystadenocarcinoma [ICD11: 2C73]
Model Name
Human ovarian serous cystadenocarcinoma cell lysate (TYK-nu)
Interaction Atlas ID
 LDD3478 
Download The Altas
  
Experiment 2313 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Astrocytoma [ICD-11:2F36]
Model Name
Human astrocytoma cell lysate (U-118-MG)
Interaction Atlas ID
 LDD3479 
Download The Altas
  
Experiment 2314 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Osteosarcoma [ICD-11:2B51]
Model Name
Human osteosarcoma cell lysate (U2OS)
Interaction Atlas ID
 LDD3480 
Download The Altas
  
Experiment 2315 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Brain
Disease Model
Glioblastoma [ICD11: 2A00]
Model Name
Human glioblastoma cell lysate (U-87MG)
Interaction Atlas ID
 LDD3481 
Download The Altas
  
Experiment 2316 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Peripheral blood
Disease Model
Acute monocytic leukemia [ICD-11:2A60]
Model Name
Human acute monocytic leukemia cell lysate (U-937)
Interaction Atlas ID
 LDD3482 
Download The Altas
  
Experiment 2317 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (UACC-257)
Interaction Atlas ID
 LDD3483 
Download The Altas
  
Experiment 2318 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (UACC-62)
Interaction Atlas ID
 LDD3484 
Download The Altas
  
Experiment 2319 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Bladder
Disease Model
Bladder cancer [ICD11: 2C94]
Model Name
Human bladder cancer cell lysate (UM-UC-3)
Interaction Atlas ID
 LDD3485 
Download The Altas
  
Experiment 2320 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Prostate
Disease Model
Prostate carcinoma [ICD-11:2C82]
Model Name
Human prostate carcinoma cell lysate (VCaP)
Interaction Atlas ID
 LDD3486 
Download The Altas
  
Experiment 2321 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Kidney
Disease Model
Renal cell carcinoma [ICD11: 2C90]
Model Name
Human renal cell carcinoma cell lysate (VMRC-RCW)
Interaction Atlas ID
 LDD3487 
Download The Altas
  
Experiment 2322 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (WM-115)
Interaction Atlas ID
 LDD3488 
Download The Altas
  
Experiment 2323 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (WM1552C)
Interaction Atlas ID
 LDD3489 
Download The Altas
  
Experiment 2324 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Melanoma [ICD-11:2C82]
Model Name
Human melanoma cell lysate (WM 266-4)
Interaction Atlas ID
 LDD3490 
Download The Altas
  
Experiment 2325 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Skin
Disease Model
Cutaneous melanoma [ICD-11:2B00]
Model Name
Human cutaneous melanoma cell lysate (WM793)
Interaction Atlas ID
 LDD3491 
Download The Altas
  
Experiment 2326 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Liver
Disease Model
Cholangiocarcinoma [ICD11: 2C12]
Model Name
Human cholangiocarcinoma cell lysate (YSCCC)
Interaction Atlas ID
 LDD3492 
Download The Altas
  
Experiment 2327 Reporting the Labelling Profiles of This Probe
REF [2]
Probe concentration
1 mM
Quantitative Method
TMT
Experiment Method
ISO-TOP ABPP
Competitor Name
KB05
 Competitor Info 
Competitor Concentration
500 uM
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Breast
Disease Model
Invasive breast carcinoma [ICD-11:2C60]
Model Name
Human invasive breast carcinoma cell lysate (ZR-75-1)
Interaction Atlas ID
 LDD3493 
Download The Altas
Qualitation: Labeling site identification
  
Experiment 1 Reporting the Labelling Profiles of This Probe
REF [5]
Probe concentration
100 uM
Quantitative Method
Isotope tag
In Vitro Experiment Model
Model Type
Cell lysate
Derived Tissue
Cervix uteri
Disease Model
Endocervical adenocarcinoma [ICD-11:2C77]
Model Name
Human endocervical adenocarcinoma cell lysate (HeLa)
Note
Mitosis vs Asynch
Interaction Atlas ID
 LDD2236 
Download The Altas

References

1 Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May;39(5):630-641. doi: 10.1038/s41587-020-00778-3. Epub 2021 Jan 4.
2 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
3 Covalent Inhibition by a Natural Product-Inspired Latent Electrophile. J Am Chem Soc. 2023 May 24;145(20):11097-11109. doi: 10.1021/jacs.3c00598. Epub 2023 May 15.
4 Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input. Cell Chem Biol. 2024 Mar 21;31(3):565-576.e4. doi: 10.1016/j.chembiol.2023.11.015. Epub 2023 Dec 19.
Mass spectrometry data entry: PXD044402
5 Global profiling of phosphorylation-dependent changes in cysteine reactivity. Nat Methods. 2022 Mar;19(3):341-352. doi: 10.1038/s41592-022-01398-2. Epub 2022 Feb 28.
Mass spectrometry data entry: PXD026730